Citrus Sinensis ID: 002688
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 892 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.954 | 0.956 | 0.534 | 0.0 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.965 | 0.982 | 0.518 | 0.0 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.963 | 0.985 | 0.502 | 0.0 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.933 | 0.945 | 0.501 | 0.0 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.974 | 0.966 | 0.503 | 0.0 | |
| C0LGG3 | 885 | Probable LRR receptor-lik | no | no | 0.970 | 0.978 | 0.490 | 0.0 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.933 | 0.949 | 0.493 | 0.0 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.955 | 0.978 | 0.475 | 0.0 | |
| C0LGD9 | 871 | Probable LRR receptor-lik | no | no | 0.941 | 0.964 | 0.490 | 0.0 | |
| O81069 | 884 | Probable leucine-rich rep | no | no | 0.979 | 0.988 | 0.482 | 0.0 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 892 bits (2304), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/881 (53%), Positives = 603/881 (68%), Gaps = 30/881 (3%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGL-PKDSSYTETSTKLRYTSDANYIE 59
M+ F L + F + V AQ+QAGFISLDCGL PK+++YTE ST + Y SD +YI+
Sbjct: 1 MKSLHWFLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYID 60
Query: 60 TGLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNL 119
+GL I Y+ QQQVW++RSFP G RNCY NLT N KYLIR TF+YGNYD N
Sbjct: 61 SGLVGKINDAYKTQFQQQVWAVRSFPVGQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQF 120
Query: 120 PEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLD 179
P FD+H+GPN W ++KI V+ EIIHV+ D L VC+V T TPFIS+LE+RPL+
Sbjct: 121 PSFDLHIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLN 180
Query: 180 NNTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGS 239
N +Y+TQ+ SL L R+ S+S++ RY +D +DRVW + DE ST +D S
Sbjct: 181 NESYLTQSGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDETVWISTDLPIDT--S 238
Query: 240 KNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITR 299
++ P MK+A P NAS + T+Q YVYMHFAE++ L ANE+R FNIT
Sbjct: 239 NSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFNITY 298
Query: 300 NGNL-WYGPLKLNYLSSTTVFSQSAMSG--GQYNFSLIKTGNSTHPPIINAIEIYEVKEF 356
NG L W+ L+ LS +T+F+ A+S G +NF+ TGNST PP++NA+EIY V +
Sbjct: 299 NGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYTVVDI 358
Query: 357 SQSQTDEQDVDAIMNIKSFYGLKK--NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNL 414
Q +T++ +V A+MNIK YGL K +WQGDPCAPQ Y WEGLNCSYPD + RI SLNL
Sbjct: 359 LQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNL 418
Query: 415 SASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN---KLTGPL 471
+ SELTG ++ LT+LT LDLSNN+L+G +P F +++ SLK +NL+ N LT +
Sbjct: 419 NGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTA-I 477
Query: 472 PVELLEKQENNTLELRFDGNPDLCRSASCKKEKKKF-VVPVVASVASVFVVLAALIGLWS 530
P L ++ + +L L N L + KKE KK +V + ASVA VF +L L +
Sbjct: 478 PDSLQQRVNSKSLTLILGENLTL----TPKKESKKVPMVAIAASVAGVFALLVILAIFFV 533
Query: 531 LKRKK----QLPDPQILIWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFE 586
+KRK + P P L+ + V + S S+ R+ TY EVL+MTNNFE
Sbjct: 534 IKRKNVKAHKSPGPPPLV------TPGIVKSETRSSNPSIITRERKITYPEVLKMTNNFE 587
Query: 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD 646
RVLGKGGFGTVYHG LD EVAVKMLS SS+QGYK+F+AEV+LLLRVHHR+L LVGYCD
Sbjct: 588 RVLGKGGFGTVYHGNLDGAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCD 647
Query: 647 EGTNMALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHR 705
+G N+ALIYEYMANG+L E++S +L WE R++IAVEAA GLEYLH GC+PP+VHR
Sbjct: 648 DGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHR 707
Query: 706 DVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSD 765
DVK+TNIL+NE+ AKLADFGLSR FP++G HVST +AGTPGYLDPEYY +N L+EKSD
Sbjct: 708 DVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSD 767
Query: 766 VYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVW 825
VYSFGVVLLEI+T PVI K+ E H+ WV ML KGDI+S VDP+L GD+D N W
Sbjct: 768 VYSFGVVLLEIVTNQPVIDKTRE--RPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAW 825
Query: 826 KAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKES 866
K VE+A+ACV+ ++NRRP M VVMELNDC+A+E A+++ S
Sbjct: 826 KIVELALACVNPSSNRRPTMAHVVMELNDCVALENARRQGS 866
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 877 bits (2266), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/901 (51%), Positives = 609/901 (67%), Gaps = 40/901 (4%)
Query: 6 RFALLCLCIFHLAALVCAQDQAGFISLDCGL-PKDSSYTETSTKLRYTSDANYIETGLPK 64
RF + +F + LV AQDQ+GFISLDCGL P + +Y E ST + Y SDA YI++G+P
Sbjct: 2 RFLSFLIFVFAVLGLVQAQDQSGFISLDCGLVPTEITYVEKSTNITYRSDATYIDSGVPG 61
Query: 65 SILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPEFDV 124
I YR QQQ+W+LRSFP+G RNCY F+LT KYLIR TF+YGNYD N LP FD+
Sbjct: 62 KINEVYRTQFQQQIWALRSFPEGQRNCYNFSLTAKRKYLIRGTFIYGNYDGLNQLPSFDL 121
Query: 125 HLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTYI 184
++GPN W ++ I V E+IHVL D+L +C+V T + TPFIS+LELRPL+NNTY+
Sbjct: 122 YIGPNKWTSVSIPGVRNGSVSEMIHVLRQDHLQICLVKTGETTPFISSLELRPLNNNTYV 181
Query: 185 TQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKNFKP 244
T++ SL + RL T RY +D +DR+W P+ LD ++E + D S +
Sbjct: 182 TKSGSLIVVARLYFSPTP-PFLRYDEDVHDRIWIPF-LDNKNSLLSTE-LSVDTSNFYNV 238
Query: 245 PPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNGNL- 303
P K+A P+NA+ L + + D TSQ Y+YMHFAEIE L+ANE+R FNIT NG
Sbjct: 239 PQTVAKTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLEANETREFNITYNGGEN 298
Query: 304 WYGPLKLNYLSSTTVFSQSAMSG--GQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQT 361
W+ + TTV++ +A+S G +NF+ TGNSTHPP+IN +EIY+V E Q T
Sbjct: 299 WFSYFRPPKFRITTVYNPAAVSSLDGNFNFTFSMTGNSTHPPLINGLEIYQVLELPQLDT 358
Query: 362 DEQDVDAIMNIKSFYGLKK--NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASEL 419
+ +V A+MNIK+ YGL K +WQGDPCAP+ Y WEGLNCSYP+ P+I SLNLS S L
Sbjct: 359 YQDEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLNCSYPNFAPPQIISLNLSGSNL 418
Query: 420 TGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK-LTGPLPVELLEK 478
+G ++ LT L LDLSNN+L+G +P S + +L +NL+ NK L +P L ++
Sbjct: 419 SGTITSDISKLTHLRELDLSNNDLSGDIPFVFSDMKNLTLINLSGNKNLNRSVPETLQKR 478
Query: 479 QENNTLELRFDGNPDLCRSASCKKEKKKFVVPVVASVASVFVVLAALIGLWSLKRKKQLP 538
+N +L L R + K VV + ASVASVF VL L ++ + RKKQ
Sbjct: 479 IDNKSLT--------LIRDETGKNSTN--VVAIAASVASVFAVLVILAIVFVVIRKKQRT 528
Query: 539 DPQILIWLVRLSSGRK------VDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKG 592
+ +SG + V ++ S S+ R+FTYSEVL+MT NFERVLGKG
Sbjct: 529 NE---------ASGPRSFTTGTVKSDARSSSSSIITKERKFTYSEVLKMTKNFERVLGKG 579
Query: 593 GFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMA 652
GFGTVYHG LD+ +VAVKMLS SS+QGYK+F+AEV+LLLRVHHR+L LVGYCD+G N+A
Sbjct: 580 GFGTVYHGNLDDTQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLA 639
Query: 653 LIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTN 711
LIYEYM G+L E++S S +L+WE R++IAVEAA GLEYLH GC+PP+VHRDVK TN
Sbjct: 640 LIYEYMEKGDLRENMSGKHSVNVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTN 699
Query: 712 ILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGV 771
IL+NE+ QAKLADFGLSR FPV+G +HV T +AGTPGYLDPEYY +N L+EKSDVYSFGV
Sbjct: 700 ILLNERSQAKLADFGLSRSFPVDGESHVMTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGV 759
Query: 772 VLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIA 831
VLLEI+T PV++K+ E H+ +WV ML GDI+S VDP+L D+D N VWK VE+A
Sbjct: 760 VLLEIVTNQPVMNKNRE--RPHINEWVMFMLTNGDIKSIVDPKLNEDYDTNGVWKVVELA 817
Query: 832 MACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNLHTELSPLA 891
+ACV+ +++RRP M VVMELN+CLA+E +K+ S T S E + + ++ SPLA
Sbjct: 818 LACVNPSSSRRPTMPHVVMELNECLALEIERKQGS-QATYIKESVEF-SPSSASDFSPLA 875
Query: 892 R 892
R
Sbjct: 876 R 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 868 bits (2243), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/905 (50%), Positives = 609/905 (67%), Gaps = 46/905 (5%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGL-PKDSSYTETSTKLRYTSDANYIE 59
M+ F L + + + V AQDQ GFISLDCGL PK+++YTE +T + Y SDANYI+
Sbjct: 1 MKSIHGFLLFLITAYVILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYID 60
Query: 60 TGLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNL 119
+GL I +Y+ QQQ W++RSFP+G RNCY FNLT ++YLIRATF YGNYD +
Sbjct: 61 SGLVGRISAEYKAQLQQQTWTVRSFPEGERNCYNFNLTAKSRYLIRATFTYGNYDGLRQV 120
Query: 120 PEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLD 179
P+FD+H+GP+ W ++K++ V +E+IHVL+ D L +C+V T KG PFIS+LELRPL+
Sbjct: 121 PKFDIHIGPSKWTSVKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLN 180
Query: 180 NNTYITQTDSLELSIRLDVGSTSNATF-RYIDDAYDRVWWPYDLDEWEPFSTSEAVDADG 238
NNTY+TQ+ SL R+ +T TF RY +D +DRVW + + ST VD
Sbjct: 181 NNTYLTQSGSLIGFARVFFSAT--PTFIRYDEDIHDRVWVRQFGNGLKSISTDLLVDT-- 236
Query: 239 SKNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNIT 298
S + P K+A P NAS L F + TSQ YVYMHFAEI+ LK N+ R FNIT
Sbjct: 237 SNPYDVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNIT 296
Query: 299 RNGNL-WYGPLKLNYLSSTTVFSQSAMSG--GQYNFSLIKTGNSTHPPIINAIEIYEVKE 355
NG Y L+ +T+F +S G ++ S KTGNST PP+IN +EIY+V +
Sbjct: 297 YNGGQNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGLEIYKVLD 356
Query: 356 FSQSQTDEQDVDAIMNIKSFYGLKK--NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLN 413
+ +TD+ +V A++NIK+ Y L K +WQGDPCAP+ Y WEGLNCSYP+ D PRI SLN
Sbjct: 357 LLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSDQPRIISLN 416
Query: 414 LSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN-KLTGPLP 472
L+ ++LTG ++ LT L LDLS N+L+G +P+F + + LK +NL+ N L +P
Sbjct: 417 LAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINLSGNLGLNSTIP 476
Query: 473 VELLEKQENNTLELRFDGNPDLCRSASCKKEKKKF-VVPVVASVASVFVVLAALIGLWSL 531
+ ++ ++ +L L + + ++ + K + KK ++P+VASVA VF +L L + +
Sbjct: 477 DSIQQRLDSKSLILIL--SKTVTKTVTLKGKSKKVPMIPIVASVAGVFALLVILAIFFVV 534
Query: 532 KRKKQLPDPQILIWLVRLSSGRKVDANCNRSYE-SLDLSSRQFTYSEVLRMTNNFERVLG 590
+RK + N+ S+ R+ TY EVL+MTNNFERVLG
Sbjct: 535 RRK---------------------NGESNKGTNPSIITKERRITYPEVLKMTNNFERVLG 573
Query: 591 KGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTN 650
KGGFGTVYHG L++ +VAVKMLS SS+QGYK+F+AEV+LLLRVHHRNL LVGYCD+G N
Sbjct: 574 KGGFGTVYHGNLEDTQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRNLVGLVGYCDDGDN 633
Query: 651 MALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKS 709
+ALIYEYMANG+L+E++S +L WE R++IAVEAA GLEYLH GC PP+VHRDVK+
Sbjct: 634 LALIYEYMANGDLKENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKT 693
Query: 710 TNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSF 769
TNIL+NE++ AKLADFGLSR FPV+G +HVST +AGTPGYLDPEYY +N L+EKSDVYSF
Sbjct: 694 TNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSF 753
Query: 770 GVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVE 829
GVVLLEI+T PV K+ E TH+ +WV SML KGDI+S +DP+L GD+D N WK VE
Sbjct: 754 GVVLLEIVTNQPVTDKTRE--RTHINEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVE 811
Query: 830 IAMACVSSNANRRPFMNQVVMELNDCLAMEAA--QKKESITTTDSNNSFEMITVNLHTEL 887
+A+ACV+ ++NRRP M VV ELN+C+A+E A Q +E + T+ + + + +E
Sbjct: 812 LALACVNPSSNRRPTMAHVVTELNECVALENARRQGREEMHTS----GYVDFSRSSASEF 867
Query: 888 SPLAR 892
SP AR
Sbjct: 868 SPGAR 872
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 847 bits (2187), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/866 (50%), Positives = 582/866 (67%), Gaps = 33/866 (3%)
Query: 9 LLCLCIFHL-AALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIETGLPKSIL 67
++ C F + LV AQDQ+GF+S+DCG+P+DSSY + +T ++Y SDA ++E+G SI
Sbjct: 10 IIFACFFAVFVLLVRAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIHSID 69
Query: 68 LQYRRMK-QQQVWSLRSFPDGIRNCYRFN--LTRNTKYLIRATFMYGNYDEQNNLPEFDV 124
+++ ++Q ++RSFP+G RNCY + KYLIR FMYGNYD P+FD+
Sbjct: 70 PEFQTSSLEKQFQNVRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDL 129
Query: 125 HLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTYI 184
+LG N+W ++ I+N + + EIIH L SD++ VC+V+ N+GTPF+SALE+R L +NTY
Sbjct: 130 YLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKSNTYE 189
Query: 185 TQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKNFKP 244
T DSL L R D+G RY DD +DR+W P ++ F+ S +D++ ++ F+P
Sbjct: 190 TPYDSLILFKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFNASLTIDSNNNEGFQP 249
Query: 245 PPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRN-GNL 303
M +A P + S + FS DPT + +VYMHFAE+ EL +NE+R F + N +
Sbjct: 250 ARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKVLLNEKEI 309
Query: 304 WYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQTDE 363
YL + T+F Q+ +SG + F L +T ST PPIINAIE Y V EF QS TD+
Sbjct: 310 NMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQSPTDQ 369
Query: 364 QDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGF 423
QDVDAIM IKS YG+KK+W GDPCAP Y W+ +NCSY D++SPRI S+NLS+S LTG
Sbjct: 370 QDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGLTGEI 429
Query: 424 AHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483
+NLT+L LDLSNN+LTG +P FL L +L LNL NKL+G +PV+LLE+
Sbjct: 430 DAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKL 489
Query: 484 LELRFDGNPDLCRSASC-----KKEKKKFVVPVVASVASVFVVLAALIGLWSLKRKKQLP 538
+ LR DGNPDLC SASC K +K +++P+VASV V ++ A I L+ L +K+
Sbjct: 490 ILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLA-IALFLLYKKRH-- 546
Query: 539 DPQILIWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVY 598
R V A LD + R + YSEV+++TNNFERVLG+GGFG VY
Sbjct: 547 ---------RRGGSGGVRAG------PLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVY 591
Query: 599 HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658
HG L++D+VAVK+LS SS+QGYK+F+AEV+LLLRVHH+NLT L+GYC EG MALIYE+M
Sbjct: 592 HGVLNDDQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFM 651
Query: 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF 718
ANG L ++LS +L+WEERL+I+++AA GLEYLH GCKPPIV RDVK NILINEK
Sbjct: 652 ANGTLGDYLSGEKSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKL 711
Query: 719 QAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
QAK+ADFGLSR ++G +T +AGT GYLDPEY+++ +L+EKSD+YSFGVVLLE+++
Sbjct: 712 QAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVS 771
Query: 779 GHPVISKS---AENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACV 835
G PVI++S AEN H+ V ML GDIR VDP+L FD S WK E+AMAC
Sbjct: 772 GQPVIARSRTTAEN--IHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACA 829
Query: 836 SSNANRRPFMNQVVMELNDCLAMEAA 861
SS++ RP M+ VV EL + ++ A
Sbjct: 830 SSSSKNRPTMSHVVAELKESVSRARA 855
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 826 bits (2133), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/904 (50%), Positives = 600/904 (66%), Gaps = 35/904 (3%)
Query: 8 ALLCLCIFHLAALVCAQDQAGFISLDCG-LPKDSSYTETSTKLRYTSDANYIETGLPKSI 66
AL+ + + L LV AQDQ GFISLDCG LP + Y + ST L Y++D ++++G I
Sbjct: 12 ALIFISFYALLHLVEAQDQKGFISLDCGSLPNEPPYNDPSTGLTYSTDDGFVQSGKTGRI 71
Query: 67 LLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPEFDVHL 126
+ + + LR FPDG RNCY N+T++T YLI+A F+YGNYD NN P FD++L
Sbjct: 72 QKAFESIFSKPSLKLRYFPDGFRNCYTLNVTQDTNYLIKAVFVYGNYDGLNNPPSFDLYL 131
Query: 127 GPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTYITQ 186
GPNLW T+ + + EIIH S L VC+V T +P I+ LELRPL NNTY TQ
Sbjct: 132 GPNLWVTVDMNGRTNGTIQEIIHKTISKSLQVCLVKTGTSSPMINTLELRPLKNNTYNTQ 191
Query: 187 TDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPY-DLDEWEPFSTSEAVDADGSKNFKPP 245
+ SL+ R S S RY DD DR W+P+ D EW +T+ ++ + S + PP
Sbjct: 192 SGSLKYFFRYYF-SGSGQNIRYPDDVNDRKWYPFFDAKEWTELTTN--LNINSSNGYAPP 248
Query: 246 PRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNGNLWY 305
M SA P++ + +FS T+Q YVYMHFAEI+ L++ ++R F +T NG L Y
Sbjct: 249 EVVMASASTPISTFGTWNFSWLLPSSTTQFYVYMHFAEIQTLRSLDTREFKVTLNGKLAY 308
Query: 306 GPLKLNYLSSTTVFSQSAMS--GGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQTDE 363
L++ T+F + G L KT ST PP++NA+E++ V +F Q +T+
Sbjct: 309 ERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPLMNALEVFTVIDFPQMETNP 368
Query: 364 QDVDAIMNIKSFYGLKK-NWQGDPCAPQDYLWEGLNCSYPDDDSPRI-TSLNLSASELTG 421
DV AI +I+S YGL K +WQGDPC P+ +LWEGLNC+ D+ +P I TSLNLS+S LTG
Sbjct: 369 DDVAAIKSIQSTYGLSKISWQGDPCVPKQFLWEGLNCNNLDNSTPPIVTSLNLSSSHLTG 428
Query: 422 GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQEN 481
A + NLT L LDLSNNNLTG +P+FL+ + SL +NL+ N G +P LL+K+
Sbjct: 429 IIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLSGNNFNGSIPQILLQKK-- 486
Query: 482 NTLELRFDGNPDL-CRSASC-------KKEKKKFVVPVVASVASVFVVLAALIGLWSLKR 533
L+L +GN +L C C +K V+P+VASVA V VVL + + + + +
Sbjct: 487 -GLKLILEGNANLICPDGLCVNKAGNGGAKKMNVVIPIVASVAFV-VVLGSALAFFFIFK 544
Query: 534 KKQLPDPQIL--IWLVRLSSGRKVDANCNRSYESLDLS-SRQFTYSEVLRMTNNFERVLG 590
KK+ + Q L ++S R + RS ES ++ +R+FTYSEV+ MTNNFERVLG
Sbjct: 545 KKKTSNSQDLGPSSYTQVSEVRTI-----RSSESAIMTKNRRFTYSEVVTMTNNFERVLG 599
Query: 591 KGGFGTVYHGKLDNDE-VAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT 649
KGGFG VYHG ++N E VAVKMLS SSSQGYK+F+AEV+LLLRVHH+NL LVGYCDEG
Sbjct: 600 KGGFGMVYHGTVNNTEQVAVKMLSHSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCDEGE 659
Query: 650 NMALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVK 708
N+ALIYEYMANG+L EH+S ILNWE RL+I VE+A GLEYLH GCKPP+VHRDVK
Sbjct: 660 NLALIYEYMANGDLREHMSGKRGGSILNWETRLKIVVESAQGLEYLHNGCKPPMVHRDVK 719
Query: 709 STNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYS 768
+TNIL+NE AKLADFGLSR FP+EG THVST +AGTPGYLDPEYY +N L EKSDVYS
Sbjct: 720 TTNILLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGTPGYLDPEYYRTNWLNEKSDVYS 779
Query: 769 FGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAV 828
FG+VLLEIIT VI++S E H+A+WV ML KGDI++ +DP+L GD+D SVW+AV
Sbjct: 780 FGIVLLEIITNQLVINQSRE--KPHIAEWVGLMLTKGDIQNIMDPKLYGDYDSGSVWRAV 837
Query: 829 EIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNLHTELS 888
E+AM+C++ ++ RRP M+QVV+ELN+CL+ E A+ S +S +S E +++N +
Sbjct: 838 ELAMSCLNPSSARRPTMSQVVIELNECLSYENARGGTS-QNMNSESSIE-VSMNFDIGAT 895
Query: 889 PLAR 892
P AR
Sbjct: 896 PDAR 899
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG3|Y5182_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51820 OS=Arabidopsis thaliana GN=At1g51820 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 823 bits (2126), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/911 (49%), Positives = 604/911 (66%), Gaps = 45/911 (4%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLPK-DSSYTETSTKLRYTSDANYIE 59
ME F L IFHL V AQ+Q GFIS+DCGL +S Y T L YTSDA+ +
Sbjct: 1 MERHFVFIATYLLIFHL---VQAQNQTGFISVDCGLSLLESPYDAPQTGLTYTSDADLVA 57
Query: 60 TGLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNL 119
+G + ++ + + +LR FP+G+RNCY N+T +T YLI+ATF+YGNYD N
Sbjct: 58 SGKTGRLAKEFEPLVDKPTLTLRYFPEGVRNCYNLNVTSDTNYLIKATFVYGNYDGLNVG 117
Query: 120 PEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLD 179
P F+++LGPNLW T+ S D EII V S+ L VC+V T PFI+ LELRP+
Sbjct: 118 PNFNLYLGPNLWTTVS----SNDTIEEIILVTRSNSLQVCLVKTGISIPFINMLELRPMK 173
Query: 180 NNTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGS 239
N Y+TQ+ SL+ R + S S+ R+ DD YDR W+P D W +T+ V+ S
Sbjct: 174 KNMYVTQSGSLKYLFRGYI-SNSSTRIRFPDDVYDRKWYPLFDDSWTQVTTNLKVNT--S 230
Query: 240 KNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITR 299
++ P M A P+ A+++L+ + PT+Q Y Y+H AEI+ L+ANE+R FN+T
Sbjct: 231 ITYELPQSVMAKAATPIKANDTLNITWTVEPPTTQFYSYVHIAEIQALRANETREFNVTL 290
Query: 300 NGNLWYGPLKLNYLSSTTV--FSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFS 357
NG +GP L + ++ S GG+ ++KT ST PP++NAIE + V +F
Sbjct: 291 NGEYTFGPFSPIPLKTASIVDLSPGQCDGGRCILQVVKTLKSTLPPLLNAIEAFTVIDFP 350
Query: 358 QSQTDEQDVDAIMNIKSFYGLKK-NWQGDPCAPQDYLWEGLNCSYPDDDSPRI-TSLNLS 415
Q +T+E DV I N++ YGL + +WQGDPC P+ LW+GLNC D +P I TSL+LS
Sbjct: 351 QMETNENDVAGIKNVQGTYGLSRISWQGDPCVPKQLLWDGLNCKNSDISTPPIITSLDLS 410
Query: 416 ASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVEL 475
+S LTG + NLT L LDLS+NNLTG VP+FL+ + SL +NL+ N L+G +P L
Sbjct: 411 SSGLTGIITQAIKNLTHLQILDLSDNNLTGEVPEFLADIKSLLVINLSGNNLSGSVPPSL 470
Query: 476 LEKQENNTLELRFDGNPD-LCRSASC------KKEKKKFVVPVVASVASVFVVLAALIGL 528
L+K+ ++L +GNP LC + SC +KK +VPVVAS+AS+ V++ AL+
Sbjct: 471 LQKK---GMKLNVEGNPHILCTTGSCVKKKEDGHKKKSVIVPVVASIASIAVLIGALVLF 527
Query: 529 WSLKRKK----QLPDPQILIWLVRLSSGRKVDANCNRSYE-SLDLSSRQFTYSEVLRMTN 583
L++K+ + P P + + D RS E ++ +R+F+YS+V+ MTN
Sbjct: 528 LILRKKRSPKVEGPPPSYM---------QASDGRLPRSSEPAIVTKNRRFSYSQVVIMTN 578
Query: 584 NFERVLGKGGFGTVYHGKLDNDE-VAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
NF+R+LGKGGFG VYHG ++ E VAVK+LS SSSQGYKQF+AEV+LLLRVHH+NL LV
Sbjct: 579 NFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGLV 638
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
GYCDEG N+ALIYEYMANG+L+EH+S + ++ ILNW RL+I +E+A GLEYLH GCKPP
Sbjct: 639 GYCDEGDNLALIYEYMANGDLKEHMSGTRNRFILNWGTRLKIVIESAQGLEYLHNGCKPP 698
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
+VHRDVK+TNIL+NE F+AKLADFGLSR F +EG THVST +AGTPGYLDPEY+ +N LT
Sbjct: 699 MVHRDVKTTNILLNEHFEAKLADFGLSRSFLIEGETHVSTVVAGTPGYLDPEYHRTNWLT 758
Query: 762 EKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821
EKSDVYSFG++LLEIIT VI +S E H+ +WV ML KGDI+S +DP L D+D
Sbjct: 759 EKSDVYSFGILLLEIITNRHVIDQSREK--PHIGEWVGVMLTKGDIQSIMDPSLNEDYDS 816
Query: 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITV 881
SVWKAVE+AM+C++ ++ RRP M+QVV+ELN+CLA E A+ S +S +S E +++
Sbjct: 817 GSVWKAVELAMSCLNHSSARRPTMSQVVIELNECLASENARGGAS-RDMESKSSIE-VSL 874
Query: 882 NLHTELSPLAR 892
TE+SP AR
Sbjct: 875 TFGTEVSPNAR 885
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 813 bits (2100), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/867 (49%), Positives = 566/867 (65%), Gaps = 34/867 (3%)
Query: 1 MEMFQRFALLCLCIFHLA-ALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIE 59
M F L+ F + LVCAQDQ+GF+S+DCG+P+DSSY + T ++Y SDA ++E
Sbjct: 1 MGNFNFLPLVSFASFVVVLVLVCAQDQSGFVSIDCGIPEDSSYYDEKTDIKYISDAAFVE 60
Query: 60 TGLPKSILLQYRRMK-QQQVWSLRSFPDGIRNCYRFN--LTRNTKYLIRATFMYGNYDEQ 116
+G SI ++++ ++Q +RSFP+G +NCY + KYLIR FMYGNYD
Sbjct: 61 SGTIHSIDSKFQKKNLEKQFQKVRSFPEGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNL 120
Query: 117 NNLPEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELR 176
P+FD++LG NLW ++ +EN + + EII+ L SD + VC+V+ +GTPF+S LELR
Sbjct: 121 GKAPDFDLYLGVNLWDSVTLENSTTIVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELR 180
Query: 177 PLDNNTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDA 236
L NN Y T +DSL L R D+G+T + RY DD +DR W P + +TS +D
Sbjct: 181 LLKNNIYETASDSLMLYRRWDLGATGDLPARYKDDIFDRFWMPLMFPNFLILNTSLMIDP 240
Query: 237 DGSKNFKPPPRAMKSAVRPVNAS-NSLDFSINASDPTSQLYVYMHFAEIEELKANESRLF 295
S F PP M +AV P+N+S + DP + Y+Y+HFAE+E+L +NE+R F
Sbjct: 241 TSSNGFLPPSVVMSTAVAPMNSSIEQIMVYWEPRDPNWKFYIYIHFAEVEKLPSNETREF 300
Query: 296 NITRNGNLW--YGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEV 353
++ N + +YL + T++ Q+ +SG F L + ST PPI+NAIE Y
Sbjct: 301 SVFLNKEQIDTTSVFRPSYLYTDTLYVQNPVSGPFLEFVLRQGVKSTRPPIMNAIETYRT 360
Query: 354 KEFSQSQTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLN 413
EF TD+ DVDAIM IK+ Y +KKNW GDPCAP Y W+G+NCSY ++ PRI S+N
Sbjct: 361 NEFLDLPTDQNDVDAIMKIKTKYKVKKNWLGDPCAPFGYPWQGINCSYTANNPPRIISVN 420
Query: 414 LSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPV 473
LS S LTG LT L LDLSNN LTG VP FL+ L L LNL NKLTG LP
Sbjct: 421 LSFSGLTGQIDPVFITLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPE 480
Query: 474 ELLEKQENNTLELRFDGNPDLCRSASC---KKEKKKFVVPVVASVASVFVVLAALIGLWS 530
+LLE+ ++ +L LR GNPDLC S SC K E+K++++P VASV +F +L ALI W
Sbjct: 481 KLLERSKDGSLSLRVGGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLALISFWQ 540
Query: 531 LKRKKQLPDPQILIWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLG 590
K+++Q + +G LD + R + YSE++ +TNNFERVLG
Sbjct: 541 FKKRQQ-----------SVKTG------------PLD-TKRYYKYSEIVEITNNFERVLG 576
Query: 591 KGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTN 650
+GGFG VY+G L ++VA+KMLS SS+QGYK+F+AEV+LLLRVHH+NL L+GYC EG
Sbjct: 577 QGGFGKVYYGVLRGEQVAIKMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIGYCHEGDQ 636
Query: 651 MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKST 710
MALIYEY+ NG L ++LS + IL+WEERL+I+++AA GLEYLH GCKPPIVHRDVK T
Sbjct: 637 MALIYEYIGNGTLGDYLSGKNSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPT 696
Query: 711 NILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFG 770
NILINEK QAK+ADFGLSR F +EG + VST +AGT GYLDPE+Y + +EKSDVYSFG
Sbjct: 697 NILINEKLQAKIADFGLSRSFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFG 756
Query: 771 VVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEI 830
VVLLE+ITG PVIS+S + H++ VS ML KGDI+S VDP+L F+ WK E+
Sbjct: 757 VVLLEVITGQPVISRSRTEENRHISDRVSLMLSKGDIKSIVDPKLGERFNAGLAWKITEV 816
Query: 831 AMACVSSNANRRPFMNQVVMELNDCLA 857
A+AC S + R M+QVV EL + L
Sbjct: 817 ALACASESTKTRLTMSQVVAELKESLC 843
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 809 bits (2090), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/911 (47%), Positives = 595/911 (65%), Gaps = 59/911 (6%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLP-KDSSYTETSTKLRYTSDANYIE 59
ME F ++ I HL V AQD GFI+LDCGL + S Y E+ST L YTSD +++
Sbjct: 1 MERHCLFFVIFSLILHL---VQAQDPIGFINLDCGLSIQGSPYKESSTGLTYTSDDGFVQ 57
Query: 60 TGLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNL 119
+G I + + ++ +LR FPDG+RNC+ N+TR TKYLI+ TF+YGNYD +N +
Sbjct: 58 SGKIGKITKELESLYKKPERTLRYFPDGVRNCFSLNVTRGTKYLIKPTFLYGNYDGRNVI 117
Query: 120 PEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLD 179
P+FD+++GPN+W T+ +N EI+HV S+ L VC+V T P+I+ LELRPL
Sbjct: 118 PDFDLYIGPNMWITVNTDNTIK----EILHVSKSNTLQVCLVKTGTSIPYINTLELRPLA 173
Query: 180 NNTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVW---WPYDLDEWEPFSTSEAVDA 236
++ Y ++ SL R+ S Y DD +DR+W PY +W+ +T+ ++
Sbjct: 174 DDIYTNESGSLNYLFRVYY-SNLKGYIEYPDDVHDRIWKQILPYQ--DWQILTTNLQINV 230
Query: 237 DGSKNFKPPPRAMKSAVRPVNASNS-LDFSINASDPTSQLYVYMHFAEIEELKANESRLF 295
S ++ P R MK+AV P+ AS + ++F N PTSQ Y+++HFAE++ L+ANE+R F
Sbjct: 231 --SNDYDLPQRVMKTAVTPIKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQANETREF 288
Query: 296 NITRNGNLWYGPLKLNYLSSTTVFSQSA--MSGGQYNFSLIKTGNSTHPPIINAIEIYEV 353
N+ NGN+ + +L TV+S + GG+ L+KT ST PP+INA+E Y V
Sbjct: 289 NVVLNGNVTFKSYSPKFLEMQTVYSTAPKQCDGGKCLLQLVKTSRSTLPPLINAMEAYTV 348
Query: 354 KEFSQSQTDEQDVDAIMNIKSFYGLKKN-WQGDPCAPQDYLWEGLNCSYPDDDSPRI-TS 411
+F Q +T+ +V AI NI+S YGL K WQGDPC P+ +LW+GLNC+ DD +P I TS
Sbjct: 349 LDFPQIETNVDEVIAIKNIQSTYGLSKTTWQGDPCVPKKFLWDGLNCNNSDDSTPPIITS 408
Query: 412 LNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPL 471
LNLS+S LTG + NL L LDLSNNNL+G VP+FL+ + SL +NL+ N L+G +
Sbjct: 409 LNLSSSGLTGIIVLTIQNLANLQELDLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVV 468
Query: 472 PVELLEKQENNTLELRFDGNPDL-CRSASC-------KKEKKKFVVPVVASVASVFVVLA 523
P +L+EK+ L+L +GNP L C SC ++ K +P+VAS+ SV
Sbjct: 469 PQKLIEKK---MLKLNIEGNPKLNCTVESCVNKDEEGGRQIKSMTIPIVASIGSVVAFTV 525
Query: 524 ALIGLWSLKRKKQLPDPQILIWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTN 583
AL+ +++ D + + A+ S ++ +++FTY+EVL MTN
Sbjct: 526 ALMIFCVVRKNNPSND--------EAPTSCMLPADSRSSEPTIVTKNKKFTYAEVLTMTN 577
Query: 584 NFERVLGKGGFGTVYHGKLDNDE-VAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
NF+++LGKGGFG VY+G ++ E VAVKMLS SS+QGYKQF+AEV+LLLRVHH+NL LV
Sbjct: 578 NFQKILGKGGFGIVYYGSVNGTEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLV 637
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
GYC+EG +ALIYEYMANG+L+EH+S ILNW RL+IA+EAA GLEYLH GCKP
Sbjct: 638 GYCEEGDKLALIYEYMANGDLDEHMSGKRGGSILNWGTRLKIALEAAQGLEYLHNGCKPL 697
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
+VHRDVK+TNIL+NE F KLADFGLSR FP+EG THVST +AGT GYLDPEYY +N LT
Sbjct: 698 MVHRDVKTTNILLNEHFDTKLADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLT 757
Query: 762 EKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821
EKSDVYSFGVVLL +IT PVI ++ E H+A+WV ML KGDI+S DP L GD++
Sbjct: 758 EKSDVYSFGVVLLVMITNQPVIDQNRE--KRHIAEWVGGMLTKGDIKSITDPNLLGDYNS 815
Query: 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITV 881
SVWKAVE+AM+C++ ++ RP M+QVV EL +CLA E++++ +++
Sbjct: 816 GSVWKAVELAMSCMNPSSMTRPTMSQVVFELKECLASESSRE---------------VSM 860
Query: 882 NLHTELSPLAR 892
TE++P+AR
Sbjct: 861 TFGTEVAPMAR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD9|Y1756_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07560 OS=Arabidopsis thaliana GN=At1g07560 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 801 bits (2068), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/878 (49%), Positives = 586/878 (66%), Gaps = 38/878 (4%)
Query: 23 AQDQAGFISLDCGLPKDSS-YTETSTKLRYTSDANYIETGLPKSI--LLQYRRMKQQQVW 79
AQDQ GFISLDCGL D S YTE TKL +TSDA++I++G I + +K V
Sbjct: 24 AQDQQGFISLDCGLQADESPYTEPLTKLTFTSDADFIKSGKSGKIQNVPGMEYIKPYTV- 82
Query: 80 SLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPEFDVHLGPNLWGTIKIENV 139
LR FPDG+RNCY + + T YLI A F YGNYD N P+FD++LGPN+W T+ ++
Sbjct: 83 -LRYFPDGVRNCYTLIVIQGTNYLIVAMFTYGNYDNLNTHPKFDLYLGPNIWTTVDLQRN 141
Query: 140 SVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTYITQTDSLELSIRLDVG 199
EIIH+ S L +C+V T TP ISALELRPL NNTYI Q+ SL+ R+ +
Sbjct: 142 VNGTRAEIIHIPRSTSLQICLVKTGTTTPLISALELRPLRNNTYIPQSGSLKTLFRVHL- 200
Query: 200 STSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKNFKPPPRAMKSAVRPVNAS 259
+ S T RY +D +DR+W P+ + EW TS V+ + P + +A P N S
Sbjct: 201 TDSKETVRYPEDVHDRLWSPFFMPEWRLLRTSLTVNTSDDNGYDIPEDVVVTAATPANVS 260
Query: 260 NSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNGNLWYGPLKLNYLSSTTVF 319
+ L S N P +Y Y+H AEI+ L+ N++R FNI+ ++ YGP+ + T+F
Sbjct: 261 SPLTISWNLETPDDLVYAYLHVAEIQSLRENDTREFNISAGQDVNYGPVSPDEFLVGTLF 320
Query: 320 SQSAMS--GGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQTDEQDVDAIMNIKSFYG 377
+ S + GG + LIKT ST PP++NAIE + EF QS+T+ DV AI +I++ YG
Sbjct: 321 NTSPVKCEGGTCHLQLIKTPKSTLPPLLNAIEAFITVEFPQSETNANDVLAIKSIETSYG 380
Query: 378 LKK-NWQGDPCAPQDYLWEGLNCSYPDDDSP-RITSLNLSASELTGGFAHYLTNLTMLTS 435
L + +WQGDPC PQ LW+GL C Y + +P RI SL+LS+SELTG + NLT L
Sbjct: 381 LSRISWQGDPCVPQQLLWDGLTCEYTNMSTPPRIHSLDLSSSELTGIIVPEIQNLTELKK 440
Query: 436 LDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNPDLC 495
LD SNNNLTG VP+FL+++ SL +NL+ N L+G +P LL K +N L+L GNP+LC
Sbjct: 441 LDFSNNNLTGGVPEFLAKMKSLLVINLSGNNLSGSVPQALLNKVKNG-LKLNIQGNPNLC 499
Query: 496 RSASCKKEKKKFVVPVVASVASVFVVLAALIGLWSLKRKKQLPDPQILIWLVRLSSGRKV 555
S+SC K+K ++PVVAS+AS LAA+I + +L + + + R SS RK
Sbjct: 500 FSSSCNKKKNSIMLPVVASLAS----LAAIIAMIAL----------LFVCIKRRSSSRKG 545
Query: 556 DANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKLDN-DEVAVKMLSP 614
+ +S E++ +++TY+EVL MT FERVLGKGGFG VYHG ++ +EVAVK+LSP
Sbjct: 546 PSPSQQSIETI---KKRYTYAEVLAMTKKFERVLGKGGFGMVYHGYINGTEEVAVKLLSP 602
Query: 615 SSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEI 674
SS+QGYK+F+ EV+LLLRV+H NL +LVGYCDE ++ALIY+YM NG+L++H S SS I
Sbjct: 603 SSAQGYKEFKTEVELLLRVYHTNLVSLVGYCDEKDHLALIYQYMVNGDLKKHFSGSS--I 660
Query: 675 LNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734
++W +RL IAV+AA GLEYLH GCKP IVHRDVKS+NIL++++ QAKLADFGLSR FP+
Sbjct: 661 ISWVDRLNIAVDAASGLEYLHIGCKPLIVHRDVKSSNILLDDQLQAKLADFGLSRSFPIG 720
Query: 735 GGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHV 794
+HVST +AGT GYLD EYY +NRL+EKSDVYSFGVVLLEIIT PVI + + H+
Sbjct: 721 DESHVSTLVAGTFGYLDHEYYQTNRLSEKSDVYSFGVVLLEIITNKPVIDHNRD--MPHI 778
Query: 795 AQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854
A+WV ML +GDI + +DP+L+G +D S WKA+E+AM CV+ ++ +RP M+ VV EL +
Sbjct: 779 AEWVKLMLTRGDISNIMDPKLQGVYDSGSAWKALELAMTCVNPSSLKRPNMSHVVHELKE 838
Query: 855 CLAMEAAQKKESITTTDSNNSFEMITVNLHTELSPLAR 892
CL E + ++ D++ S + I ++ T+++P AR
Sbjct: 839 CLVSENNRTRD----IDTSRSMD-INLSFGTDVNPKAR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81069|Y2899_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g28990 OS=Arabidopsis thaliana GN=At2g28990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 799 bits (2064), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/896 (48%), Positives = 586/896 (65%), Gaps = 22/896 (2%)
Query: 6 RFALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSS-YTETSTKLRYTSDANYIETGLPK 64
+ LL I ++ AQDQ GFISLDCGLP D S Y ++ L +TSD+ +I+TG
Sbjct: 2 KIHLLLAMIGTFVVIIGAQDQEGFISLDCGLPSDESPYDDSFNGLTFTSDSTFIQTGKID 61
Query: 65 SILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPEFDV 124
S+ +Q +LR FP+G RNCY ++ R T YLI +F+YGNYD N P FD+
Sbjct: 62 SVDKDLNINLSKQYLTLRYFPEGKRNCYSLDVKRGTTYLIVVSFVYGNYDGLNRDPNFDI 121
Query: 125 HLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTYI 184
HLGPN W I ++ EIIH S+ L +C+V T + P ISA+E+RPL NNTY+
Sbjct: 122 HLGPNKWKRIDLDGEKEGTREEIIHKARSNSLDICLVKTGETLPIISAIEIRPLRNNTYV 181
Query: 185 TQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKNFKP 244
TQ+ SL +S R+ + S S+A+ RY DD +DR+W P++ +T ++ + S ++
Sbjct: 182 TQSGSLMMSFRVYL-SNSDASIRYADDVHDRIWSPFNGSSHTHITTD--LNINNSNAYEI 238
Query: 245 PPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNGNLW 304
P +++A P NAS L + + +++Y+YMHFAEI+ L+ANE+R F++ GN
Sbjct: 239 PKNILQTAAIPRNASAPLIITWDPLPINAEVYLYMHFAEIQTLEANETRQFDVILRGNFN 298
Query: 305 YGPLKLNYLSSTTVFSQSAMSGGQYN--FSLIKTGNSTHPPIINAIEIYEVKEFSQSQTD 362
+ L T++++ M G L+KT NST PP+INAIE Y V EFSQ +T
Sbjct: 299 HSGFSPTKLKVFTLYTEEPMKCGSEGCYLQLVKTPNSTLPPLINAIEAYSVIEFSQLETS 358
Query: 363 EQDVDAIMNIKSFYGLKK-NWQGDPCAPQDYLWEGLNCSYPDDD-SPRITSLNLSASELT 420
DVDAI NIK+ Y L K WQGDPC PQD WE + C+Y D SP I SL+LS S L
Sbjct: 359 LSDVDAIKNIKNTYKLNKITWQGDPCLPQDLSWESIRCTYVDGSTSPTIISLDLSKSGLN 418
Query: 421 GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQE 480
G L N T L LDLSNN+LTGPVP FL+ + +L +NL+ N L+G +P LL+K E
Sbjct: 419 GSIPQILQNFTQLQELDLSNNSLTGPVPIFLANMKTLSLINLSGNNLSGSVPQALLDK-E 477
Query: 481 NNTLELRFDGNPDLCRSASCKKEKK-KFVVPVVASVASVFVVLAALIGLWSLKRKKQLPD 539
L L+ +GNPDLC+S+ C EKK KF++PV+AS AS+ +V+ + + ++KK P
Sbjct: 478 KEGLVLKLEGNPDLCKSSFCNTEKKNKFLLPVIASAASLVIVVVVVALFFVFRKKKASPS 537
Query: 540 PQILIWLVRLSSGRKVDANCNRSYESLDLSSR-QFTYSEVLRMTNNFERVLGKGGFGTVY 598
L S + N ES S + +FTYSEV MTNNF++ LG+GGFG VY
Sbjct: 538 N-----LHAPPSMPVSNPGHNSQSESSFTSKKIRFTYSEVQEMTNNFDKALGEGGFGVVY 592
Query: 599 HGKLDN-DEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657
HG ++ ++VAVK+LS SSSQGYK F+AEV+LL+RVHH NL +LVGYCDEG ++ALIYEY
Sbjct: 593 HGFVNVIEQVAVKLLSQSSSQGYKHFKAEVELLMRVHHINLVSLVGYCDEGEHLALIYEY 652
Query: 658 MANGNLEEHLSDSSKE-ILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE 716
M NG+L++HLS +L+WE RL+I ++AALGLEYLH GC PP+VHRD+K+TNIL+++
Sbjct: 653 MPNGDLKQHLSGKHGGFVLSWESRLKIVLDAALGLEYLHTGCVPPMVHRDIKTTNILLDQ 712
Query: 717 KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEI 776
QAKLADFGLSR FP+ +VST +AGTPGYLDPEYY +N LTEKSD+YSFG+VLLEI
Sbjct: 713 HLQAKLADFGLSRSFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTEKSDIYSFGIVLLEI 772
Query: 777 ITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVS 836
I+ P+I +S E H+ +WVS M+ KGD+RS +DP L D+DI SVWKA+E+AM+CVS
Sbjct: 773 ISNRPIIQQSREK--PHIVEWVSFMITKGDLRSIMDPNLHQDYDIGSVWKAIELAMSCVS 830
Query: 837 SNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNLHTELSPLAR 892
++ RRP M++VV EL +CL E ++ E +S S E + +++ E+ P AR
Sbjct: 831 LSSARRPNMSRVVNELKECLISETSRIGEG-RDMESKGSMEF-SRDIYNEVIPQAR 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 892 | ||||||
| 255549706 | 886 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.979 | 0.986 | 0.563 | 0.0 | |
| 255549700 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.976 | 0.985 | 0.581 | 0.0 | |
| 255549716 | 892 | Nodulation receptor kinase precursor, pu | 0.968 | 0.968 | 0.577 | 0.0 | |
| 255549708 | 883 | Nodulation receptor kinase precursor, pu | 0.986 | 0.996 | 0.570 | 0.0 | |
| 255549712 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.976 | 0.985 | 0.569 | 0.0 | |
| 255549714 | 915 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.967 | 0.943 | 0.558 | 0.0 | |
| 356550478 | 895 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.978 | 0.540 | 0.0 | |
| 356556621 | 892 | PREDICTED: probable LRR receptor-like se | 0.980 | 0.980 | 0.545 | 0.0 | |
| 351723025 | 897 | stress-induced receptor-like kinase 2 pr | 0.982 | 0.976 | 0.533 | 0.0 | |
| 358248460 | 898 | putative leucine-rich repeat receptor-li | 0.985 | 0.978 | 0.525 | 0.0 |
| >gi|255549706|ref|XP_002515904.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544809|gb|EEF46324.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1026 bits (2654), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/898 (56%), Positives = 649/898 (72%), Gaps = 24/898 (2%)
Query: 3 MFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIETGL 62
+FQ F+ + L LV QDQ+GFISLDCGLP ++SY++ +T L + SDA+YIE G+
Sbjct: 5 LFQFFSKF-FGVLALIVLVHCQDQSGFISLDCGLPGNTSYSDATTTLNFISDASYIEIGI 63
Query: 63 PKSILLQYRRMKQ-QQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPE 121
KS+ ++ + +W +RSFP G RNCY LT++T+YLIRATFMYGNYD N P
Sbjct: 64 SKSLAPEFSTNSIFRPLWYVRSFPQGSRNCYNVTLTKDTEYLIRATFMYGNYDGINQRPS 123
Query: 122 FDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNN 181
FD++LGPN W +++I N S+ EIIH Y+ VC+VNTN GTPFISALELRPL N
Sbjct: 124 FDLYLGPNKWVSVQILNGSIPVRKEIIHHPKRKYIHVCLVNTNSGTPFISALELRPLKNG 183
Query: 182 TYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKN 241
TY++++ SL L R D+ S +N T RY DD YDR W P+ EW ST+E +D S +
Sbjct: 184 TYVSESGSLALFDRADISSITNQTVRYPDDVYDRRWSPFHFVEWTDISTTETIDLGKSNS 243
Query: 242 FKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNG 301
++ P M+SA P N+S+ ++ +I A DPT + Y Y HFAEI +L AN+SR FNIT NG
Sbjct: 244 YQLPSTVMRSAGTPRNSSSPMEVTIAAEDPTLKFYAYFHFAEIVKLDANQSREFNITLNG 303
Query: 302 NLWYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQT 361
++WYGP+ L+YL STTV S A+SGG Y+F + K G ST PP++NA+E+Y + E Q +T
Sbjct: 304 DIWYGPITLHYLYSTTVSSGYAISGGTYDFQIFKVGGSTLPPLLNAVEVYYIVELLQLET 363
Query: 362 DEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTG 421
++DV A++ IKS Y + +NWQGDPCAPQDY+WEGL C+Y + SP I SL+LS+S LTG
Sbjct: 364 KQEDVYAMIKIKSTYKITRNWQGDPCAPQDYVWEGLKCNYSNSASPVIISLDLSSSGLTG 423
Query: 422 GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQEN 481
NL L SLDLSNN+LTGPVP FLSQL SLK L+L NKLTG +P +L ++ ++
Sbjct: 424 DVPPVFANLKSLESLDLSNNSLTGPVPDFLSQLKSLKVLDLTGNKLTGIIPDDLFKRSQS 483
Query: 482 NTLELRFDGNPDLCRSASCK------KEKKKFVVPVVASVASVFVVLAALIGLWSLKRKK 535
L L F GNP+LC S SC K+ FVVPVVAS+A++ V++AAL + +R+K
Sbjct: 484 GLLLLSFGGNPELCASVSCSNNNKKKKKNNNFVVPVVASIAALLVIVAALTIICCCRRRK 543
Query: 536 QLPDPQILIWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFG 595
Q R +A+ +YE ++ +R+FTYSEVL++T NFE VLG+GGFG
Sbjct: 544 Q-------------QVARNEEADTKETYEPREMRNRRFTYSEVLKLTKNFESVLGRGGFG 590
Query: 596 TVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655
TVY+G L + EVAVK+LS SS QGYK+F+AEVKLLLRVHH+NLTTLVGYCDEG NM LIY
Sbjct: 591 TVYYGYLGDIEVAVKVLSTSSVQGYKEFEAEVKLLLRVHHKNLTTLVGYCDEGGNMILIY 650
Query: 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN 715
EYMANGNL +HLS +IL+WE RL+IA+E A GLEYLH GCKPPIVHRDVK+ NIL++
Sbjct: 651 EYMANGNLRQHLSGEHPDILSWEGRLKIALETAQGLEYLHNGCKPPIVHRDVKTANILLD 710
Query: 716 EKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE 775
+KFQAKLADFGLSR+FP EGGTHVST +AGTPGYLDPEYY+ N LTEKSDVYSFGVVLLE
Sbjct: 711 DKFQAKLADFGLSRMFPAEGGTHVSTIVAGTPGYLDPEYYVRNWLTEKSDVYSFGVVLLE 770
Query: 776 IITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACV 835
IIT VIS+++E THV+QWV ML++GDI++ VD RL GDFD N+ WKA E+AMACV
Sbjct: 771 IITSRSVISQTSEK--THVSQWVKPMLERGDIKNIVDSRLCGDFDTNTAWKAAELAMACV 828
Query: 836 SSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVN-LHTELSPLAR 892
S+ + RP M+QVVMEL++CL E A+ +E + SN+S E+++VN L T LSP +R
Sbjct: 829 SATSTERPSMSQVVMELSECLKTEMARTREGYCSAQSNSSAELMSVNVLSTVLSPRSR 886
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549700|ref|XP_002515901.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544806|gb|EEF46321.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2651), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/900 (58%), Positives = 661/900 (73%), Gaps = 29/900 (3%)
Query: 2 EMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIETG 61
+M F + + L A V AQDQ+GFIS+DCGLP +SSYT+ +T L Y SDA++I+ G
Sbjct: 5 KMLWDFLFRFIPVLFLTA-VYAQDQSGFISIDCGLPANSSYTDETTSLNYISDASFIDVG 63
Query: 62 LPKSIL--LQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNL 119
+ +I + +QQ+ S+RSFP+G RNC+ L +NTKYLIRA F +G+YD N L
Sbjct: 64 IITTITPKVTTNSTDRQQL-SVRSFPEGDRNCFNVELAKNTKYLIRAIFAHGDYDGSNEL 122
Query: 120 PEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLD 179
PEFD+HLGPN W T+KI N S+ EIIH + +Y+ +C+VNT+ G PFISALELRPL
Sbjct: 123 PEFDLHLGPNKWVTVKILNASIPVIKEIIHTPTLNYIHICLVNTDSGMPFISALELRPLK 182
Query: 180 NNTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGS 239
N TY+ Q+ +L S RLD+GS +N T RY DD +DR+W P +W ST + VDA
Sbjct: 183 NTTYVAQSGALVKSTRLDLGSLTNKTVRYPDDVFDRIWTPDHFHKWTDLSTPDTVDAQNH 242
Query: 240 KNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITR 299
+F+PP M++A P NAS +++F I+ D TS YVYMHFAEI EL+AN+SRLFNI+
Sbjct: 243 IDFQPPSVVMRTANMPTNASENMEFYIDIDDTTSLFYVYMHFAEIVELQANQSRLFNISL 302
Query: 300 NGNLWYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQS 359
NG +WYGP+ N+LSS TV+SQ + GG FSL K ST PP++NAIEIY V + SQS
Sbjct: 303 NGTIWYGPVIPNHLSSGTVYSQFPIIGGNNMFSLFKIEGSTLPPLLNAIEIYFVVDLSQS 362
Query: 360 QTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASEL 419
+TD+ DVDAIM IKS YG+ KNWQGDPCAPQ Y+W GLNCSY DDD P + SLNLS+S L
Sbjct: 363 ETDQDDVDAIMKIKSTYGITKNWQGDPCAPQAYVWHGLNCSYSDDDPPTVKSLNLSSSGL 422
Query: 420 TGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQ 479
G + NL L LDLSNN+L+G +P FLS+++SLK LNL NKLTG +P +L E+
Sbjct: 423 RGEIVSEIANLRSLELLDLSNNSLSGSLPDFLSRMTSLKVLNLTGNKLTGTIPADLFERS 482
Query: 480 ENNTLELRFDGNPDLCRSASCKKEKKKFVVPVVASVASVFVVLAALIGLWSLKRKKQLPD 539
+ +L L GNP+LC S SC K+KK VVPVVASV + F++ AAL+
Sbjct: 483 QQGSLLLSVSGNPELCPSVSCTKKKKSVVVPVVASVVAFFILAAALV------------- 529
Query: 540 PQILIWLVRLSSGRKVDANCNRSYES-----LDLSSRQFTYSEVLRMTNNFERVLGKGGF 594
IL + S + +A SYE+ ++ RQF+YSE+L++TNNF+++LGKGGF
Sbjct: 530 -VILRYFFVRSQAKTNEAKI--SYETNDEPLVESKKRQFSYSEILKITNNFDKILGKGGF 586
Query: 595 GTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMAL 653
GTVYHG L D +VAVK+LS SS+QGYK+FQAEVKLLLRVHHRNLTTLVGYC+EGTN+ L
Sbjct: 587 GTVYHGTLNDGTQVAVKVLSLSSAQGYKEFQAEVKLLLRVHHRNLTTLVGYCNEGTNLGL 646
Query: 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNIL 713
IYEYMANGNLE++LSDS L+WE RLRIA EAA GLEYLH GCKP IVHRDVK+TNIL
Sbjct: 647 IYEYMANGNLEDYLSDSCLNTLSWEIRLRIATEAAQGLEYLHNGCKPQIVHRDVKTTNIL 706
Query: 714 INEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVL 773
+N+KFQAKLADFGLSR+FPV+G TH+ST +AGTPGYLDPEYY++N LT+KSDV+SFGVVL
Sbjct: 707 LNDKFQAKLADFGLSRIFPVDGSTHISTVVAGTPGYLDPEYYVNNWLTDKSDVFSFGVVL 766
Query: 774 LEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMA 833
LEIITG P I+++ E TH++QWVSSML+KGDI VDPRL GDF+INSVWKA E+AM
Sbjct: 767 LEIITGRPAIAQTRE--RTHISQWVSSMLEKGDIHGIVDPRLNGDFEINSVWKAAELAMG 824
Query: 834 CVSSNANRRPFMNQVVMELNDCLAMEAAQKKES-ITTTDSNNSFEMITVNLHTELSPLAR 892
CVS+++ RRP MNQ V+ELNDCL +E + +E + + ++NS E++TVN+HTE SPLAR
Sbjct: 825 CVSASSARRPTMNQAVVELNDCLNIEMGRTREGQSSQSFNSNSIELMTVNVHTEASPLAR 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549716|ref|XP_002515909.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544814|gb|EEF46329.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1022 bits (2642), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/885 (57%), Positives = 655/885 (74%), Gaps = 21/885 (2%)
Query: 19 ALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIETGLPKSILLQYRRMK-QQQ 77
+V QDQ+GFISLDCGLP +++YT+ +T L Y SDA++I+TG+ KS+ + ++Q
Sbjct: 18 CMVHGQDQSGFISLDCGLPANTTYTDETTSLNYNSDASFIDTGISKSLAPGFTTDNLRRQ 77
Query: 78 VWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPEFDVHLGPNLWGTIKIE 137
+W +RSFP+G RNCY L ++T+YLIRATFMYGNYD N LPEFD+H+GPN W ++KI
Sbjct: 78 LWYIRSFPEGDRNCYNLTLAKDTEYLIRATFMYGNYDGLNQLPEFDLHIGPNKWVSVKIL 137
Query: 138 NVSVDYSVEII-HVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTYITQTDSLELSI-- 194
N S + EII S Y+ VC+V + GTPFISALE RPL N TY+T++ SL L++
Sbjct: 138 NASTSVTEEIIIGSPKSKYIHVCLVTKDTGTPFISALETRPLKNGTYVTESGSLGLALFT 197
Query: 195 RLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKNFKPPPRAMKSAVR 254
R DVGS +N RY +D YDR W+PY ST+ VD D +F+PP M+SAV
Sbjct: 198 REDVGSLNNRIVRYPNDVYDRRWFPYHFKRGTDISTTLTVDLDDHNDFQPPSIVMRSAVI 257
Query: 255 PVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNGNLWYGPLKLNYLS 314
+N S+ L+F IN +D T +LY YMHFAEI +L+AN+SR FNI+ NG +WYGP+ YL
Sbjct: 258 SINTSSPLEFYIN-NDTTYKLYAYMHFAEIVKLEANQSRQFNISLNGKIWYGPVTPTYLY 316
Query: 315 STTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQTDEQDVDAIMNIKS 374
+TTV+S SA++ G Y FSL K S PP++NAIE+Y V + Q +T+++DV IMNIKS
Sbjct: 317 TTTVYSTSAITDGMYEFSLSKVEGSALPPLLNAIELYYVVDLLQPETNQRDVIGIMNIKS 376
Query: 375 FYGLKK-NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTML 433
Y + + NWQGDPCAP+D++WEGL+C Y SP I SLNLS+S L G A + NL L
Sbjct: 377 TYRISRTNWQGDPCAPEDFVWEGLSCKYNVTSSPVIISLNLSSSGLHGEIAPDIANLKSL 436
Query: 434 TSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNPD 493
LDLSNNNLT VP FLSQL SLKFLNL N+L G +P +LL K+ ++ L L DGNP+
Sbjct: 437 EILDLSNNNLTALVPDFLSQLQSLKFLNLTGNRLNGTIPDDLL-KRADSGLTLSVDGNPE 495
Query: 494 LCRSASCKKE-----KKKFVVPVVASVASVFVVLAALIGLWSLKRKKQLPDPQILIWLVR 548
LC+S SC K+ F+VPVVASVA++ V++ L +W LKR+KQ +L +
Sbjct: 496 LCKSVSCNKKKKKKKNTDFIVPVVASVAALLVIIVVLTTIWYLKRRKQKG-----TYLHK 550
Query: 549 LSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKLDNDEVA 608
+ +A +++E L+L+ RQFTYS+VL++TNNF VLG+GGFGTVYHG LD+ EVA
Sbjct: 551 YILAGRTEAEAKKTHEPLELNKRQFTYSDVLKITNNFGSVLGRGGFGTVYHGYLDDVEVA 610
Query: 609 VKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLS 668
VKMLSPSS QGYK+F AEV+LLLRVHH+NLTTLVGYCDEG NM LIYEYMANGNL+ HLS
Sbjct: 611 VKMLSPSSVQGYKEFHAEVRLLLRVHHKNLTTLVGYCDEGNNMGLIYEYMANGNLKHHLS 670
Query: 669 DSSK-EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGL 727
IL+WE RL+IA+EAA GL+YLH GCKPPIVHRDVK+TNIL+N++FQAKLADFGL
Sbjct: 671 GCDHPSILSWEGRLQIALEAAQGLDYLHNGCKPPIVHRDVKTTNILLNDRFQAKLADFGL 730
Query: 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSA 787
SR FPVE G+HVST +AGTPGYLDP+YY++N LTEKSDVYS+GVVLLEIIT PVI+++
Sbjct: 731 SRTFPVEDGSHVSTVVAGTPGYLDPDYYVTNWLTEKSDVYSYGVVLLEIITSRPVIARTR 790
Query: 788 ENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQ 847
+ THV+QWV +MLDKGDI++ VDPRL+GDFD NSVWK E+AMAC+S+ + RP M+Q
Sbjct: 791 DK--THVSQWVKAMLDKGDIKNIVDPRLRGDFDNNSVWKVTELAMACLSTTSGERPSMSQ 848
Query: 848 VVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNLHTELSPLAR 892
VVMELNDCL E A+ +E +T S++S E+I+++LHT +SPLAR
Sbjct: 849 VVMELNDCLTTEMARAREG-RSTQSSSSVEVISLHLHTGVSPLAR 892
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549708|ref|XP_002515905.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544810|gb|EEF46325.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1017 bits (2630), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/895 (57%), Positives = 646/895 (72%), Gaps = 15/895 (1%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIET 60
M +F F LCI + LV QDQ+GFISLDCGL +SSYT+ T L+Y SDA +IET
Sbjct: 1 MVLFCPFFFKFLCILAVRVLVHGQDQSGFISLDCGLQANSSYTDEKTGLKYISDAAFIET 60
Query: 61 GLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLP 120
G+ KSI ++ QQ+ +RSFP G RNCY+ L +NT+YLIRATF+Y NYD N LP
Sbjct: 61 GVTKSIAPEFLGSFNQQLRQVRSFPKGDRNCYKVELVKNTRYLIRATFLYANYDGLNKLP 120
Query: 121 EFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDN 180
FD+H+GPN W ++I N + EIIH + + + VC+V T TPFISALE+RPL N
Sbjct: 121 AFDLHIGPNKWVNVQITNPLIYPIKEIIHAPTFNNIYVCLVRTGPWTPFISALEIRPLHN 180
Query: 181 NTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSK 240
+TY+ Q+ SL L R+DVGS +N T RY DD YDR+W P+ D+ ST E + + G
Sbjct: 181 STYVAQSGSLSLFNRVDVGSLTNQTIRYPDDVYDRMWLPFHFDKGTDISTKENITS-GID 239
Query: 241 NFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRN 300
F+ P M SA P+NAS + +I+ D T Q YVY+HFAEI L+ N+SR FNI+ N
Sbjct: 240 YFQLPSTVMNSATVPLNASEQIILNIDTQDNTFQAYVYIHFAEIVRLEPNQSRRFNISLN 299
Query: 301 GNLWYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQ 360
G + YGP+ +L +TTV+SQSA+ GG++ FS G ST PP++NA+E+Y V + S+
Sbjct: 300 GKILYGPVTPKHLEATTVYSQSAIPGGKFLFSFYGVGGSTLPPLLNALELYSVVDLLHSE 359
Query: 361 TDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELT 420
T++ DV+AI IKS YG+ +NWQGDPC+PQDY W+GLNC+Y + SP ITSL+ S+S LT
Sbjct: 360 TNQVDVNAITKIKSTYGITRNWQGDPCSPQDYKWDGLNCTYSNTASPVITSLDFSSSGLT 419
Query: 421 GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQE 480
G ++NL L +LDLSNN+LTGPVP FLSQL LK LNLA N LTG +P +L + +
Sbjct: 420 GEIDPDISNLKWLETLDLSNNSLTGPVPDFLSQLP-LKSLNLAGNNLTGTIPADLFNRWQ 478
Query: 481 NNTLELRFDGNPDLCRSASCKKEKKK-FVVPVVASVASVFVVLA-ALIGLWSLK-RKKQL 537
++ L L GNP LC S SC + KK VPV+ SV ++FV++A + I LW LK RK+Q
Sbjct: 479 SDLLFLSVSGNPQLCASVSCNSDNKKNITVPVIISVTALFVIIAGSAIILWRLKKRKQQG 538
Query: 538 PDPQILIWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTV 597
P W++ K++A R E L+L RQ Y E++++TNNF+R+LGKGGFGTV
Sbjct: 539 TVPNGFCWVMIWPVVGKMEAEAKR--EPLELQKRQLRYFEIVQITNNFQRILGKGGFGTV 596
Query: 598 YHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657
YHG LD+ EVAVKMLSPSS+QGYK+FQ EVKLLLRVHHRNLT+LVGYCDEG MALIYEY
Sbjct: 597 YHGHLDDMEVAVKMLSPSSAQGYKEFQTEVKLLLRVHHRNLTSLVGYCDEGNKMALIYEY 656
Query: 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK 717
MANGNL ++LSD + L+WEERLRIA+EAA GLEYLH GCKPPI+HRDVK TNIL+N K
Sbjct: 657 MANGNLRDNLSDGNGNFLSWEERLRIALEAAQGLEYLHNGCKPPIIHRDVKPTNILLNNK 716
Query: 718 FQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEII 777
FQAKLADFGLSR+ PVEGG+HVST +AGTPGYLDPEYY +N LTEKSDV+SFGVVLLEII
Sbjct: 717 FQAKLADFGLSRICPVEGGSHVSTIVAGTPGYLDPEYYATNWLTEKSDVFSFGVVLLEII 776
Query: 778 TGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSS 837
T PVISK+ + TH++QW SSM++KGDI+S VDPRL DFDINS+WK VE+AMACVS+
Sbjct: 777 TSGPVISKTRDGDTTHLSQWFSSMVEKGDIQSIVDPRLGDDFDINSLWKVVELAMACVSA 836
Query: 838 NANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNLHTELSPLAR 892
+ +RP MNQVV+EL++CLA E + T S+ S+ + LHTEL+PLAR
Sbjct: 837 TSAQRPTMNQVVIELSECLATETVK-----TEGTSSQSYSTV---LHTELTPLAR 883
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549712|ref|XP_002515907.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544812|gb|EEF46327.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 993 bits (2568), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/890 (56%), Positives = 646/890 (72%), Gaps = 19/890 (2%)
Query: 7 FALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIETGLPKSI 66
F L I LA LV QDQ+GFIS+DCGLP +SSYT+ +T L Y SDA +I+TG+ ++
Sbjct: 10 FLFRFLPILALAILVHCQDQSGFISIDCGLPANSSYTDATTGLNYVSDAAFIDTGIINNL 69
Query: 67 L--LQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPEFDV 124
L + +QQ+ S+RSFP+G RNCY+ LTR TKYLIRA F+Y NYD + LP FD+
Sbjct: 70 APGLNTSSIDRQQL-SVRSFPEGDRNCYQVELTRGTKYLIRAIFLYRNYDGLSKLPHFDL 128
Query: 125 HLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTY- 183
HLGPN W T+KI N ++ EII+ +Y+ VC+VNT GTPFISALELRPL N TY
Sbjct: 129 HLGPNKWITVKILNATIPVITEIIYTPILNYIHVCLVNTGLGTPFISALELRPLKNTTYE 188
Query: 184 ITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKNFK 243
I +L RLD GS +N T RY DD YDR+W P +W ST E +DA +F+
Sbjct: 189 IRSEGALAKFARLDFGSVTNKTVRYPDDVYDRIWTPDHYYKWTDLSTPETIDAQFHNDFQ 248
Query: 244 PPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNGNL 303
PP M +A P NAS + F I+ D + Q Y YMHFAEI +L+AN+SR FNI+ NG +
Sbjct: 249 PPSIVMSTANVPTNASEDMQFFIDNEDTSLQFYFYMHFAEIVKLEANQSRQFNISLNGTI 308
Query: 304 WYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQTDE 363
++GP+ +YL +++V++ ++ G FSL K G ST PP++NAIEIY + SQSQTD+
Sbjct: 309 FFGPVIPDYLYTSSVYNGLPINAGSNVFSLFKIGGSTLPPLLNAIEIYFFVDLSQSQTDQ 368
Query: 364 QDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGF 423
DVDAI IKS YG+ +NWQGD CAPQ Y+W+GLNCSY D+D P+ITSLNLS+S LTG
Sbjct: 369 DDVDAITKIKSTYGITRNWQGDACAPQAYVWQGLNCSYSDNDPPKITSLNLSSSGLTGEI 428
Query: 424 AHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483
+ NL L LDLSNN+L+GPVP FLSQ+ SLK LNL NKLTG +PV+L E+ + +
Sbjct: 429 VSDIANLKSLEFLDLSNNSLSGPVPDFLSQMPSLKVLNLTGNKLTGRIPVDLFERTQKGS 488
Query: 484 LELRFDGNPDLCRSASCKKEKKKFVVPVVASVASVFVVLAALIGLWSLKRKKQLPDPQIL 543
L L GNP+LC S SCKK++K VPVVASVASVF++ AA+ + +
Sbjct: 489 LLLSVSGNPELCPSVSCKKKEKSIAVPVVASVASVFILAAAVAVILRYR----------- 537
Query: 544 IWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKL- 602
++R S + S E ++L ++QFTYSEVL++TNNFE+VLGKGGFGTVY+G L
Sbjct: 538 --ILRSVSETGETKLSHESNEPMELKNKQFTYSEVLKITNNFEKVLGKGGFGTVYYGTLA 595
Query: 603 DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662
D +VAVK+LS SS QGYK+F AEVKLL+RVHHRNLTTLVG C EGTNM LIYEYMANGN
Sbjct: 596 DGTQVAVKILSQSSVQGYKEFLAEVKLLMRVHHRNLTTLVGCCIEGTNMGLIYEYMANGN 655
Query: 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKL 722
LE++LS S+ L+WE RLRIA+EA GLEYLH GCK PIVHRDVK+TNIL+N+KFQAK+
Sbjct: 656 LEDYLSGSNLNTLSWEARLRIALEAGQGLEYLHGGCKLPIVHRDVKTTNILLNDKFQAKI 715
Query: 723 ADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPV 782
+DFGLSR+FP +GGTHVST +AGTPGYLDPEYY++N LT+KSDVYSFGVVLLEIIT PV
Sbjct: 716 SDFGLSRIFPADGGTHVSTIVAGTPGYLDPEYYVTNWLTDKSDVYSFGVVLLEIITCRPV 775
Query: 783 ISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRR 842
I+++ + ++H++QWVSSM++ GD+ S DPRL G++++NSVWK VE+AM C+S+ + RR
Sbjct: 776 IAQNRNHENSHISQWVSSMIENGDVNSIADPRLNGEYEVNSVWKIVELAMECLSTTSARR 835
Query: 843 PFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNLHTELSPLAR 892
P MNQVV+ELN+CL E A+ +E +T S S E++TVN+ TE SPLAR
Sbjct: 836 PTMNQVVIELNECLKTEMARTREG-QSTQSYYSIELVTVNVDTESSPLAR 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549714|ref|XP_002515908.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544813|gb|EEF46328.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 989 bits (2558), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/892 (55%), Positives = 637/892 (71%), Gaps = 29/892 (3%)
Query: 3 MFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIETGL 62
M + + L I L A+V AQ Q+GFIS+DCG+ ++++YT+++T + Y SDA +I+TG
Sbjct: 32 MLKYYPFPLLSIIALLAVVQAQAQSGFISIDCGISENATYTDSTTSIDYVSDAAFIDTGK 91
Query: 63 PKSILLQYRRMK-QQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPE 121
KSI +Y R QQ+ ++RSF +G+RNCY+ L + KYLIRA F+YGNYD QN P
Sbjct: 92 SKSIAAEYTRYNINQQLQNVRSFAEGVRNCYKIGLKKGAKYLIRAEFLYGNYDGQNKAPI 151
Query: 122 FDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNN 181
FD++LG + W T+ N ++ + EIIH++++ Y+ VC+VNT GTPF+S LELRP+ +
Sbjct: 152 FDLYLGSSKWETVDTINSTMIITKEIIHLINTSYIDVCLVNTGSGTPFMSKLELRPIRIS 211
Query: 182 TYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKN 241
Y T SL R DVGST+N T RY DD YDR+W P +W STSE +DA +
Sbjct: 212 AYSTSLGSLARFSRSDVGSTTNRTLRYADDVYDRIWTPNHFFKWAEISTSETIDALAQND 271
Query: 242 FKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNG 301
++PP M++A P N + + SI+ D T + VYMHFAEI +L+ANESR FNI+ NG
Sbjct: 272 YRPPSIVMRTAGIPANDNEPMTVSIDFEDTTFRFLVYMHFAEILKLEANESRQFNISLNG 331
Query: 302 NLWYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQT 361
W+GPL+ +YL +TTVFS + +SGGQY FS+ KT NST PP++NAIEIY + + SQ Q+
Sbjct: 332 EHWFGPLRPDYLYTTTVFSPTVLSGGQYEFSIYKTENSTLPPLLNAIEIYYILDLSQPQS 391
Query: 362 DEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTG 421
+++DVDAI NIKS YG+K+NWQGDPCAPQ YLWEGLNCSY + PRI SLNLS+S LTG
Sbjct: 392 NQEDVDAITNIKSSYGIKRNWQGDPCAPQAYLWEGLNCSYSGNVMPRIISLNLSSSGLTG 451
Query: 422 GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQEN 481
+++LT L SLDLSNN LTG VP FLSQL SL L L N+L+G +P L+EK E
Sbjct: 452 EIPSSISSLTSLESLDLSNNYLTGSVPDFLSQLPSLNVLILTGNRLSGSVPPSLVEKSEQ 511
Query: 482 NTLELRFDGNPDLCRSASCKKEKK-KFVVPVVASVASVFVVLAALIG-LWSLKRKKQLPD 539
N L L GN +LC +SCK EKK VVPVVAS+A V ++++AL L++ KR+KQ
Sbjct: 512 NLLVLSVGGNANLCLKSSCKNEKKNNVVVPVVASIAGVLIIISALAAILYTRKRRKQ--- 568
Query: 540 PQILIWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYH 599
++ D + Y L+ RQFTYSE+L +TNNFERVLGKGGFGTVYH
Sbjct: 569 -------------QEEDTKTSNIYGPLESKERQFTYSEILNITNNFERVLGKGGFGTVYH 615
Query: 600 GKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659
G LD+ +VAVK+LSP S+QGYK+F AEVKLLLRVHHRNLT+LVG+C+EGT M LIYEYMA
Sbjct: 616 GYLDDTQVAVKILSPLSAQGYKEFHAEVKLLLRVHHRNLTSLVGFCNEGTKMGLIYEYMA 675
Query: 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQ 719
NG+LE LS ++ +L WE RL IAVEAA GLEYLH GCKPPIVHRD+K+ NIL+N++FQ
Sbjct: 676 NGDLEHLLSGRNRHVLKWERRLDIAVEAAKGLEYLHNGCKPPIVHRDIKTANILLNDQFQ 735
Query: 720 AKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG 779
A+LADFGLS+ FPVEGGTHVST +AGTPGYLDPEY ++N LTEKSDVYSFGVVLL+IITG
Sbjct: 736 ARLADFGLSKSFPVEGGTHVSTVVAGTPGYLDPEYSMTNWLTEKSDVYSFGVVLLKIITG 795
Query: 780 HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNA 839
PVI+ E H++ WVSS++ GDI++ +DP L GDFDINSVWKAVE+AMAC S +
Sbjct: 796 RPVIAVIDERS-IHISHWVSSLVANGDIKTVIDPCLGGDFDINSVWKAVEVAMACTSPTS 854
Query: 840 NRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNLHTELSPLA 891
RP MNQVV EL + LA E A+ +E T ++ + TE +PLA
Sbjct: 855 AGRPTMNQVVRELIESLAEETARAEEGHKTK---------SIVMMTESTPLA 897
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550478|ref|XP_003543614.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g51860-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2483), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/911 (54%), Positives = 631/911 (69%), Gaps = 35/911 (3%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSSYTE-TSTKLRYTSDANYIE 59
M M + F + + LA L+ AQDQ+GFIS+DCG P SYTE T T + Y SDAN+I+
Sbjct: 1 MGMSRSFLVGFIGGLVLAVLIQAQDQSGFISIDCGAPAGVSYTELTRTGINYISDANFID 60
Query: 60 TGLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNL 119
TG+ + I+ + + + QQQ+W +RSFP+G RNCY+ ++TR + YLIR +F+YGNYD N
Sbjct: 61 TGVSRKIVSELKSVYQQQLWDVRSFPEGKRNCYKISITRGSTYLIRTSFLYGNYDGLNTE 120
Query: 120 PEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLD 179
P+FD+HLG N W T+ I N ++ Y+ EIIHV S DY+ +C+VNT G PFISA+ELR L
Sbjct: 121 PQFDIHLGANRWATVIIYNATIYYAKEIIHVPSQDYVQICLVNTGHGIPFISAIELRTLK 180
Query: 180 NNTYITQTDSLELS---IRLDVGSTSNATFRYIDDAYDRVWWPYDLDE-WEP-FSTSEAV 234
N+TY+TQ SLE R D+GS + +RY DD YDR W D DE W P + S
Sbjct: 181 NDTYVTQFGSLETYNDYERCDLGSNTGG-YRYKDDVYDRFWNTCDFDEDWTPVLNASIPA 239
Query: 235 DADGSKNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRL 294
D+ +++PP + +AV P N S L DPT Q YVYMHF EI+ L N++R
Sbjct: 240 DSLEQNDYEPPAIVLSTAVTPANVSVPLVIKWVPQDPTDQFYVYMHFLEIQVLATNQTRQ 299
Query: 295 FNITRNGNLWYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVK 354
F+IT NG W+ L S T++S A+SG Q +S T NST PPII+AIEIY V
Sbjct: 300 FSITENGKTWFPNLSPTNQSVDTIYSLRAVSGEQIKYSFEMTENSTLPPIISAIEIYRVI 359
Query: 355 EFSQSQTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNL 414
+F QS T + DVDAI IKS YG+ ++WQGDPCAP DYLW+GLNC+YP +DSPRIT+LNL
Sbjct: 360 DFQQSDTFQGDVDAITAIKSVYGVTRDWQGDPCAPIDYLWDGLNCTYPGNDSPRITTLNL 419
Query: 415 SASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVE 474
S+S L+G + NLTML +LDLSNN+L VP FLSQL LK LNL +N L+G +P
Sbjct: 420 SSSGLSGKIDPSILNLTMLENLDLSNNSLKDEVPDFLSQLQHLKILNLEKNNLSGSIPST 479
Query: 475 LLEKQENNTLELRFDGNPDLCRSASCKK---------EKKKFVVPVVASVASVFVVLAAL 525
L+EK + +L L NP LC S C + ++K V PVVASV ++L L
Sbjct: 480 LVEKSKEGSLALSVGQNPYLCESGQCNQKEKEKEKGKDEKSIVTPVVASVGGAVILLVVL 539
Query: 526 IG-LWSLKRKKQLPDPQILIWLVRLSSGRKVDANCNRSYESLDLSSRQ-FTYSEVLRMTN 583
+ LW+LKR+K Q I L + D + +S S +Q ++YS+VL++TN
Sbjct: 540 VAILWTLKRRKSKEKDQSQISL------QYTDQD-----DSFLQSKKQIYSYSDVLKITN 588
Query: 584 NFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
NF +LGKGGFGTVY G +D+ VAVKMLSPSS GY+QFQAEVKLL+RVHH+ LT+LVG
Sbjct: 589 NFNAILGKGGFGTVYLGYIDDTPVAVKMLSPSSVHGYQQFQAEVKLLMRVHHKCLTSLVG 648
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSD--SSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
YC+EG + LIYEYMANGNL+EHL+ S + WEERLRIAV+AALGLEYL GCKPP
Sbjct: 649 YCNEGNDKCLIYEYMANGNLQEHLTGKRSKTKFFTWEERLRIAVDAALGLEYLQNGCKPP 708
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
I+HRDVKSTNIL+NE FQAKL+DFGLS++ P +G THVST +AGTPGYLDPEY+I+NRLT
Sbjct: 709 IIHRDVKSTNILLNEHFQAKLSDFGLSKIIPTDGVTHVSTVVAGTPGYLDPEYFITNRLT 768
Query: 762 EKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821
EKSDVYSFGVVLLEIIT PVI++ E+ H+++WVSS++ KGDI + VDPRL+GDFD
Sbjct: 769 EKSDVYSFGVVLLEIITSQPVIARKEES--IHISEWVSSLIAKGDIEAIVDPRLEGDFDS 826
Query: 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITV 881
NSVWKAVEIA AC+S N N+RP + +V+EL + LAME A+ K S ++ +S + +T+
Sbjct: 827 NSVWKAVEIATACLSPNMNKRPITSVIVIELKESLAMELARTKYS--GVETRDSVKTVTM 884
Query: 882 NLHTELSPLAR 892
NL+TE SP AR
Sbjct: 885 NLNTEFSPQAR 895
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556621|ref|XP_003546622.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g51880-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 953 bits (2463), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/909 (54%), Positives = 620/909 (68%), Gaps = 34/909 (3%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIET 60
M M + F + L LA L+ AQDQ+GFIS+ CG P ++T +T L YTSDAN+I T
Sbjct: 1 MGMSRSFLVTFLGCLVLAVLIQAQDQSGFISIACGAPAGVNFTVPNTGLNYTSDANFINT 60
Query: 61 GLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLP 120
G+ ++I+ + R Q VW+LRSFP+G RNCY+ N+TR +KYLIRA+F+YGNYD N LP
Sbjct: 61 GVSRTIVPELRDQFLQNVWNLRSFPEGQRNCYKINITRGSKYLIRASFLYGNYDGLNMLP 120
Query: 121 EFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDN 180
+FD+ LG N W T+ I N SV EII+V S DY+ +C+V+T GTPFISA+ELR L
Sbjct: 121 KFDLLLGANRWLTVNINNASVSLDFEIIYVPSLDYVHICMVDTGHGTPFISAIELRTLRI 180
Query: 181 NTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSK 240
+ Y T+ SLE R+D+GS N +RY D YDR W DLD W P + D+
Sbjct: 181 DIYETRFGSLETDFRVDLGS--NRGYRYNYDVYDRYWSGADLDTWRPLNFPIDADSLVQN 238
Query: 241 NFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRN 300
++KPP M +A+ P N S L S DP YVY+HF EI+ L N++R FNIT N
Sbjct: 239 DYKPPAVVMSTAITPANVSAPLVISWKPDDPKDSFYVYLHFTEIQVLAKNQTREFNITLN 298
Query: 301 GNLWYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQ 360
GN W + Y S T++S S +SG + NFS + T ST PPIINAIEIY VKEF Q
Sbjct: 299 GNPWTENISPRYHSVNTIYSTSGISGEKINFSFVMTETSTLPPIINAIEIYRVKEFPQPD 358
Query: 361 TDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELT 420
T + DVDAI IKS YG+ ++WQGDPC+P+DYLWEGLNC+YP DSPRI +LNLS+S L+
Sbjct: 359 TYQGDVDAITTIKSVYGVTRDWQGDPCSPKDYLWEGLNCTYPVVDSPRIITLNLSSSGLS 418
Query: 421 GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQE 480
G + NLTML LDLSNN+L G VP FLSQL LK LNL N L+G +P L+EK +
Sbjct: 419 GKIDPSILNLTMLEKLDLSNNSLDGEVPDFLSQLQHLKILNLENNNLSGSIPSTLVEKSK 478
Query: 481 NNTLELRFDGNPDLCRSASCK---------KEKKKFVVPVVASVASVFVVLAALIG-LWS 530
+L L NP LC S C ++KK V PVVAS V ++L A+ L +
Sbjct: 479 EGSLSLSVGQNPHLCESGQCNEKEKEKGEEEDKKNIVTPVVASAGGVVILLLAVAAILRT 538
Query: 531 LKRKKQLPDPQILIWLVRLSSGRKVDANCNRSY----ESLDLSSRQ-FTYSEVLRMTNNF 585
LKR+ + S K + + Y +SL S +Q ++YS+VL +TNNF
Sbjct: 539 LKRRNS-----------KASMVEKDQSPISPQYTGQDDSLLQSKKQIYSYSDVLNITNNF 587
Query: 586 ERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYC 645
++GKGG GTVY G +D+ VAVKMLSPSS GY+QFQAEVKLL+RVHH+NL +LVGYC
Sbjct: 588 NTIVGKGGSGTVYLGYIDDTPVAVKMLSPSSVHGYQQFQAEVKLLMRVHHKNLISLVGYC 647
Query: 646 DEGTNMALIYEYMANGNLEEHLSD--SSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
+EG N ALIYEYM NGNL+EH++ S + WE+RLRIAV+AA GLEYL GCKPPI+
Sbjct: 648 NEGDNKALIYEYMNNGNLQEHITGKRSKTKFFTWEDRLRIAVDAASGLEYLQNGCKPPII 707
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEK 763
HRDVKSTNIL+NE FQAKL+DFGLS++ P +G THVST IAGTPGYLDPEYYI+NRLTEK
Sbjct: 708 HRDVKSTNILLNEHFQAKLSDFGLSKIIPTDGSTHVSTVIAGTPGYLDPEYYITNRLTEK 767
Query: 764 SDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823
SDVYSFGVVLLEIIT PVI+K+ E TH++QWVSS++ KGDI+S VD RL+GDFD NS
Sbjct: 768 SDVYSFGVVLLEIITSKPVITKNQE--KTHISQWVSSLVAKGDIKSIVDSRLEGDFDNNS 825
Query: 824 VWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNL 883
VWKAVEIA ACVS N NRRP ++ +V EL + LAME A+ K DS +S + +T+NL
Sbjct: 826 VWKAVEIAAACVSPNPNRRPIISVIVTELKESLAMELARTKYG--GPDSRDSVKPVTMNL 883
Query: 884 HTELSPLAR 892
+TE SP AR
Sbjct: 884 NTEFSPQAR 892
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351723025|ref|NP_001238288.1| stress-induced receptor-like kinase 2 precursor [Glycine max] gi|188036451|gb|ACD45980.1| stress-induced receptor-like kinase 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 950 bits (2456), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/913 (53%), Positives = 625/913 (68%), Gaps = 37/913 (4%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIET 60
M M + F + L LA L+ AQDQ+GFIS+ CG P ++T T L YTSDAN+I T
Sbjct: 1 MRMSRSFLVAFLGFLVLAVLIQAQDQSGFISIACGAPAGVNFTVRQTGLNYTSDANFINT 60
Query: 61 GLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLP 120
G+ ++I+ + R + VW+LRSFP+G RNCY+ N+TR +KYLI A+F+YGNYD N LP
Sbjct: 61 GVSRTIVPELRHEFLRNVWNLRSFPEGKRNCYKINITRGSKYLIGASFLYGNYDGLNMLP 120
Query: 121 EFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDN 180
+FD+ LG N W T+ I+N SV EII+V S DY+ +C+V+T GTPFISA+ LR L N
Sbjct: 121 KFDLLLGANRWDTVDIKNASVSRHFEIIYVPSLDYVHICMVDTGLGTPFISAITLRSLRN 180
Query: 181 NTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVW-------WPYDLDEWEPFSTSEA 233
+ Y T+ SL+ IR D+GS N +RY DD YDR W W ++D+W+ +
Sbjct: 181 DIYETEFGSLQTYIRRDLGS--NKGYRYDDDVYDRYWSYDEADTWYDNVDKWKQLNFPID 238
Query: 234 VDADGSKNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESR 293
D+ +++PP M +AV P N S L S DP YVYMHF EI+ L N++R
Sbjct: 239 ADSLVQNHYQPPAVVMSTAVTPANVSAPLVISWKPYDPKESFYVYMHFTEIQVLAKNQTR 298
Query: 294 LFNITRNGNLWYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEV 353
FNIT NG LWY Y S T++S S +SG NFS + T ST PPIINAIEIY V
Sbjct: 299 EFNITLNGKLWYENESPRYHSVNTIYSTSGISGKLINFSFVMTETSTLPPIINAIEIYRV 358
Query: 354 KEFSQSQTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLN 413
KEF Q T + DVDAI IKS YG+ +WQGDPC+P+DYLWEGLNC+YP DSPRI +LN
Sbjct: 359 KEFPQQDTYQGDVDAITTIKSVYGVTGDWQGDPCSPKDYLWEGLNCTYPVIDSPRIITLN 418
Query: 414 LSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPV 473
LS+S L+G + NLTML LDLSNN+L G VP FLSQL LK LNL N L+G +P
Sbjct: 419 LSSSGLSGKIGPSILNLTMLEKLDLSNNSLNGEVPDFLSQLQYLKILNLENNNLSGSIPS 478
Query: 474 ELLEKQENNTLELRFDGNPDLCRSASC---KKEKKKFVVPVVASVASVFVVLAALIGLWS 530
L+EK + +L L NP LC S C KK+K P+VAS++ V ++L A+ LW+
Sbjct: 479 TLVEKSKEGSLSLSVGQNPYLCESGQCNFEKKQKNIVTAPIVASISGVLILLVAVAILWT 538
Query: 531 LKRKKQLPDPQILI------WLVRLSSGRKVDANCNRSYESLDLSSRQ-FTYSEVLRMTN 583
LKR+K L+ + RL S +K D SL +Q ++YS+VL++TN
Sbjct: 539 LKRRKSKEKSTALMEVNDESEISRLRSTKKDD--------SLAQVKKQIYSYSDVLKITN 590
Query: 584 NFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
NF ++GKGGFGTVY G +D+ VAVK+LSPSS G++QFQAEVKLL+RVHH+NLT+L+G
Sbjct: 591 NFNTIIGKGGFGTVYLGYIDDSPVAVKVLSPSSVNGFRQFQAEVKLLVRVHHKNLTSLIG 650
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSD--SSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
YC+EGTN ALIYEYMANGNL+EHLS S L+WE+RLRIAV+AALGLEYL GCKPP
Sbjct: 651 YCNEGTNKALIYEYMANGNLQEHLSGKHSKSTFLSWEDRLRIAVDAALGLEYLQNGCKPP 710
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
I+HRDVKSTNIL+NE FQAKL+DFGLS+ P +G +HVST +AGTPGYLDP +IS+RLT
Sbjct: 711 IIHRDVKSTNILLNEHFQAKLSDFGLSKAIPTDGESHVSTVVAGTPGYLDPHCHISSRLT 770
Query: 762 EKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821
+KSDV SFG VLLEIIT PV++++ E G H+++ VSS+++KGDIR+ VD RL+GD+DI
Sbjct: 771 QKSDVLSFGEVLLEIITNQPVMARNQEKG--HISERVSSLIEKGDIRAIVDSRLEGDYDI 828
Query: 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSF--EMI 879
NS WKA+EIAMACVS N N RP M+ + +EL + LA+E A+ K D+N + E +
Sbjct: 829 NSAWKALEIAMACVSLNPNERPIMSGIAIELKETLAIEIARAKH----CDANPRYLVEAV 884
Query: 880 TVNLHTELSPLAR 892
+VN+ TE PLAR
Sbjct: 885 SVNVDTEFMPLAR 897
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248460|ref|NP_001240141.1| putative leucine-rich repeat receptor-like protein kinase At2g19210-like precursor [Glycine max] gi|223452414|gb|ACM89534.1| stress-induced receptor-like kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2441), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/911 (52%), Positives = 622/911 (68%), Gaps = 32/911 (3%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIET 60
M M + F + L LA + AQDQ+GF+S+ CG P ++T T L YTSDAN+I T
Sbjct: 1 MRMSRSFLVAFLGCLLLAVPIQAQDQSGFLSIACGAPAGVNFTVPITGLNYTSDANFINT 60
Query: 61 GLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLP 120
G+ +I+ + R Q+ VW+LRSFP+G RNCY+ N+TR +KYLIRA+F+YGNYD N LP
Sbjct: 61 GVKSTIVSELRDQFQRHVWNLRSFPEGKRNCYKINITRGSKYLIRASFLYGNYDGLNMLP 120
Query: 121 EFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDN 180
+FD+ LG N W T+ I+N SV EII+V S DY+ +C+V+T GTPFISA+ELR L N
Sbjct: 121 QFDLLLGANRWRTVNIKNASVSRHFEIIYVPSLDYVHICMVDTGLGTPFISAIELRSLRN 180
Query: 181 NTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVW-------WPYDLDEWEPFSTSEA 233
+ Y T+ SLE IR D+GS N +RY DD YDR W W ++D+W+ +
Sbjct: 181 DIYETEFGSLEKYIRRDLGS--NKGYRYDDDVYDRYWNYDDADTWYDNVDKWKQLNFPID 238
Query: 234 VDADGSKNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESR 293
D+ K ++PP M +AV P N S L S DP YVYMHF EI+ L N++R
Sbjct: 239 ADSLVQKQYQPPAVVMSTAVTPANVSAPLVISWEPYDPKDSFYVYMHFTEIQVLAKNQTR 298
Query: 294 LFNITRNGNLWYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEV 353
FNIT NG LWY Y S T+++ S +SG NFS + T ST PPIINAIEIY V
Sbjct: 299 EFNITLNGKLWYENESPRYHSVDTIYTPSGISGKLINFSFVMTETSTLPPIINAIEIYRV 358
Query: 354 KEFSQSQTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLN 413
KEF Q T + DVDAI IKS YG+ ++WQGDPC+P+DYLWEGLNC+YP DSPRI +LN
Sbjct: 359 KEFPQQDTYQGDVDAITTIKSVYGVTRDWQGDPCSPKDYLWEGLNCTYPVIDSPRIITLN 418
Query: 414 LSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPV 473
LS+S L+G + NLT L LDLSNN+L G VP FLSQL LK LNL N L+G +P
Sbjct: 419 LSSSGLSGKIDPSILNLTKLEKLDLSNNSLNGEVPDFLSQLQYLKILNLENNNLSGSIPS 478
Query: 474 ELLEKQENNTLELRFDGNPDLCRSASC---KKEKKKFVVPVVASVASVFVVLAALIGLWS 530
L+EK + +L L NP LC S C KK+K P+V S++ +++ A+ LW+
Sbjct: 479 TLVEKSKEGSLSLSVSQNPYLCESGQCNFEKKQKNIVTPPIVPSISGALILIVAVAILWT 538
Query: 531 LKRKKQLPDPQILI------WLVRLSSGRKVDANCNRSYESLDLSSRQ-FTYSEVLRMTN 583
LKR+K L+ ++RL S +K D SL +Q ++YS+VL++TN
Sbjct: 539 LKRRKSKEKSTALMEVNDESEILRLRSTKKDD--------SLAQVKKQIYSYSDVLKITN 590
Query: 584 NFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
NF ++GKGGFGTVY G +D+ VAVK+LSPS+ G++QFQAEVKLL+RVHH+NLT+L+G
Sbjct: 591 NFNTIIGKGGFGTVYLGYIDDSPVAVKVLSPSAVHGFQQFQAEVKLLIRVHHKNLTSLIG 650
Query: 644 YCDEGTNMALIYEYMANGNLEEHLS--DSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
YC+EGTN ALIYEYMANGNL+EHLS S L+WE+RLRIAV+AALGLEYL GCKPP
Sbjct: 651 YCNEGTNKALIYEYMANGNLQEHLSGKHSKSTFLSWEDRLRIAVDAALGLEYLQNGCKPP 710
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
I+HRDVKSTNIL+NE FQAKL+DFGLS+ P++G +HVST +AGTPGYLDP Y+ +RLT
Sbjct: 711 IIHRDVKSTNILLNEHFQAKLSDFGLSKAIPIDGESHVSTVVAGTPGYLDPHYHKFSRLT 770
Query: 762 EKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821
+KSDV+SFGVVLLEIIT PV+ ++ E G H++ V S+++KGDIR+ VD RL+GD+DI
Sbjct: 771 QKSDVFSFGVVLLEIITNQPVMERNQEKG--HISGRVRSLIEKGDIRAIVDSRLEGDYDI 828
Query: 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITV 881
NS WKA+EIAMACVS N N RP M+++ +EL + LA+E + + + + E ++V
Sbjct: 829 NSAWKALEIAMACVSQNPNERPIMSEIAIELKETLAIEELARAKH-CDANPRHLVEAVSV 887
Query: 882 NLHTELSPLAR 892
N+ TE PLAR
Sbjct: 888 NVDTEFMPLAR 898
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 892 | ||||||
| TAIR|locus:2017557 | 894 | IOS1 "IMPAIRED OOMYCETE SUSCEP | 0.979 | 0.977 | 0.49 | 7.2e-226 | |
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.957 | 0.959 | 0.502 | 9.4e-217 | |
| TAIR|locus:2195830 | 837 | AT1G51870 [Arabidopsis thalian | 0.364 | 0.388 | 0.610 | 9.4e-211 | |
| TAIR|locus:2195855 | 876 | AT1G51910 [Arabidopsis thalian | 0.548 | 0.558 | 0.451 | 6.6e-210 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.551 | 0.558 | 0.440 | 2.3e-207 | |
| TAIR|locus:2195825 | 865 | AT1G51850 [Arabidopsis thalian | 0.810 | 0.835 | 0.473 | 6.1e-207 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.974 | 0.983 | 0.471 | 4.7e-206 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.964 | 0.981 | 0.469 | 4.9e-204 | |
| TAIR|locus:2017572 | 882 | AT1G51790 [Arabidopsis thalian | 0.951 | 0.962 | 0.454 | 1.9e-202 | |
| TAIR|locus:2017647 | 885 | AT1G51820 [Arabidopsis thalian | 0.976 | 0.984 | 0.462 | 2.2e-199 |
| TAIR|locus:2017557 IOS1 "IMPAIRED OOMYCETE SUSCEPTIBILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2180 (772.5 bits), Expect = 7.2e-226, P = 7.2e-226
Identities = 441/900 (49%), Positives = 593/900 (65%)
Query: 7 FALLCLCIFHLAALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIETGLPKSI 66
F L+ L IF L AQDQ+GFISLDCG P+++S+ E +T + Y SDAN+I TG+ SI
Sbjct: 7 FLLVLLQIFSALLLCLAQDQSGFISLDCGSPRETSFREKTTNITYISDANFINTGVGGSI 66
Query: 67 LLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPEFDVHL 126
YR QQQ W+LRSFP GIRNCY NLT +YLIRA F++G YD++ + +F+++L
Sbjct: 67 KQGYRTQFQQQTWNLRSFPQGIRNCYTLNLTIGDEYLIRANFLHGGYDDKPST-QFELYL 125
Query: 127 GPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTYITQ 186
GPNLW T+ N + E+IH+L++D L +C+V T TPFISALELR L N TY+T+
Sbjct: 126 GPNLWSTVTTTNETEASIFEMIHILTTDRLQICLVKTGNATPFISALELRKLMNTTYLTR 185
Query: 187 TDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKNFKPPP 246
SL+ IR DVG+T N +RY D +DRVW PY+ W ST+++V+ + +++PP
Sbjct: 186 QGSLQTFIRADVGATVNQGYRYGIDVFDRVWTPYNFGNWSQISTNQSVNINN--DYQPPE 243
Query: 247 RAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNGNLWYG 306
AM +A P + +++ S+ + T Q YV+MHFAEI+ELK+N++R FNI N YG
Sbjct: 244 IAMVTASVPTDPDAAMNISLVGVERTVQFYVFMHFAEIQELKSNDTREFNIMYNNKHIYG 303
Query: 307 PLK-LNYLSSTTVFSQS---AMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQTD 362
P + LN+ +S+ VF+ + A + GQY FSL +TGNST PP++NA+EIY V Q +TD
Sbjct: 304 PFRPLNFTTSS-VFTPTEVVADANGQYIFSLQRTGNSTLPPLLNAMEIYSVNLLPQQETD 362
Query: 363 EQDVDAIMNIKSFYGLKK-NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTG 421
++VDA+MNIKS YG+ K +W+GDPC P DY W G+NC+Y D+++P+I SL+LS S LTG
Sbjct: 363 RKEVDAMMNIKSAYGVNKIDWEGDPCVPLDYKWSGVNCTYVDNETPKIISLDLSTSGLTG 422
Query: 422 GFAHYXXXXXXXXXXXXXXXXXXGPVPXXXXXXXXXXXXXXARNKLTGPLPVELLEKQEN 481
+ G VP + N+L G +P LL+K+
Sbjct: 423 EILEFISDLTSLEVLDLSNNSLTGSVPEFLANMETLKLINLSGNELNGSIPATLLDKERR 482
Query: 482 NTLELRFDGNPDLCRSASCXXXXXXXXXXXXX-XXXXXXXXXXXXIGLWS---LKRKKQL 537
++ L +GN LC S SC G+ + LKRKK+
Sbjct: 483 GSITLSIEGNTGLCSSTSCATTKKKKKNTVIAPVAASLVSVFLIGAGIVTFLILKRKKRT 542
Query: 538 PDPQILIWLVRLSSGRKVDANCNRSYESLD----LSSRQFTYSEVLRMTNNFERVLGKGG 593
+ L +SG +RS+ + +R+ TY +V+++TNNFERVLG+GG
Sbjct: 543 K-----LGL-NPNSGTGTTPLHSRSHHGFEPPVIAKNRKLTYIDVVKITNNFERVLGRGG 596
Query: 594 FGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMAL 653
FG VY+G L+N+ VAVKML+ S++ GYKQF+AEV+LLLRVHH++LT LVGYC+EG M+L
Sbjct: 597 FGVVYYGVLNNEPVAVKMLTESTALGYKQFKAEVELLLRVHHKDLTCLVGYCEEGDKMSL 656
Query: 654 IYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNI 712
IYE+MANG+L+EHLS IL WE RLRIA E+A GLEYLH GCKP IVHRD+K+TNI
Sbjct: 657 IYEFMANGDLKEHLSGKRGPSILTWEGRLRIAAESAQGLEYLHNGCKPQIVHRDIKTTNI 716
Query: 713 LINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVV 772
L+NEKFQAKLADFGLSR FP+ THVST +AGTPGYLDPEYY +N LTEKSDV+SFGVV
Sbjct: 717 LLNEKFQAKLADFGLSRSFPLGTETHVSTIVAGTPGYLDPEYYRTNWLTEKSDVFSFGVV 776
Query: 773 LLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAM 832
LLE++T PVI E +H+A+WV ML +GDI S VDP+L+GDFD N++WK VE AM
Sbjct: 777 LLELVTNQPVIDMKREK--SHIAEWVGLMLSRGDINSIVDPKLQGDFDPNTIWKVVETAM 834
Query: 833 ACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNLHTELSPLAR 892
C++ +++RRP M QVVM+L +CL ME A+ S T +N+S +++N TEL+P AR
Sbjct: 835 TCLNPSSSRRPTMTQVVMDLKECLNMEMARNMGSRMTDSTNDSSIELSMNFTTELNPGAR 894
|
|
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2094 (742.2 bits), Expect = 9.4e-217, P = 9.4e-217
Identities = 441/878 (50%), Positives = 561/878 (63%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGL-PKDSSYTETSTKLRYTSDANYIE 59
M+ F L + F + V AQ+QAGFISLDCGL PK+++YTE ST + Y SD +YI+
Sbjct: 1 MKSLHWFLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYID 60
Query: 60 TGLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNL 119
+GL I Y+ QQQVW++RSFP G RNCY NLT N KYLIR TF+YGNYD N
Sbjct: 61 SGLVGKINDAYKTQFQQQVWAVRSFPVGQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQF 120
Query: 120 PEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLD 179
P FD+H+GPN W ++KI V+ EIIHV+ D L VC+V T TPFIS+LE+RPL+
Sbjct: 121 PSFDLHIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLN 180
Query: 180 NNTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGS 239
N +Y+TQ+ SL L R+ S+S++ RY +D +DRVW + DE ST +D S
Sbjct: 181 NESYLTQSGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDETVWISTDLPIDT--S 238
Query: 240 KNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITR 299
++ P MK+A P NAS + T+Q YVYMHFAE++ L ANE+R FNIT
Sbjct: 239 NSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFNITY 298
Query: 300 NGNL-WYGPLKLNYLSSTTVFSQSAMSG--GQYNFSLIKTGNSTHPPIINAIEIYEVKEF 356
NG L W+ L+ LS +T+F+ A+S G +NF+ TGNST PP++NA+EIY V +
Sbjct: 299 NGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYTVVDI 358
Query: 357 SQSQTDEQDVDAIMNIKSFYGLKK--NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNL 414
Q +T++ +V A+MNIK YGL K +WQGDPCAPQ Y WEGLNCSYPD + RI SLNL
Sbjct: 359 LQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNL 418
Query: 415 SASELTGGFAHYXXXXXXXXXXXXXXXXXXGPVPXXXXXXXXXXXXXXARN---KLTGPL 471
+ SELTG G +P + N LT +
Sbjct: 419 NGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTA-I 477
Query: 472 PVELLEKQENNTLELRFDGNPDLC--RSASCXXXXXXXXXXXXXXXXXXXXXXXXXIGLW 529
P L ++ + +L L N L + + I
Sbjct: 478 PDSLQQRVNSKSLTLILGENLTLTPKKESKKVPMVAIAASVAGVFALLVILAIFFVIKRK 537
Query: 530 SLKRKKQLPDPQILIWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVL 589
++K K P P L+ + G V + S S+ R+ TY EVL+MTNNFERVL
Sbjct: 538 NVKAHKS-PGPPPLV-----TPGI-VKSETRSSNPSIITRERKITYPEVLKMTNNFERVL 590
Query: 590 GKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT 649
GKGGFGTVYHG LD EVAVKMLS SS+QGYK+F+AEV+LLLRVHHR+L LVGYCD+G
Sbjct: 591 GKGGFGTVYHGNLDGAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGD 650
Query: 650 NMALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVK 708
N+ALIYEYMANG+L E++S +L WE R++IAVEAA GLEYLH GC+PP+VHRDVK
Sbjct: 651 NLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVK 710
Query: 709 STNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYS 768
+TNIL+NE+ AKLADFGLSR FP++G HVST +AGTPGYLDPEYY +N L+EKSDVYS
Sbjct: 711 TTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYS 770
Query: 769 FGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAV 828
FGVVLLEI+T PVI K+ E H+ WV ML KGDI+S VDP+L GD+D N WK V
Sbjct: 771 FGVVLLEIVTNQPVIDKTRER--PHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIV 828
Query: 829 EIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKES 866
E+A+ACV+ ++NRRP M VVMELNDC+A+E A+++ S
Sbjct: 829 ELALACVNPSSNRRPTMAHVVMELNDCVALENARRQGS 866
|
|
| TAIR|locus:2195830 AT1G51870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1044 (372.6 bits), Expect = 9.4e-211, Sum P(2) = 9.4e-211
Identities = 204/334 (61%), Positives = 256/334 (76%)
Query: 562 SYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYK 621
S S+ R+ TY +VL+MTNNFERVLGKGGFGTVYHG +++ +VAVKMLS SS+QGYK
Sbjct: 510 SNPSIMRKDRKITYPQVLKMTNNFERVLGKGGFGTVYHGNMEDAQVAVKMLSHSSAQGYK 569
Query: 622 QFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEH-LSDSSKEILNWEER 680
+F+AEV+LLLRVHHR+L LVGYCD+G N+ALIYEYMANG+L E+ L +L WE R
Sbjct: 570 EFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMLGKRGGNVLTWENR 629
Query: 681 LRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740
++IAVEAA GLEYLH GC PP+VHRDVK+TNIL+N + AKLADFGLSR FP++G HVS
Sbjct: 630 MQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNAQCGAKLADFGLSRSFPIDGECHVS 689
Query: 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSS 800
T +AGTPGYLDPEYY +N L+EKSDVYSFGVVLLEI+T PVI+++ E H+ +WV
Sbjct: 690 TVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVINQTRER--PHINEWVGF 747
Query: 801 MLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEA 860
ML KGDI+S VDP+L GD+D N WK VE+ +ACV+ ++N RP M VV+ELN+C+A E
Sbjct: 748 MLSKGDIKSIVDPKLMGDYDTNGAWKIVELGLACVNPSSNLRPTMAHVVIELNECVAFEN 807
Query: 861 AQKK--ESITTTDSNNSFEMITVNLHTELSPLAR 892
A+++ E + T S N F + + E SP AR
Sbjct: 808 ARRQGSEEMYTRSSTN-FSHTSAS---EFSPGAR 837
|
|
| TAIR|locus:2195855 AT1G51910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1046 (373.3 bits), Expect = 6.6e-210, Sum P(2) = 6.6e-210
Identities = 225/498 (45%), Positives = 295/498 (59%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGL-PKDSSYTETSTKLRYTSDANYIE 59
M+ F LL F + LV AQ Q+GFISLDCGL PKD++YTE T + Y SDA+YI+
Sbjct: 1 MKTMNGFLLLSTIAFAVFHLVQAQSQSGFISLDCGLIPKDTTYTEQITNITYISDADYID 60
Query: 60 TGLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNL 119
+GL + I Y+ QQQ W+LRSFP+G RNCY FNL N KYLIR TF+YGNYD N +
Sbjct: 61 SGLTERISDSYKSQLQQQTWTLRSFPEGQRNCYNFNLKANLKYLIRGTFVYGNYDGLNQM 120
Query: 120 PEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLD 179
P+FD+H+GPN W ++ +E V+ EIIHVL+ D L VC+V T + TPFIS+LELRPL+
Sbjct: 121 PKFDLHIGPNKWTSVILEGVANATIFEIIHVLTQDRLQVCLVKTGQTTPFISSLELRPLN 180
Query: 180 NNTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGS 239
N+TY+TQ SL R+ T+ RY DD YDRVW P+ +E ST+ VD S
Sbjct: 181 NDTYVTQGGSLMSFARIYFPKTAYF-LRYSDDLYDRVWVPFSQNETVSLSTNLPVDTS-S 238
Query: 240 KNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITR 299
++ P SA+ P A++ L+ + + + YVYMHFAEI+ LKAN+ R FNIT
Sbjct: 239 NSYNVPQNVANSAIIPAEATHPLNIWWDLQNINAPSYVYMHFAEIQNLKANDIREFNITY 298
Query: 300 NGN-LWYGPLKLNYLSSTTVFSQSAM--SGGQYNFSLIKTGNSTHPPIINAIEIYEVKEF 356
NG +W ++ + LS TT+ S +A+ S G +NF+ T ST PP+INA+E+Y + E
Sbjct: 299 NGGQVWESSIRPHNLSITTISSPTALNSSDGFFNFTFTMTTTSTLPPLINALEVYTLVEN 358
Query: 357 SQSQTDEQDVDAIMNIKSFYGLKK--NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNL 414
+T + +V A+MNIK YGL K +WQGDPC+PQ Y WEGLNC Y D D P ITSLNL
Sbjct: 359 LLLETYQDEVSAMMNIKKTYGLSKKISWQGDPCSPQIYRWEGLNCLYLDSDQPLITSLNL 418
Query: 415 SASELTGGFAHYXXXXXXXXXXXXXXXXXXGPVPXXXXXXXXXXXXXXARN-KLTGPLPV 473
S LTG H G +P N KL +P
Sbjct: 419 RTSGLTGIITHDISNLIQLRELDLSDNDLSGEIPDFLADMKMLTLVNLKGNPKLNLTVPD 478
Query: 474 ELLEKQENNTLELRFDGN 491
+ + N +L+L D N
Sbjct: 479 SIKHRINNKSLKLIIDEN 496
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 2.3e-207, Sum P(2) = 2.3e-207
Identities = 219/497 (44%), Positives = 303/497 (60%)
Query: 9 LLCLCIFHL-AALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIETGLPKSIL 67
++ C F + LV AQDQ+GF+S+DCG+P+DSSY + +T ++Y SDA ++E+G SI
Sbjct: 10 IIFACFFAVFVLLVRAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIHSID 69
Query: 68 LQYRRMK-QQQVWSLRSFPDGIRNCYRFNLTRNT--KYLIRATFMYGNYDEQNNLPEFDV 124
+++ ++Q ++RSFP+G RNCY + KYLIR FMYGNYD P+FD+
Sbjct: 70 PEFQTSSLEKQFQNVRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDL 129
Query: 125 HLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTYI 184
+LG N+W ++ I+N + + EIIH L SD++ VC+V+ N+GTPF+SALE+R L +NTY
Sbjct: 130 YLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKSNTYE 189
Query: 185 TQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKNFKP 244
T DSL L R D+G RY DD +DR+W P ++ F+ S +D++ ++ F+P
Sbjct: 190 TPYDSLILFKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFNASLTIDSNNNEGFQP 249
Query: 245 PPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNGN-L 303
M +A P + S + FS DPT + +VYMHFAE+ EL +NE+R F + N +
Sbjct: 250 ARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKVLLNEKEI 309
Query: 304 WYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQTDE 363
YL + T+F Q+ +SG + F L +T ST PPIINAIE Y V EF QS TD+
Sbjct: 310 NMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQSPTDQ 369
Query: 364 QDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGF 423
QDVDAIM IKS YG+KK+W GDPCAP Y W+ +NCSY D++SPRI S+NLS+S LTG
Sbjct: 370 QDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGLTGEI 429
Query: 424 AHYXXXXXXXXXXXXXXXXXXGPVPXXXXXXXXXXXXXXARNKLTGPLPVELLEKQENNT 483
G +P NKL+G +PV+LLE+
Sbjct: 430 DAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKL 489
Query: 484 LELRFDGNPDLCRSASC 500
+ LR DGNPDLC SASC
Sbjct: 490 ILLRIDGNPDLCVSASC 506
|
|
| TAIR|locus:2195825 AT1G51850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1690 (600.0 bits), Expect = 6.1e-207, Sum P(2) = 6.1e-207
Identities = 356/752 (47%), Positives = 478/752 (63%)
Query: 155 YLSVCIVNTNKGTPFISALELRPLDNNTYITQTDSLELSIRLDVGSTSNATFRYIDDAYD 214
+ +VC++ T PFI+ LELRP+ N Y+TQ +SL R+ + S S+ R+ DD YD
Sbjct: 129 WTTVCLIKTGISIPFINVLELRPMKKNMYVTQGESLNYLFRVYI-SNSSTRIRFPDDVYD 187
Query: 215 RVWWPYDLDEWEPFSTSEAVDADGSKNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQ 274
R W+PY + W +T+ +D + S ++ P M A P+ A+++L+ + PT++
Sbjct: 188 RKWYPYFDNSWTQVTTT--LDVNTSLTYELPQSVMAKAATPIKANDTLNITWTVEPPTTK 245
Query: 275 LYVYMHFAEIEELKANESRLFNITRNGNLWYGPLKLNYLSSTTVFSQ--SAMSGGQYNFS 332
Y YMHFAE++ L+AN++R FN+T NG YGP L + T++ + GG
Sbjct: 246 FYSYMHFAELQTLRANDAREFNVTMNGIYTYGPYSPKPLKTETIYDKIPEQCDGGACLLQ 305
Query: 333 LIKTGNSTHPPIINAIEIYEVKEFSQSQTDEQDVDAIMNIKSFYGLKK-NWQGDPCAPQD 391
++KT ST PP++NAIE + V +F Q +T+ DVDAI N++ YG+ + +WQGDPC P+
Sbjct: 306 VVKTLKSTLPPLLNAIEAFTVIDFPQMETNGDDVDAIKNVQDTYGISRISWQGDPCVPKL 365
Query: 392 YLWEGLNCSYPDDD-SPRITSLNLSASELTGGFAHYXXXXXXXXXXXXXXXXXXGPVPXX 450
+LW+GLNC+ D+ SP ITSL+LS+S LTG G +P
Sbjct: 366 FLWDGLNCNNSDNSTSPIITSLDLSSSGLTGSITQAIQNLTNLQELDLSDNNLTGEIPDF 425
Query: 451 XXXXXXXXXXXXARNKLTGPLPVELLEKQENNTLELRFDGNPDL-CRSASCXXXXXXXXX 509
+ N L+G +P LL+K+ ++L +GNP L C + SC
Sbjct: 426 LGDIKSLLVINLSGNNLSGSVPPSLLQKKG---MKLNVEGNPHLLCTADSCVKKGEDGHK 482
Query: 510 XXXXXX--XXXXXXXXXXIG---LWSLKRKKQLPDPQ-ILIWLVRLSSGRKVDANCNRSY 563
IG L+ + RKK+ P + ++ S GR RS
Sbjct: 483 KKSVIVPVVASIASIAVLIGALVLFFILRKKKSPKVEGPPPSYMQASDGRSP-----RSS 537
Query: 564 E-SLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKLDNDE-VAVKMLSPSSSQGYK 621
E ++ +R+FTYS+V MTNNF+R+LGKGGFG VYHG ++ E VAVK+LS SSSQGYK
Sbjct: 538 EPAIVTKNRRFTYSQVAIMTNNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYK 597
Query: 622 QFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEI-LNWEER 680
+F+AEV+LLLRVHH+NL LVGYCDEG NMALIYEYMANG+L+EH+S + LNW R
Sbjct: 598 EFKAEVELLLRVHHKNLVGLVGYCDEGENMALIYEYMANGDLKEHMSGTRNRFTLNWGTR 657
Query: 681 LRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740
L+I VE+A GLEYLH GCKPP+VHRDVK+TNIL+NE FQAKLADFGLSR FP+EG THVS
Sbjct: 658 LKIVVESAQGLEYLHNGCKPPMVHRDVKTTNILLNEHFQAKLADFGLSRSFPIEGETHVS 717
Query: 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSS 800
T +AGTPGYLDPEYY +N LTEKSDVYSFG+VLLE+IT PVI KS E H+A+WV
Sbjct: 718 TVVAGTPGYLDPEYYKTNWLTEKSDVYSFGIVLLELITNRPVIDKSREK--PHIAEWVGV 775
Query: 801 MLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEA 860
ML KGDI S +DP L D+D SVWKAVE+AM+C++ ++ RRP M+QVV+ELN+C+A E
Sbjct: 776 MLTKGDINSIMDPNLNEDYDSGSVWKAVELAMSCLNPSSARRPTMSQVVIELNECIASEN 835
Query: 861 AQKKESITTTDSNNSFEMITVNLHTELSPLAR 892
++ S DS +S E +++ TELSP AR
Sbjct: 836 SRGGAS-RDMDSKSSIE-VSLTFDTELSPTAR 865
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1993 (706.6 bits), Expect = 4.7e-206, P = 4.7e-206
Identities = 428/907 (47%), Positives = 567/907 (62%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGL-PKDSSYTETSTKLRYTSDANYIE 59
ME + F + I HL V AQDQ GFI++DCGL P+DS Y T L YTSD +
Sbjct: 1 MESHRVFVATFMLILHL---VQAQDQPGFINVDCGLLPRDSPYNALGTGLVYTSDVGLVS 57
Query: 60 TGLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNL 119
+G I ++ +LR FPDG RNCY N++R+T Y+I+ATF+YGNYD +
Sbjct: 58 SGKTGKIAKEFEENNSTPNLTLRYFPDGARNCYNLNVSRDTNYMIKATFVYGNYDGHKDE 117
Query: 120 PEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLD 179
P FD++LGPNLW T+ + +V+ EIIHV SD L VC+ T PFI+ LELRPL
Sbjct: 118 PNFDLYLGPNLWATVS-RSETVE---EIIHVTKSDSLQVCLAKTGDFIPFINILELRPLK 173
Query: 180 NNTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDE-WEPFSTSEAVDADG 238
N Y+T++ SL+L R S S T RY DD YDRVW L+ W ST+ V+
Sbjct: 174 KNVYVTESGSLKLLFR-KYFSDSGQTIRYPDDIYDRVWHASFLENNWAQVSTTLGVNV-- 230
Query: 239 SKNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNIT 298
+ N+ M + P+N S +L+ + N PT+++Y YMHFAE+E L+AN++R FN+
Sbjct: 231 TDNYDLSQDVMATGATPLNDSETLNITWNVEPPTTKVYSYMHFAELETLRANDTREFNVM 290
Query: 299 RNGN-LW--YGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKE 355
NGN L+ Y P+ L + T + + G L+KT ST PP++NAIE + V +
Sbjct: 291 LNGNDLFGPYSPIPLKTETETNLKPEECEDGACI-LQLVKTSKSTLPPLLNAIEAFTVID 349
Query: 356 FSQSQTDEQDVDAIMNIKSFYGL--KKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLN 413
F Q +TDE D AI N+++ YGL + +WQGDPC P+ Y W+GL CSY D P I L+
Sbjct: 350 FLQVETDEDDAAAIKNVQNAYGLINRSSWQGDPCVPKQYSWDGLKCSYSDSTPPIINFLD 409
Query: 414 LSASELTGGFAHYXXXXXXXXXXXXXXXXXXGPVPXXXXXXXXXXXXXXARNKLTGPLPV 473
LSAS LTG A G VP N L+GP+P
Sbjct: 410 LSASGLTGIIAPAIQNLTHLEILALSNNNLTGEVPEFLADLKSIMVIDLRGNNLSGPVPA 469
Query: 474 ELLEKQENNTLELRFDGNPD-LCRSASCXXXXXXXXXXXXXXXXXXXXXXXXXIG---LW 529
LL+K+ L L D NP LC + SC IG L+
Sbjct: 470 SLLQKKG---LMLHLDDNPHILCTTGSCMHKGEGEKKSIIVPVVASIVSLAVIIGALILF 526
Query: 530 SLKRKKQLPDPQ-ILIWLVRLSSGRKVDANCNRSYE-SLDLSSRQFTYSEVLRMTNNFER 587
+ RKK+ + L ++ S GR RS E ++ +++FTYS+V+ MTNNF+R
Sbjct: 527 LVFRKKKASKVEGTLPSYMQASDGRSP-----RSSEPAIVTKNKRFTYSQVVIMTNNFQR 581
Query: 588 VLGKGGFGTVYHGKLDN-DEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD 646
+LGKGGFG VYHG ++ ++VAVK+LS SSSQGYKQF+AEV+LLLRVHH+NL LVGYCD
Sbjct: 582 ILGKGGFGIVYHGFVNGVEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGLVGYCD 641
Query: 647 EGTNMALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHR 705
EG NMALIYEYMANG+L+EH+S + ++ ILNWE RL+I +++A GLEYLH GCKP +VHR
Sbjct: 642 EGENMALIYEYMANGDLKEHMSGTRNRFILNWETRLKIVIDSAQGLEYLHNGCKPLMVHR 701
Query: 706 DVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSD 765
DVK+TNIL+NE F+AKLADFGLSR FP+ G THVST +AGTPGYLDPEYY +NRLTEKSD
Sbjct: 702 DVKTTNILLNEHFEAKLADFGLSRSFPIGGETHVSTVVAGTPGYLDPEYYKTNRLTEKSD 761
Query: 766 VYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVW 825
VYSFG+VLLE+IT PVI +S E ++++WV ML KGDI S +DP L GD+D SVW
Sbjct: 762 VYSFGIVLLEMITNRPVIDQSREK--PYISEWVGIMLTKGDIISIMDPSLNGDYDSGSVW 819
Query: 826 KAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNLHT 885
KAVE+AM+C++ ++ RRP M+QV++ LN+CL E ++ S DS +S E +++ T
Sbjct: 820 KAVELAMSCLNPSSTRRPTMSQVLIALNECLVSENSRGGAS-RDMDSKSSLE-VSLTFDT 877
Query: 886 ELSPLAR 892
++SP+AR
Sbjct: 878 DVSPMAR 884
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1974 (699.9 bits), Expect = 4.9e-204, P = 4.9e-204
Identities = 415/884 (46%), Positives = 542/884 (61%)
Query: 6 RFALLC-LCIFHLAALVCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIETGLPK 64
R LL + I LV AQDQ+GFIS+DCG+P DSSYT+ T ++Y SD ++E+G
Sbjct: 3 RLRLLSWISITSCVCLVFAQDQSGFISIDCGIPDDSSYTDEKTNMKYVSDLGFVESGTSH 62
Query: 65 SILLQYRRMK-QQQVWSLRSFPDGIRNCY--RFNLTRNTKYLIRATFMYGNYDEQNNLPE 121
SI+ + ++Q ++RSFP+G RNCY R + KYLIR FMYGNYD + PE
Sbjct: 63 SIVSDLQTTSLERQFQNVRSFPEGKRNCYDIRPQQGKGFKYLIRTRFMYGNYDGFSKTPE 122
Query: 122 FDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNN 181
FD+++G NLW ++ + N + + EII+ SD++ VC+V+ N+GTPF+S LE+R L N+
Sbjct: 123 FDLYIGANLWESVVLINETAIMTKEIIYTPPSDHIHVCLVDKNRGTPFLSVLEIRFLKND 182
Query: 182 TYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKN 241
TY T ++L L R D G+ +N RY DD YDR+W PY + +TS +D
Sbjct: 183 TYDTPYEALMLGRRWDFGTATNLQIRYKDDFYDRIWMPYKSPYQKTLNTSLTIDETNHNG 242
Query: 242 FKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNG 301
F+P M+SA+ P N SN L F+ DP S+ Y+YMHFAE+ EL+ NE+R F+I N
Sbjct: 243 FRPASIVMRSAIAPGNESNPLKFNWAPDDPRSKFYIYMHFAEVRELQRNETREFDIYIND 302
Query: 302 NLWYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQT 361
+ + YL + T + + L +TG ST PPIINAIEIY++ EF Q T
Sbjct: 303 VILAENFRPFYLFTDTRSTVDPVGRKMNEIVLQRTGVSTLPPIINAIEIYQINEFLQLPT 362
Query: 362 DEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDD-SPRITSLNLSASELT 420
D+QDVDA+ IK Y +KKNWQGDPC P D WEGL C + D++ SP+ +LNLS+S LT
Sbjct: 363 DQQDVDAMTKIKFKYRVKKNWQGDPCVPVDNSWEGLECLHSDNNTSPKSIALNLSSSGLT 422
Query: 421 GGFAHYXXXXXXXXXXXXXXXXXXGPVPXXXXXXXXXXXXXXARNKLTGPLPVELLEKQE 480
G G VP NKLTG +P +LLEK +
Sbjct: 423 GQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPAKLLEKSK 482
Query: 481 NNTLELRFDGNPDLCRSASCXXXXXXXXXXXXXXXXXXXXXXXXXIGLWSLKRKKQLPDP 540
+ +L LRF GNPDLC+S SC I L +L
Sbjct: 483 DGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAGLL---IVLTALA-------- 531
Query: 541 QILIWLVRLSSGRKVDANCNRSYES--LDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVY 598
LIW + S R +N + LD + R F YSEV+ +TNNFERVLGKGGFG VY
Sbjct: 532 --LIWHFKKRSRRGTISNKPLGVNTGPLDTAKRYFIYSEVVNITNNFERVLGKGGFGKVY 589
Query: 599 HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658
HG L+ D+VAVK+LS S+QGYK+F+AEV+LL+RVHH NLT+L+GYC+E +MALIYEYM
Sbjct: 590 HGFLNGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLIGYCNEDNHMALIYEYM 649
Query: 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF 718
ANGNL ++LS S IL+WEERL+I+++AA GLEYLH GCKPPIVHRDVK NIL+NE
Sbjct: 650 ANGNLGDYLSGKSSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENL 709
Query: 719 QAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
QAK+ADFGLSR FPVEG + VST +AGT GYLDPEYY + ++ EKSDVYSFGVVLLE+IT
Sbjct: 710 QAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVIT 769
Query: 779 GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSN 838
G P I S H++ V SML GDI+ VD RL F++ S WK E+A+AC S +
Sbjct: 770 GKPAIWHSRTES-VHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWKITELALACASES 828
Query: 839 ANRRPFMNQVVMELNDCL---AMEAAQKKESITTTDSNNSFEMI 879
+ +RP M+QVVMEL + + K+ + N EM+
Sbjct: 829 SEQRPTMSQVVMELKQSIFGRVNNRSDHKDPVRMVTMNLDTEMV 872
|
|
| TAIR|locus:2017572 AT1G51790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1959 (694.7 bits), Expect = 1.9e-202, P = 1.9e-202
Identities = 397/874 (45%), Positives = 553/874 (63%)
Query: 8 ALLCLCIFHLAALVCAQDQAGFISLDCGL-PKDSSYTETSTKLRYTSDANYIETGLPKSI 66
AL +C L L AQDQ+GFIS+DCGL P++SSYTETST ++Y SD++Y +TG +
Sbjct: 8 ALTFICCVALLNLAIAQDQSGFISIDCGLQPENSSYTETSTDIKYVSDSSYTDTGTSYFV 67
Query: 67 LLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPEFDVHL 126
+ R+ +Q +WS+RSFP+GIRNCY + +TKYLIRA FMYGNYD +N +P FD+HL
Sbjct: 68 APENRQNMKQSMWSVRSFPEGIRNCYTIAVNSSTKYLIRADFMYGNYDSRNEIPGFDLHL 127
Query: 127 GPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTYITQ 186
GPN W T+++ + S EII+ + +D + VC+VNT GTPFIS LELR L N++Y Q
Sbjct: 128 GPNKWDTVELVSPLQTVSKEIIYYVLTDTIQVCLVNTGNGTPFISVLELRQLPNSSYAAQ 187
Query: 187 TDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFST-SEAVDADGSKNFKPP 245
++SL+L RLD GST+N T RY +D +DR+W+P + +P S S ++ ++ + NF+ P
Sbjct: 188 SESLQLFQRLDFGSTTNLTVRYPNDVFDRIWFPATPNGTKPLSDPSTSLTSNSTGNFRLP 247
Query: 246 PRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKAN--ESRLFNITRNGNL 303
M++ + P N +DF DP+ + + Y++F E+++ + E+R F I NG
Sbjct: 248 QVVMRTGIVPDNPRGFVDFGWIPDDPSLEFFFYLYFTELQQPNSGTVETREFVILLNGKS 307
Query: 304 WYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQTDE 363
+ PL LNY + +F+ + + + FSL +T +S+ PP+INA+E Y V + QS TD
Sbjct: 308 FGEPLSLNYFRTLALFTSNPLKAESFQFSLRQTQSSSLPPLINAMETYFVNKLPQSSTDP 367
Query: 364 QDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGF 423
D+ A+ NIKS Y +K+NW+GD C PQ Y WEGLNCS+ + PR+ +LNLS++ LTG
Sbjct: 368 NDLSAMRNIKSAYKVKRNWEGDVCVPQAYTWEGLNCSFNGTNMPRVIALNLSSAGLTGEI 427
Query: 424 AHYXXXXXXXXXXXXXXXXXXGP-VPXXXXXXXXXXXXXXARNKLTGPLPVELLEKQENN 482
GP VP A N+L+GP+P L+E+ ++
Sbjct: 428 TSDISRLSQLQILDLSNNNLSGPAVPAFLAQLQFLRVLHLANNQLSGPIPSSLIERLDS- 486
Query: 483 TLELRFDGNPDLCRSASCXXXXXXXXXXXXXXXXXXXXXXXXXIGLWSLKRKKQLPDPQI 542
F GNP +C + +C GL L + I
Sbjct: 487 -----FSGNPSICSANACEEVSQNRSKKNKLPSFVIPLVASLA-GLLLLF----IISAAI 536
Query: 543 LIWLVRLSSGRKVDANCNRS-YESLDL--SSRQFTYSEVLRMTNNFERVLGKGGFGTVYH 599
+ L+R +K D N + ++ DL S+R+FTY+E++ +TN F+R GK GFG Y
Sbjct: 537 FLILMRK---KKQDYGGNETAVDAFDLEPSNRKFTYAEIVNITNGFDRDQGKVGFGRNYL 593
Query: 600 GKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659
GKLD EV VK++S SSQGYKQ +AEVK L R+HH+NL T++GYC+EG MA+IYEYMA
Sbjct: 594 GKLDGKEVTVKLVSSLSSQGYKQLRAEVKHLFRIHHKNLITMLGYCNEGDKMAVIYEYMA 653
Query: 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQ 719
NGNL++H+S++S + +WE+RL IAV+ A GLEYLH GCKPPI+HR+VK TN+ ++E F
Sbjct: 654 NGNLKQHISENSTTVFSWEDRLGIAVDVAQGLEYLHTGCKPPIIHRNVKCTNVFLDESFN 713
Query: 720 AKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG 779
AKL FGLSR F G+H++T IAGTPGY+DPEYY SN LTEKSDVYSFGVVLLEI+T
Sbjct: 714 AKLGGFGLSRAFDAAEGSHLNTAIAGTPGYVDPEYYTSNMLTEKSDVYSFGVVLLEIVTA 773
Query: 780 HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNA 839
P I K+ E H++QWV S+L + +I +DP L GD+D NS +K VEIA+ACV N+
Sbjct: 774 KPAIIKNEER--MHISQWVESLLSRENIVEILDPSLCGDYDPNSAFKTVEIAVACVCRNS 831
Query: 840 NRRPFMNQVVMELNDCLAMEAAQKKE-SITTTDS 872
RP M+QVV L + LA+E +KK + +TDS
Sbjct: 832 GDRPGMSQVVTALKESLAVEVERKKHLPVGSTDS 865
|
|
| TAIR|locus:2017647 AT1G51820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1930 (684.5 bits), Expect = 2.2e-199, P = 2.2e-199
Identities = 419/906 (46%), Positives = 565/906 (62%)
Query: 1 MEMFQRFALLCLCIFHLAALVCAQDQAGFISLDCGLPK-DSSYTETSTKLRYTSDANYIE 59
ME F L IFHL V AQ+Q GFIS+DCGL +S Y T L YTSDA+ +
Sbjct: 1 MERHFVFIATYLLIFHL---VQAQNQTGFISVDCGLSLLESPYDAPQTGLTYTSDADLVA 57
Query: 60 TGLPKSILLQYRRMKQQQVWSLRSFPDGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNL 119
+G + ++ + + +LR FP+G+RNCY N+T +T YLI+ATF+YGNYD N
Sbjct: 58 SGKTGRLAKEFEPLVDKPTLTLRYFPEGVRNCYNLNVTSDTNYLIKATFVYGNYDGLNVG 117
Query: 120 PEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLD 179
P F+++LGPNLW T+ N +++ EII V S+ L VC+V T PFI+ LELRP+
Sbjct: 118 PNFNLYLGPNLWTTVS-SNDTIE---EIILVTRSNSLQVCLVKTGISIPFINMLELRPMK 173
Query: 180 NNTYITQTDSLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGS 239
N Y+TQ+ SL+ R + S S+ R+ DD YDR W+P D W +T+ V+ S
Sbjct: 174 KNMYVTQSGSLKYLFRGYI-SNSSTRIRFPDDVYDRKWYPLFDDSWTQVTTNLKVNT--S 230
Query: 240 KNFKPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITR 299
++ P M A P+ A+++L+ + PT+Q Y Y+H AEI+ L+ANE+R FN+T
Sbjct: 231 ITYELPQSVMAKAATPIKANDTLNITWTVEPPTTQFYSYVHIAEIQALRANETREFNVTL 290
Query: 300 NGNLWYGPLKLNYLSSTTV--FSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFS 357
NG +GP L + ++ S GG+ ++KT ST PP++NAIE + V +F
Sbjct: 291 NGEYTFGPFSPIPLKTASIVDLSPGQCDGGRCILQVVKTLKSTLPPLLNAIEAFTVIDFP 350
Query: 358 QSQTDEQDVDAIMNIKSFYGLKK-NWQGDPCAPQDYLWEGLNCSYPDDDSPRI-TSLNLS 415
Q +T+E DV I N++ YGL + +WQGDPC P+ LW+GLNC D +P I TSL+LS
Sbjct: 351 QMETNENDVAGIKNVQGTYGLSRISWQGDPCVPKQLLWDGLNCKNSDISTPPIITSLDLS 410
Query: 416 ASELTGGFAHYXXXXXXXXXXXXXXXXXXGPVPXXXXXXXXXXXXXXARNKLTGPLPVEL 475
+S LTG G VP + N L+G +P L
Sbjct: 411 SSGLTGIITQAIKNLTHLQILDLSDNNLTGEVPEFLADIKSLLVINLSGNNLSGSVPPSL 470
Query: 476 LEKQENNTLELRFDGNPD-LCRSASCXXXXXXXXXXXXXXX--XXXXXXXXXXIG---LW 529
L+K+ ++L +GNP LC + SC IG L+
Sbjct: 471 LQKKG---MKLNVEGNPHILCTTGSCVKKKEDGHKKKSVIVPVVASIASIAVLIGALVLF 527
Query: 530 SLKRKKQLPDPQILIWLVRLSSGRKVDANCNRSYE-SLDLSSRQFTYSEVLRMTNNFERV 588
+ RKK+ P + S + D RS E ++ +R+F+YS+V+ MTNNF+R+
Sbjct: 528 LILRKKRSPKVEG----PPPSYMQASDGRLPRSSEPAIVTKNRRFSYSQVVIMTNNFQRI 583
Query: 589 LGKGGFGTVYHGKLDNDE-VAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE 647
LGKGGFG VYHG ++ E VAVK+LS SSSQGYKQF+AEV+LLLRVHH+NL LVGYCDE
Sbjct: 584 LGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGLVGYCDE 643
Query: 648 GTNMALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRD 706
G N+ALIYEYMANG+L+EH+S + ++ ILNW RL+I +E+A GLEYLH GCKPP+VHRD
Sbjct: 644 GDNLALIYEYMANGDLKEHMSGTRNRFILNWGTRLKIVIESAQGLEYLHNGCKPPMVHRD 703
Query: 707 VKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDV 766
VK+TNIL+NE F+AKLADFGLSR F +EG THVST +AGTPGYLDPEY+ +N LTEKSDV
Sbjct: 704 VKTTNILLNEHFEAKLADFGLSRSFLIEGETHVSTVVAGTPGYLDPEYHRTNWLTEKSDV 763
Query: 767 YSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWK 826
YSFG++LLEIIT VI +S E H+ +WV ML KGDI+S +DP L D+D SVWK
Sbjct: 764 YSFGILLLEIITNRHVIDQSREK--PHIGEWVGVMLTKGDIQSIMDPSLNEDYDSGSVWK 821
Query: 827 AVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTTDSNNSFEMITVNLHTE 886
AVE+AM+C++ ++ RRP M+QVV+ELN+CLA E A+ S +S +S E +++ TE
Sbjct: 822 AVELAMSCLNHSSARRPTMSQVVIELNECLASENARGGAS-RDMESKSSIE-VSLTFGTE 879
Query: 887 LSPLAR 892
+SP AR
Sbjct: 880 VSPNAR 885
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 892 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 1e-120 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-45 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-23 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.003 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 368 bits (947), Expect = e-120
Identities = 153/339 (45%), Positives = 205/339 (60%), Gaps = 21/339 (6%)
Query: 32 LDCGLPKDSSYTETSTKLRYTSDANYIETGLPKSILLQYRRMK-QQQVWSLRSFPDGIRN 90
+DCGLP + SYT+ ST + + SDA +I+TG +I + + +LRSFPDG RN
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFPDGKRN 60
Query: 91 CYRFNLT--RNTKYLIRATFMYGNYDEQNNL---PEFDVHLGPNLWGTIKIENVSVDYSV 145
CY +T + TKYLIRATF+YGNYD N++ P FD++LG NLW T+ + N S D V
Sbjct: 61 CYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSVV 120
Query: 146 E--IIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTYITQTDS--LELSIRLDVGST 201
+ IIHV SD LSVC+VNT GTPFISALELRPL ++ Y + S L+L RL+ G +
Sbjct: 121 KEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGSQALKLVARLNFGGS 180
Query: 202 SNATFRYIDDAYDRVWWPYDL-DEWEPFSTSEAVDADGSKN-FKPPPRAMKSAVRPVNAS 259
T RY DD YDR+W P+ W STS +VD + + PP +++AV P NAS
Sbjct: 181 -EGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVTPTNAS 239
Query: 260 NSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNGNLWYGPLKLNYLSSTTVF 319
L+F+ + DP + YVY+HFAEI+ L E+R F+I NG YG + YL + T
Sbjct: 240 APLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGDVSPKYLGTDTGA 296
Query: 320 SQS-----AMSGGQYNFSLIKTGNSTHPPIINAIEIYEV 353
GG N SL+ T ST PP++NA+EI++V
Sbjct: 297 LYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 585 FERVLGKGGFGTVYHGKLDND------EVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRN 637
+ LG+G FG VY G L EVAVK L +S Q ++F E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ L+G C E + ++ EYM G+L ++L + + L+ + L A++ A G+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG---YLDPEY 754
+HRD+ + N L+ E K++DFGLSR + + G ++ PE
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
+ T KSDV+SFGV+L EI T
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-49
Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 18/204 (8%)
Query: 585 FERVLGKGGFGTVYHGKLDN------DEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRN 637
+ LG+G FG VY GKL EVAVK L +S Q ++F E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ L+G C E + ++ EYM G+L +L + ++ + + L A++ A G+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL-SLSDLLSFALQIARGMEYLESK 121
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG---YLDPEY 754
+HRD+ + N L+ E K++DFGLSR + G ++ PE
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
+ T KSDV+SFGV+L EI T
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-49
Identities = 70/193 (36%), Positives = 113/193 (58%), Gaps = 11/193 (5%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTTLVGYC 645
LG+GGFGTVY K +VA+K++ S + E+++L +++H N+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 646 DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHR 705
++ ++ L+ EY G+L++ L ++ + L+ +E LRI ++ GLEYLH I+HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 706 DVKSTNILINEK-FQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR-LTEK 763
D+K NIL++ + KLADFGLS++ + TI GTP Y+ PE + +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 764 SDVYSFGVVLLEI 776
SD++S GV+L E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 4e-48
Identities = 73/206 (35%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 587 RVLGKGGFGTVYHGKLDND-----EVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTT 640
+ LG+G FG VY GKL EVAVK L S + K F E +++ ++ H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHL-------SDSSKEILNWEERLRIAVEAALGLEY 693
L+G C E + L+ EYM G+L ++L K L+ ++ L A++ A G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDP 752
L VHRD+ + N L+ E K++DFGLSR + + T P ++ P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIIT 778
E T KSDV+SFGV+L EI T
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 4e-48
Identities = 75/203 (36%), Positives = 112/203 (55%), Gaps = 14/203 (6%)
Query: 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTT 640
R LG G FGTVY K VAVK+L S S+ + + E+++L R+ H N+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCK 699
L+ ++ ++ L+ EY G+L ++LS L+ +E +IA++ GLEYLH G
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
I+HRD+K NIL++E K+ADFGL++ + TT GTP Y+ PE +
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 760 L-TEKSDVYSFGVVLLEIITGHP 781
K DV+S GV+L E++TG P
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKP 197
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-47
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGY-KQFQAEVKLLLRVHHRNLTTL 641
LG+G FG VY K VA+K++ + ++ E+K+L ++ H N+ L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKP 700
++ + L+ EY G+L + L + L+ +E + LEYLH +G
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILSALEYLHSKG--- 117
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
IVHRD+K NIL++E KLADFGL+R TT GTP Y+ PE +
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 761 TEKSDVYSFGVVLLEIITGHP 781
+ D++S GV+L E++TG P
Sbjct: 174 GKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 70/207 (33%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 585 FERVLGKGGFGTVYHGKLDND------EVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRN 637
+ LG+G FG VY G L D +VAVK L +S+ ++ F E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ L+G C +G + ++ EYM G+L + L E L ++ L++A++ A G+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLD-----P 752
VHRD+ + N L+ E K++DFGLSR G L P
Sbjct: 122 ---NFVHRDLAARNCLVTENLVVKISDFGLSRD-----IYEDDYYRKRGGGKLPIKWMAP 173
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIITG 779
E + T KSDV+SFGV+L EI T
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 2e-40
Identities = 129/475 (27%), Positives = 207/475 (43%), Gaps = 75/475 (15%)
Query: 80 SLRSFP--DGIRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPEFDVHLGPNLWGTIKIE 137
+LR FP DG NCY N Y +R F ++ P FDV + ++K
Sbjct: 71 TLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSG 130
Query: 138 NVSVD---YSVEIIHVLSSDYLSVCIVNTNKGTPFISALELRPLDNNTY-----ITQTDS 189
S D ++ ++ + S+C +T G P I ++E+ +D+ Y Q
Sbjct: 131 WSSHDEQVFAEALVFLTDGS-ASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWGQGVI 189
Query: 190 LELSIRLDVGS-TSNATFRYIDDAY--DRVWWP---YDLDEWEPFSTSEAV-DADGSKNF 242
L + RL G+ S Y D + DR W + + ST + A + NF
Sbjct: 190 LRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNF 249
Query: 243 KPPPRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEE-LKANESRLFNITRNG 301
P +SA+ + L ++++ DP V++HFAEI+ + A R+F++ NG
Sbjct: 250 YPES-LYQSALVSTDTQPDLSYTMDV-DPNRNYSVWLHFAEIDNSITAEGKRVFDVLING 307
Query: 302 NLWYGPLKLNYLSSTTVFSQSAMSGGQY-----NFSLIKTGN----STHP-----PIINA 347
+ + + + MSG +Y N ++ +G P IINA
Sbjct: 308 DTAFKDVDI-----------VKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTHAIINA 356
Query: 348 IEIYEVKEFSQSQTDEQDVDAIMNIKSFYGL--KKNWQGDPCAPQDYLWEGLNCSY---- 401
IE++E+ ++S+T ++V A+ +KS GL + W GDPC PQ + W G +C +
Sbjct: 357 IEVFEIIT-AESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTK 415
Query: 402 -------------------PDDDSP--RITSLNLSASELTGGFAHYLTNLTMLTSLDLSN 440
P+D S + S+NLS + + G L ++T L LDLS
Sbjct: 416 GKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSY 475
Query: 441 NNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNPDLC 495
N+ G +P+ L QL+SL+ LNL N L+G +P L + + F N LC
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA-SFNFTDNAGLC 529
|
Length = 623 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVK--MLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
+LG+G FG+VY K + +AVK LS S + + + E+++L + H N+ V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI---V 62
Query: 643 GY----CDEGTNMALIY-EYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLH- 695
Y DE N I+ EY++ G+L L K L E +R L GL YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LP-EPVIRKYTRQILEGLAYLHS 119
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
G IVHRD+K NIL++ KLADFG ++ + ++ GTP ++ PE
Sbjct: 120 NG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHPV 782
+D++S G ++E+ TG P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 9/202 (4%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
+GKGGFG VY K EVA+K++ S + ++ E+++L + H N+ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVH 704
+ + ++ E+ + G+L++ L S+ + L + + E GLEYLH I+H
Sbjct: 66 YLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIH 121
Query: 705 RDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKS 764
RD+K+ NIL+ + KL DFGLS + T+ GTP ++ PE K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGKPYDYKA 178
Query: 765 DVYSFGVVLLEIITGHPVISKS 786
D++S G+ +E+ G P S+
Sbjct: 179 DIWSLGITAIELAEGKPPYSEL 200
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVK--MLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
+ +GKG FG VY K D +K LS S + + EVK+L +++H N+ +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---I 62
Query: 643 GYCD---EGTNMALIYEYMANGNLEEHLSDSSK--------EILNWEERLRIAVEAALGL 691
Y + E + ++ EY G+L + + K +IL+W V+ L L
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW------FVQLCLAL 116
Query: 692 EYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLD 751
+YLH I+HRD+K NI + KL DFG+S+V ++ T+ GTP YL
Sbjct: 117 KYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPYYLS 171
Query: 752 PEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
PE + KSD++S G VL E+ T
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 77/231 (33%), Positives = 110/231 (47%), Gaps = 41/231 (17%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKMLS-PSSSQGYKQFQAEVK 628
V R T +R LG+G FG V+ G+ + E VAVK L +S+ K F+ E +
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL------------SDSSKEILN 676
LL H N+ G C EG +++EYM +G+L + L DS L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 677 WEERLRIAVEAALGLEYL---HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR---- 729
+ L+IAV+ A G+ YL H VHRD+ + N L+ K+ DFG+SR
Sbjct: 121 LSQLLQIAVQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174
Query: 730 --VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ V G T + ++ PE + + T +SDV+SFGVVL EI T
Sbjct: 175 TDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (326), Expect = 1e-32
Identities = 84/319 (26%), Positives = 143/319 (44%), Gaps = 28/319 (8%)
Query: 584 NFERVLGKGGFGTVYHGKLDNDEVAVKMLSP---SSSQGYKQFQAEVKLLLRV-HHRNLT 639
R LG+G FG VY + D VA+K+L+ S S+ ++F E+++L + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHL-SDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
L + + ++ L+ EY+ G+LE+ L K L+ E L I + LEYLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 699 KPPIVHRDVKSTNILINEK-FQAKLADFGLSRVFPVEGGT----HVSTTIAGTPGYLDPE 753
I+HRD+K NIL++ KL DFGL+++ P G T + +T GTPGY+ PE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 754 YYISNRL---TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRST 810
+ L + SD++S G+ L E++TG P E + +Q + +L+ +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLP--PFEGEKNSSATSQTLKIILELPT--PS 234
Query: 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESITTT 870
+ L A ++ ++ + R + L+ + + +
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRL-------SSSSDLSHDLLAHLKLKESD 287
Query: 871 DSNNSFEMITVNLHTELSP 889
S+ + L L P
Sbjct: 288 LSDLLKPDDSAPLRLSLPP 306
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 583 NNFERV--LGKGGFGTVY---HGKLDNDEVAVKML-SPSSSQGYKQFQAEVKLLLRVHHR 636
++ ERV LG+G G VY H K A+K + + KQ E+K L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRH-KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59
Query: 637 NLTTLVG-YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL--RIAVEAALGLEY 693
+ G + EG ++++ EYM G+L + L K++ E + IA + GL+Y
Sbjct: 60 YVVKCYGAFYKEGE-ISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDY 114
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
LH I+HRD+K +N+LIN K + K+ADFG+S+V +E T GT Y+ PE
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPE 170
Query: 754 YYISNRLTEKSDVYSFGVVLLEIITGH 780
+ +D++S G+ LLE G
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 588 VLGKGGFGTVYHG--KLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
++G+G FG VY G D VA+K +S + K E+ LL + H N+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKPPI 702
+ ++ +I EY NG+L + + + GL YLH QG +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGLAYLHEQG----V 120
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE 762
+HRD+K+ NIL + KLADFG++ ++ GTP ++ PE + +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGAST 178
Query: 763 KSDVYSFGVVLLEIITGHP 781
SD++S G ++E++TG+P
Sbjct: 179 ASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 61/189 (32%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 589 LGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG 648
+GKG FG V G +VAVK L S + F AE ++ + H NL L+G +G
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 649 TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVK 708
+ ++ EYMA G+L ++L + ++ ++L A++ G+EYL + VHRD+
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLA 129
Query: 709 STNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSDVY 767
+ N+L++E AK++DFGL++ P + PE + + KSDV+
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 768 SFGVVLLEI 776
SFG++L EI
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-31
Identities = 125/488 (25%), Positives = 219/488 (44%), Gaps = 62/488 (12%)
Query: 402 PDDDSP--RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKF 459
PD+ S ++ SL+LS ++L+G + + +L+ LDLS N L+G +PK L + SL
Sbjct: 516 PDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ 575
Query: 460 LNLARNKLTGPLPVELLEKQENNTLELRFDGNPDLCRSAS------CKK-EKKKFVVPVV 512
+N++ N L G LP N + GN DLC + CK+ K +
Sbjct: 576 VNISHNHLHGSLPSTGAFLAINAS---AVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYI 632
Query: 513 ASVASVFVVLA-ALIGLWSLKRKKQLPDPQIL----IWLVRLSSGRKVDANCNRSYESLD 567
F+VLA G ++ + L ++ W ++ +
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSK-------------- 678
Query: 568 LSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKLDNDEV--AVKMLSPSSSQGYKQFQA 625
S+ T +++L + E V+ +G G Y GK + + VK ++ +S +
Sbjct: 679 -VSKSITINDIL-SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SS 732
Query: 626 EVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV 685
E+ + ++ H N+ L+G C LI+EY+ NL E L + L+WE R +IA+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAI 787
Query: 686 EAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG 745
A L +LH C P +V ++ I+I+ K + L L + + +S+
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS---- 842
Query: 746 TPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENG-HTHVAQWVSSMLDK 804
Y+ PE + +TEKSD+Y FG++L+E++TG AE G H + +W
Sbjct: 843 --AYVAPETRETKDITEKSDIYGFGLILIELLTGKS--PADAEFGVHGSIVEWARYCYSD 898
Query: 805 GDIRSTVDPRLKGDFDIN--SVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQ 862
+ +DP ++GD +N + + + +A+ C +++ RP N V+ +E+A
Sbjct: 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK------TLESAS 952
Query: 863 KKESITTT 870
+ S T
Sbjct: 953 RSSSSCVT 960
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 8/204 (3%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDND-EVAVKMLSPSSSQGYKQFQAEVKLLLRVHH 635
E+ R + R LG G FG V+ G +N VAVK L P + K F AE +++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRH 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
L L C + ++ E M G+L E+L + L + + +A + A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
+HRD+ + N+L+ E K+ADFGL+RV + + + A P + PE
Sbjct: 121 A---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED--IYEAREGAKFPIKWTAPEA 175
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
+ NR + KSDV+SFG++L EI+T
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 586 ERVLGKGGFGTVYHGK-LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
ER LG G FG V+ G + VA+K+L + FQ EV+ L R+ H++L +L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVH 704
C G + +I E M G+L L ++L + +A + A G+ YL + +H
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIH 127
Query: 705 RDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEK 763
RD+ + NIL+ E K+ADFGL+R+ + I P + PE + K
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHGTFSTK 184
Query: 764 SDVYSFGVVLLEIIT 778
SDV+SFG++L E+ T
Sbjct: 185 SDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 68/204 (33%), Positives = 107/204 (52%), Gaps = 8/204 (3%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDND-EVAVKMLSPSSSQGYKQFQAEVKLLLRVHH 635
E+ R + ER LG G FG V+ G + +VAVK L P + + F E +++ ++ H
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRH 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
L L C E + ++ EYM+ G+L + L + L + + +A + A G+ YL
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
+HRD+ + NIL+ E K+ADFGL+R+ +E + + A P + PE
Sbjct: 121 S---RNYIHRDLAARNILVGENLVCKIADFGLARL--IEDDEYTAREGAKFPIKWTAPEA 175
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
R T KSDV+SFG++L EI+T
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 69/200 (34%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 589 LGKGGFGTVYHGKLDNDEV--AVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNLTTLVG 643
LGKG FG V + + A+K+L K+ + E +L R++H + L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR-IAVEAALGLEYLH-QGCKPP 701
+ L+ EY G L HLS + + EER R A E L LEYLH G
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLS--KEGRFS-EERARFYAAEIVLALEYLHSLG---- 113
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
I++RD+K NIL++ KL DFGL++ EG + T GTP YL PE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLLGKGYG 171
Query: 762 EKSDVYSFGVVLLEIITGHP 781
+ D +S GV+L E++TG P
Sbjct: 172 KAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 67/216 (31%), Positives = 113/216 (52%), Gaps = 17/216 (7%)
Query: 585 FERVLGKGGFGTVYHGKLDN------DEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRN 637
F + LG+G FG V + D ++VAVK L+ S Q F+ E+++L + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 638 LTTLVGYCDE--GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
+ G C++ G ++ LI EY+ +G+L ++L +I + L + + G++YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL-KRLLLFSSQICKGMDYLG 126
Query: 696 -QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG-YLDPE 753
Q +HRD+ + NIL+ + K++DFGL++V P + + +P + PE
Sbjct: 127 SQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 754 YYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAE 788
+++ + SDV+SFGV L E+ T G P S AE
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 67/193 (34%), Positives = 105/193 (54%), Gaps = 9/193 (4%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD 646
LG G +G VY G K + VAVK L + + ++F E ++ + H NL L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 647 EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRD 706
+I E+M GNL ++L + +++ +N L +A + + +EYL K +HRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129
Query: 707 VKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSD 765
+ + N L+ E K+ADFGLSR+ + G T+ + A P + PE N+ + KSD
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 766 VYSFGVVLLEIIT 778
V++FGV+L EI T
Sbjct: 188 VWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 78/230 (33%), Positives = 107/230 (46%), Gaps = 31/230 (13%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYH----GKLDNDE---VAVKMLSP-SSSQGYKQFQAEVK 628
E R + R +G+G FG V+ G L + VAVKML +S+ FQ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSS----------------- 671
L+ H N+ L+G C G M L++EYMA G+L E L S
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 672 ---KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLS 728
L+ E+L IA + A G+ YL + VHRD+ + N L+ E K+ADFGLS
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 729 RVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
R S A ++ PE NR T +SDV+++GVVL EI +
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 57/230 (24%)
Query: 585 FERVLGKGGFGTVYHGKL--DNDE-----VAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHR 636
F LG+G FG VY G+L N+ VA+K L ++ +Q F+ E +L+ + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHL--------------SDSSKEILNWEERLR 682
N+ L+G C + +++EY+A+G+L E L ++ K L+ + L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 683 IAVEAALGLEYL--HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR----------- 729
IA++ A G+EYL H VHRD+ + N L+ E K++DFGLSR
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 730 ---VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEI 776
+ PV ++ PE + + T +SD++SFGVVL EI
Sbjct: 184 SKSLLPVR--------------WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 585 FERVLGKGGFGTVYHGK-LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
F + LG G FG V+ GK +VA+KM+ + F E K+++++ H NL L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
C + + ++ EYMANG L +L K L E L + + +EYL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTE 762
HRD+ + N L+ E K++DFGL+R V + S+ P + PE + +R +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 763 KSDVYSFGVVLLEIITG 779
KSDV+SFGV++ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 10/197 (5%)
Query: 587 RVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTTLVGY 644
+GKG FG VY G L N EVAVK + K+ F E ++L + H N+ L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVH 704
C + + ++ E + G+L L L ++ L+++++AA G+EYL +H
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 705 RDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH-VSTTIAGTP-GYLDPEYYISNRLTE 762
RD+ + N L+ E K++DFG+SR EGG + VS + P + PE R T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 763 KSDVYSFGVVLLEIITG 779
+SDV+S+G++L E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 583 NNFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTT 640
N E+ +G+G G VY + EVA+K + Q + E+ ++ H N+
Sbjct: 22 KNLEK-IGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVD 79
Query: 641 LVG-YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
Y + ++ EYM G+L + + + +N + + E GLEYLH
Sbjct: 80 YYDSYLVGDE-LWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGLEYLHSQ-- 135
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS--TTIAGTPGYLDPEYYIS 757
++HRD+KS NIL+++ KLADFG F + S ++ GTP ++ PE
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190
Query: 758 NRLTEKSDVYSFGVVLLEIITGHP 781
K D++S G++ +E+ G P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 588 VLGKGGFGTVY--HGKLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
+GKG FGTV K D + K + + + +Q +EV +L + H N+ V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI---VR 63
Query: 644 YCDEGTNMA-----LIYEYMANGNLEEHLSDSSKEILNWEER--LRIAVEAALGLEYLHQ 696
Y D + + ++ EY G+L + + KE EE RI + L L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 697 GCKPP--IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
P ++HRD+K NI ++ KL DFGL+++ + + + T GTP Y+ PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQ 181
Query: 755 YISNRLTEKSDVYSFGVVLLEIITGHP 781
EKSD++S G ++ E+ P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 80/285 (28%), Positives = 128/285 (44%), Gaps = 49/285 (17%)
Query: 586 ERVLGKGGFGTVYHGKL-----DNDEVAVKMLSPSSSQGYK-QFQAEVKLLLRVHHRNLT 639
E+V+G G FG V G+L +VA+K L SS + F E ++ + H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
L G + + +I EYM NG+L++ L ++ + + + + A G++YL +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG-TP-GYLDPEYYIS 757
VHRD+ + NIL+N K++DFGLSR T+ TT G P + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY--TTKGGKIPIRWTAPEAIAY 182
Query: 758 NRLTEKSDVYSFGVVLLEII----------TGHPVISKSAENGHTHVAQWVSSMLDKGDI 807
+ T SDV+SFG+V+ E++ + VI K+ E+G+
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDGY---------------- 225
Query: 808 RSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852
RL D S ++ + C + N RP +Q+V L
Sbjct: 226 ------RLPPPMDCPSA--LYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 65/232 (28%), Positives = 101/232 (43%), Gaps = 51/232 (21%)
Query: 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQF------QAEVKL----LLR 632
F +++G+G F TV K N E A+K+L K+ VK+ L R
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKEVLTR 57
Query: 633 V-HHRNLTTLVGYC---DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAA 688
+ H + L Y DE N+ + EY NG L +++ L+ + A E
Sbjct: 58 LNGHPGIIKL--YYTFQDE-ENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEIL 112
Query: 689 LGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP----VEGGTHVSTTI 743
L LEYLH G I+HRD+K NIL+++ K+ DFG ++V E +T I
Sbjct: 113 LALEYLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 744 A--------------GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
GT Y+ PE + SD+++ G ++ +++TG P
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 28/217 (12%)
Query: 579 LRMTNNFE----RVLGKGGFGTVYHG--KLDND----EVAVKMLSPSSS-QGYKQFQAEV 627
LR+ E +VLG G FGTVY G + + VA+K+L +S + K+ E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 628 KLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSD-----SSKEILNWEERLR 682
++ V H ++ L+G C + + LI + M G L +++ + S+ +LNW
Sbjct: 61 YVMASVDHPHVVRLLGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW----- 114
Query: 683 IAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742
V+ A G+ YL + +VHRD+ + N+L+ K+ DFGL+++ V
Sbjct: 115 -CVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV-DEKEYHAE 169
Query: 743 IAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
P ++ E + T KSDV+S+GV + E++T
Sbjct: 170 GGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 587 RVLGKGGFGTVY---HGKLDNDEVAVK-MLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
LG G G V H + +AVK + + KQ E+ +L + + +
Sbjct: 7 GELGAGNSGVVSKVLH-RPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL-RIAVEAALGLEYLHQGCKPP 701
G ++++ EYM G+L++ L + I E L +IAV GL YLH+ K
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKGLTYLHEKHK-- 121
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
I+HRDVK +NIL+N + Q KL DFG+S ++ T GT Y+ PE N +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV----NSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 762 EKSDVYSFGVVLLEIITG 779
KSD++S G+ L+E+ TG
Sbjct: 178 VKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 67/242 (27%), Positives = 111/242 (45%), Gaps = 24/242 (9%)
Query: 584 NFE--RVLGKGGFGTVYH-GKLDNDEV-AVKMLSPS---SSQGYKQFQAEVKLLLRVHHR 636
+FE RV+GKG FG V K D ++ A+K ++ + E ++L ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 637 NLTTL-VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYL 694
L L + DE NM L+ + + G+L HLS K EE+++ E L LEYL
Sbjct: 61 FLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFS---EEQVKFWICEIVLALEYL 116
Query: 695 H-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
H +G I+HRD+K NIL++E+ + DF ++ ++T+ +GTPGY+ PE
Sbjct: 117 HSKG----IIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTSGTPGYMAPE 169
Query: 754 YYISNRLTEKSDVYSFGVVLLEIITG---HPVISKSAENGHTHVAQWVSSMLDKGDIRST 810
+ D +S GV E + G + S++ + + +
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEA 229
Query: 811 VD 812
+D
Sbjct: 230 ID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 69/203 (33%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 585 FERVLGKGGFGTV----YHGKLDN--DEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNL 638
F + LGKG FG+V Y DN + VAVK L S+++ + F+ E+++L + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 639 TTLVGYCDEG--TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
G C N+ L+ EY+ G+L ++L +E L+ + L A + G+EYL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYL-- 124
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGY-LDPEYY 755
G K VHRD+ + NIL+ + + K+ DFGL++V P + + +P + PE
Sbjct: 125 GSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 756 ISNRLTEKSDVYSFGVVLLEIIT 778
++ + SDV+SFGVVL E+ T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 52/284 (18%)
Query: 588 VLGKGGFGTVYHGKLDNDE-VAVKM--LSPS----SSQGYKQFQAEVKLLLRVHHRNLTT 640
VLGKG +GTVY G + + +AVK L S + + Y++ Q EV LL + H N+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 641 LVGYCDEGTNMALIYEYMANGNL-----------EEHLSDSSKEILNWEERLRIAVEAAL 689
+G C + +++ E++ G++ E +K+IL+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------- 113
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG--GTH--VSTTIAG 745
G+ YLH C +VHRD+K N+++ KL DFG +R G GTH + ++ G
Sbjct: 114 GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 746 TPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG 805
TP ++ PE + KSD++S G + E+ TG P ++ +++M G
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR---------LAAMFYIG 221
Query: 806 DIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVV 849
R + PRL F A++ +C++ + + RP Q++
Sbjct: 222 AHRGLM-PRLPDSFSAA----AIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQA---EVKLLLRVHHRNLTTL 641
RV+G+G FG V+ K D V +K + P + A E ++L + H N+
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNI--- 61
Query: 642 VGYCD---EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
+ Y + E + ++ EY G L E++ +L+ + L V+ L L ++H
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT-- 119
Query: 699 KPPIVHRDVKSTNILINE-KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
I+HRD+K+ NIL+++ K K+ DFG+S++ + T+ GTP Y+ PE
Sbjct: 120 -KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEG 175
Query: 758 NRLTEKSDVYSFGVVLLEI 776
+KSD+++ G VL E+
Sbjct: 176 KPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/192 (28%), Positives = 105/192 (54%), Gaps = 9/192 (4%)
Query: 589 LGKGGFGTVYHGK-LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE 647
+G G FG V+ G L+ +VA+K + + + F E ++++++ H L L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 648 GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDV 707
+ + L++E+M +G L ++L + + + E L + ++ G+ YL ++HRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 708 KSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSDV 766
+ N L+ E K++DFG++R V + S+T P + PE + ++ + KSDV
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRF--VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 767 YSFGVVLLEIIT 778
+SFGV++ E+ +
Sbjct: 185 WSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 35/216 (16%)
Query: 589 LGKGGFGTVY-----HGKLDNDE--VAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
LG+G FG V+ + + D+ VAVK L +S + FQ E +LL + H+++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 642 VGYCDEGTNMALIYEYMANGNL---------EEHLSDSSKEI----LNWEERLRIAVEAA 688
G C EG + +++EYM +G+L + + +++ L + L IA + A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR------VFPVEGGTHVSTT 742
G+ YL VHRD+ + N L+ + K+ DFG+SR + V G T +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
++ PE + + T +SD++SFGVVL EI T
Sbjct: 190 ------WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQA--EVKLLLRVHHRNLTTLVGY 644
+GKG FG V+ K D A+K + S ++ +A E ++L ++ + + Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI---IRY 64
Query: 645 CD---EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
+ + + ++ EY NG+L + L L ++ R ++ LGL +LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
I+HRD+KS N+ ++ K+ D G++++ + T+ + TI GTP YL PE
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 762 EKSDVYSFGVVLLEIITGH 780
EKSDV++ GVVL E TG
Sbjct: 180 EKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 43/215 (20%)
Query: 586 ERVLGKGGFGTVYHG--KLDNDEVAVKMLS-PSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
+GKG FG VY K N VA+K++ + + Q E++ L + +T
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 643 GYCDEGTNMALIYEYMANGNL----------EEHLSDSSKEILNWEERLRIAVEAALGLE 692
G +G+ + +I EY G+ E +++ +E+L LGLE
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-------------LGLE 112
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI------AGT 746
YLH+ K +HRD+K+ NIL++E+ KLADFG+S +++T+ GT
Sbjct: 113 YLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNTFVGT 161
Query: 747 PGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
P ++ PE + EK+D++S G+ +E+ G P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 588 VLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYC 645
LG+G +G+VY K VA+K++ + ++ E+ +L + + G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 646 DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHR 705
+ T++ ++ EY G++ + + ++K L EE I + GLEYLH +HR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKGLEYLHSN---KKIHR 123
Query: 706 DVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSD 765
D+K+ NIL+NE+ QAKLADFG+S + T+ GTP ++ PE K+D
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181
Query: 766 VYSFGVVLLEIITGHP 781
++S G+ +E+ G P
Sbjct: 182 IWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 70/216 (32%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 585 FERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRN 637
+R LG+G FG V+ + D VAVK L +S K F E +LL + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEI-----------LNWEERLRIAVE 686
+ G C EG + +++EYM +G+L + L + L + L IA +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 687 AALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR-VFPVEG---GTHVSTT 742
A G+ YL VHRD+ + N L+ E K+ DFG+SR V+ + G H
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
I P PE + + T +SDV+S GVVL EI T
Sbjct: 186 IRWMP----PESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 59/191 (30%), Positives = 104/191 (54%), Gaps = 11/191 (5%)
Query: 588 VLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE 647
++G+G FG V G+ +VAVK + + + F E ++ ++HH+NL L+G
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 648 GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDV 707
+ ++ E M+ GNL L + +++ + L+ +++ A G+EYL +VHRD+
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDL 126
Query: 708 KSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVY 767
+ NIL++E AK++DFGL+RV G + + T PE + + KSDV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGS-MGVDNSKLPVKWTA----PEALKHKKFSSKSDVW 181
Query: 768 SFGVVLLEIIT 778
S+GV+L E+ +
Sbjct: 182 SYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 9/204 (4%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLD-NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH 635
E+ R + + LG G FG V+ G + N +VAVK L P + + F E +++ ++ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRH 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
L L E + ++ EYM+ G+L + L D L + +A + A G+ Y+
Sbjct: 61 DKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
+ +HRD++S NIL+ + K+ADFGL+R+ +E + + A P + PE
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 174
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
+ R T KSDV+SFG++L E++T
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 25/216 (11%)
Query: 585 FERVLGKGGFGTVYHGKL-----DNDE-VAVKMLSP-SSSQGYKQFQAEVKLLLRVHHRN 637
F LG+ FG +Y G L D+ + VA+K L ++ Q + +FQ E L+ +HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHL------SD---------SSKEILNWEERLR 682
+ L+G + + +++EY+ G+L E L SD + K L+ + L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 683 IAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742
IA++ A G+EYL VH+D+ + NILI E+ K++D GLSR V
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
++ PE + + + SD++SFGVVL EI +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 68/215 (31%), Positives = 111/215 (51%), Gaps = 28/215 (13%)
Query: 585 FERVLGKGGFGTVYHGKLDND----EVAVKMLSPSSSQG-YKQFQAEVKLLLRV-HHRNL 638
FE V+G+G FG V + D A+KML +S+ ++ F E+++L ++ HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDS--------------SKEILNWEERLRIA 684
L+G C+ + + EY GNL + L S + L ++ L+ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 685 VEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744
+ A G++YL + +HRD+ + N+L+ E +K+ADFGLSR V +V T+
Sbjct: 126 SDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEV----YVKKTMG 178
Query: 745 GTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
P ++ E + T KSDV+SFGV+L EI++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 25/207 (12%)
Query: 587 RVLGKGGFGTVYHGKL-DND----EVAVKMLSP-SSSQGYKQFQAEVKLLLRVHHRNLTT 640
RV+GKG FG VYHG L D+D AVK L+ + + +QF E ++ H N+ +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 641 LVGYC--DEGTNMALIYEYMANGNLEEHLSDSS-----KEILNWEERLRIAVEAALGLEY 693
L+G C EG+ + ++ YM +G+L + + K+++ + ++ A G+EY
Sbjct: 61 LLGICLPSEGSPLVVL-PYMKHGDLRNFIRSETHNPTVKDLIGF------GLQVAKGMEY 113
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR-VFPVEGGTHVSTTIAGTP-GYLD 751
L VHRD+ + N +++E F K+ADFGL+R ++ E + + T A P ++
Sbjct: 114 LAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 752 PEYYISNRLTEKSDVYSFGVVLLEIIT 778
E + + T KSDV+SFGV+L E++T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 7e-23
Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 586 ERVLGKGGFGTVYHGKL-----DNDEVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLT 639
++V+G G FG V+ G L VA+K L P ++ +Q F +E ++ + H N+
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
L G + +I EYM NG L+++L D E +++ + + A G++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ-LVGMLRGIAAGMKYLSD--- 125
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISN 758
VHRD+ + NIL+N + K++DFGLSRV + +T+ P + PE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 759 RLTEKSDVYSFGVVLLEIIT 778
+ T SDV+SFG+V+ E+++
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 9e-23
Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 9/204 (4%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDND-EVAVKMLSPSSSQGYKQFQAEVKLLLRVHH 635
EV R T + LG G FG V+ G + +VA+K L S + F AE L+ ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQH 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
L L + + +I EYM NG+L + L L + + +A + A G+ ++
Sbjct: 61 PRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
+ +HRD+++ NIL++E K+ADFGL+R+ +E + + A P + PE
Sbjct: 120 R---KNYIHRDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEA 174
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
T KSDV+SFG++L EI+T
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 67/215 (31%), Positives = 115/215 (53%), Gaps = 28/215 (13%)
Query: 585 FERVLGKGGFGTVYHGKLDND----EVAVKMLSPSSSQG-YKQFQAEVKLLLRV-HHRNL 638
F+ V+G+G FG V ++ D + A+K + +S+ ++ F E+++L ++ HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHL--------------SDSSKEILNWEERLRIA 684
L+G C+ + L EY +GNL + L ++S+ L+ ++ L A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 685 VEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744
+ A G++YL Q +HRD+ + NIL+ E + AK+ADFGLSR V +V T+
Sbjct: 131 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMG 183
Query: 745 GTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
P ++ E + T SDV+S+GV+L EI++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 60/201 (29%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKM--LSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
+ +G+G FG +Y K D++ +K L+ + + + EV LL ++ H N+ T
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
E + ++ EY G+L + ++ + + ++ L V+ +LGL+++H I
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKI 122
Query: 703 VHRDVKSTNILINEKFQ-AKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
+HRD+KS NI +++ AKL DFG++R + ++ T GTP YL PE +
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQNRPYN 180
Query: 762 EKSDVYSFGVVLLEIIT-GHP 781
K+D++S G VL E+ T HP
Sbjct: 181 NKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 71/219 (32%), Positives = 105/219 (47%), Gaps = 32/219 (14%)
Query: 585 FERVLGKGGFGTV-----YHGKLDNDE--VAVKMLSPSSSQGYKQFQAEVKLLLRVHHRN 637
+R LG+G FG V Y+ D+ VAVK L + K FQ E +LL + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEE----HLSDS----------SKEILNWEERLRI 683
+ G C +G + +++EYM +G+L + H D+ +K L + L I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 684 AVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR-VFPVEG---GTHV 739
A + A G+ YL VHRD+ + N L+ K+ DFG+SR V+ + G H
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
I P PE + + T +SDV+SFGV+L EI T
Sbjct: 186 MLPIRWMP----PESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 8/204 (3%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDND-EVAVKMLSPSSSQGYKQFQAEVKLLLRVHH 635
E+ R + + LG G FG V+ G +N +VAVK L P + + F E L+ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQH 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
L L + + +I EYMA G+L + L + + + + + A G+ Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
+ +HRD+++ N+L++E K+ADFGL+RV +E + + A P + PE
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEA 175
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
T KSDV+SFG++L EI+T
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 589 LGKGGFGTVYHGK--LDNDEVAVKMLSPS-SSQGYKQFQA--EVKLLLRVHHRNLTTLVG 643
+G+G +G VY + L + VA+K + S+G + A E+KLL ++H N+ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPK-TALREIKLLKELNHPNIIKLLD 65
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLHQGCKPPI 702
++ L++E+M + +L + + D + + E ++ + L GL + H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLP--ESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL-T 761
+HRD+K N+LIN + KLADFGL+R F + T T Y PE + ++ +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRWYRAPELLLGDKGYS 177
Query: 762 EKSDVYSFGVVLLEIITGHP 781
D++S G + E+++ P
Sbjct: 178 TPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 60/196 (30%), Positives = 104/196 (53%), Gaps = 17/196 (8%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
+ +GKG FG V G ++VAVK + ++ + F AE ++ ++ H NL L+G
Sbjct: 10 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67
Query: 645 -CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
+E + ++ EYMA G+L ++L + +L + L+ +++ +EYL V
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT--IAGTP-GYLDPEYYISNRL 760
HRD+ + N+L++E AK++DFGL++ S+T P + PE +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREKKF 176
Query: 761 TEKSDVYSFGVVLLEI 776
+ KSDV+SFG++L EI
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-22
Identities = 67/202 (33%), Positives = 113/202 (55%), Gaps = 14/202 (6%)
Query: 587 RVLGKGGFGTV----YHGKLDN--DEVAVKMLSPSSSQGY-KQFQAEVKLLLRVHHRNLT 639
R LG+G FG V Y + DN ++VAVK L P S + + E+++L ++H N+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 640 TLVGYCDE--GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
G C E G + LI E++ +G+L+E+L + +I N +++L+ AV+ G++YL G
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI-NLKQQLKYAVQICKGMDYL--G 126
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGY-LDPEYYI 756
+ VHRD+ + N+L+ + Q K+ DFGL++ + + +P + PE I
Sbjct: 127 SRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 757 SNRLTEKSDVYSFGVVLLEIIT 778
++ SDV+SFGV L E++T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 61/195 (31%), Positives = 104/195 (53%), Gaps = 11/195 (5%)
Query: 588 VLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYK-QFQAEVKLLLRVHHRNLTTLVGYC 645
+LGKG FG V+ G L D VAVK Q K +F +E ++L + H N+ L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 646 DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKPPIVH 704
+ + ++ E + G+ L K+ L ++ ++ A++AA G+ YL + C +H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 705 RDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEK 763
RD+ + N L+ E K++DFG+SR + G + S+ + P + PE R + +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 764 SDVYSFGVVLLEIIT 778
SDV+S+G++L E +
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 6e-22
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 584 NFERVLGKGGFGTVYHGKLDNDE--VAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNL 638
F + LG G FG V + A+K+LS + KQ + E ++L + H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
L G + +N+ L+ EY+ G L HL S + A + L LEYLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR--FPEPVARFYAAQVVLALEYLH-SL 120
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
IV+RD+K N+L++ K+ DFG ++ V+G T+ T+ GTP YL PE I +
Sbjct: 121 D--IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTY---TLCGTPEYLAPE-IILS 172
Query: 759 RLTEKS-DVYSFGVVLLEIITGHP 781
+ K+ D ++ G+++ E++ G+P
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 6e-22
Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 571 RQFTYSEVLRMTNN---FERVLGKGGFGTVY----HGKLDND---EVAVKMLSPSSSQGY 620
Q Y N F + LG G FG V +G +D +VAVKML P++
Sbjct: 22 TQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE 81
Query: 621 KQ-FQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWE 678
++ +E+K++ + +H N+ L+G C G + +I EY G+L L + L E
Sbjct: 82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE 141
Query: 679 ERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737
+ L + + A G+ +L + C +HRD+ + N+L+ K+ DFGL+R +
Sbjct: 142 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI-MNDSN 196
Query: 738 HVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+V A P ++ PE + T +SDV+S+G++L EI +
Sbjct: 197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 587 RVLGKGGFGTVYHG-KLDNDE-VAVK--MLSPSSSQGY---KQFQAEVKLLLRVHHRNLT 639
+LG G FG+VY G LD+ + AVK L+ G KQ + E+ LL ++ H N+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLS--DSSKE--ILNWEERLRIAVEAALGLEYLH 695
+G E N+ + E + G+L + L S E I + ++ LGLEYLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LLGLEYLH 119
Query: 696 -QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
+ VHRD+K NIL++ KLADFG+++ + G+P ++ PE
Sbjct: 120 DRN----TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWMAPEV 172
Query: 755 YIS-NRLTEKSDVYSFGVVLLEIITGHP 781
+D++S G +LE+ TG P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 9/204 (4%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLD-NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH 635
E+ R + E LG+G FG V+ G + VA+K L P + + F E +++ ++ H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
L L E + ++ EYM+ G+L + L + L + + +A + A G+ Y+
Sbjct: 61 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
+ VHRD+++ NIL+ E K+ADFGL+R+ +E + + A P + PE
Sbjct: 120 ---RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 174
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
+ R T KSDV+SFG++L E+ T
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 60/198 (30%), Positives = 105/198 (53%), Gaps = 13/198 (6%)
Query: 585 FERVLGKGGFGTVYHGKLDND-EVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
F + LG G FG V +GK +VA+KM+ S +F E K+++++ H L L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL--HQGCKPP 701
C + + ++ EYM+NG L +L + K + L + + G+ YL Q
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLESKQ----- 120
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRL 760
+HRD+ + N L++++ K++DFGLSR V + S+ + P + PE + ++
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 761 TEKSDVYSFGVVLLEIIT 778
+ KSDV++FGV++ E+ +
Sbjct: 179 SSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 19/202 (9%)
Query: 589 LGKGGFGTVYHGK--LDNDEVAVKMLSPSS-SQGYKQFQA-EVKLLLRVHHRNLTTLVGY 644
LGKG +G+VY K DN A+K + S SQ ++ E+++L V+H N+ + Y
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---ISY 64
Query: 645 CD---EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL--RIAVEAALGLEYLHQGCK 699
+ +G + ++ EY G+L + +S K+ E+ RI ++ GL+ LH+
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-- 122
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
I+HRD+KS NIL+ K+ D G+S+V T I GTP Y+ PE +
Sbjct: 123 -KILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYMAPEVWKGRP 177
Query: 760 LTEKSDVYSFGVVLLEIITGHP 781
+ KSD++S G +L E+ T P
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 587 RVLGKGGFG--TVYHGKLDNDEVAVKM--LSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
RVLGKG FG T+Y D+ V K L+ S + + E+ +L + H N+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
+ + + + EY G L + + ++ E L + + Y+H K I
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE 762
+HRD+K+ NI + + KL DFG+S++ E ++ T+ GTP Y+ PE +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 763 KSDVYSFGVVLLEIIT 778
KSD+++ G VL E++T
Sbjct: 181 KSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNLTTLVG 643
+ KG +G V+ K D A+K++ + Q E +L + + L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 644 YCDEGT-NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
Y +G N+ L+ EY+ G+L L + L+ + E L LEYLH I
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHS-NG--I 114
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRV------FPVEGGTHVSTTIAGTPGYLDPEYYI 756
+HRD+K NILI+ KL DFGLS+V + I GTP Y+ PE +
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 757 SNRLTEKSDVYSFGVVLLEIITGHP 781
++ D +S G +L E + G P
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 28/223 (12%)
Query: 573 FTYSEVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKMLSPSSSQGYKQ-FQ 624
F S + +T LG+G FG V+ K E V VK L + + + F+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 625 AEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEI-------LNW 677
E+ + ++ H+N+ L+G C E +I EY G+L++ L + + L+
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 678 EERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR-VFPVEGG 736
++++ + + ALG+++L VHRD+ + N L++ + + K++ LS+ V+ E
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 737 THVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ I P +L PE + + KSDV+SFGV++ E+ T
Sbjct: 174 KLRNALI---PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 2e-21
Identities = 66/212 (31%), Positives = 111/212 (52%), Gaps = 28/212 (13%)
Query: 588 VLGKGGFGTVYHGKLDND----EVAVKMLSPSSSQG-YKQFQAEVKLLLRV-HHRNLTTL 641
V+G+G FG V ++ D + A+K + +S+ ++ F E+++L ++ HH N+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDS--------------SKEILNWEERLRIAVEA 687
+G C+ + L EY +GNL + L S + L+ ++ L A +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 688 ALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP 747
A G++YL Q +HRD+ + NIL+ E + AK+ADFGLSR V +V T+ P
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGRLP 174
Query: 748 -GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
++ E + T SDV+S+GV+L EI++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 585 FERV--LGKGGFGTVYHG--KLDNDEVAVKMLS--------PSSSQGYKQFQAEVKLLLR 632
+E++ LG+G +G VY K + VA+K + PS++ E+ LL
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL------REISLLKE 54
Query: 633 VHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLE 692
+ H N+ L+ + L++EY +L+++L D L+ I + GL
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
Y H I+HRD+K NILIN KLADFGL+R F + T+ + T Y P
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAP 167
Query: 753 EYYISNRLTEKS-DVYSFGVVLLEIITGHP 781
E + ++ + D++S G + E+ITG P
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 59/198 (29%), Positives = 85/198 (42%), Gaps = 19/198 (9%)
Query: 591 KGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHR-----NLTTLVG 643
KG FG+VY K D A+K+L S Q VK + + L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVT-NVKAERAIMMIQGESPYVAKLYY 64
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
+ L+ EY+ G+ + +W ++ E LG+E LHQ I+
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQR---GII 119
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEK 763
HRD+K N+LI++ KL DFGLSR + GTP YL PE + +
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVGDDKM 173
Query: 764 SDVYSFGVVLLEIITGHP 781
SD +S G V+ E + G+P
Sbjct: 174 SDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 589 LGKGGFGTVYHGKL---DNDE--VAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTTLV 642
LG G FG+V G E VAVK L K+ F E ++ ++ H + L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSD----SSKEILNWEERLRIAVEAALGLEYLHQGC 698
G C +G + L+ E G L ++L ++ A + A+G+ YL +
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYL-ESK 114
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPE--YY 755
VHRD+ + N+L+ + QAK++DFG+SR + +TT P + PE Y
Sbjct: 115 H--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 756 ISNRLTEKSDVYSFGVVLLEI----------ITGHPVISKSAENGH 791
+ + KSDV+S+GV L E + G + E+G
Sbjct: 173 --GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 64/195 (32%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYK-QFQAEVKLLLRVHHRNLTTLV 642
ER+ G+G FG V+ G+L DN VAVK + K +F E ++L + H N+ L+
Sbjct: 1 ERI-GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
G C + + ++ E + G+ L L +E +++ AA G+EYL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---C 115
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST-TIAGTP-GYLDPEYYISNRL 760
+HRD+ + N L+ EK K++DFG+SR E G + ST + P + PE R
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 761 TEKSDVYSFGVVLLE 775
+ +SDV+SFG++L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 589 LGKGGFGTVY------HGKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLT 639
LGKGGFG V GK+ A K L +G + E K+L +V R +
Sbjct: 1 LGKGGFGEVCACQVKATGKM----YACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
+L + ++ L+ M G+L+ H+ + + + A + GLE+LHQ
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
IV+RD+K N+L+++ +++D GL+ AGTPGY+ PE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEV 170
Query: 760 LTEKSDVYSFGVVLLEIITGH 780
D ++ G L E+I G
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 60/204 (29%), Positives = 109/204 (53%), Gaps = 9/204 (4%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLD-NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH 635
E+ R + + LG+G FG V+ G + +VA+K L P + + F E +++ ++ H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRH 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
L L E + ++ E+M G+L + L + + L + + +A + A G+ Y+
Sbjct: 61 DKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
+ +HRD+++ NIL+ + K+ADFGL+R+ +E + + A P + PE
Sbjct: 120 ---RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 174
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
+ R T KSDV+SFG++L E++T
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 63/217 (29%), Positives = 93/217 (42%), Gaps = 44/217 (20%)
Query: 589 LGKGGFGTVYHG-KLDNDEV-AVKM--LSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG- 643
+G G FG VY LD E+ AVK + + + K+ E+K+L + H NL G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 644 ------------YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-G 690
YC GT + E + +G + + E +R+ L G
Sbjct: 68 EVHREKVYIFMEYCSGGT----LEELLEHGRILD------------EHVIRVYTLQLLEG 111
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST---TIAGTP 747
L YLH IVHRD+K NI ++ KL DFG + T + ++AGTP
Sbjct: 112 LAYLHS-HG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQSLAGTP 167
Query: 748 GYLDPEYYISNRLTEK---SDVYSFGVVLLEIITGHP 781
Y+ PE + +D++S G V+LE+ TG
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 584 NFERVLGKGGFGTVY----HGKLDNDE--------------VAVKMLSPSSSQGYKQ-FQ 624
NF LG+G FG V+ G D E VAVK+L P +S ++ F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 625 AEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDS---------SKEIL 675
EVK+L R+ N+ L+G C + +I EYM NG+L + L + + L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 676 NWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR------ 729
++ L +A + A G+ YL VHRD+ + N L+ + + K+ADFG+SR
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ V+G + E + + T KSDV++FGV L EI+T
Sbjct: 185 YYRVQGRAPLPIRWMAW------ESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 585 FERVLGKGGFGTVYHGKLDND-EVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
F + LG G FG V+ GK +VA+K ++ + + F E K+++++ H L L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDS----SKEILNWEERLRIAVEAALGLEYLHQGCK 699
C + + ++ E+M NG L +L SK++L L + + G+EYL +
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERN-- 119
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISN 758
+HRD+ + N L++ K++DFG++R V + S++ A P + PE + +
Sbjct: 120 -SFIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 759 RLTEKSDVYSFGVVLLEIIT 778
+ + KSDV+SFGV++ E+ T
Sbjct: 177 KYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 47/232 (20%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDN-------DEVAVKMLSPSSSQGYK-QFQAEVK 628
E+ R R LG+G FG VY G VA+K ++ ++S + +F E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL-SDSSKE-------ILNWEER 680
++ + ++ L+G G ++ E MA G+L+ +L S + ++
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 681 LRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR----------- 729
+++A E A G+ YL VHRD+ + N ++ E K+ DFG++R
Sbjct: 122 IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 730 ---VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ PV ++ PE T KSDV+SFGVVL E+ T
Sbjct: 179 GKGLLPVR--------------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 584 NFERVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTT 640
V+G G VY +N++VA+K + Q + + EV+ + + +H N+
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV---EAALGLEYLH-Q 696
G + L+ Y++ G+L + + S +E + IA E GLEYLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL-DEAI-IATVLKEVLKGLEYLHSN 121
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT---HVSTTIAGTPGYLDPE 753
G +HRD+K+ NIL+ E K+ADFG+S +GG V T GTP ++ PE
Sbjct: 122 G----QIHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 754 YYISNR-LTEKSDVYSFGVVLLEIITGHPVISK 785
K+D++SFG+ +E+ TG SK
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 587 RVLGKGGFGTVYHGKLDND--------EVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRN 637
LG G FG VY G + VAVK L ++ Q K+F E L+ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKE-----ILNWEERLRIAVEAALGLE 692
+ L+G C +I E M G+L +L D+ E +L +E L I ++ A G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQA-----KLADFGLSR------VFPVEGGTHVST 741
YL Q +HRD+ + N L++EK K+ DFGL+R + EG +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
++ PE + + T +SDV+SFGV++ EI+T
Sbjct: 178 R------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 77/234 (32%), Positives = 111/234 (47%), Gaps = 30/234 (12%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNLTTL 641
R +G G FG VY N+ VA+K +S S Q +++Q EV+ L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 642 VG-YCDEGTNMALIYEYM---ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
G Y E T L+ EY A+ LE H K+ L E I A GL YLH
Sbjct: 81 KGCYLREHTAW-LVMEYCLGSASDILEVH-----KKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFG-LSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
+ +HRD+K+ NIL+ E KLADFG S V P + + GTP ++ PE +
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWMAPEVIL 184
Query: 757 S---NRLTEKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSMLDKGD 806
+ + K DV+S G+ +E+ P+ + +A + H+AQ S L D
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 587 RVLGKGGFGTVYHGKLDNDE-----VAVKM--LSPSSSQGYKQFQAEVKLLLRVHHRNLT 639
++LG+G FG+V G+L D+ VAVK L + ++F +E + H N+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 640 TLVGYCDEGTNMA------LIYEYMANGNLEEHLSDS----SKEILNWEERLRIAVEAAL 689
L+G C E +++ +I +M +G+L L S E L + L+ V+ AL
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-G 748
G+EYL +HRD+ + N ++ E +ADFGLS+ G + IA P
Sbjct: 125 GMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPVK 180
Query: 749 YLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
++ E T KSDV++FGV + EI T
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 55/197 (27%), Positives = 79/197 (40%), Gaps = 11/197 (5%)
Query: 589 LGKGGFGTVYHGKLDND-----EVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTTLV 642
LG G FG V G+ VAVK L F E ++ + H NL L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
G + ++ E G+L + L + AV+ A G+ YL
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRF 118
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLT 761
+HRD+ + NIL+ + K+ DFGL R P +V P + PE + +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 762 EKSDVYSFGVVLLEIIT 778
SDV+ FGV L E+ T
Sbjct: 179 HASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 588 VLGKGGFGTVYHGK--LDNDEVAVKMLS-PSSSQGYKQFQAEVKLLLRVHH---RNLTTL 641
++G+G +G VY GK VA+K+++ + Q EV LL ++ N+T
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV---EAALGLEYLHQGC 698
G +G + +I EY G++ L + E+ I+V E + L+Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGP----IAEKY-ISVIIREVLVALKYIH--- 118
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
K ++HRD+K+ NIL+ KL DFG++ + + +T GTP ++ PE
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 759 RLTE-KSDVYSFGVVLLEIITGHPVISK 785
+ + K+D++S G+ + E+ TG+P S
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 37/224 (16%)
Query: 587 RVLGKGGFGTVYH-------GKLDNDEVAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRNL 638
+ LG+G FG V G+ VAVKML ++S + +E LL +V+H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSK----------------------EILN 676
L G C + + LI EY G+L L +S K L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 677 WEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR-VFPVEG 735
+ + A + + G++YL + +VHRD+ + N+L+ E + K++DFGLSR V+ E
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY--EE 180
Query: 736 GTHVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
++V + P ++ E + T +SDV+SFGV+L EI+T
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 55/220 (25%)
Query: 589 LGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG--- 643
+G G +G VY + + VA+K++ ++ Q E+ +L H N+ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 644 ----------YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIA---VEAALG 690
YC G ++ IY+ G L E L+IA E G
Sbjct: 71 RRDKLWIVMEYC-GGGSLQDIYQVT-RGPLSE---------------LQIAYVCRETLKG 113
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA------ 744
L YLH+ K +HRD+K NIL+ E KLADFG+S ++ TIA
Sbjct: 114 LAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVS--------AQLTATIAKRKSFI 162
Query: 745 GTPGYLDPEYYISNRL---TEKSDVYSFGVVLLEIITGHP 781
GTP ++ PE R K D+++ G+ +E+ P
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 587 RVLGKGGFGT---VYHGKLDNDEVAVKMLS-PSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
RV+G+G FG V H + + A+K + P SS + + E LL ++ H N+
Sbjct: 6 RVVGEGSFGRALLVQH-VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
+ ++ ++ EY G+L + + ++ + L+ V+ LG++++H + +
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRV 121
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE 762
+HRD+KS NI + + + KL DFG +R+ G + T GTP Y+ PE + +
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNN 179
Query: 763 KSDVYSFGVVLLEIIT-GHPVISKSAEN 789
KSD++S G +L E+ T HP + S +N
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 83/307 (27%), Positives = 141/307 (45%), Gaps = 57/307 (18%)
Query: 589 LGKGGFGTVYHGK---LDNDE------VAVKML-SPSSSQGYKQFQAEVKLLLRV-HHRN 637
LG+G FG V + LD ++ VAVKML S ++ + +E++++ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHL--------------SDSSKEILNWEERLRI 683
+ L+G C + + +I EY + GNL E+L + +E L++++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 684 AVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743
A + A G+EYL +HRD+ + N+L+ E K+ADFGL+R H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 197
Query: 744 AGTPG-----YLDPEYYISNRLTEKSDVYSFGVVLLEIIT--GHPVISKSAENGHTHVAQ 796
T G ++ PE T +SDV+SFGV+L EI T G P E
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------- 250
Query: 797 WVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856
+ +L +G + D N + + C + ++RP Q+V +L+ L
Sbjct: 251 -LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300
Query: 857 AMEAAQK 863
A+ + Q+
Sbjct: 301 ALTSNQE 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 38/219 (17%)
Query: 589 LGKGGFGTVYHGK---LDNDE----VAVKMLSPSSS-QGYKQFQAEVKLLLRV-HHRNLT 639
LG+G FG V + LDN VAVKML ++ + +E++++ + H+N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSD--------SSKEILNWEERL------RIAV 685
L+G C + + ++ EY A+GNL + L S + EE L A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 686 EAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV-----S 740
+ A G+E+L +HRD+ + N+L+ E K+ADFGL+R H
Sbjct: 140 QVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR------DIHHIDYYRK 190
Query: 741 TTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
TT P ++ PE T +SDV+SFGV+L EI T
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 39/219 (17%)
Query: 585 FERV--LGKGGFGTVYHG--KLDNDEVAVKMLSPSSS-QGYKQFQA-EVKLLLRVHHRNL 638
+E++ +G+G +G VY K + VA+K + + +G+ E+KLL ++ H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 639 TTLVGYC--DEGTNMALIYEYMA---NGNLEE---HLSDS-----SKEILNWEERLRIAV 685
L ++ +++EYM G L+ ++S K++L
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE--------- 111
Query: 686 EAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF-PVEGGTHVSTTIA 744
GL+YLH I+HRD+K +NILIN KLADFGL+R + + + I
Sbjct: 112 ----GLQYLHS-NG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163
Query: 745 GTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLEIITGHPV 782
T Y PE + + R + D++S G +L E+ G P+
Sbjct: 164 -TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 589 LGKGGFGTVYHGKLDNDE--VAVKMLSPSSSQGY-KQFQAEVKLLLRVHHRNLTTLVGYC 645
LG+G G+V +L N A+K ++ + KQ E+++ + G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 646 --DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEER--LRIAVEAALGLEYLHQGCKPP 701
+ +++ + EY G+L+ K E+ +IA GL YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RK 125
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
I+HRD+K +NIL+ K Q KL DFG+S E ++ T GT Y+ PE +
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSG----ELVNSLAGTFTGTSFYMAPERIQGKPYS 181
Query: 762 EKSDVYSFGVVLLEI 776
SDV+S G+ LLE+
Sbjct: 182 ITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQ---FQA--EVKLLLRVHHRN 637
+ LG+G + VY K VA+K + + K F A E+KLL + H N
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIA-VEAAL-----GL 691
+ L+ +N+ L++E+M +LE+ + D K I L A +++ + GL
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKVIKD--KSI-----VLTPADIKSYMLMTLRGL 115
Query: 692 EYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLD 751
EYLH I+HRD+K N+LI KLADFGL+R F T T Y
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRA 170
Query: 752 PE-YYISNRLTEKSDVYSFGVVLLEIITGHP 781
PE + + D++S G + E++ P
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-19
Identities = 69/206 (33%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 587 RVLGKGGFGTV--YHGKLDNDE----VAVKML----SPSSSQGYKQFQAEVKLLLRVHHR 636
RVLG+G FG V Y ND VAVK L ++ G+K+ E+ +L ++H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINILKTLYHE 66
Query: 637 NLTTLVGYCDE--GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
N+ G C E G + LI EY+ G+L ++L K LN + L A + G+ YL
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYL 123
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG-TPGY-LDP 752
H +HRD+ + N+L++ K+ DFGL++ P EG + G +P +
Sbjct: 124 HS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAV 179
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIIT 778
E N+ + SDV+SFGV L E++T
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 586 ERVLGKGGFGTVYHGKLD-----NDEVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLT 639
E+V+G G FG V G+L VA+K L ++ ++ F +E ++ + H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHL--SDSSKEILNWEERLRIAVEAALGLEYLHQG 697
L G + + ++ EYM NG+L+ L D ++ LR A G++YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSD- 124
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYI 756
VHRD+ + NIL+N K++DFGLSRV + +T P + PE
Sbjct: 125 --MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 757 SNRLTEKSDVYSFGVVLLEIIT 778
+ T SDV+S+G+V+ E+++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 35/214 (16%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKM-----LSPSSSQGYKQFQAEVKLLLRVHHRNLT 639
++LG+G FG VY + E+AVK SP + + + E++LL + H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEH------LSDS-----SKEILNWEERLRIAVEAA 688
G + +++ EYM G++++ L+++ +++IL
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE------------ 115
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLS-RVFPVEGGTHVSTTIAGTP 747
G+EYLH IVHRD+K NIL + KL DFG S R+ + ++ GTP
Sbjct: 116 -GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 748 GYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
++ PE K+DV+S G ++E++T P
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 587 RVLGKGGFGTVYHGK---LDND----EVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNL 638
R LG G FG VY G D D +VAVK L S S Q F E ++ + +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEI-----LNWEERLRIAVEAALGLEY 693
L+G E ++ E MA G+L+ L ++ L ++ L A + A G +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQ---AKLADFGLSR-VFPVE---GGTHVSTTIAGT 746
L + +HRD+ + N L+ K AK+ADFG++R ++ G I
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 747 PGYLDPEYYISNRLTEKSDVYSFGVVLLEI 776
P PE ++ T K+DV+SFGV+L EI
Sbjct: 189 P----PEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 39/229 (17%)
Query: 585 FERVLGKGGFGTVYHGKLDNDE------------------VAVKMLSPSSSQGYKQ-FQA 625
F+ LG+G FG V+ ++ N + VAVK+L P +++ + F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 626 EVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLS----------------- 668
EVK+L R+ N+ L+G C + + +I EYM NG+L + LS
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 669 DSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLS 728
+++ L +A++ A G++YL VHRD+ + N L+ E K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 729 RVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEII 777
R + ++ E + + T SDV++FGV L EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 72/230 (31%), Positives = 118/230 (51%), Gaps = 34/230 (14%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGK---LDNDE------VAVKMLSPSSS-QGYKQFQAE 626
E+ R + LG+G FG V + +D D+ VAVKML ++ + +E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 627 VKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLS-----------DSSK-- 672
++++ + H+N+ L+G C + + ++ EY + GNL E+L D+ K
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 673 -EILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR- 729
E L +++ + A + A G+EYL Q C +HRD+ + N+L+ E K+ADFGL+R
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 730 VFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
V ++ + TT P ++ PE T +SDV+SFGV+L EI T
Sbjct: 184 VHNID--YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 587 RVLGKGGFGTVYHGK-LDNDE-VAVKMLSPSSSQGYKQFQA--EVKLLLRVHHRNLTTLV 642
+G+G G V+ K + E VA+K ++ +G QA E+K L H + L+
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
G+ L+ EYM + L E L D + + + + G+ Y+H I
Sbjct: 66 DVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMH---ANGI 120
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE-YYISNRLT 761
+HRD+K N+LI+ K+ADFGL+R+F E S +A T Y PE Y + +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGARKYD 179
Query: 762 EKSDVYSFGVVLLEIITGHP 781
D+++ G + E++ G P
Sbjct: 180 PGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 36/223 (16%)
Query: 589 LGKGGFGTVYHGK---LDNDE------VAVKMLSPSSSQ-GYKQFQAEVKLLLRV-HHRN 637
LG+G FG V + +D D+ VAVKML +++ +E++++ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHL--------------SDSSKEILNWEERLRI 683
+ L+G C + + +I EY + GNL E+L + E + +++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 684 AVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742
+ A G+EYL Q C +HRD+ + N+L+ E K+ADFGL+R V + T
Sbjct: 143 TYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKT 196
Query: 743 IAG--TPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT--GHP 781
G ++ PE T +SDV+SFGV++ EI T G P
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 582 TNNFER-VLGKGGFGTVYHGK-LDND-EVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNL 638
N ER VLGKG +G VY + L +A+K + S+ + E+ L + HRN+
Sbjct: 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLHQG 697
+G E + E + G+L L + + E+ + + L GL+YLH
Sbjct: 68 VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 698 CKPPIVHRDVKSTNILINE-KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
IVHRD+K N+L+N K++DFG S+ + G + T GT Y+ PE I
Sbjct: 128 ---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMAPE-VI 181
Query: 757 SNRLT---EKSDVYSFGVVLLEIITGHP 781
+D++S G ++E+ TG P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 582 TNNF--ERVLGKGGFGTVYHG--KLDNDEVAVK------MLSPSSSQGYKQFQAEVKLLL 631
NF E+ +GKG F VY LD VA+K M+ + Q + E+ LL
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57
Query: 632 RVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL--RIAVEAAL 689
++ H N+ + E + ++ E G+L + K+ ER + V+
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGY 749
LE++H I+HRD+K N+ I KL D GL R F + T + ++ GTP Y
Sbjct: 118 ALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYY 172
Query: 750 LDPEYYISNRLTEKSDVYSFGVVLLEI 776
+ PE N KSD++S G +L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 585 FERVLGKGGFGTV---YHGKLDNDEVAVKM-LSPSSSQGYKQFQAEVKLLLRVHHRNLTT 640
F RV+GKG +G V H V K+ L +S + K + E +LL ++ H N+
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 641 LV-GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
+ E + ++ + G+L L + ++L + + V+ A+ L+YLH+
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE--- 120
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
I+HRD+K+ N+ + K+ D G++RV +E +++T+ GTP Y+ PE + +
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPELFSNKP 178
Query: 760 LTEKSDVYSFGVVLLEIIT 778
KSDV++ G + E+ T
Sbjct: 179 YNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 588 VLGKGGFGTVYHGKLDND------EVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTT 640
+L +G FG +++G L ++ EV VK + +S+ E LL + H+N+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 641 LVGYCDEGTNMALI-YEYMANGNLEEHLSDSSKEILNWEERLR------IAVEAALGLEY 693
++ C E + Y YM GNL+ L N + L +A++ A G+ Y
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR-VFPVEGGTHVSTTIAGTP-GYLD 751
LH K ++H+D+ + N +I+E+ Q K+ D LSR +FP H P ++
Sbjct: 133 LH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP--MDYHCLGDNENRPVKWMA 187
Query: 752 PEYYISNRLTEKSDVYSFGVVLLEIIT 778
E ++ + SDV+SFGV+L E++T
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 9/204 (4%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLD-NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH 635
E+ R + E+ LG G FG V+ + + +VAVK + P S + F AE ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
L L + + +I E+MA G+L + L + + + + A G+ ++
Sbjct: 61 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
Q +HRD+++ NIL++ K+ADFGL+RV +E + + A P + PE
Sbjct: 120 Q---RNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEA 174
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
T KSDV+SFG++L+EI+T
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-18
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 589 LGKGGFGTVYH------GKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLT 639
LGKGGFG V GKL A K L+ +GY+ E ++L +VH R +
Sbjct: 1 LGKGGFGEVSACQMRATGKL----YACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIV 56
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI--AVEAALGLEYLHQG 697
+L T++ L+ M G+L H+ + +E + E + GLE+LHQ
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
I++RD+K N+L++ +++D GL+ ++ G + AGTPG++ PE
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQG 171
Query: 758 NRLTEKSDVYSFGVVLLEII 777
D ++ GV L E+I
Sbjct: 172 EEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 16/207 (7%)
Query: 580 RMTNNFERVLGKGGFGTVYHGKLDN---DEVAVKMLSPSSSQG-YKQFQAEVKLLLRVHH 635
+ ER+ GKG FG VY G +DN + VA+K++ ++ + Q E+ +L +
Sbjct: 4 ELFTKLERI-GKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
+T G +GT + +I EY+ G+ + L E LR E GL+YLH
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR---EILKGLDYLH 118
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS-TTIAGTPGYLDPEY 754
K +HRD+K+ N+L++E+ KLADFG++ T + T GTP ++ PE
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPEV 172
Query: 755 YISNRLTEKSDVYSFGVVLLEIITGHP 781
+ K+D++S G+ +E+ G P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 70/227 (30%), Positives = 112/227 (49%), Gaps = 44/227 (19%)
Query: 589 LGKGGFGTVYHGK---LDNDE------VAVKMLSPSSS-QGYKQFQAEVKLL-LRVHHRN 637
LG+G FG V + +D VAVKML +++ + +E++L+ L H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHL--------------SDSSKEILNWEERLRI 683
+ L+G C + + +I EY A GNL E L + +E L++++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 684 AVEAALGLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH---- 738
A + A G+EYL + C +HRD+ + N+L+ E K+ADFGL+R G H
Sbjct: 140 AYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLAR------GVHDIDY 189
Query: 739 -VSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT--GHP 781
T+ P ++ PE T +SDV+SFG+++ EI T G P
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 73/221 (33%), Positives = 106/221 (47%), Gaps = 28/221 (12%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNLTTLVG 643
+G G FG VY N+ VAVK +S S Q +++Q EVK L ++ H N G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 644 -YCDEGTNMALIYEYM---ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
Y E T L+ EY A+ LE H K+ L E I A GL YLH
Sbjct: 89 CYLKEHTAW-LVMEYCLGSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS-- 757
+HRD+K+ NIL+ E Q KLADFG + + + + GTP ++ PE ++
Sbjct: 143 ---IHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAMD 193
Query: 758 -NRLTEKSDVYSFGVVLLEIITGHP-VISKSAENGHTHVAQ 796
+ K DV+S G+ +E+ P + + +A + H+AQ
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 64/235 (27%), Positives = 97/235 (41%), Gaps = 43/235 (18%)
Query: 583 NNFERV--LGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQ---FQAEVKLLLRVHH 635
++FE + +G+G FG V+ K A+K+L S Q +AE +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEE-RLRIAVEAALGLEYL 694
+ L + ++ L+ EYM G+L L K++ E R IA E L L+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIA-ELVLALDSV 117
Query: 695 HQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLS------------------------- 728
H+ G +HRD+K NILI+ KLADFGL
Sbjct: 118 HKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 729 --RVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
R + + + GTP Y+ PE + D +S GV+L E++ G P
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 589 LGKGGFGTVYHGKLDNDE---VAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRNLTTLVGY 644
+GKG FG V+ G +DN VA+K++ ++ + Q E+ +L + +T G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVH 704
+GT + +I EY+ G+ + L + L+ E GL+YLH K +H
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKK---IH 124
Query: 705 RDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS-TTIAGTPGYLDPEYYISNRLTEK 763
RD+K+ N+L++E+ KLADFG++ T + T GTP ++ PE + K
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 764 SDVYSFGVVLLEIITGHP 781
+D++S G+ +E+ G P
Sbjct: 182 ADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 70/244 (28%), Positives = 106/244 (43%), Gaps = 60/244 (24%)
Query: 562 SYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVY---H---GKL-------DNDEVA 608
S S S + SE+ R+ +G G GTVY H G+L N E
Sbjct: 60 SSASGSAPSAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT 114
Query: 609 VKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEH-- 666
V+ +Q E+++L V+H N+ D + ++ E+M G+LE
Sbjct: 115 VR----------RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI 164
Query: 667 -----LSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAK 721
L+D +++IL+ G+ YLH + IVHRD+K +N+LIN K
Sbjct: 165 ADEQFLADVARQILS-------------GIAYLH---RRHIVHRDIKPSNLLINSAKNVK 208
Query: 722 LADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE------KSDVYSFGVVLLE 775
+ADFG+SR+ S+ GT Y+ PE I+ L D++S GV +LE
Sbjct: 209 IADFGVSRILAQTMDPCNSSV--GTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILE 265
Query: 776 IITG 779
G
Sbjct: 266 FYLG 269
|
Length = 353 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-17
Identities = 76/229 (33%), Positives = 110/229 (48%), Gaps = 28/229 (12%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNLTTL 641
R +G G FG VY N+ VA+K +S S Q +++Q EVK L R+ H N
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 642 VG-YCDEGTNMALIYEYM---ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
G Y E T L+ EY A+ LE H K+ L E I A GL YLH
Sbjct: 91 KGCYLREHTAW-LVMEYCLGSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
++HRD+K+ NIL+ E Q KLADFG + + + + GTP ++ PE ++
Sbjct: 145 ---NMIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILA 195
Query: 758 ---NRLTEKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSML 802
+ K DV+S G+ +E+ P+ + +A + H+AQ S L
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL 244
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 20/194 (10%)
Query: 597 VYHGKLDNDEVAVKMLSPSSSQGYK----QFQAEVKLLLRVHHRNLTTLVGY----CDEG 648
+Y G +N EV ++ +G+K + E+K L R+ N+ + G+ D+
Sbjct: 36 IYKGIFNNKEVIIRTFK-KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 649 TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVK 708
++LI EY G L E L D K+ L+++ +L +A++ GL L++ P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVL-DKEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 709 STNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY--ISNRLTEKSDV 766
S + L+ E ++ K+ GL ++ +V+ + Y + I + T K D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDI 205
Query: 767 YSFGVVLLEIITGH 780
YS GVVL EI TG
Sbjct: 206 YSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 29/223 (13%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHG---KLDNDE----VAVKMLSPSSSQGYK-QFQAEVK 628
EV R R LG+G FG VY G + DE VA+K ++ ++S + +F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL--------SDSSKEILNWEER 680
++ + ++ L+G +G +I E M G+L+ +L ++ + + ++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 681 LRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR-----VFPVEG 735
+++A E A G+ YL+ VHRD+ + N ++ E F K+ DFG++R + +G
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
G + ++ PE T SDV+SFGVVL EI T
Sbjct: 179 GKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 11/209 (5%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYK-QFQAEVKLLLRVHHRNLTTLVGYC 645
LG+G + TVY G KL ++ VA+K + +G EV LL + H N+ TL
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 646 DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHR 705
++ L++EY+ + +L+++L D +N + GL Y H + ++HR
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCH---RRKVLHR 128
Query: 706 DVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI-SNRLTEKS 764
D+K N+LINE+ + KLADFGL+R + T+ + + T Y P+ + S + +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQI 186
Query: 765 DVYSFGVVLLEIITGHPVISKSAENGHTH 793
D++ G + E+ TG P+ S H
Sbjct: 187 DMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 570 SRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKL--DNDE----VAVKMLSPSSSQGYKQF 623
+R +E+ ++ ++LG G FGTV+ G + D VA+K + S + + F
Sbjct: 1 ARILKETELRKL-----KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTF 53
Query: 624 QAEVKLLLRV---HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL-----SDSSKEIL 675
Q +L + H + L+G C G ++ L+ + G+L +H+ S + +L
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 676 NWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735
NW V+ A G+ YL + +VHR++ + NIL+ ++ADFG++ + +
Sbjct: 113 NW------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163
Query: 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ + ++ E + R T +SDV+S+GV + E+++
Sbjct: 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 27/203 (13%)
Query: 589 LGKGGFGTVYHGKLDND-------EVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
+G+G FG K D E+ + +SP + + + EV +L + H N+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQY 64
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSD------SSKEILNWEERLRIAVEAALGLEYLH 695
+E N+ ++ +Y G+L + ++ +IL+W V+ L L+++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVH 118
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
I+HRD+KS NI + + KL DFG++RV + ++ T GTP YL PE
Sbjct: 119 D---RKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEIC 173
Query: 756 ISNRLTEKSDVYSFGVVLLEIIT 778
+ KSD+++ G VL E+ T
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 588 VLGKGGFGTVYHG--KLDNDEVAVKM--LSPSSSQGYKQ-------FQAEVKLLLRVHHR 636
++G G FG+VY G + +AVK L S+ + E+ LL + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL-RIAVEAAL-GLEYL 694
N+ +G + ++ + EY+ G++ L++ +EE L R V L GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYL 122
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT------IAGTPG 748
H I+HRD+K NIL++ K K++DFG+S+ +E + + T + G+
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQGSVF 177
Query: 749 YLDPEYYISNRLTEKSDVYSFGVVLLEIITG-HP 781
++ PE T K+D++S G +++E++TG HP
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 59/215 (27%), Positives = 109/215 (50%), Gaps = 31/215 (14%)
Query: 584 NFERV--LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQA-EVKLLLRVHHRNL 638
NF+++ LG+G + TVY G + + VA+K + + +G E+ L+ + H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL--------- 689
L + L++EYM + +L++++ D+ R A++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYM-DTHGV--------RGALDPNTVKSFTYQLL 110
Query: 690 -GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG 748
G+ + H+ ++HRD+K N+LIN++ + KLADFGL+R F + T + + T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLW 165
Query: 749 YLDPEYYISNRLTEKS-DVYSFGVVLLEIITGHPV 782
Y P+ + +R S D++S G ++ E+ITG P+
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 589 LGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQ---FQAEVKLLLRVHHRNLTTLVG 643
LG GGFG V K N A+K + Q +E ++L +H + L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIA--VEAALGLEYLH-QGCKP 700
+ + ++ EY G L L D + R IA V A EYLH +G
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLA---FEYLHNRG--- 113
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
I++RD+K N+L++ KL DFG ++ T T GTP Y+ PE ++
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPEIILNKGY 169
Query: 761 TEKSDVYSFGVVLLEIITGHPVISKSAE 788
D +S G++L E++TG P + E
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 60/236 (25%)
Query: 582 TNNFE--RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV---- 633
T FE V+G+G +G VY + VA+K++ + + E+K +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-----EEEIKEEYNILRKY 59
Query: 634 -HHRNLTTLVG------YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR---- 682
+H N+ T G + L+ E G++ +D K + +RL+
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV----TDLVKGLRKKGKRLKEEWI 115
Query: 683 --IAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740
I E GL YLH+ ++HRD+K NIL+ + + KL DFG+S +
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--------QLD 164
Query: 741 TTIA------GTPGYLDPE---------YYISNRLTEKSDVYSFGVVLLEIITGHP 781
+T+ GTP ++ PE R SDV+S G+ +E+ G P
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR----SDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 9e-17
Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 27/195 (13%)
Query: 606 EVAVKML---SPSSSQGYKQFQAEVKLLLRVHHRNLTTLV--GYCDEGTNMALIYEYMAN 660
EVA+K+L +P +F+ E L R++H N+ L+ G G A ++EY+
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYVPG 63
Query: 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKPPIVHRDVKSTNILINE--- 716
L E L+ + L E R+ ++ L H QG IVHRD+K NI++++
Sbjct: 64 RTLREVLA--ADGALPAGETGRLMLQVLDALACAHNQG----IVHRDLKPQNIMVSQTGV 117
Query: 717 KFQAKLADFGLSRVFPVEGGTH--------VSTTIAGTPGYLDPEYYISNRLTEKSDVYS 768
+ AK+ DFG+ + P G +T + GTP Y PE +T SD+Y+
Sbjct: 118 RPHAKVLDFGIGTLLP---GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 769 FGVVLLEIITGHPVI 783
+G++ LE +TG V+
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 587 RVLGKGGFGTVYHGKLDND------EVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLT 639
+VLG G FGTVY G D VA+K+L ++S + K+ E ++ V +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDS-----SKEILNWEERLRIAVEAALGLEYL 694
L+G C T + L+ + M G L +++ ++ S+++LNW V+ A G+ YL
Sbjct: 73 RLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
+ +VHRD+ + N+L+ K+ DFGL+R+ ++ + + ++ E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
+ R T +SDV+S+GV + E++T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 585 FERVLGKGGFGTVY-------HGKLDND-----------EVAVKMLSPSSSQGYKQ-FQA 625
F+ LG+G FG V+ +D D VAVKML +++ + F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 626 EVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLS---------DSSKEILN 676
E+K++ R+ N+ L+ C + +I EYM NG+L + LS + ++
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 677 WEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736
+ + +A + A G++YL VHRD+ + N L+ + + K+ADFG+SR G
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-YSGD 184
Query: 737 THVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ A P ++ E + + T SDV++FGV L EI+T
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 76/247 (30%), Positives = 117/247 (47%), Gaps = 32/247 (12%)
Query: 587 RVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNLTTL 641
R +G G FG VY + +++ VA+K +S S Q +++Q EV+ L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 642 VG-YCDEGTNMALIYEYM---ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
G Y E T L+ EY A+ LE H K+ L E + A GL YLH
Sbjct: 81 RGCYLREHTAW-LVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
++HRDVK+ NIL++E KL DFG + + + GTP ++ PE ++
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVILA 185
Query: 758 ---NRLTEKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSMLDKGD----IRS 809
+ K DV+S G+ +E+ P+ + +A + H+AQ S L G R+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245
Query: 810 TVDPRLK 816
VD L+
Sbjct: 246 FVDSCLQ 252
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYK-QFQAEVKLLLRVHHRNLTTLVGYC 645
LG+G + TV+ G KL + VA+K + +G EV LL + H N+ TL
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 646 DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHR 705
++ L++EY+ + +L++++ D I++ + GL Y H + ++HR
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCH---RRKVLHR 128
Query: 706 DVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI-SNRLTEKS 764
D+K N+LINE+ + KLADFGL+R V T+ + + T Y P+ + S+ + +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQI 186
Query: 765 DVYSFGVVLLEIITGHPVISKSAENGHTHV 794
D++ G + E+ +G P+ S H+
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 586 ERVLGKGGFGTVYHGKLD-----NDEVAVKML-SPSSSQGYKQFQAEVKLLLRVHHRNLT 639
E V+G G FG V G+L VA+K L S + + + F +E ++ + H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHL--SDSSKEILNWEERLRIAVEAALGLEYLHQG 697
L G + + +I E+M NG L+ L +D ++ LR A G++YL +
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSE- 124
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG-----YLDP 752
VHRD+ + NIL+N K++DFGLSR +E T T + G + P
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRF--LEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIIT 778
E + T SDV+S+G+V+ E+++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 585 FERVLGKGGFGTVYHGKLDN----------------DEVAVKMLSPS-SSQGYKQFQAEV 627
+ LG+G FG V+ + + VAVKML + F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 628 KLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEI------------L 675
K++ R+ + N+ L+G C + +I EYM NG+L + L S +EI +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANNIPSV 126
Query: 676 NWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735
+ L +AV+ A G++YL VHRD+ + N L+ + K+ADFG+SR
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ ++ E + + T SDV++FGV L E+ T
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 11/210 (5%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYK-QFQAEVKLLLRVHHRNLTTLVGYC 645
LG+G + TV+ G KL + VA+K + +G EV LL + H N+ TL
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 646 DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHR 705
+ L++EY+ + +L+++L D+ +++ + GL Y H K I+HR
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127
Query: 706 DVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI-SNRLTEKS 764
D+K N+LINEK + KLADFGL+R V T+ + + T Y P+ + S +
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYSTPI 185
Query: 765 DVYSFGVVLLEIITGHPVISKSAENGHTHV 794
D++ G +L E+ TG P+ S H+
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 587 RVLGKGGFGTVYHGK--LDNDEVAVKMLS----PSSSQG--YKQFQAEVKLLLRVHHRNL 638
+ LG G F + Y + +AVK ++ SS Q + + E++L+ R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV--EAALGLEYLHQ 696
++G E ++ L E+MA G++ LS ++E + I + GL YLH+
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA----FKEAVIINYTEQLLRGLSYLHE 121
Query: 697 GCKPPIVHRDVKSTNILINEKFQ-AKLADFGLSRVFP--VEGGTHVSTTIAGTPGYLDPE 753
I+HRDVK N+LI+ Q ++ADFG + G + GT ++ PE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 754 YYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813
+ DV+S G V++E+ T P + + H + ++S I + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 814 RLKGDFDINSVWKAVEIAMACVSSNANRRP 843
L+ ++ + C+ RP
Sbjct: 239 GLR------------DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 589 LGKGGFGTVY---HGKLDNDE-------VAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNL 638
LGKG FGTVY K +E + V L+P+ + Q E +LL ++ H +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHPAI 64
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSK--EILNWEERLRIAVEAALGLEYLHQ 696
E +I EY +L+ L + + L+ + ++ LG+ Y+HQ
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
I+HRD+K+ NI + K+ DFG+SR+ + G ++TT GTP Y+ PE
Sbjct: 125 ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALK 178
Query: 757 SNRLTEKSDVYSFGVVLLEI 776
KSD++S G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 26/207 (12%)
Query: 587 RVLGKGGFGTVY-----HGKLDNDEVAVKMLSPSSSQGYKQFQA--EVKLLLRVHHRNLT 639
+VLG+G FG V+ G A+K+L ++ + + + E +L V+H +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 640 TL-VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV-EAALGLEYLHQG 697
L + EG + LI +++ G+L LS KE++ EE ++ + E AL L++LH
Sbjct: 62 KLHYAFQTEG-KLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLH-- 115
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA--GTPGYLDPEYY 755
I++RD+K NIL++E+ KL DFGLS+ E H + GT Y+ PE
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPE-- 168
Query: 756 ISNRL--TEKSDVYSFGVVLLEIITGH 780
+ NR T+ +D +SFGV++ E++TG
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGS 195
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 583 NNFER--VLGKGGFGTVY--HGKLDNDEVAVKML--SPSSSQGYKQFQAEVKLLLRVHHR 636
N +E V+G+G +G V K + VA+K S K EVK+L ++ H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
N+ L + L++EY+ L E L ++S L + + + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER-TLLELL-EASPGGLPPDAVRSYIWQLLQAIAYCH- 117
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
I+HRD+K NIL++E KL DFG +R T T Y PE +
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFARALR-ARPASPLTDYVATRWYRAPELLV 174
Query: 757 SNRLTEKS-DVYSFGVVLLEIITGHP 781
+ K DV++ G ++ E++ G P
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 587 RVLGKGGFGTVYHGKLDN-DEV-AVKMLSPS---SSQGYKQFQAEVKLL-LRVHHRNLTT 640
+VLGKG FG V +L DE+ AVK+L + E ++L L H LT
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 641 LVGYCDEGT--NMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQG 697
L + T + + EY+ G+L H+ S + E R R A E LGL++LH+
Sbjct: 61 L--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD---EPRARFYAAEIVLGLQFLHE- 114
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
I++RD+K N+L++ + K+ADFG+ + + G T ++T GTP Y+ PE
Sbjct: 115 --RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSY 170
Query: 758 NRLTEKSDVYSFGVVLLEIITGHP 781
D ++ GV+L E++ G
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 23/202 (11%)
Query: 589 LGKGGFGTVYHGKLDNDE---VAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRNLTTLVGY 644
+GKG FG V+ G +DN VA+K++ ++ + Q E+ +L + +T G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVH 704
+ T + +I EY+ G+ + L L+ + I E GL+YLH K +H
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK---IH 124
Query: 705 RDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI-----AGTPGYLDPEYYISNR 759
RD+K+ N+L++E + KLADFG++ G T I GTP ++ PE +
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVA-------GQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 760 LTEKSDVYSFGVVLLEIITGHP 781
K+D++S G+ +E+ G P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 79/285 (27%), Positives = 121/285 (42%), Gaps = 39/285 (13%)
Query: 587 RVLGKGGFGTVYHG--KLDND---EVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLT 639
R+LGKG FG+V K ++ +VAVKML SS ++F E + H N+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 640 TLVGYCDEGTNMA------LIYEYMANGNLEEHL--SDSSKEILNWEER--LRIAVEAAL 689
L+G +I +M +G+L L S +E + +R ++ A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-G 748
G+EYL +HRD+ + N ++NE +ADFGLS+ G + + P
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKI-YSGDYYRQGCASKLPVK 180
Query: 749 YLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR 808
+L E N T SDV++FGV + EI+T EN + + L KG+
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY------NYLIKGN-- 232
Query: 809 STVDPRLKGDFD-INSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852
RLK D + V+ E+ C S RP + +L
Sbjct: 233 -----RLKQPPDCLEDVY---ELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKML-----SPSSSQGYKQFQAEVKLLLRVHHRNLT 639
++LG+G FG VY + E+AVK + SP +S+ + E++LL + H +
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 640 TLVGYCDEGT--NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
G + +++ E+M G++++ L S L + + G+ YLH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV--EGGTHVSTTIAGTPGYLDPEYY 755
IVHRD+K NIL + KL DFG S+ GT + ++ GTP ++ PE
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-SVTGTPYWMSPEVI 181
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
K+D++S G ++E++T P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-16
Identities = 73/279 (26%), Positives = 118/279 (42%), Gaps = 47/279 (16%)
Query: 586 ERVLGKGGFGTVYHGKL--DNDEVAVKM--LSPSSSQGYKQFQAEVKLLLRVH------- 634
RVLG G GTV K D + AVK+ + S + QAEV LL
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 635 HRNLTTLVGYCDEGTN-----MALIYEYMANGNLEEHLSDSSKEILNWEERLR--IAVEA 687
H + D +AL+ +Y G+L + + +K + E + ++
Sbjct: 97 HEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 688 ALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP 747
L + ++H ++HRD+KS NIL+ KL DFG S+++ V T GTP
Sbjct: 153 LLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 748 GYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDI 807
Y+ PE + ++K+D++S GV+L E++T + D ++
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLT-------------------LKRPFDGENM 250
Query: 808 RSTVDPRLKGDFDI---NSVWKAVEIAMACVSSNANRRP 843
+ L G +D + + EI A +SS+ RRP
Sbjct: 251 EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKML-----SPSSSQGYKQFQAEVKLLLRVHHRNLT 639
++LG+G FG VY + E+A K + SP +S+ + E++LL + H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 640 TLVGYC--DEGTNMALIY-EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
G C D I+ EYM G++++ L + L + + G+ YLH
Sbjct: 68 QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYLHS 124
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV--EGGTHVSTTIAGTPGYLDPEY 754
IVHRD+K NIL + KL DFG S+ GT + ++ GTP ++ PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR-SVTGTPYWMSPEV 180
Query: 755 YISNRLTEKSDVYSFGVVLLEIITGHP 781
K+DV+S G ++E++T P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 588 VLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQA--EVKLLLRVHHRNLTTL-- 641
+G+G +G VY K + VA+K + + + A E+K+L +++HRN+ L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 642 --------VGYCDEGTNMALIYEYMAN---GNLEEHLSDSSKEILNWEERLRIAVEAAL- 689
+ + + L++EYM + G LE L S E+ ++ ++ L
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS------EDHIKSFMKQLLE 127
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGY 749
GL Y H K +HRD+K +NIL+N K Q KLADFGL+R++ E + + T Y
Sbjct: 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWY 183
Query: 750 LDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAE 788
PE + R DV+S G +L E+ T P+ + E
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 587 RVLGKGGFGTVYHGKLD--NDEVAVKMLSPS---SSQGYKQFQAEVKLL-LRVHHRNLTT 640
+VLGKG FG V +L N+ A+K L + E ++L L H LT
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 641 LVGYCDEGTNMALIY--EYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQG 697
L +C T L + EY+ G+L H+ S + E R R A E GL++LH
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD---EARARFYAAEIICGLQFLH-- 113
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
K I++RD+K N+L+++ K+ADFG+ + G ++T GTP Y+ PE
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCGTPDYIAPEILKG 170
Query: 758 NRLTEKSDVYSFGVVLLEIITG 779
+ E D +SFGV+L E++ G
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 621 KQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE---EHLSDSSKEILNW 677
KQ E++++ + + G N+ + E+M G+L+ + EIL
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG- 106
Query: 678 EERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737
+IAV GL YL+ I+HRD+K +NIL+N + Q KL DFG+S E
Sbjct: 107 ----KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG----ELIN 156
Query: 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG 779
++ T GT Y+ PE + T KSDV+S G+ ++E+ G
Sbjct: 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-15
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 28/211 (13%)
Query: 587 RVLGKGGFGTVY------HGKLDNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLT 639
+VLG G FGTVY G+ VA+K+L+ ++ + +F E ++ + H +L
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSD-----SSKEILNWEERLRIAVEAALGLEYL 694
L+G C T + L+ + M +G L +++ + S+ +LNW V+ A G+ YL
Sbjct: 73 RLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP--GYLDP 752
+ +VHRD+ + N+L+ K+ DFGL+R+ +EG G ++
Sbjct: 126 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL--LEGDEKEYNADGGKMPIKWMAL 180
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIIT--GHP 781
E + T +SDV+S+GV + E++T G P
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 22/214 (10%)
Query: 587 RVLGKGGFGTVY-----HGKLDNDEVAVKMLSPS----SSQGYKQFQAEVKLLLRVHHRN 637
+VLGKGG+G V+ G A+K+L + + + +AE +L V H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV-EAALGLEYLH- 695
+ L+ G + LI EY++ G L HL +E + E+ + E +L LE+LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQ 118
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
QG I++RD+K NIL++ + KL DFGL + + GT V+ T GT Y+ PE
Sbjct: 119 QG----IIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGT-VTHTFCGTIEYMAPEIL 172
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHPVISKSAEN 789
+ + + D +S G ++ +++TG P +AEN
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPF--TAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNLTT 640
E+ +G+G F VY LD VA+K + K Q E+ LL +++H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL--RIAVEAALGLEYLHQGC 698
+ E + ++ E G+L + + K+ ER + V+ +E++H
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-- 124
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
++HRD+K N+ I KL D GL R F + T + ++ GTP Y+ PE N
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHEN 181
Query: 759 RLTEKSDVYSFGVVLLEI 776
KSD++S G +L E+
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 71/273 (26%), Positives = 128/273 (46%), Gaps = 36/273 (13%)
Query: 588 VLGKGGFGTVYHG-KLDNDEV-AVKM--LSPSSSQGYKQFQ--------AEVKLLLRVHH 635
++GKG +G VY + E+ AVK L + + + Q +E++ L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL-RIAVEAAL-GLEY 693
N+ +G+ +++ EY+ G++ L + +EE+L R E L GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR----FEEQLVRFFTEQVLEGLAY 123
Query: 694 LH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
LH +G I+HRD+K+ N+L++ K++DFG+S+ + ++ G+ ++ P
Sbjct: 124 LHSKG----ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 753 EYYISNR--LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRST 810
E S + K D++S G V+LE+ G S + +++M G+ RS
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE---------EAIAAMFKLGNKRSA 230
Query: 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRP 843
P + D +N A++ AC + N + RP
Sbjct: 231 --PPIPPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 588 VLGKGGFGTVYHGK-LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYC 645
++G G +G VY G+ + ++A + + ++ + E+ +L + HHRN+ T G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 646 DEGT------NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
+ + L+ E+ G++ + + ++ L E I E GL +LHQ
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
++HRD+K N+L+ E + KL DFG+S G T GTP ++ PE +
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPEVIACDE 187
Query: 760 LTE-----KSDVYSFGVVLLEIITGHP 781
+ KSD++S G+ +E+ G P
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 587 RVLGKGGFGTVYHGKLDNDE----VAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTT 640
+ LG+G FG+V G+L+ D+ VAVK + + + + F +E + H N+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 641 LVGYCDEGTNM------ALIYEYMANGNLEEHLSDS----SKEILNWEERLRIAVEAALG 690
L+G C + +I +M +G+L L S + L + ++ + A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GY 749
+EYL +HRD+ + N ++NE +ADFGLS+ G + IA P +
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKMPVKW 180
Query: 750 LDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ E T KSDV+SFGV + EI T
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 589 LGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNLTTLV- 642
LG G FG V K + A+K L KQ Q E +L+ + H + ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
+ DE + + E++ G L HL + + N + A E L EYLH I
Sbjct: 86 SFQDE-NRVYFLLEFVVGGELFTHLRKAGR-FPNDVAKFYHA-ELVLAFEYLHS---KDI 139
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE 762
++RD+K N+L++ K K+ DFG ++ P + T+ GTP YL PE S +
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGK 194
Query: 763 KSDVYSFGVVLLEIITGHP 781
D ++ GV+L E I G+P
Sbjct: 195 AVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 33/225 (14%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHG------KLDND-EVAVKMLSPSSSQGYK-QF--QAE 626
EV R R LG+G FG VY G K + + VAVK ++ S+S + +F +A
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 627 VKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILN--------WE 678
V HH + L+G +G ++ E MA+G+L+ +L E N +
Sbjct: 62 VMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 679 ERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR-----VFPV 733
E +++A E A G+ YL+ VHRD+ + N ++ F K+ DFG++R +
Sbjct: 120 EMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176
Query: 734 EGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+GG + ++ PE T SD++SFGVVL EI +
Sbjct: 177 KGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 588 VLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQA--EVKLLLRVHHRNLTTLVG 643
LG+G + TVY G KL VA+K + +G F A E LL + H N+ TL
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLHQGCKPPI 702
+ L++EY+ + +L++++ D L+ +R+ + L GL Y HQ +
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLS-MHNVRLFLFQLLRGLAYCHQ---RRV 124
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI-SNRLT 761
+HRD+K N+LI+E+ + KLADFGL+R V T+ + + T Y P+ + S +
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 762 EKSDVYSFGVVLLEIITGHPV 782
D++ G + E+ TG P+
Sbjct: 183 TSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 589 LGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV-GYC 645
LG G FG VY K A K++ S + + F E+ +L H N+ L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 646 DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLHQGCKPPIVH 704
E + ++ E+ G L+ + + L E ++R L L +LH ++H
Sbjct: 73 YEN-KLWILIEFCDGGALDS-IMLELERGLT-EPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 705 RDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY-----YISNR 759
RD+K+ NIL+ KLADFG+S T GTP ++ PE + N
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNP 184
Query: 760 LTEKSDVYSFGVVLLEIITGHP 781
K+D++S G+ L+E+ P
Sbjct: 185 YDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTL 641
++ +LG G GTVY L +AVK++ + + KQ +E+++L + +
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
G +++ E+M G+L+ + + +L RIAV GL YL K
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRK-IPEHVLG-----RIAVAVVKGLTYL-WSLK-- 115
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
I+HRDVK +N+L+N + Q KL DFG+S ++ T GT Y+ PE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQYG 171
Query: 762 EKSDVYSFGVVLLEIITG---HPVISKS 786
SDV+S G+ +E+ G +P I K+
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 587 RVLGKGGFGTVYHGKLD--NDEVAVKMLSPS---SSQGYKQFQAEVKLL-LRVHHRNLTT 640
++LGKG FG V+ +L N A+K L + E ++L L H LT
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 641 LVGYCDEGT--NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
L YC T N+ + EY+ G+L H+ K + A E GL++LH
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHS-- 114
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
IV+RD+K NIL++ K+ADFG+ + + G + T GTP Y+ PE +
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCGTPDYIAPEILLGQ 171
Query: 759 RLTEKSDVYSFGVVLLEIITGH 780
+ D +SFGV+L E++ G
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 584 NFERV--LGKGGFGTVYHGKLDNDEV-----AVKMLSPSSSQGYKQFQ---AEVKLLLRV 633
+ ER+ +G G FG V+ L D + A+K+++ KQ Q E ++L V
Sbjct: 2 DLERIKTVGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 634 HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEY 693
H + L + + ++ EY+ G L +L +S + + L A E LEY
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEY 116
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
LH IV+RD+K NIL++++ KL DFG ++ + T T+ GTP YL PE
Sbjct: 117 LHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTW---TLCGTPEYLAPE 168
Query: 754 YYISNRLTEKSDVYSFGVVLLEIITGHP 781
S + D ++ G+++ E++ G+P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 587 RVLGKGGFGTVYHG---KLDNDE--VAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTT 640
R +G+G FG VY G +N++ VAVK +S ++ F E ++ + H ++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
L+G E + ++ E G L +L +K L+ + + + + L YL
Sbjct: 72 LIGVITE-NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNR 759
VHRD+ + N+L++ KL DFGLSR E S P ++ PE R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG--KLPIKWMAPESINFRR 184
Query: 760 LTEKSDVYSFGVVLLEII 777
T SDV+ FGV + EI+
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 67/204 (32%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 587 RVLGKGGFGTVYHGKLDNDEV--AVKMLSPSS---SQGYKQFQAEVKLLLR-VHHRNLTT 640
+V+GKG FG V K D AVK+L + + K AE +LL+ V H L
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCK 699
L + + +Y+ G L HL +E E R R A E A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG--GTHVSTTIAGTPGYLDPEYYIS 757
I++RD+K NIL++ + L DFGL + EG + ++T GTP YL PE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 758 NRLTEKSDVYSFGVVLLEIITGHP 781
D + G VL E++ G P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKML--SPSSSQGYKQFQA---EVKLLLRVHHRNLT 639
++LG+G FG VY + E+AVK + P S + K+ A E++LL + H +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 640 TLVGYC---DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
G C E +++ EYM G++++ L + L R + G+ YLH
Sbjct: 68 QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSYLHS 124
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV--EGGTHVSTTIAGTPGYLDPEY 754
IVHRD+K NIL + KL DFG S+ GT + ++ GTP ++ PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK-SVTGTPYWMSPEV 180
Query: 755 YISNRLTEKSDVYSFGVVLLEIITGHP 781
K+DV+S ++E++T P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 8e-15
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTL 641
RVLGKG FG V +L AVK+L + E ++L + T
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 642 VGYCDEGTN-MALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCK 699
+ C + + + + E++ G+L H+ S + E R R A E L +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEITSALMFLHD--- 114
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
I++RD+K N+L++ + KLADFG+ + G T ++T GTP Y+ PE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEML 172
Query: 760 LTEKSDVYSFGVVLLEIITGH 780
D ++ GV+L E++ GH
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 587 RVLGKGGFGTVYHGKLDND------EVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLT 639
+VLG G FGTVY G + VA+K L ++S + K+ E ++ V + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDS-----SKEILNWEERLRIAVEAALGLEYL 694
L+G C T + LI + M G L +++ + S+ +LNW V+ A G+ YL
Sbjct: 73 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 125
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
+ +VHRD+ + N+L+ K+ DFGL+++ + + + ++ E
Sbjct: 126 EE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
+ T +SDV+S+GV + E++T
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 589 LGKGGFGTVYHGKLDNDE---VAVKMLS-PSSSQGYKQFQA-EVKLLLRVH---HRNLTT 640
+G G +GTVY + D VA+K + ++ G EV LL R+ H N+
Sbjct: 8 IGVGAYGTVYKAR-DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 641 LVGYC-----DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
L+ C D T + L++E++ + +L +L L E + + GL++LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
C IVHRD+K NIL+ Q KLADFGL+R++ + T + T Y PE
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL---TPVVVTLWYRAPEVL 179
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788
+ + D++S G + E+ P+ ++E
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 587 RVLGKGGFGTV--YHGKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTL 641
++LGKG FG V K A+K+L + E ++L H LT+L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCKP 700
+ + EY+ G L HLS +E + E+R R E L+YLH G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSG--- 114
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST--TIAGTPGYLDPEYYISN 758
IV+RD+K N+++++ K+ DFGL + EG T +T T GTP YL PE N
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAPEVLEDN 170
Query: 759 RLTEKSDVYSFGVVLLEIITG 779
D + GVV+ E++ G
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 27/225 (12%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQGYKQ-FQAEVK 628
E+ T F LG+ FG VY G L VA+K L + ++ F+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL------SD--------SSKEI 674
+ R+ H N+ L+G + +++I+ Y ++ +L E L SD + K
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 675 LNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR-VFPV 733
L + + I + A G+E+L +VH+D+ + N+L+ +K K++D GL R V+
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 734 EGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ + ++ ++ PE + + + SD++S+GVVL E+ +
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-14
Identities = 44/132 (33%), Positives = 73/132 (55%), Gaps = 5/132 (3%)
Query: 651 MALIYEYMANGNLEEHLSDSSKEILNWEERLR--IAVEAALGLEYLHQGCKPPIVHRDVK 708
+ LI EY + G+L + + KE L ++E + + L L+ +H ++HRD+K
Sbjct: 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLK 196
Query: 709 STNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYS 768
S NI + KL DFG S+ + V+++ GTP YL PE + R ++K+D++S
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256
Query: 769 FGVVLLEIITGH 780
GV+L E++T H
Sbjct: 257 LGVILYELLTLH 268
|
Length = 478 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
FE++ G+G GTVY EVA+K ++ + E+ ++ H N+ V
Sbjct: 24 FEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI---V 79
Query: 643 GYCDE---GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV--EAALGLEYLHQG 697
Y D G + ++ EY+A G+L + ++++ +E AV E LE+LH
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN 134
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
++HRD+KS NIL+ KL DFG E +T+ GTP ++ PE
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTR 189
Query: 758 NRLTEKSDVYSFGVVLLEIITGHP 781
K D++S G++ +E++ G P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 27/231 (11%)
Query: 584 NFE--RVLGKGGFGTVY---------HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLR 632
NFE RVLG G +G V+ GKL +V K ++ + + E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 633 VHHRN-LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV-EAALG 690
V L TL T + LI +Y+ G L HL E +R+ + E L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT---ESEVRVYIAEIVLA 117
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYL 750
L++LHQ I++RD+K NIL++ + L DFGLS+ F + + + GT Y+
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYM 173
Query: 751 DPEYYISNRLT----EKSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQ 796
PE + + + D +S GV+ E++TG P +N + +++
Sbjct: 174 APE--VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR 222
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 2e-14
Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 585 FERVLGKGGFGTVYHGKLD---NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
FE++ G+G GTVY +D EVA+K ++ Q K+ L++R ++N +
Sbjct: 24 FEKI-GQGASGTVYTA-IDIATGQEVAIKQMN-LQQQPKKELIINEILVMR-ENKN-PNI 78
Query: 642 VGYCDE---GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
V Y D G + ++ EY+A G+L + ++++ ++ + + E L++LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFLHSN- 134
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGL-SRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
++HRD+KS NIL+ KL DFG +++ P + +T+ GTP ++ PE
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 189
Query: 758 NRLTEKSDVYSFGVVLLEIITGHP 781
K D++S G++ +E++ G P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 587 RVLGKGGFGTV------YHGKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRN 637
RVLGKGGFG V GK+ A K L +G E ++L +V+ R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ +L + + L+ M G+L+ H+ + + A E GLE LHQ
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ- 120
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
IV+RD+K NIL+++ +++D GL+ P EG T GT GY+ PE +
Sbjct: 121 --ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGRV--GTVGYMAPEVVKN 175
Query: 758 NRLTEKSDVYSFGVVLLEIITGH 780
R T D ++ G +L E+I G
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 40/167 (23%)
Query: 589 LGKGGFGTVYHGK--LDNDEVAVKMLS-PSSSQGYKQFQA-EVKLLLRV---HHRNLTTL 641
+G+G +GTVY + VA+K + P S +G E+ LL ++ H N+ L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 642 VGYC-----DEGTNMALIYEYM------------ANGNLEEHLSDSSKEILNWEERLRIA 684
+ C D + L++E++ G E + D +++L
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR-------- 118
Query: 685 VEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731
G+++LH IVHRD+K NIL+ Q K+ADFGL+R++
Sbjct: 119 -----GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 68/204 (33%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 587 RVLGKGGFGTVYHGKLD-NDEV-AVKMLSPSS---SQGYKQFQAEVKLL-LRVHHRNLTT 640
+VLGKG FG V +L DEV A+K+L E ++L L H LT
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 641 LVGYCDEGTNMALIY--EYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQG 697
L +C T L + EY+ G+L + S K E R R A E L L +LH+
Sbjct: 61 L--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD---EPRSRFYAAEVTLALMFLHRH 115
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
+++RD+K NIL++ + KLADFG+ + + G T +TT GTP Y+ PE
Sbjct: 116 ---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQE 170
Query: 758 NRLTEKSDVYSFGVVLLEIITGHP 781
D ++ GV++ E++ G P
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 66/202 (32%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 587 RVLGKGGFGTVYHGKLDNDEV--AVKMLSPSS---SQGYKQFQAEVKLLLR-VHHRNLTT 640
+V+GKG FG V + +E AVK+L + + K +E +LL+ V H L
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCK 699
L + + +Y+ G L HL +E E R R A E A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHS--- 114
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
IV+RD+K NIL++ + L DFGL + GT ++T GTP YL PE
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQP 172
Query: 760 LTEKSDVYSFGVVLLEIITGHP 781
D + G VL E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 40/232 (17%)
Query: 578 VLRMTNNFERV--LGKGGFGTVYHG--KLDNDEVAVKMLS--------PSSSQGYKQFQA 625
R FE++ +G+G +G VY + VA+K + P SS
Sbjct: 2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL------R 55
Query: 626 EVKLLLRVHHRNLTTL----VGYCDEGTNMALIYEYMANGNLEEH----LSDSSKEILNW 677
E+ LLL + H N+ L VG ++ L+ EY E L D+ +
Sbjct: 56 EITLLLNLRHPNIVELKEVVVG--KHLDSIFLVMEYC------EQDLASLLDNMPTPFSE 107
Query: 678 EERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737
+ + ++ GL+YLH+ I+HRD+K +N+L+ +K K+ADFGL+R + +
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164
Query: 738 HVSTTIAGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788
+ T Y PE + T D+++ G +L E++ P++ +E
Sbjct: 165 MTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 60/199 (30%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTL 641
++LGKG FG V K A+K+L + E ++L H LT L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCKP 700
+ + EY G L HLS +E + E+R R E L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSC--- 114
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
+V+RD+K N+++++ K+ DFGL + +G T T GTP YL PE N
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDY 172
Query: 761 TEKSDVYSFGVVLLEIITG 779
D + GVV+ E++ G
Sbjct: 173 GRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 585 FERV--LGKGGFGTVYHG--KLDNDEVAVKMLS--------PSSSQGYKQFQAEVKLLLR 632
+++V +G+G +G VY KL + VA+K + PS++ E+ LL
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI------REISLLKE 54
Query: 633 VHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GL 691
++H N+ L+ + L++E++ + +L++++ DSS ++ + L G+
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 692 EYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTHVSTTIAGTPGY 749
Y H ++HRD+K N+LI+ + KLADFGL+R F PV TH T+ Y
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL----WY 165
Query: 750 LDPEYYISNRLTEKS-DVYSFGVVLLEIITGHPVISKSAE 788
PE + +R D++S G + E++ P+ +E
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 48/196 (24%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 589 LGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD 646
+G+G GTV+ EVA+K ++ + E+ ++ + + N+ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 647 EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRD 706
G + ++ EY+A G+L + ++++ ++ + + E LE+LH ++HRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETC---MDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 707 VKSTNILINEKFQAKLADFGL-SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSD 765
+KS N+L+ KL DFG +++ P + +T+ GTP ++ PE K D
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 766 VYSFGVVLLEIITGHP 781
++S G++ +E++ G P
Sbjct: 198 IWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 46/217 (21%)
Query: 587 RVLGKGGFGTVYHGK-LDNDE-VAVKMLSPSSSQGYKQFQA-----EVKLLLRV-HHRNL 638
+ LG G FG+VY + + E VA+K + + + ++ EVK L ++ H N+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR-IAVEAALGLEYLHQG 697
L E + ++EYM GNL + + D + + E +R I + GL ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQILQGLAHIH-- 116
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
K HRD+K N+L++ K+ADFGL+R I P Y D Y+S
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAR------------EIRSRPPYTD---YVS 160
Query: 758 NR--------LTEKS-----DVYSFGVVLLEIITGHP 781
R L S D+++ G ++ E+ T P
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 39/222 (17%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVK-MLSPSSSQGYK-QFQAEVKLLLRVHHRNLTTL--- 641
LG+G FG VY VA+K +L + G+ E+K+L ++ H N+ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 642 -VGYCDEGTN----MALIYEYMA---NGNLEE---HLSDSSKEILNWEERLRIAVEAALG 690
V D+ + ++ YM +G LE L++S +I + +L +E G
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES--QIKCYMLQL---LE---G 127
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF---------PVEGGTHVST 741
+ YLH+ I+HRD+K+ NILI+ + K+ADFGL+R + GGT T
Sbjct: 128 INYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 742 TIAGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPV 782
+ T Y PE + R T D++ G V E+ T P+
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 56/246 (22%)
Query: 583 NNFE--RVLGKGGFGTV--YHGKLDNDEVAVKMLSPSSSQGYKQ---FQAEVKLLLRVHH 635
++FE +V+G+G FG V K A+K L S +Q +AE +L +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 636 RNLTTLVGYC---DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEE-RLRIAVEAALGL 691
+ L Y DE + LI EY+ G++ L K+ EE R IA E L +
Sbjct: 61 PWVVKL--YYSFQDE-NYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIA-ETILAI 114
Query: 692 EYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLS-------------RVFPVEGGTH 738
+ +H K +HRD+K N+L++ K KL+DFGL +
Sbjct: 115 DSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 739 VSTT-----------------------IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE 775
+ GTP Y+ PE ++ ++ D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 776 IITGHP 781
++ G+P
Sbjct: 232 MLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 24/222 (10%)
Query: 586 ERVLGKGGFGTVYHG--KLDNDE---VAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLT 639
ER+LG G FG + G KL + VA+ L S ++ F AE L + H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
L G G M ++ EYM+NG L+ L + L + + + A G++YL +
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSE--- 125
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYL--DPEYYIS 757
VH+ + + +L+N K++ F R + + TT++G L PE
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 758 NRLTEKSDVYSFGVVLLEIIT---------GHPVISKSAENG 790
+ + SDV+SFG+V+ E+++ + K+ E+G
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 582 TNNFERVLGKGGFGTVYHGKLD-NDEV-AVKMLSPS---SSQGYKQFQAEVKLLLRVHHR 636
NF VLGKG FG V + DE+ A+K+L + E ++L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 637 NLTTLVGYCDEGTN-MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
T + C + + + + EY+ G+L H+ K + + A E ++GL +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLH 118
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
+ I++RD+K N++++ + K+ADFG+ + V+G T + T GTP Y+ PE
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEII 173
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
+ D +++GV+L E++ G P
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 585 FERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
FE++ G+G GTVY EVA++ ++ Q K+ L++R ++N +V
Sbjct: 25 FEKI-GQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMR-ENKN-PNIV 80
Query: 643 GYCDE---GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
Y D G + ++ EY+A G+L + ++++ ++ + + E LE+LH
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN-- 135
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGL-SRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
++HRD+KS NIL+ KL DFG +++ P + +T+ GTP ++ PE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRK 191
Query: 759 RLTEKSDVYSFGVVLLEIITGHP 781
K D++S G++ +E+I G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNLTT 640
E+ +G+G F VY LD VA+K + K E+ LL +++H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL--RIAVEAALGLEYLHQGC 698
E + ++ E G+L + K+ E+ + V+ LE++H
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-- 124
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
++HRD+K N+ I KL D GL R F + T + ++ GTP Y+ PE N
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHEN 181
Query: 759 RLTEKSDVYSFGVVLLEI 776
KSD++S G +L E+
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 587 RVLGKGGFGTV------YHGKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRN 637
RVLGKGGFG V GK+ A K L +G E ++L +V+ R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 638 LTTLVGYCDEGTN-MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
+ +L Y E + + L+ M G+L+ H+ + + + + A E GLE L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ- 119
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
+ IV+RD+K NIL++++ +++D GL+ P EG T GT GY+ PE
Sbjct: 120 --RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGETVRGRV--GTVGYMAPEVIN 174
Query: 757 SNRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788
+ + T D + G ++ E+I G K E
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 66/292 (22%), Positives = 127/292 (43%), Gaps = 28/292 (9%)
Query: 584 NFERVLGKGGFGTVYHGKLDNDE----VAVKML--SPSSSQGYKQFQAEVKLLLRVHHRN 637
N V G+G +G V K + E VA+K S K E+++L ++ H N
Sbjct: 5 NLGLV-GEGSYGMVM--KCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
L L+ + L++E++ + L++ + L+ + + G+E+ H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
I+HRD+K NIL+++ KL DFG +R + V T T Y PE +
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYRAPELLVG 174
Query: 758 N-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816
+ + D+++ G ++ E++TG P+ G + + Q + G++ PR +
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFP-----GDSDIDQLYHIIKCLGNL----IPRHQ 225
Query: 817 GDFDINSVWKAVEIAMACVSSNANRR-PFMNQVVMEL-NDCLAMEAAQKKES 866
F N ++ + + +R P ++ +V++L CL ++ + S
Sbjct: 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 22/201 (10%)
Query: 589 LGKGGFGTV--YHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD 646
+G+G G V K +VAVKM+ Q + EV ++ H+N+ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 647 EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLH-QGCKPPIVH 704
G + ++ E++ G L + +S + LN EE++ E+ L L YLH QG ++H
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR---LN-EEQIATVCESVLQALCYLHSQG----VIH 140
Query: 705 RDVKSTNILINEKFQAKLADFG----LSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
RD+KS +IL+ + KL+DFG +S+ P ++ GTP ++ PE
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR------KSLVGTPYWMAPEVISRTPY 194
Query: 761 TEKSDVYSFGVVLLEIITGHP 781
+ D++S G++++E++ G P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 587 RVLGKGGFGTVYHGK-LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGY 644
V+G G +G VY G+ + ++A + + ++ + E+ +L + HHRN+ T G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 645 CDEGT------NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
+ + + L+ E+ G++ + + ++ L + I E GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
++HRD+K N+L+ E + KL DFG+S G T GTP ++ PE +
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPEVIACD 196
Query: 759 RLTE-----KSDVYSFGVVLLEIITGHP 781
+ +SD++S G+ +E+ G P
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 589 LGKGGFGTVYHGKLDND--------EVAVKMLS-----PSSSQGYKQFQAEVKLLL-RVH 634
LG G FG VY + N+ E+ V + + +EV ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 635 HRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNW-EERL-RIAVEAALGLE 692
H N+ E + ++ + + L EH + ++ + EER+ I V+ L L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
YLH+ + IVHRD+ NI++ E + + DFGL++ + T++ GT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIITGHPV 782
E + EK+DV++FG +L ++ T P
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 587 RVLGKGGFGTV------YHGKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRN 637
RVLGKGGFG V GK+ A K L +G E ++L +V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKM----YACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ L + + L+ M G+L+ H+ + E L A E GLE LH+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR- 120
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
V+RD+K NIL+++ +++D GL+ P G + + GT GY+ PE +
Sbjct: 121 --ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP--EGESIRGRV-GTVGYMAPEVLNN 175
Query: 758 NRLTEKSDVYSFGVVLLEIITGH 780
R T D + G ++ E+I G
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 63/223 (28%), Positives = 114/223 (51%), Gaps = 36/223 (16%)
Query: 585 FERV--LGKGGFGTVYHG--KLDNDEVAVKMLS--------PSSSQGYKQFQAEVKLLLR 632
+E+V +G+G +G VY ++ N+ +A+K + PS++ E+ LL
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI------REISLLKE 57
Query: 633 VHHRNLTTL--VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL- 689
+ H N+ L V + ++ + L++EY+ + +L++H+ DSS + ++ + L
Sbjct: 58 MQHGNIVRLQDVVHSEK--RLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQILR 113
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILINEKFQA-KLADFGLSRVF--PVEGGTHVSTTIAGT 746
G+ Y H ++HRD+K N+LI+ + A KLADFGL+R F PV TH T+
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL--- 167
Query: 747 PGYLDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPVISKSAE 788
Y PE + +R + D++S G + E++ P+ +E
Sbjct: 168 -WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209
|
Length = 294 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 21/228 (9%)
Query: 584 NFE--RVLGKGGFGTVY---------HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLR 632
NFE +VLG G +G V+ GKL +V K ++ + + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 633 VHHRNLTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGL 691
+ + Y T + LI +Y+ G L HLS +E +E + E L L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLS--QRERFKEQEVQIYSGEIVLAL 118
Query: 692 EYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLD 751
E+LH K I++RD+K NIL++ L DFGLS+ F E + + GT Y+
Sbjct: 119 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEYMA 174
Query: 752 PEYYISNRLTEKS--DVYSFGVVLLEIITG-HPVISKSAENGHTHVAQ 796
P+ D +S GV++ E++TG P +N +++
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR 222
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 18/129 (13%)
Query: 656 EYMANGNLEEHLSDSSK---EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNI 712
E+M G+L++ L + + IL +I++ GL YL + K I+HRDVK +NI
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMHRDVKPSNI 131
Query: 713 LINEKFQAKLADFGLSRVFPVEGGTHVS--TTIAGTPGYLDPEYYISNRLTEKSDVYSFG 770
L+N + + KL DFG+S G S + GT Y+ PE T +SD++S G
Sbjct: 132 LVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
Query: 771 VVLLEIITG 779
+ L+E+ G
Sbjct: 186 LSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 587 RVLGKGGFGTVYHGK--LDNDEVAVKMLSPSS---SQGYKQFQAEVKLLLR-VHHRNLTT 640
+V+GKG FG V K D AVK+L + + AE +LL+ + H L
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCK 699
L + + +Y+ G L HL +E E R R A E A + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHS--- 114
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
I++RD+K NIL++ + L DFGL + T ++T GTP YL PE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEP 172
Query: 760 LTEKSDVYSFGVVLLEIITGHP 781
D + G VL E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 49/229 (21%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLS----PSSSQGYKQ--------FQA--EVKLLLR 632
LG+G +G V L VA+K + + +Q F E+K++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 633 VHHRNLTTLVG-YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR------IAV 685
+ H N+ LV Y + + L+ + MA SD K +++ + RL I +
Sbjct: 77 IKHENIMGLVDVYVEGDF-INLVMDIMA--------SDLKK-VVDRKIRLTESQVKCILL 126
Query: 686 EAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR--VFPVEGGT-----H 738
+ GL LH K +HRD+ NI IN K K+ADFGL+R +P T
Sbjct: 127 QILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 739 VSTTIAGTPG-----YLDPEYYI-SNRLTEKSDVYSFGVVLLEIITGHP 781
+ T Y PE + + + D++S G + E++TG P
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 36/216 (16%)
Query: 584 NFERVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQF---QAEVKLLL------- 631
VLG+G FG V K + A+K L K + EV+ L+
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALK-------KGDIIARDEVESLMCEKRIFE 54
Query: 632 ---RVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEA 687
H L L ++ + EY A G+L H+ ++ + E R A
Sbjct: 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH---TDVFS-EPRAVFYAACV 110
Query: 688 ALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST--TIAG 745
LGL+YLH+ IV+RD+K N+L++ + K+ADFGL + EG T G
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCG 163
Query: 746 TPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
TP +L PE T D + GV++ E++ G
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 63/201 (31%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 587 RVLGKGGFGTV--YHGKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTL 641
++LGKG FG V K A+K+L + E ++L H LT L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCKP 700
+ + EY G L HLS +E + EER R E LEYLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHS---R 114
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST--TIAGTPGYLDPEYYISN 758
+V+RD+K N+++++ K+ DFGL + EG + +T T GTP YL PE N
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 759 RLTEKSDVYSFGVVLLEIITG 779
D + GVV+ E++ G
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 42/231 (18%)
Query: 589 LGKGGFGTVYHGKLDN---DEVAVKML-SPSSSQGY-KQFQAEVKLLLRVHHRNLTTLVG 643
+G G +GTV LD +VA+K L P S+ + K+ E++LL + H N+ L+
Sbjct: 23 VGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 644 Y------CDEGTNMALIYEYMAN--GNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYL 694
D + L+ +M G L +H E L+ E+R++ V L GL+Y+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH------EKLS-EDRIQFLVYQMLKGLKYI 134
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG---TPGYLD 751
H I+HRD+K N+ +NE + K+ DFGL+R + + G T Y
Sbjct: 135 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYVVTRWYRA 183
Query: 752 PEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSM 801
PE ++ T+ D++S G ++ E++TG P+ GH H+ Q + M
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF-----KGHDHLDQLMEIM 229
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 589 LGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-HRNLTTLVGY- 644
+GKG +G V+ K + + AVK+L P ++ +AE +L + H N+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 645 ----CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR------IAVEAALGLEYL 694
G + L+ E G++ +D K L ER+ I EA +GL++L
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSV----TDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
H +HRDVK NIL+ + KL DFG+S + T GTP ++ PE
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTSTRLRRNTSVGTPFWMAPEV 195
Query: 755 Y-----ISNRLTEKSDVYSFGVVLLEIITGHP 781
+ + + DV+S G+ +E+ G P
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 66/201 (32%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 589 LGKGGFGTVYH-GKLDNDEV-AVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNLTTLVG 643
+GKG FG VY K D + A+K+LS K+ E +L+R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 644 Y---CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV-EAALGLEYLHQGCK 699
+++ L+ +YM+ G L HL KE E+R + + E L LE+LH K
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLH---K 114
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
IV+RD+K NIL++ L DFGLS+ + T + T GT YL PE + +
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEK 172
Query: 760 -LTEKSDVYSFGVVLLEIITG 779
T+ D +S GV++ E+ G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQA--EVKLLLRVHHRNLT 639
N E+ LG+G + TVY G +++ VA+K++S + +G F A E LL + H N+
Sbjct: 9 NLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIV 66
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
L + ++EYM + +L +++ + + RL + GL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---G 121
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI-SN 758
I+HRD+K N+LI+ + KLADFGL+R + T+ S + T Y P+ + +
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGAT 179
Query: 759 RLTEKSDVYSFGVVLLEIITGHPV 782
+ D++ G + +E++ G P
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 48/193 (24%), Positives = 98/193 (50%), Gaps = 11/193 (5%)
Query: 589 LGKGGFGTVYHG--KLDNDE--VAVKMLSPSSSQGYK-QFQAEVKLLLRVHHRNLTTLVG 643
LG G FG V G K+ + VA+K+L + + + + E +++ ++ + + ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
C E + L+ E + G L + LS K+ + + + + ++G++YL V
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLS-GKKDEITVSNVVELMHQVSMGMKYLEG---KNFV 117
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTE 762
HRD+ + N+L+ + AK++DFGLS+ + + + + P + PE + +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 763 KSDVYSFGVVLLE 775
+SDV+S+G+ + E
Sbjct: 178 RSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 31/221 (14%)
Query: 582 TNNFERV--LGKGGFGTVYH--GKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHR 636
T+ +E + +GKG +G VY K D AVK+L P S ++ +AE +L + +H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79
Query: 637 NLTTLVGY---CDE--GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV------ 685
N+ G D+ G + L+ E G++ E + K +L +RL A+
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAMISYILY 135
Query: 686 EAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG 745
A LGL++LH I+HRDVK NIL+ + KL DFG+S + T G
Sbjct: 136 GALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTSTRLRRNTSVG 190
Query: 746 TPGYLDPEYYISNRLTEKS-----DVYSFGVVLLEIITGHP 781
TP ++ PE + + S DV+S G+ +E+ G P
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 589 LGKGGFGTVYHG-KLDNDE-VAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
+G+GG+G V+ K D E VA+K + S + E +L L L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ-GCKPPI 702
+ + L EY+ G+ L++ +L+ + E ++ LH+ G
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG----Y 122
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE 762
+HRD+K N LI+ KL DFGLS+ G + ++ G+P Y+ PE
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGYDF 177
Query: 763 KSDVYSFGVVLLEIITGHPVISKSAEN 789
D +S G +L E + G P S S N
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPN 204
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 587 RVLGKGGFGTVYHGKLD--NDEVAVKMLSPSSSQGYKQFQAEV--KLLLRVHHRN--LTT 640
+VLGKG FG V +L + AVK L + + K +L + N LT
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
L ++ + E++ G+L H+ D + + A E GL++LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK--- 115
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSR--VFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
I++RD+K N++++ K+ADFG+ + VF G + ++T GTP Y+ PE
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----GDNRASTFCGTPDYIAPEILQGL 171
Query: 759 RLTEKSDVYSFGVVLLEIITGH 780
+ T D +SFGV+L E++ G
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQA--EVKLLLRVHHRNLTTLVGY 644
+G+G +G VY G K VA+K + S + A E+ LL + H N+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ------GC 698
+ + + LI+E+++ +L+++L K ++A L YL+Q C
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQY---------MDAELVKSYLYQILQGILFC 117
Query: 699 -KPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTHVSTTIAGTPGYLDPEYY 755
++HRD+K N+LI+ K KLADFGL+R F PV TH T+ Y PE
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL----WYRAPEVL 173
Query: 756 I-SNRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788
+ S R + D++S G + E+ T P+ +E
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-13
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 584 NFE--RVLGKGGFGTVYHGKLDN-DEV-AVKMLSPSSSQGYKQ---FQAEVKLLLRVHHR 636
+FE +V+G+G FG V KL N D+V A+K+L+ + F+ E +L+ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
+TTL + N+ L+ +Y G+L LS + R +A E + ++ +HQ
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVIAIDSVHQ 120
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
VHRD+K NIL++ +LADFG S + +E GT S+ GTP Y+ PE
Sbjct: 121 ---LHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 757 S-----NRLTEKSDVYSFGVVLLEIITG 779
+ + + D +S GV + E++ G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 60/242 (24%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD 646
+G+G G V K +VAVK + Q + EV ++ HH N+ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 647 EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKPPIVHR 705
G + ++ E++ G L + ++ + +N E+ + + L YLH QG ++HR
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQG----VIHR 142
Query: 706 DVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSD 765
D+KS +IL+ + KL+DFG E ++ GTP ++ PE + D
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 766 VYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVW 825
++S G++++E+I G P + +M IR + PR+K ++SV
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPP---------LQAMR---RIRDNLPPRVKDSHKVSSVL 248
Query: 826 KA 827
+
Sbjct: 249 RG 250
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 587 RVLGKGGFGTV---YHGKLDNDEVAVKMLSPSSSQGYKQFQ-AEVKLLLRVHHRNLTTL- 641
+G+G +G V H K +VA+K +SP Q + Q E+K+L R H N+ +
Sbjct: 11 SYIGEGAYGMVCSATH-KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGIL 69
Query: 642 ----VGYCDEGTNMALIYEYMANGNL-----EEHLSDSSKEILNWEERLRIAVEAALGLE 692
+ ++ ++ E M +L +HLS+ + ++ LR GL+
Sbjct: 70 DIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQ-ILR-------GLK 120
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF-PVEGGTHVSTTIAGTPGYLD 751
Y+H ++HRD+K +N+L+N K+ DFGL+R+ P T T T Y
Sbjct: 121 YIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 752 PEYYISNRLTEKS-DVYSFGVVLLEIITGHPV 782
PE ++++ K+ D++S G +L E+++ P+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 69/250 (27%), Positives = 112/250 (44%), Gaps = 33/250 (13%)
Query: 589 LGKGGFGTVYHGKLDNDEV----AVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
LG G FG VY K N E A K++ S + + + E+ +L H N+ L+
Sbjct: 13 LGDGAFGKVY--KAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLHQGCKPPIV 703
N+ ++ E+ A G ++ + + + + E ++R+ + L L YLH+ I+
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLT--EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE- 762
HRD+K+ NIL KLADFG+S + GTP ++ PE + +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 763 ----KSDVYSFGVVLLEIITGHP---------VISKSAENGHTHVAQ---WVSSMLD--K 804
K+DV+S G+ L+E+ P V+ K A++ +AQ W S D K
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243
Query: 805 GDIRSTVDPR 814
+ VD R
Sbjct: 244 KCLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 584 NFERV--LGKGGFGTVYHG--KLDNDEVAVKMLS-PSSSQGYKQFQA-EVKLLLRVHHRN 637
NF++V +G+G +G VY KL + VA+K + + ++G E+ LL ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ L+ + L++E++ + +L++ + S + + GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTHVSTTIAGTPGYLDPEYY 755
++HRD+K N+LIN + KLADFGL+R F PV TH T+ Y PE
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL----WYRAPEIL 172
Query: 756 ISNRL-TEKSDVYSFGVVLLEIIT 778
+ + + D++S G + E++T
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 68/202 (33%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 587 RVLGKGGFGTVYHGK--LDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLR-VHHRNLTT 640
+V+GKG FG V K LD AVK+L + + K AE +LL+ V H L
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCK 699
L + + +++ G L HL +E E R R A E A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
IV+RD+K NIL++ + L DFGL + + T +TT GTP YL PE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQP 172
Query: 760 LTEKSDVYSFGVVLLEIITGHP 781
D + G VL E++ G P
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 584 NFERVLGKGGFGTV--YHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
NF ++ G+G G V K +VAVK + Q + EV ++ H N+ +
Sbjct: 23 NFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALG-LEYLH-QGCK 699
G + ++ E++ G L + ++ + EE++ A L L +LH QG
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMN----EEQIATVCLAVLKALSFLHAQG-- 135
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFG----LSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
++HRD+KS +IL+ + KL+DFG +S+ P ++ GTP ++ PE
Sbjct: 136 --VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR------KSLVGTPYWMAPE-V 186
Query: 756 ISNRL---TEKSDVYSFGVVLLEIITGHP 781
IS RL TE D++S G++++E++ G P
Sbjct: 187 IS-RLPYGTE-VDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 587 RVLGKGGFGTV------YHGKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRN 637
RVLGKGGFG V GK+ A K L +G E ++L +V+ R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ +L + + L+ M G+L+ H+ + + E + A E GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH-- 119
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
+ IV+RD+K NIL+++ +++D GL+ P EG T GT GY+ PE +
Sbjct: 120 -RERIVYRDLKPENILLDDYGHIRISDLGLAVEIP-EGETIRGRV--GTVGYMAPEVVKN 175
Query: 758 NRLTEKSDVYSFGVVLLEIITGH 780
R T D + G ++ E+I G
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 589 LGKGGFGTV----YHGKLDNDEVAVKMLSP--SSSQGYKQFQAEVKLLLRVH-HRNLTTL 641
LG+G +G V + + VA+K ++ S K+ E+KLL H+N+T L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 642 VGYCDEGTNMALIYEYMANG-NLEEHLSDSS-KEILNWEERLRIA------VEAALGLEY 693
+M +++ N L E L ++ +I+ + L A + GL+Y
Sbjct: 68 Y-------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF---PVEGGTHVSTTIAGTPGYL 750
+H ++HRD+K N+L+N + K+ DFGL+R F P E ++ +A T Y
Sbjct: 121 IHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWYR 176
Query: 751 DPEYYISNRLTEKS-DVYSFGVVLLEIITGHPV 782
PE +S + K+ DV+S G +L E++ PV
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 589 LGKGGFGTVYHGKLDN--DEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
LGKGGFG V ++ N A K L G K E ++L +V+ + L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
+ T++ L+ M G+L+ H+ + + L E + + + G+ +LH IV
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEK 763
+RD+K N+L++++ +L+D GL+ +G T T AGT GY+ PE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMAPEILKEEPYSYP 174
Query: 764 SDVYSFGVVLLEIITG 779
D ++ G + E++ G
Sbjct: 175 VDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 29/230 (12%)
Query: 578 VLRMTNNFERV--LGKGGFGTVYHGK--LDNDEVAVK-MLSP-SSSQGYKQFQAEVKLLL 631
V +TN + + +G G FG V + L VA+K ++ P S+ K+ E+KLL
Sbjct: 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64
Query: 632 RVHHRNLTTLVG-YCDEGTNMALIYEYMANGNLEEHLSDS--SKEILNWEERLRIAVEAA 688
+ H N+ +L + ++ + E + +L L+ K+ + + +
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-----FLYQIL 118
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG 748
GL+Y+H +VHRD+K +NILINE K+ DFGL+R+ + +VST
Sbjct: 119 RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 749 YLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQW 797
Y PE ++ + + D++S G + E++ G P+ G HV Q+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP-----GKDHVNQF 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 584 NFERVLGKGGFGTVYHG-KLDNDEV-AVKMLSPS---SSQGYKQFQAEVKLL-LRVHHRN 637
NF VLGKG FG V + DE+ A+K+L + E ++L L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI--AVEAALGLEYLH 695
LT L + + EY+ G+L H+ K ++E + A E A+GL +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGLFFLH 118
Query: 696 -QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
+G I++RD+K N++++ + K+ADFG+ + G T + T GTP Y+ PE
Sbjct: 119 SKG----IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYIAPE- 171
Query: 755 YISNRLTEKS-DVYSFGVVLLEIITGHP 781
I+ + KS D ++FGV+L E++ G P
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 584 NFERVLGKGGFGTVYHG-KLDNDEV-AVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNL 638
NF VLGKG FG V + DE+ A+K+L + E ++L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 639 TTLVGYCDEGTN-MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
T + C + + + + EY+ G+L + + + A E A+GL +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHS- 119
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
I++RD+K N++++ + K+ADFG+ + +G T + T GTP Y+ PE
Sbjct: 120 --KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAY 175
Query: 758 NRLTEKSDVYSFGVVLLEIITGHP 781
+ D ++FGV+L E++ G
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 588 VLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD- 646
++G+GGFG VY G D + + + K Q E L ++ R + +LV D
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGET---LALNERIMLSLVSTGDC 56
Query: 647 -----------EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
+ I + M G+L HLS + + +E A E LGLE++H
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH 114
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
+V+RD+K NIL++E +++D GL+ F + H S GT GY+ PE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV---GTHGYMAPEVL 167
Query: 756 ISNRLTEKS-DVYSFGVVLLEIITGH 780
+ S D +S G +L +++ GH
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 588 VLGKGGFGTVYH-GKLDNDEV-AVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYC 645
++G+GGFG VY K D ++ A+K L + K Q E L ++ R + +LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGET---LALNERIMLSLVSTG 54
Query: 646 D------------EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEY 693
D ++ I + M G+L HLS + + E A E LGLE+
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEH 112
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
+H +V+RD+K NIL++E +++D GL+ F + H S GT GY+ PE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV---GTHGYMAPE 165
Query: 754 YYISNRLTEKS-DVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811
+ S D +S G +L +++ GH P ++ H +D+ + T+
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---------IDRMTL--TM 214
Query: 812 DPRLKGDF 819
L F
Sbjct: 215 AVELPDSF 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 44/110 (40%), Positives = 58/110 (52%), Gaps = 20/110 (18%)
Query: 682 RIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS- 740
+IAV LEYLH ++HRDVK +N+LIN Q KL DFG+S G V
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-------GYLVDS 157
Query: 741 ---TTIAGTPGYLDPEYYISNRLTE-----KSDVYSFGVVLLEIITG-HP 781
T AG Y+ PE I+ L + KSDV+S G+ ++E+ TG P
Sbjct: 158 VAKTIDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 60/199 (30%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 587 RVLGKGGFGTV--YHGKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTL 641
++LGKG FG V K A+K+L + E ++L H LT L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCKP 700
+ + EY G L HLS +E + E+R R E L+YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHS--EK 115
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
+V+RD+K N+++++ K+ DFGL + +G T T GTP YL PE N
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDY 173
Query: 761 TEKSDVYSFGVVLLEIITG 779
D + GVV+ E++ G
Sbjct: 174 GRAVDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 73/277 (26%), Positives = 116/277 (41%), Gaps = 39/277 (14%)
Query: 589 LGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG 648
LGKG +G+VY V + M +F + L +H +V +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 649 TNMALIY---EYMANGNLEEHLSDSSKEILNWEERL--RIAVEAALGLEYL---HQGCKP 700
+Y EYM G+L++ L E + RI GL++L H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---- 123
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
I+HRDVK TN+L+N Q KL DFG+S ++ T G Y+ PE S
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGP 178
Query: 761 TE------KSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813
+ +SDV+S G+ +LE+ G +P ++ N + +S+++D GD P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSAIVD-GD-----PP 228
Query: 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850
L + + A + C++ NRRP Q++
Sbjct: 229 TLPSGYSDD----AQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 44/232 (18%)
Query: 580 RMTNNFERV--LGKGGFGTVYHG--KLDNDEVAVKMLS--------PSSSQGYKQFQAEV 627
R + +E++ + +G +G VY K + VA+K L P +S E+
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL------REI 55
Query: 628 KLLLRVHHRNLTTLVGYCDE---GTNMALIY---EYMANGNLEEH----LSDSSKEILNW 677
+LL++ H N+ T+ E G+N+ IY EY+ EH L ++ K+
Sbjct: 56 NILLKLQHPNIVTV----KEVVVGSNLDKIYMVMEYV------EHDLKSLMETMKQPFLQ 105
Query: 678 EERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737
E + ++ G+ +LH I+HRD+K++N+L+N + K+ DFGL+R +
Sbjct: 106 SEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP--L 160
Query: 738 HVSTTIAGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLEIITGHPVISKSAE 788
T + T Y PE + + + D++S G + E++T P+ +E
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 61/228 (26%), Positives = 91/228 (39%), Gaps = 39/228 (17%)
Query: 587 RVLGKGGFGTVYHGKLDNDEV--AVKMLSPSSSQG---YKQFQAEVKLLLRVHHRNLTTL 641
++LGKG G V+ +L A+K+L K+ E ++L + H L TL
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLH-QGCK 699
T + L+ +Y G L L + L+ EE R A E L LEYLH G
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS-EEVARFYAAEVLLALEYLHLLG-- 123
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG----------- 748
IV+RD+K NIL++E L+DF LS+ VE G+
Sbjct: 124 --IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 749 ----------------YLDPEYYISNRLTEKSDVYSFGVVLLEIITGH 780
Y+ PE + D ++ G++L E++ G
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 22/165 (13%)
Query: 627 VKLLLRVHHRNLTTLVG-----YCDEGTNMALIYEYMANGNLEEHLSDSSK---EILNWE 678
++ L +H N +VG Y D +++ E+M G+L++ L ++ + EIL
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKEAKRIPEEILG-- 106
Query: 679 ERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738
++++ GL YL + K I+HRDVK +NIL+N + + KL DFG+S
Sbjct: 107 ---KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DS 157
Query: 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG-HPV 782
++ + GT Y+ PE + +SD++S G+ L+E+ G +P+
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 52/219 (23%), Positives = 85/219 (38%), Gaps = 36/219 (16%)
Query: 585 FERVLGK----GGFGTVYHGKLDNDEVAVKM--LSPSSSQGYKQFQAEVKLLLRVHHRNL 638
++GK + K N VAVK L S + K Q E+ ++ H N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 639 TTLVGYCDEGTNMALIYEYMANGN----LEEHLSDSSKEILNWEERLRIAV---EAALGL 691
V + + ++ MA G+ L+ H + E+ IA + L
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA-------IAFILKDVLNAL 114
Query: 692 EYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGY- 749
+Y+H G +HR VK+++IL++ + L+ S ++ G + P
Sbjct: 115 DYIHSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSM-IKHGKR-QRVVHDFPKSS 168
Query: 750 ------LDPEYYISNRL--TEKSDVYSFGVVLLEIITGH 780
L PE N EKSD+YS G+ E+ GH
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 589 LGKGGFGTVYHGKLDNDEV----AVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
LG G FG VY K N E A K++ S + + + E+++L +H + L+G
Sbjct: 20 LGDGAFGKVYKAK--NKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLHQGCKPPIV 703
+ ++ E+ G ++ + + + + E ++++ L L+YLH I+
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLT--EPQIQVICRQMLEALQYLHS---MKII 132
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST-----TIAGTPGYLDPEYYISN 758
HRD+K+ N+L+ KLADFG+S +V T + GTP ++ PE +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS-------AKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 759 RLTE-----KSDVYSFGVVLLEIITGHP 781
+ + K+D++S G+ L+E+ P
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-12
Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 36/226 (15%)
Query: 587 RVLGKGGFGTVYHGKLDND---EVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRN------ 637
R LG G G V+ +D+D VAVK + + Q K E+K++ R+ H N
Sbjct: 11 RPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 638 --------LTTLVGYCDEGTNMALIYEYMAN--GNLEEHLSDSSKEI-LNWEERLRIAVE 686
LT VG E ++ ++ EYM N+ E S + L + LR
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR---- 125
Query: 687 AALGLEYLHQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVFP--VEGGTHVSTTI 743
GL+Y+H ++HRD+K N+ IN E K+ DFGL+R+ ++S +
Sbjct: 126 ---GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 744 AGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788
T Y P +S N T+ D+++ G + E++TG P+ + + E
Sbjct: 180 V-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 9/102 (8%)
Query: 682 RIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741
++ V L YL + K ++HRDVK +NIL++ KL DFG+S V+ T
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAK--T 172
Query: 742 TIAGTPGYLDPEYYISNRLTEK----SDVYSFGVVLLEIITG 779
AG Y+ PE K +DV+S G+ L+E+ TG
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG 214
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 589 LGKGGFGTVYHGKLDN----DEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVG 643
+G G FG V G+ V VK L S++ F EV+ ++H N+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 644 YCDEGTNMALIYEYMANGNLEEHL--------SDSSKEILNWEERLRIAVEAALGLEYLH 695
C E L+ E+ G+L+ +L + K++L R+A E A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL-----QRMACEVASGLLWLH 117
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
Q +H D+ N + K+ D+GL+ E A +L PE
Sbjct: 118 QA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 756 -------ISNRLTEKSDVYSFGVVLLEIIT 778
+ T+KS+++S GV + E+ T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 583 NNFERVLGKGGFGTV------YHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHR 636
+NF ++ G+G G V GKL VAVK + Q + EV ++ H
Sbjct: 23 DNFIKI-GEGSTGIVCIATVKSSGKL----VAVKKMDLRKQQRRELLFNEVVIMRDYQHE 77
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH- 695
N+ + G + ++ E++ G L + ++ + +N E+ + + L LH
Sbjct: 78 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHA 134
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
QG ++HRD+KS +IL+ + KL+DFG V ++ GTP ++ PE
Sbjct: 135 QG----VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELI 188
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
+ D++S G++++E++ G P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 583 NNFERV--LGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQA--EVKLLLRVHHR 636
+++E++ LG+G + TVY GK ++ VA+K++ +G F A E LL + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHA 63
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
N+ L + L++EY+ + +L +++ D L+ E + GL Y+HQ
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
I+HRD+K N+LI++ + KLADFGL+R V T+ + + T Y P+ +
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLL 176
Query: 757 SNRLTEKS---DVYSFGVVLLEIITG 779
+ TE S D++ G + +E+I G
Sbjct: 177 GS--TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 584 NFERV--LGKGGFGTVYHGKLDN--DEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLT 639
+FE + +G G +G VY + N + A+K++ + + Q E+ ++ H N+
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEE--HLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
G + + E+ G+L++ H++ E + ++ E GL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES----QIAYVSRETLQGLYYLHSK 125
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA------GTPGYLD 751
K +HRD+K NIL+ + KLADFG+S ++ TIA GTP ++
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVS--------AQITATIAKRKSFIGTPYWMA 174
Query: 752 PEYYISNR---LTEKSDVYSFGVVLLEIITGHP 781
PE R + D+++ G+ +E+ P
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-11
Identities = 56/236 (23%), Positives = 97/236 (41%), Gaps = 44/236 (18%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSP--SSSQGYKQFQAEVKLLLRVHHRNLT 639
+ +G G +G V K +VA+K +S K+ E+KLL + H N+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENII 62
Query: 640 TL--VGYCDEGTNMALIY---EYMANGNLEEHLSD-----SSKEILNWEERLR-IAVEAA 688
L + + +Y E M +D S + L ++ ++ +
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELME--------TDLHKVIKSPQPLT-DDHIQYFLYQIL 113
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG 748
GL+YLH ++HRD+K +NIL+N K+ DFGL+R + T
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT-----E 165
Query: 749 YLDPEYY-------ISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQW 797
Y+ +Y S+R T+ D++S G + E++T P+ G ++ Q
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-----PGRDYIDQL 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 584 NFERVLGKGGFGTVYHGKLDNDE---VAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRN 637
NF R LG G FG V N++ VA+K S KQ +E K+L ++H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
L G + + + L+ E++ G L +K N + A + L EYL
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPN-DVGCFYAAQIVLIFEYLQS- 149
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
IV+RD+K N+L+++ K+ DFG ++V V+ T+ T+ GTP Y+ PE ++
Sbjct: 150 --LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDTRTY---TLCGTPEYIAPEILLN 202
Query: 758 NRLTEKSDVYSFGVVLLEIITGHP 781
+ +D ++ G+ + EI+ G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 41/216 (18%)
Query: 583 NNFERV--LGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLR-------- 632
++FE++ LG G G V+ K+ + + M K E+K +R
Sbjct: 5 DDFEKISELGAGNGGVVF--KVSHKPSGLIM-------ARKLIHLEIKPAIRNQIIRELQ 55
Query: 633 -VHHRNLTTLVG-----YCDEGTNMALIYEYMANGNLEEHLSDSSK---EILNWEERLRI 683
+H N +VG Y D +++ E+M G+L++ L + + +IL ++
Sbjct: 56 VLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KV 108
Query: 684 AVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743
++ GL YL + K I+HRDVK +NIL+N + + KL DFG+S ++ +
Sbjct: 109 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSF 162
Query: 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG 779
GT Y+ PE + +SD++S G+ L+E+ G
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 589 LGKGGFGTV----YHGKLDNDEVAVKMLSPSSSQGY--KQFQAEVKLLLRVHHRNLTTLV 642
LG G FGTV Y K VAVK+L ++ + E ++ ++ + + ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
G C E + L+ E G L + L + + + + + ++G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEET---NF 116
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLT 761
VHRD+ + N+L+ + AK++DFGLS+ + + + T P + PE + +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 762 EKSDVYSFGVVLLE 775
KSDV+SFGV++ E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 585 FERV--LGKGGFGTVYHGKLDNDE----VAVKMLSPSSS--QGYKQFQAEVKLLLRVHHR 636
+E++ +G+G +G V+ K N E VA+K S K E+++L ++ H
Sbjct: 3 YEKLSKIGEGSYGVVF--KCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH- 695
NL L+ + L++EY + L E + + + +I + + + H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
C +HRDVK NILI ++ Q KL DFG +R+ + G T T Y PE
Sbjct: 119 HNC----IHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELL 172
Query: 756 ISN-RLTEKSDVYSFGVVLLEIITGHPV 782
+ + + DV++ G V E++TG P+
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 62/260 (23%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 584 NFE--RVLGKGGFGTV-YHGKLDNDEV-AVKMLSPSSSQGYKQ---FQAEVKLLLRVHHR 636
+FE +V+G+G FG V K D V A+K+L + +Q +AE +L+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
+ + + N+ LI E++ G++ L K+ L EE E L ++ +HQ
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFG----------------LSRVFPVE------ 734
+HRD+K N+L++ K KL+DFG L+ P +
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 735 -----------GGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGH-PV 782
++ + GTP Y+ PE ++ + D +S GV++ E++ G+ P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 783 ISKSAENGHTHVAQWVSSML 802
S++ + + V W +++
Sbjct: 237 CSETPQETYKKVMNWKETLI 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 64/226 (28%), Positives = 95/226 (42%), Gaps = 61/226 (26%)
Query: 587 RVLGKGGFGT---VYHGK--LDNDEVAVKMLSPSSSQGYKQFQ--------AEVKLLLRV 633
++LGK G GT V + A+K + K F+ E++ L R+
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRL 54
Query: 634 -HHRNLTTL--VGYCDEGTN-MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL 689
H N+ L V + D T +AL++E M + NL E + K L + +
Sbjct: 55 SPHPNILRLIEVLF-DRKTGRLALVFELM-DMNLYELIKGR-KRPLPEKRVKSYMYQLLK 111
Query: 690 GLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG 748
L+++H+ G I HRD+K NILI + KLADFG R I P
Sbjct: 112 SLDHMHRNG----IFHRDIKPENILIKDD-ILKLADFGSCR------------GIYSKPP 154
Query: 749 YLDPEYYISNR--------LTE-----KSDVYSFGVVLLEIITGHP 781
Y + YIS R LT+ K D+++ G V EI++ P
Sbjct: 155 YTE---YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 589 LGKGGFGTVYHGK-LDNDE--VAVKMLSPSSSQGYKQFQA--EVKLLLRVH---HRNLTT 640
+G+G +G V+ + L N VA+K + + + EV +L + H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 641 LVGYC-----DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
L C D T + L++E++ + +L +L + + E + + GL++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
+VHRD+K NIL+ Q KLADFGL+R++ + T++ T Y PE
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVL 181
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788
+ + D++S G + E+ P+ S++
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 586 ERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRN---- 637
+G G +G V +VA+K + + K+ E+K+L H N
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLHQ 696
L + ++ ++ + M + +L H+ S + + EE +R + L GL+Y+H
Sbjct: 70 RDILRPPGADFKDVYVVMDLMES-DLH-HIIHSDQPLT--EEHIRYFLYQLLRGLKYIHS 125
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV---FPVEGGTHVSTTIAGTPGYLDPE 753
++HRD+K +N+L+NE + ++ DFG++R P E ++ +A T Y PE
Sbjct: 126 AN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRWYRAPE 181
Query: 754 YYIS-NRLTEKSDVYSFGVVLLEII 777
+S T D++S G + E++
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-11
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQG---YKQFQAEVKLLLRVHHRNLTTL 641
R++GKGG G VY + + + VA+K + S+ K+F E K+ + H + +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHL-SDSSKEILNWEERLRIAVEAAL--------GLE 692
C +G + Y+ L+ L S KE L+ E + +V A L +E
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 693 YLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV------------FPVEGGTHV 739
Y+H +G ++HRD+K NIL+ + + D+G + +
Sbjct: 128 YVHSKG----VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 740 STT----IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
S T I GTP Y+ PE + +E +D+Y+ GV+L +++T
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 584 NFERVLGKGGFGTVYHGKL----DNDEVAVKMLSPSSSQGYKQFQA---EVKLLLRVHHR 636
E +G+G +G VY K D E A+K Q Q+ E+ LL + H
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 637 NLTTLVGYCDEGTNMA--LIYEYMANGNLEEHLSDSSKEILNWEER-LRIAVEAAL---- 689
N+ +LV E + + L+++Y EH +I+ + + R+++ ++
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDY------AEH---DLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 690 ------GLEYLHQGCKPPIVHRDVKSTNILI----NEKFQAKLADFGLSRVF-----PVE 734
G+ YLH ++HRD+K NIL+ E+ K+ D GL+R+F P+
Sbjct: 114 LWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 735 GGTHVSTTIAGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPV 782
V TI Y PE + R T+ D+++ G + E++T P+
Sbjct: 171 DLDPVVVTI----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 26/230 (11%)
Query: 584 NFE--RVLGKGGFGTVY---------HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLR 632
NFE +VLG G +G V+ GKL +V K ++ + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 633 VHHRN-LTTLVGYCDEGTNMALIYEYMANGNLEEHL--SDSSKEILNWEERLRIAV-EAA 688
V L TL + LI +Y++ G + HL D+ E + +R E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGEII 115
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG 748
L LE+LH K IV+RD+K NIL++ + L DFGLS+ F E + + GT
Sbjct: 116 LALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIE 171
Query: 749 YLDPEYYISNRLTEKS-DVYSFGVVLLEIITG-HPVISKSAENGHTHVAQ 796
Y+ PE K+ D +S G+++ E++TG P + N + V++
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 577 EVLRMT--NNFERV--LGKGGFGTVYHG-KLDNDEVA-VKMLSPSSSQGYKQFQAEVKLL 630
++LR +++E + +G G +G VY L E+A VK++ + Q E+ ++
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60
Query: 631 LRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEE--HLSDSSKEILNWEERLRIAV--- 685
H N+ G + + EY G+L++ H++ E L+IA
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-------LQIAYVCR 113
Query: 686 EAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA- 744
E GL YLH K +HRD+K NIL+ + KLADFG++ ++ TIA
Sbjct: 114 ETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--------AKITATIAK 162
Query: 745 -----GTPGYLDPEYYISNR---LTEKSDVYSFGVVLLEIITGHP 781
GTP ++ PE + + D+++ G+ +E+ P
Sbjct: 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 56/215 (26%)
Query: 589 LGKGGFGTVYHGK--------------LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH 634
+G+G +GTV+ K LD+D+ V PSS+ E+ LL +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSAL------REICLLKELK 57
Query: 635 HRNLTTLVGYCDEGTNMALIYEYM----------ANGNLEEHLSDSSKEILNWEERLRIA 684
H+N+ L + L++EY NG+++ + S L L+
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL-----LK-- 110
Query: 685 VEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTHVSTT 742
GL + H ++HRD+K N+LIN+ + KLADFGL+R F PV + T
Sbjct: 111 -----GLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVT 162
Query: 743 IAGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLEI 776
+ Y P+ +L S D++S G + E+
Sbjct: 163 L----WYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 62/261 (23%), Positives = 114/261 (43%), Gaps = 46/261 (17%)
Query: 583 NNFE--RVLGKGGFGTV-YHGKLDNDEV-AVKMLSPSSSQGYKQ---FQAEVKLLLRVHH 635
++FE +V+G+G FG V K D + A+K+L + +Q +AE +L+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
+ + + N+ LI E++ G++ L K+ L+ E E L ++ +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIH 118
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLS-------RVFPVEGGTH---------- 738
Q +HRD+K N+L++ K KL+DFGL R TH
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 739 ----------------VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGH-P 781
++ + GTP Y+ PE ++ + D +S GV++ E++ G+ P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 782 VISKSAENGHTHVAQWVSSML 802
S++ + + V W +++
Sbjct: 236 FCSETPQETYRKVMNWKETLV 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 26/225 (11%)
Query: 583 NNFERV--LGKGGFGTVYHG--KLDNDEVAVKM-LSPSSSQGYKQFQA--EVKLLLRVHH 635
+ +E++ +G+G FG V+ K VA+K L + +G+ A E+K+L + H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP-ITALREIKILQLLKH 70
Query: 636 RNLTTLVGYCDEGTNM-----ALIYEYMANGNLEEH----LSDSSKEILNWEERLRIAVE 686
N+ L+ C Y EH L + E ++
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFE---FCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 687 AALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTHVSTTIA 744
GL Y+H+ I+HRD+K+ NILI + KLADFGL+R F + T
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 745 GTPGYLDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPVISKSAE 788
T Y PE + R D++ G ++ E+ T P++ + E
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 584 NFERVLGKGGFGTV---YHGKLDNDEVAVKMLS-PSSSQGY-KQFQAEVKLLLRVHHRNL 638
+G G +G V + K +VA+K LS P S + K+ E++LL + H N+
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGR-KVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 639 TTLVG-YCDEGTNMALIYEYMANGNLEEHLSDSS------KEILNWEERLRIAVEAAL-G 690
L+ + + Y+ HL + + L+ ++ ++ V L G
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVT-----HLMGADLNNIVKCQKLS-DDHIQFLVYQILRG 130
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYL 750
L+Y+H I+HRD+K +NI +NE + K+ DFGL+R E +V T Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYR 182
Query: 751 DPEYYISNRL--TEKSDVYSFGVVLLEIITGHP 781
PE + N + + D++S G ++ E++TG
Sbjct: 183 APE-IMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-10
Identities = 29/81 (35%), Positives = 51/81 (62%), Gaps = 5/81 (6%)
Query: 393 LWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLS 452
LW+G+ C+ +S R+ S++LS ++G + + L + +++LSNN L+GP+P +
Sbjct: 59 LWQGITCN----NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIF 114
Query: 453 QLS-SLKFLNLARNKLTGPLP 472
S SL++LNL+ N TG +P
Sbjct: 115 TTSSSLRYLNLSNNNFTGSIP 135
|
Length = 968 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 11/148 (7%)
Query: 589 LGKGGFGTVYHGKLDND----EVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVG 643
+G G FG V G++++ +V VK L S+S Q +F E + + H NL +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 644 YCDEGTNMALIYEYMANGNLEEHL-SDSSKEILNWEERL--RIAVEAALGLEYLHQGCKP 700
C E T L+ E+ G+L+ +L S E++ + R+A E ALGL +LH K
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLS 728
+H D+ N L+ K+ D+GLS
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 50/218 (22%)
Query: 589 LGKGGFGTVY---HGKLDNDEVAVKML-SPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
+G+G FGTV H +AVK + S + K+ ++ +++R + +V +
Sbjct: 12 IGRGAFGTVNKMLHKPS-GTIMAVKRIRSTVDEKEQKRLLMDLDVVMR--SSDCPYIVKF 68
Query: 645 ------------CDE--GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALG 690
C E ++ Y+Y L+ + + EIL +IAV
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKY-VYEVLKSVIPE---EILG-----KIAVATVKA 119
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGT---- 746
L YL + K I+HRDVK +NIL++ KL DFG+S + +IA T
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS--------GQLVDSIAKTRDAG 169
Query: 747 --PGYLDPEYYISNRLTE---KSDVYSFGVVLLEIITG 779
P Y+ PE + +SDV+S G+ L E+ TG
Sbjct: 170 CRP-YMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 583 NNFE--RVLGKGGFGTVYHGKLDNDE--VAVKMLSPSSSQGYKQ---FQAEVKLLLRVHH 635
++FE +V+G+G FG V K+ + E A+K+L+ + F+ E +L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
+ +TTL + + L+ +Y G+L LS + R IA E L + +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIH 119
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
Q VHRD+K N+L++ +LADFG S + + GT S+ GTP Y+ PE
Sbjct: 120 Q---LHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 756 IS-----NRLTEKSDVYSFGVVLLEIITG 779
+ + + D +S GV + E++ G
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQA------------EVKLLLRV- 633
LGKG +G V+ + + VA+K K F A E+ L +
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQELG 64
Query: 634 HHRNLTTL--VGYCDEGTNMALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALG 690
H N+ L V + ++ L++EYM E L IL + I +
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH---VSTTIAGTP 747
L+Y+H G ++HRD+K +NIL+N + KLADFGL+R V T T
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 748 GYLDPEYYI-SNRLTEKSDVYSFGVVLLEIITGHPV 782
Y PE + S R T+ D++S G +L E++ G P+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 14/120 (11%)
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGY 749
GL YLH I+HRDVK+ NI IN+ Q + D G ++ FPV + +AGT
Sbjct: 169 GLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVET 222
Query: 750 LDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVI--------SKSAENGHTHVAQWVSSM 801
PE ++ K+D++S G+VL E++ I + ++ H+H+ + +S++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282
|
Length = 357 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 589 LGKGGFGTVYH-GKLDNDEV-AVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
+GKG FG V K D + A+K + + S AE +L +V+ + L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
+ L+ ++ G L HL + L R A E LE LH K ++
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL-SRARFYTA-ELLCALENLH---KFNVI 115
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEK 763
+RD+K NIL++ + L DFGL ++ + + T GTP YL PE + + T+
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 764 SDVYSFGVVLLEIITGHP 781
D ++ GV+L E++TG P
Sbjct: 174 VDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 583 NNFE--RVLGKGGFGTVYHGKLDN-DEV-AVKMLSPSSSQGYKQ---FQAEVKLLLRVHH 635
++FE +V+G+G FG V K+ N +V A+K+L+ + F+ E +L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 636 RNLTTL-VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
R +T L + DE N+ L+ +Y G+L LS + R +A E L ++ +
Sbjct: 61 RWITNLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSV 118
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
HQ VHRD+K N+L+++ +LADFG S + + GT S GTP Y+ PE
Sbjct: 119 HQ---LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 755 YIS-----NRLTEKSDVYSFGVVLLEIITG 779
+ R + D +S GV + E++ G
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 7e-10
Identities = 65/246 (26%), Positives = 117/246 (47%), Gaps = 32/246 (13%)
Query: 563 YESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTV---YHGKLDNDEVAVKMLS-PSSSQ 618
+ S+++ FT VL+ N + +G G G V Y LD + VA+K LS P +Q
Sbjct: 3 FYSVEVGDSTFT---VLKRYQNL-KPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQ 57
Query: 619 GY-KQFQAEVKLLLRVHHRNLTTLVGY------CDEGTNMALIYEYMANGNLEEHLSDSS 671
+ K+ E+ L+ V+H+N+ +L+ +E ++ L+ E M + +L
Sbjct: 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVI 112
Query: 672 KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731
+ L+ E + + G+++LH I+HRD+K +NI++ K+ DFGL+R
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 167
Query: 732 PVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGH 791
G + + T T Y PE + E D++S G ++ E++ H ++ G
Sbjct: 168 -TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFP----GR 221
Query: 792 THVAQW 797
++ QW
Sbjct: 222 DYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 40/114 (35%), Positives = 55/114 (48%), Gaps = 19/114 (16%)
Query: 680 RLRIAVEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV----- 733
R+ A E L LEYLH G IVHRD+K N+LI KL DFGLS++ +
Sbjct: 104 RMYFA-ETVLALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158
Query: 734 --EGGTHVST------TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG 779
EG T + GTP Y+ PE + + D ++ G++L E + G
Sbjct: 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 588 VLGKGGFGTVY--HGKLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLV 642
++G+G FG V K D A+K++ S + + F+ E +L + + L
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEE---RLRIAVEAALGLEYLHQGCK 699
+ N+ L+ EY G+L LS ++ ++E + +A E L + +HQ
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQ--- 120
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
VHRD+K N+LI+ KLADFG + S GTP Y+ PE +
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN-KMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 760 LTEKS------DVYSFGVVLLEIITG 779
K D +S GV+ E+I G
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYG 205
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 36/208 (17%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLS-PSSSQGY-KQFQAEVKLLLRVHHRNL------ 638
+G G +G+V K ++VA+K LS P S+ + K+ E+ LL + H N+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 639 -TTLVGYCDEGTNMALIYEYMANGNLEE----HLSDSSKEILNWEERLRIAVEAAL-GLE 692
T+ V DE + L+ YM +L++ LS E++++ V L GL+
Sbjct: 83 FTSAVSG-DEFQDFYLVMPYMQT-DLQKIMGHPLS---------EDKVQYLVYQMLCGLK 131
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
Y+H I+HRD+K N+ +NE + K+ DFGL+R E +V T Y P
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAP 183
Query: 753 EYYIS-NRLTEKSDVYSFGVVLLEIITG 779
E ++ + D++S G ++ E++TG
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 42/133 (31%), Positives = 61/133 (45%), Gaps = 11/133 (8%)
Query: 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNI 712
++ EYM G+L +S+ +I R A E L L+ +H +HRDVK N+
Sbjct: 120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTA-EVVLALDAIH---SMGFIHRDVKPDNM 173
Query: 713 LINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT----EKSDVYS 768
L+++ KLADFG G T + GTP Y+ PE S + D +S
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 769 FGVVLLEIITGHP 781
GV L E++ G
Sbjct: 233 VGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 55/228 (24%), Positives = 103/228 (45%), Gaps = 13/228 (5%)
Query: 587 RVLGKGGFGTVYHGKLD-NDEV-AVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTL 641
RV+G+G + V +L ND++ A+K++ + Q E + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 642 VGYCDEGTN-MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
+ C + T+ + L+ EY+ G+L H+ K L E A E + L +LH+
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHE---R 115
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
I++RD+K N+L++ KL D+G+ + G T ++T GTP Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEY 173
Query: 761 TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR 808
D ++ GV++ E++ G +N + ++ ++ + IR
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 38/206 (18%)
Query: 607 VAVKMLS-PSSSQGY-KQFQAEVKLLLRVHHRNLTTLVGY------CDEGTNMALIYEYM 658
VAVK LS P +Q + K+ E+ LL V+H+N+ +L+ +E ++ L+ E M
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 659 ANGNLEE--HLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE 716
+ NL + H+ L+ E + + G+++LH I+HRD+K +NI++
Sbjct: 109 -DANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 158
Query: 717 KFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-----GYLDPEYYISNRLTEKSDVYSFGV 771
K+ DFGL+R T TP Y PE + E D++S G
Sbjct: 159 DCTLKILDFGLART--------ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 210
Query: 772 VLLEIITGHPVISKSAENGHTHVAQW 797
++ E++ G + G H+ QW
Sbjct: 211 IMGELVKGSVIF-----QGTDHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 65/249 (26%), Positives = 117/249 (46%), Gaps = 32/249 (12%)
Query: 560 NRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTV---YHGKLDNDEVAVKMLS-PS 615
+ ++ S+++ FT VL+ N + +G G G V Y L+ + VA+K LS P
Sbjct: 7 DNNFYSVEIGDSTFT---VLKRYQNL-KPIGSGAQGIVCAAYDAILERN-VAIKKLSRPF 61
Query: 616 SSQGY-KQFQAEVKLLLRVHHRNLTTLVGY------CDEGTNMALIYEYMANGNLEEHLS 668
+Q + K+ E+ L+ V+H+N+ L+ +E ++ ++ E M + +L
Sbjct: 62 QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLC 116
Query: 669 DSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLS 728
+ L+ E + + G+++LH I+HRD+K +NI++ K+ DFGL+
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 729 RVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788
R G + + T T Y PE + E D++S G ++ E+I G +
Sbjct: 174 R---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP---- 226
Query: 789 NGHTHVAQW 797
G H+ QW
Sbjct: 227 -GTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 39/117 (33%), Positives = 63/117 (53%), Gaps = 7/117 (5%)
Query: 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKL 722
+E + KE L E+ + + + A G+E+L + C +HRD+ + NIL++E K+
Sbjct: 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKI 214
Query: 723 ADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
DFGL+R + +V A P ++ PE T +SDV+SFGV+L EI +
Sbjct: 215 CDFGLARDI-YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-09
Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 40/250 (16%)
Query: 563 YESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTV---YHGKLDNDEVAVKMLS-PSSSQ 618
+ S+++ FT VL+ N + +G G G V Y + VA+K LS P +
Sbjct: 2 FYSVEVGDSTFT---VLKRYQNL-KPIGSGAQGIVCAAYDTVTGQN-VAIKKLSRPFQNV 56
Query: 619 GY-KQFQAEVKLLLRVHHRNLTTLVGY------CDEGTNMALIYEYMANGNLEEHLSDSS 671
+ K+ E+ L+ V+H+N+ L+ +E ++ L+ E M + NL
Sbjct: 57 THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANL-------- 107
Query: 672 KEILNWE---ERLRIAVEAAL-GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGL 727
+++ + ER+ + L G+++LH I+HRD+K +NI++ K+ DFGL
Sbjct: 108 CQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164
Query: 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSA 787
+R G + + T T Y PE + E D++S G ++ E+I G +
Sbjct: 165 AR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP--- 218
Query: 788 ENGHTHVAQW 797
G H+ QW
Sbjct: 219 --GTDHIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 583 NNFE--RVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQA----EVKLLLRVH 634
N FE V+G+G +G V K + VA+K S+ ++ + E+K+L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLK 58
Query: 635 HRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
N+ L + L++EY+ N+ E L + + E++R + + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVP--PEKVRSYIYQLI--KAI 113
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
H K IVHRD+K N+LI+ KL DFG +R EG T T Y PE
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPEL 172
Query: 755 YISNRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788
+ + D++S G +L E+ G P+ +E
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-08
Identities = 47/147 (31%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 591 KGGFGTVYHGKLDNDE--VAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYC 645
+G FG VY G+ N+ AVK++ + + Q QAE L + L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 646 DEGTNMALIYEYMANGNLEE--HLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
N+ L+ EY+ G+++ H+ E E ++ E AL L+YLH+ I+
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDE----EMAVKYISEVALALDYLHRH---GII 126
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRV 730
HRD+K N+LI+ + KL DFGLS+V
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 57/230 (24%), Positives = 105/230 (45%), Gaps = 15/230 (6%)
Query: 587 RVLGKGGFGTVYHGKLDNDE--VAVKMLSP---SSSQGYKQFQAEVKLLLRV-HHRNLTT 640
RV+G+G + V +L E A+K++ + + Q E + + +H L
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
L + + + EY+ G+L H+ K L E + E +L L YLH+
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHE---R 115
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
I++RD+K N+L++ + KL D+G+ + G T ++T GTP Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDY 173
Query: 761 TEKSDVYSFGVVLLEIITGHPV--ISKSAENGHTHVAQWVSSMLDKGDIR 808
D ++ GV++ E++ G I S++N + ++ ++ + IR
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 37/128 (28%), Positives = 66/128 (51%), Gaps = 9/128 (7%)
Query: 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCKPPIVHRDVKSTN 711
+ E+++ G+L H+ K EE R + E +L L +LH+ I++RD+K N
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLP---EEHARFYSAEISLALNFLHER---GIIYRDLKLDN 126
Query: 712 ILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGV 771
+L++ + KL D+G+ + G T ++T GTP Y+ PE D ++ GV
Sbjct: 127 VLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 772 VLLEIITG 779
++ E++ G
Sbjct: 185 LMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 587 RVLGKGGFGTV--YHGKLDNDEVAVKMLSP-----SSSQGYKQFQAEVKLLLRVHHRNLT 639
+V+G+G FG V K A+K+LS S + F E ++ + +
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVV 106
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
L + + ++ EYM G+L +S+ W + E L L+ +H
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP-EKWAKFY--TAEVVLALDAIHS--- 160
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN- 758
++HRDVK N+L+++ KLADFG G T + GTP Y+ PE S
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 759 ---RLTEKSDVYSFGVVLLEIITG 779
+ D +S GV L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 39/117 (33%), Positives = 63/117 (53%), Gaps = 7/117 (5%)
Query: 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKL 722
E D K++L E+ + + + A G+E+L + C +HRD+ + NIL++E K+
Sbjct: 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSENNVVKI 220
Query: 723 ADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
DFGL+R + +V A P ++ PE T +SDV+SFGV+L EI +
Sbjct: 221 CDFGLARDI-YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 74/293 (25%)
Query: 583 NNFE--RVLGKGGFGTV-YHGKLDNDEV-AVKMLSPSSSQGYKQFQ-----AEVKLLLRV 633
+F +V+GKG FG V K D ++ A+K L S+ +K+ Q AE +L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL--KSEMFKKDQLAHVKAERDVLAES 58
Query: 634 HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWE------ERLRIAVEA 687
+ +L + + LI E++ G+L L + ++ R +A E
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMA-EC 110
Query: 688 ALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF-----------PVEGG 736
L +E +H K +HRD+K NILI+ KL+DFGLS F ++G
Sbjct: 111 VLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167
Query: 737 THVST--------------------TIA--------------GTPGYLDPEYYISNRLTE 762
++ + IA GTP Y+ PE ++ +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227
Query: 763 KSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814
+ D +S G ++ E + G P S+++ + + W ++ DI +V+
Sbjct: 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAE 280
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 39/126 (30%), Positives = 64/126 (50%), Gaps = 7/126 (5%)
Query: 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNIL 713
Y+ + ++ LSD E L + L + A G+E+L + C VHRD+ + N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVL 269
Query: 714 INEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVV 772
+ + K+ DFGL+R + +VS P ++ PE N T SDV+S+G++
Sbjct: 270 LAQGKIVKICDFGLARDI-MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 773 LLEIIT 778
L EI +
Sbjct: 329 LWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-08
Identities = 30/76 (39%), Positives = 45/76 (59%)
Query: 400 SYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKF 459
S P P + +L+LS + L+G + + + + L LDL N L G +P L+ L+SL+F
Sbjct: 133 SIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192
Query: 460 LNLARNKLTGPLPVEL 475
L LA N+L G +P EL
Sbjct: 193 LTLASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGY---KQFQAEVKLLLRVHHRNLTT 640
+R +G G FG V+ D VA+K + P+ Q K+ E+K+L H N+ +
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 641 LV-----GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWE----ERLRIAVEAAL-G 690
+ + D + ++ E M SD K I++ + + +++ + L G
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQ--------SDLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYL 750
L+YLH I+HRD+K N+L+N K+ DFGL+RV + H++ + T Y
Sbjct: 116 LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYR 171
Query: 751 DPEYYI-SNRLTEKSDVYSFGVVLLEIITG 779
PE + S T D++S G + E++
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYL 750
++YLH+ I+HRD+K+ NI IN L DFG + FPV+ + AGT
Sbjct: 195 IQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIATN 250
Query: 751 DPEYYISNRLTEKSDVYSFGVVLLEIITGH 780
PE + D++S G+VL E+ T H
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 579 LRM-TNNFE--RVLGKGGFGTV--YHGKLDNDEVAVKMLSP-----SSSQGYKQFQAEVK 628
LRM ++E +V+G+G FG V K A+K+LS S + F E
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERD 95
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAA 688
++ + + L + + ++ EYM G+L +S+ ++ R A E
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTA-EVV 152
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG 748
L L+ +H +HRDVK N+L+++ KLADFG EG T + GTP
Sbjct: 153 LALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPD 208
Query: 749 YLDPEYYISN----RLTEKSDVYSFGVVLLEIITG 779
Y+ PE S + D +S GV L E++ G
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS-TTIAGTPG 748
L+Y+H + HRD+K NIL N + K+ DFGL+RV + T + T T
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 749 YLDPEYYIS--NRLTEKSDVYSFGVVLLEIITGHPV 782
Y PE S ++ T D++S G + E++TG P+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-08
Identities = 38/126 (30%), Positives = 62/126 (49%), Gaps = 7/126 (5%)
Query: 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNIL 713
Y A + L++ + + + + A G+E+L + C VHRD+ + N+L
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVL 271
Query: 714 INEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVV 772
I E K+ DFGL+R + ++S P ++ PE +N T SDV+SFG++
Sbjct: 272 ICEGKLVKICDFGLARDI-MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330
Query: 773 LLEIIT 778
L EI T
Sbjct: 331 LWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-08
Identities = 30/78 (38%), Positives = 46/78 (58%)
Query: 412 LNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPL 471
L+L + L G + LTNLT L L L++N L G +P+ L Q+ SLK++ L N L+G +
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 472 PVELLEKQENNTLELRFD 489
P E+ N L+L ++
Sbjct: 229 PYEIGGLTSLNHLDLVYN 246
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 30/73 (41%), Positives = 45/73 (61%)
Query: 414 LSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPV 473
L + L+G + + LT L LDL NNLTGP+P L L +L++L L +NKL+GP+P
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 474 ELLEKQENNTLEL 486
+ Q+ +L+L
Sbjct: 279 SIFSLQKLISLDL 291
|
Length = 968 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 589 LGKGGFGTVYHGK--LDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
+G+G +G V K N++VA+K ++ + + K+ E+KLL + H N+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 645 C-----DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLHQGC 698
+ ++ ++YE M + + H S + L+ ++ + + L GL+Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLS-DDHCQYFLYQLLRGLKYIHSA- 127
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS- 757
++HRD+K +N+L+N K+ DFGL+R +G T T Y PE ++
Sbjct: 128 --NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNC 183
Query: 758 NRLTEKSDVYSFGVVLLEIITGHPV 782
+ T DV+S G + E++ P+
Sbjct: 184 SEYTTAIDVWSVGCIFAELLGRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 589 LGKGGFGTV---YHGKLDNDEVAVKMLS-PSSSQGY-KQFQAEVKLLLRVHHRNLTTLVG 643
+G G +G+V Y +L +VAVK LS P S + ++ E++LL + H N+ L+
Sbjct: 23 VGSGAYGSVCSAYDTRL-RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 644 YCDEGTNMALIYE-YMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLHQGCKPP 701
T++ E Y+ + L++ K +E ++ + L GL+Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---G 138
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS-NRL 760
I+HRD+K +N+ +NE + ++ DFGL+R E +V+T Y PE ++
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHY 193
Query: 761 TEKSDVYSFGVVLLEIITG 779
+ D++S G ++ E++ G
Sbjct: 194 NQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 2e-07
Identities = 50/195 (25%), Positives = 83/195 (42%), Gaps = 36/195 (18%)
Query: 622 QFQAEVKLLLRVHHRNLTTLVGYCDEGTNMA-----LIYEYMANGNLEEHLSDSSKEILN 676
Q EV ++ + H+N+ V Y D N A ++ E+ G+L ++ K
Sbjct: 58 QLVIEVNVMRELKHKNI---VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114
Query: 677 WEERLRIAVEAAL--GLEYLHQGCKPP----IVHRDVKSTNILI---------------- 714
EE + + L L Y H P ++HRD+K NI +
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 715 -NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI--SNRLTEKSDVYSFGV 771
N + AK+ DFGLS+ +E H + GTP Y PE + + +KSD+++ G
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231
Query: 772 VLLEIITGHPVISKS 786
++ E+ +G K+
Sbjct: 232 IIYELCSGKTPFHKA 246
|
Length = 1021 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 578 VLRMTNNFERVLGKGGFGTVY----HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV 633
V+RM N L G G V+ HG +V VK ++ G K E+ +L +
Sbjct: 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTI 143
Query: 634 HHRNLTTLVGYCDEGTNMALI---YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALG 690
HR + L+ + + ++ Y+ ++ ++ + + RL +EA
Sbjct: 144 SHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL---LEA--- 197
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT----IAGT 746
L YLH I+HRDVK+ NI ++E A L DFG + + H T +GT
Sbjct: 198 LAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA----CKLDAHPDTPQCYGWSGT 250
Query: 747 PGYLDPEYYISNRLTEKSDVYSFGVVLLEI 776
PE + K+D++S G+VL E+
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-07
Identities = 26/64 (40%), Positives = 41/64 (64%)
Query: 412 LNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPL 471
L L ++L+G + +L L SLDLS+N+L+G +P+ + QL +L+ L+L N TG +
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324
Query: 472 PVEL 475
PV L
Sbjct: 325 PVAL 328
|
Length = 968 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 7/106 (6%)
Query: 675 LNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733
L E+ + + + A G+E+L + C +HRD+ + NIL++E K+ DFGL+R
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDI-Y 225
Query: 734 EGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ +V A P ++ PE T +SDV+SFGV+L EI +
Sbjct: 226 KDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 64/268 (23%), Positives = 105/268 (39%), Gaps = 60/268 (22%)
Query: 587 RVLGKGGFGTV-YHGKLDNDEV-AVKMLSPSSSQGYKQF---QAEVKLLLRVHHRNLTTL 641
+ LG G FG V K+D + A+K L Q +AE +L + + L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHL--SDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
+ N+ + +Y+ G++ L + E+L R IA E L +E +H K
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIA-ELTLAIESVH---K 119
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFP-------VEGGTHV------------- 739
+HRD+K NILI+ KL DFGL F + G+H+
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 740 -------------------------STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 774
+ ++ GTP Y+ PE + T+ D +S GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 775 EIITGH-PVISKSAENGHTHVAQWVSSM 801
E++ G P ++ + V W +++
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 11/104 (10%)
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVF--PVEGGTHVSTTIAG 745
G+ + H K ++HRD+K N+L++ +K K+AD GL R F PV+ TH T+
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL-- 175
Query: 746 TPGYLDPEYYI-SNRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788
Y PE + S + D++S G + E+ P+ +E
Sbjct: 176 --WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 46/176 (26%), Positives = 70/176 (39%), Gaps = 52/176 (29%)
Query: 650 NMALIYEYMANGNLEEHLSDSSKEILNWEERLR---IAVEAALGLEYLHQGCKPPIVHRD 706
N+ + +Y+ G++ L I +EE L IA E +E +H K +HRD
Sbjct: 75 NLYFVMDYIPGGDMMSLLI--RLGI--FEEDLARFYIA-ELTCAIESVH---KMGFIHRD 126
Query: 707 VKSTNILINEKFQAKLADFGLSRVFP-------VEGGTH--------------------- 738
+K NILI+ KL DFGL F + G H
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 739 -------------VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
++ ++ GTP Y+ PE + T+ D +S GV+L E++ G P
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-06
Identities = 24/64 (37%), Positives = 36/64 (56%)
Query: 412 LNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPL 471
L L++++L G L + L + L NNL+G +P + L+SL L+L N LTGP+
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 472 PVEL 475
P L
Sbjct: 253 PSSL 256
|
Length = 968 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 51/174 (29%), Positives = 76/174 (43%), Gaps = 28/174 (16%)
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL--RIAVEAALGLEYL 694
N+ L Y ++ L+ ++ G L H+S + LN E R A E + L+ L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS----KFLNIPEECVKRWAAEMVVALDAL 101
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFG-LSRVFPVEGGTHVSTTIAGTPGYLDPE 753
H+ IV RD+ NIL++++ +L F S V G V Y PE
Sbjct: 102 HR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPE 152
Query: 754 YYISNRLTEKSDVYSFGVVLLEIITG------HPVISKSAENGHT--HVAQWVS 799
+ TE D +S G +L E++TG HP S N HT ++ +WVS
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHP----SGINTHTTLNIPEWVS 202
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 33/207 (15%)
Query: 589 LGKGGFGTVYHGKLDND---EVAVKMLS-PSSSQGY-KQFQAEVKLLLRVHHRNLTTLVG 643
+G G +G+V D VAVK LS P S + K+ E++LL + H N+ L+
Sbjct: 25 VGSGAYGSVC-AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 644 YCDEGT-----NMALIYEYMANGNLE-----EHLSDSSKEILNWEERLRIAVEAALGLEY 693
N + ++ +L + L+D + L ++ LR GL+Y
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-ILR-------GLKY 135
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
+H I+HRD+K +N+ +NE + K+ DFGL+R E +V+T Y PE
Sbjct: 136 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 187
Query: 754 YYIS-NRLTEKSDVYSFGVVLLEIITG 779
++ + D++S G ++ E++TG
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 589 LGKGGFGTVYHG---------KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLT 639
LG+G F ++ G +L EV +K+L S + F ++ ++ H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
G C G ++ EY+ G+L+ +L +K ++N +L +A + A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLED--- 118
Query: 700 PPIVHRDVKSTNILINEKFQA--------KLADFGLS-RVFPVEGGTHVSTTIAGTPGYL 750
+ H +V + N+L+ + KL+D G+S V P E + I P
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---ILLERIPWVP--- 172
Query: 751 DPEYYISN--RLTEKSDVYSFGVVLLEIITG 779
PE I N L+ +D +SFG L EI +G
Sbjct: 173 -PE-CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 34/106 (32%), Positives = 60/106 (56%), Gaps = 7/106 (6%)
Query: 675 LNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733
L+ ++ LR + + A G+++L + C +HRDV + N+L+ + AK+ DFGL+R +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI-M 263
Query: 734 EGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+V A P ++ PE T +SDV+S+G++L EI +
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 9/101 (8%)
Query: 585 FERVLGKGGFGTVYH------GKLDND-EVAVKMLSPSSSQGYKQ-FQAEVKLLLRV-HH 635
F + LG G FG V GK DN VAVKML S+ ++ +E+K+L + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILN 676
+N+ L+G C G + +I EY G+L L ++ LN
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLN 142
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 3e-06
Identities = 25/60 (41%), Positives = 32/60 (53%)
Query: 408 RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKL 467
+ SL+LS + LT L L LDLS NNLT P+ S L SL+ L+L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 18/186 (9%)
Query: 607 VAVKM--LSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664
V V++ L + + K Q EV L H N+ T G+ + +I +MA G+
Sbjct: 28 VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87
Query: 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLA 723
L E ++ I A GL YLHQ G +HR++K+++ILI+ L+
Sbjct: 88 SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGDGLVSLS 143
Query: 724 DFGLSRVFPVEGGTHVSTTIAGTPGY-------LDPEYYISNR--LTEKSDVYSFGVVLL 774
GLS ++ + + + P + L PE + KSD+YS G+
Sbjct: 144 --GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITAC 201
Query: 775 EIITGH 780
E+ TG
Sbjct: 202 ELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 40/162 (24%), Positives = 62/162 (38%), Gaps = 49/162 (30%)
Query: 686 EAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP-------VEGGTH 738
E +E +H K +HRD+K NILI+ KL DFGL F + G H
Sbjct: 109 ELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165
Query: 739 V--------------------------------------STTIAGTPGYLDPEYYISNRL 760
V + ++ GTP Y+ PE +
Sbjct: 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225
Query: 761 TEKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSM 801
T+ D +S GV+L E++ G P ++++ V W +S+
Sbjct: 226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-06
Identities = 24/70 (34%), Positives = 43/70 (61%), Gaps = 3/70 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTM-LTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
P I ++NLS ++L+G + + L L+LSNNN TG +P+ + +L+ L+L+ N
Sbjct: 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNN 150
Query: 466 KLTGPLPVEL 475
L+G +P ++
Sbjct: 151 MLSGEIPNDI 160
|
Length = 968 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 36/119 (30%), Positives = 59/119 (49%), Gaps = 12/119 (10%)
Query: 675 LNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733
L+ E+ L + + A G+ +L + C +HRD+ + NIL+ K+ DFGL+R
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 734 EGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-------GHPVISK 785
+ V ++ PE + T +SDV+S+G++L EI + G PV SK
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK 325
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 69/264 (26%), Positives = 114/264 (43%), Gaps = 40/264 (15%)
Query: 589 LGKGGFGTVYHGKL----DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL--V 642
+G+G +G VY K D E A+K + + E+ LL + H N+ L V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQKV 66
Query: 643 GYCDEGTNMALIYEYMANGNLEE--HLSDSSKEILNWEERLRIAVEAAL-----GLEYLH 695
+ L+++Y A +L +SK + R V++ L G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 696 QGCKPPIVHRDVKSTNILI----NEKFQAKLADFGLSRVF--PVEGGTHVSTTIAGTPGY 749
++HRD+K NIL+ E+ + K+AD G +R+F P++ + + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 181
Query: 750 LDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPV-------ISKSAENGHTHVAQWVSSM 801
PE + R T+ D+++ G + E++T P+ I S H + + S M
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241
Query: 802 -----LDKGDIRSTVD-PRLKGDF 819
D DIR + P L+ DF
Sbjct: 242 GFPADKDWEDIRKMPEYPTLQKDF 265
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 17/202 (8%)
Query: 589 LGKGGFGTVYHGKLDND----EVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
+G G FG V ++ D V VK L + SS+ +F + + H N+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL--RIAVEAALGLEYLHQGCKPP 701
C E L++EY G+L+ +LS N + L R+A E A G+ ++H K
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY------- 754
+H D+ N + K+ D+G+ E +L PE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 755 YISNRLTEKSDVYSFGVVLLEI 776
I+ T+ S+V++ GV L E+
Sbjct: 180 LITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 10/93 (10%)
Query: 585 FERVLGKGGFGTVYHGK---LDNDE----VAVKMLSP-SSSQGYKQFQAEVKLLLRV-HH 635
+ LG+G FG V ++ VAVKML +++ YK E+K+L+ + HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 636 RNLTTLVGYCDE-GTNMALIYEYMANGNLEEHL 667
N+ L+G C + G + +I EY GNL +L
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 27/224 (12%)
Query: 589 LGKGGFGTVYHGKL----DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL--V 642
+G+G +G VY K D+ + A+K + + E+ LL + H N+ +L V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 66
Query: 643 GYCDEGTNMALIYEYMANGNLEE--HLSDSSKEILNWEERLRIAVEAAL-----GLEYLH 695
+ L+++Y A +L +SK + R V++ L G+ YLH
Sbjct: 67 FLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 696 QGCKPPIVHRDVKSTNILI----NEKFQAKLADFGLSRVF--PVEGGTHVSTTIAGTPGY 749
++HRD+K NIL+ E+ + K+AD G +R+F P++ + + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 181
Query: 750 LDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPVISKSAENGHT 792
PE + R T+ D+++ G + E++T P+ E+ T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 1e-05
Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 11/94 (11%)
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILINE-KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG 748
L LH K I+H D+K N+L + K + L D+GL ++ + GT
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI------IGTPSCYDGTLD 171
Query: 749 YLDPEYYISNRLTEKSDVYSFGVVLLEIITG-HP 781
Y PE + D ++ GV+ E++TG HP
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 1/77 (1%)
Query: 408 RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKL 467
++ SL+LS + L+G + L L L L +NN TG +P L+ L L+ L L NK
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 468 TGPLPVELLEKQENNTL 484
+G +P L K N T+
Sbjct: 345 SGEIPKN-LGKHNNLTV 360
|
Length = 968 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 17/92 (18%)
Query: 691 LEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGL------SRVFPVEGGTHVSTTI 743
++Y+H +G I+HRD+K+ N+L+N L DFG S P G I
Sbjct: 273 IDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG------I 322
Query: 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE 775
AGT PE + T D++S G+V+ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 587 RVLGKGGFGTVYHGK---LDNDE----VAVKMLSPSSSQGYKQ-FQAEVKLLLRV-HHRN 637
R+LG G FG V G L + VAVKML P++ KQ +E+K++ + H N
Sbjct: 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILN 676
+ L+G C + + +I EY G+L +L + L+
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLS 141
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 585 FERVLGKGGFGTVY----HGKLDNDE---VAVKMLSPSSSQGYKQ-FQAEVKLLLRV-HH 635
F + LG G FG V +G +D VAVKML PS+ ++ +E+K+L + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNL 663
N+ L+G C G +I EY G+L
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDL 126
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-04
Identities = 26/78 (33%), Positives = 39/78 (50%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
+T L+LS + LTG L + L L L +N+L G +PK L SL+ + L N +
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 469 GPLPVELLEKQENNTLEL 486
G LP E + L++
Sbjct: 418 GELPSEFTKLPLVYFLDI 435
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 26/65 (40%), Positives = 35/65 (53%), Gaps = 5/65 (7%)
Query: 408 RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKL 467
R+ + S EL F T L ++ LD+SNNNL G + + SL+ L+LARNK
Sbjct: 410 RLQDNSFSG-ELPSEF----TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464
Query: 468 TGPLP 472
G LP
Sbjct: 465 FGGLP 469
|
Length = 968 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 42/177 (23%), Positives = 76/177 (42%), Gaps = 28/177 (15%)
Query: 615 SSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALI--------YEYMANGNLEEH 666
+ S+ Q + E+ L R++H N+ + N +I Y +M + +
Sbjct: 202 AGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-- 259
Query: 667 LSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFG 726
D L + R I + +EY+H ++HRD+K NI +N + L DFG
Sbjct: 260 WKDRP---LLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFG 312
Query: 727 LSRVF-----PVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ F + G V T +P L + Y E +D++S G++LL++++
Sbjct: 313 TAMPFEKEREAFDYG-WVGTVATNSPEILAGDGY-----CEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 70/291 (24%), Positives = 111/291 (38%), Gaps = 60/291 (20%)
Query: 589 LGKGGFGTVYHGKLDN------------DEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHR 636
LG+G F +Y G L V +K+L S + F L+ ++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEI-LNWEERLRIAVEAALGLEYLH 695
+L L G C N+ ++ EY+ G L+ L + L+W +L +A + A L YL
Sbjct: 62 HLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 696 QGCKPPIVHRDVKSTNILI-----NEKFQ--AKLADFGLSR-VFPVEGGTHVSTTIAGTP 747
+VH +V NIL+ NE + KL+D G+ V E IA
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIA--- 172
Query: 748 GYLDPEYY--ISNRLTEKSDVYSFGVVLLEIITGHPV---ISKSAENGHTHVAQWVSSML 802
PE LT +D +SFG LLEI + S+E + Q M
Sbjct: 173 ----PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMP 228
Query: 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853
D ++ + + C + + +RP ++ +LN
Sbjct: 229 DCAELANLI--------------------NQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 27/69 (39%), Positives = 36/69 (52%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
PR+ L L +++ +G L LT LDLS NNLTG +P+ L +L L L N
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 467 LTGPLPVEL 475
L G +P L
Sbjct: 392 LEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 30/77 (38%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 408 RITSLN---LSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
+TSLN L + LTG L NL L L L N L+GP+P + L L L+L+
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293
Query: 465 NKLTGPLPVELLEKQEN 481
N L+G +P EL+ + +N
Sbjct: 294 NSLSGEIP-ELVIQLQN 309
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-04
Identities = 23/61 (37%), Positives = 36/61 (59%)
Query: 412 LNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPL 471
L+L ++ TG LT+L L L L +N +G +PK L + ++L L+L+ N LTG +
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 472 P 472
P
Sbjct: 373 P 373
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 587 RVLGKGGFGTVY----HGKLDND---EVAVKMLSPSSSQGYKQ-FQAEVKLLLRVH-HRN 637
R LG G FG V HG + +VAVKML ++ KQ +E+K++ + H N
Sbjct: 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLN 102
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHL 667
+ L+G C +G + +I EY G+L ++L
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 18/36 (50%), Positives = 21/36 (58%)
Query: 433 LTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
L SLDLSNN LT L +LK L+L+ N LT
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT 37
|
Length = 60 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 31/150 (20%), Positives = 61/150 (40%), Gaps = 17/150 (11%)
Query: 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTT--LVGY 644
++L G VY +++ +K+ + + EV +L + + L ++
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVLKINPS--REKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV- 703
+ L+ E++ G + +S+ KE IA + A L LHQ P +V
Sbjct: 62 GESDGWSYLLMEWIE-GETLDEVSEEEKE--------DIAEQLAELLAKLHQ--LPLLVL 110
Query: 704 -HRDVKSTNILINEKFQAKLADFGLSRVFP 732
H D+ NIL+++ + D+ + P
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 19/38 (50%), Positives = 27/38 (71%), Gaps = 2/38 (5%)
Query: 431 TMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
T L +LDLSNN +T +P LS L +L+ L+L+ NK+T
Sbjct: 1 TNLETLDLSNNQITD-LP-PLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 44/216 (20%)
Query: 589 LGKGGFGTVYHGKL----DNDE----------VAVKMLSPSSSQGYKQFQAEVKLLLRVH 634
LG+G +Y G L D+++ V +K+L PS F ++ +V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 635 HRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
H+++ L G C ++ E++ G L+ + S ++L + ++A + A L YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYL 121
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP------- 747
+VH +V + NIL LA G+ E G + + G P
Sbjct: 122 ED---KDLVHGNVCTKNIL--------LAREGIDG----ECGPFIKLSDPGIPITVLSRQ 166
Query: 748 ------GYLDPEYYISNR-LTEKSDVYSFGVVLLEI 776
++ PE ++ L+ +D +SFG L EI
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 30/184 (16%)
Query: 607 VAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEH 666
V +K+L PS F L+ +V H +L + G C G+ ++ E++ +G L+
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 667 LSDSSKEI-LNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQA----- 720
L + + W ++ +A + A L YL +VH +V + NIL+ A
Sbjct: 107 LRKEKGRVPVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSP 161
Query: 721 --KLADFG-----LSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVV 772
KL+D G LSR VE P ++ PE N L+ +D +SFG
Sbjct: 162 FIKLSDPGVSFTALSREERVE----------RIP-WIAPECVPGGNSLSTAADKWSFGTT 210
Query: 773 LLEI 776
LLEI
Sbjct: 211 LLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 63/298 (21%), Positives = 107/298 (35%), Gaps = 84/298 (28%)
Query: 589 LGKGGFGTVYHGKLDNDEVAVK---MLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYC 645
LG+G FG VY L N + + +L ++ G E+ + RV + +
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNERVRRACPNSCADFV 195
Query: 646 ---------DEGTNMALIYEY---------MANG----NLEEHLSDSSKEILNWEERLRI 683
+ L++ Y M + N+E +L +++ ER
Sbjct: 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENK 255
Query: 684 AVEAALG--LEYLHQGCKPPIVHRDVKSTNILINEKFQA-KLADFGLS---RVFPVEGGT 737
++ + L L IVHRDVK NI+ +E + K+ D G + RV G
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRV----GIN 311
Query: 738 HVSTTIAGTPGYLDPEYYISNRLT----------------------EKSDVYSFGVVLLE 775
++ P Y PE YI + T ++ D+YS G++ L+
Sbjct: 312 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 371
Query: 776 II-----TGHPVIS---KSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD----FDI 821
+ + +I + N + VA W R V+PR D F++
Sbjct: 372 MAFPNLRSDSNLIQFNRQLKRNDYDLVA-W----------RKLVEPRASPDLRRGFEV 418
|
Length = 566 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 59/260 (22%), Positives = 112/260 (43%), Gaps = 46/260 (17%)
Query: 553 RKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGK-LDNDE-VAVK 610
+ +D + NRS ++ + ++ N ++G G FG VY +D E VA+K
Sbjct: 54 KMIDNDINRS------PNKSY------KLGN----IIGNGSFGVVYEAICIDTSEKVAIK 97
Query: 611 MLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYC--------DEGTNMALIYEYMANG- 661
+ YK E+ ++ ++H N+ L Y ++ + ++ E++
Sbjct: 98 KVLQDPQ--YKN--RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV 153
Query: 662 -NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQA 720
+H + ++ + + +L + + L Y+H I HRD+K N+LI+
Sbjct: 154 HKYMKHYARNNHALPLFLVKL-YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHT 209
Query: 721 -KLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLEIIT 778
KL DFG ++ S + + Y PE + + T D++S G ++ E+I
Sbjct: 210 LKLCDFGSAKNLL---AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 779 GHPVISKSAENGHTHVAQWV 798
G+P+ S G + V Q V
Sbjct: 267 GYPIFS-----GQSSVDQLV 281
|
Length = 440 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 892 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.76 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.93 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.89 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.87 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.84 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.58 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.57 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.55 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.52 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.51 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.34 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.31 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.17 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.16 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.13 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.1 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.08 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.07 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.01 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.99 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.97 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.94 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.93 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.88 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.85 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.8 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 97.77 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.75 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.71 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.68 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.68 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.66 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.65 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.64 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.59 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.59 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.56 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.52 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.4 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 97.39 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.39 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.38 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.3 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.3 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.29 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 97.28 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.25 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-86 Score=792.83 Aligned_cols=487 Identities=26% Similarity=0.448 Sum_probs=363.9
Q ss_pred HhhcCCCCceEeccCCCCCCCcccCCCceEeecCccccccCCccccchhhccccccccccccccC--CCCcceeeeeecC
Q 002688 21 VCAQDQAGFISLDCGLPKDSSYTETSTKLRYTSDANYIETGLPKSILLQYRRMKQQQVWSLRSFP--DGIRNCYRFNLTR 98 (892)
Q Consensus 21 ~~~~~~~~~~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~tlR~Fp--~~~~nCY~l~~~~ 98 (892)
+.++++.++++||||++.+. +++.+|++|++|..|+. |.....+. +....++|+|+|+|| +|+||||+||+++
T Consensus 17 ~~~~~~~~~~~I~CGs~~~~--~~d~~~~~w~~D~~~~~-~~~~~~~~--~~~~~~~~~t~R~F~~~~g~~~cY~~~~~~ 91 (623)
T PLN03150 17 SLASPEPFTMRISCGARVNV--RTAPTNTLWYKDFAYTG-GIPANATR--PSFIAPPLKTLRYFPLSDGPENCYNINRVP 91 (623)
T ss_pred ccccCCCccEEEeCCCCCCc--ccCCCCCEEcCCccccc-CccccccC--cccccchhhccccCCcccccccceEeeecC
Confidence 35556789999999986443 22458999999988864 33333321 134567899999999 5789999999999
Q ss_pred CceeEEeEEeeecCCCCCCCCCceeEEeCCceeeeeeecC--CccceEEEEEEEeccCceeEEEEecCCCCcceeeeeee
Q 002688 99 NTKYLIRATFMYGNYDEQNNLPEFDVHLGPNLWGTIKIEN--VSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFISALELR 176 (892)
Q Consensus 99 ~~~ylvR~~f~ygnyd~~~~~p~Fd~~~~~~~w~~v~~~~--~~~~~~~e~i~~~~~~~~~vcl~~~~~~~pfis~lE~~ 176 (892)
+||||||++|+|||||+.+++|.|||++|||+|.+|+.+. .....++|+|+.+++++++|||+++++|+||||+||||
T Consensus 92 ~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iEv~ 171 (623)
T PLN03150 92 KGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEIL 171 (623)
T ss_pred CCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEEEE
Confidence 9999999999999999999999999999999999998642 33346789999999999999999999999999999999
Q ss_pred ecCCcccccc---Ccc--hheeeehhcCCCC-CCcccccCCCC--CccccCCCC---CCCccccccccccCCCCCCCCCC
Q 002688 177 PLDNNTYITQ---TDS--LELSIRLDVGSTS-NATFRYIDDAY--DRVWWPYDL---DEWEPFSTSEAVDADGSKNFKPP 245 (892)
Q Consensus 177 ~l~~~~y~~~---~~~--l~~~~r~~~g~~~-~~~~ryp~D~~--dR~W~p~~~---~~~~~~~t~~~i~~~~~~~~~~P 245 (892)
||++++|... +++ |++++|+|+|+.+ ...+|||||+| ||+|.|... +.|..+++...|+......+.+|
T Consensus 172 ~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P 251 (623)
T PLN03150 172 QVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYP 251 (623)
T ss_pred EcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccCh
Confidence 9999999644 223 9999999999864 34689999999 999998654 55888988887776655668899
Q ss_pred HHHHhhcccccCCCcceEEeeCCCCCCcceEEeeehhhccc-cccccceEEEEEECCccccCCccccCce-----eeEEE
Q 002688 246 PRAMKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEE-LKANESRLFNITRNGNLWYGPLKLNYLS-----STTVF 319 (892)
Q Consensus 246 ~~v~~tA~t~~~~~~~l~~~~~~~~~~~~~~v~lhFae~~~-~~~~~~R~F~i~ing~~~~~~~~p~~~~-----~~~v~ 319 (892)
+.|||||+++.++..++.+.|+. +++..|+|+|||||++. ....++|+|||+|||+...+++++.... +....
T Consensus 252 ~~VyqTA~~~~~~~~~lty~~~v-~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~ 330 (623)
T PLN03150 252 ESLYQSALVSTDTQPDLSYTMDV-DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLN 330 (623)
T ss_pred HHHhhhhccccCCCCceEEEeec-CCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEE
Confidence 99999999987766677777764 57889999999999974 5566899999999999888877653322 22221
Q ss_pred eeeeccCCceEEEEEecCCCCCCcccceeeEEEeecccCCCCChhHHHHHHHHHHhcCCC--CCCCCCCCCCCCCCCCee
Q 002688 320 SQSAMSGGQYNFSLIKTGNSTHPPIINAIEIYEVKEFSQSQTDEQDVDAIMNIKSFYGLK--KNWQGDPCAPQDYLWEGL 397 (892)
Q Consensus 320 ~~~~~~~~~~~~~l~~~~~s~lpp~ina~e~~~~~~~~~~~~~~~d~~al~~~k~~~~~~--~~w~~~~C~~~~~~w~gv 397 (892)
......++.++|++.++..+ ||+|||+|||++++.. .+|.++|+.||+.+|+.++.. .+|+|+||+|..+.|.||
T Consensus 331 ~~v~~~~g~l~isl~p~~~s--~pilNaiEI~~~~~~~-~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~C~p~~~~w~Gv 407 (623)
T PLN03150 331 KTVAVSGRTLTIVLQPKKGT--HAIINAIEVFEIITAE-SKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGA 407 (623)
T ss_pred eEEeecCCeEEEEEeeCCCC--cceeeeeeeeeccccc-cccCchHHHHHHHHHHhcCCcccCCCCCCCCCCcccccccc
Confidence 12233458899999998755 7999999999999954 689999999999999998653 389999999988899999
Q ss_pred eecCCCC-C------------------------CCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCC
Q 002688 398 NCSYPDD-D------------------------SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLS 452 (892)
Q Consensus 398 ~C~~~~~-~------------------------~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~ 452 (892)
.|+.... . .++|+.|+|++|+|+|.+|..+++|++|+.|||++|+|+|.+|..++
T Consensus 408 ~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~ 487 (623)
T PLN03150 408 DCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487 (623)
T ss_pred eeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHh
Confidence 9963211 1 13444555555555555555555555555555555555555555555
Q ss_pred CCCCCCEEEcCCCcCCCCCchhhhhhccCCceeeeccCCCCCCCC---ccccccCc-ceEEeehhHHHH
Q 002688 453 QLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNPDLCRS---ASCKKEKK-KFVVPVVASVAS 517 (892)
Q Consensus 453 ~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~l~l~~~~n~~~c~~---~~c~~~~~-~iii~iv~~v~~ 517 (892)
+|++|+.|+|++|+|+|.+|..+..+. +....+.+.+|+++|+. ..|..... ..++++++++++
T Consensus 488 ~L~~L~~L~Ls~N~l~g~iP~~l~~~~-~~~~~l~~~~N~~lc~~p~l~~C~~~~~~~~~i~~~~~~~~ 555 (623)
T PLN03150 488 QLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAFGVSV 555 (623)
T ss_pred cCCCCCEEECcCCcccccCChHHhhcc-ccCceEEecCCccccCCCCCCCCcccCCCceEEEEEhHHHH
Confidence 555555555555555555555544321 12234667889999986 35754322 344555554443
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-71 Score=618.75 Aligned_cols=321 Identities=41% Similarity=0.700 Sum_probs=278.8
Q ss_pred eccCCCCCCC-cccCCCceEeecCccccccCCccccchhh---ccccccccccccccCCCCcceeeeeec--CCceeEEe
Q 002688 32 LDCGLPKDSS-YTETSTKLRYTSDANYIETGLPKSILLQY---RRMKQQQVWSLRSFPDGIRNCYRFNLT--RNTKYLIR 105 (892)
Q Consensus 32 idCG~~~~~~-~~~~~~~~~~~~D~~~~~~g~~~~i~~~~---~~~~~~~~~tlR~Fp~~~~nCY~l~~~--~~~~ylvR 105 (892)
||||++.+++ |+|+.|||+|++|.+|+++|+++.|+.+. .....++|+|||+||+|.||||+||+. +|+|||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliR 80 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIR 80 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEEEE
Confidence 8999988887 99999999999999999999999994322 256678899999999999999999998 57799999
Q ss_pred EEeeecCCCCCC-----CCCceeEEeCCceeeeeeecCCc-cceEEEEEEEec-cCceeEEEEecCCCC-cceeeeeeee
Q 002688 106 ATFMYGNYDEQN-----NLPEFDVHLGPNLWGTIKIENVS-VDYSVEIIHVLS-SDYLSVCIVNTNKGT-PFISALELRP 177 (892)
Q Consensus 106 ~~f~ygnyd~~~-----~~p~Fd~~~~~~~w~~v~~~~~~-~~~~~e~i~~~~-~~~~~vcl~~~~~~~-pfis~lE~~~ 177 (892)
++|+|||||+++ .+|.|||++|+|.|.+|+.+++. ..+++|+|+.+. +++++|||+++++|+ ||||+|||||
T Consensus 81 l~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~~ 160 (347)
T PF12819_consen 81 LHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELRP 160 (347)
T ss_pred EEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEEE
Confidence 999999999884 37889999999999999988732 347889555554 899999999999999 9999999999
Q ss_pred cCCcccccc--Ccc--hheeeehhcCCCCCCcccccCCCCCccccCCC-CCCCcccccccccc-CCCCCCCCCCHHHHhh
Q 002688 178 LDNNTYITQ--TDS--LELSIRLDVGSTSNATFRYIDDAYDRVWWPYD-LDEWEPFSTSEAVD-ADGSKNFKPPPRAMKS 251 (892)
Q Consensus 178 l~~~~y~~~--~~~--l~~~~r~~~g~~~~~~~ryp~D~~dR~W~p~~-~~~~~~~~t~~~i~-~~~~~~~~~P~~v~~t 251 (892)
|++++|+.. .++ |.+++|.|+|+..+. ||||+|+|||+|+|+. .+.|..+++...|+ ....+.|.||.+||+|
T Consensus 161 lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~~-iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~T 239 (347)
T PF12819_consen 161 LPDSLYPDTDANSSQALETVYRLNVGGSSSF-IRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQT 239 (347)
T ss_pred CCccceeccccCCCceeEEEEeecCCCcccc-cCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHh
Confidence 999999532 333 999999999987654 9999999999999974 56799999988776 4466779999999999
Q ss_pred cccccCCCcceEEeeCCCCCCcceEEeeehhhccccccc-cceEEEEEECCccccCCccccCceeeEE--Eeee---ecc
Q 002688 252 AVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKAN-ESRLFNITRNGNLWYGPLKLNYLSSTTV--FSQS---AMS 325 (892)
Q Consensus 252 A~t~~~~~~~l~~~~~~~~~~~~~~v~lhFae~~~~~~~-~~R~F~i~ing~~~~~~~~p~~~~~~~v--~~~~---~~~ 325 (892)
|+++.+.+.+++++|...+++..|||+||||||+.+..+ ++|+|||||||+.++++++|.++...++ |... ...
T Consensus 240 A~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 319 (347)
T PF12819_consen 240 ARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPD 319 (347)
T ss_pred hhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecC
Confidence 999998888899999998999999999999999986544 4899999999999988999988887665 4333 234
Q ss_pred CCceEEEEEecCCCCCCcccceeeEEEe
Q 002688 326 GGQYNFSLIKTGNSTHPPIINAIEIYEV 353 (892)
Q Consensus 326 ~~~~~~~l~~~~~s~lpp~ina~e~~~~ 353 (892)
++.++|+|.++..|+|||+|||+|||++
T Consensus 320 ~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 320 SGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred CCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 5678999999999999999999999985
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-54 Score=479.55 Aligned_cols=289 Identities=52% Similarity=0.906 Sum_probs=255.9
Q ss_pred CCCccCHHHHHHHhhhhh--ceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEe
Q 002688 569 SSRQFTYSEVLRMTNNFE--RVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYC 645 (892)
Q Consensus 569 ~~~~~~~~el~~~t~~f~--~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~ 645 (892)
..+.|++.||.++|++|. +.||+|+||.||+|.+ ++..||||++.....+..++|..|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999998 6999999999999999 5589999988776543145699999999999999999999999
Q ss_pred ecCC-cEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEee
Q 002688 646 DEGT-NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLAD 724 (892)
Q Consensus 646 ~~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~D 724 (892)
.+.+ +.+||||||++|+|.++|+......++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999886543689999999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc
Q 002688 725 FGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK 804 (892)
Q Consensus 725 fGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~ 804 (892)
||+|+..+.. ..+......||.+|+|||++..+..++|+|||||||+|+||+||+++.+.........+.+|+...+.+
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999765431 222211118999999999999999999999999999999999999999876655566699999999999
Q ss_pred CCCccccCCCCC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 002688 805 GDIRSTVDPRLK-GDFDI-NSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 805 ~~~~~~~D~~l~-~~~~~-~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~ 858 (892)
+.+.+++||++. +.+.. +++.+++.+|.+|++.+|++||+|.||+++|+++...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999998 66664 7899999999999999999999999999999765433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=509.08 Aligned_cols=423 Identities=26% Similarity=0.491 Sum_probs=308.5
Q ss_pred CCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCCcee
Q 002688 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLE 485 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~l~ 485 (892)
.+.++.|+|++|+++|.+|..+++|++|++|+|++|+|+|.+|..++.|++|+.|||++|+++|.+|..+..+..|+.++
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 45677888888888888888888888888888888888888888888888888888888888888888887777666555
Q ss_pred e---------------------eccCCCCCCCCc------cccccCc--ceEEeehhHHHHHHHHHHHHHHhhhhcccCC
Q 002688 486 L---------------------RFDGNPDLCRSA------SCKKEKK--KFVVPVVASVASVFVVLAALIGLWSLKRKKQ 536 (892)
Q Consensus 486 l---------------------~~~~n~~~c~~~------~c~~~~~--~iii~iv~~v~~~~vvl~~~i~~~~~rrk~~ 536 (892)
+ .+.||+++|+.. .|....+ ...+.+++.++++++++++++++++++||+.
T Consensus 578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (968)
T PLN00113 578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN 657 (968)
T ss_pred ccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 3 356888889753 4543211 1222222222222222222222333333221
Q ss_pred CCCchhhHHhhhccCCCcccccccCCccccccCCCccCHHHHHHHhhhhhceecccccEEEEEEEE--CCcEEEEEEccC
Q 002688 537 LPDPQILIWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSP 614 (892)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~ 614 (892)
....+. . ...+. ... .... ......++++++.... ...+.||+|+||.||+|+. ++..||||++..
T Consensus 658 ~~~~~~-~----~~~~~---~~~-~~~~--~~~~~~~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~ 725 (968)
T PLN00113 658 LELKRV-E----NEDGT---WEL-QFFD--SKVSKSITINDILSSL-KEENVISRGKKGASYKGKSIKNGMQFVVKEIND 725 (968)
T ss_pred cccccc-c----ccccc---ccc-cccc--cccchhhhHHHHHhhC-CcccEEccCCCeeEEEEEECCCCcEEEEEEccC
Confidence 111000 0 00000 000 0000 0011235555555432 3456899999999999987 788999999865
Q ss_pred CCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHH
Q 002688 615 SSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694 (892)
Q Consensus 615 ~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL 694 (892)
... ...+|++.+++++|||||+++++|.+....++||||+++|+|.++++. ++|..+.+|+.|+|+||+||
T Consensus 726 ~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yL 796 (968)
T PLN00113 726 VNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFL 796 (968)
T ss_pred Ccc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHh
Confidence 432 123568899999999999999999999999999999999999999963 89999999999999999999
Q ss_pred HhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHH
Q 002688 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 774 (892)
Q Consensus 695 H~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ 774 (892)
|..+.++|+||||||+||+++.++.+++. +|....... .....++..|||||++.+..++.++|||||||++|
T Consensus 797 H~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ 869 (968)
T PLN00113 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILI 869 (968)
T ss_pred ccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHH
Confidence 98777899999999999999999988876 666543311 12236789999999999999999999999999999
Q ss_pred HHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002688 775 EIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD--FDINSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852 (892)
Q Consensus 775 ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L 852 (892)
||++|+.||+... .....+.+|++...........+||.+... .+.+++.++.+++.+|++.+|++||+|+||+++|
T Consensus 870 el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 870 ELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred HHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 9999999996443 234568888887766666677788877543 3456778899999999999999999999999999
Q ss_pred HHHHh
Q 002688 853 NDCLA 857 (892)
Q Consensus 853 ~~~~~ 857 (892)
+++.+
T Consensus 949 ~~~~~ 953 (968)
T PLN00113 949 ESASR 953 (968)
T ss_pred HHhhc
Confidence 98754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=393.33 Aligned_cols=252 Identities=38% Similarity=0.565 Sum_probs=211.9
Q ss_pred hceecccccEEEEEEEECCcE-EEEEEccCCCch--hhHHHHHHHHHHHhccccceeeEeeEeecCC-cEEEEEEeccCC
Q 002688 586 ERVLGKGGFGTVYHGKLDNDE-VAVKMLSPSSSQ--GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT-NMALIYEYMANG 661 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~~~~~-vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~-~~~LV~Ey~~~g 661 (892)
.+.||+|+||+||+|.+.|+. ||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 356999999999999999988 999999875432 2568999999999999999999999999887 799999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC-ccccCCCCccEEEcCCC-cEEEeeecCcccccCCCCccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP-IVHRDVKSTNILINEKF-QAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiHrDLkp~NILl~~~~-~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|.++|+...+..+++..+++++.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 999999885455699999999999999999999998 6 99999999999999997 99999999998764221 23
Q ss_pred cccccCCCCccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYI--SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~--~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.+...||..|||||++. ...|+.|+|||||||+||||+||+.||..... .+-+..+...+...
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp--------- 265 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRP--------- 265 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCC---------
Confidence 34478999999999999 56899999999999999999999999985432 22233333222211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
..+..+...+..++.+||..+|+.||++.+++..|+.+..
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1122255667899999999999999999999999998865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=388.44 Aligned_cols=261 Identities=27% Similarity=0.428 Sum_probs=220.8
Q ss_pred HHHHHhhhhhceecccccEEEEEEEECCc-EEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 577 EVLRMTNNFERVLGKGGFGTVYHGKLDND-EVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 577 el~~~t~~f~~~IG~G~fG~Vy~~~~~~~-~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
++.+....+.+.||+|-||.||.|++++. .||||.++.... ..+.|.+|+++|++++|+|||+++|+|..++.++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 45556666778999999999999999776 999999987633 3468999999999999999999999999988999999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
|||+.|+|.++|+...+..+.-.+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||||+.. .++
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI-GDD 356 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc-CCC
Confidence 999999999999986677799999999999999999999999 9999999999999999999999999999944 344
Q ss_pred CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
.........-...|.|||.+..++++.|||||||||+||||+| |+.|+.... ..+-+..+-+..++.
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~ev~~~le~GyRlp------ 424 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEEVLELLERGYRLP------ 424 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHHHHHHHhccCcCC------
Confidence 4445555556779999999999999999999999999999999 788876543 223333333333322
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~ 858 (892)
.+..++..+.+++..||..+|++|||++.+...|+++...
T Consensus 425 ----~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 425 ----RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ----CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 2345677788999999999999999999999999887543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=361.42 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=213.6
Q ss_pred ccCHHHHHHHhhhhhceecccccEEEEEEEE--CCcEEEEEEccCC-CchhhHHHHHHHHHHHhccccceeeEeeEeecC
Q 002688 572 QFTYSEVLRMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG 648 (892)
Q Consensus 572 ~~~~~el~~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~ 648 (892)
.++..||++. +.||+|..|+|||+++ +++-+|+|.+... ....++++.+|++++++.+||+||.++|.|...
T Consensus 75 ~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 4666676654 5899999999999998 6788999999544 445678999999999999999999999999998
Q ss_pred C-cEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecC
Q 002688 649 T-NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGL 727 (892)
Q Consensus 649 ~-~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGl 727 (892)
. ...++||||++|+|++.+...++ +++...-+|+.++++||.|||+. .+||||||||+|||++..|++||||||.
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence 8 49999999999999999987643 89999999999999999999963 2999999999999999999999999999
Q ss_pred cccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCC
Q 002688 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDI 807 (892)
Q Consensus 728 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 807 (892)
++.+... ......||..|||||.+.+..|+.++||||||+.++|+.+|+-|+....+ ......+.+.....+..
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~pp- 299 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDEPP- 299 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcCCC-
Confidence 9877432 44577899999999999999999999999999999999999999986521 22334444433333221
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 808 RSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 808 ~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
|.+... ....++.+++..|++.+|.+||+.+|+++
T Consensus 300 -----P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 -----PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -----CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 233322 34566789999999999999999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=395.04 Aligned_cols=260 Identities=31% Similarity=0.505 Sum_probs=221.9
Q ss_pred HHHHHhhhhhceecccccEEEEEEEEC-------CcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecC
Q 002688 577 EVLRMTNNFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEG 648 (892)
Q Consensus 577 el~~~t~~f~~~IG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~ 648 (892)
++.+.-..+.+.||+|+||+||+|+.. ...||||.++..... .+++|++|++++..++|||||+|+|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344444456678999999999999872 346999999987665 789999999999999999999999999999
Q ss_pred CcEEEEEEeccCCchhhhccccC--------cc----cCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC
Q 002688 649 TNMALIYEYMANGNLEEHLSDSS--------KE----ILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE 716 (892)
Q Consensus 649 ~~~~LV~Ey~~~gsL~~~L~~~~--------~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~ 716 (892)
+.+++|+|||..|||.++|..+. .+ .|+-.+.+.||.|||.||+||-++ .++||||.++|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 99999999999999999996433 22 388999999999999999999998 9999999999999999
Q ss_pred CCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHH
Q 002688 717 KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVA 795 (892)
Q Consensus 717 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~ 795 (892)
+..|||+||||++.....+.........-..+|||||.++.++++.+||||||||+|||+++ |+.|+.+....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------ 712 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------ 712 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------
Confidence 99999999999998876666655445556779999999999999999999999999999999 88888765532
Q ss_pred HHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 796 QWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 796 ~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
-|-..++.+++. ..+..+..++..|+..||+.+|++||+++||-..|+..
T Consensus 713 -EVIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 713 -EVIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -HHHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 234445555542 23456778899999999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=357.79 Aligned_cols=194 Identities=29% Similarity=0.556 Sum_probs=176.9
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
.+.||+|+||+||+|++ ++..||||.+... ..+..+.+..|+.+|+.++|||||.+++++..++.++||||||.+|
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 35699999999999998 7789999999876 5566777899999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC------CcEEEeeecCcccccCCC
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK------FQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~------~~vkl~DfGla~~~~~~~ 735 (892)
+|.++|+..++ +++.....+..|+|.||++||++ +||||||||+||||+.. -.+||+|||+|+.+..
T Consensus 95 DLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~-- 167 (429)
T KOG0595|consen 95 DLSDYIRRRGR--LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP-- 167 (429)
T ss_pred CHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc--
Confidence 99999998754 99999999999999999999999 99999999999999865 5689999999998853
Q ss_pred CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSA 787 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~ 787 (892)
.......+|++-|||||+++..+|+.|+|+||+|+++|||++|++||+...
T Consensus 168 -~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 168 -GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred -hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 334567899999999999999999999999999999999999999998543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=369.52 Aligned_cols=244 Identities=25% Similarity=0.458 Sum_probs=206.4
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
++...+.||+|||+.+|+++. .|..||+|++.+. .....+...+|+++.+.|+|||||+++++|++.+++|+|.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 344457899999999999988 7899999999764 33445678999999999999999999999999999999999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
+|++|+|..+++. ++.+++.++..+.+||+.||.|||+. +|+|||||-.|++|+++.++||+|||||..+..++
T Consensus 99 LC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 99 LCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred ecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999999984 45599999999999999999999999 99999999999999999999999999999885443
Q ss_pred ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhH-hhcCCCccccCCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSM-LDKGDIRSTVDPRL 815 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~D~~l 815 (892)
......+||+.|+|||++.....+..+||||+|||||.|+.|+|||+... +.+-...+ ..+..+.
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~~Y~~P------- 238 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLNEYSMP------- 238 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhcCcccc-------
Confidence 34457899999999999999999999999999999999999999998432 22212111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
........+|+.++++.+|.+|||+.+|+.
T Consensus 239 -----~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 -----SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122344669999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.56 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=204.0
Q ss_pred HHHhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCch-------hhHHHHHHHHHHHhccccceeeEeeEeecCC
Q 002688 579 LRMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ-------GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT 649 (892)
Q Consensus 579 ~~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~-------~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~ 649 (892)
....+-+.+.||+|+||.|-+|.- +++.||||+++..... ......+|+++|++++|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 344455678999999999999976 8899999999765221 1223579999999999999999999999999
Q ss_pred cEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC---CcEEEeeec
Q 002688 650 NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK---FQAKLADFG 726 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~---~~vkl~DfG 726 (892)
..|+|||||++|+|.+.+-.++. +.+.....++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999876653 77777889999999999999999 99999999999999766 789999999
Q ss_pred CcccccCCCCccccccccCCCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh
Q 002688 727 LSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD 803 (892)
Q Consensus 727 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~ 803 (892)
+|+... ....+.+.+||+.|.|||++.++. +..++|+||+||+||-+++|.+||...... ..+.+ .+.
T Consensus 325 lAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~e----QI~ 395 (475)
T KOG0615|consen 325 LAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKE----QIL 395 (475)
T ss_pred hhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHH----HHh
Confidence 999763 445667899999999999998664 334889999999999999999999865432 21222 122
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 804 KGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 804 ~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.|... +.| ....+-..+.++++.+|+..||++|||+.|+++
T Consensus 396 ~G~y~--f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYA--FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCccc--ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 23221 111 112345567889999999999999999999987
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=377.16 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=218.0
Q ss_pred HhhhhhceecccccEEEEEEEE--C---CcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL--D---NDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~--~---~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV 654 (892)
....++++||.|-||.||+|++ . ...||||.++....+ .+.+|+.|+.+|.+++||||++|-|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 3334467999999999999988 3 346999999987544 457899999999999999999999999999999999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
.|||++|+|+.+|+.+.++ +.+.+...++++||.||+||.+. +++||||.++|||++.+..+||+||||++.+.++
T Consensus 709 TEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999999998876 99999999999999999999998 9999999999999999999999999999987544
Q ss_pred CCc-cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccC
Q 002688 735 GGT-HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 735 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D 812 (892)
... .....-.-..+|.|||.+...+++.++|||||||+|||.++ |.+||+..... + +.+.+.+
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---d----VIkaIe~-------- 849 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---D----VIKAIEQ-------- 849 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---H----HHHHHHh--------
Confidence 321 12222223468999999999999999999999999999887 89999865532 1 2222221
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhh
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEA 860 (892)
Q Consensus 813 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e~ 860 (892)
.+.-..++++...|.+|++.||+.+-.+||.+.|++..|++++..-.
T Consensus 850 -gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 850 -GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred -ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 22223456788899999999999999999999999999999875433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.61 Aligned_cols=256 Identities=23% Similarity=0.400 Sum_probs=209.1
Q ss_pred HhhhhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEee-EeecCCc-EEEE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVG-YCDEGTN-MALI 654 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g-~~~~~~~-~~LV 654 (892)
+.+.+.++||+|.||+|||+.. ++..+|.|.++.. ..+..++...|+.+|++++|||||++++ .+.++.. +.+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3355668999999999999976 8999999998754 3455677899999999999999999998 4444444 8999
Q ss_pred EEeccCCchhhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCC--ccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 655 YEYMANGNLEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGCKPP--IVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
||++..|+|...++..+ ++.+++..+++++.|+++||.++|.+. ++ |+||||||.||+|+.+|.+||+||||++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999997543 567999999999999999999999843 24 89999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccc
Q 002688 731 FPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRST 810 (892)
Q Consensus 731 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 810 (892)
+... .......+||+.||+||.+.+..|+.|+||||+||++|||+.-++||.+. ++.+... .+..++...
T Consensus 178 l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~-KI~qgd~~~- 247 (375)
T KOG0591|consen 178 LSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCK-KIEQGDYPP- 247 (375)
T ss_pred hcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHH-HHHcCCCCC-
Confidence 7432 33445778999999999999999999999999999999999999999753 3444333 344443321
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 811 ~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
+. +......+.+|+..|+..||+.||+...+++.+..
T Consensus 248 ----~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 ----LP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----Cc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 23455678899999999999999997666665554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=338.49 Aligned_cols=236 Identities=26% Similarity=0.444 Sum_probs=198.0
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.++||+|+||.||.++. +++.+|+|++++.. ....+...+|..+|.+++||.||++.-.|++.++++||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 357999999999999987 67889999998753 3345667899999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
||.|..+|++.+. +++....-++.+|+.||.|||++ +||||||||+|||||++|+++|+||||++..... ...
T Consensus 109 GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~~ 181 (357)
T KOG0598|consen 109 GGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GDA 181 (357)
T ss_pred CccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC--CCc
Confidence 9999999987554 88998999999999999999999 9999999999999999999999999999864322 233
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
....+||+.|||||++.+..|+..+|.||+|+++|||++|.+||... +..++..+..... .. .-|.
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~------~~~~~~~~I~~~k-~~--~~p~----- 247 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE------DVKKMYDKILKGK-LP--LPPG----- 247 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc------cHHHHHHHHhcCc-CC--CCCc-----
Confidence 44689999999999999999999999999999999999999999743 3455555554433 10 0011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC
Q 002688 820 DINSVWKAVEIAMACVSSNANRRP 843 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RP 843 (892)
--.....+++.+.+..+|++|.
T Consensus 248 --~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 248 --YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --cCCHHHHHHHHHHhccCHHHhc
Confidence 0123455888999999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.54 Aligned_cols=263 Identities=29% Similarity=0.484 Sum_probs=212.2
Q ss_pred HHHHHhhhhhceecccccEEEEEEEECCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEE
Q 002688 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 577 el~~~t~~f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV 654 (892)
|+......+.+.||+|.||+||+|+|.| .||||++... ..+..+.|..|+..+++-+|.||+-+.|||..... .+|
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 3444444456799999999999999965 6899999765 34456889999999999999999999999998877 999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
..+|++-+|+.+|+.... .++..+.+.|+.|||+||.|||.+ +|||||||+.||+|.++++|||+||||+.....-
T Consensus 466 TqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred ehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999999997653 499999999999999999999999 9999999999999999999999999999875444
Q ss_pred CCccccccccCCCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcccc
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811 (892)
Q Consensus 735 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 811 (892)
..........|...|||||+++. ..|++.+||||||+|+|||++|..||..... ++ .+.. +..|-+
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dq----Iifm-VGrG~l---- 610 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQ----IIFM-VGRGYL---- 610 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hh----eEEE-eccccc----
Confidence 33344445567889999999974 3689999999999999999999999972211 11 1111 111211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
.|.+. .....+...+.+|+..||..++++||.+.+|+..|++++.
T Consensus 611 ~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 MPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred Cccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11111 1223566778899999999999999999999999998765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=351.30 Aligned_cols=259 Identities=29% Similarity=0.457 Sum_probs=203.3
Q ss_pred HhhhhhceecccccEEEEEEEE-------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecC-Cc
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG-TN 650 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~-~~ 650 (892)
..+.+.+.||+|+||.||+|.. ++..||||++.... ....+.+.+|+.++.++ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 3455678999999999999974 23579999987543 23456789999999999 899999999988764 45
Q ss_pred EEEEEEeccCCchhhhccccC-----------------------------------------------------------
Q 002688 651 MALIYEYMANGNLEEHLSDSS----------------------------------------------------------- 671 (892)
Q Consensus 651 ~~LV~Ey~~~gsL~~~L~~~~----------------------------------------------------------- 671 (892)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 889999999999999886432
Q ss_pred -cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccccCCCCcc
Q 002688 672 -KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYL 750 (892)
Q Consensus 672 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~ 750 (892)
...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 13488899999999999999999998 99999999999999999999999999998653322222223345677899
Q ss_pred CccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHH
Q 002688 751 DPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVE 829 (892)
Q Consensus 751 aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~ 829 (892)
|||++.+..++.++|||||||++|||++ |+.||...... . ... ..+..+... ... ......+.+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~---~~~-~~~~~~~~~-----~~~----~~~~~~l~~ 308 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--E---EFC-QRLKDGTRM-----RAP----ENATPEIYR 308 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--H---HHH-HHHhcCCCC-----CCC----CCCCHHHHH
Confidence 9999999999999999999999999997 99999753321 1 111 112222111 111 122345779
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 830 IAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 830 l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
++.+|++.+|++||++.|+++.|++++.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=377.26 Aligned_cols=266 Identities=30% Similarity=0.451 Sum_probs=218.0
Q ss_pred HHHHHHHhhhhhceecccccEEEEEEEE---CCc----EEEEEEccCC-CchhhHHHHHHHHHHHhccccceeeEeeEee
Q 002688 575 YSEVLRMTNNFERVLGKGGFGTVYHGKL---DND----EVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD 646 (892)
Q Consensus 575 ~~el~~~t~~f~~~IG~G~fG~Vy~~~~---~~~----~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~ 646 (892)
+.++.+..-.+.+.||+|+||.||+|.. ++. .||||.++.. +.+...+|.+|..+|++++|||||+++|.|.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 3345556666778999999999999988 333 4999999876 4556789999999999999999999999999
Q ss_pred cCCcEEEEEEeccCCchhhhccccC-----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEE
Q 002688 647 EGTNMALIYEYMANGNLEEHLSDSS-----KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAK 721 (892)
Q Consensus 647 ~~~~~~LV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vk 721 (892)
+....++++|||++|+|..+|++.+ ...+.....+.++.|||+|+.||+++ ++|||||.++|+||+....+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence 9999999999999999999998763 34589999999999999999999999 999999999999999999999
Q ss_pred EeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHh
Q 002688 722 LADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSS 800 (892)
Q Consensus 722 l~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~ 800 (892)
|+|||||+.+...+.........-...|||||.++.+.++.|+|||||||+|||++| |..||..... ..+ ...
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---~~v---~~~ 916 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---FEV---LLD 916 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch---HHH---HHH
Confidence 999999996644443333222234568999999999999999999999999999999 7888875432 111 112
Q ss_pred HhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 002688 801 MLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAME 859 (892)
Q Consensus 801 ~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e 859 (892)
+...+++. .+..+...+.+++..||+.+|++||++..+++++..+++.-
T Consensus 917 ~~~ggRL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 917 VLEGGRLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHhCCccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 23334222 12345667789999999999999999999999998876543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=337.81 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=203.0
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCC--cEEEEEEeccC
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT--NMALIYEYMAN 660 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~--~~~LV~Ey~~~ 660 (892)
..+.||+|+||.||.+.. ++...|||..........+.+.+|+.+|.+++|||||+++|.....+ .+.+.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 457899999999999988 47899999987664444677899999999999999999999855544 69999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC-CCcEEEeeecCcccccC-CCCcc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-KFQAKLADFGLSRVFPV-EGGTH 738 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-~~~vkl~DfGla~~~~~-~~~~~ 738 (892)
|+|.+++...+. .++...+.++.+||++||+|||++ +|+||||||+|||++. ++.+||+|||+++.... .....
T Consensus 101 GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 101 GSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 999999998776 699999999999999999999998 9999999999999999 79999999999987643 11122
Q ss_pred ccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
......||+.|||||++..+ ....++|||||||++.||+||++||... .....+.-........ |.+..
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----P~ip~ 246 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----PEIPD 246 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----CCCCc
Confidence 33457899999999999864 3345999999999999999999999853 1122233222222211 22222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.......+++.+|++.+|++|||+.++++.-.-
T Consensus 247 ----~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 247 ----SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ----ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 233456699999999999999999999987654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.54 Aligned_cols=246 Identities=22% Similarity=0.364 Sum_probs=200.8
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCCchh---hHHHHHHHHHHHhccccceeeEeeEeec----CCcEEEEEEecc
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQG---YKQFQAEVKLLLRVHHRNLTTLVGYCDE----GTNMALIYEYMA 659 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~---~~~f~~Ei~~l~~l~H~NIv~l~g~~~~----~~~~~LV~Ey~~ 659 (892)
..||+|++|.||+|+++++.||||.++...... .+.|.+|+++|++++||||+++++++.+ ....++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 479999999999999999999999997653322 4678899999999999999999999876 356899999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++.... .++|....+++.+++.||+|||+.. +++||||||+|||+++++.+||+|||+++.+....
T Consensus 106 ~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 106 RGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 999999997653 4899999999999999999999732 78899999999999999999999999988653221
Q ss_pred cccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+........+. . +.+
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~------~~~~~~~i~~~~~-~----~~~-- 243 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT------TKEIYDLIINKNN-S----LKL-- 243 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhcCC-C----CCC--
Confidence 23457889999999976 689999999999999999999999997432 1222222222211 1 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
+......+.+++.+||+.+|++||+++|+++.|+++-
T Consensus 244 --~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 --PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1123456789999999999999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=339.20 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=203.3
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.|.+.||.|+|++|++|+. .++++|||++.+. .....+....|-+.|.+| .||.|++|+..|.+...+|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 3568999999999999987 7889999998764 122334567888999999 899999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.++|++.+. ++......++.+|+.||+|||+. |||||||||+|||||.++++||+|||.|+.+.+....
T Consensus 156 A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 156 APNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred cCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 999999999998754 89999999999999999999999 9999999999999999999999999999988543221
Q ss_pred ---------cc--cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCC
Q 002688 738 ---------HV--STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD 806 (892)
Q Consensus 738 ---------~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 806 (892)
.. ....+||..|.+||++..+..+..+|+|+|||++|+|+.|++||....+ +..+.+-+-....
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----yliFqkI~~l~y~ 305 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----YLIFQKIQALDYE 305 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----HHHHHHHHHhccc
Confidence 11 1457899999999999999999999999999999999999999986443 2211111111111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 807 IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 807 ~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
+...+ ...+.+|+.+.+..+|.+|++.+|+-+.
T Consensus 306 --------fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 306 --------FPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------CCCCC----CHHHHHHHHHHHccCccccccHHHHhhC
Confidence 22222 2456799999999999999999888763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.87 Aligned_cols=250 Identities=29% Similarity=0.437 Sum_probs=208.0
Q ss_pred CccCHHHHHHHhhhhhceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCc
Q 002688 571 RQFTYSEVLRMTNNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTN 650 (892)
Q Consensus 571 ~~~~~~el~~~t~~f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~ 650 (892)
.++.+++|.+. +-||.|+.|.||.|++.++.||||+++.. -+.+|.-|++|+|+||+.+.|+|.....
T Consensus 119 WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISEL-----EWLGSGAQGAVFLGRLHNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhh-----hhhccCcccceeeeeccCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence 34566666554 46999999999999999999999998542 2457888999999999999999999999
Q ss_pred EEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 651 MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 651 ~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
+++|||||..|-|...|+.... +.-.....+..+||.||.|||.+ .|||||||+-||||..+..+||+|||-++.
T Consensus 187 yCIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred eEEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 9999999999999999987553 77888899999999999999999 999999999999999999999999999887
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccc
Q 002688 731 FPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRST 810 (892)
Q Consensus 731 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 810 (892)
.... ...-.++||..|||||++..+..++|+||||||||||||+||..||...+.. .+..|-
T Consensus 262 ~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----------AIIwGV---- 323 (904)
T KOG4721|consen 262 LSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----------AIIWGV---- 323 (904)
T ss_pred hhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----------eeEEec----
Confidence 6322 3345678999999999999999999999999999999999999999743321 111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 811 ~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
-...|.-..+..+..-+.-|+++||+..|..||++++++..|+-.
T Consensus 324 GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 324 GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 011122223445667778899999999999999999999999854
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.50 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=207.7
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.|++.+.||.|..++||+|+. .+..||||++..... ...+.+.+|+..|+.++||||+++...|..+..+++||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 355678999999999999987 678999999976533 33588999999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
.+|++.+++...-+..+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.+||+|||.+..+...+...
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999999988777899999999999999999999999 99999999999999999999999999887765443221
Q ss_pred c-c-ccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 739 V-S-TTIAGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 739 ~-~-~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
. . ....|++.|||||+++. ..|+.|+||||||+...||.+|+.||.....- +-....++. ......-..
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn-~pp~~~t~~ 256 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQN-DPPTLLTSG 256 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcC-CCCCccccc
Confidence 1 1 45689999999999654 46999999999999999999999999855421 111111211 111110001
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+..+........+.+++..|++.||++|||++++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111122336779999999999999999999986
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=344.23 Aligned_cols=255 Identities=29% Similarity=0.416 Sum_probs=206.5
Q ss_pred hhceecccccEEEEEEEE--C-C--cE-EEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 585 FERVLGKGGFGTVYHGKL--D-N--DE-VAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~-~--~~-vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
+.+.||+|+||.||+|++ . + .. ||||..+.. .....++|.+|+++|+.++|||||+++|++...+.+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 347999999999999988 2 2 23 899998852 3556789999999999999999999999999999999999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
|+|.||+|.++|++... .++..+++.++.++|+||+|||++ ++|||||.++|+|++.++.+||+||||++.-. .
T Consensus 241 El~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--~ 314 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS--Q 314 (474)
T ss_pred EecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc--c
Confidence 99999999999998765 599999999999999999999999 99999999999999999999999999987532 1
Q ss_pred CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
.........-...|+|||.+....++.++|||||||++||+++ |..||.+... ..+..++ ...+. +.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~~v~~kI---~~~~~-r~----- 382 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---YEVKAKI---VKNGY-RM----- 382 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---HHHHHHH---HhcCc-cC-----
Confidence 1111112235679999999999999999999999999999999 7888875432 1122222 12221 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhh
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEA 860 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e~ 860 (892)
..+......+..+..+|+..+|++||+|.++.+.|+.+.....
T Consensus 383 ---~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 ---PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1122344556678889999999999999999999999865544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=333.26 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=201.0
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecC--CcEEEEEEecc
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMALIYEYMA 659 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~LV~Ey~~ 659 (892)
.++||+|.||.||||+. +|+.||+|++.... ........+||.+|++|+||||++|.+...+. +.+|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 35899999999999988 78899999988764 33345568999999999999999999998766 68999999998
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
. +|.-++.... -.++..++..++.|++.||+|+|.+ +|+|||||.+|||||++|.+||+|||||+.+..... ..
T Consensus 202 h-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~-~~ 275 (560)
T KOG0600|consen 202 H-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS-AP 275 (560)
T ss_pred c-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCC-cc
Confidence 8 8888887643 2389999999999999999999999 999999999999999999999999999998754432 33
Q ss_pred cccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHH----------HHHHhHhhcCCCc
Q 002688 740 STTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVA----------QWVSSMLDKGDIR 808 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~----------~~~~~~~~~~~~~ 808 (892)
.+..+-|.-|+|||.+.+. .|+...|+||.||||.||++|++.|.+..+.+.-+.. .|....+. ..
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP---~~ 352 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP---HA 352 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC---cc
Confidence 5667789999999999875 6999999999999999999999999877653221111 12111110 00
Q ss_pred cccCCCCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 809 STVDPRLKGDFDI-----NSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 809 ~~~D~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+.|.-.-.... ......++|+..++..||.+|.|+.++++
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111111100011 12334679999999999999999999886
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=342.39 Aligned_cols=242 Identities=25% Similarity=0.445 Sum_probs=204.5
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
+.||+|+.|.||.|+. +++.||||++........+-+..|+.+|+..+|+|||.++..+..+++++.|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 5799999999999977 78899999998876666677899999999999999999999999999999999999999999
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
+.+.... +++.++..|++++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+..... .....+
T Consensus 359 DvVt~~~---~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmV 430 (550)
T KOG0578|consen 359 DVVTKTR---MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMV 430 (550)
T ss_pred hhhhccc---ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cccccc
Confidence 9998754 89999999999999999999999 999999999999999999999999999987753322 445678
Q ss_pred CCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHH
Q 002688 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSV 824 (892)
Q Consensus 745 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~ 824 (892)
||+.|||||+.....|..|.||||||++++||+.|++||-... ...+.|. +...| -|++.. .....
T Consensus 431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~----PlrAlyL--Ia~ng------~P~lk~--~~klS 496 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRALYL--IATNG------TPKLKN--PEKLS 496 (550)
T ss_pred CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC----hHHHHHH--HhhcC------CCCcCC--ccccC
Confidence 9999999999999999999999999999999999999997422 1111121 11111 122221 12234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 825 WKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 825 ~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+.++..+|++.|+++||+++|+++
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 45679999999999999999999997
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.36 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=202.2
Q ss_pred hhhhhceecccccEEEEEEEEC------------------CcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEe
Q 002688 582 TNNFERVLGKGGFGTVYHGKLD------------------NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLV 642 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~~------------------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~ 642 (892)
.+.+.+.||+|+||.||++.+. +..||+|.+.... ....++|.+|++++.+++|+||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 3456789999999999999752 2369999987653 33456799999999999999999999
Q ss_pred eEeecCCcEEEEEEeccCCchhhhccccC-----------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcccc
Q 002688 643 GYCDEGTNMALIYEYMANGNLEEHLSDSS-----------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHR 705 (892)
Q Consensus 643 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr 705 (892)
+++......++||||+++|+|.+++.... ...++|..+.+++.|++.||+|||+. +|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 99999999999999999999999885432 12478899999999999999999998 99999
Q ss_pred CCCCccEEEcCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 002688 706 DVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT--GHPVI 783 (892)
Q Consensus 706 DLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt--G~~p~ 783 (892)
||||+|||+++++.+||+|||+++.+.............++..|+|||++.++.++.++||||||+++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999986643322222233456788999999988899999999999999999997 45666
Q ss_pred CccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 784 SKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 784 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
..... ......+............. .....+...+.+++.+|++.+|++||++.||.+.|++
T Consensus 243 ~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 54321 22233333322221111000 0011234567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.13 Aligned_cols=249 Identities=34% Similarity=0.569 Sum_probs=197.0
Q ss_pred hhceecccccEEEEEEEEC------CcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 585 FERVLGKGGFGTVYHGKLD------NDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~~------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.+.||.|.||.||+|.+. +..|+||.++.... ...++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999986 57899999976533 3478899999999999999999999999988889999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.++|.......+++..+..|+.|+++||+|||+. +++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987556699999999999999999999998 9999999999999999999999999999876322222
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
...........|+|||.+.+..++.++||||||+++|||++ |+.|+... ...++.... .++.... .
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~-~~~~~~~-~----- 226 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKL-KQGQRLP-I----- 226 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHH-HTTEETT-S-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccc-cccccce-e-----
Confidence 22334456778999999999999999999999999999999 67887543 222333333 2221111 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L 852 (892)
.......+.+++.+||..+|++||+++++++.|
T Consensus 227 ---~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ---PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112334577999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=344.77 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=202.7
Q ss_pred HhhhhhceecccccEEEEEEEE-------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNM 651 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~ 651 (892)
..+.+.+.||+|+||.||+|+. ++..||||+++... ....+.+.+|++++..+ +||||++++++|..+...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3456678999999999999974 34579999997543 33456788999999999 899999999999999999
Q ss_pred EEEEEeccCCchhhhccccC------------------------------------------------------------
Q 002688 652 ALIYEYMANGNLEEHLSDSS------------------------------------------------------------ 671 (892)
Q Consensus 652 ~LV~Ey~~~gsL~~~L~~~~------------------------------------------------------------ 671 (892)
++||||+++|+|.++++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999886432
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 672 -------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 672 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
...++|..+.+++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 12478999999999999999999998 99999999999999999999999999998764332222
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..+.++ +..+... ..+.
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~----~~~~~~~--~~~~--- 340 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKM----IKEGYRM--LSPE--- 340 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHH----HHhCccC--CCCC---
Confidence 2223345678999999999999999999999999999998 88888643221 112222 2222110 0111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.....+.+++.+|++.+|++||++.||++.|++.
T Consensus 341 ----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 ----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1124577999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=323.57 Aligned_cols=264 Identities=28% Similarity=0.430 Sum_probs=203.9
Q ss_pred hhceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHH--hccccceeeEeeEeecCC----cEEEEEEec
Q 002688 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLL--RVHHRNLTTLVGYCDEGT----NMALIYEYM 658 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~--~l~H~NIv~l~g~~~~~~----~~~LV~Ey~ 658 (892)
+.++||+|+||.||||+++++.||||++.... .+.|..|-++.. .++|+||++++++-..+. +++||+||.
T Consensus 214 l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhccCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 45689999999999999999999999997543 455666666654 558999999999887766 899999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhC------CCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG------CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
++|+|.++|..+. ++|....+|+..+++||+|||+. .+|+|+|||||++||||.+|+++.|+|||||..+.
T Consensus 291 ~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 291 PKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred cCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 9999999998765 99999999999999999999975 46789999999999999999999999999999987
Q ss_pred CCCCccccccccCCCCccCccccccCC-CC-----chhhHHHHHHHHHHHHhCCCCCC--------cccc---CCCccHH
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNR-LT-----EKSDVYSFGVVLLEIITGHPVIS--------KSAE---NGHTHVA 795 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-----~ksDV~SlGvvl~ELltG~~p~~--------~~~~---~~~~~l~ 795 (892)
...........+||.+|||||++.+.. +. .+.||||+|.|||||+++..-+. ...+ +....+.
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 554444445688999999999997642 22 36899999999999999753332 1111 1222233
Q ss_pred HHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 002688 796 QWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 796 ~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~ 858 (892)
+...-++++..-..+-|.- .....+..+.+.+..||..||+.|.|+.=|.+.+.++.-.
T Consensus 448 ~mq~~VV~kK~RP~~p~~W----~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAW----RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HHHHHHHhhccCCCChhhh----hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 3222223222211111111 1235567788999999999999999999999888876443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=301.64 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=203.0
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCch--hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ--GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.-.+.+|+|.||.||+|+. +|+.||||+++..... -.....+|+..|+.++|+||+.+++.+.+.+...||+|||+
T Consensus 5 ~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~ 84 (318)
T KOG0659|consen 5 EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP 84 (318)
T ss_pred hhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc
Confidence 3456899999999999998 7899999999876432 13457899999999999999999999999999999999998
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
. +|+..++... ..++-.....++.++++||+|+|++ .|+||||||.|+|++++|.+||+|||+|+.+.......
T Consensus 85 t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~- 158 (318)
T KOG0659|consen 85 T-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ- 158 (318)
T ss_pred c-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence 6 8999888764 4588999999999999999999999 99999999999999999999999999999986544332
Q ss_pred cccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHH--hHhhcCC------Cccc
Q 002688 740 STTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVS--SMLDKGD------IRST 810 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~--~~~~~~~------~~~~ 810 (892)
+..+-|.-|+|||.+.+. .|+...||||.||++.||+-|.+-|.+..+ +.+... ..+.... +.+.
T Consensus 159 -~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-----idQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 159 -THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-----IDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred -ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-----HHHHHHHHHHcCCCCcccCcccccc
Confidence 333678899999999875 699999999999999999999988875543 222211 1111111 1111
Q ss_pred cC-------CCC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 811 VD-------PRL-KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 811 ~D-------~~l-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
-| |.. ....-..+...+++++..++..||.+|++++|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 110 011112345566899999999999999999999874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=343.37 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=202.7
Q ss_pred HhhhhhceecccccEEEEEEEE-------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNM 651 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~ 651 (892)
..+.+.+.||+|+||.||+|+. ++..||||+++... ....+.+.+|+++++.+ +|+||++++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 3455678999999999999875 22479999997643 33446788999999999 899999999999999999
Q ss_pred EEEEEeccCCchhhhccccC------------------------------------------------------------
Q 002688 652 ALIYEYMANGNLEEHLSDSS------------------------------------------------------------ 671 (892)
Q Consensus 652 ~LV~Ey~~~gsL~~~L~~~~------------------------------------------------------------ 671 (892)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885421
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccc
Q 002688 672 --------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743 (892)
Q Consensus 672 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 743 (892)
...+++..+.+++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 12478899999999999999999998 9999999999999999999999999999865332222222233
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHH
Q 002688 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDIN 822 (892)
Q Consensus 744 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~ 822 (892)
.++..|||||++.+..++.++|||||||++|||++ |+.||....... .+ ......+. .+.... .
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----~~~~~~~~-----~~~~~~----~ 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----YKMVKRGY-----QMSRPD----F 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----HHHHHccc-----CccCCC----C
Confidence 45678999999998899999999999999999997 999997533211 11 11111111 000110 1
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 823 SVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 823 ~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
....+.+++.+|++.+|++||++.+|++.|++++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1346779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=325.22 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=202.4
Q ss_pred HhhhhhceecccccEEEEEEEE-----CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL-----DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV 654 (892)
..+.+.+.||+|+||.||+|++ .+..||+|.++.... ...+.|.+|+..+++++||||+++++++..+...++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 4456678999999999999976 245899999886533 3346789999999999999999999999999999999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999997643 3489999999999999999999998 9999999999999999999999999987653211
Q ss_pred CCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 735 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
. ........++..|+|||.+.+..++.++|||||||++||+++ |++||..... .+.... +..+...
T Consensus 161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~------~~~~~~-~~~~~~~----- 227 (266)
T cd05064 161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG------QDVIKA-VEDGFRL----- 227 (266)
T ss_pred c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHH-HHCCCCC-----
Confidence 1 111112335678999999999999999999999999999875 9999975432 111111 1221110
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.. .......+.+++.+|++.+|++||++.++.+.|+++
T Consensus 228 ~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 PA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11 122345677999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.81 Aligned_cols=272 Identities=24% Similarity=0.383 Sum_probs=211.4
Q ss_pred HHHHHHhhhhhceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHh--ccccceeeEeeEeecC----C
Q 002688 576 SEVLRMTNNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLR--VHHRNLTTLVGYCDEG----T 649 (892)
Q Consensus 576 ~el~~~t~~f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~NIv~l~g~~~~~----~ 649 (892)
+.-.+.+-.+.+.||+|.||+||+|++.|+.||||++..... +.+.+|.++.+. ++|+||+.+++.-..+ .
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccccCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 333444555678999999999999999999999999986644 345666666654 4999999999887544 3
Q ss_pred cEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHh-----CCCCCccccCCCCccEEEcCCCcEEEee
Q 002688 650 NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ-----GCKPPIVHRDVKSTNILINEKFQAKLAD 724 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiHrDLkp~NILl~~~~~vkl~D 724 (892)
.++||.+|.+.|||.|+|... .++-...++++..+|.||++||- +.+|.|.|||||+.|||+..++.+.|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 589999999999999999864 48999999999999999999995 3578999999999999999999999999
Q ss_pred ecCcccccCCCCc--cccccccCCCCccCccccccCC----C--CchhhHHHHHHHHHHHHhC----------CCCCCcc
Q 002688 725 FGLSRVFPVEGGT--HVSTTIAGTPGYLDPEYYISNR----L--TEKSDVYSFGVVLLEIITG----------HPVISKS 786 (892)
Q Consensus 725 fGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~----~--s~ksDV~SlGvvl~ELltG----------~~p~~~~ 786 (892)
+|||......... ......+||.+|||||++.... + -..+||||||.|+||+..+ ++||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999876543221 1234678999999999986432 2 2468999999999999764 5666544
Q ss_pred ccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 002688 787 AENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 787 ~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~ 858 (892)
...+. .+ +-.++++--.+++..++.+.. +.+.+..+.++++.||..+|.-|-|+-.+-+.|.++.+.
T Consensus 440 Vp~DP-s~-eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 440 VPSDP-SF-EEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCC-CH-HHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 43221 11 122333333444444444443 457888999999999999999999999999999998643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=331.88 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=205.4
Q ss_pred HhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhH-HHHHHHHHHHhcc-ccceeeEeeEeecCC-cEEEEE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYK-QFQAEVKLLLRVH-HRNLTTLVGYCDEGT-NMALIY 655 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~-~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~-~~~LV~ 655 (892)
.+|...+.||.|.||.||+|+- ++..||||+++..-....+ .-++|+..|+++. |||||++.+.+.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 4566678999999999999987 7889999999876433222 2378999999998 999999999998877 899999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
|||+. +|.++++.+ ++.++...+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+||||||.+...
T Consensus 90 E~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK- 163 (538)
T ss_pred Hhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC-
Confidence 99976 999999887 67799999999999999999999999 9999999999999999999999999999987432
Q ss_pred CccccccccCCCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCc------
Q 002688 736 GTHVSTTIAGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR------ 808 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------ 808 (892)
...+..+.|.-|+|||++. .+-|+.+.|+|++|||++|+.+-++.|.+..+-+..... -.++......
T Consensus 164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI---c~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI---CEVLGTPDKDSWPEGY 238 (538)
T ss_pred --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH---HHHhCCCccccchhHH
Confidence 3345667899999999986 467899999999999999999999999877653211111 1111111000
Q ss_pred ---cccC---C-----CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 809 ---STVD---P-----RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 809 ---~~~D---~-----~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
..+. | .+..-. .....+.++++.+|+.+||++|||+.|+++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111 0 111111 1256678899999999999999999999874
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=326.14 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=198.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
...+.||+|+||.||++.. +++.||||.+.... ......+.+|++++.+++|+||+++.+++...+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 3457899999999999987 78899999986542 223346789999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 156 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--- 156 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---
Confidence 999999888655445689999999999999999999998 99999999999999999999999999998653221
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .+-+...+..... .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~----------~ 223 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQE----------E 223 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcccc----------c
Confidence 12345689999999999999999999999999999999999999985433211 1111111111110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPF-----MNQVVM 850 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eVl~ 850 (892)
+.......+.+|+.+|++.+|++||+ ++++++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11122345779999999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=312.31 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=198.8
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
.++|+|++|.|||.+. +|+.||||++..... .-.+-.++|+.+|++++|+|+|.++.+|.....++||+||++. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 3689999999999988 788999999976543 3345578999999999999999999999999999999999988 4
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 742 (892)
+.+-|+.. ...++.....+++.|++.|+.|+|++ ++|||||||+||||+.++.+||||||.|+.+...+ ...+.
T Consensus 87 vL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTD 160 (396)
T KOG0593|consen 87 VLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTD 160 (396)
T ss_pred HHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc--chhhh
Confidence 44444443 33489999999999999999999999 99999999999999999999999999999885322 23345
Q ss_pred ccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHH--------HHhHhhcC------CC
Q 002688 743 IAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQW--------VSSMLDKG------DI 807 (892)
Q Consensus 743 ~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~------~~ 807 (892)
.+.|.-|+|||.+.+ .+|...+||||.||++.||++|.+.|.+.++-+.-....- -++++... .+
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 677899999999987 6899999999999999999999999986654221111100 01111111 11
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 808 RSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 808 ~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+.-+++-.+..-.....-+++++..|++.||++|++-+|++.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 2222221111111122346789999999999999999999886
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=325.20 Aligned_cols=252 Identities=29% Similarity=0.515 Sum_probs=203.8
Q ss_pred hhhceecccccEEEEEEEECC-------cEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKLDN-------DEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~~~-------~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
.+.+.||+|+||.||+|...+ ..||+|.+..... ....+|.+|++.+.+++|+||+++++++......+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 455789999999999998722 4699999875533 34567899999999999999999999999989999999
Q ss_pred EeccCCchhhhccccCc--------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEE
Q 002688 656 EYMANGNLEEHLSDSSK--------------EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAK 721 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vk 721 (892)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence 99999999999865421 4588999999999999999999998 999999999999999999999
Q ss_pred EeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHh
Q 002688 722 LADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSS 800 (892)
Q Consensus 722 l~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~ 800 (892)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+.+.
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~~--- 238 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIEM--- 238 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---
Confidence 999999986543332223334456788999999998899999999999999999998 9999875332 112221
Q ss_pred HhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 801 MLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 801 ~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
+..+.... ........+.+++.+|++.+|++||+++||++.|+.
T Consensus 239 -i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 -IRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 22222111 112344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=321.38 Aligned_cols=255 Identities=29% Similarity=0.462 Sum_probs=205.1
Q ss_pred HHHhhhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 579 LRMTNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 579 ~~~t~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.+...++.+.||+|++|.||+|.. +++.||+|.++.... ..+++.+|++++++++|+||+++.+++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 344556778999999999999988 567899999876432 356789999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++...... .
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-Y 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-c
Confidence 9999999999776555689999999999999999999998 99999999999999999999999999998764221 1
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
........+..|+|||++.+..++.++||||||++++||++ |+.||..... ..+. .. +.... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~---~~-~~~~~-~~------- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVL---QQ-VDQGY-RM------- 223 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH---HH-HHcCC-CC-------
Confidence 11112223457999999998899999999999999999999 9999864321 1111 11 11111 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.........+.+++.+|++.+|++||++.++++.|++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111233567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=321.46 Aligned_cols=252 Identities=29% Similarity=0.416 Sum_probs=204.5
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
..+.+.||+|++|.||+|.. +++.||+|.+... ....+++.+|++++++++|+||+++++++......++||||+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 44567899999999999988 5788999998754 33456789999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........ ...
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~ 162 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAH 162 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee-ecc
Confidence 9999999776556689999999999999999999998 999999999999999999999999999987642211 111
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
....++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ..+...... .+. .+..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~------~~~~~~~~~-~~~-----~~~~---- 226 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE-KGY-----RMER---- 226 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHH-CCC-----CCCC----
Confidence 12234568999999998999999999999999999998 899986432 122222211 110 0111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.......+.+++.+|++.+|++||++.+++++|+.+
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112335678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.68 Aligned_cols=241 Identities=29% Similarity=0.455 Sum_probs=207.9
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+-+.||+|.||.||||+. +.+.||+|.+.+. ..+..+.+.+|++++++++|||||.++++|+...+.++|.||+.+
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence 346799999999999977 6678999998765 344567799999999999999999999999999999999999987
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
+|..+|..... +++..+..++.++..||.|||+. +|+|||+||.|||++.++.+|++|||+|+.+. ......
T Consensus 86 -~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t~vl 157 (808)
T KOG0597|consen 86 -DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TNTSVL 157 (808)
T ss_pred -hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc--cCceee
Confidence 99999987655 99999999999999999999999 99999999999999999999999999999874 345667
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
+.+.||+-|||||...+..|+..+|+||+||++|||++|+|||... .+.+.++.+..+.- . .+
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~v-------~----~p 220 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDPV-------K----PP 220 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCCC-------C----Cc
Confidence 7899999999999999999999999999999999999999999642 34455554443221 1 12
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......+..+++..+..||.+|.+..+++.
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 234456778999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.48 Aligned_cols=243 Identities=27% Similarity=0.443 Sum_probs=201.6
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCC----Cc-hhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS----SS-QGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~----~~-~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~L 653 (892)
.+.+.+.||+|.||.|+.|+. ++..||||.+... .. ...+.+.+|+.++++++ ||||+++..++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 345567999999999999987 7899999977653 12 23456678999999999 9999999999999999999
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC-CcEEEeeecCccccc
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK-FQAKLADFGLSRVFP 732 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~-~~vkl~DfGla~~~~ 732 (892)
||||+.+|+|.+++...+ .+.+.+..+++.|++.|++|+|+. +|+||||||+|||++.+ +++||+|||++....
T Consensus 98 vmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999998833 388899999999999999999999 99999999999999999 999999999998763
Q ss_pred CCCCccccccccCCCCccCccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCC--Cc
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNR-LT-EKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD--IR 808 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~~ 808 (892)
.........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ....... +..+. +.
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~k-i~~~~~~~p 243 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRK-IRKGEFKIP 243 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHH-HhcCCccCC
Confidence 2233456789999999999999877 86 78999999999999999999998522 2222222 22222 11
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002688 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVV 849 (892)
Q Consensus 809 ~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl 849 (892)
..++ ...+..++.+|+..+|.+|+++.+++
T Consensus 244 ~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 244 SYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111 45677999999999999999999998
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=330.64 Aligned_cols=271 Identities=26% Similarity=0.413 Sum_probs=225.1
Q ss_pred cCHHHHHHHhhhhhceecccccEEEEEEEECC-cEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCc
Q 002688 573 FTYSEVLRMTNNFERVLGKGGFGTVYHGKLDN-DEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTN 650 (892)
Q Consensus 573 ~~~~el~~~t~~f~~~IG~G~fG~Vy~~~~~~-~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~ 650 (892)
-.+.|..+..-.|.++||+|-||+|.....++ ..||||+++.... ...++|.+|+.+|.+++||||++++|.|..++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 34566677777788999999999999999966 8999999998754 455899999999999999999999999999999
Q ss_pred EEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 651 MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 651 ~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
+++|+|||++|+|.++|.++....+.-....+|+.|||.||+||.+. +++||||.++|+|++.++++||+|||+++-
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence 99999999999999999988655456667788999999999999998 999999999999999999999999999997
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCccccCCCccHHHHHHhHhhcCCCc
Q 002688 731 FPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT--GHPVISKSAENGHTHVAQWVSSMLDKGDIR 808 (892)
Q Consensus 731 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 808 (892)
+...+..+......-..+|||||.+..++++.++|||+||+.+||+++ ...||..... ...++-...+++.+...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcc
Confidence 766666666556667789999999999999999999999999999865 6778875442 22334344444333222
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 809 ~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
..+ ..+.-+...+.+++.+||..+.++||+++++...|.+.
T Consensus 764 ~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 211 11234567788999999999999999999999998863
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.02 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=202.4
Q ss_pred hhhhceecccccEEEEEEEE--CCc----EEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DND----EVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~----~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
+...+.||+|+||.||+|++ ++. .||||.++... ....+++.+|+.+++.++|+||++++++|... ...+|+
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~ 87 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 87 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence 34457899999999999986 333 38999987543 34456789999999999999999999999764 567999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 88 e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 88 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred ecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 9999999999997654 3488999999999999999999998 99999999999999999999999999998764333
Q ss_pred CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||..... .++. .....+... ..
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------~~~~-~~~~~~~~~-~~--- 232 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEIS-SILEKGERL-PQ--- 232 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHH-HHHhCCCCC-CC---
Confidence 2222223344678999999999999999999999999999998 9999864321 1111 122211110 00
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAME 859 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e 859 (892)
...+...+.+++.+|++.+|++||++.+++..|.++....
T Consensus 233 -----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 233 -----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1122345779999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.50 Aligned_cols=262 Identities=28% Similarity=0.407 Sum_probs=218.7
Q ss_pred HHHHHHHhhhhhceecccccEEEEEEEEC--CcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEE
Q 002688 575 YSEVLRMTNNFERVLGKGGFGTVYHGKLD--NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMA 652 (892)
Q Consensus 575 ~~el~~~t~~f~~~IG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~ 652 (892)
-.|+++....+..+||-|-+|.||.|.|. .-.||||.++.... ..++|++|..+|+.++|||+|+|+|+|......|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 34555555556789999999999999994 45799999987643 4689999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+|.|||.+|+|.++|++..+..++-...+.++.||+.||+||..+ ++|||||.++|+|+.++..+||+||||++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999999888889899999999999999999998 99999999999999999999999999999985
Q ss_pred CCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCcccc
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 811 (892)
.+.. .......-...|.|||.+..+.++.|+|||+|||+|||+.| |-.||.+- ++.+- -.++.+
T Consensus 417 gDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------dlSqV-Y~LLEk------- 481 (1157)
T KOG4278|consen 417 GDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQV-YGLLEK------- 481 (1157)
T ss_pred CCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc------cHHHH-HHHHhc-------
Confidence 4322 22233344678999999999999999999999999999998 67777642 22221 122222
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
.+.-+.+..|..++.+|++.||+++|.+||+++|+-+.++.+.+
T Consensus 482 --gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 482 --GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred --cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 12223345677889999999999999999999999999998854
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.45 Aligned_cols=259 Identities=30% Similarity=0.467 Sum_probs=203.7
Q ss_pred HhhhhhceecccccEEEEEEEE-------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeec-CCc
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDE-GTN 650 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~-~~~ 650 (892)
..+.+.+.||+|+||.||+|.. .++.||+|++.... ....+.+.+|++++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 3456778999999999999965 23679999987543 23346788999999999 89999999998864 456
Q ss_pred EEEEEEeccCCchhhhccccC-----------------------------------------------------------
Q 002688 651 MALIYEYMANGNLEEHLSDSS----------------------------------------------------------- 671 (892)
Q Consensus 651 ~~LV~Ey~~~gsL~~~L~~~~----------------------------------------------------------- 671 (892)
.++++||+++|+|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999885422
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccccCCCCccC
Q 002688 672 KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLD 751 (892)
Q Consensus 672 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~a 751 (892)
...++|..+.+++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 12589999999999999999999998 999999999999999999999999999987643322222233456678999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHH
Q 002688 752 PEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEI 830 (892)
Q Consensus 752 PE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l 830 (892)
||++.+..++.++|||||||+++||++ |+.||...... ..+ ...+..+... .. .......+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~~-~~--------~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEF----CRRLKEGTRM-RA--------PEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHH----HHHHhccCCC-CC--------CccCCHHHHHH
Confidence 999999999999999999999999998 99998753221 111 1122222111 00 11223467899
Q ss_pred HHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 831 AMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 831 ~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
+.+|++.+|++||++.|+++.|+++++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.79 Aligned_cols=253 Identities=28% Similarity=0.460 Sum_probs=204.1
Q ss_pred hhhhceecccccEEEEEEEEC-----CcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKLD-----NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
+.+.+.||+|+||.||+|++. ...||||.++... ....++|.+|+.++++++|+||+++++++...+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 345679999999999999872 3479999987653 3345678999999999999999999999999999999999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
|+++++|.+++..... .+++..+.+++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.+.....
T Consensus 86 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 86 YMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred cCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 9999999999976543 489999999999999999999998 999999999999999999999999999987742222
Q ss_pred ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.+.. ..+... +.
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~----~~- 229 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDGYRL----PP- 229 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCC----CC-
Confidence 222223345678999999998899999999999999999998 9999864321 1121211 111110 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.......+.+++.+|++.+|++||++.||++.|+++
T Consensus 230 ----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 ----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112345678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.44 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=196.6
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
+.||+|+||.||+|+. +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999987 78899999886543 33456789999999999999999999999999999999999999999
Q ss_pred hhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccc
Q 002688 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743 (892)
Q Consensus 664 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 743 (892)
.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99987543 3489999999999999999999998 9999999999999999999999999998764321111111112
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHH
Q 002688 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDIN 822 (892)
Q Consensus 744 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~ 822 (892)
..+..|+|||.+.++.++.++||||||+++|||++ |..||...... . ....+.... . . .....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~----~~~~~~~~~-~----~----~~~~~ 220 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---Q----TREAIEQGV-R----L----PCPEL 220 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---H----HHHHHHcCC-C----C----CCccc
Confidence 23457999999998899999999999999999998 88888643211 1 111111110 0 0 11112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 823 SVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 823 ~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
....+.+++.+|++.+|++||++.++.++|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=330.98 Aligned_cols=240 Identities=24% Similarity=0.343 Sum_probs=195.3
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
+.||+|+||.||+++. +++.||||+++... ......+.+|++++++++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 67899999987532 233456788999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~ 153 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence 9999987643 489999999999999999999998 9999999999999999999999999998753221 12223
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+. ..+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~-~~~------~~~p~---- 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELIL-MEE------IRFPR---- 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHH-cCC------CCCCC----
Confidence 45799999999999999999999999999999999999999964321 11111111 111 11111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRP-----FMNQVVM 850 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~ 850 (892)
.....+.+++.+|++.+|++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2234567999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=338.11 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=203.1
Q ss_pred hhhhhceecccccEEEEEEEEC-------CcEEEEEEccCCCc-hhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMA 652 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~ 652 (892)
...+.+.||+|+||.||+|+.. +..||||++..... ...+.+.+|+++++++. ||||++++++|.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 3445689999999999999862 23699999976533 33467899999999996 999999999999999999
Q ss_pred EEEEeccCCchhhhccccC-------------------------------------------------------------
Q 002688 653 LIYEYMANGNLEEHLSDSS------------------------------------------------------------- 671 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~------------------------------------------------------------- 671 (892)
+||||+++|+|.++|+...
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 9999999999998876421
Q ss_pred ---------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC
Q 002688 672 ---------------------------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF 718 (892)
Q Consensus 672 ---------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~ 718 (892)
...+++..+..++.|+++||+|||+. +|+||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCC
Confidence 12478889999999999999999998 999999999999999999
Q ss_pred cEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHH
Q 002688 719 QAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQW 797 (892)
Q Consensus 719 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~ 797 (892)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||.....+ ..+
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~--- 349 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF--- 349 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH---
Confidence 999999999987643322222233456788999999998899999999999999999997 88998743221 111
Q ss_pred HHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 798 VSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 798 ~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
...+..+. . +.. .......+.+++.+|++.+|++||++.+|+++|++++
T Consensus 350 -~~~~~~~~-~----~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 -YNKIKSGY-R----MAK----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -HHHHhcCC-C----CCC----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11121111 0 001 1123456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.04 Aligned_cols=251 Identities=28% Similarity=0.444 Sum_probs=203.1
Q ss_pred hhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 583 NNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
..+.+.||+|+||.||+|.. ++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+......+++|||+++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence 34557899999999999988 66789999986543 23568899999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....... .....
T Consensus 87 ~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 162 (261)
T cd05072 87 SLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTARE 162 (261)
T ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc-eeccC
Confidence 999999765555689999999999999999999998 99999999999999999999999999998753221 11122
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
...++..|+|||++....++.++||||||+++|||++ |+.||..... .....++ ..+... + ...
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~----~~~~~~----~-~~~--- 227 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSAL----QRGYRM----P-RME--- 227 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCC----C-CCC---
Confidence 3345678999999988889999999999999999998 9999864321 1122221 111110 1 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.....+.+++.+|+..+|++||+++++.+.|++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 -NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 123457799999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.06 Aligned_cols=252 Identities=28% Similarity=0.454 Sum_probs=207.8
Q ss_pred hhhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 582 TNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.+.||.|+||.||+|.. ++..+|+|.+.........++..|+++++.++|+||+++++++......++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 345668999999999999998 6788999999877665667899999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++....... ...
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--~~~ 161 (261)
T cd05148 87 GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLS 161 (261)
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc--ccc
Confidence 9999999876666689999999999999999999998 99999999999999999999999999998763221 112
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
....++..|+|||.+.+..++.++||||||++++||++ |+.||..... ....+. ....... ..
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~---~~~~~~~----------~~ 225 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQ---ITAGYRM----------PC 225 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH---HHhCCcC----------CC
Confidence 23445678999999988899999999999999999998 8999864331 111111 1111110 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 12334567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.34 Aligned_cols=236 Identities=25% Similarity=0.378 Sum_probs=191.8
Q ss_pred ecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 589 LGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 589 IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
||+|+||.||+++. +++.||+|++... .....+.+.+|++++.+++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999988 5778999998643 233446788999999999999999999999999999999999999999
Q ss_pred hhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccc
Q 002688 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743 (892)
Q Consensus 664 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 743 (892)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~ 153 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF 153 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence 99997643 389999999999999999999998 9999999999999999999999999998754222 1223456
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHH
Q 002688 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823 (892)
Q Consensus 744 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~ 823 (892)
.|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .. .+. ...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~-~~------~~~----~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQE-PL------RFP----DGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcC-CC------CCC----CcC
Confidence 78999999999999999999999999999999999999997432 22333332221 11 111 112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHH
Q 002688 824 VWKAVEIAMACVSSNANRRPFMNQV 848 (892)
Q Consensus 824 ~~~l~~l~~~Cl~~~P~~RPsm~eV 848 (892)
...+.+++.+|++.+|++||+..++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 2456789999999999999865433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.82 Aligned_cols=254 Identities=30% Similarity=0.486 Sum_probs=204.8
Q ss_pred HhhhhhceecccccEEEEEEEE-C------CcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL-D------NDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMA 652 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~-~------~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~ 652 (892)
.++.+.+.||+|+||.||+|+. + +..||||.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 3456678999999999999976 2 367999999766544 4578999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhccccC------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcE
Q 002688 653 LIYEYMANGNLEEHLSDSS------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQA 720 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~v 720 (892)
+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999986542 23488999999999999999999998 99999999999999999999
Q ss_pred EEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHH
Q 002688 721 KLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVS 799 (892)
Q Consensus 721 kl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~ 799 (892)
||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....+..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECI- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH-
Confidence 9999999876533222222233445778999999999999999999999999999998 9999864322 1122221
Q ss_pred hHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 800 SMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 800 ~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
..+..... .......+.+++.+|++.+|++||++.||++.|+
T Consensus 238 ---~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---TQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 12221110 1123356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.31 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=205.7
Q ss_pred hhhhceecccccEEEEEEEE-------CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
..+.+.||+|+||.||++.. ++..+|+|.+........+.+.+|++++++++|+||+++.+++......++||
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 34567899999999999974 23468999988766666678999999999999999999999999999999999
Q ss_pred EeccCCchhhhccccC-----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEee
Q 002688 656 EYMANGNLEEHLSDSS-----------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLAD 724 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~D 724 (892)
||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEecc
Confidence 9999999999986432 23489999999999999999999998 999999999999999999999999
Q ss_pred ecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhh
Q 002688 725 FGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLD 803 (892)
Q Consensus 725 fGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~ 803 (892)
||+++...............++..|+|||++.+..++.++||||||++++||++ |++||..... .+.... +.
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~------~~~~~~-i~ 236 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIEC-IT 236 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HH
Confidence 999986533222222223345778999999998899999999999999999998 8999864331 111111 12
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 804 KGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 804 ~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
.+.... ... .....+.+++.+|++.+|.+||++.+|++.|+++..
T Consensus 237 ~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 237 QGRVLQ-----RPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred cCCcCC-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 222111 111 123457899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.33 Aligned_cols=255 Identities=28% Similarity=0.462 Sum_probs=206.5
Q ss_pred hhhceecccccEEEEEEEE-------CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
.+.+.||+|+||.||+|+. ++..+++|.+........+.+.+|++.+++++|+||+++++++......++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE 87 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence 3457899999999999975 235689999887666666789999999999999999999999999999999999
Q ss_pred eccCCchhhhccccC--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEE
Q 002688 657 YMANGNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKL 722 (892)
Q Consensus 657 y~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl 722 (892)
|+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence 999999999986532 23489999999999999999999998 9999999999999999999999
Q ss_pred eeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhH
Q 002688 723 ADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSM 801 (892)
Q Consensus 723 ~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~ 801 (892)
+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+... .
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~-~ 237 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIE-C 237 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH-H
Confidence 99999976543322222334456788999999999999999999999999999999 9999864332 11111 1
Q ss_pred hhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 802 LDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 802 ~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
...+...+. .......+.+++.+|++.+|++||++++|+++|+++..
T Consensus 238 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 222221111 11233567899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.52 Aligned_cols=253 Identities=30% Similarity=0.495 Sum_probs=201.5
Q ss_pred hhhhceecccccEEEEEEEE------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
..+.+.||+|+||.||+|+. .+..||+|.+.... ....+++.+|++++++++|+||+++++++..+...++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 34568899999999999975 34689999997543 334467899999999999999999999999999999999
Q ss_pred EeccCCchhhhccccC---------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcE
Q 002688 656 EYMANGNLEEHLSDSS---------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQA 720 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~v 720 (892)
||+++|+|.+++.... ...+++...+.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 9999999999885321 23488999999999999999999998 99999999999999999999
Q ss_pred EEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHH
Q 002688 721 KLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVS 799 (892)
Q Consensus 721 kl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~ 799 (892)
||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..||..... ..+.+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~--- 237 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE--- 237 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---
Confidence 9999999987643332223334445678999999988889999999999999999998 9888864321 11112
Q ss_pred hHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 800 SMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 800 ~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.+....... .. ......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 238 -~~~~~~~~~-----~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 -MVRKRQLLP-----CS----EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHcCCcCC-----CC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 122111110 11 1223457789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.24 Aligned_cols=240 Identities=26% Similarity=0.373 Sum_probs=194.2
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
+.||+|+||.||+++. ++..||+|++... .......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999987 6889999998754 2233456788999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~ 153 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence 9998887543 489999999999999999999998 99999999999999999999999999987532211 1223
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......... +.. .+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~~~~-~~~------~~p~---- 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILM-EEI------RFPR---- 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CCC------CCCC----
Confidence 45689999999999999999999999999999999999999964321 111111111 111 1111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRP-----FMNQVVM 850 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~ 850 (892)
.....+.+++.+|++.+|++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1234567999999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=319.07 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=202.2
Q ss_pred hhceecccccEEEEEEEEC-------CcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 585 FERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
+.+.||+|+||.||+|+.. ...+++|.+..... ...+++.+|+++++.++||||+++++.+......++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4578999999999999862 24689998876543 345678999999999999999999999999999999999
Q ss_pred eccCCchhhhccccC----------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEE
Q 002688 657 YMANGNLEEHLSDSS----------------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI 714 (892)
Q Consensus 657 y~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl 714 (892)
|+.+|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 999999999875421 23488999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCcc
Q 002688 715 NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTH 793 (892)
Q Consensus 715 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~ 793 (892)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |+.||..... ..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~ 237 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---ER 237 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---HH
Confidence 9999999999999986543322222233445678999999988899999999999999999998 9999864321 11
Q ss_pred HHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 794 VAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 794 l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
+.+ ....+. .+.. .......+.+++.+|++.+|++||+++|+++.|++++.
T Consensus 238 ~~~----~~~~~~-----~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFN----LLKTGY-----RMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHH----HHhCCC-----CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 112 222111 0111 11233567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.46 Aligned_cols=247 Identities=26% Similarity=0.456 Sum_probs=198.5
Q ss_pred hhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 584 NFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
.+.+.||+|+||.||++.+ ++..+|+|.+.... ...+++.+|++++++++||||+++++++......++||||+++|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 4457899999999999988 55689999886443 234678999999999999999999999999999999999999999
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 742 (892)
|.++++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...... ......
T Consensus 86 L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05114 86 LLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSG 160 (256)
T ss_pred HHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc-eeccCC
Confidence 9999875433 489999999999999999999998 99999999999999999999999999987653221 111222
Q ss_pred ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 743 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.+..... +.. ...|..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~-~~~--~~~~~~------ 225 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISR-GFR--LYRPKL------ 225 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHC-CCC--CCCCCC------
Confidence 335568999999988889999999999999999999 8999864321 122222211 111 111111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L 852 (892)
....+.+++.+|++.+|++||+++++++.|
T Consensus 226 -~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 -ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 224678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.16 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=196.7
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+|+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 4567899999999999988 58899999986532 223456889999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 84 PGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999999997654 488999999999999999999998 9999999999999999999999999998865321
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....... +.. .+..
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~~~~~~i~~-~~~------~~~~- 219 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN------PFGIYEKILA-GKL------EFPR- 219 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHh-CCc------CCCc-
Confidence 123568999999999998889999999999999999999999997432 1222222221 111 1111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPF-----MNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eVl~~ 851 (892)
.....+.+++.+|++.||.+||+ ++|+++.
T Consensus 220 ---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 ---HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11335679999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=317.03 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=196.9
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|+||.||+++. +++.||||++.... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 4567899999999999998 57789999987542 2334678899999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
++.+..+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... ...
T Consensus 84 ~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (287)
T cd07848 84 KNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NAN 157 (287)
T ss_pred CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-ccc
Confidence 88776554332 3489999999999999999999998 99999999999999999999999999998763222 112
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHH---------HHHHhHhhcCCCccc
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVA---------QWVSSMLDKGDIRST 810 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~---------~~~~~~~~~~~~~~~ 810 (892)
.....|+..|+|||++.+..++.++|||||||++|||++|++||......+..... .+.............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23456899999999999889999999999999999999999999754321100000 000000001111111
Q ss_pred cCCCCCCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 811 VDPRLKGDF------DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 811 ~D~~l~~~~------~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+...... .......+.+++.+|++.+|++||+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111000 0112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=317.13 Aligned_cols=265 Identities=25% Similarity=0.360 Sum_probs=200.4
Q ss_pred hhhceecccccEEEEEEEE------CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecC--CcEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL------DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMALI 654 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~------~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~LV 654 (892)
.+.+.||+|+||+||.++. ++..||+|.+..... ...+.+.+|++++++++|+||+++.+++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4557899999999987653 567899999876533 3456788999999999999999999988653 458899
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
|||+++|+|.+++... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999998754 389999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCcc-ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 735 GGTH-VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 735 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
.... ......++..|+|||.+.+..++.++||||||++++||++|+.|+....... ..+..+.........+.+.++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhc
Confidence 2111 1122345667999999988889999999999999999999999976432110 0001000000000011111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
......+......+.+++.+|++.+|++||+++++++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111223446788999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=321.78 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=209.1
Q ss_pred HHhhhhhceecccccEEEEEEEE---------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecC
Q 002688 580 RMTNNFERVLGKGGFGTVYHGKL---------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG 648 (892)
Q Consensus 580 ~~t~~f~~~IG~G~fG~Vy~~~~---------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~ 648 (892)
...+.+.+.||+|+||.||+|+. ++..||+|.+.... ....+++.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 34445668999999999999974 23469999987543 34457789999999999 899999999999999
Q ss_pred CcEEEEEEeccCCchhhhccccC--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEE
Q 002688 649 TNMALIYEYMANGNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI 714 (892)
Q Consensus 649 ~~~~LV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl 714 (892)
...++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999987532 23578999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCcc
Q 002688 715 NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTH 793 (892)
Q Consensus 715 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~ 793 (892)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 9999999999999987643322222233445678999999998889999999999999999998 788875332
Q ss_pred HHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 002688 794 VAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAA 861 (892)
Q Consensus 794 l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e~~ 861 (892)
..++.... ..+.... ........+.+++.+|++.+|++||++.|+++.|++++.....
T Consensus 245 ~~~~~~~~-~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 245 VEELFKLL-KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred HHHHHHHH-HcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 22333222 2111110 0112345677899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=327.95 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=199.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+|+. +++.||||+++... ....+.+.+|++++..++|+||+++++++..+...++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 3557899999999999998 57899999987542 233456889999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 84 PGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 9999999997543 488999999999999999999998 999999999999999999999999999976532
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+............ -.|... .
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~--~~~~~~-~ 224 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP------NETWENLKYWKETL--QRPVYD-D 224 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH------HHHHHHHHhccccc--cCCCCC-c
Confidence 22345789999999999999999999999999999999999999975332 11111111110000 001110 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
........+.+++.+|+..+|++||++.++++.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 011234457789999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=339.56 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=202.3
Q ss_pred hhhhceecccccEEEEEEEE--C-CcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 583 NNFERVLGKGGFGTVYHGKL--D-NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+.+.||+|+||.||+|.. + +..||+|.+..........+.+|+++++.++||||+++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 45678999999999999976 3 57789998766555555678889999999999999999999999999999999999
Q ss_pred CCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 660 NGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 660 ~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+|+|.++|... ....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988643 234588999999999999999999998 9999999999999999999999999999876433222
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....... +... + .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~------~~~~~~~~~~-~~~~----~-~-- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS------QREIMQQVLY-GKYD----P-F-- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHh-CCCC----C-C--
Confidence 23445679999999999999999999999999999999999999996432 1222222221 1111 1 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.......+.+++.+|++.+|++||++.++++
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122345779999999999999999999875
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=317.69 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=200.0
Q ss_pred hhhhhceecccccEEEEEEEEC-------CcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~L 653 (892)
.+.+.+.||+|+||.||+|... +..||||++.... .....++.+|+.+++.++|+||+++++++..+...++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 3455688999999999998763 3579999986543 2344678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhccccC--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeee
Q 002688 654 IYEYMANGNLEEHLSDSS--------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADF 725 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~Df 725 (892)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCC
Confidence 999999999999986532 12368899999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhc
Q 002688 726 GLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDK 804 (892)
Q Consensus 726 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 804 (892)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... .+...... .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~~~~-~ 236 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLRFVM-E 236 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHH-c
Confidence 99876543222222222345678999999998899999999999999999999 6888864321 12221111 1
Q ss_pred CCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 805 GDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 805 ~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
+.... . .......+.+++.+|++.+|++||++.|+++.|++
T Consensus 237 ~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111 1 11233467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=326.80 Aligned_cols=195 Identities=26% Similarity=0.378 Sum_probs=170.6
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||+|+||.||+++. ++..+|+|.+.... ....+++.+|++++++++|+||+++++++..++..++||||+++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (331)
T cd06649 8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (331)
T ss_pred eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence 3457899999999999988 57789999987653 33456799999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 88 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~ 159 (331)
T cd06649 88 GSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 159 (331)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----cc
Confidence 99999997643 3889999999999999999999851 5999999999999999999999999998765321 12
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKS 786 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~ 786 (892)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 3456899999999999989999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=297.73 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=210.2
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCC-----cEEEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT-----NMALI 654 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~-----~~~LV 654 (892)
++.+.+.+|.|||+-||.++. +++-+|+|++...+.+..+..++|++..++++|||++++++++..+. +.+|+
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 456778999999999999875 88899999999888788889999999999999999999999885443 48999
Q ss_pred EEeccCCchhhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 655 YEYMANGNLEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
++|...|+|.+.+.... +..+++.+.+.|+.++++||++||+. .++++||||||.|||+.+.+.+++.|||.+...+
T Consensus 102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~ 180 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP 180 (302)
T ss_pred eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence 99999999999987654 44699999999999999999999997 4579999999999999999999999999987653
Q ss_pred CCCCc-------cccccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHh
Q 002688 733 VEGGT-------HVSTTIAGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSML 802 (892)
Q Consensus 733 ~~~~~-------~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~ 802 (892)
..-.. ........|..|+|||.+. +...++++|||||||+||+|+.|..||+...+.++. +.
T Consensus 181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-la------- 252 (302)
T KOG2345|consen 181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-LA------- 252 (302)
T ss_pred eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-EE-------
Confidence 21111 0112345688999999985 446789999999999999999999999865442211 11
Q ss_pred hcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 803 ~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
..+..+.+.-.-+......+.+++..|++.||.+||++.+++..++.++
T Consensus 253 -----LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 -----LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0111222222222235567889999999999999999999999998764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=328.43 Aligned_cols=242 Identities=24% Similarity=0.382 Sum_probs=196.7
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.+.+.||+|+||.||+|+. +++.||||.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 34568999999999999988 67889999986532 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 100 VVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred CCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999999997654 378899999999999999999998 9999999999999999999999999999865322
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... ..+... +..
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i-~~~~~~------~p~ 236 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKI-LAGRLK------FPN 236 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHH-hcCCcC------CCC
Confidence 1235689999999999999999999999999999999999999964321 1112221 122111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPF-----MNQVVME 851 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eVl~~ 851 (892)
.....+.+++.+|++.+|++||+ +++++..
T Consensus 237 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 ----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11234679999999999999997 6777643
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=321.43 Aligned_cols=262 Identities=29% Similarity=0.439 Sum_probs=206.4
Q ss_pred HHhhhhhceecccccEEEEEEEEC---------CcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecC
Q 002688 580 RMTNNFERVLGKGGFGTVYHGKLD---------NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG 648 (892)
Q Consensus 580 ~~t~~f~~~IG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~ 648 (892)
...+.+.+.||+|+||.||+++.. ...+|+|.+.... .....++..|+++++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 344566789999999999999752 2469999997643 34456788999999999 799999999999999
Q ss_pred CcEEEEEEeccCCchhhhccccC--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEE
Q 002688 649 TNMALIYEYMANGNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI 714 (892)
Q Consensus 649 ~~~~LV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl 714 (892)
...++||||+++|+|.+++.... ...+++..+++++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 99999999999999999997542 13489999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCcc
Q 002688 715 NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTH 793 (892)
Q Consensus 715 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~ 793 (892)
++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |++||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence 9999999999999876532221111122234568999999998889999999999999999998 888885322
Q ss_pred HHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhh
Q 002688 794 VAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEA 860 (892)
Q Consensus 794 l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e~ 860 (892)
..+.... +..+...+ ........+.+++.+|+..+|++||+|.+|++.|+++++...
T Consensus 248 ~~~~~~~-~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 248 VEELFKL-LKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHHHH-HHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 2222222 22221110 111233567789999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=300.61 Aligned_cols=230 Identities=27% Similarity=0.433 Sum_probs=191.5
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCCchhh---HHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGY---KQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~---~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.||.|+||+|..++. ++.-+|+|++.+...-.. +....|..+|+.+.||+++++.+.+.+..+.++||||+++
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 36899999999999887 788899999987644333 3457799999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|.|..+|++.++ ++......++.||+.||+|||+. +|++|||||+|||||++|.+||+|||.|+.+... .
T Consensus 129 GElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T 198 (355)
T KOG0616|consen 129 GELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----T 198 (355)
T ss_pred ccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-----E
Confidence 999999988655 99999999999999999999998 9999999999999999999999999999987422 3
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
-+.+||+.|+|||.++.+.+...+|.|||||++|||+.|.+||..... .+...+.+ ++++. ++
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~-~~~v~----------fP 261 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKIL-EGKVK----------FP 261 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHH-hCccc----------CC
Confidence 468999999999999999999999999999999999999999975432 12222222 22221 11
Q ss_pred HHHHHHHHHHHHHccccCCCCC
Q 002688 821 INSVWKAVEIAMACVSSNANRR 842 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~R 842 (892)
.--...+.+|+...++.|-.+|
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhh
Confidence 1112335577778888887777
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=338.80 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=209.9
Q ss_pred hhhhceecccccEEEEEEEE-CC-cEEEEEEccCCCchhhHHHHHHHHHHHhcc-ccceeeEeeEe-e----c--CCcEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL-DN-DEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-HRNLTTLVGYC-D----E--GTNMA 652 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~-~~-~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~-~----~--~~~~~ 652 (892)
..+++.|-+|||+.||.|.. .+ .++|+|++-..+....+...+|+++|++|. |+|||.+++.. . . ..+++
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34668999999999999998 44 899999988878888899999999999997 99999999933 1 1 24689
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
|.||||.+|.|-+++..+....|++.++++|+.++++|+++||. ++++|||||||.+||||+.++..||||||.|....
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 99999999999999987665569999999999999999999998 48899999999999999999999999999987543
Q ss_pred CCCCcc-cc------ccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHh
Q 002688 733 VEGGTH-VS------TTIAGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSML 802 (892)
Q Consensus 733 ~~~~~~-~~------~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~ 802 (892)
...... .. -..--|+.|+|||++. +...++|+|||+|||+||-|+....||+....
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------------- 263 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------------- 263 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------------
Confidence 222111 00 1223588999999984 66799999999999999999999999985421
Q ss_pred hcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 002688 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 803 ~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~ 858 (892)
..+++..+.-.........+.+||..||+.+|++||++-||+..+.++...
T Consensus 264 -----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 -----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 123333333222346677899999999999999999999999999987543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=325.99 Aligned_cols=241 Identities=25% Similarity=0.374 Sum_probs=195.7
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
+.||+|+||.||+++. +++.||||++... .....+.+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 6789999998754 2234467889999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 153 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK 153 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence 9998886543 489999999999999999999998 9999999999999999999999999998753221 11223
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +. ..+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~-~~------~~~p~---- 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILM-ED------IKFPR---- 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhcc-CC------ccCCC----
Confidence 45789999999999988999999999999999999999999964321 122222111 11 11111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRP-----FMNQVVME 851 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~~ 851 (892)
.....+.+++.+|++.+|++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1234567899999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=320.23 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=204.2
Q ss_pred hhhhhceecccccEEEEEEEE-------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMA 652 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~ 652 (892)
...+.+.||+|+||.||+++. ++..||||+++... ....+.+.+|+++++++ +|+||+++++++...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 345668999999999999974 23479999987653 33456789999999999 7999999999999999999
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+||||+.+|+|.++++......+++.++..++.|++.||+|||+. +++|+||||+|||++.++.+|++|||+++...
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 999999999999999765544589999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCcccc
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 811 (892)
............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .... .....+...
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~----~~~~~~~~~--- 263 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFY----KLIKEGYRM--- 263 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHH----HHHHcCCcC---
Confidence 3322222223345778999999998899999999999999999998 99998643321 1111 111111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.. .......+.+++.+|+..+|++||++.|+++.|+++
T Consensus 264 --~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 --AQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --CC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 011234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=315.77 Aligned_cols=252 Identities=24% Similarity=0.420 Sum_probs=199.1
Q ss_pred hhceecccccEEEEEEEE--CCc----EEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 585 FERVLGKGGFGTVYHGKL--DND----EVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~----~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.+.||+|+||.||+|++ +++ .+++|.+..... ....++..|+..+++++|+||+++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence 347899999999999988 444 478888764432 334678888999999999999999998864 557889999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 90 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 90 SPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred CCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 99999999997643 3489999999999999999999998 9999999999999999999999999999876433332
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
.......++..|+|||.+.++.++.++||||||+++|||++ |+.||..... ..+.++ +..+... ..+..
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~--~~~~~- 235 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDL----LEKGERL--AQPQI- 235 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCcC--CCCCC-
Confidence 33334557789999999998899999999999999999998 9999864321 112222 2222211 11111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
+...+.+++.+|+..+|++||++.|+++.|..+..
T Consensus 236 ------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 236 ------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 22356788999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=319.47 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=202.9
Q ss_pred hhhhceecccccEEEEEEEEC-------CcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~L 653 (892)
+.+.+.||+|+||.||++... ...+|+|.+.... .....++.+|++++.++ +|+||+++++++..++..++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 345578999999999999862 2579999987642 33446788999999999 89999999999999999999
Q ss_pred EEEeccCCchhhhcccc--------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCc
Q 002688 654 IYEYMANGNLEEHLSDS--------------SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQ 719 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~ 719 (892)
+|||+++|+|.++++.. ....+++..+++++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCe
Confidence 99999999999998642 234589999999999999999999998 9999999999999999999
Q ss_pred EEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHH
Q 002688 720 AKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWV 798 (892)
Q Consensus 720 vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~ 798 (892)
+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+..
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~ 244 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------EELF 244 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH------HHHH
Confidence 99999999987643322222223345678999999988899999999999999999998 8888864321 1111
Q ss_pred HhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 799 SSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 799 ~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
.....+... .........+.+++.+|+..+|++|||+.|+++.|++++
T Consensus 245 -~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 -KLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111110 111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=331.20 Aligned_cols=261 Identities=28% Similarity=0.402 Sum_probs=204.4
Q ss_pred HHHHhhhhhceecccccEEEEEEEEC-------CcEEEEEEccCCCc-hhhHHHHHHHHHHHhcc-ccceeeEeeEeecC
Q 002688 578 VLRMTNNFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEG 648 (892)
Q Consensus 578 l~~~t~~f~~~IG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~ 648 (892)
+......+.+.||+|+||.||+|++. +..||||+++.... ...+.+.+|++++.++. |+||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33444455689999999999999863 35799999976533 23457889999999997 99999999999999
Q ss_pred CcEEEEEEeccCCchhhhccccC---------------------------------------------------------
Q 002688 649 TNMALIYEYMANGNLEEHLSDSS--------------------------------------------------------- 671 (892)
Q Consensus 649 ~~~~LV~Ey~~~gsL~~~L~~~~--------------------------------------------------------- 671 (892)
...++|+||+++|+|.++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999986432
Q ss_pred ---------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccE
Q 002688 672 ---------------------------------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNI 712 (892)
Q Consensus 672 ---------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NI 712 (892)
...+++...++++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 12467888999999999999999988 999999999999
Q ss_pred EEcCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCC
Q 002688 713 LINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGH 791 (892)
Q Consensus 713 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~ 791 (892)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--- 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--- 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc---
Confidence 999999999999999986532222112223456788999999998889999999999999999998 8888864321
Q ss_pred ccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 792 THVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 792 ~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
.+.....+..+.. +.. +......+.+++.+|+..+|++||+++|+++.|++++
T Consensus 348 ---~~~~~~~~~~~~~-----~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 ---NEQFYNAIKRGYR-----MAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---hHHHHHHHHcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111122222211 001 1122356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.30 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=200.9
Q ss_pred hhhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 582 TNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.+.||+|+||.||+|.. ++..+|+|.+..... ..+.+.+|++++++++|+|++++++++.. ...+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK 84 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence 456678999999999999987 567899999876433 34678999999999999999999998854 567899999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.......+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||++..+..... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 160 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TAR 160 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc-ccc
Confidence 9999999765555689999999999999999999998 999999999999999999999999999987643221 111
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
....++..|+|||.+.+..++.++||||||++++||++ |++||..... .+.......... +. .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~------~~----~ 224 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYR------MP----C 224 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC------CC----C
Confidence 22335668999999988899999999999999999999 8889864321 111222111111 01 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.......+.+++.+|+..+|++|||++++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=317.36 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=201.9
Q ss_pred hhhhceecccccEEEEEEEEC-------CcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV 654 (892)
+.+.+.||+|+||.||+|+.. +..||||+++..... ..+.+.+|+.++..++|+||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 455678999999999999862 367999999865433 345688999999999999999999999999999999
Q ss_pred EEeccCCchhhhccccC--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcE
Q 002688 655 YEYMANGNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQA 720 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~v 720 (892)
+||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence 99999999999884221 23488999999999999999999998 99999999999999999999
Q ss_pred EEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHH
Q 002688 721 KLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVS 799 (892)
Q Consensus 721 kl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~ 799 (892)
||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..||.... ..++..
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~ 237 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------NQDVIE 237 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHH
Confidence 9999999886643322222233446778999999988889999999999999999998 888876432 122232
Q ss_pred hHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 800 SMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 800 ~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.... +... ....+....+.+++..|++.+|++||++++|++.|+.
T Consensus 238 ~i~~-~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRN-RQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHc-CCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2222 1111 1112234557799999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=312.62 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=202.4
Q ss_pred HhhhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
..+.+.+.||+|+||.||+|+. +...||+|+++.... ..+++.+|++++++++|+||+++++++.. ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 3456778999999999999988 445799999875432 34678999999999999999999998754 56789999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.+..... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence 99999999865555689999999999999999999998 999999999999999999999999999986643221 11
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.....++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+.... ...+. . . .
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~------~~~~~~-~~~~~-~----~----~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQ-VERGY-R----M----P 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh------HHHHHH-HhcCC-C----C----C
Confidence 223346678999999988899999999999999999999 8888864321 111111 11111 0 0 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
...+....+.+++.+|++.+|++||+++++++.|++..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 11234456789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.65 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=203.7
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+.||+|+.|.|-.|++ +|+.+|||++.+.. ......+++|+.+|+-+.|||++++++.+++..++|||.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 457899999999999998 89999999997652 2223568899999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|-|.++|-.+++ +...+..+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|..-.. ...
T Consensus 96 gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---gkl 167 (786)
T KOG0588|consen 96 GGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP---GKL 167 (786)
T ss_pred CchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC---Ccc
Confidence 9999999977654 89999999999999999999998 999999999999999999999999999986432 234
Q ss_pred cccccCCCCccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
-.+.||++.|.|||++++..|+ .++||||+||||+.|+||+.||++ +++.....+ ++.|.+.
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlK-V~~G~f~---------- 230 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLK-VQRGVFE---------- 230 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHH-HHcCccc----------
Confidence 4567999999999999999986 689999999999999999999973 334443333 2333221
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.+.....++.+|+.+|+..||+.|.|++||++.
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 011223346699999999999999999999984
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.79 Aligned_cols=252 Identities=26% Similarity=0.435 Sum_probs=199.5
Q ss_pred hhceecccccEEEEEEEE--CC---cEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCc------E
Q 002688 585 FERVLGKGGFGTVYHGKL--DN---DEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTN------M 651 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~---~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~------~ 651 (892)
+.+.||+|+||.||+|+. ++ ..||||+++... ......+.+|++.++.++|+||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 457899999999999987 22 579999987542 3345678999999999999999999998866554 7
Q ss_pred EEEEEeccCCchhhhcccc----CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecC
Q 002688 652 ALIYEYMANGNLEEHLSDS----SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGL 727 (892)
Q Consensus 652 ~LV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGl 727 (892)
++++||+++|+|..++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 9999999999999988543 234589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCC
Q 002688 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGD 806 (892)
Q Consensus 728 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 806 (892)
++.+.............++..|+|||.+.+..++.++||||||+++|||++ |.+||..... ..+.++. .. +.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~---~~-~~ 232 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL---RH-GN 232 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---Hc-CC
Confidence 987643332222222345678999999988889999999999999999999 8888864321 1122222 11 11
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 807 IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 807 ~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.. .. .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 ~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RL-----KQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC-----CC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 11 112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=317.52 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=195.0
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+.+.||+|+||.||+|+. ++..||+|.++.... .....+.+|++++++++|+||+++++++......++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 34457899999999999987 678999999875432 234567899999999999999999999999889999999998
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 87 ~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~ 159 (288)
T cd07871 87 S-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KT 159 (288)
T ss_pred c-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--cc
Confidence 5 8988886543 3478999999999999999999998 99999999999999999999999999987643221 12
Q ss_pred cccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh------------cCC
Q 002688 740 STTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD------------KGD 806 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~------------~~~ 806 (892)
.....+++.|+|||.+.+ ..++.++||||+||++|||++|++||......+ .......... ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE---ELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHHhhccccchh
Confidence 234467899999999875 568999999999999999999999997543211 1111111110 000
Q ss_pred CccccCCCCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 807 IRSTVDPRLKGDF----DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 807 ~~~~~D~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......+...... .........+++.+|++.+|++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111111000 0012345679999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.43 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=197.1
Q ss_pred hhceecccccEEEEEEEEC--Cc--EEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecC------CcEE
Q 002688 585 FERVLGKGGFGTVYHGKLD--ND--EVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG------TNMA 652 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~~--~~--~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~------~~~~ 652 (892)
+.+.||+|+||.||+|+.. +. .+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 4578999999999999883 22 5899988754 234456789999999999999999999987432 2478
Q ss_pred EEEEeccCCchhhhcccc----CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCc
Q 002688 653 LIYEYMANGNLEEHLSDS----SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLS 728 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla 728 (892)
+++||+++|+|.+++... ....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999887422 234589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCC
Q 002688 729 RVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDI 807 (892)
Q Consensus 729 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 807 (892)
+.+.............++..|+|||...+..++.++||||||+++|||++ |+.||..... .+... .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~-~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------SEIYD-YLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH-HHHcCCC
Confidence 87643322112223345678999999998899999999999999999999 7888864221 11111 2222221
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 808 RSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 808 ~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.. . .......+.+++.+|++.+|++||++.++++.|+++
T Consensus 233 ~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 0 112234578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.89 Aligned_cols=253 Identities=27% Similarity=0.446 Sum_probs=201.7
Q ss_pred hhhceecccccEEEEEEEE--CCc---EEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DND---EVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~---~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
...+.||+|+||.||+|+. +++ .+|+|.+.... ....+++..|++++++++|+|++++.+++...+..++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 3457899999999999987 333 69999987653 33456789999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 88 MENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999997643 3489999999999999999999998 9999999999999999999999999998866432211
Q ss_pred cc-cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 738 HV-STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 738 ~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
.. ......+..|+|||++....++.++||||||+++|||++ |+.||..... .++.......... |
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~~~~~-----~-- 230 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAINDGFRL-----P-- 230 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhcCCCC-----C--
Confidence 11 111223457999999988889999999999999999998 9999864321 1222222111111 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
...+....+.+++.+|++.+|++||+|.+|++.|++++
T Consensus 231 ---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 231 ---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11123456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=330.27 Aligned_cols=237 Identities=27% Similarity=0.441 Sum_probs=197.3
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.|.++||+|.||+|+.+.+ +++.+|||++++.. ....+..+.|..++... +||.++.++.++...+++++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 3568999999999999988 67789999998863 34456677788777766 599999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+.||++..+.+.. .++.....-++..++.||+|||++ +|||||||-+|||||.+|.+||+||||++.-. ...
T Consensus 451 ~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g 522 (694)
T KOG0694|consen 451 VAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQG 522 (694)
T ss_pred cCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC--CCC
Confidence 9999965555433 399999999999999999999999 99999999999999999999999999998643 233
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
....+.+||+.|||||++.+..|+..+|.|||||+||||+.|+.||.+.++++ ....++.. |+.
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d-------~~~--- 586 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVND-------EVR--- 586 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcC-------CCC---
Confidence 45678999999999999999999999999999999999999999998765432 11121111 122
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFM 845 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm 845 (892)
|+.-...+.+.++++++..+|++|..+
T Consensus 587 -yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 -YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCcccHHHHHHHHHHhccCcccccCC
Confidence 233445667899999999999999987
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=316.47 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=199.1
Q ss_pred hhhceecccccEEEEEEEE------CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeec--CCcEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL------DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE--GTNMALIY 655 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~--~~~~~LV~ 655 (892)
.+.+.||+|+||.||++.. ++..||+|.+........+.+.+|++++++++|+||+++.+++.. ....++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 4557899999999999874 467899999987766667789999999999999999999998753 34689999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 87 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 87 EYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999997543 2489999999999999999999998 99999999999999999999999999998764332
Q ss_pred Cccc-cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccC---------CCccHHHHHHhHhhcC
Q 002688 736 GTHV-STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAEN---------GHTHVAQWVSSMLDKG 805 (892)
Q Consensus 736 ~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~---------~~~~l~~~~~~~~~~~ 805 (892)
.... .....++..|+|||++.+..++.++||||||++++||++|..++...... ...............+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 2111 11222345699999999889999999999999999999987665322110 0000001111111111
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 806 DIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 806 ~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.. + .........+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 243 ~~-------~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 243 GR-------L--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred Cc-------C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 0 01112335678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.80 Aligned_cols=247 Identities=28% Similarity=0.462 Sum_probs=204.4
Q ss_pred hhhhceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 583 NNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
..+.+.||+|+||.||+|...++.||||.+..... ..+++.+|+.++++++|+||+++++++......++||||+++++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred ccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 34567999999999999999999999999976644 56789999999999999999999999998899999999999999
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 742 (892)
|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||.++...... ..
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~ 158 (256)
T cd05039 87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DS 158 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc-----cc
Confidence 99999876655699999999999999999999998 99999999999999999999999999998652211 12
Q ss_pred ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 743 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
...+..|+|||++.+..++.++||||||++++||++ |+.||..... ..+ ...+..+... .. ..
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~~-----~~----~~ 222 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDV----VPHVEKGYRM-----EA----PE 222 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHhcCCCC-----CC----cc
Confidence 334568999999988899999999999999999997 9999864321 111 1112111110 01 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.....+.+++.+|+..+|++||++.|++++|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 223567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=318.22 Aligned_cols=258 Identities=22% Similarity=0.361 Sum_probs=192.4
Q ss_pred hhhhceecccccEEEEEEEE---CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhc---cccceeeEeeEee-----cCC
Q 002688 583 NNFERVLGKGGFGTVYHGKL---DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRV---HHRNLTTLVGYCD-----EGT 649 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~---~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~NIv~l~g~~~-----~~~ 649 (892)
+.+.+.||+|+||.||+|+. ++..||||.++.... .....+.+|+++++.+ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 34567899999999999986 357899999865422 2234566777777665 6999999999885 345
Q ss_pred cEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcc
Q 002688 650 NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~ 729 (892)
..++||||++ ++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999997 5899998766555689999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh---cCC
Q 002688 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD---KGD 806 (892)
Q Consensus 730 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~ 806 (892)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|++||...... .....+..... ...
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEED 232 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChhh
Confidence 65322 2233456899999999998889999999999999999999999999754321 11111111110 000
Q ss_pred C-------ccccCCCCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 807 I-------RSTVDPRLKGD---FDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 807 ~-------~~~~D~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
. ...+.+.-... ...+....+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 00011100000 00112345679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=321.97 Aligned_cols=241 Identities=30% Similarity=0.457 Sum_probs=203.3
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
+.||+|.||.||||.. .++.||+|++.-.. ....++..+|+.++..++|+||.+++|.+..+..++++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 6899999999999988 67889999997653 33457889999999999999999999999999999999999999999
Q ss_pred hhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccc
Q 002688 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743 (892)
Q Consensus 664 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 743 (892)
.+.|+.... +++....-|.++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+.... ......
T Consensus 99 ~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr~tf 171 (467)
T KOG0201|consen 99 LDLLKSGNI--LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--KRRKTF 171 (467)
T ss_pred hhhhccCCC--CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh--hccccc
Confidence 999987542 47778888999999999999999 99999999999999999999999999998764332 223577
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHH
Q 002688 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823 (892)
Q Consensus 744 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~ 823 (892)
+||+.|||||++....|+.|+||||||++.+||.+|.+|+........ + -.+.+.--|.+.+ ..
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------l--flIpk~~PP~L~~----~~ 235 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------L--FLIPKSAPPRLDG----DF 235 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------E--EeccCCCCCcccc----cc
Confidence 899999999999988999999999999999999999999975443110 0 0112223344444 33
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 824 VWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 824 ~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
...+.+++..|+..+|+.||++.++++
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 455779999999999999999999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.12 Aligned_cols=238 Identities=24% Similarity=0.382 Sum_probs=193.3
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCchh---hHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQG---YKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~---~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
++||+|+||.||.++- +|..+|+|++++..... .+-...|-.+|...+++.||+|+..|.+.+++||||||++||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 6899999999999976 78899999998875433 345678999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC-------
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE------- 734 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~------- 734 (892)
++..+|.... .|+......++.+++.|++-||+. |+|||||||+|+|||..|++||+||||+..+...
T Consensus 227 D~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 227 DMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred cHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 9999997654 489999999999999999999999 9999999999999999999999999998654210
Q ss_pred ---------------CCcc----c-------------------cccccCCCCccCccccccCCCCchhhHHHHHHHHHHH
Q 002688 735 ---------------GGTH----V-------------------STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEI 776 (892)
Q Consensus 735 ---------------~~~~----~-------------------~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~EL 776 (892)
+... . ....+||+-|||||++.+..|+..+|.||||||||||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 0000 0 0135799999999999999999999999999999999
Q ss_pred HhCCCCCCccccCC-CccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 002688 777 ITGHPVISKSAENG-HTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPF 844 (892)
Q Consensus 777 ltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs 844 (892)
+.|.|||....... -..+..|........ +.+...+..+|+.+|+. ||++|-.
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999998654321 223334432221111 11222556789999999 9999986
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.64 Aligned_cols=247 Identities=22% Similarity=0.372 Sum_probs=196.2
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+++. +++.||+|.++.. .....+.+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 6788999998754 223345677888888777 799999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence 99998886543 489999999999999999999998 99999999999999999999999999987532211 122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccC--CCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAEN--GHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... .......+....+...... +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------~p-- 225 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------IP-- 225 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC------CC--
Confidence 3457899999999999999999999999999999999999999643211 1122334444433332221 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPF------MNQVVM 850 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPs------m~eVl~ 850 (892)
......+.+++.+|++.+|++||+ +.++++
T Consensus 226 --~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 226 --RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred --CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 122345679999999999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.15 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=196.4
Q ss_pred ecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 589 LGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 589 IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
||+|+||.||+++. +++.+|+|.+.... ....+.+..|++++++++||||+++.+++..+.+.++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999987 68899999986432 12234566799999999999999999999999999999999999999
Q ss_pred hhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccc
Q 002688 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743 (892)
Q Consensus 664 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 743 (892)
.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 9988766555689999999999999999999998 9999999999999999999999999998765322 122345
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHH
Q 002688 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823 (892)
Q Consensus 744 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~ 823 (892)
.|+..|+|||++.+..++.++|||||||++|||++|+.||....+.. ...+....... .... ... ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~-~~~~------~~~---~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE-DEVK------FEH---QNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc-cccc------ccc---ccC
Confidence 68899999999998889999999999999999999999997433211 11122222111 1110 000 012
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 824 VWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 824 ~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
...+.+++.+|++.+|++||+++|+++.+..
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 3356799999999999999999887654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.22 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=199.6
Q ss_pred hhhhhceecccccEEEEEEEECC----------------cEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeE
Q 002688 582 TNNFERVLGKGGFGTVYHGKLDN----------------DEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGY 644 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~~~----------------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~ 644 (892)
.+.+.+.||+|+||.||++...+ ..||+|.++... ......|.+|++++++++|+|+++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 45566889999999999986521 248999987653 3345679999999999999999999999
Q ss_pred eecCCcEEEEEEeccCCchhhhccccC----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEE
Q 002688 645 CDEGTNMALIYEYMANGNLEEHLSDSS----------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI 714 (892)
Q Consensus 645 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl 714 (892)
+......++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill 162 (295)
T cd05097 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLV 162 (295)
T ss_pred EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEE
Confidence 999999999999999999999986432 12378999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCccccCCCc
Q 002688 715 NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT--GHPVISKSAENGHT 792 (892)
Q Consensus 715 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt--G~~p~~~~~~~~~~ 792 (892)
++++.+||+|||++................++..|+|||++.+..++.++||||||++++||++ |..||..... .
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---~ 239 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---E 239 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---H
Confidence 9999999999999976543322222223345678999999998899999999999999999998 5566654321 1
Q ss_pred cHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 793 HVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 793 ~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
...+............... ..+......+.+++.+|++.+|++||+|.+|++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111111100000 0011123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.84 Aligned_cols=255 Identities=29% Similarity=0.420 Sum_probs=205.1
Q ss_pred HHHHhhhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 578 VLRMTNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 578 l~~~t~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
+.+..+++.++||+|+||.||+|.. +++.||+|.+..... ...++.+|++++++++|+|++++.+++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4456677788999999999999988 778999999876543 3467899999999999999999999874 457899999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
|+++|+|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE- 156 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence 99999999998766555689999999999999999999998 99999999999999999999999999997664221
Q ss_pred ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
........++..|+|||++.+..++.++||||||++++||++ |++||..... ..+.+ .. ..+.. +..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~---~~-~~~~~-----~~~ 224 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQ---NL-ERGYR-----MPR 224 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHH---HH-HcCCC-----CCC
Confidence 112223345678999999988889999999999999999999 9999974321 11111 11 11110 011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
. ......+.+++.+|+..+|++||++++++..|+.
T Consensus 225 ~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 P----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 1123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.09 Aligned_cols=198 Identities=25% Similarity=0.365 Sum_probs=171.7
Q ss_pred HhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
..+++.+.||+|+||.||++.. ++..+|+|.+.... ....+++.+|++++++++|+||+++++++..+++.++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 3455668899999999999988 57789999887643 33446789999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++.... .+++.....++.+++.||+|||+. .+++||||||+|||+++++.+||+|||++..+...
T Consensus 85 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 85 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 99999999997643 388999999999999999999974 16999999999999999999999999998765321
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKS 786 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~ 786 (892)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123456889999999999888999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.80 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=197.5
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
++||+|+||.||+++. +++.||||+++... ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999988 67899999997532 23345678899999888 799999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence 99998886543 489999999999999999999998 9999999999999999999999999998753211 1122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCC--CccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENG--HTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
....|+..|+|||++.+..++.++|||||||++|||++|+.||+...... .....++..+.+..+... +..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~p~- 226 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IPR- 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------CCC-
Confidence 34678999999999999999999999999999999999999997432211 222334444444333221 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPF------MNQVVM 850 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPs------m~eVl~ 850 (892)
.....+.+++.+|++.+|++||+ ++++++
T Consensus 227 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 ---SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12345679999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.85 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=205.7
Q ss_pred HHhhhhhceecccccEEEEEEEE-C-----CcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeec-CCcE
Q 002688 580 RMTNNFERVLGKGGFGTVYHGKL-D-----NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE-GTNM 651 (892)
Q Consensus 580 ~~t~~f~~~IG~G~fG~Vy~~~~-~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~-~~~~ 651 (892)
+..+.+.+.||+|+||.||+|.. + +..|++|++.... ....+.+.+|++++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 34455678999999999999987 3 4789999987543 3345678899999999999999999998866 4678
Q ss_pred EEEEEeccCCchhhhccccCc------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeee
Q 002688 652 ALIYEYMANGNLEEHLSDSSK------EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADF 725 (892)
Q Consensus 652 ~LV~Ey~~~gsL~~~L~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~Df 725 (892)
++++||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999865431 4589999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhc
Q 002688 726 GLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDK 804 (892)
Q Consensus 726 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 804 (892)
|+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+..+.. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK---DG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH---cC
Confidence 99987643332222233456778999999988889999999999999999999 9999864321 12222221 11
Q ss_pred CCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 805 GDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 805 ~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
.... . .......+.+++.+|+..+|++||++.++++.|+++..
T Consensus 236 ~~~~------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YRLA------Q----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCC------C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111 0 11123467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=323.54 Aligned_cols=243 Identities=25% Similarity=0.355 Sum_probs=190.3
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
+.+.||+|+||.||+|+. +++.||||++..... ...+.+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 346899999999999988 678999999865433 34567899999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+.. ...+..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.... ....
T Consensus 158 ~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 226 (353)
T PLN00034 158 SLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCN 226 (353)
T ss_pred cccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cccc
Confidence 986543 256677889999999999999998 99999999999999999999999999998753221 1223
Q ss_pred cccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 742 TIAGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
...|+..|+|||++.. ...+.++|||||||++|||++|+.||...... ............ . .+..
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~-~-----~~~~- 296 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWASLMCAICMS-Q-----PPEA- 296 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHhcc-C-----CCCC-
Confidence 4568999999998743 23456899999999999999999999733221 111111111110 0 0111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.......+.+++.+|++.+|++||++.|+++.
T Consensus 297 ---~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 ---PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223457799999999999999999999874
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.50 Aligned_cols=251 Identities=28% Similarity=0.449 Sum_probs=201.4
Q ss_pred hhhceecccccEEEEEEEE-------CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
.+.+.||+|+||.||++.. ++..+|+|.+........+.+.+|+++++.++|+||+++++++..+...++++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 3467899999999999964 355799999887766667789999999999999999999999999999999999
Q ss_pred eccCCchhhhccccCc-------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEe
Q 002688 657 YMANGNLEEHLSDSSK-------------EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLA 723 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~ 723 (892)
|+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence 9999999999865431 3489999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHh
Q 002688 724 DFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSML 802 (892)
Q Consensus 724 DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~ 802 (892)
|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |++||..... .+......
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~ 238 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------TEAIECIT 238 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH------HHHHHHHH
Confidence 9999876533222122223345678999999999999999999999999999998 8999864321 11111111
Q ss_pred hcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 803 ~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
.+... .. .......+.+++.+|++.+|++||++.||++.|+
T Consensus 239 -~~~~~-----~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 -QGREL-----ER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -cCccC-----CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11110 00 1122345779999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=325.83 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=195.7
Q ss_pred hhhhceecccccEEEEEEEE--C-CcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--D-NDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~-~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
+.+.+.||+|+||.||+|+. . +..||+|++... .....+.+.+|+++++.++||||+++++++......++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 45568999999999999986 2 357999998643 22334568899999999999999999999999999999999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 y~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999999997654 389999999999999999999998 9999999999999999999999999999865321
Q ss_pred ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
.....||+.|+|||++.+..++.++|||||||++|||++|++||..... ...... +..+... +.
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~-i~~~~~~------~p 248 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------LLIYQK-ILEGIIY------FP 248 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------HHHHHH-HhcCCCC------CC
Confidence 2345789999999999988899999999999999999999999974321 111111 2122111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRP-----FMNQVVME 851 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~~ 851 (892)
.. ....+.+++.+|++.+|++|+ +++++++.
T Consensus 249 ~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 KF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11 123456899999999999995 78887764
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.40 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=201.8
Q ss_pred hhhhceecccccEEEEEEEE--CC---cEEEEEEccCC-CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DN---DEVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~---~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
.++.+.||+|+||.||+|+. ++ ..||||.+... .....++|..|+.++++++||||+++.+++..+...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 45678999999999999987 33 35999998765 33445789999999999999999999999999999999999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
|+++|+|.+++....+ .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 86 FMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred cCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 9999999999876543 489999999999999999999998 999999999999999999999999999876543222
Q ss_pred cccccc-cc--CCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccC
Q 002688 737 THVSTT-IA--GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 737 ~~~~~~-~~--gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D 812 (892)
...... .. .+..|+|||++.+..++.++||||||+++|||++ |+.||..... ....+++.. .....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~---~~~~~---- 231 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQ---DYRLP---- 231 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHc---CCcCC----
Confidence 111111 11 2357999999998999999999999999999986 9999864321 122233211 10000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 813 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
...+....+.+++.+|++.+|++||++.+|++.|+++
T Consensus 232 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112345577999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.18 Aligned_cols=246 Identities=23% Similarity=0.398 Sum_probs=195.7
Q ss_pred eecccccEEEEEEEE----CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 588 VLGKGGFGTVYHGKL----DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~----~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
.||+|+||.||+|.+ ++..+|+|+++... ....+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 46789999986543 234567899999999999999999999885 45678999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc-cc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH-VS 740 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~-~~ 740 (892)
+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999987543 489999999999999999999998 99999999999999999999999999998764332211 11
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
....++..|+|||.+....++.++||||||+++|||++ |++||..... .++... +..+... ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~-i~~~~~~-----~~~--- 220 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------NEVTQM-IESGERM-----ECP--- 220 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HHCCCCC-----CCC---
Confidence 22334578999999988889999999999999999998 9999974321 122222 2222211 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
......+.+++.+|++.+|++||++.+|.+.|++.
T Consensus 221 -~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 -QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 12334577999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.52 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=203.4
Q ss_pred hhhhhceecccccEEEEEEEECC------------------cEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEe
Q 002688 582 TNNFERVLGKGGFGTVYHGKLDN------------------DEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLV 642 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~~~------------------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~ 642 (892)
.+.+.+.||+|+||.||+|+... ..||+|.+.... ....+++.+|++++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34556899999999999987622 458999987654 33457889999999999999999999
Q ss_pred eEeecCCcEEEEEEeccCCchhhhccccC---------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEE
Q 002688 643 GYCDEGTNMALIYEYMANGNLEEHLSDSS---------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNIL 713 (892)
Q Consensus 643 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NIL 713 (892)
+++..+...++++||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence 99999999999999999999999986543 12589999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCccccCCC
Q 002688 714 INEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT--GHPVISKSAENGH 791 (892)
Q Consensus 714 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt--G~~p~~~~~~~~~ 791 (892)
+++++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.... .
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---~ 239 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---D 239 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC---h
Confidence 99999999999999886543332222334456778999999988899999999999999999998 667775322 1
Q ss_pred ccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 792 THVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 792 ~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
....................+ ........+.+++.+|++.+|++||++.|+++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 122222222221111111111 11123356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.90 Aligned_cols=248 Identities=28% Similarity=0.446 Sum_probs=197.6
Q ss_pred hhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 583 NNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
..+.+.||+|+||.||+|+. ++..+|+|.+..... ...++.+|++++++++|+||+++++++......++|+||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 34567899999999999988 556899999865432 2357889999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..... ......
T Consensus 85 ~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~-~~~~~~ 159 (256)
T cd05059 85 CLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSSQ 159 (256)
T ss_pred CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc-cccccC
Confidence 99999976443 589999999999999999999998 9999999999999999999999999998765321 111111
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .... .. +..+ ..+.. .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~---~~-~~~~-----~~~~~----~ 223 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVV---ES-VSAG-----YRLYR----P 223 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHH---HH-HHcC-----CcCCC----C
Confidence 2234457999999998899999999999999999999 7998864322 1111 11 1111 01111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L 852 (892)
......+.+++.+|+..+|++||++.|++++|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12345688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.02 Aligned_cols=240 Identities=29% Similarity=0.449 Sum_probs=193.3
Q ss_pred ceecccccEEEEEEEE-----CCcEEEEEEccCCC----chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 587 RVLGKGGFGTVYHGKL-----DNDEVAVKMLSPSS----SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.||+|+||.||+++. +++.||||+++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 46789999987531 22335678899999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++.... .+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 99999999987543 378888899999999999999998 99999999999999999999999999987542221
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +.. .+.+
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~-~~~--~~~~---- 221 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILK-GKL--NLPP---- 221 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHc-CCC--CCCC----
Confidence 122345689999999999988899999999999999999999999974321 122222221 111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRP-----FMNQVVM 850 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~ 850 (892)
.....+.+++.+|++.+|++|| ++.++++
T Consensus 222 ----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 ----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1224567999999999999999 7887766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=324.55 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=193.2
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecC-----CcEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG-----TNMALI 654 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~-----~~~~LV 654 (892)
.+.+.||+|+||.||+|+. ++..||||++... ......++.+|++++++++||||+++++++... ...++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 4567899999999999987 6789999998743 223445788999999999999999999988543 248999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
|||+. ++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 83 FELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 99995 68988887543 389999999999999999999998 9999999999999999999999999999865322
Q ss_pred CCc-cccccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh--------
Q 002688 735 GGT-HVSTTIAGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD-------- 803 (892)
Q Consensus 735 ~~~-~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~-------- 803 (892)
... .......|+..|+|||++.+ ..++.++|||||||++|||++|++||...... .....+.....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV---HQLDLITDLLGTPSPETIS 233 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCCHHHHH
Confidence 211 12234568999999999875 67899999999999999999999999753311 00111111000
Q ss_pred ---cCCCccc---cCCCCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 804 ---KGDIRST---VDPRLKGDFD---INSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 804 ---~~~~~~~---~D~~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.....+. +.+....... ......+.+++.+|++.+|++||+++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 0000000000 0122456799999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=305.80 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=197.2
Q ss_pred ceecccccEEEEEEEE-CCcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
++||+|+||.||+|.. +++.+|+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4689999999999987 6788999998765433 3356889999999999999999999999999999999999999999
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
+++.... ..+++..+..++.+++.+|.|||+. +++||||||+||++++++.+||+|||++....... ........
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQ 155 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCC
Confidence 9987543 3489999999999999999999998 99999999999999999999999999987542211 11112223
Q ss_pred CCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHH
Q 002688 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823 (892)
Q Consensus 745 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~ 823 (892)
++..|+|||++.+..++.++||||||+++|||++ |+.||..... .. ....+..+... . .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------~~-~~~~~~~~~~~-----~----~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN------QQ-AREQVEKGYRM-----S----CPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------HH-HHHHHHcCCCC-----C----CCCCC
Confidence 4568999999998899999999999999999998 9999864321 11 11111111110 0 11123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 824 VWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 824 ~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
...+.+++.+|+..+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.34 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=202.6
Q ss_pred hhhhhceecccccEEEEEEEEC-------CcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~L 653 (892)
.+.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+++++.++|+||+++++++..+...++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 3445678999999999999873 2579999987553 2345678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhccccC--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeee
Q 002688 654 IYEYMANGNLEEHLSDSS--------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADF 725 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~Df 725 (892)
||||+++|+|.+++.... ...++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCc
Confidence 999999999999986532 22478999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhc
Q 002688 726 GLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDK 804 (892)
Q Consensus 726 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 804 (892)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.++. ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~----~~ 236 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFV----ID 236 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHH----hc
Confidence 99986643332222334456789999999988889999999999999999998 8998864321 1122221 11
Q ss_pred CCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 805 GDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 805 ~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
+... ... ......+.+++.+|++.+|++|||+.++++.|+
T Consensus 237 ~~~~-----~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHL-----DLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCC-----CCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111 111 122456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.88 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=197.5
Q ss_pred hhhceecccccEEEEEEEEC-------CcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
.+.+.||+|++|.||+|... +..||+|.+.... ......|.+|+.++++++|+||+++++++.+....++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 34578999999999999883 3578999887543 334467899999999999999999999999888999999
Q ss_pred EeccCCchhhhccccCc-----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC---cEEEeeecC
Q 002688 656 EYMANGNLEEHLSDSSK-----EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF---QAKLADFGL 727 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~---~vkl~DfGl 727 (892)
||+++++|.+++..... ..++|..++.++.|++.||+|||+. +++||||||+||+++.++ .+||+|||+
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcc
Confidence 99999999999876431 3589999999999999999999998 999999999999998754 599999999
Q ss_pred cccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCC
Q 002688 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGD 806 (892)
Q Consensus 728 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 806 (892)
++................+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~ 239 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN------QEVMEFVTGGGR 239 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCCc
Confidence 987632221111122233568999999998999999999999999999997 9999874322 111111111111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 807 IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 807 ~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
. .........+.+++.+|++.+|++||++.+|++.|+
T Consensus 240 ~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 L----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 011122356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.89 Aligned_cols=248 Identities=27% Similarity=0.442 Sum_probs=198.6
Q ss_pred hhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 584 NFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
.+.+.||+|+||.||+|+. ++..+|||.+..... ..+++.+|++++.+++||||+++++++......++||||+.+|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 4567899999999999988 445699999875432 34678999999999999999999999998889999999999999
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 742 (892)
|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++...... ......
T Consensus 86 l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05113 86 LLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVG 160 (256)
T ss_pred HHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeecCC
Confidence 9999876443 589999999999999999999998 99999999999999999999999999988653321 111222
Q ss_pred ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 743 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... .......... ... .
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~---~~~~~~~~~~------~~~----~ 224 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SET---VEKVSQGLRL------YRP----H 224 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHH---HHHHhcCCCC------CCC----C
Confidence 345678999999988889999999999999999999 9999864321 111 1111111110 000 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
.....+.+++.+|++.+|++||++.++++.|+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12356789999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=306.48 Aligned_cols=252 Identities=27% Similarity=0.359 Sum_probs=192.5
Q ss_pred ceecccccEEEEEEEEC----CcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 587 RVLGKGGFGTVYHGKLD----NDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~----~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
+.||+|+||.||+|+.. +..+|+|.++.... .....+.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999862 34699999876543 34457889999999999999999999999989999999999999
Q ss_pred chhhhccccC---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 662 NLEEHLSDSS---KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 662 sL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
+|.+++.... ....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987533 22467888889999999999999998 99999999999999999999999999987543222222
Q ss_pred ccccccCCCCccCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccc
Q 002688 739 VSTTIAGTPGYLDPEYYISN-------RLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRST 810 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 810 (892)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||...... ....+ ... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHH---Hhh-cccCCC
Confidence 22344577889999998642 35789999999999999996 99999643321 11111 111 111122
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 811 ~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
.++.+... ....+.+++.+|+ .+|++||+++||++.|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22332211 2234567888998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=324.22 Aligned_cols=241 Identities=25% Similarity=0.367 Sum_probs=194.2
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
+.||+|+||.||+++. ++..||+|.+... .......+..|++++..++|+||+++.+++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 7789999998753 2233456788999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
+|..++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM 153 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence 9999886543 48999999999999999999997 5 89999999999999999999999999987532211 122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+...... .+.. .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~~~~~~i~-~~~~------~~p~--- 217 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELIL-MEEI------RFPR--- 217 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH------HHHHHHHh-cCCC------CCCC---
Confidence 345689999999999999999999999999999999999999964321 11111111 1111 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRP-----FMNQVVME 851 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~~ 851 (892)
.....+.+++.+|++.+|++|+ ++.++++.
T Consensus 218 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 -TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1224567899999999999996 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.53 Aligned_cols=247 Identities=28% Similarity=0.431 Sum_probs=200.9
Q ss_pred hhhhceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEee-cCCcEEEEEEeccCC
Q 002688 583 NNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD-EGTNMALIYEYMANG 661 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~-~~~~~~LV~Ey~~~g 661 (892)
+.+.+.||+|+||.||++...+..+|+|.++... ..+.+.+|+.++++++|+|++++++++. .+...++++||+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred CeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 4456899999999999999999999999986543 3467899999999999999999999764 556789999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++.......+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...... .
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~ 157 (256)
T cd05082 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 157 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-----C
Confidence 999999876655689999999999999999999998 99999999999999999999999999987643211 2
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
...++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+..... ..+... .. .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~------~~~~~~~~~-~~~~~~-----~~----~ 221 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRV-EKGYKM-----DA----P 221 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHH-hcCCCC-----CC----C
Confidence 2334568999999988899999999999999999998 99988632 222222222 111111 11 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
......+.+++.+|++.+|++||++.++++.|+++
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 12345677999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=311.93 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=199.3
Q ss_pred hhhceecccccEEEEEEEE--CCc----EEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DND----EVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~----~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
.+.+.||+|+||.||+|++ ++. .||+|.+.... ....+++.+|+.++..++|+||+++++++.. ...++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence 3457899999999999986 444 48999987543 3345678899999999999999999999975 45779999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.+.....
T Consensus 89 ~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 89 LMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999997643 3489999999999999999999998 999999999999999999999999999987643222
Q ss_pred ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
........++..|+|||...+..++.++||||||+++|||++ |++||..... ..+..++. .+.... .
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~----~~~~~~-----~ 232 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLE----KGERLP-----Q 232 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CCCcCC-----C
Confidence 212222345678999999998899999999999999999998 8998864321 12222222 111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
.......+.+++.+|++.+|++||++.++++.|+++.
T Consensus 233 ----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 233 ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1123346779999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=306.55 Aligned_cols=247 Identities=25% Similarity=0.409 Sum_probs=202.7
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|++|.||+|+. +++.|++|.+... .....+++.+|++++++++|+|++++++++......++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 3457899999999999988 6789999998643 33456778999999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.+.... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~ 157 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NF 157 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc--ch
Confidence 99999999876555699999999999999999999998 99999999999999999999999999988764322 12
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.....|+..|+|||+..+..++.++|+||||++++||++|+.||..... ........ .+... .+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~-----~~~--- 222 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKII-RGVFP-----PVS--- 222 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-cCCCC-----CCc---
Confidence 2345678899999999998899999999999999999999999974331 11111111 11111 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......+.+++.+|++.+|++||++.++++.
T Consensus 223 -~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 -QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1233567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.85 Aligned_cols=264 Identities=27% Similarity=0.411 Sum_probs=218.4
Q ss_pred HHHHHhhhhhceecccccEEEEEEEEC----C--cEEEEEEccCC-CchhhHHHHHHHHHHHhccccceeeEeeEeecCC
Q 002688 577 EVLRMTNNFERVLGKGGFGTVYHGKLD----N--DEVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT 649 (892)
Q Consensus 577 el~~~t~~f~~~IG~G~fG~Vy~~~~~----~--~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~ 649 (892)
+|.++...+.++||.|-||.||+|.+. | -.||||.-+.. .....+.|++|..+|++++||||++++|.|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 455666667789999999999999882 2 25899998774 45567789999999999999999999999986 4
Q ss_pred cEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcc
Q 002688 650 NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~ 729 (892)
..++|||.++.|.|.++|+.++ ..++......++.||+.+|+|||+. +++||||.++|||+.....+|++||||++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence 6899999999999999998765 3488999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCc
Q 002688 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIR 808 (892)
Q Consensus 730 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 808 (892)
.+..+...+.+ ...-...|||||.+.-.+++.++|||-|||.|||++. |..||.+....+.. ..+..|.
T Consensus 540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGe-- 609 (974)
T KOG4257|consen 540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGE-- 609 (974)
T ss_pred hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCC--
Confidence 98665544433 4445678999999999999999999999999999877 89999865432211 1111221
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhhhc
Q 002688 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQ 862 (892)
Q Consensus 809 ~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e~~~ 862 (892)
++ ..+..|...+..|+.+||..+|.+||++.|+...|+++++.|...
T Consensus 610 -----Rl--P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~ 656 (974)
T KOG4257|consen 610 -----RL--PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN 656 (974)
T ss_pred -----CC--CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence 11 234456677889999999999999999999999999998866544
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=319.20 Aligned_cols=238 Identities=27% Similarity=0.407 Sum_probs=188.9
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+. +++.||||.++... ....+.+..|..++... +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999988 56789999987532 22334556677777654 899999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 99999987643 388999999999999999999998 99999999999999999999999999997643222 223
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....||..|+|||++.+..++.++|||||||++|||++|+.||..... .+........ . +.+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-~------~~~~---- 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILND-R------PHFP---- 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-C------CCCC----
Confidence 345789999999999998999999999999999999999999974321 1222222111 0 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQV 848 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eV 848 (892)
......+.+++.+|++.+|++||++.+.
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence 1123456789999999999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=308.04 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=204.0
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+|+. +++.||||.+... .......+.+|++++++++||||+++++++......++++||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 4567899999999999987 7889999987643 2334457899999999999999999999999989999999999
Q ss_pred cCCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 659 ANGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 659 ~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
++|+|.+++... ....++...+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 999999888542 234578999999999999999999998 99999999999999999999999999988753221
Q ss_pred ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
.......++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ....++..... ... .+...
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~~~-~~~-----~~~~~ 229 (267)
T cd08228 161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLFSLCQKIE-QCD-----YPPLP 229 (267)
T ss_pred -HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc----ccHHHHHHHHh-cCC-----CCCCC
Confidence 11223468889999999998889999999999999999999999986422 12223332221 111 11111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.......+.+++.+|++.+|++||++.+|++.|+++
T Consensus 230 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 ---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 112335678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=304.38 Aligned_cols=248 Identities=33% Similarity=0.493 Sum_probs=204.1
Q ss_pred ceecccccEEEEEEEEC-----CcEEEEEEccCCCchh-hHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKLD-----NDEVAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~~~~-~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+.. +..|++|.++...... .+++.+|++.++.++|+|++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999884 7789999998764433 67899999999999999999999999999999999999999
Q ss_pred CchhhhccccC-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 661 GNLEEHLSDSS-------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 661 gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998752 24589999999999999999999998 999999999999999999999999999987754
Q ss_pred CCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccC
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D 812 (892)
...........++..|+|||.+....++.++||||||++++||++ |+.||.... ..+....... +...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~-~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS------NEEVLEYLRK-GYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHc-CCCC----
Confidence 332233345567889999999988899999999999999999999 599987542 1122222221 1100
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 813 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
.. .......+.+++.+|++.+|++||++.|+++.|+
T Consensus 227 -~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -PK----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CC----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11 1122456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=313.94 Aligned_cols=254 Identities=30% Similarity=0.463 Sum_probs=200.0
Q ss_pred hhhceecccccEEEEEEEE--CCc--EEEEEEccCC-CchhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DND--EVAVKMLSPS-SSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~--~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.+.+.||+|+||.||+|.. ++. .+++|.++.. .....+.+.+|++++.++ +||||+++++++......++++||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 4567899999999999987 332 4788888753 334456789999999999 799999999999998999999999
Q ss_pred ccCCchhhhccccC--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEe
Q 002688 658 MANGNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLA 723 (892)
Q Consensus 658 ~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~ 723 (892)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence 99999999986532 13488999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHh
Q 002688 724 DFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSML 802 (892)
Q Consensus 724 DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~ 802 (892)
|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+......
T Consensus 162 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------~~~~~~~~ 232 (297)
T cd05089 162 DFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------AELYEKLP 232 (297)
T ss_pred CcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHh
Confidence 9999864311 111111223557999999988889999999999999999997 9999864321 22222221
Q ss_pred hcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 002688 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAME 859 (892)
Q Consensus 803 ~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e 859 (892)
. +. .+... ......+.+++.+|++.+|.+||++.++++.|++++...
T Consensus 233 ~-~~-----~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 233 Q-GY-----RMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred c-CC-----CCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 10 11111 112345779999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=313.33 Aligned_cols=259 Identities=23% Similarity=0.320 Sum_probs=193.6
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+.+.||+|+||.||+|+. +++.||||++...... ....+.+|+++++.++|+||+++.+++..+...++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 34567899999999999988 6789999998754322 23467889999999999999999999999999999999996
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 87 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 159 (303)
T cd07869 87 -TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HT 159 (303)
T ss_pred -cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--cc
Confidence 57887776543 3488899999999999999999998 99999999999999999999999999987543221 22
Q ss_pred cccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCC---Cc-----cc
Q 002688 740 STTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD---IR-----ST 810 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~-----~~ 810 (892)
.....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+.......... .. ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhccc
Confidence 234567899999999875 45889999999999999999999999753211 011111111110000 00 00
Q ss_pred cCCCCCC---CCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 811 VDPRLKG---DFDI-------NSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 811 ~D~~l~~---~~~~-------~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+++.-.. .... .....+.+++.+|++.+|++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1111000 0000 01235678999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=322.33 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=201.4
Q ss_pred HHhhhhhceecccccEEEEEEEE-------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecC-C
Q 002688 580 RMTNNFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG-T 649 (892)
Q Consensus 580 ~~t~~f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~-~ 649 (892)
+..+.+.+.||+|+||.||+|+. +++.||||+++... ......+.+|++++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 34456778999999999999973 45789999997643 23346788999999999 689999999988654 5
Q ss_pred cEEEEEEeccCCchhhhccccC----------------------------------------------------------
Q 002688 650 NMALIYEYMANGNLEEHLSDSS---------------------------------------------------------- 671 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~---------------------------------------------------------- 671 (892)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999886431
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccccc
Q 002688 672 -------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 672 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12378889999999999999999998 99999999999999999999999999998653322222222334
Q ss_pred CCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHH
Q 002688 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823 (892)
Q Consensus 745 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~ 823 (892)
++..|+|||.+.+..++.++||||||+++|||++ |..||...... . . ....+..+.... .... .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~---~-~~~~~~~~~~~~-----~~~~----~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E---E-FCRRLKEGTRMR-----APDY----T 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--H---H-HHHHHhccCCCC-----CCCC----C
Confidence 5678999999998899999999999999999997 89888643211 1 1 111122221110 0111 1
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 824 VWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 824 ~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
...+.+++.+|++.+|++||++.|+++.|+++++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2357799999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=312.69 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=198.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc---hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS---QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
+..+.||+|+||.||++.. +++.||||.+..... .....+.+|++++++++|+||+++.+++..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence 3457899999999999987 678999999865422 22345788999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|+|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 156 (285)
T cd05605 83 NGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--- 156 (285)
T ss_pred CCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---
Confidence 999999988665445689999999999999999999998 99999999999999999999999999987653221
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...... ...+.+...+.... ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~----------~~ 223 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREEVERRVKEDQ----------EE 223 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHHHHHHhhhcc----------cc
Confidence 123446899999999999889999999999999999999999999753321 11111111111111 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRP-----FMNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~~ 851 (892)
+.......+.+++.+|++.+|++|| ++.++++.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1112334567999999999999999 77777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.62 Aligned_cols=247 Identities=21% Similarity=0.404 Sum_probs=195.1
Q ss_pred eecccccEEEEEEEE----CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 588 VLGKGGFGTVYHGKL----DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~----~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
.||+|+||.||+|++ ++..||+|.+..... ...+.+.+|++++++++|+||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 389999999999976 244699999876543 33467899999999999999999999885 457899999999999
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc-cc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV-ST 741 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~-~~ 741 (892)
|.+++.... ..+++..+++++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999987543 3489999999999999999999998 999999999999999999999999999986543322111 12
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .++.. .+..+... ..+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~~~---------~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PEVMS-FIEQGKRL---------DCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HHHHH-HHHCCCCC---------CCC
Confidence 2234578999999988889999999999999999996 9999874321 11221 12222111 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
..+...+.+++.+|++.+|++||++.+|.+.|+.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22345677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.15 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=199.7
Q ss_pred hhhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 582 TNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.+.||+|++|.||+|.. .+..+|+|.+..... ..+.+.+|++++++++|+|++++.+++.. ...+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK 84 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence 355667899999999999988 445799998865432 34678899999999999999999998754 567899999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........ ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 160 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TAR 160 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc-ccc
Confidence 9999999776555689999999999999999999998 999999999999999999999999999976532211 111
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
....++..|+|||...+..++.++||||||+++|||++ |+.||..... ....++. ..... +..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~---~~~~~------~~~---- 224 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQV---ERGYR------MPC---- 224 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---HcCCC------CCC----
Confidence 22345678999999988899999999999999999999 8999874321 1111111 11111 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.......+.+++.+|+..+|++||++++|++.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11233567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=319.91 Aligned_cols=241 Identities=28% Similarity=0.431 Sum_probs=193.3
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+. +++.||||++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999988 56789999987532 23345677888888866 799999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|...+.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 99999887543 388999999999999999999998 99999999999999999999999999987542221 122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .. ..|.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~~~-~~---~~p~------ 217 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESILHD-DV---LYPV------ 217 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHHcC-CC---CCCC------
Confidence 345689999999999988999999999999999999999999975332 1222222221 11 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRP-------FMNQVVME 851 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RP-------sm~eVl~~ 851 (892)
.....+.+++.+|++.+|++|| ++.++++.
T Consensus 218 -~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 -WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1224567899999999999999 77777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=324.46 Aligned_cols=256 Identities=19% Similarity=0.204 Sum_probs=192.9
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.+.||+|+||.||++.. +++.||+|.... +.+.+|++++++++||||+++++++......++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 355668999999999999987 678899997532 356889999999999999999999999999999999985
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 167 -~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~~ 239 (391)
T PHA03212 167 -TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANK 239 (391)
T ss_pred -CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc-cccc
Confidence 68888876543 489999999999999999999998 9999999999999999999999999999753221 1122
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCC-C----ccHHHHHHhHhh-cCC-------
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENG-H----THVAQWVSSMLD-KGD------- 806 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~-~----~~l~~~~~~~~~-~~~------- 806 (892)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+....... . ..+...+...-. ...
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 234579999999999999899999999999999999999998875432111 0 011111100000 000
Q ss_pred -Ccc---------ccCCCCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 807 -IRS---------TVDPRLKGDF--DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 807 -~~~---------~~D~~l~~~~--~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+.+ ...+...... .......+.+++.+|++.+|++|||++|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000000000 0122346789999999999999999999985
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.91 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=204.7
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.+.+.||+|+||.||++.. ++..+|||.+... .....+++.+|+++++.++|+||+++++++..+...+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 34567899999999999986 7889999987653 223446788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 658 MANGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 658 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
+++++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 9999999988642 234589999999999999999999998 99999999999999999999999999987653222
Q ss_pred CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
.......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ...++..... +...+.+
T Consensus 161 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~------~~~~~~~ 228 (267)
T cd08229 161 --TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE------QCDYPPL 228 (267)
T ss_pred --cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhh------cCCCCCC
Confidence 112344688899999999888899999999999999999999999864321 1122222111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
. .......+.+++.+|+..+|++||+|.+|++.++++
T Consensus 229 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 P---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 112344677999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=309.36 Aligned_cols=244 Identities=23% Similarity=0.361 Sum_probs=193.1
Q ss_pred ecccccEEEEEEEE--CCcEEEEEEccCCCc---hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 589 LGKGGFGTVYHGKL--DNDEVAVKMLSPSSS---QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 589 IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
||+|+||+||+++. +++.||+|.+..... ...+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999987 678999999865422 2345678899999999999999999999999999999999999999
Q ss_pred hhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 664 EEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 664 ~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+.... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9887432 234589999999999999999999998 99999999999999999999999999997653322 1223
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
...|++.|+|||++.+..++.++||||||+++|||++|+.||....... ........... +.. ....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~-~~~----------~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRILN-DSV----------TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHHhhcc-cCC----------CCcc
Confidence 4568999999999999999999999999999999999999997543211 11111111111 100 1111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRP-----FMNQVVM 850 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~ 850 (892)
.....+.+++.+|++.+|++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2334577999999999999999 5566665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=333.82 Aligned_cols=251 Identities=28% Similarity=0.417 Sum_probs=200.7
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCC--------
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT-------- 649 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~-------- 649 (892)
.+.+.+.||+|+||.||+|+. +++.||||++... .......+.+|+..+..++|+|++++...+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 345678999999999999987 7899999998654 3344567889999999999999999887664322
Q ss_pred cEEEEEEeccCCchhhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecC
Q 002688 650 NMALIYEYMANGNLEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGL 727 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGl 727 (892)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 3689999999999999986532 34589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCC
Q 002688 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDI 807 (892)
Q Consensus 728 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 807 (892)
++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.+..... +..
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~------~~~~~~~~~~~-~~~ 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE------NMEEVMHKTLA-GRY 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHhc-CCC
Confidence 98764332223334567999999999999999999999999999999999999999643 22333333222 111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 808 RSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 808 ~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
. + +. ......+.+++.+|++.+|++||++.++++.
T Consensus 263 ~----~-~~----~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 D----P-LP----PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C----C-CC----CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 1 11 1223457799999999999999999999763
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=319.36 Aligned_cols=235 Identities=28% Similarity=0.409 Sum_probs=190.1
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+. +++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999988 5788999998753 223445677888888876 699999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT 153 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence 99999887653 389999999999999999999998 9999999999999999999999999998754221 1223
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +.. ..| .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~-~~~---~~~---~--- 217 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILN-DEV---VYP---T--- 217 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhc-CCC---CCC---C---
Confidence 345789999999999988999999999999999999999999974331 222222221 111 011 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFM 845 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm 845 (892)
.....+.+++.+|++.+|++||++
T Consensus 218 -~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 -WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCHHHHHHHHHHcccCHHHCCCC
Confidence 123456799999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=308.44 Aligned_cols=248 Identities=30% Similarity=0.477 Sum_probs=196.0
Q ss_pred ceecccccEEEEEEEE--CCc--EEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DND--EVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~--~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+. ++. .+++|.++... ....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 3689999999999988 333 47888887543 34456789999999999 899999999999999999999999999
Q ss_pred CchhhhccccC--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeec
Q 002688 661 GNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFG 726 (892)
Q Consensus 661 gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfG 726 (892)
|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 13478999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcC
Q 002688 727 LSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKG 805 (892)
Q Consensus 727 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 805 (892)
++..... .........+..|+|||++....++.++||||||++++||++ |+.||..... .+...... .+
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~-~~ 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLP-QG 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHh-CC
Confidence 9863211 111112234567999999988889999999999999999997 9999864321 12222221 11
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 806 DIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 806 ~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
... .. .......+.+++.+|+..+|.+||++.++++.|++++
T Consensus 228 ~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL-----EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC-----CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 100 01 1122345779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=318.18 Aligned_cols=243 Identities=22% Similarity=0.355 Sum_probs=194.8
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+++. +++.||+|+++... ....+.+..|+.++.++ +|+||+++.+++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 66889999997542 23345678899999888 699999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence 99998886543 489999999999999999999998 9999999999999999999999999998753211 1122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|++.|+|||++.+..++.++|||||||++|||++|+.||............++..+.+...... +..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~p~--- 224 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR------IPR--- 224 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC------CCC---
Confidence 34678999999999999999999999999999999999999997544333333334444433332211 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMN 846 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~ 846 (892)
.....+.+++.+|++.+|++|+++.
T Consensus 225 -~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 225 -FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1224467999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=314.76 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=202.3
Q ss_pred hhhceecccccEEEEEEEE--CCc--EEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DND--EVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~--~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.+.+.||+|+||.||+|.. ++. .+|+|.++... ....+++.+|++++.++ +|+||+++.+++..++..++|+||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 4567899999999999987 343 46888776543 33456788999999999 899999999999999999999999
Q ss_pred ccCCchhhhccccC--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEe
Q 002688 658 MANGNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLA 723 (892)
Q Consensus 658 ~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~ 723 (892)
+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeC
Confidence 99999999986532 23588999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHh
Q 002688 724 DFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSML 802 (892)
Q Consensus 724 DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~ 802 (892)
|||+++.... ........++..|+|||++.+..++.++|||||||+++||+| |+.||..... .+.....
T Consensus 167 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~- 236 (303)
T cd05088 167 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKL- 236 (303)
T ss_pred ccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh------HHHHHHH-
Confidence 9999864311 111112234567999999988889999999999999999998 9999864321 1122211
Q ss_pred hcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhhhccc
Q 002688 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKK 864 (892)
Q Consensus 803 ~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e~~~~~ 864 (892)
..+. .+.. .......+.+++.+|++.+|++||++.++++.|++++..+.....
T Consensus 237 ~~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~ 289 (303)
T cd05088 237 PQGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 289 (303)
T ss_pred hcCC-----cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhh
Confidence 1110 0000 111234577999999999999999999999999988766654443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=305.16 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=197.9
Q ss_pred ceecccccEEEEEEEE--CC---cEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DN---DEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~---~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|++ .+ ..+|+|.+..... ...+++.+|+++++++.|+|++++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 4699999999999987 22 5799999886644 34567899999999999999999999876 4568999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc-
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV- 739 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~- 739 (892)
|+|.+++.... .+++..+..++.|++.||+|||.. +++|+||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997654 489999999999999999999998 999999999999999999999999999987643322111
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.....++..|+|||.+.+..++.++||||||+++|||++ |++||..... ..+..++.+ +....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~----~~~~~--------- 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLES----GERLP--------- 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc----CCcCC---------
Confidence 112223567999999998899999999999999999998 9999864321 222222221 11100
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
........+.+++.+|+..+|++||++.++++.|+++
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112335678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.82 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=201.1
Q ss_pred HhhhhhceecccccEEEEEEEEC-------CcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMA 652 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~~-------~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~ 652 (892)
..+.+.+.||+|+||.||+|... +..||+|.+..... .....+.+|+..++.++|+||+++++++......+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 34556689999999999998652 34799999875432 33456889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhccccC--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEee
Q 002688 653 LIYEYMANGNLEEHLSDSS--------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLAD 724 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~D 724 (892)
+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999996532 23357788899999999999999998 999999999999999999999999
Q ss_pred ecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhh
Q 002688 725 FGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLD 803 (892)
Q Consensus 725 fGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~ 803 (892)
||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.||..... .+.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~ 236 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLKFVMD 236 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHc
Confidence 999886543322222223345678999999998899999999999999999999 7888864321 122222221
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 804 KGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 804 ~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.+... . .......+.+++.+|++.+|++||++.++++.|++.
T Consensus 237 ~~~~~------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 237 GGYLD------Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCC------C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11110 1 112235688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.44 Aligned_cols=254 Identities=27% Similarity=0.423 Sum_probs=203.6
Q ss_pred HHHhhhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 579 LRMTNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 579 ~~~t~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.+....+.+.||+|+||.||+|.. ++..+|+|.+.... ...+.+.+|++++++++|+|++++.+++.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 345566778999999999999987 56779999887543 234678999999999999999999999887 778999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y 157 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC-c
Confidence 9999999999775555689999999999999999999998 99999999999999999999999999987653221 1
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
.......++..|+|||++....++.++|+||||++++||++ |+.||..... ..+.++.. .+... ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~----~~~~~-----~~- 224 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALE----RGYRM-----PR- 224 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHh----CCCCC-----CC-
Confidence 11223345678999999998889999999999999999999 8999864321 12222221 11110 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223467799999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.75 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=194.1
Q ss_pred ceecccccEEEEEEEE-----CCcEEEEEEccCC-CchhhHHHHHHHHHHHhccccceeeEeeEee-cCCcEEEEEEecc
Q 002688 587 RVLGKGGFGTVYHGKL-----DNDEVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD-EGTNMALIYEYMA 659 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~-----~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~-~~~~~~LV~Ey~~ 659 (892)
+.||+|+||.||+|+. +...+|+|.+... .....+.+.+|+.+++.++|||++++++++. .+...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 4689999999999986 2347999998643 3344578889999999999999999999875 4556889999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc-
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH- 738 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~- 738 (892)
+|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999976432 367888899999999999999998 99999999999999999999999999997653221111
Q ss_pred -ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 739 -VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 739 -~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
......++..|+|||.+.+..++.++||||||+++|||++| .+||.... ..+........... ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~------~~~ 224 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRRL------LQP 224 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCCC------CCC
Confidence 11233456789999999888999999999999999999995 55664321 12222222211111 001
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
. .....+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 225 ~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 225 E----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred C----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1 12345779999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=305.63 Aligned_cols=254 Identities=29% Similarity=0.460 Sum_probs=203.7
Q ss_pred HHhhhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 580 RMTNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 580 ~~t~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
+..+.+.+.||+|+||.||+|.. ++..+|||.+..... ..+++.+|++++++++|+|++++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 33445678999999999999988 557899999876433 3467899999999999999999999999888999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++++|.+++.......+++..+..++.+++.||+|||+. +++|+||||+||++++++.+||+|||++..+.... ..
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence 999999999876655699999999999999999999998 99999999999999999999999999988664211 11
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
......++..|+|||.+.+..++.++||||||++++||++ |+.||..... ....+ ...... ....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~---~~~~~~--~~~~------ 225 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLE---QVERGY--RMPR------ 225 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HHHcCC--CCCC------
Confidence 1122334568999999998889999999999999999999 9999864321 11111 111110 0000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.......+.+++.+|+..+|++||+++++++.|+.
T Consensus 226 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 --PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=318.60 Aligned_cols=265 Identities=28% Similarity=0.438 Sum_probs=208.2
Q ss_pred HHHHHhhhhhceecccccEEEEEEEEC---------CcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEe
Q 002688 577 EVLRMTNNFERVLGKGGFGTVYHGKLD---------NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYC 645 (892)
Q Consensus 577 el~~~t~~f~~~IG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~ 645 (892)
++....+.+.+.||+|+||.||++... ...||+|.+.... ....+++.+|+++++++ +|+||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 344455677889999999999999751 2368999887543 33457889999999999 799999999999
Q ss_pred ecCCcEEEEEEeccCCchhhhccccC--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCcc
Q 002688 646 DEGTNMALIYEYMANGNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTN 711 (892)
Q Consensus 646 ~~~~~~~LV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~N 711 (892)
......++++||+++|+|.+++.... ...++|..++.++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999986532 23488999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCC
Q 002688 712 ILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENG 790 (892)
Q Consensus 712 ILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~ 790 (892)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--- 241 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--- 241 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---
Confidence 9999999999999999986533221111222334567999999999999999999999999999998 888886432
Q ss_pred CccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhh
Q 002688 791 HTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEA 860 (892)
Q Consensus 791 ~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e~ 860 (892)
..++..... .+...+ . .......+.+++.+|++.+|++||++.|+++.|+++.....
T Consensus 242 ---~~~~~~~~~-~~~~~~-----~----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 242 ---VEELFKLLK-EGHRMD-----K----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ---HHHHHHHHH-cCCCCC-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 222322222 111111 0 11223467799999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=310.91 Aligned_cols=259 Identities=26% Similarity=0.463 Sum_probs=203.6
Q ss_pred hhhhceecccccEEEEEEEEC------CcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeec--CCcEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKLD------NDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDE--GTNMAL 653 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~~------~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~--~~~~~L 653 (892)
..+.+.||+|+||.||+|+++ +..+|||.+...... ..++|.+|++.+++++|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345578999999999999873 568999999866443 46789999999999999999999999877 567899
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999976543 489999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCcc-ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCC---------ccHHHHHHhHhh
Q 002688 734 EGGTH-VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGH---------THVAQWVSSMLD 803 (892)
Q Consensus 734 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~---------~~l~~~~~~~~~ 803 (892)
..... ......++..|+|||.+.+..++.++||||||++++||++|+.|+........ .....+. ..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-ELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-HHHH
Confidence 22211 11223455679999999888999999999999999999999988764322110 0011111 1111
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 804 KGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 804 ~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.+. . . .........+.+++.+|++.+|++||+|.||+++|+++
T Consensus 241 ~~~-~------~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGE-R------L--PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCC-c------C--CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111 0 0 01112335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=315.94 Aligned_cols=240 Identities=27% Similarity=0.421 Sum_probs=190.5
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+. +++.||||.++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999988 56789999987542 22335567778888764 899999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence 99999987543 388999999999999999999998 99999999999999999999999999987532211 122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+..... .... +.+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~i-~~~~------~~~~~--- 217 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EELFQSI-RMDN------PCYPR--- 217 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhCC------CCCCc---
Confidence 345689999999999998999999999999999999999999974321 1112211 1111 11111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMN-QVVM 850 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~-eVl~ 850 (892)
.....+.+++.+|++.+|++||++. ++.+
T Consensus 218 -~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 -WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1223467899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=314.29 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=201.8
Q ss_pred hhhhhceecccccEEEEEEEE---------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCc
Q 002688 582 TNNFERVLGKGGFGTVYHGKL---------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTN 650 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~---------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~ 650 (892)
...+.+.||+|+||.||+++. ....+|+|.++... .....++.+|+++++++ +|+||+++++++.....
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 344668999999999999974 23469999987543 33456788999999999 69999999999999899
Q ss_pred EEEEEEeccCCchhhhccccC--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC
Q 002688 651 MALIYEYMANGNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE 716 (892)
Q Consensus 651 ~~LV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~ 716 (892)
.++++||+++|+|.+++.... ...++|.++.+++.|++.||+|||+. +++||||||+|||+++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~ 169 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTE 169 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcC
Confidence 999999999999999986532 23489999999999999999999998 9999999999999999
Q ss_pred CCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHH
Q 002688 717 KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVA 795 (892)
Q Consensus 717 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~ 795 (892)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------~ 243 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------E 243 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH------H
Confidence 99999999999986643221111112234467999999998899999999999999999999 8888864321 1
Q ss_pred HHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 796 QWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 796 ~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
+.. ..+..+...+ . .......+.+++.+|+..+|++||++.|+++.|+++..
T Consensus 244 ~~~-~~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 ELF-KLLREGHRMD-----K----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHH-HHHHcCCCCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111 1122221111 1 11223467799999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=303.61 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=200.9
Q ss_pred ceecccccEEEEEEEEC---C--cEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKLD---N--DEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~---~--~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|++|.||+|.+. + ..||||.+..... ...+++.+|++.+++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 46899999999999872 2 2689999987766 566789999999999999999999999988 889999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc-c
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH-V 739 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~-~ 739 (892)
|+|.+++.......++|.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999775534589999999999999999999998 99999999999999999999999999998774432211 1
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.....++..|+|||++.+..++.++||||||++++||++ |+.||..... .+............ .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~-------~-- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKIDKEGERL-------E-- 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCcC-------C--
Confidence 223457789999999998899999999999999999999 9999864321 12222211111100 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
........+.+++.+|++.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01122356789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=308.55 Aligned_cols=249 Identities=30% Similarity=0.457 Sum_probs=197.3
Q ss_pred ceecccccEEEEEEEECC--------cEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 587 RVLGKGGFGTVYHGKLDN--------DEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~--------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.||+|+||.||+|+... ..+|||.+.... .....++.+|+++++.++|+||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998732 569999886543 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhccccC-----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC-----cEEEeeecC
Q 002688 658 MANGNLEEHLSDSS-----KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF-----QAKLADFGL 727 (892)
Q Consensus 658 ~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~-----~vkl~DfGl 727 (892)
+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.+. .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 23488999999999999999999998 999999999999999877 899999999
Q ss_pred cccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCC
Q 002688 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGD 806 (892)
Q Consensus 728 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 806 (892)
++...............++..|+|||++.+..++.++||||||+++|||++ |+.||..... ... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~---~~~~~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEV---LQHVTAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHH---HHHHhcCCc
Confidence 876533222222223345678999999999999999999999999999998 9999864321 111 111111111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 807 IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 807 ~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.. ........+.+++.+|++.+|++||++.++++.|++
T Consensus 232 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 LQ----------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cC----------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 111234567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=316.54 Aligned_cols=239 Identities=26% Similarity=0.388 Sum_probs=190.2
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+. +++.||+|.++... ....+.+..|..++... +|+||+++++++...++.++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999988 67889999987532 22344567788777654 899999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence 99999887643 388999999999999999999998 9999999999999999999999999998753211 1223
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+..... ..+ .+.+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~------~~~~~~~-~~~------~~~~~~--- 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------DELFESI-RVD------TPHYPR--- 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhC------CCCCCC---
Confidence 456789999999999999999999999999999999999999974321 1111111 111 111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMN-QVV 849 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~-eVl 849 (892)
.....+.+++.+|++.+|++||++. ++.
T Consensus 218 -~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 -WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1234567899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=317.12 Aligned_cols=241 Identities=26% Similarity=0.400 Sum_probs=190.4
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHH---HhccccceeeEeeEeecCCcEEEEEE
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLL---LRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l---~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
+.+.||+|+||.||+|.. +++.||||+++... ....+.+..|++++ +.++||||+++++++..++..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 457899999999999987 67899999987532 22334566666554 56789999999999999999999999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
|+++|+|..++... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05589 83 YAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-- 154 (324)
T ss_pred CCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC--
Confidence 99999999888643 489999999999999999999998 9999999999999999999999999998753221
Q ss_pred ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+........ .. ...
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~-~~------~~p 221 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVND-EV------RYP 221 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-CC------CCC
Confidence 1223356789999999999999999999999999999999999999974321 1222222211 11 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPF-----MNQVVM 850 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eVl~ 850 (892)
. .....+.+++.+|++.+|++||+ +.++++
T Consensus 222 ~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 222 R----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred C----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1 12345678999999999999995 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.43 Aligned_cols=250 Identities=22% Similarity=0.372 Sum_probs=194.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCch--------------hhHHHHHHHHHHHhccccceeeEeeEeec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ--------------GYKQFQAEVKLLLRVHHRNLTTLVGYCDE 647 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~--------------~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~ 647 (892)
.+.+.||+|.||.|-+|+. +++.||||++.+.... ..++..+|+.+|++++|+|||+|+.+..+
T Consensus 100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD 179 (576)
T KOG0585|consen 100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD 179 (576)
T ss_pred ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence 3456899999999999987 8899999998754211 12467899999999999999999999976
Q ss_pred C--CcEEEEEEeccCCchhhhccccCccc-CCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEee
Q 002688 648 G--TNMALIYEYMANGNLEEHLSDSSKEI-LNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLAD 724 (892)
Q Consensus 648 ~--~~~~LV~Ey~~~gsL~~~L~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~D 724 (892)
. +.+|||+|||..|.+...=. .+. ++..+..++++++..||+|||.+ +||||||||+|+||+++|++||+|
T Consensus 180 P~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 180 PESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred cccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeec
Confidence 5 57999999999887644322 223 89999999999999999999999 999999999999999999999999
Q ss_pred ecCcccccCCC---CccccccccCCCCccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHH
Q 002688 725 FGLSRVFPVEG---GTHVSTTIAGTPGYLDPEYYISNR----LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQW 797 (892)
Q Consensus 725 fGla~~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~ 797 (892)
||.+..+.... .........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-...+ .+.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------~~l 327 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------LEL 327 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH------HHH
Confidence 99988663221 111223468999999999998743 35678999999999999999999975432 222
Q ss_pred HHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 798 VSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 798 ~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
..+.+. ..|.-.-..+....+.+|++++++.||++|.+..+|....--
T Consensus 328 ~~KIvn---------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 328 FDKIVN---------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHHHhc---------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 222221 112111122445567799999999999999999999876653
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=316.41 Aligned_cols=240 Identities=27% Similarity=0.419 Sum_probs=193.5
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+. +++.||||.++... ......+..|.+++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999988 57789999987532 23345677888888888 699999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT 153 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence 99999887653 389999999999999999999998 99999999999999999999999999987532111 122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+....... ... ...
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~-~~~------~~~---- 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILE-DEV------RYP---- 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHc-CCC------CCC----
Confidence 345689999999999999999999999999999999999999974321 122222211 111 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFM-----NQVVM 850 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm-----~eVl~ 850 (892)
......+.+++.+|++.+|++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1123457799999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.62 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=189.9
Q ss_pred eecccccEEEEEEEE----CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 588 VLGKGGFGTVYHGKL----DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~----~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
.||+|+||.||+|+. ....+|+|.+..... .....+.+|++.++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999976 234688888765433 344678899999999999999999999999999999999999999
Q ss_pred hhhhccccC---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 663 LEEHLSDSS---KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 663 L~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
|.+++.... ....++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999997643 23356888899999999999999998 999999999999999999999999999875432222222
Q ss_pred cccccCCCCccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCcccc
Q 002688 740 STTIAGTPGYLDPEYYIS-------NRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~-------~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 811 (892)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||...... +-.......+. ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~-~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQD-IKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccC-ccCC
Confidence 233445678999998743 356889999999999999999 77888643211 11112222221 1122
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
++.+.. .....+.+++..|+ .+|++||++++|++.|.
T Consensus 232 ~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222221 22344557778888 49999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.34 Aligned_cols=248 Identities=23% Similarity=0.412 Sum_probs=210.1
Q ss_pred HHHhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEE
Q 002688 579 LRMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 579 ~~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~L 653 (892)
++-+++|.+.||+|.+|.|-+|.. .|+.||||.+++.. .+..-.+.+|+++|+.++||||+.++.+|+..+.+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 456678889999999999999965 78999999998764 3344557899999999999999999999999999999
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
||||..+|.|.+++.+.+. |++.+...+++||..|+.|+|.+ +++|||||-+|||||+++++||+||||+.++..
T Consensus 131 vMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999988654 99999999999999999999999 999999999999999999999999999998753
Q ss_pred CCCccccccccCCCCccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccC
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D 812 (892)
. ...+.++|++-|.+||+..+..|. +.+|-|||||+||.|+.|.-||++.+ ....+++ +..|..++
T Consensus 206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQ-Is~GaYrE--- 272 (668)
T KOG0611|consen 206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQ-ISRGAYRE--- 272 (668)
T ss_pred c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHH-hhcccccC---
Confidence 3 345678999999999999998874 78999999999999999999998543 2334444 33333332
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852 (892)
Q Consensus 813 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L 852 (892)
|.- .....-|+++|+-.+|++|-|+.+|....
T Consensus 273 P~~--------PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 PET--------PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CCC--------CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 222 22345789999999999999999998753
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=321.59 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=192.0
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 457899999999999988 67899999986542 2334578899999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC---
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG--- 736 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~--- 736 (892)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 85 GGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 999999987644 388899999999999999999998 999999999999999999999999999764311000
Q ss_pred ------------------------------------------ccccccccCCCCccCccccccCCCCchhhHHHHHHHHH
Q 002688 737 ------------------------------------------THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 774 (892)
Q Consensus 737 ------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ 774 (892)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 00012356999999999999888999999999999999
Q ss_pred HHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHH
Q 002688 775 EIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMA--CVSSNANRRPFMNQVVME 851 (892)
Q Consensus 775 ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPsm~eVl~~ 851 (892)
||++|+.||...... +............ ..... ......+.+++.+ |...+|..||++.|+++.
T Consensus 240 elltG~~Pf~~~~~~------~~~~~i~~~~~~~-----~~~~~--~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 240 EMLVGQPPFLAPTPT------ETQLKVINWENTL-----HIPPQ--VKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHhCCCCCcCCCHH------HHHHHHHcccccc-----CCCCC--CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999753321 1111111111000 01000 0112345566665 566677779999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.18 Aligned_cols=252 Identities=33% Similarity=0.486 Sum_probs=200.4
Q ss_pred hhhceecccccEEEEEEEE-------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
.+.+.||+|+||.||+|+. ++..||+|.+.... ....+++.+|++++++++|+||+++++++..+...++|+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence 4457899999999999986 35689999987653 334567999999999999999999999999999999999
Q ss_pred EeccCCchhhhccccC--------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEc
Q 002688 656 EYMANGNLEEHLSDSS--------------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN 715 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~ 715 (892)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~ 164 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVG 164 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEec
Confidence 9999999999986432 12478899999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccH
Q 002688 716 EKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHV 794 (892)
Q Consensus 716 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l 794 (892)
+++.+||+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||.... .
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~------~ 238 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA------H 238 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------H
Confidence 999999999999876533222222223344667999999988899999999999999999998 877875322 1
Q ss_pred HHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 795 AQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 795 ~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.++... +..+.... . .......+.+++.+|++.+|++||++.|+++.|++
T Consensus 239 ~~~~~~-~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYY-VRDGNVLS-----C----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHH-HhcCCCCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 222222 22222211 0 11223567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=315.07 Aligned_cols=238 Identities=25% Similarity=0.398 Sum_probs=190.0
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
++.+.||+|+||.||+|+. +++.||||.+.... ....+.+..|..++..+ +|++|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 3457899999999999988 56789999987542 22334567788888777 589999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-- 155 (323)
T cd05616 83 VNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-- 155 (323)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--
Confidence 99999999886543 388999999999999999999998 99999999999999999999999999987542211
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... ... .+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~i~~-~~~------~~-- 220 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIME-HNV------AY-- 220 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCC------CC--
Confidence 122345789999999999999999999999999999999999999974331 111222211 111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFM 845 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm 845 (892)
+......+.+++.+|++.+|++|++.
T Consensus 221 --p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 --PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11223456799999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=327.29 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=211.1
Q ss_pred hceecccccEEEEEEEE--CCc----EEEEEEccCC-CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 586 ERVLGKGGFGTVYHGKL--DND----EVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~----~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.++||+|+||+||||.+ +++ +||||++... ..+..+++++|+-+|.+++|+|+++++|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 47999999999999998 433 6899998654 4556789999999999999999999999998766 88999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
+.|+|.++++.++. .+.-...+.+..|||+||.|||++ +++||||.++|+|+..-..+||.|||+++.+..++...
T Consensus 780 P~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 99999999988653 488899999999999999999998 99999999999999999999999999999987766655
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
......-.+.|||=|.+....++.++|||||||.+||++| |..|+++..-+ -+...++.|.- |.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-------eI~dlle~geR-------Ls- 920 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-------EIPDLLEKGER-------LS- 920 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------HhhHHHhcccc-------CC-
Confidence 5555556778999999999999999999999999999999 88888754322 22233333321 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
.+.-+..++..++.+||..|++.||+++++..++.+...
T Consensus 921 -qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 921 -QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 233466778899999999999999999999999988643
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=316.86 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=194.7
Q ss_pred hhhceecccccEEEEEEEE-----CCcEEEEEEccCCC----chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL-----DNDEVAVKMLSPSS----SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~L 653 (892)
.+.+.||+|+||.||+++. +++.||+|++.... ....+.+..|++++.++ +|+||+++.+++......++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 3567899999999999875 56789999986431 22345678899999999 59999999999999999999
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999987543 489999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccC
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D 812 (892)
... .......||..|+|||++.+. .++.++|||||||++|||++|+.||....... ........... .+
T Consensus 158 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~-------~~ 227 (332)
T cd05614 158 EEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--TQSEVSRRILK-------CD 227 (332)
T ss_pred cCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--CHHHHHHHHhc-------CC
Confidence 221 122345799999999999865 47889999999999999999999997543221 11122222211 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRP-----FMNQVVM 850 (892)
Q Consensus 813 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~ 850 (892)
+.+.. .....+.+++.+|++.+|++|| +++++++
T Consensus 228 ~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 PPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 22221 1224567899999999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.20 Aligned_cols=247 Identities=27% Similarity=0.429 Sum_probs=197.9
Q ss_pred ceecccccEEEEEEEE-CCcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
++||+|+||.||++.. +++.||+|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4689999999999988 4889999998765443 5578999999999999999999999999999999999999999999
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
+++..... .+++..+..++.+++.+|+|||+. +++||||||+||+++.++.+||+|||++................
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99865432 488999999999999999999998 99999999999999999999999999987653211111111223
Q ss_pred CCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHH
Q 002688 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823 (892)
Q Consensus 745 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~ 823 (892)
.+..|+|||.+.+..++.++|+||||++++||++ |..||..... ....+. +..+. . . ......
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~----~~~~~-~------~--~~~~~~ 220 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRER----IESGY-R------M--PAPQLC 220 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHH----HhcCC-C------C--CCCccC
Confidence 4567999999988899999999999999999999 7888864332 111111 11110 0 0 011123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 824 VWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 824 ~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
...+.+++.+|+..+|++||++.|+++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.37 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=199.7
Q ss_pred hhhhceecccccEEEEEEEE------------------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEee
Q 002688 583 NNFERVLGKGGFGTVYHGKL------------------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVG 643 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~------------------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g 643 (892)
+.+.+.||+|+||.||++.. +...+|+|.+.... ....+++.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 45668999999999998853 13368999987653 334568999999999999999999999
Q ss_pred EeecCCcEEEEEEeccCCchhhhccccCc---------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEE
Q 002688 644 YCDEGTNMALIYEYMANGNLEEHLSDSSK---------EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI 714 (892)
Q Consensus 644 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl 714 (892)
++......++||||+++|+|.+++..... ..+++.....++.|++.||+|||+. +++||||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence 99999999999999999999999865431 2478889999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCccccCCCc
Q 002688 715 NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT--GHPVISKSAENGHT 792 (892)
Q Consensus 715 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt--G~~p~~~~~~~~~~ 792 (892)
++++.+||+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~--- 240 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE--- 240 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH---
Confidence 9999999999999986533222111222334678999999888899999999999999999998 67777643221
Q ss_pred cHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 793 HVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 793 ~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
................. ..+. ...+...+.+++.+|++.+|++||++.+|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGEFFRDQGRQV-YLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHhhccccc-cCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111111110 0111 11233567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=321.70 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=199.5
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++..++|+||+++++++.++...++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 4567899999999999998 58899999987532 234467889999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC---
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG--- 735 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~--- 735 (892)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 84 PGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999765 3489999999999999999999998 99999999999999999999999999998764322
Q ss_pred ------------------------CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCC
Q 002688 736 ------------------------GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGH 791 (892)
Q Consensus 736 ------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~ 791 (892)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--- 235 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL--- 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH---
Confidence 00122345689999999999999999999999999999999999999975331
Q ss_pred ccHHHHHHhHhhc-CCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 002688 792 THVAQWVSSMLDK-GDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPF-MNQVVME 851 (892)
Q Consensus 792 ~~l~~~~~~~~~~-~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-m~eVl~~ 851 (892)
.......... .... -|.. ......+.+++.+|+. +|++||+ ++|+++.
T Consensus 236 ---~~~~~~i~~~~~~~~---~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 ---QETYNKIINWKESLR---FPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ---HHHHHHHhccCCccc---CCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1112222210 1110 0000 0123456789999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.65 Aligned_cols=237 Identities=26% Similarity=0.352 Sum_probs=191.0
Q ss_pred ceecccccEEEEEEEE-----CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 587 RVLGKGGFGTVYHGKL-----DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.||+|+||.||+++. +++.||+|++..... .....+..|++++++++|+||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998864 568899999875422 233567789999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence 999999986543 489999999999999999999998 99999999999999999999999999987653221 12
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||..... .+....... ... .+.
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~-~~~------~~p--- 218 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILK-AKL------GMP--- 218 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHc-CCC------CCC---
Confidence 2345789999999999988899999999999999999999999974321 112222211 111 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQ 847 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~e 847 (892)
......+.+++.+|++.+|++||++.+
T Consensus 219 -~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 -QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112245678999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.47 Aligned_cols=260 Identities=23% Similarity=0.355 Sum_probs=199.3
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEcc--CCCchhhHHHHHHHHHHHhccccceeeEeeEeec-----CCcEEEEEE
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLS--PSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE-----GTNMALIYE 656 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~--~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~-----~~~~~LV~E 656 (892)
.+.||+|++|.|.+++. ++..||||++. .......++-.+|+.+|++++|+||+.+.+.+.. -...++|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 36799999999999988 78999999997 4455567888999999999999999999998854 356999999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
+|+ .+|...++... .++......+..|+++||.|+|+. +|+||||||+|+|++.+..+||+|||||+.......
T Consensus 107 lMe-tDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 107 LME-TDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred HHh-hHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 995 48999998654 388999999999999999999999 999999999999999999999999999998754323
Q ss_pred ccccccccCCCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHH--------HhHhhcCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWV--------SSMLDKGDI 807 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~ 807 (892)
....+..+.|.-|.|||.+. ...|+...||||.|||+.||++|++-|.+.+....-.+..-+ ...+.....
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 33446667899999999986 457999999999999999999999999876532111110000 000000000
Q ss_pred ccccC--CCCC-CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 808 RSTVD--PRLK-GDF---DINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 808 ~~~~D--~~l~-~~~---~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
+..+. |... ..+ -.......++|+.+|+..||.+|+|++|+++.
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 0000 000 01233456799999999999999999999874
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=315.57 Aligned_cols=238 Identities=26% Similarity=0.410 Sum_probs=189.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhcccc-ceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHR-NLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~-NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.+.+.||+|+||.||+|+. +++.||||++... .....+.+..|.+++..++|+ +|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 4567899999999999988 5678999998753 223456678899999999765 588888999888999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05587 83 VNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-- 155 (324)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--
Confidence 99999999987543 388999999999999999999998 99999999999999999999999999987532111
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+...... ... +.+..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~-~~~------~~~~~ 222 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQSIM-EHN------VSYPK 222 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHH-cCC------CCCCC
Confidence 122345689999999999999999999999999999999999999974331 11111111 111 11111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFM 845 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm 845 (892)
.....+.+++.+|+..+|++|++.
T Consensus 223 ----~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 ----SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 123456799999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=303.35 Aligned_cols=246 Identities=27% Similarity=0.393 Sum_probs=195.7
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC-CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||+|+||.||+|+. +++.||+|.+... .....+++.+|++++.+++||||+++++++......++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 3457899999999999987 7788999998654 233456789999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|..+. .+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++...... ..
T Consensus 84 ~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~ 150 (279)
T cd06619 84 GSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IA 150 (279)
T ss_pred CChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cc
Confidence 9986552 267888999999999999999998 9999999999999999999999999998765322 12
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCc-cHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHT-HVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
....++..|+|||++.+..++.++||||||+++|||++|+.||......... ....+........ .+.+.
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~--- 221 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLP--- 221 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCC---
Confidence 3456889999999999889999999999999999999999999754322111 1112221111111 11111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11122356799999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=317.78 Aligned_cols=236 Identities=29% Similarity=0.409 Sum_probs=188.6
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHH-HHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVK-LLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+. +++.||||++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999998 68899999986532 222344555554 56789999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT 153 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence 99999887643 488999999999999999999998 9999999999999999999999999998753221 1223
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ... +.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~-~~~--~~~------- 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNILNK-PLR--LKP------- 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHHcC-CCC--CCC-------
Confidence 34578999999999999999999999999999999999999997432 22222222221 110 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMN 846 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~ 846 (892)
.....+.+++.+|++.+|++||+++
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234567999999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=305.64 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=201.1
Q ss_pred hhhhceecccccEEEEEEEE--CC---cEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DN---DEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~---~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
+.+.+.||+|+||.||+|+. ++ ..+|+|.++... ....+.+..|++++++++||||+++.+++..++..++|||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 34568999999999999986 22 369999987543 2345678999999999999999999999999999999999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
|+++++|.+++..... .+++.++..++.|++.||+|||+. +++||||||+|||++.++.+|++|||++..+.....
T Consensus 86 ~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 86 YMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred cCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 9999999999976543 489999999999999999999998 999999999999999999999999999987643221
Q ss_pred ccc-cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 737 THV-STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 737 ~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
... .....++..|+|||++.+..++.++|+||||++++|+++ |+.||..... ........ ++. . +.
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~----~~~-~----~~ 229 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIE----EGY-R----LP 229 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHh----CCC-c----CC
Confidence 111 112223567999999998899999999999999999887 9999864321 11222221 111 0 00
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
. .......+.+++.+|++.+|++||+|.++++.|+++
T Consensus 230 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 A----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 112234677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.49 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=202.5
Q ss_pred HhhhhhceecccccEEEEEEEEC-----CcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKLD-----NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV 654 (892)
....+.+.||+|+||.||+|+.. ...||||...... ....+.+.+|++++++++|+||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 33456689999999999999872 2368999987665 3455689999999999999999999998875 457899
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
|||+++|+|.+++..... .+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999976432 489999999999999999999998 9999999999999999999999999998866432
Q ss_pred CCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 735 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
. ........++..|+|||.+....++.++||||||++++||++ |+.||...... ....+. ..+...
T Consensus 161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~~~~~----- 227 (270)
T cd05056 161 S-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI----ENGERL----- 227 (270)
T ss_pred c-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCCcC-----
Confidence 1 112223334568999999988889999999999999999996 99999754321 111111 111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAME 859 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e 859 (892)
... ......+.+++.+|+..+|++||++.++++.|+++...+
T Consensus 228 ~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 PMP----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011 122346778999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=304.55 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=201.9
Q ss_pred hhhhhceecccccEEEEEEEE------CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecC--CcEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKL------DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMA 652 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~ 652 (892)
++...+.||+|+||.||.++. ++..||+|.++... ....+.+.+|++++++++|+|++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 344567899999999999874 46789999987553 33446789999999999999999999998765 5689
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999986543 2489999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCc-cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---------CCCccHHHHHHhHh
Q 002688 733 VEGGT-HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAE---------NGHTHVAQWVSSML 802 (892)
Q Consensus 733 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~---------~~~~~l~~~~~~~~ 802 (892)
..... .......++..|+|||++.+..++.++||||||+++|||++++.|...... ........++. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HH
Confidence 32221 112234567789999999888899999999999999999998766432211 00111111111 11
Q ss_pred hcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 803 ~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
..+.... ........+.+++.+|++.+|++||++.++++.|+++
T Consensus 240 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111110 0112345788999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.43 Aligned_cols=258 Identities=23% Similarity=0.384 Sum_probs=195.5
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCC-----cEEEEEEec
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT-----NMALIYEYM 658 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~-----~~~LV~Ey~ 658 (892)
.+++|.|+||.||+|++ +++.||||+.-.... .-.+|+++|++++|||||+|+-++.... ...||||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 36899999999999998 668999999765422 2257999999999999999999886432 356899999
Q ss_pred cCCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC-CcEEEeeecCcccccCCC
Q 002688 659 ANGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK-FQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 659 ~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~-~~vkl~DfGla~~~~~~~ 735 (892)
+. +|.+.++.. .++.++...+.-+..|+.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+....
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 87 899988753 234578888889999999999999998 99999999999999976 999999999999885433
Q ss_pred CccccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcC---CC----
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG---DI---- 807 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~---- 807 (892)
.. .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+. ...+...++ ++... ++
T Consensus 181 pn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik-~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 181 PN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIK-VLGTPTREDIKSMN 254 (364)
T ss_pred Cc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHH-HhCCCCHHHHhhcC
Confidence 22 334467899999999875 699999999999999999999999987542 122222222 11110 00
Q ss_pred ---ccccCCCCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHHHh
Q 002688 808 ---RSTVDPRLKGD-----FDINSVWKAVEIAMACVSSNANRRPFMNQVVM--ELNDCLA 857 (892)
Q Consensus 808 ---~~~~D~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~--~L~~~~~ 857 (892)
.+.-.|.+... .......+.++++.++++.+|.+|.+..|+++ ..+++..
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 01111222211 22345567889999999999999999999986 3444433
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.55 Aligned_cols=244 Identities=27% Similarity=0.391 Sum_probs=204.0
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
++.+.||+|-||.||.|+. ++-.||+|++.+.. .+..+++.+|+++-+.++||||+++++++.+....+|++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 3468999999999999988 56689999987653 233468899999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
..|.+...|++.....++......++.|+|.||.|+|.+ ++|||||||+|+|++..+..||+|||.+..-+ ..
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~ 177 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SN 177 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC----CC
Confidence 999999999977666689999999999999999999998 99999999999999999999999999886532 33
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.....+||.-|.+||...+...+...|+|++|++.||++.|.+||.....+ ..+.+ +.+ .+..+|
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--etYkr-I~k-------~~~~~p----- 242 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--ETYKR-IRK-------VDLKFP----- 242 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--HHHHH-HHH-------ccccCC-----
Confidence 445778999999999999999999999999999999999999999854421 11111 111 112222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......+.+++.+|+..+|.+|.+..||+..
T Consensus 243 --~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 --STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1223456799999999999999999998763
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=298.59 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=205.2
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.+.+.||+|+||.||+|.. +++.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 34568899999999999988 6889999988643 223356789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 658 MANGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 658 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
+++|+|.+++... ....+++..+..++.+++.||+|||+. +++||||||+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 9999999988643 234589999999999999999999998 99999999999999999999999999987653221
Q ss_pred CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ....+...... .+... ..
T Consensus 161 --~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~~~-----~~ 228 (267)
T cd08224 161 --TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIE-KCDYP-----PL 228 (267)
T ss_pred --cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhh-cCCCC-----CC
Confidence 11223457889999999998889999999999999999999999986332 22222222211 11111 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
. .......+.+++.+|+..+|++||++.+|+++|+++
T Consensus 229 ~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 P---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 112344677999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=306.57 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=198.1
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.+.||+|+||.||+|+. +++.||+|++........+.+.+|+.++++++|+||+++++++..++..++|+||+++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 44567899999999999987 6788999999766555556788999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.++++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+.... ...
T Consensus 91 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~ 163 (267)
T cd06646 91 GSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKR 163 (267)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc--ccc
Confidence 99999987543 489999999999999999999998 99999999999999999999999999998653221 112
Q ss_pred ccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
....++..|+|||.+. ...++.++|||||||+++||++|+.|+........ ...+ ..... ..+....
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~-----~~~~~---~~~~~~~ 233 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLM-----SKSNF---QPPKLKD 233 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heee-----ecCCC---CCCCCcc
Confidence 2346788999999884 34578899999999999999999999864321110 0000 00000 0111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L 852 (892)
.......+.+++.+|+..+|++||+++++++.|
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112235678999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=317.29 Aligned_cols=243 Identities=28% Similarity=0.390 Sum_probs=190.0
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHH-HHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVK-LLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+++. +++.||+|++.... ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999988 66789999986532 122234444444 56788999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.... .+.......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~ 153 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTT 153 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCc
Confidence 99999987643 377888889999999999999998 9999999999999999999999999998754221 1123
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|++.|+|||++.+..++.++|||||||++|||++|++||..... .+........ .. .+.+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~-~~--~~~~~------ 218 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK-PL--QLKPN------ 218 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhC-Cc--CCCCC------
Confidence 355799999999999999999999999999999999999999974321 2222222211 11 01111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
....+.+++.+|++.+|.+||++.+.+.++.
T Consensus 219 --~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 219 --ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred --CCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 2235678999999999999999875544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.80 Aligned_cols=247 Identities=25% Similarity=0.339 Sum_probs=197.1
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
..+.||+|+||.||++.. +++.||||.+.... ....+.+.+|+.++++++|+|++++.+.+...+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 447899999999999988 67899999986542 2223457789999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....... .
T Consensus 84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 157 (285)
T cd05630 84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---T 157 (285)
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---c
Confidence 99999998765555689999999999999999999998 99999999999999999999999999987653221 1
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||......... +-........ . ....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~--~----~~~~--- 225 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEV--Q----EEYS--- 225 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhh--h----hhcC---
Confidence 12346899999999999989999999999999999999999999754321110 0011111100 0 0111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPF-----MNQVVM 850 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eVl~ 850 (892)
......+.+++.+|++.+|++||+ +.|+++
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 -EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 112234679999999999999999 788877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=318.99 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=195.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.+.+.||+|+||.||+++. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05596 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY 124 (370)
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcC
Confidence 44567899999999999988 6789999998643 122334578899999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++... .++......++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 125 ~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~ 197 (370)
T cd05596 125 MPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-M 197 (370)
T ss_pred CCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-c
Confidence 9999999998654 378888889999999999999998 99999999999999999999999999998653222 1
Q ss_pred cccccccCCCCccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
.......|++.|+|||.+.+. .++.++|||||||++|||++|++||..... ............. .
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~--~--- 266 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNS--L--- 266 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCc--C---
Confidence 122345799999999998653 478999999999999999999999974321 1112222211100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANR--RPFMNQVVME 851 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eVl~~ 851 (892)
.... .......+.+++.+|++.+|++ ||++.|+++.
T Consensus 267 ~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0110 1122346678999999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=320.30 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=194.1
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+.||+|+||.||+++. +++.||||++.... ....+.+.+|++++..++|+||+++++++.++...++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 457899999999999988 67899999986532 2334567889999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc-
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH- 738 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~- 738 (892)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+.......
T Consensus 85 ~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 85 GGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 999999987643 489999999999999999999998 99999999999999999999999999987643211000
Q ss_pred -----------------------------------ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002688 739 -----------------------------------VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVI 783 (892)
Q Consensus 739 -----------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~ 783 (892)
......||+.|+|||++.+..++.++|||||||++|||++|++||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011246899999999999999999999999999999999999999
Q ss_pred CccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002688 784 SKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPF---MNQVVM 850 (892)
Q Consensus 784 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---m~eVl~ 850 (892)
..... .+............ .+ | . .......+.+++.+|+. +|.+|++ +.|+++
T Consensus 240 ~~~~~------~~~~~~i~~~~~~~-~~-~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 240 CSDNP------QETYRKIINWKETL-QF-P---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCH------HHHHHHHHcCCCcc-CC-C---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 74331 11122222111000 00 0 0 00122345688888886 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.20 Aligned_cols=246 Identities=27% Similarity=0.402 Sum_probs=199.4
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+...+.||+|+||.||+|.. ++..||+|.+.... ....+.+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 344457899999999999987 57789999987543 334567899999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++++|.+++... .+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++..+.... .
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06642 85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc--h
Confidence 999999988653 488999999999999999999998 99999999999999999999999999987653221 1
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
......++..|+|||++.+..++.++||||||++++||++|+.|+...... .+... +..+ ..+.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~-~~~~-----~~~~~~-- 222 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM------RVLFL-IPKN-----SPPTLE-- 222 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh------hHHhh-hhcC-----CCCCCC--
Confidence 223346788999999999889999999999999999999999998643211 11111 1111 111121
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......+.+++.+|++.+|++||+|.++++.
T Consensus 223 --~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 --GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2234567899999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=316.75 Aligned_cols=197 Identities=26% Similarity=0.452 Sum_probs=170.3
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+.||+|+||+||+++. +++.||||++.... ......+.+|+.++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 457899999999999987 67899999986532 2233567889999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc--
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT-- 737 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~-- 737 (892)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 85 GGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 999999997643 489999999999999999999998 9999999999999999999999999998765321100
Q ss_pred -------------------------------cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 002688 738 -------------------------------HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKS 786 (892)
Q Consensus 738 -------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~ 786 (892)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012357999999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=323.89 Aligned_cols=257 Identities=20% Similarity=0.260 Sum_probs=192.5
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
.+.+.||+|+||.||++.. .++.||||.... ..+.+|++++++++|+||+++++++..++..++|||++. +
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 3457899999999999998 567899996432 346789999999999999999999999999999999995 6
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++.... ..++|..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++............
T Consensus 245 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 245 DLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 8888886543 2599999999999999999999998 99999999999999999999999999998764332222233
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-CCCccHHHHHHhHhhcCCCc-cccCC----CC
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAE-NGHTHVAQWVSSMLDKGDIR-STVDP----RL 815 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~-~~~D~----~l 815 (892)
...||..|+|||++.+..++.++|||||||++|||++|..++..... ........-+.+.+...... ..+.+ ++
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 56799999999999999999999999999999999998765533221 11111111111111111110 00000 00
Q ss_pred ------------CCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 816 ------------KGDFD-------INSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 816 ------------~~~~~-------~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
..... ......+.+|+.+|++.||++|||+.|+++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0112256789999999999999999999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=318.29 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=197.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+++. +++.||+|+++... ....+.+.+|+.+++.++|+||+++.+++.+....++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 4567899999999999987 68899999987542 224456889999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+..... .
T Consensus 84 ~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~ 158 (330)
T cd05601 84 PGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-V 158 (330)
T ss_pred CCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-e
Confidence 9999999997653 3489999999999999999999998 999999999999999999999999999987643221 2
Q ss_pred ccccccCCCCccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccC
Q 002688 739 VSTTIAGTPGYLDPEYYI------SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~------~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D 812 (892)
......|++.|+|||++. ...++.++|||||||++|||++|+.||.... .................
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------~~~~~~~i~~~~~~~~~-- 230 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT------SAKTYNNIMNFQRFLKF-- 230 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC------HHHHHHHHHcCCCccCC--
Confidence 233456899999999986 4567899999999999999999999996432 12222332222111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 813 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
| . .......+.+++..|+. +|++||++.++++
T Consensus 231 ~---~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 P---E--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C---C--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0 01123456788899998 9999999999886
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=338.08 Aligned_cols=258 Identities=23% Similarity=0.337 Sum_probs=201.6
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+|+. +++.||||++.... ....++|.+|++++++++||||+++++++.+++..++||||+
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 4457899999999999987 67899999987542 233467999999999999999999999999999999999999
Q ss_pred cCCchhhhccccC---------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcc
Q 002688 659 ANGNLEEHLSDSS---------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 659 ~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~ 729 (892)
++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999886421 23467888899999999999999998 99999999999999999999999999998
Q ss_pred cccCCCC----------------ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCcc
Q 002688 730 VFPVEGG----------------THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTH 793 (892)
Q Consensus 730 ~~~~~~~----------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~ 793 (892)
....... ........||+.|||||++.+..++.++|||||||+++||++|+.||...... .
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~---k 238 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR---K 238 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh---h
Confidence 6521110 00112346899999999999999999999999999999999999999753211 1
Q ss_pred HHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHhh
Q 002688 794 VAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRP-FMNQVVMELNDCLAM 858 (892)
Q Consensus 794 l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-sm~eVl~~L~~~~~~ 858 (892)
+. +. ..+ .+|.-... ..+....+.+++.+|++.+|++|| +++++.+.|+..++.
T Consensus 239 i~-~~------~~i---~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 IS-YR------DVI---LSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh-hh------hhc---cChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 10 00 000 11100000 012234567899999999999995 678888888887654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=316.43 Aligned_cols=248 Identities=24% Similarity=0.417 Sum_probs=209.2
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCc-EEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTN-MALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~-~~LV~Ey 657 (892)
+...+++|+|+||.++..++ ++..+++|.+.-.. ....+...+|+.++++++|||||.+.+.+.+++. .++||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 34557899999999987655 78899999986543 3344567899999999999999999999998888 9999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
++||++.+.+.+.++..++.....+++.|++.|+.|||++ +|+|||||+.||+++.+..+||.|||+|+.+....
T Consensus 86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 9999999999888777899999999999999999999988 99999999999999999999999999999875443
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.....+.||+.||+||.+.+..|..|+|||||||++|||++-+++|... ++...+.+..... ++|
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~------~m~~Li~ki~~~~-----~~P---- 225 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS------NMSELILKINRGL-----YSP---- 225 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc------chHHHHHHHhhcc-----CCC----
Confidence 2445678999999999999999999999999999999999999999743 3333343333211 122
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.+......+..++..|++.+|+.||++.+++.+
T Consensus 226 -lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 -LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 223345567789999999999999999999986
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.16 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=202.7
Q ss_pred hhhhceecccccEEEEEEEE--CCc----EEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DND----EVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~----~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
+.+.+.||+|+||.||+|.. ++. .+|+|.+..... ....++.+|++.+++++|+|++++++++.. ...++|+
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 45567999999999999987 333 589998876543 345678999999999999999999999987 7889999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 88 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 88 QLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred ecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999976543 389999999999999999999998 99999999999999999999999999998764332
Q ss_pred CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
.........++..|+|||.+....++.++|+||||++++|+++ |+.||.... ..++..... .+... -.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~-~~~~~--~~-- 232 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP------AVEIPDLLE-KGERL--PQ-- 232 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC------HHHHHHHHh-CCCCC--CC--
Confidence 2222222334568999999988899999999999999999999 999986432 222222222 11110 00
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
+..+...+.+++.+|+..+|++||++.++++.|+++..
T Consensus 233 -----~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 -----PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11123457799999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.02 Aligned_cols=245 Identities=22% Similarity=0.388 Sum_probs=199.0
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
.+.+.||+|+||.||+|+. +++.||+|.+........+.+.+|+.+++.++|+|++++++.+..+.+.++||||++++
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~ 102 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (296)
T ss_pred eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence 3457899999999999986 67899999988765555678899999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 103 ~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~ 174 (296)
T cd06654 103 SLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 174 (296)
T ss_pred CHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc--cccC
Confidence 999998643 378999999999999999999998 99999999999999999999999999987653221 1123
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
...++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+.. ....+. +.+. ...
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-----~~~~~~-~~~~~~------~~~~--~~~ 240 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYL-IATNGT------PELQ--NPE 240 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-----HHhHHH-HhcCCC------CCCC--Ccc
Confidence 34688899999999988899999999999999999999999974332 111111 111110 0111 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.....+.+++.+|+..+|++||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 22345778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=317.84 Aligned_cols=242 Identities=30% Similarity=0.405 Sum_probs=191.2
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHH-HHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVK-LLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~-~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+. +++.+|+|++... .....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 6889999998653 1223345556655 46778999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT 153 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence 99998886543 489999999999999999999998 9999999999999999999999999998753211 1223
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|+..|+|||++.+..++.++|||||||++|||++|++||.... ..+........ .. .+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~~~~~-~~--~~~~------- 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD------VAEMYDNILHK-PL--VLRP------- 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC------HHHHHHHHHcC-Cc--cCCC-------
Confidence 35578999999999999999999999999999999999999997432 12222222221 11 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L 852 (892)
.....+.+++.+|++.+|++||++++.++++
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 1234566899999999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.93 Aligned_cols=250 Identities=29% Similarity=0.499 Sum_probs=198.3
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhH--HHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYK--QFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~--~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|+||+||+++. +++.+|+|.+......... ...+|+.++++++|+||+++++++......++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 4567999999999999999 5568999999887554332 34569999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|.+++.. ...+++..+..++.|+++||++||+. +++|+||||+||++++++.++|+|||.+... ......
T Consensus 82 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~ 154 (260)
T PF00069_consen 82 GGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN 154 (260)
T ss_dssp TEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred cccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccccc
Confidence 9999999983 23489999999999999999999998 9999999999999999999999999998754 122233
Q ss_pred cccccCCCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.....++..|+|||.+. +...+.++||||+|+++++|++|+.|+...... +............ .. ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~-~~----~~~~-- 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILKRP-LP----SSSQ-- 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHHTH-HH----HHTT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhccccc-cc----cccc--
Confidence 44567889999999998 788999999999999999999999999854111 1111111111100 00 0000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
........+.+++.+|++.+|++||++.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011267889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.05 Aligned_cols=238 Identities=25% Similarity=0.389 Sum_probs=187.8
Q ss_pred eecccccEEEEEEEEC--------------------------CcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeE
Q 002688 588 VLGKGGFGTVYHGKLD--------------------------NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~~--------------------------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l 641 (892)
.||+|+||.||+|++. ...||+|.+..........|.+|+++++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999999751 12489999876555555678899999999999999999
Q ss_pred eeEeecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC---
Q 002688 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF--- 718 (892)
Q Consensus 642 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~--- 718 (892)
+++|......++||||+++|+|..++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999886543 3488999999999999999999998 999999999999997643
Q ss_pred ----cEEEeeecCcccccCCCCccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCccccCCCc
Q 002688 719 ----QAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEII-TGHPVISKSAENGHT 792 (892)
Q Consensus 719 ----~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELl-tG~~p~~~~~~~~~~ 792 (892)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--- 228 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS--- 228 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH---
Confidence 3899999987643211 12346788999998865 56899999999999999995 689988643321
Q ss_pred cHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 793 HVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 793 ~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
....+.. ... .+... ....+.+++.+|++.+|++||++.+|++.|.
T Consensus 229 ~~~~~~~----~~~-------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EKERFYE----KKH-------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHH----hcc-------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111111 110 01111 1135779999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.88 Aligned_cols=239 Identities=24% Similarity=0.404 Sum_probs=189.2
Q ss_pred ceecccccEEEEEEEECC--------------cEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEE
Q 002688 587 RVLGKGGFGTVYHGKLDN--------------DEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMA 652 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~--------------~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~ 652 (892)
+.||+|+||.||+|++.. ..|++|.+........+.|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998621 258999987665555667899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCc-------EEEeee
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQ-------AKLADF 725 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~-------vkl~Df 725 (892)
+||||+++|+|..++.... ..+++..+.+++.|+++||+|||+. +|+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999998886543 3489999999999999999999998 9999999999999987654 899999
Q ss_pred cCcccccCCCCccccccccCCCCccCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCccccCCCccHHHHHHhHhh
Q 002688 726 GLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLEII-TGHPVISKSAENGHTHVAQWVSSMLD 803 (892)
Q Consensus 726 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SlGvvl~ELl-tG~~p~~~~~~~~~~~l~~~~~~~~~ 803 (892)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+...... ... ...
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~----~~~- 222 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA---EKE----RFY- 222 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---HHH----HHH-
Confidence 998754221 2345778899999886 466899999999999999998 588877532211 010 111
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 804 KGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 804 ~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
.+... .. ......+.+++.+|++.+|++||++.++++.|+
T Consensus 223 ~~~~~-~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQCM-LV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCcc-CC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11110 00 112345779999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=319.33 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=198.8
Q ss_pred HHHHHhhhhhceecccccEEEEEEEE----CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEE
Q 002688 577 EVLRMTNNFERVLGKGGFGTVYHGKL----DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMA 652 (892)
Q Consensus 577 el~~~t~~f~~~IG~G~fG~Vy~~~~----~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~ 652 (892)
.+....+.+.+.||+|+||.||++.. .+..||||.+... +...+|++++++++|+||+++++++......+
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 34445567778999999999999876 3467999988653 34568999999999999999999999999999
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+|||++. ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 163 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 9999986 5888888433 3489999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCc-cHHHHHHhHhhcCCC----
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHT-HVAQWVSSMLDKGDI---- 807 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~---- 807 (892)
............||..|+|||++.+..++.++|||||||++|||++|+.||......... .+.... ..+.....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~-~~~~~~~~~~~~ 315 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII-RCMQVHPLEFPQ 315 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH-HHhccCccccCC
Confidence 333333334567999999999999999999999999999999999999999754332111 111111 11110000
Q ss_pred -------------ccccCCCCC--CCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 808 -------------RSTVDPRLK--GDF-DINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 808 -------------~~~~D~~l~--~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.....+... ... .......+.+++.+|+..+|++||++.|++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000 00123456789999999999999999999875
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.59 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=191.1
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhc---cccceeeEeeEeec-----CCcE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRV---HHRNLTTLVGYCDE-----GTNM 651 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~NIv~l~g~~~~-----~~~~ 651 (892)
.+.+.||+|+||.||+|+. +++.||+|.++.... .....+.+|+++++.+ +|+||+++++++.. ....
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 4557899999999999988 678899999875422 1223556777777665 79999999998754 3458
Q ss_pred EEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccc
Q 002688 652 ALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731 (892)
Q Consensus 652 ~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~ 731 (892)
++||||+.+ +|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 83 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 83 TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 999999985 898888766555689999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh--cCCCc-
Q 002688 732 PVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD--KGDIR- 808 (892)
Q Consensus 732 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~- 808 (892)
.... ......++..|+|||++.+..++.++|||||||++|||++|++||...... ..+.+....... .....
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 159 SCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHHHHHHhCCCChhhCcc
Confidence 3221 123456789999999999889999999999999999999999998643321 111111110000 00000
Q ss_pred ------cccCCCCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 809 ------STVDPRLKG---DFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 809 ------~~~D~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+.+.... ....+....+.+++.+|++.||++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001110000 001122345679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=303.20 Aligned_cols=243 Identities=25% Similarity=0.327 Sum_probs=193.3
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
..+.||+|+||+||+|+. +++.+|+|.+.... ....+.+.+|++++++++|+|++++.+.+..++..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 346899999999999988 67899999986542 2233457889999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~ 157 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---S 157 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---c
Confidence 99999988765545699999999999999999999998 99999999999999999999999999987653221 1
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.....|+..|+|||++.+..++.++|+||||+++|||++|+.||....+.. ....+. ....... .. ..
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~-~~~~~~~--~~----~~--- 225 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVD-RRVLETE--EV----YS--- 225 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-Hhhhccc--cc----cC---
Confidence 234568999999999998899999999999999999999999997433211 111111 1111111 01 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMN 846 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~ 846 (892)
......+.+++.+|++.+|++||++.
T Consensus 226 -~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 226 -AKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred -ccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11223567899999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.73 Aligned_cols=237 Identities=25% Similarity=0.405 Sum_probs=189.4
Q ss_pred ceecccccEEEEEEEECCc------------EEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEE
Q 002688 587 RVLGKGGFGTVYHGKLDND------------EVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~------------~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV 654 (892)
+.||+|+||.||+|..... .+++|.+...... ...|.+|++++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4689999999999988322 4788887655433 5788999999999999999999999988 778999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC-------cEEEeeecC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF-------QAKLADFGL 727 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~-------~vkl~DfGl 727 (892)
+||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976543 489999999999999999999998 999999999999999887 799999999
Q ss_pred cccccCCCCccccccccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhc
Q 002688 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDK 804 (892)
Q Consensus 728 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 804 (892)
+..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+...... ....+.. ..
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~~~---~~ 222 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERFYQ---DQ 222 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHHHh---cC
Confidence 886532 1233466789999999876 78999999999999999999 46776543211 1111111 11
Q ss_pred CCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 805 GDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 805 ~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
.. +. ......+.+++.+|+..+|.+||++.++++.|+
T Consensus 223 ~~--------~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HR--------LP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC--------CC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 001156789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=299.41 Aligned_cols=246 Identities=26% Similarity=0.445 Sum_probs=194.0
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEeecC------CcEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG------TNMALI 654 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~------~~~~LV 654 (892)
++.+.||+|+||.||+|+. +++.||+|.+.... .....+..|+.++.++ +|+|++++++++... ...++|
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 3456899999999999988 67889999986543 3346788999999998 799999999998643 458999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
|||+.+|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 9999999999999876555689999999999999999999998 9999999999999999999999999998765321
Q ss_pred CCccccccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcc
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRS 809 (892)
Q Consensus 735 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 809 (892)
. .......|+..|+|||++. +..++.++|||||||++|||++|+.||..... ...+.. .......
T Consensus 165 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----~~~~~~--~~~~~~~- 234 (272)
T cd06637 165 V--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----MRALFL--IPRNPAP- 234 (272)
T ss_pred c--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----HHHHHH--HhcCCCC-
Confidence 1 1223456889999999986 34588899999999999999999999864321 111111 1111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 810 TVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 810 ~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+. .......+.+++.+|+..+|.+||++.|+++
T Consensus 235 ----~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 235 ----RLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----CCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 1122345779999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=299.99 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=196.6
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
++.+.||+|+||.||+|.. ++..+++|.+........+.+.+|+++++.++|+|++++++++..+...++|+||++++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 4457899999999999988 56788999987766666678999999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|..++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... .....
T Consensus 88 ~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 161 (282)
T cd06643 88 AVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD 161 (282)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence 9998876532 3489999999999999999999998 9999999999999999999999999998765321 12223
Q ss_pred cccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 742 TIAGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
...++..|+|||++. +..++.++|||||||++|||++|++||..... .+-+........ .....+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~-~~~~~~--- 231 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEP-PTLAQP--- 231 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcCC-CCCCCc---
Confidence 456889999999984 34578899999999999999999999864321 111111111111 000011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......+.+++.+|++.+|++||++.++++
T Consensus 232 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 232 ----SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112345779999999999999999998875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=311.46 Aligned_cols=238 Identities=26% Similarity=0.426 Sum_probs=190.3
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
++.+.||+|+||.||+|+. +++.||+|++.... ....+.+..|.+++..+. |++|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 4568999999999999987 67899999987532 233456778888888885 57788899999988999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-- 155 (323)
T cd05615 83 VNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-- 155 (323)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC--
Confidence 99999999987543 389999999999999999999998 99999999999999999999999999987542221
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.......|++.|+|||++.+..++.++|||||||++|||++|++||..... ......... ... .+.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~-~~~------~~p- 221 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSIME-HNV------SYP- 221 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCC------CCC-
Confidence 122345689999999999988999999999999999999999999975432 112222221 111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFM 845 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm 845 (892)
......+.+++.+|++.+|++|++.
T Consensus 222 ---~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 ---KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1123456789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=298.83 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=191.1
Q ss_pred eecccccEEEEEEEE-CC---cEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 588 VLGKGGFGTVYHGKL-DN---DEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~-~~---~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
.||+|+||.||+|+. ++ ..+++|.+.... ....+.|.+|+..++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999976 33 246677766543 3455789999999999999999999999999999999999999999
Q ss_pred hhhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 663 LEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 663 L~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|.+++.... ....++.....++.|++.||+|||+. +++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997643 23467778889999999999999998 9999999999999999999999999998643222211222
Q ss_pred ccccCCCCccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccC
Q 002688 741 TTIAGTPGYLDPEYYIS-------NRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~-------~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D 812 (892)
....++..|+|||++.. ..++.++||||||+++|||++ |..||....+ .+.....+.+ ......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccccCC
Confidence 34567889999999753 245789999999999999997 4667753221 2222222322 2233344
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 813 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
|.+...++ ..+.+++..|+ .+|++||++++|++.|.
T Consensus 232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 54443332 34567888999 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=309.55 Aligned_cols=256 Identities=18% Similarity=0.254 Sum_probs=194.1
Q ss_pred hhceeccc--ccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 585 FERVLGKG--GFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 585 f~~~IG~G--~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
+.++||+| +|++||+++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 7899999987 78899999987542 223456778999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++||+........+...
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999765545589999999999999999999998 99999999999999999999999998654432111110
Q ss_pred -----ccccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcccc
Q 002688 739 -----VSTTIAGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811 (892)
Q Consensus 739 -----~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 811 (892)
......++..|+|||++.+ ..++.++|||||||+++||++|+.||....... ....... +.....+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~-----~~~~~~~ 231 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLN-----GTVPCLL 231 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhc-----CCccccc
Confidence 1122346778999999976 458999999999999999999999997432110 0000000 0000000
Q ss_pred -------------------CCCC-----------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 812 -------------------DPRL-----------------KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 812 -------------------D~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+..+ ...........+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 00011123446789999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=299.42 Aligned_cols=247 Identities=26% Similarity=0.492 Sum_probs=198.7
Q ss_pred hhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 584 NFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
.+.+.||+|+||.||+|.+ ++..+|+|.+..... ...+|.+|++++++++|+|++++++++......++|+||+++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 4567899999999999988 578899999875432 24578999999999999999999999999999999999999999
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 742 (892)
|.+++..... .+++..+..++.+++.+|+|||+. +++|+||||+||+++.++.+||+|||+++...... ......
T Consensus 86 L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05112 86 LSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTG 160 (256)
T ss_pred HHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc-ccccCC
Confidence 9999875433 478999999999999999999998 99999999999999999999999999987653221 111122
Q ss_pred ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 743 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
..++.+|+|||.+.++.++.++||||||+++|||++ |+.||.... ..+..... .++. ....+..
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~~-~~~~--~~~~~~~------ 225 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS------NSEVVETI-NAGF--RLYKPRL------ 225 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC------HHHHHHHH-hCCC--CCCCCCC------
Confidence 335678999999998899999999999999999998 899986432 12222222 1111 1112222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L 852 (892)
....+.+++.+|++.+|++||++.|++++|
T Consensus 226 -~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 -ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 235678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=299.03 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=196.6
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCc-----hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-----QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~-----~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
..+.||+|++|.||++.. +++.+|+|.+..... ...+.+.+|++++++++|+||+++++++..++..++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 457899999999999987 678999999865421 1235688999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++++|.+++.... .+++.....++.|++.||+|||+. +++||||||+||++++++.++|+|||+++........
T Consensus 86 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 86 MPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred CCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999987543 388899999999999999999998 9999999999999999999999999998765322111
Q ss_pred c-ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 738 H-VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 738 ~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ... ......... .+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~~~~~-----~~~~- 228 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----MAA-IFKIATQPT-----NPQL- 228 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----HHH-HHHHhccCC-----CCCC-
Confidence 1 11234578899999999998999999999999999999999999864221 111 111111111 0111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
+......+.+++.+|+..+|++||++.|+++.
T Consensus 229 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 ---PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11233457799999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.42 Aligned_cols=245 Identities=27% Similarity=0.480 Sum_probs=198.6
Q ss_pred hhhhceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 583 NNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
+.+.+.||+|+||.||+++..++.||+|.++... ..+.+.+|+.++++++|+|++++.+++... ..++||||+++|+
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred ceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 4556899999999999999999999999986543 235788999999999999999999998664 4789999999999
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 742 (892)
|.+++.......+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~ 156 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDN 156 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-----CCC
Confidence 99999876555689999999999999999999998 9999999999999999999999999998754211 112
Q ss_pred ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 743 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
...+..|+|||++.+..++.++|+||||++++||++ |+.||.... ..++... ...+... ++ ..
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~-~~~~~~~---~~------~~ 220 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS------LKEVKEC-VEKGYRM---EP------PE 220 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC------HHHHHHH-HhCCCCC---CC------CC
Confidence 234568999999988899999999999999999998 999986432 1222222 1111111 11 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.....+.+++.+|++.+|++||+++++++.|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 223567799999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.53 Aligned_cols=244 Identities=26% Similarity=0.431 Sum_probs=194.3
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
..||+|+||.||+|+. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 4799999999999987 56789999988776666778999999999999999999999999999999999999999999
Q ss_pred hhccccCcccC--CHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC-CCcEEEeeecCcccccCCCCccccc
Q 002688 665 EHLSDSSKEIL--NWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-KFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 665 ~~L~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+++..... .+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++....... ....
T Consensus 94 ~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~ 167 (268)
T cd06624 94 ALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTE 167 (268)
T ss_pred HHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCC--Cccc
Confidence 99976432 24 7888999999999999999998 9999999999999986 6799999999987653221 1122
Q ss_pred cccCCCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 742 TIAGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~--~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
...++..|+|||++.+.. ++.++||||||+++|||++|++||..... .....|...... ..+.+.
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~---~~~~~~~~~~~~-------~~~~~~--- 234 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE---PQAAMFKVGMFK-------IHPEIP--- 234 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC---hhhhHhhhhhhc-------cCCCCC---
Confidence 345788999999986543 78999999999999999999999864321 111111111110 011111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......+.+++.+|++.+|++||++.|+++
T Consensus 235 -~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 -ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 122345678999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=318.48 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=193.8
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCC-----cEEEEE
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT-----NMALIY 655 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~-----~~~LV~ 655 (892)
..+.||+|+||.||+++. +++.||||++... .....+++.+|+++++.++|+||+++++++.... ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 457899999999999987 7889999998653 2334567899999999999999999999998766 789999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
||+. ++|.+.+.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 84 e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred eccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9997 57877775433 489999999999999999999998 99999999999999999999999999998653222
Q ss_pred CccccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCC----------ccHHHH------H
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGH----------THVAQW------V 798 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~----------~~l~~~------~ 798 (892)
........++..|+|||.+.+. .++.++|||||||+++||++|++||........ ....++ .
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 158 -SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred -cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1222344678899999998874 479999999999999999999999975432110 000000 0
Q ss_pred HhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 799 SSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 799 ~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
...+..........+.+. ....+....+.+++.+|++.||++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 011100000000000000 0111224467799999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=304.28 Aligned_cols=239 Identities=23% Similarity=0.385 Sum_probs=189.6
Q ss_pred ceecccccEEEEEEEEC---------CcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 587 RVLGKGGFGTVYHGKLD---------NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.||+|+||.||+|... ...+|+|.+........+.+.+|+.+++.++|+|++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999762 234888888665555557789999999999999999999999998999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCc--------EEEeeecCcc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQ--------AKLADFGLSR 729 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~--------vkl~DfGla~ 729 (892)
+++|+|.++++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976543 489999999999999999999998 9999999999999987765 6999999886
Q ss_pred cccCCCCccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCccccCCCccHHHHHHhHhhcCCC
Q 002688 730 VFPVEGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSMLDKGDI 807 (892)
Q Consensus 730 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~ 807 (892)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|. +|+..... ..... .... .
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------~~~~~-~~~~-~- 221 (258)
T cd05078 157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------QKKLQ-FYED-R- 221 (258)
T ss_pred ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------HHHHH-HHHc-c-
Confidence 5422 123457889999999986 45799999999999999999995 55542211 11111 1111 0
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 808 RSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 808 ~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
..+. ......+.+++.+|++.+|++||+++++++.|+
T Consensus 222 -----~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -----HQLP----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----ccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111 112245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.08 Aligned_cols=258 Identities=23% Similarity=0.376 Sum_probs=193.5
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+.+.||+|+||.||+|+. +++.||+|.++.... .....+.+|++++++++|+||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 34457899999999999987 677899999875432 233467889999999999999999999999999999999998
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 88 ~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 160 (309)
T cd07872 88 K-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KT 160 (309)
T ss_pred C-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc--cc
Confidence 5 8888776543 3488999999999999999999998 99999999999999999999999999987643221 11
Q ss_pred cccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcC------------C
Q 002688 740 STTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG------------D 806 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~------------~ 806 (892)
.....++..|+|||.+.+ ..++.++||||||+++|||++|++||......+ ...-........ .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED---ELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHhhhcchhh
Confidence 223457889999999865 468999999999999999999999997543211 111111110000 0
Q ss_pred CccccCCCCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 807 IRSTVDPRLKGD----FDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 807 ~~~~~D~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
....-.+..... ........+.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 00112345679999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=319.09 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=192.5
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+..+.++||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 3457899999999999987 78899999986432 233456888999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc-
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT- 737 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~- 737 (892)
++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 84 PGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999987543 488899999999999999999998 9999999999999999999999999998643211000
Q ss_pred --------------------------------------------cccccccCCCCccCccccccCCCCchhhHHHHHHHH
Q 002688 738 --------------------------------------------HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVL 773 (892)
Q Consensus 738 --------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl 773 (892)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 000124689999999999998999999999999999
Q ss_pred HHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 002688 774 LEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRR---PFMNQVVM 850 (892)
Q Consensus 774 ~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Psm~eVl~ 850 (892)
|||++|++||..... .+............ .+... ......+.+++.+|+. +|.+| +++.|+++
T Consensus 239 ~elltG~~Pf~~~~~------~~~~~~i~~~~~~~-----~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 239 FECLIGWPPFCSENS------HETYRKIINWRETL-----YFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhcCCCCCCCCCH------HHHHHHHHccCCcc-----CCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 999999999974331 11111211111000 01110 1123456788899997 66665 59988887
Q ss_pred H
Q 002688 851 E 851 (892)
Q Consensus 851 ~ 851 (892)
.
T Consensus 305 h 305 (377)
T cd05629 305 H 305 (377)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.33 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=203.9
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+++.+.||+|+||+||++.. +++.||+|++.... ....+++.+|+++++.++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence 345567899999999999988 58889999876543 344578899999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++++|.+++.... .+++.....++.+++.+|.|||+. .+++||||||+||++++++.++|+|||++......
T Consensus 86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---- 157 (284)
T cd06620 86 DCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---- 157 (284)
T ss_pred CCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence 9999999887643 489999999999999999999973 27999999999999999999999999998754221
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccC-----CCccHHHHHHhHhhcCCCccccCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAEN-----GHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~-----~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
......|+..|+|||++.+..++.++|||||||+++||++|+.||...... ....+.++......... +
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 231 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------P 231 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC------C
Confidence 112356899999999998889999999999999999999999999854431 11112233333332211 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
.+. ..+....+.+++.+|++.+|++||++.|++++.-
T Consensus 232 ~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 RLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 111 1123346789999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=296.96 Aligned_cols=247 Identities=24% Similarity=0.421 Sum_probs=200.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC-CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||+|+||.||+++. ++..+|+|.++.. .....+.+.+|+.+++.++|+|++++.+.+..+...+++|||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 3567899999999999987 6789999998643 334456788999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.......++......++.|++.||+|||+. +++|+||||+||++++++.++++|||++....... ...
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYA 157 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc--ccc
Confidence 9999988765555688999999999999999999998 99999999999999999999999999987653221 122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....++..|+|||++.+..++.++|+||||+++++|++|+.||.... ......... .+.... +..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~-----~~~--- 222 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS------WKNLILKVC-QGSYKP-----LPS--- 222 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC------HHHHHHHHh-cCCCCC-----CCc---
Confidence 34568889999999998889999999999999999999999997422 122222211 122111 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.....+.+++.+|++.+|++||++.+++..
T Consensus 223 -~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 -HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122356799999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.71 Aligned_cols=250 Identities=21% Similarity=0.370 Sum_probs=197.9
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.+.||+|+||.||+|+. +++.||+|.++.........+.+|+.+++.++|+||+++++.+...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 345567899999999999987 678999999876655555678899999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|.+++.... .+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...... ...
T Consensus 90 ~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~ 162 (267)
T cd06645 90 GGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK 162 (267)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence 999999987544 489999999999999999999998 9999999999999999999999999998765321 112
Q ss_pred cccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 740 STTIAGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||....... . +..... .... .+...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~----~~~~~~-~~~~---~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--A----LFLMTK-SNFQ---PPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--h----HHhhhc-cCCC---CCccc
Confidence 23456889999999974 4568899999999999999999999986432111 0 111111 1110 11111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
... .....+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccC--CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 100 11235679999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.17 Aligned_cols=236 Identities=28% Similarity=0.392 Sum_probs=187.4
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHH-HHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVK-LLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
++||+|+||.||+|+. +++.||+|++.... ....+++.+|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999988 67889999986532 122344555554 57889999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|..++.... .++......++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT 153 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence 99998886543 478888999999999999999998 9999999999999999999999999998753211 1122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+........ .. .+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~-~~------~~----~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHK-PL------QL----P 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcC-CC------CC----C
Confidence 34568999999999998899999999999999999999999997432 22222222211 11 01 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMN 846 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~ 846 (892)
......+.+++.+|++.+|++||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12234577999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=308.56 Aligned_cols=252 Identities=24% Similarity=0.425 Sum_probs=198.3
Q ss_pred hceecccccEEEEEEEE--CCc----EEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 586 ERVLGKGGFGTVYHGKL--DND----EVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~----~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.||+|+||.||+|+. ++. .||+|.+..... ....++.+|+.+++.++|+||++++++|... ...+++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 46899999999999987 443 478998876533 3345788999999999999999999998754 467999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+.......
T Consensus 91 ~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 91 PHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 9999999987643 2488999999999999999999998 99999999999999999999999999998764332222
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....++. ..+.... .
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~-----~-- 232 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLL----EKGERLP-----Q-- 232 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HCCCCCC-----C--
Confidence 2223445678999999998899999999999999999997 8888864321 1122222 2211110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~ 858 (892)
...+...+.+++..|+..+|++||+++++++.|+++...
T Consensus 233 --~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 233 --PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111234678999999999999999999999999986443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=316.26 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=193.3
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.+.+.||+|+||.||+++. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 44567899999999999988 5788999998642 222345678899999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 125 ~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~ 197 (370)
T cd05621 125 MPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M 197 (370)
T ss_pred CCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence 9999999998654 378889999999999999999998 99999999999999999999999999998763222 1
Q ss_pred cccccccCCCCccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..............
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~----- 266 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSL----- 266 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCccc-----
Confidence 122356799999999998754 378899999999999999999999974321 11222222111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANR--RPFMNQVVME 851 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eVl~~ 851 (892)
.... .......+.+++.+|+..++.+ ||++.|+++.
T Consensus 267 ~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0110 1112344567888888755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.29 Aligned_cols=245 Identities=25% Similarity=0.389 Sum_probs=200.1
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+...+.||+|+||.||+|+. ++..||+|.+.... ....+.+.+|++++++++|+||+++++++..+...++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 33456799999999999987 57899999987543 3445678999999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 86 ~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06640 86 GGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cc
Confidence 99999998753 388999999999999999999998 99999999999999999999999999997664322 12
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.....++..|+|||++.+..++.++|+||||+++|||++|+.|+...... ..... ...+. ....
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~-~~~~~---------~~~~ 221 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------RVLFL-IPKNN---------PPTL 221 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------hHhhh-hhcCC---------CCCC
Confidence 23345788999999999888999999999999999999999998743211 11111 11110 1112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.......+.+++.+|++.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 23455678899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=318.36 Aligned_cols=197 Identities=26% Similarity=0.412 Sum_probs=168.6
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+.||+|+||.||+|+. +++.||+|++.... ....+.+.+|++++++++|+||+++++.+.++...++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 457899999999999987 67889999987542 2234568899999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC---
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG--- 736 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~--- 736 (892)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 85 GGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 999999987643 478888999999999999999998 999999999999999999999999999754311000
Q ss_pred ------------------------------------------ccccccccCCCCccCccccccCCCCchhhHHHHHHHHH
Q 002688 737 ------------------------------------------THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 774 (892)
Q Consensus 737 ------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ 774 (892)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00012346899999999999999999999999999999
Q ss_pred HHHhCCCCCCcc
Q 002688 775 EIITGHPVISKS 786 (892)
Q Consensus 775 ELltG~~p~~~~ 786 (892)
||++|++||...
T Consensus 240 elltG~~Pf~~~ 251 (382)
T cd05625 240 EMLVGQPPFLAQ 251 (382)
T ss_pred HHHhCCCCCCCC
Confidence 999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=303.18 Aligned_cols=246 Identities=22% Similarity=0.376 Sum_probs=199.1
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.+.||+|+||.||+|+. +++.||+|.+........+.+.+|+.+++.++|+|++++++++..+...++||||+++
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100 (297)
T ss_pred ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence 34557899999999999986 7889999999776555567789999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.+. .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 101 ~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 172 (297)
T cd06656 101 GSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (297)
T ss_pred CCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc--cCc
Confidence 9999998653 378999999999999999999998 99999999999999999999999999987653222 112
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....++..|+|||.+.+..++.++|+|||||++|+|++|+.||......... ......+ .+.+. ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~~~~~------~~~~~--~~ 238 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG------TPELQ--NP 238 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eeeccCC------CCCCC--Cc
Confidence 3346788999999999888999999999999999999999999653321100 0000000 00110 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......+.+++.+|++.+|++||+++++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122344678999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=289.58 Aligned_cols=252 Identities=22% Similarity=0.354 Sum_probs=197.4
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCch-h-hHHHHHHHHHHHhccccceeeEeeEeec--CCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ-G-YKQFQAEVKLLLRVHHRNLTTLVGYCDE--GTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~-~-~~~f~~Ei~~l~~l~H~NIv~l~g~~~~--~~~~~LV~Ey~~~ 660 (892)
+.|++|.||.||+|+. +++.||+|+++..... + --.-.+|+.+|.+.+|||||.+..+... -+.+++|||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 5799999999999998 7788999999865322 1 1245899999999999999999887753 3579999999998
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
+|..+++..+ +.+...+...+..|+++|++|||.. -|+|||||++|+|++..|.+||+|||||+.+... ....
T Consensus 162 -DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~ 234 (419)
T KOG0663|consen 162 -DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPY 234 (419)
T ss_pred -hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC--cccC
Confidence 8999988765 5689999999999999999999998 9999999999999999999999999999988533 2345
Q ss_pred ccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC------
Q 002688 741 TTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP------ 813 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~------ 813 (892)
+..+-|.-|+|||.+.+. .|+...|+||+|||+.||+++++-|.+..+-+..+ . +.+.+ |-..+.+-|
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~--~-If~ll--GtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD--K-IFKLL--GTPSEAIWPGYSELP 309 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH--H-HHHHh--CCCccccCCCccccc
Confidence 667789999999999875 59999999999999999999999998766532111 1 11111 111111111
Q ss_pred -------------CCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 814 -------------RLKGDFDIN-SVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 814 -------------~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+...+... -...-.++....+..||++|-|+.|.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 111111111 1244568889999999999999999987
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=305.39 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=197.2
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||+|+||.||+++. ++..+|+|.++... ....+++.+|++++.+++||||+++++++..+++.++|+||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 3457899999999999988 57789999887543 33446788999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.... .+++..+..++.|++.||+|||+. .+++||||||+|||+++++.+||+|||++...... ..
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~ 155 (308)
T cd06615 84 GSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 155 (308)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc----cc
Confidence 99999997653 488999999999999999999973 18999999999999999999999999998765321 12
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcc-----------
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRS----------- 809 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----------- 809 (892)
....++..|+|||.+.+..++.++||||||++++||++|+.||..... .....+............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA---KELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch---hhHHHhhcCccccccccCCcccccCCCCC
Confidence 345688999999999888899999999999999999999999864321 111111111000000000
Q ss_pred ----------------ccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 810 ----------------TVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 810 ----------------~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
...|.+.. ......+.+++.+|+..+|++||++.||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011100 0123357899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=318.19 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=191.7
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+++. +++.||||++.... ....+.+.+|++++++++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 3457899999999999987 67899999986532 123456788999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC---
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG--- 735 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~--- 735 (892)
++|+|.+++.... .++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 84 PGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999997643 478888899999999999999998 99999999999999999999999999975331000
Q ss_pred --------------------------------------CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHH
Q 002688 736 --------------------------------------GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEII 777 (892)
Q Consensus 736 --------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELl 777 (892)
.........||+.|||||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 000112356999999999999999999999999999999999
Q ss_pred hCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 002688 778 TGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRP---FMNQVVME 851 (892)
Q Consensus 778 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP---sm~eVl~~ 851 (892)
+|+.||..... .++........... ..+. .......+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 239 ~G~~Pf~~~~~------~~~~~~i~~~~~~~--~~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTP------AETQLKVINWETTL--HIPS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCH------HHHHHHHhccCccc--cCCC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999975432 11222211111000 0010 0112234556777765 4999999 88888864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=295.39 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=198.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.+.||+|+||.||+|+. ++..+++|.+..... .+++.+|++++++++|+||+++++++......++++||+++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 34557899999999999998 468999999875432 67899999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....... ...
T Consensus 83 ~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 156 (256)
T cd06612 83 GSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AKR 156 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc--ccc
Confidence 99999986543 3589999999999999999999998 99999999999999999999999999988764322 122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....++..|+|||++.+..++.++||||||++++||++|++||....... ... . .... ..+.+. .+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-----~~~-~-~~~~-----~~~~~~--~~ 222 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-----AIF-M-IPNK-----PPPTLS--DP 222 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-----hhh-h-hccC-----CCCCCC--ch
Confidence 33457889999999998899999999999999999999999997433211 000 0 0000 001111 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......+.+++.+|++.+|++||++.||++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 122345789999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=298.49 Aligned_cols=248 Identities=22% Similarity=0.341 Sum_probs=197.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.+.||+|+||.||+|+. ++..+++|.+........+.+.+|+++++.++|+|++++++.+..+...++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 44567899999999999988 5788999999877666678899999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|..++.... ..+++..+..++.|++.+|+|||+. +++||||||+||+++.++.+||+|||++...... ....
T Consensus 94 ~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~ 167 (292)
T cd06644 94 GAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRR 167 (292)
T ss_pred CcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc--cccc
Confidence 99988876543 3489999999999999999999998 9999999999999999999999999998754221 1122
Q ss_pred ccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 741 TTIAGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
....++..|+|||++. ...++.++|||||||++|||++|++||..... .+.......... +..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~------~~~ 235 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEP------PTL 235 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCCC------ccC
Confidence 3445788999999985 34468899999999999999999999864321 111112111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
. .+......+.+++.+|++.+|++||++.++++
T Consensus 236 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 S--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1 01122345778999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.75 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=202.6
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|+||.||.++. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 4567899999999988876 7889999987654 34455678999999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........ .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~ 157 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M 157 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence 99999999876555689999999999999999999998 999999999999999999999999999886643221 2
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.....++..|+|||.+.+..++.++||||||++++||++|+.||.... ..+....... +.....
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~-~~~~~~--------- 221 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------PLNLVVKIVQ-GNYTPV--------- 221 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHc-CCCCCC---------
Confidence 234568899999999988889999999999999999999999986422 2222222221 221111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L 852 (892)
.......+.+++.+|++.+|++||++.++++.+
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 012234577999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=304.48 Aligned_cols=245 Identities=21% Similarity=0.369 Sum_probs=198.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
.+.+.||.|++|.||+|+. +++.||+|.+........+.+.+|++.++.++|+|++++++++......++|+||++++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 3457899999999999986 78899999987665555677899999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++... .+++.++..++.+++.||+|||+. +++||||||+||+++.++.+||+|||++........ ...
T Consensus 102 ~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 173 (296)
T cd06655 102 SLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRS 173 (296)
T ss_pred cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCC
Confidence 999988653 389999999999999999999998 999999999999999999999999999876532221 123
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...... ........ ..... +.. ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~~-~~~~~-----~~~--~~ 239 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIAT-NGTPE-----LQN--PE 239 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-cCCcc-----cCC--cc
Confidence 346888999999999888999999999999999999999999754321 11111111 11111 100 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.....+.+++.+|+..+|++||++.++++
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 12235678999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=322.02 Aligned_cols=254 Identities=20% Similarity=0.327 Sum_probs=186.7
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecC--------CcEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--------TNMA 652 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--------~~~~ 652 (892)
+.+.+.||+|+||.||+|+. +++.||||++.... ....+|+.+++.++|+||+++.+++... ...+
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 44568999999999999988 67899999885432 2345799999999999999999876432 2467
Q ss_pred EEEEeccCCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC-cEEEeeecCcc
Q 002688 653 LIYEYMANGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF-QAKLADFGLSR 729 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~-~vkl~DfGla~ 729 (892)
+||||+++ +|.+++... ....+++.....++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 89999985 677666432 234589999999999999999999998 999999999999999664 79999999998
Q ss_pred cccCCCCccccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcC---
Q 002688 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG--- 805 (892)
Q Consensus 730 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~--- 805 (892)
.+.... ......|++.|+|||++.+. .++.++|||||||++|||++|++||...... ..+....+ .....
T Consensus 220 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~-~~~~p~~~ 293 (440)
T PTZ00036 220 NLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQ-VLGTPTED 293 (440)
T ss_pred hccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHH-HhCCCCHH
Confidence 764222 12245679999999998764 6899999999999999999999999754321 11111111 11000
Q ss_pred -------CCccccCCC-----CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 806 -------DIRSTVDPR-----LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 806 -------~~~~~~D~~-----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
...+.--|. +...++......+.+++.+|++.+|++||++.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000000 111111123356789999999999999999999985
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=316.24 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=207.4
Q ss_pred hhceecccccEEEEEEEEC---Cc--EEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 585 FERVLGKGGFGTVYHGKLD---ND--EVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~~---~~--~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
+-|.||+|.||.|++|.|+ |+ .||||.++..... ...+|.+|+..|.+|+|+|+++|+|...+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3468999999999999993 33 5999999877554 66899999999999999999999999987 7789999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
+.|+|.+.|++..+..+-......++.|||.||.||..+ ++|||||.++|+||-..-.+||+||||.+.+...+..+
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 999999999985566688889999999999999999998 99999999999999999999999999999987665555
Q ss_pred ccc-cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 739 VST-TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 739 ~~~-~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
.+. ...-...|+|||.+...+++.++|||+|||.+|||+| |+.||.+... .+.. +.+|..-.
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------~qIL----------~~iD~~er 333 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------IQIL----------KNIDAGER 333 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------HHHH----------Hhcccccc
Confidence 443 3345668999999999999999999999999999999 5778765432 1111 22221111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
-.....|.+++.++++.||..+|++||++..+.+.+-.
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 12244678889999999999999999999999865443
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.11 Aligned_cols=248 Identities=23% Similarity=0.425 Sum_probs=199.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeec-CCcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE-GTNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~-~~~~~LV~Ey 657 (892)
+.+.+.||+|++|.||+++. +++.+|+|.+.... ....+.+.+|++++++++|+|++++.+.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 34568999999999999987 67889999986542 3345678899999999999999999988764 4467899999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++++|.+++.......+++.++..++.+++.||++||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-- 156 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-- 156 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC--
Confidence 9999999999876555689999999999999999999998 99999999999999999999999999998663221
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.......+++.|+|||++.+..++.++||||||++++||++|+.||.... ......... .+.+. .+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~-~~~~~-----~~-- 222 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRII-EGKLP-----PM-- 222 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHH-hcCCC-----CC--
Confidence 12234567889999999999999999999999999999999999986422 222222222 12211 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.......+.+++.+|++.+|++||++.++++.
T Consensus 223 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 --PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11233467799999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.07 Aligned_cols=248 Identities=29% Similarity=0.494 Sum_probs=200.4
Q ss_pred hhceecccccEEEEEEEECC------cEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 585 FERVLGKGGFGTVYHGKLDN------DEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~~~------~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.+.||+|+||.||+++... ..||+|++...... ..+.+.+|++.+..++|+||+++++++...+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999999843 78999999766443 567899999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999765544489999999999999999999998 9999999999999999999999999999876433221
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
. .....++..|+|||.+.+..++.++||||+|++++||++ |++||.... ..+....... +.... ..
T Consensus 160 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~-~~~~~-----~~ 226 (258)
T smart00219 160 K-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS------NEEVLEYLKK-GYRLP-----KP 226 (258)
T ss_pred c-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhc-CCCCC-----CC
Confidence 1 112336789999999988889999999999999999998 788876421 1222222211 11110 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L 852 (892)
......+.+++.+|+..+|++||++.|+++.|
T Consensus 227 ----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 ----ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11344677899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=305.43 Aligned_cols=195 Identities=24% Similarity=0.385 Sum_probs=159.4
Q ss_pred ceecccccEEEEEEEE----CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeec--CCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL----DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE--GTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~----~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~--~~~~~LV~Ey~~~ 660 (892)
++||+|+||.||+|+. +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 5799999999999986 346899999875432 2457889999999999999999998854 4568899999865
Q ss_pred CchhhhccccC-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEE----cCCCcEEEeeecCcc
Q 002688 661 GNLEEHLSDSS-------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI----NEKFQAKLADFGLSR 729 (892)
Q Consensus 661 gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl----~~~~~vkl~DfGla~ 729 (892)
+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 7877764321 23488999999999999999999998 99999999999999 456789999999998
Q ss_pred cccCCCCc-cccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccc
Q 002688 730 VFPVEGGT-HVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSA 787 (892)
Q Consensus 730 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~ 787 (892)
.+...... .......||+.|+|||++.+. .++.++||||+||+++||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76322111 122345789999999998764 58999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=295.76 Aligned_cols=245 Identities=24% Similarity=0.434 Sum_probs=196.3
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCch---------hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEE
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ---------GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~---------~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~L 653 (892)
+.+.||+|++|.||+|.. +++.+|+|.+...... ..+.+.+|++++++++|+||+++++++......++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 457899999999999987 6789999988654321 22568899999999999999999999999999999
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 84 FLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999997643 388999999999999999999998 999999999999999999999999999987642
Q ss_pred CCCcc----ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcc
Q 002688 734 EGGTH----VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRS 809 (892)
Q Consensus 734 ~~~~~----~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 809 (892)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... . +-+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~-~~~~~~~~------ 226 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----L-QAIFKIGE------ 226 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----H-HHHHHHhc------
Confidence 21111 11234578899999999988899999999999999999999999974321 1 11111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 810 TVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 810 ~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
...+.+. ......+.+++.+|++.+|++||++.|+++
T Consensus 227 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 NASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1112221 122356778999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.47 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=196.7
Q ss_pred hhceecccccEEEEEEEE-----CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCC------cE
Q 002688 585 FERVLGKGGFGTVYHGKL-----DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT------NM 651 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~-----~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~------~~ 651 (892)
+.+.||+|+||.||+|.+ ++..||||++... .....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 457899999999999986 3578999998754 2344567899999999999999999999886432 24
Q ss_pred EEEEEeccCCchhhhccccC----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecC
Q 002688 652 ALIYEYMANGNLEEHLSDSS----KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGL 727 (892)
Q Consensus 652 ~LV~Ey~~~gsL~~~L~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGl 727 (892)
++++||+.+|+|.+++.... ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 78899999999988774321 22478999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCC
Q 002688 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGD 806 (892)
Q Consensus 728 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 806 (892)
++...............++..|++||.+....++.++||||||+++|||++ |++||..... ..+..+. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~---~~~~~ 233 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYL---IKGNR 233 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHH---HcCCc
Confidence 987643222222223345678999999988889999999999999999999 8888864321 1122221 11111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 807 IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 807 ~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.. . .......+.+++.+|++.+|++||++.++++.|+++
T Consensus 234 ~~------~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LK------Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 0 112335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.59 Aligned_cols=244 Identities=28% Similarity=0.463 Sum_probs=199.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||.|++|.||+|+. +++.||+|.+.... ......+.+|+++++.++|+|++++.+++..+...++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 4557899999999999988 67899999987653 33456788999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++...... ...
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 84 GSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred CcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 9999998764 489999999999999999999998 99999999999999999999999999998764321 122
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....++..|+|||++.+..++.++||||||+++|||++|+.||..... .+.... +.... .+.+...
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~------~~~~~~-~~~~~-----~~~~~~~-- 221 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP------MRVLFL-IPKNN-----PPSLEGN-- 221 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch------HHHHHH-hhhcC-----CCCCccc--
Confidence 344678899999999988899999999999999999999999964331 111111 11111 1111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.....+.+++.+|+..+|++||+++++++
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02335778999999999999999999977
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=311.69 Aligned_cols=258 Identities=21% Similarity=0.286 Sum_probs=192.0
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecC------CcEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG------TNMA 652 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~------~~~~ 652 (892)
+.+.+.||+|+||.||++.. .++.||||++... .....+.+.+|+.+++.++|+||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 34457899999999999987 6788999998754 233446788999999999999999999988543 3579
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+||||+++ +|.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 99 lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 99 LVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred EEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 99999975 66666643 378899999999999999999998 99999999999999999999999999998642
Q ss_pred CCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCcc---------HH-------H
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTH---------VA-------Q 796 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~---------l~-------~ 796 (892)
. ........|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .. .
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 2 222234568999999999999899999999999999999999999997543110000 00 0
Q ss_pred HHHhHhhc-CCCccccCCCCC--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 797 WVSSMLDK-GDIRSTVDPRLK--------GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 797 ~~~~~~~~-~~~~~~~D~~l~--------~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.+...... ........+... ..........+.+++.+|++.+|++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00111100 000000000000 00111123467899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=297.89 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=192.9
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.||+|++|.||+|+. ++..||||.+.... ....+.+.+|+.++++++|+|++++++++..+...++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 457899999999999988 67899999986542 2234678899999999999999999999999999999999997
Q ss_pred CchhhhccccC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 661 GNLEEHLSDSS-KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 661 gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....... ..
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~ 157 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RV 157 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--cc
Confidence 68888876543 25589999999999999999999998 99999999999999999999999999987653221 11
Q ss_pred cccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc-----------CCC
Q 002688 740 STTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK-----------GDI 807 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~-----------~~~ 807 (892)
.....++..|+|||.+.+. .++.++||||||++++||++|++||....+.. .+.......... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHHH
Confidence 2234568899999988754 57899999999999999999999997543210 000000000000 000
Q ss_pred ccccCCCCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 808 RSTVDPRLKG---DFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 808 ~~~~D~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
...++..... ........++.+++.+|++.+|++||++.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 000012345679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=295.04 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=199.0
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCch--hhHHHHHHHHHHHhccccc-eeeEeeEeecCC------cEEEEE
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ--GYKQFQAEVKLLLRVHHRN-LTTLVGYCDEGT------NMALIY 655 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~N-Iv~l~g~~~~~~------~~~LV~ 655 (892)
++||+|+||+||+|+. +|+.||+|++.-.... ......+|+.++++++|+| |+++.+++...+ ..++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 5699999999999987 7889999998765432 3345689999999999999 999999998877 788999
Q ss_pred EeccCCchhhhccccCc--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 656 EYMANGNLEEHLSDSSK--EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
||++. +|..++....+ +.++...+..+..|+++||+|||++ +|+||||||.|||++++|.+||+|||+|+.+.-
T Consensus 97 e~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 97 EFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred Eeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 99976 89999987653 4577788999999999999999999 999999999999999999999999999997642
Q ss_pred CCCccccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc----CCCc
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK----GDIR 808 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~----~~~~ 808 (892)
.. ...+...+|.-|+|||++.+. .|+...||||+||++.||+++++-|.+..+.+ ...-+...+.. .|..
T Consensus 173 p~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 173 PM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred Cc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCCccCCCC
Confidence 22 224456788899999999987 69999999999999999999999998766511 11111111111 1111
Q ss_pred cccCCCCC----CCC---C--HH---HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 809 STVDPRLK----GDF---D--IN---SVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 809 ~~~D~~l~----~~~---~--~~---~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
...-|+.. ... . .. ......+++.+|++.+|+.|.|++.++++
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00001111 000 0 00 11357899999999999999999999886
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=309.13 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=192.6
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+++. +++.||+|.+... .......+.+|..++..++|+||+++.+++...+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 4567899999999999988 6778999998653 1223345788999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 84 ~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 158 (331)
T cd05624 84 VGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TV 158 (331)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-ce
Confidence 9999999997643 2488999999999999999999998 99999999999999999999999999997653322 12
Q ss_pred ccccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 739 VSTTIAGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
......|++.|+|||++.+ +.++.++|||||||++|||++|+.||.... ..+.......... .-.+.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~-~~~~p~ 231 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHEE-RFQFPS 231 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC------HHHHHHHHHcCCC-cccCCC
Confidence 2234569999999999875 467899999999999999999999996432 1222222221111 000111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANR--RPFMNQVVME 851 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eVl~~ 851 (892)
.. .+....+.+++.+|+...+++ |++++++++.
T Consensus 232 ~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 232 HI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11 112345678888888765543 4678888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=310.83 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=191.3
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecC------CcEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG------TNMA 652 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~------~~~~ 652 (892)
+.+.+.||+|+||.||+++. ++..||||++... .....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 44568999999999999987 6789999998653 233456788999999999999999999988644 3479
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 103 lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 103 LVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred EEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 99999976 56665542 278889999999999999999998 99999999999999999999999999997542
Q ss_pred CCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHH--------------
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWV-------------- 798 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~-------------- 798 (892)
. ........|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ...|.
T Consensus 175 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 175 T---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-----IDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred c---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCcHHHH
Confidence 2 1222345689999999999999999999999999999999999999975431 11111
Q ss_pred -------HhHhhcC-CC-----cccc----CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 799 -------SSMLDKG-DI-----RSTV----DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 799 -------~~~~~~~-~~-----~~~~----D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
....... .. .+.+ .+... .........+.+++.+|++.+|++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSES-ERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhcccccccccc-ccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111000 00 0000 00000 0001123457799999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=310.75 Aligned_cols=188 Identities=27% Similarity=0.364 Sum_probs=160.7
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.+.||+|+||.||+|+. ++..||+|..... ....|+.++++++|+||+++++++......++|+|++.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 455668999999999999998 5568999975432 23568999999999999999999999999999999995
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 141 -~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~ 212 (357)
T PHA03209 141 -SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PA 212 (357)
T ss_pred -CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC---cc
Confidence 58888886543 3489999999999999999999998 9999999999999999999999999998753211 12
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVI 783 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~ 783 (892)
.....||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 23456899999999999999999999999999999999965554
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=317.29 Aligned_cols=241 Identities=29% Similarity=0.486 Sum_probs=198.1
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEE---EEccC-CCchhhHHHHHHHHHHHhccccceeeEeeEeecCCc--EEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAV---KMLSP-SSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTN--MALIY 655 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAV---K~l~~-~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~--~~LV~ 655 (892)
.|.++||+|+|-+||||.. +|-+||= |.-.. .+....++|..|+.+|+.|+|+||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3557899999999999988 4555542 22111 234456889999999999999999999999976654 88999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC-CCcEEEeeecCcccccCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-KFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-~~~vkl~DfGla~~~~~~ 734 (892)
|.|..|+|..++.+.++ ++......+++||++||.|||++ .|+|||||||-+||+|+. -|.|||+|+|||..+..
T Consensus 123 EL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~- 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK- 198 (632)
T ss_pred ecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc-
Confidence 99999999999988765 88899999999999999999997 689999999999999985 58999999999997632
Q ss_pred CCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcC---CCcccc
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG---DIRSTV 811 (892)
Q Consensus 735 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~ 811 (892)
.+ ...+.||+.|||||++. +.|++.+||||||+.|+||+|+.-||. +-.+-++..+++...- .+..+-
T Consensus 199 --s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 199 --SH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred --cc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHHcCCCHHHhhccC
Confidence 22 23478999999999876 899999999999999999999999997 3455666666665432 233333
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
||+ +.+++.+|+.. .++|||+.|+++
T Consensus 270 dPe------------vr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 DPE------------VREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CHH------------HHHHHHHHhcC-chhccCHHHHhh
Confidence 443 45899999999 999999999987
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=296.07 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=199.5
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.+.||+|++|.||+|+. ++..+|+|.+........+.+.+|++++++++|+|++++++.+..+...++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 45567899999999999988 5788999999877666667899999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++....... ...
T Consensus 87 ~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~ 160 (280)
T cd06611 87 GALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKR 160 (280)
T ss_pred CcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc--ccc
Confidence 99999987643 3489999999999999999999998 99999999999999999999999999887643221 122
Q ss_pred ccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 741 TTIAGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
....++..|+|||.+. ...++.++||||||+++|||++|++||..... .+...... .+.. +.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~-----~~~ 228 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------MRVLLKIL-KSEP-----PTL 228 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------HHHHHHHh-cCCC-----CCc
Confidence 3456888999999975 34477899999999999999999999974321 11111111 1111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.. +......+.+++.+|++.+|++||++.++++.
T Consensus 229 ~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CC--cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 11122456789999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.58 Aligned_cols=243 Identities=28% Similarity=0.433 Sum_probs=196.8
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC-----chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-----SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
..+.||+|++|.||+|.. +++.|++|.+.... .+..+.+.+|++++++++|+||+++.+++..+...++++||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 457899999999999988 68899999986543 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 84 VPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 99999999997653 388999999999999999999998 99999999999999999999999999987653222
Q ss_pred cccccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
......++..|+|||.+.... ++.++|+||||++++||++|++||..... .+............ .+
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~-~~----- 223 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELP-PI----- 223 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCC-Cc-----
Confidence 223456888999999987766 89999999999999999999999864331 11111111111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.......+.+++.+|++.+|++||++.++++
T Consensus 224 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 ---PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112345678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=293.31 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=196.2
Q ss_pred hhceecccccEEEEEEEE-CCcEEEEEEccCCC------chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 585 FERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSS------SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
..+.||+|+||.||+|+. +++.+|||.+.... ....+.+.+|++++++++|+||+++++++.+....++++||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 346899999999999987 77889999886432 12235688999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC-
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG- 736 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~- 736 (892)
+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 84 VPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999997543 378999999999999999999998 999999999999999999999999999876532111
Q ss_pred ---ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 737 ---THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 737 ---~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
........++..|+|||++.+..++.++||||||++++||++|+.||..... ...........+. .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-----~~ 228 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAAMFYIGAHRGL-----MP 228 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHHHHHhhhccCC-----CC
Confidence 1112345688899999999988899999999999999999999999974321 1111111100011 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+.. .....+.+++.+|++.+|++||++.|+++
T Consensus 229 ~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2221 22345679999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=303.55 Aligned_cols=195 Identities=25% Similarity=0.387 Sum_probs=158.9
Q ss_pred ceecccccEEEEEEEE----CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEee--cCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL----DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD--EGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~----~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~--~~~~~~LV~Ey~~~ 660 (892)
..||+|+||.||+|+. ++..||+|.+..... ...+.+|++++++++|+||+++++++. .+...++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 4799999999999986 346799999875432 246788999999999999999999885 34578999999875
Q ss_pred Cchhhhcccc-------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEE----cCCCcEEEeeecCcc
Q 002688 661 GNLEEHLSDS-------SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI----NEKFQAKLADFGLSR 729 (892)
Q Consensus 661 gsL~~~L~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl----~~~~~vkl~DfGla~ 729 (892)
+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777766421 123488999999999999999999998 99999999999999 566799999999998
Q ss_pred cccCCCCc-cccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccc
Q 002688 730 VFPVEGGT-HVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSA 787 (892)
Q Consensus 730 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~ 787 (892)
........ .......++..|+|||++.+. .++.++|||||||++|||+||++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76322211 122345688999999998764 58999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=304.20 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=193.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||+|+||.||+|+. +++.||+|.+.... ......+.+|++++++++|+||+++++++......++||||++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~- 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence 4457899999999999987 57889999986543 2233567889999999999999999999999999999999997
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++....... ...
T Consensus 88 ~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 161 (301)
T cd07873 88 KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTY 161 (301)
T ss_pred cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--Ccc
Confidence 58988886543 3488999999999999999999998 99999999999999999999999999987643221 112
Q ss_pred ccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc---CCCcccc-----
Q 002688 741 TTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK---GDIRSTV----- 811 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~----- 811 (892)
....++..|+|||.+.+. .++.++|||||||++|||++|++||...... ............ ......+
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhhccccc
Confidence 234568899999998754 5788999999999999999999999754321 111111111100 0000000
Q ss_pred ----CCCCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 812 ----DPRLKGDF----DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 812 ----D~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+...... .......+.+++.+|++.+|.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01111000 0112345679999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.78 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=191.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+++. +++.||+|++... .....+.+.+|+.++..++|+||+++.+++..+.+.++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 4567899999999999988 6789999998642 2223456888999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 84 ~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (331)
T cd05597 84 VGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TV 158 (331)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Cc
Confidence 9999999997532 3488999999999999999999998 99999999999999999999999999987653222 12
Q ss_pred ccccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 739 VSTTIAGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
......|++.|+|||++.. ..++.++|||||||++|||++|+.||.... ..+............. +.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~~~~~i~~~~~~~~-~~~ 231 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKEHFQ-FPP 231 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHHHHHHHHcCCCccc-CCC
Confidence 2233468999999999863 457889999999999999999999996432 2222222222111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSS--NANRRPFMNQVVME 851 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~--~P~~RPsm~eVl~~ 851 (892)
.. ......+.+++.+|+.. ++..||++.++++.
T Consensus 232 ~~-----~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 DV-----TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cc-----CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11 01233455677776644 44458899998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=312.22 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=194.1
Q ss_pred HhhhhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
..+.+.+.||+|+||.||+++. +++.+|+|++... .....+.+.+|+.+++.++||||+++++.+..+...++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 3445568999999999999988 6788999998642 1223455788999999999999999999999999999999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 123 Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 123 EYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred cCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 999999999998654 378888999999999999999998 99999999999999999999999999998763221
Q ss_pred CccccccccCCCCccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcccc
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 811 (892)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .................-
T Consensus 197 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~~~~~ 269 (371)
T cd05622 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMNHKNSLTFP 269 (371)
T ss_pred -cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCcccCC
Confidence 2223456799999999998754 37899999999999999999999997432 122222222211111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANR--RPFMNQVVMEL 852 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eVl~~L 852 (892)
+ .......+.+++.+|+...+.+ ||++.|+++..
T Consensus 270 ~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 270 D-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred C-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0 1122345668889999844433 77888888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=292.35 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=201.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|+||.+|+++. +++.||+|.+... .....+++.+|++++++++|+||+++.+++....+.++|+||+.
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 4557899999999999987 7789999998643 23345688999999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|.+++.......+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 99999998765555589999999999999999999998 99999999999999999999999999987653221 11
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.....|+..|+|||++.+..++.++|+||||++++||++|+.||.... ..+.+...... ... ..
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~-~~~-----~~---- 221 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRG-SYP-----PV---- 221 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcC-CCC-----CC----
Confidence 223457889999999998889999999999999999999999986321 22233332221 111 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.......+.+++.+|++.+|++||+|.+|++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11223457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=309.97 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=191.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecC------CcEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG------TNMA 652 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~------~~~~ 652 (892)
+.+.+.||+|+||.||++.. .++.||||++... .....+.+.+|+.+++.++|+||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 44567899999999999987 6788999998754 233446788999999999999999999987543 3579
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 106 lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 106 IVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 99999975 67776643 378899999999999999999998 99999999999999999999999999997642
Q ss_pred CCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHH-------------
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVS------------- 799 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~------------- 799 (892)
. ........++..|+|||++.+..++.++|||||||++|||++|+.||....... .+.....
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHhh
Confidence 2 122234568999999999999999999999999999999999999997543210 0000000
Q ss_pred -----hHhhc-CCCc----cccCCCCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 800 -----SMLDK-GDIR----STVDPRLK----GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 800 -----~~~~~-~~~~----~~~D~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
..... .... +.+.+... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 0000 00000000 00011123467899999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=312.77 Aligned_cols=243 Identities=27% Similarity=0.449 Sum_probs=202.4
Q ss_pred eecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchhh
Q 002688 588 VLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEE 665 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 665 (892)
+||+|.+|+||.|+. +...+|||.+........+-+.+|+.+-++++|+|||+++|.|.++++.-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999988 456789999988877777889999999999999999999999999999999999999999999
Q ss_pred hccccCcccC--CHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEc-CCCcEEEeeecCcccccCCCCcccccc
Q 002688 666 HLSDSSKEIL--NWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 666 ~L~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~-~~~~vkl~DfGla~~~~~~~~~~~~~~ 742 (892)
+|+..-+ ++ ++.+.-.+.+||++||.|||+. .|+|||||-+|+|++ -.|.+||+|||-++.+. +-......
T Consensus 662 LLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TET 735 (1226)
T KOG4279|consen 662 LLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTET 735 (1226)
T ss_pred HHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc--cCCccccc
Confidence 9986543 24 6778888999999999999999 999999999999997 57899999999998863 33445567
Q ss_pred ccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 743 IAGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 743 ~~gt~~Y~aPE~~~~~--~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
.-||..|||||++..+ .|...+|||||||.+.||.||+|||...... . ..+++-|-. .+.|.+ +
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---q-----AAMFkVGmy--KvHP~i----P 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---Q-----AAMFKVGMY--KVHPPI----P 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---h-----Hhhhhhcce--ecCCCC----c
Confidence 7899999999999765 5899999999999999999999999743321 1 112222211 122333 3
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+...+...++++|+..+|.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 455667789999999999999999999986
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.11 Aligned_cols=249 Identities=22% Similarity=0.409 Sum_probs=196.9
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC------chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS------SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
..+.||+|++|.||+|+. +++.||+|.+.... ....+.+.+|+..+++++|+||+++++++.+.+..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 346899999999999986 78899999987542 1134678999999999999999999999999999999999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC-cEEEeeecCcccccCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF-QAKLADFGLSRVFPVEG 735 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~-~vkl~DfGla~~~~~~~ 735 (892)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 84 WMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred ccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999987543 488999999999999999999998 999999999999998775 59999999987764321
Q ss_pred C--ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 736 G--THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 736 ~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
. ........++..|+|||.+.+..++.++||||+|++++||++|+.||....... ............. .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~-----~~ 230 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASATT-----AP 230 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhccCC-----CC
Confidence 1 111223467889999999988889999999999999999999999986433211 1111111111000 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+......+.+++.+|+..+|++||++.|+++
T Consensus 231 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 ----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111223356778999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.81 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=196.9
Q ss_pred hhhceecccccEEEEEEEEC---CcEEEEEEccCC----------CchhhHHHHHHHHHHHh-ccccceeeEeeEeecCC
Q 002688 584 NFERVLGKGGFGTVYHGKLD---NDEVAVKMLSPS----------SSQGYKQFQAEVKLLLR-VHHRNLTTLVGYCDEGT 649 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~~---~~~vAVK~l~~~----------~~~~~~~f~~Ei~~l~~-l~H~NIv~l~g~~~~~~ 649 (892)
.+.+.||+|+||.||+|... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++..++
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 34578999999999999983 478999987532 12234567788888865 79999999999999999
Q ss_pred cEEEEEEeccCCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecC
Q 002688 650 NMALIYEYMANGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGL 727 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGl 727 (892)
..+++|||+++++|.+++... ....+++..++.++.|++.||.|||+. .+++|+||||+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988542 234589999999999999999999963 1799999999999999999999999999
Q ss_pred cccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCC
Q 002688 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDI 807 (892)
Q Consensus 728 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 807 (892)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|++||.... ......... .+..
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~-~~~~ 230 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIV-EAVY 230 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHHh-hccC
Confidence 98653322 2334568889999999998889999999999999999999999986332 122222211 1111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 808 RSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 808 ~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
. +... ......+.+++.+|++.+|++||++.||.++++
T Consensus 231 ~----~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 E----PLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred C----cCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1 1001 112345779999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=292.42 Aligned_cols=250 Identities=23% Similarity=0.392 Sum_probs=200.9
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.+.||+|+||.||+|+. +++.+++|.+........+.+.+|++++++++|+||+++++++..+...+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 34567899999999999987 5678999999876555667899999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++....... ...
T Consensus 85 ~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 158 (262)
T cd06613 85 GSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKR 158 (262)
T ss_pred CcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh--hcc
Confidence 99999887642 3489999999999999999999998 99999999999999999999999999987653221 122
Q ss_pred ccccCCCCccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISN---RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~---~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
....++..|+|||.+.+. .++.++||||||++++||++|++||....... ... . ....... .+.+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~----~-~~~~~~~---~~~~~- 227 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALF----L-ISKSNFP---PPKLK- 227 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHH----H-HHhccCC---Ccccc-
Confidence 345678899999999876 88999999999999999999999997433110 011 1 1111100 01111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
........+.+++.+|+..+|.+||++.+|+.
T Consensus 228 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 -DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11223456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=294.37 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=198.3
Q ss_pred hhceecccccEEEEEEEE-------CCcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 585 FERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
..+.||+|+||.||+|+. +...|++|.+...... ..+++.+|++++++++|+||+++++++.+....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 346899999999999986 2356999988765443 45779999999999999999999999999899999999
Q ss_pred eccCCchhhhccccCc-------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcc
Q 002688 657 YMANGNLEEHLSDSSK-------EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~ 729 (892)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||+++
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence 9999999999976541 2589999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCc
Q 002688 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIR 808 (892)
Q Consensus 730 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 808 (892)
...... ........++..|+|||.+.+...+.++||||||++++||++ |..||..... . +.+.. ...+...
T Consensus 166 ~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~---~~~~~-~~~~~~~ 237 (275)
T cd05046 166 DVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---E---EVLNR-LQAGKLE 237 (275)
T ss_pred ccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---H---HHHHH-HHcCCcC
Confidence 543221 112223345678999999988889999999999999999999 7888853221 1 11111 1111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 809 ~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
... .......+.+++.+|++.+|++||++.|+++.|.
T Consensus 238 ~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 110 1122346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=295.59 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=195.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
++.+.||+|++|.||+|+. +++.||+|++.... ....+.+.+|++++++++|+|++++++++..+...++||||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 4457899999999999988 57899999986442 2234568899999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|..++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........ .
T Consensus 84 ~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 156 (286)
T cd07847 84 HTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--D 156 (286)
T ss_pred ccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc--c
Confidence 998888775433 389999999999999999999998 999999999999999999999999999987643221 1
Q ss_pred cccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhH----------hhcCC-C
Q 002688 740 STTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSM----------LDKGD-I 807 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~----------~~~~~-~ 807 (892)
.....++..|+|||.+.+ ..++.++||||||++++||++|++||......+ .+....... ..... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhccccccc
Confidence 223457789999999876 457899999999999999999999997543211 111111100 00000 0
Q ss_pred ccccCCCCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 808 RSTVDPRLKGDFDI-----NSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 808 ~~~~D~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.....+........ .....+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00011111111111 12345779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=305.75 Aligned_cols=249 Identities=21% Similarity=0.349 Sum_probs=204.8
Q ss_pred hhhhhceecccccEEEEEEEE-CCcEEEEEEccCC--CchhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEe
Q 002688 582 TNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.++..+.||+||.+.||++.. +.+.+|+|++... ..+....|..|+..|.+++ |.+||+|++|-..++.+|+||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 344557899999999999988 6678898886543 4556678999999999995 99999999999999999999997
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
= ..+|..+|.+.......| .+..+..|++.++.++|++ +|||.||||.|+|+-. |.+||+|||+|..+..+...
T Consensus 442 G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 442 G-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred c-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence 5 449999999887665667 7888999999999999999 9999999999999976 58999999999998877777
Q ss_pred cccccccCCCCccCccccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISN-----------RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD 806 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 806 (892)
......+||+.||+||.+... +.+.++||||+|||||+|+.|++||.... -.|. +
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~a-------K 581 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIA-------K 581 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHH-------H
Confidence 777888999999999998532 26789999999999999999999996321 1222 2
Q ss_pred CccccCCCCCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 807 IRSTVDPRLKGDFDI-NSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 807 ~~~~~D~~l~~~~~~-~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+..+.||...-.|+. ...+.++++++.|+++||++||++.++++
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 334556644333321 23334899999999999999999999987
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=295.93 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=198.5
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|++|.||+|+. +++.||||++.... ....+.+.+|+.++++++|+|++++++++..+...++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 4567899999999999987 67899999987654 333567899999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|.+++.... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........ ..
T Consensus 82 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (286)
T cd07832 82 PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL 156 (286)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence 999999987544 4589999999999999999999998 999999999999999999999999999987643321 12
Q ss_pred cccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCC------------
Q 002688 740 STTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD------------ 806 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------------ 806 (892)
.....++..|+|||.+.+. .++.++||||+|++++||++|+++|..... .....++........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccCcch
Confidence 2345688899999998754 468999999999999999999888864321 111111111111000
Q ss_pred CccccCCCCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 807 IRSTVDPRLK----GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 807 ~~~~~D~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......+.-. .....+....+.+++.+|+..+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00001223677899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=294.71 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=199.3
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.+.||+|+||.||+|.. ++..||||.+.... ....+.+.+|++.+.+++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 344567899999999999987 67899999986543 234467889999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++++|.+++... .+++.....++.+++.++.|||+. +++|+||||+||+++.++.++|+|||++..+.... .
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch--h
Confidence 999999998753 389999999999999999999998 99999999999999999999999999987653221 1
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
......++..|+|||.+.+...+.++|+|||||+++||++|+.|+..... ..+.... ..+.. +.+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~-~~~~~-----~~~~-- 222 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLI-PKNNP-----PTLE-- 222 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHH-hcCCC-----CCCC--
Confidence 22334678899999999888899999999999999999999999864321 1122211 11111 1111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......+.+++.+|++.+|++||++.++++.
T Consensus 223 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 --GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1223557799999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=293.26 Aligned_cols=250 Identities=23% Similarity=0.398 Sum_probs=195.7
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCCc----------hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEE
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS----------QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~----------~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~L 653 (892)
.+.||+|+||.||+|+. +++.+|+|.++.... ...+.+.+|+++++.++|+|++++++++......++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 46899999999999976 678999998764211 112467889999999999999999999999999999
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
|+||+++|+|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999997653 489999999999999999999998 999999999999999999999999999976532
Q ss_pred CCCccccccccCCCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcccc
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 811 (892)
...........++..|+|||.+.... ++.++|+||||++++||++|+.||..... ...+. .... ......+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~-~~~~~~~ 233 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMF-KLGN-KRSAPPI 233 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHH-Hhhc-cccCCcC
Confidence 22122223456888999999987654 88999999999999999999999863221 11111 1111 1111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
++... .+....+.+++.+|+..+|++||++.+|++.
T Consensus 234 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 PPDVS----MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred Ccccc----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111 1234567789999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=302.51 Aligned_cols=243 Identities=22% Similarity=0.375 Sum_probs=196.8
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
..||+|+||.||++.. ++..||||.+........+.+.+|+..++.++|+|++++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 4699999999999987 67899999987665566677899999999999999999999999999999999999999999
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
+++... .+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....... .......
T Consensus 108 ~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 179 (292)
T cd06658 108 DIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLV 179 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceee
Confidence 988543 388999999999999999999998 99999999999999999999999999987653221 1123346
Q ss_pred CCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHH
Q 002688 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSV 824 (892)
Q Consensus 745 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~ 824 (892)
++..|+|||.+.+..++.++||||||++++||++|+.||..... . +-... +.. .+.+.+.... ...
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~-~~~~~-~~~-----~~~~~~~~~~--~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----L-QAMRR-IRD-----NLPPRVKDSH--KVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H-HHHHH-HHh-----cCCCcccccc--ccC
Confidence 88899999999888899999999999999999999999874321 1 11111 111 1111111111 122
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 825 WKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 825 ~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
..+.+++.+|+..+|++||+++|+++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 356688999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=293.88 Aligned_cols=245 Identities=25% Similarity=0.426 Sum_probs=189.5
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC-----chhhHHHHHHHHHHHhccccceeeEeeEeec--CCcEEEEE
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-----SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE--GTNMALIY 655 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~--~~~~~LV~ 655 (892)
..+.||+|+||.||+|.. ++..||+|.+.... ....+.+.+|++++++++|+||+++.+++.. ....++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 357899999999999987 67899999886432 2234568899999999999999999998865 35678999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
||+++++|.+++.... .+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 86 EYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 9999999999997643 388999999999999999999988 99999999999999999999999999987653211
Q ss_pred Cc-cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 736 GT-HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 736 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
.. .......++..|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~-----~~~~ 229 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQP-----TNPQ 229 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCC-----CCCC
Confidence 11 111234578899999999988899999999999999999999999974321 11111211111 1122
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+.. .....+.+++ +|+..+|++||+++||++
T Consensus 230 ~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 LPS----HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred Cch----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 221 1122344555 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=302.04 Aligned_cols=253 Identities=26% Similarity=0.349 Sum_probs=199.6
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCch---hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ---GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
++.+.||+|++|.||++.. +++.+|+|.+...... ..+.+..|+++++.++|+||+++++.+..+...++||||+
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 3457899999999999988 5789999998765322 4567889999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc-
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT- 737 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~- 737 (892)
.+++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999765555689999999999999999999998 9999999999999999999999999998765321110
Q ss_pred --------------------------cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCC
Q 002688 738 --------------------------HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGH 791 (892)
Q Consensus 738 --------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~ 791 (892)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-- 238 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD-- 238 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH--
Confidence 0111235788999999999888999999999999999999999999743321
Q ss_pred ccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 792 THVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 792 ~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
..+. ..... .. ... ........+.+++.+|++.+|++||+++..++++..
T Consensus 239 ---~~~~-~~~~~-~~------~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ---ETFS-NILKK-EV------TFP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ---HHHH-HHhcC-Cc------cCC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1111 11111 10 011 011134567899999999999999995555444444
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=310.29 Aligned_cols=247 Identities=22% Similarity=0.382 Sum_probs=190.4
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+.||+|+||.||+++. +++.||+|++.... ....+.+.+|+.++..++|+||+++++.+..++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 457899999999999988 67899999986432 2234567889999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc--
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT-- 737 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~-- 737 (892)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 85 GGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 999999987643 389999999999999999999998 9999999999999999999999999998754221100
Q ss_pred -------------------------------cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 002688 738 -------------------------------HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKS 786 (892)
Q Consensus 738 -------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~ 786 (892)
.......||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 0012346999999999999999999999999999999999999999743
Q ss_pred ccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002688 787 AENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPF---MNQVVM 850 (892)
Q Consensus 787 ~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---m~eVl~ 850 (892)
.. ............ ...+.+.. .....+.+++.+|+. +|++|++ +.|+++
T Consensus 240 ~~------~~~~~~i~~~~~-~~~~p~~~------~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 240 TP------QETYRKVMNWKE-TLVFPPEV------PISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CH------HHHHHHHHcCCC-ceecCCCC------CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 32 122222221110 00111111 112345567777664 9999986 555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.59 Aligned_cols=255 Identities=23% Similarity=0.381 Sum_probs=195.3
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
++.+.||+|+||.||+|.. +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..+...++|+||++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 4557899999999999998 578999999865422 234678899999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|.++..... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++....... ..
T Consensus 84 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 156 (286)
T cd07846 84 HTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EV 156 (286)
T ss_pred ccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cc
Confidence 999988765433 389999999999999999999998 99999999999999999999999999988653322 22
Q ss_pred cccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCC-----------
Q 002688 740 STTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDI----------- 807 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----------- 807 (892)
.....++..|+|||++.+ ..++.++||||||++++||++|++||..... ...+....-..+.+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-----IDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-----HHHHHHHHHHhCCCchhhHHHhccc
Confidence 233457889999999875 4578899999999999999999999864321 11111100000000
Q ss_pred ---ccccCCCCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 808 ---RSTVDPRLKGDF-----DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 808 ---~~~~D~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.....+...... .......+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000011111000 0122456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=289.14 Aligned_cols=246 Identities=24% Similarity=0.420 Sum_probs=199.2
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|++|.||++.. +++.+|||.+... .....+.+.+|++++++++|+|++++++.+..+...++|+||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 4557899999999999887 6788999998654 23345678999999999999999999999998999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC-CcEEEeeecCcccccCCCCcc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK-FQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~-~~vkl~DfGla~~~~~~~~~~ 738 (892)
+++|.+++.......+++..+..++.+++.+|+|||+. +++|+||||+||+++++ +.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--- 156 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence 99999999876555689999999999999999999998 99999999999999854 568999999998763221
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
......++..|+|||.+.+..++.++||||||++++||++|+.||.... ....+....... ... +.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~------~~~~~~~~~~~~-~~~-----~~-- 222 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN------LPALVLKIMSGT-FAP-----IS-- 222 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc------hHHHHHHHHhcC-CCC-----CC--
Confidence 1223467889999999998889999999999999999999999986432 112222222111 111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......+.+++.+|++.+|++||++.|+++.
T Consensus 223 --~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 --DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1123457799999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=297.54 Aligned_cols=243 Identities=22% Similarity=0.357 Sum_probs=196.4
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
..||+|+||.||++.. +++.||+|.+........+.+.+|+.+++.++|||++++++++..+...++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 4799999999999987 68899999987655555677889999999999999999999999999999999999999999
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .......
T Consensus 107 ~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 178 (297)
T cd06659 107 DIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLV 178 (297)
T ss_pred HHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccccee
Confidence 987543 389999999999999999999998 99999999999999999999999999987653221 1223456
Q ss_pred CCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHH
Q 002688 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSV 824 (892)
Q Consensus 745 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~ 824 (892)
++..|+|||++.+..++.++||||||++++||++|+.||..... ... ... +...... .... .....
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~---~~~-~~~~~~~-----~~~~--~~~~~ 244 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQA---MKR-LRDSPPP-----KLKN--AHKIS 244 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH---HHH-HhccCCC-----Cccc--cCCCC
Confidence 88999999999988999999999999999999999999874321 111 111 1111100 0000 01122
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 825 WKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 825 ~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
..+.+++.+|++.+|++||++.++++.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 346789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=292.29 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=201.2
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||+|++|.||++.. +++.+|+|.+.... ....+++.+|++++++++|+||+++.+.+..+...++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 3457899999999999988 57899999987653 34456789999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
++|.+++.... ..++......++.|++.||+|||+ . +++|+||||+||++++++.+||+|||.+.......
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---- 155 (265)
T cd06605 84 GSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---- 155 (265)
T ss_pred CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----
Confidence 99999997653 458899999999999999999998 6 99999999999999999999999999987653211
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.....++..|+|||.+.+..++.++||||||++++||++|+.||...... .....+..+....... +.+...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~- 227 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEPP------PRLPSG- 227 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCCC------CCCChh-
Confidence 11256788999999999999999999999999999999999999754321 1222333333222111 111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.....+.+++.+|+..+|++||++.+++.
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 13345779999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=297.13 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=198.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc---hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS---QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||++.. .++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+..+.+.++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 3457899999999999988 567899999875532 23457889999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC---
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG--- 735 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~--- 735 (892)
++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 84 EGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999997653 489999999999999999999998 99999999999999999999999999986421100
Q ss_pred ----------CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcC
Q 002688 736 ----------GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG 805 (892)
Q Consensus 736 ----------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 805 (892)
.........++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ..++........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~------~~~~~~~~~~~~ 232 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT------PEELFGQVISDD 232 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhcc
Confidence 0011123457889999999988889999999999999999999999986432 122222222111
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 806 DIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 806 ~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
. ..+.... .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 233 -~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 -I---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -c---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1 1111111 123456799999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.75 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=197.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
+++.+.||+|+||.||+|+. +++.||||.++... ....+.+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 34567899999999999988 57889999987542 333467899999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
+++.+..++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 83 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~ 156 (288)
T cd07833 83 ERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S 156 (288)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence 987776665443 3389999999999999999999998 999999999999999999999999999887643322 1
Q ss_pred ccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh------------cC
Q 002688 739 VSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD------------KG 805 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~------------~~ 805 (892)
......++..|+|||++.+. .++.++||||||+++|||++|++||...... +.......... ..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhcccCc
Confidence 22345678899999999888 8899999999999999999999998743321 11111111000 00
Q ss_pred CC-----ccccCCCC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 806 DI-----RSTVDPRL-KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 806 ~~-----~~~~D~~l-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.. .+..++.. ...+.......+.+++++|+..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 00011112566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=303.81 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=192.2
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+++. .++.+|+|.+.... ......+.+|+.++..++|+||+++.+++.+....++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 4557899999999999988 56789999986421 222345788999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 84 ~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~ 158 (332)
T cd05623 84 VGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TV 158 (332)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC-cc
Confidence 9999999997643 2489999999999999999999998 99999999999999999999999999987653222 22
Q ss_pred ccccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 739 VSTTIAGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.......... ...+.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~-~~~~p~ 231 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKE-RFQFPA 231 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCc-cccCCC
Confidence 223457999999999986 3468899999999999999999999997432 2222333222111 000111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccC--CCCCCCHHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSN--ANRRPFMNQVVME 851 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~--P~~RPsm~eVl~~ 851 (892)
.. ......+.+++.+|+..+ +..|+++.|+++.
T Consensus 232 ~~-----~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 232 QV-----TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc-----ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 112345667778877554 4447899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=290.73 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=202.7
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
++.+.||+|++|.||+|+. +++.|+||++..... ...+.+.+|++.+.+++|+|++++.+++......++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 3457899999999999988 588999999877644 4457899999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
++|.+++... ..+++..+..++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 84 GSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 9999999765 348999999999999999999999 8 9999999999999999999999999998876432211
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||....... ..+........ .. +.+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~-~~-----~~~~--- 224 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAICDG-PP-----PSLP--- 224 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHhcC-CC-----CCCC---
Confidence 124457889999999998899999999999999999999999997544211 12222222211 11 1111
Q ss_pred CHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 820 DIN-SVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 820 ~~~-~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.. ....+.+++.+|+..+|++||++.|+++.
T Consensus 225 -~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 -AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 34567899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=290.28 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=201.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
++.+.||.|+||.||+|.. ++..+|+|++.... ....+.+.+|++.++.++|+|++++.+.+..++..++|+|++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 4567899999999999987 67889999987543 33557889999999999999999999999999999999999999
Q ss_pred CchhhhccccCc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc-
Q 002688 661 GNLEEHLSDSSK-EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH- 738 (892)
Q Consensus 661 gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~- 738 (892)
++|.+++..... ..+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||++..+.......
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 999999976433 4589999999999999999999998 99999999999999999999999999988765433221
Q ss_pred -ccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 739 -VSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 739 -~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
......|+..|+|||++... .++.++|+||||++++||++|+.||...... ..+.+ ..... .+.+.
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~----~~~~~------~~~~~ 228 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLML----TLQND------PPSLE 228 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHH----HhcCC------CCCcC
Confidence 22344688899999998876 7899999999999999999999999744321 11111 11111 11111
Q ss_pred CCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 817 GDF-DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 817 ~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
... .......+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111 0123456779999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=305.25 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=207.5
Q ss_pred HHhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCch---hhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEE
Q 002688 580 RMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ---GYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 580 ~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~L 653 (892)
+..+.+.+.||+|.||.||+++. +|+.+|+|.+.+.... ..+...+|+++|+++. |||||.+.+.++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 34455668999999999999988 6889999999876443 3468899999999998 9999999999999999999
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC----CcEEEeeecCcc
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK----FQAKLADFGLSR 729 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~----~~vkl~DfGla~ 729 (892)
|||++.+|.|.+.+... .++......++.|++.+++|||+. +|+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999998776 289999999999999999999998 99999999999999643 579999999999
Q ss_pred cccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcc
Q 002688 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRS 809 (892)
Q Consensus 730 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 809 (892)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||....+... .. .+..++.
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-----~~--~i~~~~~-- 255 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-----FL--AILRGDF-- 255 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-----HH--HHHcCCC--
Confidence 8754 3345678999999999999999999999999999999999999999986553211 11 2222322
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 810 TVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 810 ~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......-......+.+++..|+..+|..|+++.++++.
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111112234566799999999999999999999983
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=321.82 Aligned_cols=257 Identities=19% Similarity=0.335 Sum_probs=185.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhcccc------ceeeEeeEeecC-CcEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHR------NLTTLVGYCDEG-TNMAL 653 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~------NIv~l~g~~~~~-~~~~L 653 (892)
+.+.+.||+|+||+||+|+. .++.||||+++... ...+++..|++++.+++|. +++++++++... .+.++
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i 209 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI 209 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence 44567899999999999987 67789999986532 2234566777777777554 588888888754 57889
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC---------------
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF--------------- 718 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~--------------- 718 (892)
|||++ +++|.+++.... .+++..+..|+.|++.||+|||++ .+|+||||||+|||++.++
T Consensus 210 v~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 210 VMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 99987 678888886543 489999999999999999999973 2899999999999998765
Q ss_pred -cEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccH---
Q 002688 719 -QAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHV--- 794 (892)
Q Consensus 719 -~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l--- 794 (892)
.+||+|||++.... .......||..|+|||++.+..++.++|||||||++|||++|++||......+....
T Consensus 285 ~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 285 CRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred ceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 49999999875421 223456799999999999999999999999999999999999999975432110000
Q ss_pred ------HHHHHh--------Hhh-cCCCccccCCCC----CCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 795 ------AQWVSS--------MLD-KGDIRSTVDPRL----KGD---FDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 795 ------~~~~~~--------~~~-~~~~~~~~D~~l----~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..|... ... .+.+....++.. ... ........+.+|+.+|++.||++|||++|+++
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 011110 000 000000111100 000 00011345679999999999999999999987
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=292.47 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=198.1
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeec--CCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE--GTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~--~~~~~LV~Ey 657 (892)
++.+.||.|+||.||++.. +++.+|+|.+... .....+++..|++++++++|+||+++++++.. +...+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 3457899999999999987 6788999998654 23345678899999999999999999998753 4568899999
Q ss_pred ccCCchhhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 658 MANGNLEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGC--KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 658 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
+++++|.+++.... ...+++..++.++.|++.||+|||..+ ..+++|+||||+||++++++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 99999999986532 345899999999999999999999332 23999999999999999999999999999987643
Q ss_pred CCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
.. .......++..|+|||.+.+..++.++|+||||+++++|++|+.||..... .+.... +..+...
T Consensus 163 ~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~----- 228 (265)
T cd08217 163 DS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASK-IKEGKFR----- 228 (265)
T ss_pred Cc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHH-HhcCCCC-----
Confidence 22 112344688999999999988899999999999999999999999975331 122211 2222111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.+ .......+.+++.+|++.+|++||++.+|++.
T Consensus 229 ~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 RI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 12234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=308.92 Aligned_cols=235 Identities=26% Similarity=0.372 Sum_probs=183.0
Q ss_pred ecccccEEEEEEEE--CCcEEEEEEccCCCc---hhhHHHHHHHHHHHhc---cccceeeEeeEeecCCcEEEEEEeccC
Q 002688 589 LGKGGFGTVYHGKL--DNDEVAVKMLSPSSS---QGYKQFQAEVKLLLRV---HHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 589 IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l---~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
||+|+||.||+|+. +++.||||++..... .....+..|..++... +||||+++.+++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 678999999864321 2223455666776655 699999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~ 153 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT 153 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence 99999887543 489999999999999999999998 99999999999999999999999999987542221 123
Q ss_pred ccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+.... +..+... +...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~------~~~~~~~-i~~~~~~------~~~~- 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED------TQQMYRN-IAFGKVR------FPKN- 219 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC------HHHHHHH-HHcCCCC------CCCc-
Confidence 346799999999998765 48999999999999999999999996432 1222222 1112111 1100
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMN 846 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~ 846 (892)
.....+.+++.+|+..+|++||++.
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 1123456899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=311.32 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=175.1
Q ss_pred HHHHHhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhcc-c-----cceeeEeeEeecC
Q 002688 577 EVLRMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-H-----RNLTTLVGYCDEG 648 (892)
Q Consensus 577 el~~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H-----~NIv~l~g~~~~~ 648 (892)
|.+..++.+.+.||+|.||.|-|+.. +++.||||+++... .-..+-..|+.+|..++ | -|+|++++++...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 34444677789999999999999987 68899999998653 23355678999999996 4 4899999999999
Q ss_pred CcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC--CcEEEeeec
Q 002688 649 TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK--FQAKLADFG 726 (892)
Q Consensus 649 ~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~--~~vkl~DfG 726 (892)
++.+||+|.++. +|.++|+.++..+++......++.||+.||.+||+. +|||+||||+||||.+. ..+||+|||
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 999999999976 999999999988899999999999999999999998 99999999999999753 479999999
Q ss_pred CcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Q 002688 727 LSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788 (892)
Q Consensus 727 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~ 788 (892)
.+......- .....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+
T Consensus 337 SSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 337 SSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 998653221 144567899999999999999999999999999999999999987765
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=294.46 Aligned_cols=257 Identities=20% Similarity=0.299 Sum_probs=193.7
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
..+.||+|++|.||+|+. +++.||||++.... ....+.+.+|++++++++|+||+++++++.++...++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 456899999999999988 67899999987543 2233578899999999999999999999999999999999996
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.......+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++....... ...
T Consensus 83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (284)
T cd07860 83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTY 157 (284)
T ss_pred cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--ccc
Confidence 6899888766556689999999999999999999998 99999999999999999999999999987653221 112
Q ss_pred ccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc---------------
Q 002688 741 TTIAGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK--------------- 804 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~-~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~--------------- 804 (892)
....++..|+|||.+.+.. ++.++||||||+++|||+||+.||....+. ..+.+.....-..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 2335678899999887654 588999999999999999999999643321 1111111100000
Q ss_pred CCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 805 GDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 805 ~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..........+.. ........+.+++.+|++.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 00011234668999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=296.16 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=191.7
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEee-----cCCcEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCD-----EGTNMALIY 655 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~-----~~~~~~LV~ 655 (892)
.+.+.||+|+||.||+++. +++.+|+|.+..... ...++.+|+.+++++ +|+||+++++++. .+...++||
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 99 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL 99 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence 3457899999999999988 678899998865322 235678899999999 6999999999874 345689999
Q ss_pred EeccCCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 656 EYMANGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
||+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred eecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 999999999987532 234588999999999999999999998 999999999999999999999999999886532
Q ss_pred CCCccccccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCc
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR 808 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 808 (892)
.. .......|+..|+|||++.. ..++.++|||||||++|||++|+.|+..... ..... .. ......
T Consensus 177 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-----~~~~~-~~-~~~~~~ 247 (286)
T cd06638 177 TR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-----MRALF-KI-PRNPPP 247 (286)
T ss_pred CC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-----hHHHh-hc-cccCCC
Confidence 21 12234468899999999853 4578899999999999999999999874321 11111 10 011111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 809 ~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
...++. .....+.+++.+|++.+|++||++.|+++.
T Consensus 248 ~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 248 TLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 111111 112357799999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=290.16 Aligned_cols=242 Identities=28% Similarity=0.338 Sum_probs=198.6
Q ss_pred hceecccccEEEEEEEECC--cEEEEEEccCCCc---hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 586 ERVLGKGGFGTVYHGKLDN--DEVAVKMLSPSSS---QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~~~--~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.||+|.-|+||.+++.+ ..+|+|++.+... +...+.+.|-++|+.++||.+..|++.++.+...+|+||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 4689999999999999954 7899999987643 3345678899999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC------
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE------ 734 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~------ 734 (892)
|+|..+++....+.++...+..++.+++.||+|||-. |||.|||||+||||.++|++-|+||.|+......
T Consensus 162 GdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 162 GDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred ccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 9999999998888899999999999999999999998 9999999999999999999999999987654210
Q ss_pred --------------------------CCc----------------------cccccccCCCCccCccccccCCCCchhhH
Q 002688 735 --------------------------GGT----------------------HVSTTIAGTPGYLDPEYYISNRLTEKSDV 766 (892)
Q Consensus 735 --------------------------~~~----------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV 766 (892)
... ..+...+||-.|+|||++.++..+.++|.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW 318 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW 318 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence 000 01124568999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002688 767 YSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFM 845 (892)
Q Consensus 767 ~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm 845 (892)
|+|||++|||+.|..||.+....+ .+ .++ +-..+.-......+..+.+|+++.+..||.+|-..
T Consensus 319 WtfGIflYEmLyG~TPFKG~~~~~--Tl----~NI---------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 319 WTFGIFLYEMLYGTTPFKGSNNKE--TL----RNI---------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred HHHHHHHHHHHhCCCCcCCCCchh--hH----HHH---------hcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence 999999999999999998654321 11 111 11111111112445667899999999999999983
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=297.36 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=196.4
Q ss_pred cCHHHHHHHhhhh--hceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEeec
Q 002688 573 FTYSEVLRMTNNF--ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDE 647 (892)
Q Consensus 573 ~~~~el~~~t~~f--~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~ 647 (892)
+++.++..++.+| .+.||+|+||.||+++. +++.+|+|.+..... ...++.+|+.+++++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 3344444444444 46899999999999988 678899999865432 245678899999999 89999999999864
Q ss_pred C-----CcEEEEEEeccCCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcE
Q 002688 648 G-----TNMALIYEYMANGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQA 720 (892)
Q Consensus 648 ~-----~~~~LV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~v 720 (892)
. ...++|+||+++|+|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 3589999999999999988642 234589999999999999999999998 99999999999999999999
Q ss_pred EEeeecCcccccCCCCccccccccCCCCccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHH
Q 002688 721 KLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN-----RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVA 795 (892)
Q Consensus 721 kl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~ 795 (892)
||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|++||...... ..+.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence 9999999886532211 12234678899999998643 3688999999999999999999998743211 1111
Q ss_pred HHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 796 QWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 796 ~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
++ . ........++ .+....+.+++.+|++.+|++||++.|+++
T Consensus 244 ~~----~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KI----P-RNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH----h-cCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 1 1111111111 122345789999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=304.43 Aligned_cols=255 Identities=21% Similarity=0.324 Sum_probs=188.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecC------CcEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG------TNMA 652 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~------~~~~ 652 (892)
+...+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++|+||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 44457899999999999987 67789999987542 22345678999999999999999999887533 3578
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+++|++ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 97 ~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 97 LVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 999987 67898887643 389999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCCccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhH----------
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSM---------- 801 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~---------- 801 (892)
.. .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+....
T Consensus 170 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred CC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHh
Confidence 21 234468999999999876 56899999999999999999999999643210 0111111000
Q ss_pred hhcCCCccccC--CCCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 802 LDKGDIRSTVD--PRLKGD----FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 802 ~~~~~~~~~~D--~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
+........+. +..... .-......+.+++.+|++.+|++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 000000 000112246799999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=328.99 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=194.1
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeec--CCcEEEEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE--GTNMALIY 655 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~--~~~~~LV~ 655 (892)
.+.+.+.||+|+||.||+++. .+..+|+|.+... .......|..|+.++++++||||+++++++.. ...+++||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM 93 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence 345668999999999999988 6678999998654 23345678999999999999999999998854 35689999
Q ss_pred EeccCCchhhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCCC----CCccccCCCCccEEEcC-------------
Q 002688 656 EYMANGNLEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGCK----PPIVHRDVKSTNILINE------------- 716 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiHrDLkp~NILl~~------------- 716 (892)
||+++|+|.++|.... ...+++..++.|+.||+.||+|||+... .+|+||||||+||||+.
T Consensus 94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 9999999999987532 2358999999999999999999998521 36999999999999964
Q ss_pred ----CCcEEEeeecCcccccCCCCccccccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCC
Q 002688 717 ----KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLEIITGHPVISKSAENG 790 (892)
Q Consensus 717 ----~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~ 790 (892)
...+||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~--- 247 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN--- 247 (1021)
T ss_pred ccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC---
Confidence 235899999999865322 12234578999999999864 458899999999999999999999996422
Q ss_pred CccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 791 HTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 791 ~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
...+.+..+. .+ +.+.. ......+.+|+..||+.+|++||++.|+++
T Consensus 248 --~~~qli~~lk-~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 --NFSQLISELK-RG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred --cHHHHHHHHh-cC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2222222221 11 11110 012345779999999999999999999984
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=291.41 Aligned_cols=244 Identities=26% Similarity=0.447 Sum_probs=196.5
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC-CchhhHHHHHHHHHHHhcc---ccceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS-SSQGYKQFQAEVKLLLRVH---HRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~---H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.+.+.||+|+||.||+|+. +++.||+|.+... .....+++.+|++++++++ |+|++++++++..+...++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 3456899999999999997 6789999998754 3334567889999999997 99999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++++|.+++... .+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06917 84 AEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-- 155 (277)
T ss_pred CCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--
Confidence 9999999998653 489999999999999999999998 99999999999999999999999999998764332
Q ss_pred cccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
.......|+..|+|||.+.++ .++.++||||||+++|||++|++||..... ..+... .... ..+.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~~~-~~~~-----~~~~~~ 223 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAMML-IPKS-----KPPRLE 223 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhhhc-cccC-----CCCCCC
Confidence 122344688899999998754 468999999999999999999999974321 111111 1111 111222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.. .....+.+++.+|++.+|++||++.|+++
T Consensus 224 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 DN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11 13356789999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=292.04 Aligned_cols=257 Identities=21% Similarity=0.312 Sum_probs=194.5
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.||.|++|.||+|+. ++..||+|++.... ....+.+.+|++.+++++|+|++++++++..+...+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 457899999999999987 78999999987543 2233568899999999999999999999999999999999995
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.......+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++..+..... ..
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~ 156 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TY 156 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--cc
Confidence 6899998766545689999999999999999999998 999999999999999999999999999876532211 11
Q ss_pred ccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcC-----------C--
Q 002688 741 TTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG-----------D-- 806 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----------~-- 806 (892)
....++..|+|||++.+. .++.++||||||+++|||++|++||...... ..+.+......... .
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 233467899999988764 5789999999999999999999999743221 01111111000000 0
Q ss_pred --CccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 807 --IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 807 --~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......+... .........+.+++.+|++.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 001112346779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=289.12 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=198.7
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
...+.||+|+||.||+|+. +++.|++|.++.... ...+.+..|++++++++|+||+++++++...+..++|+||++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 3457899999999999987 678999999876544 356789999999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 83 GGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999997643 378999999999999999999998 999999999999999999999999999887643322111
Q ss_pred --cccccCCCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 740 --STTIAGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 740 --~~~~~gt~~Y~aPE~~~~~~---~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
.....++..|+|||++.+.. .+.++||||||++++||++|+.||..... -......... + ..+.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~~~~~~~~~-~-----~~~~ 226 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EFQIMFHVGA-G-----HKPP 226 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hHHHHHHHhc-C-----CCCC
Confidence 11346788999999998766 88999999999999999999999974321 1111111111 1 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+... ......+.+++.+|++.+|++||++.|++.
T Consensus 227 ~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 IPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 112345679999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=290.52 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=190.6
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC-----chhhHHHHHHHHHHHhccccceeeEeeEeecC--CcEEEEE
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-----SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMALIY 655 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~LV~ 655 (892)
+.+.||+|+||.||+|+. ++..||||.+.... ....+.+.+|++++++++|+||+++.+++.+. ...+++|
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 457899999999999987 67899999875321 22345788899999999999999999988653 4578999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
||+++++|.+++.... .+++....+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 86 EHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 9999999999987543 378889999999999999999998 99999999999999999999999999988653211
Q ss_pred Cc-cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 736 GT-HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 736 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.||.... .... ........ ..+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~-~~~~~~~~-----~~~~ 229 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-----AMAA-IFKIATQP-----TNPV 229 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-----hHHH-HHHHhcCC-----CCCC
Confidence 11 11223458889999999988889999999999999999999999986421 1111 11111111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
. +......+.+++.+|+. +|++||+++|+++
T Consensus 230 ~----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 230 L----PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1 22233456688888885 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=295.65 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=196.1
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC-CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+++.+.||+|+||.||+++. ++..||+|.+... ......++.+|++++++++|+||+++++.+......++|+||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 34567899999999999988 5889999988754 33345678999999999999999999999999999999999999
Q ss_pred CCchhhhccccC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 660 NGNLEEHLSDSS-KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 660 ~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
+++|.+++.... ...+++..+..++.+++.||.|||+. .+++||||||+||+++.++.+||+|||++..+...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 156 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---- 156 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----
Confidence 999999887642 23589999999999999999999963 28999999999999999999999999998765321
Q ss_pred ccccccCCCCccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccC
Q 002688 739 VSTTIAGTPGYLDPEYYISNR------LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~------~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D 812 (892)
......++..|+|||.+.+.. ++.++|+|||||++|||++|+.||...... ....-... +..+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~-~~~~~~----- 227 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSA-IVDGDP----- 227 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHH-HhhcCC-----
Confidence 122345788999999985543 588999999999999999999999643211 11111111 111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 813 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+.+ ..+....+.+++.+|++.+|++||++.+++.
T Consensus 228 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 PTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111 1123455779999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-31 Score=289.56 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=196.7
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhccccceeeEeeEeecC--CcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~LV~Ey~~ 659 (892)
+.+.||.|++|.||++.. +++.+|+|.+..... ....++.+|++++++++|+||+++++++... ...++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 346899999999999998 678899999875433 4457789999999999999999999988543 46899999999
Q ss_pred CCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 660 NGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 660 ~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|.+++... ....+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 159 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-- 159 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc--
Confidence 99999887532 234588999999999999999999998 99999999999999999999999999987643211
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--CCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAE--NGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... .....+..+... . ... .+....
T Consensus 160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~-~~~-~~~~~~ 232 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---M-PNP-ELKDEP 232 (287)
T ss_pred --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---C-Cch-hhccCC
Confidence 1234578899999999988999999999999999999999999975532 111122222221 1 111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.. .......+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 10 0122456789999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=293.28 Aligned_cols=247 Identities=25% Similarity=0.437 Sum_probs=193.3
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEeec------CCcEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDE------GTNMAL 653 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~------~~~~~L 653 (892)
+.+.+.||+|+||.||+|+. +++.+|+|.+.... ....++..|+.++.++ +|+||+++.+++.. ....++
T Consensus 18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 34457899999999999998 67889999986543 3345688899999998 79999999999853 457899
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
+|||+++|+|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 99999999999999776555688999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCccccccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCc
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR 808 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 808 (892)
.. .......|+..|+|||.+. ...++.++|||||||++|||++|+.||....... . ... ....
T Consensus 174 ~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-----~-~~~-~~~~--- 241 (282)
T cd06636 174 TV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-----A-LFL-IPRN--- 241 (282)
T ss_pred cc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-----h-hhh-HhhC---
Confidence 11 1123456888999999975 3468889999999999999999999996432111 0 000 0000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 809 ~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+.+. .......+.+++.+|++.+|.+||++.|+++
T Consensus 242 --~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 --PPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --CCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 011111 1123346789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=295.10 Aligned_cols=240 Identities=27% Similarity=0.426 Sum_probs=194.9
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+++. +++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.++...++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 4567899999999999988 67899999986532 223466889999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 84 ~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 84 PGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999987653 489999999999999999999998 9999999999999999999999999998875322
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.....++..|+|||.+.+...+.++||||||++++||++|+.||..... .+-..... .+.. .+..
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~------~~~~- 219 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKIL-EGKV------RFPS- 219 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh-cCCc------cCCc-
Confidence 2344688999999999888889999999999999999999999864321 11111111 1111 1111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRP-----FMNQVVM 850 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~ 850 (892)
.....+.+++.+|+..+|++|| +++|+++
T Consensus 220 ---~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 220 ---FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1134567999999999999999 5666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=295.07 Aligned_cols=258 Identities=20% Similarity=0.295 Sum_probs=191.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|+||.||+|+. +++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 4457899999999999988 688999999865422 223567889999999999999999999999999999999997
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
++|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 83 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (284)
T cd07839 83 -QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RC 155 (284)
T ss_pred -CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CC
Confidence 47888776543 3489999999999999999999998 99999999999999999999999999988653221 11
Q ss_pred cccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCC------CccccC
Q 002688 740 STTIAGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD------IRSTVD 812 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~~D 812 (892)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.|+...... ....+.......... +.+..+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 22345688999999987654 789999999999999999998886432211 011111111100000 000000
Q ss_pred ----CCCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 813 ----PRLKGDF-----DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 813 ----~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+...... .......+.+++.+|++.+|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 0112346679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=287.79 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=200.0
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|+||.||+|.. ++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 3457899999999999988 67889999986542 2344678899999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC-cEEEeeecCcccccCCCCcc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF-QAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~-~vkl~DfGla~~~~~~~~~~ 738 (892)
+++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++ .+||+|||.+....... .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~ 157 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--E 157 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc--c
Confidence 99999999766555689999999999999999999998 999999999999999875 46999999987653221 1
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
......|+..|+|||++.+..++.++|+||||++++||++|+.||... ...+++...... .... +.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~-~~~~-~~~----- 224 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN------NLHQLVLKICQG-YFAP-ISP----- 224 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHhcc-cCCC-CCC-----
Confidence 222345888999999998888999999999999999999999998632 223344333221 1111 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.....+.+++.+|+..+|++||++.|+++.
T Consensus 225 ---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 ---NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 122457799999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=277.97 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=202.7
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCCc--------hhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEE
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--------QGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV 654 (892)
.++||+|..+.|-+... .+++.|+|++..... .-.+.-.+|+.+|+++ .||+|+.+.+++..+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 46899999999988766 788999999854321 1123456799999998 699999999999999999999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
+|.|+.|.|.++|.+.- .+++.+..+|.+|+..|++|||.. +|+||||||+|||+|++.++||+|||.+..+.+.
T Consensus 102 Fdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999998754 489999999999999999999998 9999999999999999999999999999987543
Q ss_pred CCccccccccCCCCccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCc
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR 808 (892)
Q Consensus 735 ~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 808 (892)
..-...+||++|+|||.+.. ..|+...|+|++||+||.|+.|.+||....+ -....++.+|+..
T Consensus 177 ---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~ImeGkyq 246 (411)
T KOG0599|consen 177 ---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIMEGKYQ 246 (411)
T ss_pred ---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHHhcccc
Confidence 23456799999999999853 3588899999999999999999999985432 1122344444432
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHHHhhhh
Q 002688 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM--ELNDCLAMEA 860 (892)
Q Consensus 809 ~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~--~L~~~~~~e~ 860 (892)
.-.|+.. +....+.+|+.+|++.||.+|-|.+|+++ ...++.+.++
T Consensus 247 -F~speWa-----dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~ 294 (411)
T KOG0599|consen 247 -FRSPEWA-----DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA 294 (411)
T ss_pred -cCCcchh-----hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence 1112211 23345679999999999999999999997 3444444443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-33 Score=280.01 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=198.1
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.+++.+.||+|.|+.||+... .|+.+|+|++... +..+.+++.+|+.+.+.++||||+++.....+....++|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 345567899999999998766 7888888887533 334678899999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEc---CCCcEEEeeecCcccccCC
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN---EKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~---~~~~vkl~DfGla~~~~~~ 734 (892)
|.+++|..-+-.. ..+++...-.+.+||+++|.|.|.. +|+|||+||.|+||- ...-+|++|||+|..+.
T Consensus 92 m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 92 VTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred ccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 9999998766543 4477888889999999999999999 999999999999995 34569999999999875
Q ss_pred CCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 735 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
.....-...||++|||||++...+|+..+|||+.||+|+-|+.|.+||.+.+. .+...+.. .+.. -+++.
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~------~rlye~I~-~g~y--d~~~~ 234 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYEQIK-AGAY--DYPSP 234 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH------HHHHHHHh-cccc--CCCCc
Confidence 23344577899999999999999999999999999999999999999986332 12222222 1211 11221
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.-. .......+|+.+|+..||.+|.|+.|+++
T Consensus 235 ~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 235 EWD----TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccC----cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111 12234568999999999999999988765
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=294.56 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=195.9
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCch-----hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ-----GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
.+.+.||+|++|.||+|.. +++.||||.+...... ....+..|++++++++|+||+++++++......++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 3457899999999999987 6789999998765322 23457789999999999999999999999999999999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
|+ +|+|.+++.... ..+++..+..++.|+++||+|||++ +++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 83 FM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred cc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99 899999997654 3599999999999999999999998 999999999999999999999999999987643221
Q ss_pred ccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh--------cCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD--------KGDI 807 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~--------~~~~ 807 (892)
......++..|+|||.+.+ ..++.++|||||||+++||++|.++|...... ..+......... ....
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 158 --KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred --cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHHcCCCchhhhhhcccc
Confidence 1223346778999999865 45789999999999999999998887643321 111111110000 0000
Q ss_pred ccccCCCCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 808 RSTVDPRLKGDFD-----INSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 808 ~~~~D~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
............. ......+.+++.+|++.+|++||+++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000011 1224567899999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=294.81 Aligned_cols=247 Identities=23% Similarity=0.384 Sum_probs=199.1
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.+.||+|+||.||++.. +++.||+|.+........+.+.+|+.++++++|||++++.+++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 100 (293)
T cd06647 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100 (293)
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence 34557899999999999986 6788999998765555567789999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........ ..
T Consensus 101 ~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~ 172 (293)
T cd06647 101 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (293)
T ss_pred CcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence 9999998753 378999999999999999999998 999999999999999999999999999876543221 22
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....++..|+|||.+.+..++.++||||||+++|||++|+.||........ +......+. +... ..
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~~------~~~~--~~ 238 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGT------PELQ--NP 238 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCCC------CCCC--Cc
Confidence 234578899999999888899999999999999999999999974332110 000000010 0010 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......+.+++.+|+..+|++||++.+++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223457789999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=282.45 Aligned_cols=247 Identities=24% Similarity=0.410 Sum_probs=201.1
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecC--CcEEEEEEec
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMALIYEYM 658 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~LV~Ey~ 658 (892)
..+.||+|++|.||+|+. +++.|++|++..... ...+.+.+|++.+++++|+||+++++.+... ...++++||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 347899999999999998 488999999876543 4567889999999999999999999999888 8899999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+..........
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 84 SGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999997654 589999999999999999999998 99999999999999999999999999988764332211
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
......++..|+|||.+.+...+.++||||||++++||++|+.||.... ................ .
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~---------~ 224 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP---------E 224 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc---------C
Confidence 1334568889999999988889999999999999999999999997543 1111111111111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
........+.+++.+|++.+|++||++.|+++
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122456789999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=289.20 Aligned_cols=242 Identities=21% Similarity=0.346 Sum_probs=197.3
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
+.||+|++|.||++.. +++.+++|++........+.+.+|+.+++.++|+|++++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 5899999999999986 67889999987655555667899999999999999999999999999999999999999999
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...... ........
T Consensus 105 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~ 176 (285)
T cd06648 105 DIVTHT---RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLV 176 (285)
T ss_pred HHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccccccc
Confidence 998762 389999999999999999999998 9999999999999999999999999988755322 11223345
Q ss_pred CCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHH
Q 002688 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSV 824 (892)
Q Consensus 745 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~ 824 (892)
|+..|+|||.+.+..++.++||||||++++||++|+.||.... .......... +.. +.+... ....
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~------~~~~~~~~~~-~~~-----~~~~~~--~~~~ 242 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP------PLQAMKRIRD-NLP-----PKLKNL--HKVS 242 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC------HHHHHHHHHh-cCC-----CCCccc--ccCC
Confidence 8899999999988889999999999999999999999986422 1222222211 111 111110 1123
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 825 WKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 825 ~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+.+++.+|++.+|++||++.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 46789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=294.79 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=191.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||+|++|.||+|+. +++.||||.+...... ....+.+|++++++++|+||+++.+++..+...++||||+.+
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT 87 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence 3457899999999999987 6789999998654322 234577899999999999999999999999999999999985
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
+|.+++..... .+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....... ..
T Consensus 88 -~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 160 (291)
T cd07844 88 -DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TY 160 (291)
T ss_pred -CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc--cc
Confidence 89998875443 589999999999999999999998 999999999999999999999999999875422111 11
Q ss_pred ccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc---CCCccc------
Q 002688 741 TTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK---GDIRST------ 810 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~------ 810 (892)
....++..|+|||.+.+ ..++.++||||+|+++|||++|++||....... ............ ......
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 22346788999999875 458899999999999999999999996433100 000000000000 000000
Q ss_pred -------c-CCCCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 811 -------V-DPRLKGDF-DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 811 -------~-D~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
. ...+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000000 0111256679999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=305.05 Aligned_cols=238 Identities=26% Similarity=0.418 Sum_probs=195.7
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
+.||.|+||.||-|+. +...||||++.-.. ...+.++.+|+..|.+++|||+|.+.|++......+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 4699999999999987 77889999987653 34567899999999999999999999999999999999999964
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+-.|+|.-.+ +++...++..|+.+.+.||+|||+. +.||||||+.||||++.|.|||+|||.|....+. .
T Consensus 111 SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------n 180 (948)
T KOG0577|consen 111 SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------N 180 (948)
T ss_pred cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch------h
Confidence 7777776553 4589999999999999999999999 9999999999999999999999999998876433 4
Q ss_pred cccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 742 TIAGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.++||+.|||||++. .+.|+-|+||||||++..||...+||+..... +.-.. .+...-.|.|.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----MSALY-------HIAQNesPtLq-- 246 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALY-------HIAQNESPTLQ-- 246 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----HHHHH-------HHHhcCCCCCC--
Confidence 678999999999984 57899999999999999999999999763221 11111 11111223333
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+=...+..++..|++.-|.+|||.+++++
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2233455779999999999999999998776
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-31 Score=280.07 Aligned_cols=245 Identities=27% Similarity=0.460 Sum_probs=200.9
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
..+.||+|++|.||+++. ++..+++|++........+++.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 456899999999999998 578899999987665566789999999999999999999999999999999999999999
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 742 (892)
|.+++.... ..+++..+..++.|++.+|++||+. +++|+||+|+||++++++.++|+|||.+........ ...
T Consensus 84 L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~ 156 (253)
T cd05122 84 LKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNT 156 (253)
T ss_pred HHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccc
Confidence 999987653 3589999999999999999999998 999999999999999999999999999887643321 234
Q ss_pred ccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHH
Q 002688 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDIN 822 (892)
Q Consensus 743 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~ 822 (892)
..++..|+|||.+.+..++.++||||||++++||++|+.|+..... .+....... .......++ ..
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~~-------~~ 222 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIAT-NGPPGLRNP-------EK 222 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHh-cCCCCcCcc-------cc
Confidence 5688899999999888899999999999999999999999874321 111111111 111111111 11
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 823 SVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 823 ~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
....+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1345789999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=293.06 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=192.5
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
.+.||+|+||.||+++. +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 46799999999999988 67899999987543 334567899999999996 99999999999988899999999864
Q ss_pred chhhh---ccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 662 NLEEH---LSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 662 sL~~~---L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++.++ +.......+++.....++.+++.||+|||+. .+++||||||+||+++.++.+||+|||+++.+....
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--- 162 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--- 162 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC---
Confidence 54443 3333334589999999999999999999974 289999999999999999999999999987653221
Q ss_pred ccccccCCCCccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISN---RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~---~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
......|+..|+|||++.+. .++.++||||||+++|||++|+.||.... ...+-....... ..+.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~ 231 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG------DPPIL 231 (288)
T ss_pred ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC------CCCcC
Confidence 11234578899999998766 68999999999999999999999987432 111111121111 11222
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
...........+.+++.+|++.+|++||++.+|++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222222344567899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=295.84 Aligned_cols=259 Identities=22% Similarity=0.284 Sum_probs=194.2
Q ss_pred ceeccc--ccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKG--GFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G--~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+| +||+||+++. +++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999988 78999999987542 23446788999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc--
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH-- 738 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~-- 738 (892)
|+|.+++.......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999876555689999999999999999999998 99999999999999999999999998654432211110
Q ss_pred ---ccccccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHh-------------
Q 002688 739 ---VSTTIAGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSS------------- 800 (892)
Q Consensus 739 ---~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~------------- 800 (892)
......++..|+|||++.+. .++.++|||||||+++||++|++||...... ..+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccch
Confidence 01112345679999999764 4789999999999999999999999754311 011110000
Q ss_pred -------------------HhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 801 -------------------MLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 801 -------------------~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
....+......+..+...........+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000111111221122235567889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=295.05 Aligned_cols=263 Identities=19% Similarity=0.297 Sum_probs=194.3
Q ss_pred hhhceecccccEEEEEEEE----CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecC--CcEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL----DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMALI 654 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~----~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~LV 654 (892)
.+.+.||+|+||.||+|+. ++..||+|.+.... ....+.+.+|++++.+++||||+++++++... ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 4557899999999999998 46899999988643 33346678899999999999999999999887 789999
Q ss_pred EEeccCCchhhhccccC---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC----CCcEEEeeecC
Q 002688 655 YEYMANGNLEEHLSDSS---KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE----KFQAKLADFGL 727 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~----~~~vkl~DfGl 727 (892)
|||+++ +|.+++.... ...++......++.|++.||+|||+. +++||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999975 6666664322 23588999999999999999999998 9999999999999999 99999999999
Q ss_pred cccccCCCC-ccccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCc-------cHHHHH
Q 002688 728 SRVFPVEGG-THVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHT-------HVAQWV 798 (892)
Q Consensus 728 a~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~-------~l~~~~ 798 (892)
+........ ........++..|+|||.+.+. .++.++||||||++++||++|++||......... .+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 987643222 1122345678899999988764 5789999999999999999999999755432210 111111
Q ss_pred HhHhh-----------cCCCccccCCCCCCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 799 SSMLD-----------KGDIRSTVDPRLKGDFD---------I--NSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 799 ~~~~~-----------~~~~~~~~D~~l~~~~~---------~--~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+-. ........+......+. . .....+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 10000 00000000000000000 0 23346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=289.70 Aligned_cols=248 Identities=26% Similarity=0.442 Sum_probs=194.3
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEeecCC------cEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGT------NMAL 653 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~------~~~L 653 (892)
+.+.+.||+|++|.||+|+. +++.+++|.+..... ..+++.+|+++++++ +|+||+++++++.... ..++
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 34567899999999999998 567899999876543 346789999999999 7999999999996544 4899
Q ss_pred EEEeccCCchhhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccc
Q 002688 654 IYEYMANGNLEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~ 731 (892)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 999999999999886543 45689999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCccccccccCCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCC
Q 002688 732 PVEGGTHVSTTIAGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD 806 (892)
Q Consensus 732 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 806 (892)
... ........++..|+|||++.. ..++.++||||||++++||++|+.||..... ... ..+.. ...
T Consensus 164 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~-~~~~~-~~~ 234 (275)
T cd06608 164 DST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-----MRA-LFKIP-RNP 234 (275)
T ss_pred ccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-----HHH-HHHhh-ccC
Confidence 322 112234568889999998753 3467899999999999999999999964321 111 11111 111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 807 IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 807 ~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+.+. ........+.+++.+|+..+|++|||+.|+++
T Consensus 235 -----~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 -----PPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----CCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 11123446779999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=290.38 Aligned_cols=261 Identities=20% Similarity=0.306 Sum_probs=193.9
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCch--hhHHHHHHHHHHHhccccceeeEeeEeecC--CcEEEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ--GYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMALIYE 656 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~LV~E 656 (892)
+.+.+.||+|+||.||+|+. +++.+|+|.++..... ....+.+|++++++++|+||+++++++... ...++|+|
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 34457899999999999998 5788999998754322 234577899999999999999999998777 88999999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
|+++ +|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++..+.....
T Consensus 87 ~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 87 YVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9974 89888876443 589999999999999999999998 999999999999999999999999999887643221
Q ss_pred ccccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCc-cHH---------HHHH--hHhh
Q 002688 737 THVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHT-HVA---------QWVS--SMLD 803 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~-~l~---------~~~~--~~~~ 803 (892)
......++..|+|||.+.+. .++.++|+||||++++||++|++||......... .+. .|.. ....
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 162 --PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred --ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 12234567889999998764 4689999999999999999999999744321000 000 0100 0000
Q ss_pred --cCCCccccCCCCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 804 --KGDIRSTVDPRLKGDFDIN-SVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 804 --~~~~~~~~D~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
...........+...+... ....+.+++.+|++.+|++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000011111111111111 2455779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=289.93 Aligned_cols=240 Identities=25% Similarity=0.340 Sum_probs=190.7
Q ss_pred ecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 589 LGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 589 IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
||+|+||+||++.. +++.+|+|.+.... ....+.+..|++++++++|||++++.+.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 68899999986532 22345678899999999999999999999999999999999999999
Q ss_pred hhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccc
Q 002688 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743 (892)
Q Consensus 664 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 743 (892)
.+++.......+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence 9999776555689999999999999999999998 9999999999999999999999999998765321 112234
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHH
Q 002688 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823 (892)
Q Consensus 744 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~ 823 (892)
.++..|+|||.+.+..++.++||||||++++||++|+.||....... ...+...... .. ...+. ...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~-~~------~~~~~----~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--EKEELKRRTL-EM------AVEYP----DKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--cHHHHHhccc-cc------cccCC----ccC
Confidence 57789999999988889999999999999999999999997543211 1111111100 00 01111 112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHH
Q 002688 824 VWKAVEIAMACVSSNANRRPFMNQ 847 (892)
Q Consensus 824 ~~~l~~l~~~Cl~~~P~~RPsm~e 847 (892)
...+.+++.+|++.+|++||+.++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 345679999999999999995555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-31 Score=288.75 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=190.5
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||+|+||.||+|.. +++.||+|.+...... ....+.+|+++++.++|+||+++.+++..+...++|+||+.
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~- 86 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH- 86 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence 3457899999999999987 6889999998754322 23467889999999999999999999999999999999996
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+.+.... ..+.+..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 87 ~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 160 (291)
T cd07870 87 TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TY 160 (291)
T ss_pred CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CC
Confidence 67777665433 3478888999999999999999998 999999999999999999999999999876432211 12
Q ss_pred ccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh------------cCCC
Q 002688 741 TTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD------------KGDI 807 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~------------~~~~ 807 (892)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ..+.+ ....+. ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEK-IWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHH-HHHHcCCCChhhhhhhhhcccc
Confidence 234568899999998754 57889999999999999999999997443210 00110 000000 0000
Q ss_pred ccccCCC-CCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 808 RSTVDPR-LKGDF-----DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 808 ~~~~D~~-l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+...+. ..... .......+.+++.+|+..+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 00000 0012345678999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=293.97 Aligned_cols=243 Identities=27% Similarity=0.399 Sum_probs=192.9
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+...+.||+|+||.||+|+. +++.||+|.+.... ....+++.+|+++++.++|||++++.+++..+...++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 45567899999999999987 68899999986432 23346788999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+. |++.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 97 ~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 97 CL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 97 57777665433 3489999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
....++..|+|||.+. ...++.++||||||+++|||++|++||..... ........ .... +.
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~-~~~~-----~~ 233 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIA-QNDS-----PT 233 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHh-cCCC-----CC
Confidence 2345788999999874 35688999999999999999999999864321 11111111 1110 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
+. .......+.+++.+|++.+|++||++.++++.
T Consensus 234 ~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 LS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11 11234567899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=288.95 Aligned_cols=247 Identities=25% Similarity=0.346 Sum_probs=189.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHH-HHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKL-LLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~-l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|+||.||+|+. +++.||+|++.... .....++..|+.. ++..+|+|++++++++..+...+++|||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 3457899999999999988 68899999987643 2334566667665 566789999999999999999999999997
Q ss_pred CCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 660 NGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 660 ~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
|+|.+++... ....+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--- 157 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--- 157 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc---
Confidence 6888777542 2345899999999999999999999752 7999999999999999999999999998865321
Q ss_pred cccccccCCCCccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 738 HVSTTIAGTPGYLDPEYYIS----NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
.......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..... ... ......... .+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~-~~~~~~~~~------~~ 226 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----PFQ-QLKQVVEEP------SP 226 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----CHH-HHHHHHhcC------CC
Confidence 12233467889999998864 4568899999999999999999999863221 111 111111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+.. ......+.+++.+|+..+|++||++.++++
T Consensus 227 ~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 QLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 012345779999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=288.50 Aligned_cols=254 Identities=24% Similarity=0.291 Sum_probs=191.1
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhcc-ccceeeEeeEeecC--CcEEEEEEec
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEG--TNMALIYEYM 658 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~--~~~~LV~Ey~ 658 (892)
+.+.||+|+||.||+|+. +++.||+|+++... ........+|+..+.++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 457899999999999987 67899999987542 222334567899999885 99999999999877 8899999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
+ |+|.+.+.... ..++|..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.......
T Consensus 83 ~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 83 D-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred C-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 7 58888776543 3589999999999999999999998 9999999999999999 9999999999986532211
Q ss_pred ccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHh-----------hcCC
Q 002688 739 VSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSML-----------DKGD 806 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~-----------~~~~ 806 (892)
.....++..|+|||++.. +.++.++|||||||++|||++|++||..... .....+..... ....
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 123457889999997654 5578899999999999999999999975432 11112221111 1111
Q ss_pred CccccCCCCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 807 IRSTVDPRLKGD----FDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 807 ~~~~~D~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......+...+. ........+.+++.+|++.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 111101110000 01123567889999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=291.99 Aligned_cols=244 Identities=24% Similarity=0.382 Sum_probs=204.7
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCch--hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ--GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
|++++.||+|.|+.|-.|++ .|..||||++.+.... ....+.+|++.|+-++|||||+|+.+......+|||+|.=
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 45677899999999998877 9999999999876433 3457899999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEc-CCCcEEEeeecCcccccCCCCc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~-~~~~vkl~DfGla~~~~~~~~~ 737 (892)
++|+|.++|-++. ..+.+....+++.||+.|+.|.|+. .++||||||+|+.+- .-|-+||.|||++..+.+..
T Consensus 100 D~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-- 173 (864)
T KOG4717|consen 100 DGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-- 173 (864)
T ss_pred CCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence 9999999997664 3489999999999999999999998 999999999999774 56889999999998875432
Q ss_pred cccccccCCCCccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
..+..+|+..|-|||++.+..|+ +++||||||||||-|++|++||....+. +.+..++|=.+.
T Consensus 174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmImDCKYt 237 (864)
T KOG4717|consen 174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIMDCKYT 237 (864)
T ss_pred -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhhccccc
Confidence 34567899999999999999987 5789999999999999999999854321 122233443222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+.....+..+|+..|+..+|++|-+.+||+.
T Consensus 238 --vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 --VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 23445667789999999999999999988864
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=288.34 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=185.4
Q ss_pred eecccccEEEEEEEE--CCcEEEEEEccCCCc---hhhHHHHHHHHHHH---hccccceeeEeeEeecCCcEEEEEEecc
Q 002688 588 VLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS---QGYKQFQAEVKLLL---RVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~---~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+||+|+||.||+++. +++.+|+|.+..... ...+.+.+|..+++ ..+|+|++.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 678999998865421 22233444544333 3479999999999998899999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++...... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence 999999887543 489999999999999999999998 9999999999999999999999999998755321 1
Q ss_pred cccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||....... . ......... ..+.+..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~-~~~~~~~~~------~~~~~~~- 220 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---K-HEIDRMTLT------VNVELPD- 220 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC---H-HHHHHHhhc------CCcCCcc-
Confidence 123468999999999864 568999999999999999999999997543211 1 111111110 1111211
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRP-----FMNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~~ 851 (892)
.....+.+++.+|+..+|++|| +++|+++.
T Consensus 221 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 221 ---SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2234677899999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=291.07 Aligned_cols=257 Identities=25% Similarity=0.343 Sum_probs=194.9
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecC--CcEEEEEEec
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMALIYEYM 658 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~LV~Ey~ 658 (892)
+.+.||+|++|.||+|+. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 457899999999999988 56899999998663 33345788999999999999999999999887 8899999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........ .
T Consensus 83 ~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (287)
T cd07840 83 DH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-A 156 (287)
T ss_pred cc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-c
Confidence 75 8888886543 3589999999999999999999998 999999999999999999999999999987643321 1
Q ss_pred ccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc---CCCccc----
Q 002688 739 VSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK---GDIRST---- 810 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~---- 810 (892)
......++..|+|||.+.+ ..++.++||||||++++||++|+.||...... ............ ......
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhccccccch
Confidence 1233456788999998765 45789999999999999999999999744321 111111111000 000000
Q ss_pred ----------cCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 811 ----------VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 811 ----------~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
....+...+...+...+++++.+|+..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000011112557889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=285.82 Aligned_cols=236 Identities=25% Similarity=0.367 Sum_probs=191.9
Q ss_pred ecccccEEEEEEEEC--CcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 589 LGKGGFGTVYHGKLD--NDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 589 IG~G~fG~Vy~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
||.|++|.||+++.. ++.+|+|.+.... ....+.+.+|+++++.++|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999984 8899999987543 23446789999999999999999999999999999999999999999
Q ss_pred hhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccc
Q 002688 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743 (892)
Q Consensus 664 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 743 (892)
.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 99997653 388999999999999999999998 99999999999999999999999999998764321 12234
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHH
Q 002688 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823 (892)
Q Consensus 744 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~ 823 (892)
.++..|++||.+.+..++.++|+||||+++|||++|+.||....+ +..+.......... ...++...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~---------~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNG---------KLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCC---------CCCCCccc
Confidence 678899999999888899999999999999999999999975442 12222222221110 00111112
Q ss_pred HHHHHHHHHHccccCCCCCCCH
Q 002688 824 VWKAVEIAMACVSSNANRRPFM 845 (892)
Q Consensus 824 ~~~l~~l~~~Cl~~~P~~RPsm 845 (892)
...+.+++.+|++.+|++||++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCC
Confidence 4567899999999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=293.95 Aligned_cols=242 Identities=25% Similarity=0.355 Sum_probs=197.6
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
-++||+||||.||-... +|+.+|.|++.+.. .++..-.+.|-++|.+++.+.||.+--.+...+.++||+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 36899999999997655 88999999886542 23344567899999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.-+|...+...+++.....++.+|+.||++||+. +|+.|||||.|||||+.|+++|+|+|||..++... ..
T Consensus 270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~---~~ 343 (591)
T KOG0986|consen 270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK---PI 343 (591)
T ss_pred CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC---cc
Confidence 9999999988877899999999999999999999999 99999999999999999999999999999875322 23
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
+..+||.||||||+++++.|+...|.|||||++|||+.|+.||....+.... +-+.+.+.+. + ..++
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~~-------~---~ey~ 410 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLED-------P---EEYS 410 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhcc-------h---hhcc
Confidence 4458999999999999999999999999999999999999999755432211 1122222111 1 1222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMN 846 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~ 846 (892)
..-..+..++....++.||++|..-+
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCC
Confidence 23334556778888999999987544
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=291.12 Aligned_cols=246 Identities=23% Similarity=0.382 Sum_probs=199.1
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
.+.+.||+|++|.||+|+. ++..+++|.+..... ..+.+.+|++.++.++|+|++++++++......++|+||++++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 3446899999999999998 488999999976544 5577899999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 101 ~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~ 174 (286)
T cd06614 101 SLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRN 174 (286)
T ss_pred cHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhc
Confidence 9999998754 3599999999999999999999998 99999999999999999999999999887553221 1223
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
...++..|+|||.+.+..++.++||||||+++|||++|+.||..... ......... .......+ ..
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~-------~~ 240 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP------LRALFLITT-KGIPPLKN-------PE 240 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-cCCCCCcc-------hh
Confidence 34578899999999888899999999999999999999999864321 111111111 11111111 01
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.....+.+++.+|++.+|.+||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12345779999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=293.14 Aligned_cols=245 Identities=27% Similarity=0.394 Sum_probs=193.7
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+...+.||+|+||.||+|+. ++..+|+|.+.... ....+++.+|++++++++|+|++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 44557899999999999987 67899999986442 23345788999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+. |+|.+.+.... ..++|..+..++.+++.||.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 97 57777765432 3489999999999999999999998 999999999999999999999999999875422
Q ss_pred cccccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||..... ..........+.. .
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~~------~ 243 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP------T 243 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhccCC------C
Confidence 12345788999999974 45689999999999999999999999864321 1111111111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
.. .......+.+++.+|++.+|.+||++.++++.+-
T Consensus 244 ~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 244 LQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CC---CccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 10 1122345779999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=281.52 Aligned_cols=244 Identities=27% Similarity=0.459 Sum_probs=198.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|++|.||+++. +++.|++|.+..... ...+.+.+|++++++++|+|++++++++..+...++++||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 3457899999999999987 677899999977644 455789999999999999999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (254)
T cd06627 83 NGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--D 155 (254)
T ss_pred CCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--c
Confidence 99999998765 3489999999999999999999998 999999999999999999999999999987643222 1
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.....++..|+|||...+..++.++||||+|++++||++|+.|+..... ..... .... ... +.+.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~-~~~-----~~~~--- 220 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALF-RIVQ-DDH-----PPLP--- 220 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH-HHhc-cCC-----CCCC---
Confidence 2345678899999999888889999999999999999999999874321 11111 1111 111 1111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......+.+++.+|+..+|++||++.+++.
T Consensus 221 -~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 -EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112345679999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=289.59 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=198.3
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
++.+.||+|+||.||+++. +++.||+|.+.... ....+.+.+|++++++++||||+++++.+..+...++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 4567899999999999988 58899999987542 234578899999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
.+++|.+++... ..+++.....++.|+++||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 154 (258)
T cd05578 83 LGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154 (258)
T ss_pred CCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence 999999999765 3489999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...+....... ....+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~~~~------- 221 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--ADVLY------- 221 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--ccccC-------
Confidence 223456788999999999888999999999999999999999999754422 12222222221 01111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFM--NQVV 849 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm--~eVl 849 (892)
+......+.+++.+|++.+|.+||+. +|++
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 -PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11123567799999999999999999 5443
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=291.03 Aligned_cols=261 Identities=21% Similarity=0.260 Sum_probs=196.3
Q ss_pred hceecccccEEEEEEEECCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 586 ERVLGKGGFGTVYHGKLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
.+.+|.|+++.||+++.+++.||||++... .....+.+.+|+++++.++|+||+++++++...+..+++|||+++|+|
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 345666777777787778999999998754 344557899999999999999999999999999999999999999999
Q ss_pred hhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc-----c
Q 002688 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT-----H 738 (892)
Q Consensus 664 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~-----~ 738 (892)
.+++.......+++.....++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+......... .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999876555689999999999999999999998 9999999999999999999999999988765322211 1
Q ss_pred ccccccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHh----hc-------C
Q 002688 739 VSTTIAGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSML----DK-------G 805 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~----~~-------~ 805 (892)
......++..|+|||++... .++.++|||||||+++||++|+.||...... ..+.+-..... .. .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhhcC
Confidence 12234567789999998763 5889999999999999999999999743211 01111000000 00 0
Q ss_pred CCcc----ccCCCCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 806 DIRS----TVDPRLK----GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 806 ~~~~----~~D~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.... ..++... ..........+.+++.+|++.+|++||+++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 0011100 01111234567899999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=286.95 Aligned_cols=242 Identities=21% Similarity=0.340 Sum_probs=196.0
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
..||+|+||.||++.. ++..||||++........+.+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999988 67899999987655556677999999999999999999999999999999999999999999
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
+++... .+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... .......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 987543 378999999999999999999998 99999999999999999999999999887653221 1223456
Q ss_pred CCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHH
Q 002688 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSV 824 (892)
Q Consensus 745 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~ 824 (892)
++..|+|||.+.+..++.++|+||||++++||++|+.||..... .+.... +... +.+.+... ....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~------~~~~~~-~~~~-----~~~~~~~~--~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKM-IRDN-----LPPKLKNL--HKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhh-----CCcccCCc--ccCC
Confidence 78899999999888899999999999999999999999864321 111111 1111 11111110 1123
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 825 WKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 825 ~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+.+++.+|++.+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 35678999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=287.61 Aligned_cols=245 Identities=27% Similarity=0.426 Sum_probs=196.6
Q ss_pred ecccccEEEEEEEE--CCcEEEEEEccCCCc---hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 589 LGKGGFGTVYHGKL--DNDEVAVKMLSPSSS---QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 589 IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
||+|+||.||+++. +++.+++|.+..... ...+.+.+|++++++++|+||+++.+.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999998 488999999876533 3456788999999999999999999999999999999999999999
Q ss_pred hhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC------c
Q 002688 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG------T 737 (892)
Q Consensus 664 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~------~ 737 (892)
.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997644 489999999999999999999998 999999999999999999999999999876532211 1
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.......++..|+|||.......+.++||||||++++||++|+.||..... .+....... +... ...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~------~~~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILN-GKIE------WPE 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CCcC------CCc
Confidence 122344578899999999888899999999999999999999999964331 122222211 1111 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
. ......+.+++.+|++.+|++||++.++.+.|+
T Consensus 223 ~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 D--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 012456779999999999999999977766655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=281.24 Aligned_cols=243 Identities=27% Similarity=0.352 Sum_probs=188.8
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCch---hhHHHHHHHHHH-HhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ---GYKQFQAEVKLL-LRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l-~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|+. +++.||||.+...... ....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999988 6789999998754321 223344555444 455899999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999997643 488999999999999999999998 999999999999999999999999999875422 2
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
....++..|+|||.+.+..++.++||||||+++|||++|..||..... .+...... .+... ..+...
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~--~~~~~~---- 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DAVFDNIL-SRRIN--WPEEVK---- 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-hcccC--CCCccc----
Confidence 234578899999999888899999999999999999999999964321 11122111 11111 011111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 821 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
......+.+++.+|++.+|++||++.++.+.|+
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 122355789999999999999998876655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-33 Score=282.92 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=201.6
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
++.++||+|++|.||||.+ .|+.+|||.+... ...+++.+|+.+|++.+.+++|+++|.+.....+++|||||..|
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 3456899999999999987 7899999998654 34578899999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
++.+.++.++ ++|+..++..+++..++||+|||.. .-||||||+.||||+-+|.+||+|||.|..+.. ......
T Consensus 114 SiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN 187 (502)
T KOG0574|consen 114 SISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN 187 (502)
T ss_pred cHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence 9999998654 4699999999999999999999998 789999999999999999999999999987632 222335
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcccc--CCCCCCCC
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV--DPRLKGDF 819 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--D~~l~~~~ 819 (892)
.+.||+.|||||++..-.|+.++||||||+...||..|++||..-.. ++.++ -..-...+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP------------------MRAIFMIPT~PPPTF 249 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP------------------MRAIFMIPTKPPPTF 249 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc------------------cceeEeccCCCCCCC
Confidence 67899999999999999999999999999999999999999974221 11111 11111122
Q ss_pred C--HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 820 D--INSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 820 ~--~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
. .+-...+-++++.|+-.+|++|-++.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2 222345779999999999999999999877
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=288.00 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=191.3
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|++|.||+|+. +++.||+|.+..... ...+.+.+|++++++++|+||+++++++..+...++||||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 3457899999999999987 678899999865422 234568899999999999999999999999999999999996
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC-CCcEEEeeecCcccccCCCCcc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-KFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-~~~vkl~DfGla~~~~~~~~~~ 738 (892)
++|.+++.......+++.....++.|++.||+|||++ +++||||||+||+++. ++.+||+|||++....... .
T Consensus 85 -~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~ 158 (294)
T PLN00009 85 -LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--R 158 (294)
T ss_pred -ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--c
Confidence 5888877655444468888899999999999999998 9999999999999985 5679999999997653221 1
Q ss_pred ccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcccc------
Q 002688 739 VSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV------ 811 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------ 811 (892)
......++..|+|||++.+. .++.++||||||+++|||++|++||....+. ..+.+.. ...... .....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~-~~~~~~-~~~~~~~~~~~ 234 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIF-RILGTP-NEETWPGVTSL 234 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-HHhCCC-Chhhccccccc
Confidence 12234568899999998764 5789999999999999999999999753321 0111100 000000 00000
Q ss_pred ------CCCCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 812 ------DPRLKGD----FDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 812 ------D~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
-+..... ........+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 00112345679999999999999999999986
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=287.97 Aligned_cols=255 Identities=19% Similarity=0.284 Sum_probs=189.9
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCc-----EEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTN-----MAL 653 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~-----~~L 653 (892)
...+.||+|+||.||+|.. +++.||||.+..... ...+.+.+|+.+++.++ |+||+++++++..... .++
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 3457899999999999988 678999998765432 23457888999999995 6999999999876655 899
Q ss_pred EEEeccCCchhhhccccC---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC-CCcEEEeeecCcc
Q 002688 654 IYEYMANGNLEEHLSDSS---KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-KFQAKLADFGLSR 729 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-~~~vkl~DfGla~ 729 (892)
||||+++ +|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||+++
T Consensus 84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 9999985 7888876432 23589999999999999999999998 9999999999999998 8999999999987
Q ss_pred cccCCCCccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc-CCC
Q 002688 730 VFPVEGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK-GDI 807 (892)
Q Consensus 730 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~ 807 (892)
.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|++||....+ ..+. ...... +..
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~-~~~~~~~~~~ 231 (295)
T cd07837 160 AFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-----LQQL-LHIFKLLGTP 231 (295)
T ss_pred ecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-----HHHH-HHHHHHhCCC
Confidence 6532211 1123346788999998865 4578999999999999999999999974321 1111 111110 000
Q ss_pred c-----cccC-------CCCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 808 R-----STVD-------PRLK----GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 808 ~-----~~~D-------~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
. ...+ +... ..........+.+++.+|+..+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000 0000 0000123455789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=292.36 Aligned_cols=260 Identities=23% Similarity=0.324 Sum_probs=189.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCC--------c
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT--------N 650 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~--------~ 650 (892)
+.+.+.||+|+||.||+|+. +++.||||.+..... .....+.+|++++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 34557899999999999988 688999998864322 22345678999999999999999999986543 3
Q ss_pred EEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 651 MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 651 ~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
.++||||+.+ +|.+.+.... ..+++.+...++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 94 ~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred EEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 5999999975 7887776543 3489999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCc--cccccccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh---c
Q 002688 731 FPVEGGT--HVSTTIAGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD---K 804 (892)
Q Consensus 731 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~---~ 804 (892)
+...... .......++..|+|||.+.+.. ++.++||||||++++||++|++||....... .......... .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~~~~~~~ 245 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQLCGSITP 245 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCh
Confidence 6432211 1122345778899999987654 7889999999999999999999986543211 1111111110 0
Q ss_pred CCCccc-----cCC-CCCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 805 GDIRST-----VDP-RLKGDF---------DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 805 ~~~~~~-----~D~-~l~~~~---------~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
...... .+. .+.... .......+.+++.+|+..+|++||+++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000 000 000000 0011235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=287.08 Aligned_cols=259 Identities=21% Similarity=0.362 Sum_probs=194.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||+|++|.||+|+. ++..||||.+...... ..+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 3457899999999999998 6889999998765332 345678899999999999999999999999999999999985
Q ss_pred CchhhhccccC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 661 GNLEEHLSDSS-KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 661 gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....... ..
T Consensus 83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~ 156 (284)
T cd07836 83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NT 156 (284)
T ss_pred -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--cc
Confidence 8888876543 34589999999999999999999998 99999999999999999999999999987653221 11
Q ss_pred cccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc--CCCc-----ccc
Q 002688 740 STTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK--GDIR-----STV 811 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~-----~~~ 811 (892)
.....++..|++||.+.+. .++.++||||||+++|||++|++||......+ .+.+........ .... ..+
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhHHHHhcCchh
Confidence 2234568899999998664 57899999999999999999999997543211 111100000000 0000 000
Q ss_pred CCCCCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 812 DPRLKG-------DFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 812 D~~l~~-------~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
...... .........+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 000112345779999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=290.97 Aligned_cols=254 Identities=19% Similarity=0.263 Sum_probs=180.6
Q ss_pred hhhhhceecccccEEEEEEEEC-----CcEEEEEEccCCCchhh-----------HHHHHHHHHHHhccccceeeEeeEe
Q 002688 582 TNNFERVLGKGGFGTVYHGKLD-----NDEVAVKMLSPSSSQGY-----------KQFQAEVKLLLRVHHRNLTTLVGYC 645 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~~-----~~~vAVK~l~~~~~~~~-----------~~f~~Ei~~l~~l~H~NIv~l~g~~ 645 (892)
.+.+.+.||+|+||.||+|+.. +..+|+|.......... .....+...+..++|+|++++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 4556789999999999999883 34567776433321110 1122333455667899999999876
Q ss_pred ecCC----cEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEE
Q 002688 646 DEGT----NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAK 721 (892)
Q Consensus 646 ~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vk 721 (892)
.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 93 SFKRCRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eEecCCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence 5443 34567776543 5555554332 257888899999999999999998 999999999999999999999
Q ss_pred EeeecCcccccCCCCc-----cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCC-cc--
Q 002688 722 LADFGLSRVFPVEGGT-----HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGH-TH-- 793 (892)
Q Consensus 722 l~DfGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~-~~-- 793 (892)
|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+++||++|+.||........ ..
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999999876432211 112234699999999999999999999999999999999999999976532111 00
Q ss_pred HHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 794 VAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 794 l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
..++..+.. .+... + ......+.+++..|++.+|++||++.++++.|+
T Consensus 247 ~~~~~~~~~-~~~~~------~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFIKRLH-EGKIK------I-----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhh-hhhhc------c-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 011222211 11110 0 112356779999999999999999999998763
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=294.65 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=192.3
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecC------CcEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG------TNMA 652 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~------~~~~ 652 (892)
+...+.||+|+||.||+|+. +++.||||.+... .....+++.+|+.++++++|+||+++++++... ...+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 44457899999999999987 7889999998643 233446778899999999999999999988543 3579
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+||||+.+ +|.+.+... +++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 98 lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 98 LVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 99999964 888877542 88899999999999999999998 99999999999999999999999999998653
Q ss_pred CCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHh------------
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSS------------ 800 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~------------ 800 (892)
.. .......++..|+|||.+.+..++.++|||||||++++|++|+.||..... ...|...
T Consensus 170 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 170 TS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-----IDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHhcCCCCHHHH
Confidence 22 112334578899999999999999999999999999999999999964321 1111100
Q ss_pred ---------HhhcC------CCccccCC----CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 801 ---------MLDKG------DIRSTVDP----RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 801 ---------~~~~~------~~~~~~D~----~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
..... .+.+.+.. .............+.+++.+|++.+|++||++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00011110 00001111234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=297.55 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=193.8
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhc-cccceeeEeeEeecC--CcEEEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG--TNMALI 654 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~--~~~~LV 654 (892)
.+.+.+.||+|+||.||+|.. +++.+|||++... .......+.+|+.+++++ +|+||+++++++... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 345567899999999999987 5788999988542 233445678899999999 999999999988643 468999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
|||++ ++|.+++... .++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 88 FEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99997 5998888654 488999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCc---cccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHh--------
Q 002688 735 GGT---HVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSML-------- 802 (892)
Q Consensus 735 ~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~-------- 802 (892)
... .......|+..|+|||.+.+ ..++.++||||||+++|||++|++||....... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHH
Confidence 221 12233457889999998765 457899999999999999999999996433211 000000000
Q ss_pred ---hcCCCccccC----CCCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 803 ---DKGDIRSTVD----PRLK--GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 803 ---~~~~~~~~~D----~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......+.++ .... ..........+.+++.+|++.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000010 0000 00001134567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=315.81 Aligned_cols=260 Identities=29% Similarity=0.442 Sum_probs=208.3
Q ss_pred HHHhhhhhceecccccEEEEEEEEC---------CcEEEEEEccCCC-chhhHHHHHHHHHHHhc-cccceeeEeeEeec
Q 002688 579 LRMTNNFERVLGKGGFGTVYHGKLD---------NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDE 647 (892)
Q Consensus 579 ~~~t~~f~~~IG~G~fG~Vy~~~~~---------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~ 647 (892)
.+....+.+.||+|.||.|++|... ...||||+++... ....+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3333345669999999999999762 3469999998653 34567899999999999 59999999999999
Q ss_pred CCcEEEEEEeccCCchhhhccccC------c--------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEE
Q 002688 648 GTNMALIYEYMANGNLEEHLSDSS------K--------EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNIL 713 (892)
Q Consensus 648 ~~~~~LV~Ey~~~gsL~~~L~~~~------~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NIL 713 (892)
++..++|.||+..|+|.++|+..+ . ..+.....+.++.|||.||+||++. +++||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence 999999999999999999998765 0 2388999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCcccccccc--CCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCC
Q 002688 714 INEKFQAKLADFGLSRVFPVEGGTHVSTTIA--GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENG 790 (892)
Q Consensus 714 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~ 790 (892)
+.++..+||+|||+++.....+..... ... -...|||||.+....++.|+|||||||+||||+| |..|+.+...
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-- 527 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-- 527 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence 999999999999999976544433222 122 2456999999999999999999999999999999 7888864110
Q ss_pred CccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 002688 791 HTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 791 ~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~ 857 (892)
..++.+ .+++|... ..+..+..++.++++.||..+|++||++.++++.++..+.
T Consensus 528 ~~~l~~----~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 TEELLE----FLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 112222 34444321 1122345567799999999999999999999999999654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=285.13 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=196.1
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
..+.||+|++|.||+++. +++.+++|.+..... .....+.+|++++++++|+||+++.+++..+...++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 346899999999999987 678899999876533 2456788999999999999999999999999999999999975
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
+|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+....... ...
T Consensus 83 -~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~ 155 (283)
T cd05118 83 -DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY 155 (283)
T ss_pred -CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence 8888887643 3589999999999999999999998 99999999999999999999999999988764332 112
Q ss_pred ccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc---CCCccccC----
Q 002688 741 TTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK---GDIRSTVD---- 812 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~D---- 812 (892)
....++..|+|||.+.+. .++.++|+||||+++++|++|++||......+ .+.. ....+.. .......+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFK-IFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHcCCCchHhcccchhhhhh
Confidence 234577889999998876 78999999999999999999999986543210 0000 0000000 00000000
Q ss_pred --CCCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 813 --PRLK-------GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 813 --~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.... ..........+.+++.+|++.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=287.02 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=195.2
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|++|.||+|+. +++.|+||++..... .......+|+..+++++ |+|++++++++..+...++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 3557899999999999998 567899999865432 22334567999999999 999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++.......+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~ 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---P 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC---C
Confidence 88999988776545689999999999999999999998 99999999999999999999999999987653221 1
Q ss_pred cccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCC----------ccHHHHHHhHhhcCCCc
Q 002688 740 STTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGH----------THVAQWVSSMLDKGDIR 808 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~----------~~l~~~~~~~~~~~~~~ 808 (892)
.....++..|+|||.+.+ ..++.++|+||||++++||++|++||......+. ..-..|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 123457889999998854 4578999999999999999999999865432110 00001111111111111
Q ss_pred cccCCCCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 809 STVDPRLK---GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 809 ~~~D~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+..... ..........+.+++.+|++.+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 11100000 0000112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=282.84 Aligned_cols=245 Identities=26% Similarity=0.426 Sum_probs=199.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|++|.||+++. +++.+|+|.+.... .....++.+|++++++++|+||+++.+++..+...++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 3457899999999999987 67889999987542 3345678899999999999999999999999999999999999
Q ss_pred CCchhhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 660 NGNLEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 660 ~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|.+++.... +..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 999999986532 34589999999999999999999998 9999999999999999999999999999876432
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
......++..|+|||.+.+..++.++|+||||++++||++|+.||..... .+.... ...+...
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~--------- 219 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM------QDLRYK-VQRGKYP--------- 219 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HhcCCCC---------
Confidence 22234578899999999998899999999999999999999999964321 111111 1111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.........+.+++.+|++.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112334567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=288.57 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=191.7
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCC---------
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT--------- 649 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~--------- 649 (892)
+.+.+.||+|+||.||+|+. +++.||||.++... ......+.+|++++++++|||++++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 44567999999999999998 67899999987543 223356788999999999999999999887654
Q ss_pred -cEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCc
Q 002688 650 -NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLS 728 (892)
Q Consensus 650 -~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla 728 (892)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999986 676666544 23589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcC--
Q 002688 729 RVFPVEGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG-- 805 (892)
Q Consensus 729 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 805 (892)
........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++||..... ...+.. +.......
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~-~~~~~~~~~~ 239 (302)
T cd07864 164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLEL-ISRLCGSPCP 239 (302)
T ss_pred ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHH-HHHHhCCCCh
Confidence 87643321 11223345778999998865 3578999999999999999999999974321 111111 11111100
Q ss_pred -CCccc--------cCCC------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 806 -DIRST--------VDPR------LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 806 -~~~~~--------~D~~------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
....+ .++. +.... ......+.+++.+|++.+|++||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 0000 00000 012356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=281.31 Aligned_cols=246 Identities=26% Similarity=0.427 Sum_probs=201.6
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|++|.||++.. ++..+++|++..... ...+++.+|+++++.++|+|++++.+.+..+...++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 3457899999999999998 488999999876533 456778999999999999999999999999999999999999
Q ss_pred CCchhhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 660 NGNLEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 660 ~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++|.+++.... ...+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999997653 35699999999999999999999998 99999999999999999999999999988754322
Q ss_pred cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
.......|+..|+|||...+..++.++|+||+|+++++|++|+.||.... ..+........ ... .+.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~-----~~~- 224 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKG-QYP-----PIP- 224 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcC-CCC-----CCC-
Confidence 12233467889999999988889999999999999999999999986432 22222222211 111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......+.+++.+|+..+|++||++.|+++
T Consensus 225 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 ---SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 122346779999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=298.66 Aligned_cols=262 Identities=23% Similarity=0.379 Sum_probs=193.1
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecC-----CcEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG-----TNMALI 654 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~-----~~~~LV 654 (892)
+.+.+.||+|+||.||+|+. +++.||||.+.... ......+.+|++++++++|+||+++++++... ...++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 34457899999999999987 68899999987532 23446688999999999999999999887544 357999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
+||+.+ +|.+.+... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 87 ~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 87 QELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 999975 787777543 489999999999999999999998 9999999999999999999999999998765322
Q ss_pred CCc-cccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcC---CCcc
Q 002688 735 GGT-HVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG---DIRS 809 (892)
Q Consensus 735 ~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~ 809 (892)
... .......|+..|+|||.+.+ ..++.++|||||||+++||++|++||..... ..........+... ....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCHHHHHH
Confidence 111 11233567899999998754 4689999999999999999999999964321 01111111111110 0000
Q ss_pred ccCCC-------C--CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHH
Q 002688 810 TVDPR-------L--KGDFD-----INSVWKAVEIAMACVSSNANRRPFMNQVVME--LND 854 (892)
Q Consensus 810 ~~D~~-------l--~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~--L~~ 854 (892)
+.+.. . ..... ......+.+++.+|++.+|++||++.|+++. ++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 00000 0 00000 1123457899999999999999999999886 553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=284.50 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=192.8
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhc---cccceeeEeeEeecCCc-----EE
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRV---HHRNLTTLVGYCDEGTN-----MA 652 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~NIv~l~g~~~~~~~-----~~ 652 (892)
+.+.||+|+||.||+|+. +++.+|+|++..... .....+.+|++++.++ +|+|++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 457899999999999998 478999999975422 2234566788777666 59999999999987776 99
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
++|||+.+ +|.+++.......+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..+.
T Consensus 83 l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred EEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 99999974 898888765544589999999999999999999998 99999999999999999999999999987763
Q ss_pred CCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCc----
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR---- 808 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---- 808 (892)
.... .....++..|+|||.+.+..++.++|+||||++++||++|++||...... ..+..+...........
T Consensus 159 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 159 FEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred CCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhcCCC
Confidence 2211 12334788899999999989999999999999999999999998754321 11111211111000000
Q ss_pred -----cccCCCCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 809 -----STVDPRLKGDF---DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 809 -----~~~D~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+........ ..+....+.+++.+|++.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000 1122356679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=291.20 Aligned_cols=257 Identities=22% Similarity=0.332 Sum_probs=190.3
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCch--hhHHHHHHHHHHHhccccceeeEeeEeecC--CcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ--GYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~LV~Ey 657 (892)
++.+.||+|+||.||+|+. +++.||+|.++..... ....+.+|++++++++|+|++++++++... +..++||||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 3457899999999999988 6889999998654322 223567899999999999999999998654 468999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++ +|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 90 ~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 90 CEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred CCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence 975 8888876543 3589999999999999999999998 999999999999999999999999999987643221
Q ss_pred cccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcC--CCc-cccCC
Q 002688 738 HVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG--DIR-STVDP 813 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~-~~~D~ 813 (892)
......++..|+|||.+.+ ..++.++||||||+++|||++|++||...... ....-+....... ... ..-+.
T Consensus 164 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 164 -PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred -CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhchhhhcc
Confidence 1223345778999999875 45789999999999999999999999743321 1111111111000 000 00000
Q ss_pred ------CCCC-CC-C-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 814 ------RLKG-DF-D-----INSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 814 ------~l~~-~~-~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+.. .. . ......+.+++.+|++.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 00 0 012445678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=282.31 Aligned_cols=240 Identities=25% Similarity=0.364 Sum_probs=185.9
Q ss_pred eecccccEEEEEEEE--CCcEEEEEEccCCCc---hhhHHHHHHHH---HHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 588 VLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS---QGYKQFQAEVK---LLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~---~~~~~f~~Ei~---~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.||+|+||.||+++. +++.||+|.+..... .....+..|.. .++..+|+||+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999987 578999999865422 11223344443 3444579999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..+... .
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~ 151 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence 999999886543 489999999999999999999998 9999999999999999999999999998765322 1
Q ss_pred cccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.....|+..|+|||.+.++ .++.++||||+|++++||++|+.||......... . ....... .++.+..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---~-~~~~~~~------~~~~~~~- 220 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMTLT------MAVELPD- 220 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---H-HHHHhhc------cCCCCCC-
Confidence 1234689999999998754 6899999999999999999999999754321111 1 1111110 1112221
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRP-----FMNQVVM 850 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~ 850 (892)
.....+.+++.+|+..+|.+|| ++.++++
T Consensus 221 ---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1235677999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=308.18 Aligned_cols=265 Identities=19% Similarity=0.260 Sum_probs=182.8
Q ss_pred HhhhhhceecccccEEEEEEEEC---CcEEEEE------------------EccCCCchhhHHHHHHHHHHHhcccccee
Q 002688 581 MTNNFERVLGKGGFGTVYHGKLD---NDEVAVK------------------MLSPSSSQGYKQFQAEVKLLLRVHHRNLT 639 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~~---~~~vAVK------------------~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv 639 (892)
..+.+.+.||+|+||+||++... +...++| .+. .......++.+|++++++++|+||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcC
Confidence 44566689999999999998652 2222222 111 1122345688999999999999999
Q ss_pred eEeeEeecCCcEEEEEEeccCCchhhhccccC---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC
Q 002688 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSS---KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE 716 (892)
Q Consensus 640 ~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~ 716 (892)
++++++...+..++|+|++. ++|.+++.... ...........++.|++.||+|||++ +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 46766664322 11233556778999999999999998 9999999999999999
Q ss_pred CCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCccccCCCccHH
Q 002688 717 KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPV-ISKSAENGHTHVA 795 (892)
Q Consensus 717 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p-~~~~~~~~~~~l~ 795 (892)
++.+||+|||+++.+.... ........|+..|+|||++.+..++.++|||||||++|||++|+.+ +..........+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999998764322 2222345789999999999999999999999999999999998754 3322111111111
Q ss_pred HHHHhHhh-cCCCc-------cccCC-CCCC---CC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 796 QWVSSMLD-KGDIR-------STVDP-RLKG---DF-----DINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 796 ~~~~~~~~-~~~~~-------~~~D~-~l~~---~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
+....... .+.+. +.++. .+.. .. .......+.+++.+|++.||++||++.|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11110000 00000 00000 0000 00 00112345678899999999999999999873
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=281.18 Aligned_cols=233 Identities=21% Similarity=0.286 Sum_probs=183.1
Q ss_pred ecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccCCchhh
Q 002688 589 LGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEE 665 (892)
Q Consensus 589 IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 665 (892)
||+|+||.||+++. ++..+|+|.+....... .|+.....+ +|+|++++++++...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 59999999999987 67889999986542211 122222222 79999999999999999999999999999999
Q ss_pred hccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC-cEEEeeecCcccccCCCCcccccccc
Q 002688 666 HLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF-QAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 666 ~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~-~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||++...... ....
T Consensus 99 ~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~ 167 (267)
T PHA03390 99 LLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYD 167 (267)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCC
Confidence 997654 589999999999999999999998 999999999999999988 9999999998765321 2345
Q ss_pred CCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHH
Q 002688 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSV 824 (892)
Q Consensus 745 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~ 824 (892)
++..|+|||++.+..++.++||||||++++||++|+.||....+ ......++..... ... .. .....
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~--~~~------~~----~~~~~ 234 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQQ--KKL------PF----IKNVS 234 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhhc--ccC------Cc----ccccC
Confidence 78899999999988999999999999999999999999974432 2222333333221 000 00 01233
Q ss_pred HHHHHHHHHccccCCCCCCC-HHHHHH
Q 002688 825 WKAVEIAMACVSSNANRRPF-MNQVVM 850 (892)
Q Consensus 825 ~~l~~l~~~Cl~~~P~~RPs-m~eVl~ 850 (892)
..+.+++.+|++.+|.+||+ ++|+++
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhc
Confidence 45779999999999999995 688874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=299.62 Aligned_cols=273 Identities=25% Similarity=0.364 Sum_probs=208.5
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeecCC------cEEEEEE
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT------NMALIYE 656 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~------~~~LV~E 656 (892)
.+.||+|+||.||+|+. .|+.||||.+.... ....+...+|+++|++++|+|||++++.-.... ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 46899999999999986 78999999998753 344567789999999999999999998775543 5789999
Q ss_pred eccCCchhhhccccC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC--CC--cEEEeeecCcccc
Q 002688 657 YMANGNLEEHLSDSS-KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE--KF--QAKLADFGLSRVF 731 (892)
Q Consensus 657 y~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~--~~--~vkl~DfGla~~~ 731 (892)
||.+|||...|.+.. ...|+..+.+.+..+++.||.|||++ +|+||||||.||++-. +| ..||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999997654 45699999999999999999999998 9999999999999953 23 4799999999987
Q ss_pred cCCCCccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccc
Q 002688 732 PVEGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRST 810 (892)
Q Consensus 732 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 810 (892)
+.. ...+...||..|.+||.+.. +.|+..+|.|||||++||++||..||..........-..|....-......-.
T Consensus 175 ~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 175 DDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 433 25677899999999999984 78999999999999999999999999865543221112232221111111111
Q ss_pred cCCCCCC------------CCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHHHhhhhhccc
Q 002688 811 VDPRLKG------------DFDINSVWKAVEIAMACVSSNANRRP--FMNQVVMELNDCLAMEAAQKK 864 (892)
Q Consensus 811 ~D~~l~~------------~~~~~~~~~l~~l~~~Cl~~~P~~RP--sm~eVl~~L~~~~~~e~~~~~ 864 (892)
.+++..+ .........+-+....++..+|++|- ...+..+.+.+++...-..-+
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhiF 319 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHIF 319 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEEE
Confidence 1111111 11122334455777888899999999 888888888888766554433
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=291.89 Aligned_cols=256 Identities=24% Similarity=0.304 Sum_probs=191.5
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCCchh--------------hHHHHHHHHHHHhccccceeeEeeEeecCC
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQG--------------YKQFQAEVKLLLRVHHRNLTTLVGYCDEGT 649 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~--------------~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~ 649 (892)
.+.||+|+||.||+|+. +++.||||.+....... ...+.+|++++++++|+||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 46799999999999987 68899999986542211 124778999999999999999999999999
Q ss_pred cEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcc
Q 002688 650 NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~ 729 (892)
..++||||+. |+|.+++.... .+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcccee
Confidence 9999999997 68999886543 388999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCC------------ccccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHH
Q 002688 730 VFPVEGG------------THVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQ 796 (892)
Q Consensus 730 ~~~~~~~------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~ 796 (892)
....... ........++..|+|||.+.+. .++.++||||||++++||++|++||...... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~---~~~~ 244 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI---DQLG 244 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Confidence 6541110 1111223467889999998764 4789999999999999999999999754321 1111
Q ss_pred HHHhHhhcCC---Ccccc--------CCCCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 797 WVSSMLDKGD---IRSTV--------DPRLKGD---FDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 797 ~~~~~~~~~~---~~~~~--------D~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+........ ..... .+..... ........+.+++.+|++.+|++||++.|++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111000 00000 0000000 00112456789999999999999999999986
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=283.54 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=190.4
Q ss_pred hhhceecccccEEEEEEEEC--CcEEEEEEccCCC-chhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEecc
Q 002688 584 NFERVLGKGGFGTVYHGKLD--NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+.+.||+|+||.||+|+.. ++.||||.++... ....+++..|+..+.+.. |+||+++++++..+...+++|||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 45679999999999999994 8899999987543 234456777888777775 9999999999999999999999985
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+ +|.+++.... ..+++..+..++.|++.||+|||+. .+++||||+|+||++++++.+||+|||++..+.... .
T Consensus 98 ~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~---~ 170 (296)
T cd06618 98 T-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---A 170 (296)
T ss_pred c-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC---c
Confidence 4 6776665433 3589999999999999999999973 289999999999999999999999999987653221 1
Q ss_pred cccccCCCCccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNR----LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~----~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l 815 (892)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+.......... . .+
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~-~-----~~ 239 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP-P-----SL 239 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC-C-----CC
Confidence 12335778999999987654 789999999999999999999998642211 111222221110 0 01
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 816 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.. .......+.+++.+|+..+|++||++.++++.
T Consensus 240 ~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00123467899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=285.37 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=197.2
Q ss_pred hhhceecccccEEEEEEEE-----CCcEEEEEEccCCC----chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL-----DNDEVAVKMLSPSS----SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~L 653 (892)
.+.+.||+|++|.||+++. ++..||||.++... ....+.+.+|++++.++ +|+||+++.+.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 3457899999999999875 45789999986532 22345688999999999 69999999999999999999
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
||||+++|+|.+++.... .+++.....++.|++++|+|||+. +++||||||+||+++.++.++|+|||+++.+..
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999987543 488999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCccccccccCCCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcccc
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 811 (892)
... .......|+..|+|||.+.+.. .+.++||||||++++||++|+.||..... .....++.+.....
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~------- 227 (288)
T cd05583 158 EEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE--QNSQSEISRRILKS------- 227 (288)
T ss_pred ccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc--cchHHHHHHHHHcc-------
Confidence 221 1222346788999999987665 78899999999999999999999863221 11122222222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
++..... ....+.+++.+|++.+|++|||+.+|.+.|+.
T Consensus 228 ~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 KPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111111 22346789999999999999999999887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=295.81 Aligned_cols=260 Identities=22% Similarity=0.357 Sum_probs=194.5
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecC-----CcEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG-----TNMALI 654 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~-----~~~~LV 654 (892)
...+.||+|+||.||+|+. ++..||||.+... .....+.+.+|+.+++.++|+||+++++++... ...++|
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 87 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV 87 (337)
T ss_pred eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence 3457899999999999987 6789999998753 233345678899999999999999999987543 358999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
+||+. ++|.+++.... .+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 88 YELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 99996 68888886543 489999999999999999999998 9999999999999999999999999999876332
Q ss_pred CCccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc---------
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK--------- 804 (892)
Q Consensus 735 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~--------- 804 (892)
. .......++..|+|||.+.. ..++.++||||||++++||++|++||...... ............
T Consensus 162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 162 G--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred c--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChHHhhhc
Confidence 1 12233457889999998865 46899999999999999999999999643210 000001110000
Q ss_pred --CCC-------ccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 002688 805 --GDI-------RSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME--LNDC 855 (892)
Q Consensus 805 --~~~-------~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~--L~~~ 855 (892)
+.. ....++..... .......+.+++.+|++.+|++||+++|+++. ++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 00000110000 11234567899999999999999999999986 6543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=295.43 Aligned_cols=239 Identities=25% Similarity=0.436 Sum_probs=199.6
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCc--hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.||+|.|+.|..|+. .+.+||||.+.+..- .....+.+|+++|..++|||||+++.+......+++||||+.+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 457899999999999988 789999999987643 3334589999999999999999999999999999999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|.+.++|.++.+ +.......++.|+.++++|+|++ .|+|||||+.||||+.+.++||+|||++..+. .....
T Consensus 140 ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~~~l 211 (596)
T KOG0586|consen 140 GELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD---YGLML 211 (596)
T ss_pred chhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec---ccccc
Confidence 999999988765 55688889999999999999999 99999999999999999999999999998874 33455
Q ss_pred ccccCCCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
...+|++.|.|||++++.+| .+++|+||+|+++|-|+.|..||++..- ...- ++.+.+.+
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------k~Lr-------------~rvl~gk~ 272 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------KELR-------------PRVLRGKY 272 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc------cccc-------------chheeeee
Confidence 67899999999999998876 5789999999999999999999985331 1111 11111221
Q ss_pred CH--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 820 DI--NSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 820 ~~--~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.. -...+.-+++++++..+|.+|++++++.+
T Consensus 273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11 11123348899999999999999999976
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=279.01 Aligned_cols=246 Identities=25% Similarity=0.402 Sum_probs=192.1
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC-----CchhhHHHHHHHHHHHhccccceeeEeeEeecC--CcEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS-----SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--TNMALI 654 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--~~~~LV 654 (892)
.+.+.||+|+||.||+|+. ++..||+|.+... .....+.+.+|++++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 4567999999999999987 6789999987532 223446788999999999999999999998654 457899
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
+||+++++|.+++.... .+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 85 VEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999987543 378999999999999999999998 9999999999999999999999999999865321
Q ss_pred CC-ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 735 GG-THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 735 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
.. ........++..|+|||++.+..++.++|+|||||+++||++|++||..... ... +.+..... .. +
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~-~~~~~~~~-~~----~ 228 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----MAA-IFKIATQP-TK----P 228 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----HHH-HHHHHcCC-CC----C
Confidence 11 1111234588899999999988899999999999999999999999964321 111 11111111 11 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+ +......+.+++.+|++ +|..||+..+++.
T Consensus 229 ~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 229 ML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CC----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11 12233457799999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=283.42 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=192.6
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+...+.||+|+||.||+|+. ++..+|+|.+... .....+++.+|+++++.++|+|++++.+++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 44456899999999999987 6788999998642 223446788999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+. |++.+.+.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 97 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred cC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 96 68877765433 3489999999999999999999998 9999999999999999999999999998765321
Q ss_pred cccccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 738 HVSTTIAGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
....++..|+|||.+. ...++.++|||||||++|||++|+.|+..... ......... +.. +.
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~-~~~-----~~ 233 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NES-----PA 233 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhh-cCC-----CC
Confidence 2345788999999975 35688899999999999999999999864321 111111111 111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
.. .......+.+++.+|++.+|++||++.++++.-.
T Consensus 234 ~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 11 1123345779999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=294.64 Aligned_cols=259 Identities=20% Similarity=0.316 Sum_probs=193.5
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeec----CCcEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE----GTNMALIY 655 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~----~~~~~LV~ 655 (892)
.+.+.||+|+||.||+|+. ++..||+|++.... ....+.+.+|+.++++++|+||+++.+++.. ....++|+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 87 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM 87 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence 3457899999999999987 68899999987542 2344677889999999999999999988753 35689999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
||+. |+|.+++.... .+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 88 e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 88 DLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred ehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 9996 68999886543 389999999999999999999998 99999999999999999999999999997764322
Q ss_pred Ccc--ccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh---------
Q 002688 736 GTH--VSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD--------- 803 (892)
Q Consensus 736 ~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~--------- 803 (892)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|++||...... ...........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~---~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV---HQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH---HHHHHHHHHhCCChhHhhhh
Confidence 211 1234468889999999865 46889999999999999999999999643211 01111111100
Q ss_pred --cCCCccccCC-CCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 804 --KGDIRSTVDP-RLKGDF-----DINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 804 --~~~~~~~~D~-~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
...+.+.++. ...... .......+.+++.+|++.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 000000 01234568899999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=282.34 Aligned_cols=245 Identities=26% Similarity=0.415 Sum_probs=197.1
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.+.+.||+|++|.||+|+. +++.||+|++... .....+.+.+|++++++++ |+||+++++++..++..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 4557899999999999988 7889999998753 2233467889999999998 99999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.........
T Consensus 84 ~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 84 APNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999997654 499999999999999999999998 9999999999999999999999999998876432211
Q ss_pred ------------------cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHH
Q 002688 738 ------------------HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVS 799 (892)
Q Consensus 738 ------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~ 799 (892)
.......++..|+|||...+..++.++||||||++++|+++|+.||..... ..-..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~ 232 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------YLTFQ 232 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH
Confidence 112234578899999999888899999999999999999999999975431 11111
Q ss_pred hHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 002688 800 SMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFM----NQVVM 850 (892)
Q Consensus 800 ~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm----~eVl~ 850 (892)
...... .. ........+.+++.+|++.+|++||++ +++++
T Consensus 233 ~~~~~~-------~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 KILKLE-------YS----FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHhcC-------CC----CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111100 00 111123457799999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=273.77 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=208.2
Q ss_pred hceecccccEEEEEEEE-------CCcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecC-CcEEEEEE
Q 002688 586 ERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEG-TNMALIYE 656 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~-------~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~-~~~~LV~E 656 (892)
...+-+|.||.||+|.+ +.+.|.||.++....+ ....+..|.-.+..+.|||+.++.+.+.+. ...+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 45688999999999976 3346788888765443 446788999999999999999999999654 56889999
Q ss_pred eccCCchhhhccc------cCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 657 YMANGNLEEHLSD------SSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 657 y~~~gsL~~~L~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
++.-|+|..+|.. ...+.++-.+...++.|++.|++|||.+ ++||.||.++|++||+..++||+|=.|++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccc
Confidence 9999999999972 2256688888999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCcc
Q 002688 731 FPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRS 809 (892)
Q Consensus 731 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 809 (892)
+.+.+.............||+||.+..+.|+..+|||||||+||||+| |+.|+..-+.. + +..++.+|.
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------E-m~~ylkdGy--- 515 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------E-MEHYLKDGY--- 515 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH------H-HHHHHhccc---
Confidence 887777766666667889999999999999999999999999999998 88888643221 1 222333331
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 810 TVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 810 ~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
++. -+..+..++..++..||...|++||+++|+++-|.+.-
T Consensus 516 ----Rla--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 516 ----RLA--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ----eec--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 122 13457778899999999999999999999999999853
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=282.72 Aligned_cols=240 Identities=27% Similarity=0.388 Sum_probs=189.9
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.||+|+||.||+|+. ++..|++|.+.... ....+.+.+|+++++.++|+|++++.+++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 35799999999999987 67899999986432 2334578899999999999999999999999999999999996
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|++.+++.... ..+++..+..++.|++.+|+|||+. +++|+||||+||++++++.+||+|||++.... ..
T Consensus 105 ~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~ 174 (313)
T cd06633 105 GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PA 174 (313)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC------CC
Confidence 57777775433 3489999999999999999999998 99999999999999999999999999886432 12
Q ss_pred ccccCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~ 817 (892)
....|+..|+|||++. ...++.++||||||+++|||++|++|+..... .......... .......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~-~~~~~~~----- 242 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-DSPTLQS----- 242 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc-CCCCCCc-----
Confidence 2446788999999984 45688999999999999999999999864321 1112221111 1111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 818 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......+.+++.+|++.+|++||++.+++..
T Consensus 243 ---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 ---NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112347789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=279.88 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=192.5
Q ss_pred hhhceecccccEEEEEEEE-----CCcEEEEEEccCCCc----hhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL-----DNDEVAVKMLSPSSS----QGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~~----~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~L 653 (892)
.+.+.||+|+||.||+++. ++..||+|++..... ...+.+.+|++++.++ +|+||+++.+++..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 3457899999999999876 678899999875322 2345678899999999 59999999999998889999
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
|+||+++++|.+++.... .+++.....++.|++.||+|||+. +++||||||+|||+++++.+||+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 83 ILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999987643 488899999999999999999998 999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcccc
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 811 (892)
.. ........|+..|+|||.+... .++.++||||||+++|||++|+.||..... ......+........
T Consensus 158 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~------ 228 (290)
T cd05613 158 DE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSE------ 228 (290)
T ss_pred cc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhccC------
Confidence 21 1122234588899999998753 467899999999999999999999864321 112222332222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRP-----FMNQVVM 850 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVl~ 850 (892)
+... ......+.+++.+|++.+|++|| +..+++.
T Consensus 229 -~~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -PPYP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -CCCC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111 11234567999999999999997 5666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=309.98 Aligned_cols=253 Identities=29% Similarity=0.434 Sum_probs=190.3
Q ss_pred HHHhhhhh--ceecccccEEEEEEEE--CCcEEEEEEccCCC-chhhHHHHHHHHHHHhccccceeeEeeEeec------
Q 002688 579 LRMTNNFE--RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE------ 647 (892)
Q Consensus 579 ~~~t~~f~--~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~------ 647 (892)
.+...+|+ +.||+||||.|||++. ||+.+|||++.... ........+|+..+++++|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34555665 4799999999999976 99999999997653 3345678899999999999999998621100
Q ss_pred --------------------------------------------------------------------------------
Q 002688 648 -------------------------------------------------------------------------------- 647 (892)
Q Consensus 648 -------------------------------------------------------------------------------- 647 (892)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHH
Q 002688 648 -------------------------G--------TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694 (892)
Q Consensus 648 -------------------------~--------~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL 694 (892)
+ ..+|+-||||+...|.++++.+... -.-...++++++|++||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence 0 1246778899888888887765421 13567789999999999999
Q ss_pred HhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC----------------CCCccccccccCCCCccCccccccC
Q 002688 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV----------------EGGTHVSTTIAGTPGYLDPEYYISN 758 (892)
Q Consensus 695 H~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~----------------~~~~~~~~~~~gt~~Y~aPE~~~~~ 758 (892)
|+. +||||||||.||+|+++..|||+|||+|..... .......+...||.-|+|||.+.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 999999999999999999999999999987210 0111134567899999999999754
Q ss_pred ---CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHcc
Q 002688 759 ---RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACV 835 (892)
Q Consensus 759 ---~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl 835 (892)
+|+.|+|+||+|||++||+. ||...++.. -+-..++.+.+.+- ..+...+...-.+++++++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa------~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA------SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHH------HHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 59999999999999999996 466544321 12223344444433 1222333444568999999
Q ss_pred ccCCCCCCCHHHHHH
Q 002688 836 SSNANRRPFMNQVVM 850 (892)
Q Consensus 836 ~~~P~~RPsm~eVl~ 850 (892)
+.||.+|||+.|+++
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999886
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=280.06 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=195.3
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.||+|++|.||+|+. +++.+|+|.+.... ....+.+..|++++++++|+|++++.+++.+....++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 346799999999999998 57899999988653 3334678899999999999999999999999999999999998
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
++|.+++.... ..+++..+..++.+++.||+|||+. +++||||+|+||++++++.+||+|||+++....... ..
T Consensus 82 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (282)
T cd07829 82 MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TY 155 (282)
T ss_pred cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--cc
Confidence 58999997653 3489999999999999999999998 999999999999999999999999999886533221 12
Q ss_pred ccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCC---C---ccc--c
Q 002688 741 TTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD---I---RST--V 811 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~~~--~ 811 (892)
....++..|+|||.+.+. .++.++||||||++++||++|++||...... .............. . ... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 233457789999998776 7899999999999999999999998653311 01111111110000 0 000 0
Q ss_pred CCCCCC----CC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 812 DPRLKG----DF---DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 812 D~~l~~----~~---~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+..... .. -......+.+++.+|++.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 00 0011356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=293.10 Aligned_cols=244 Identities=22% Similarity=0.375 Sum_probs=196.8
Q ss_pred ceecccccEEEEEEEECC--cEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKLDN--DEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~--~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
..||.|+||.||+|+... --.|-|++...+....++|+-|+++|...+||+||+|++.|+..+.++++.|||.||-.+
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 458999999999998733 345778888888888899999999999999999999999999999999999999999998
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
..+-.-. ..|...++..++++++.||.|||++ +|||||||+.|||++.+|.++|+|||.+.... ........+.
T Consensus 118 aimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFI 191 (1187)
T KOG0579|consen 118 AIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFI 191 (1187)
T ss_pred HHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch--hHHhhhcccc
Confidence 8776554 3499999999999999999999999 99999999999999999999999999876432 1112234678
Q ss_pred CCCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 745 GTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 745 gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
||+.|||||+.+. ..|+.++||||||+.|.||..+.||-.... ...-+.. +.+......+-|.
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllK-iaKSePPTLlqPS----- 259 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLK-IAKSEPPTLLQPS----- 259 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHH-HhhcCCCcccCcc-----
Confidence 9999999999863 469999999999999999999999865322 1111111 1111212222221
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.=...+.++..+|+..+|..||+.+++++
T Consensus 260 --~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 260 --HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 22345669999999999999999999986
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=287.16 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=188.6
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecC------CcEEEEE
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG------TNMALIY 655 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~------~~~~LV~ 655 (892)
.+.||+|+||.||+|+. +++.||||++.... ......+.+|++++++++|+||+++++++... ...++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 47899999999999987 68899999986532 22335688999999999999999999988654 2468999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
||+.. +|.+++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 100 e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 100 PYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred ccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 99964 6666543 2388999999999999999999998 9999999999999999999999999998764221
Q ss_pred CccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHH----------hHhhc
Q 002688 736 GTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVS----------SMLDK 804 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~----------~~~~~ 804 (892)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+..... .....
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 171 ----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred ----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHHhcc
Confidence 123456888999999876 468899999999999999999999997532110 0000000 00000
Q ss_pred CCCccccC--CCCC-CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHh
Q 002688 805 GDIRSTVD--PRLK-GDF---DINSVWKAVEIAMACVSSNANRRPFMNQVVME--LNDCLA 857 (892)
Q Consensus 805 ~~~~~~~D--~~l~-~~~---~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~--L~~~~~ 857 (892)
......++ +... ... .......+.+++.+|++.+|++||++.+++.. +++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000 0000 000 00123457799999999999999999999954 766543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=290.29 Aligned_cols=263 Identities=22% Similarity=0.349 Sum_probs=198.8
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCC-----cEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT-----NMALI 654 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~-----~~~LV 654 (892)
.+.+.||+|++|.||+|+. +++.||||++.... ....+.+.+|+++++.++|+||+++.+++.... ..++|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 4567899999999999998 57899999987653 344567899999999999999999999987765 78999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
|||++ ++|.+++.... .+++..+..++.+++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 83 ~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 83 TELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred ecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99998 48988887644 599999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCc-cccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc--------
Q 002688 735 GGT-HVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK-------- 804 (892)
Q Consensus 735 ~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~-------- 804 (892)
... .......++..|+|||.+.+. .++.++|+||||+++++|++|++||...... .....+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCChhHhhh
Confidence 210 112234578889999999887 7899999999999999999999999754321 001111110000
Q ss_pred ---CCCccccC---CCCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 002688 805 ---GDIRSTVD---PRLK---GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME--LNDC 855 (892)
Q Consensus 805 ---~~~~~~~D---~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~--L~~~ 855 (892)
......+. ..-. ..........+.+++.+|++.+|++||++.++++. +++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00000000 0000 00001124557899999999999999999999974 5543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=274.75 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=192.0
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC-----CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS-----SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~ 655 (892)
+.+.+.||+|+||.||+++. .+..+++|.++.. ......++..|+.++++++||||+++++++......++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 34567899999999999987 3345666665432 1223345778999999999999999999999889999999
Q ss_pred EeccCCchhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 656 EYMANGNLEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
||+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||++++ +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988642 234589999999999999999999998 9999999999999986 4699999999877633
Q ss_pred CCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
.. .......++..|+|||.+.+..++.++|+||||+++++|++|+.||.... .......... +. .+
T Consensus 158 ~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~~-----~~ 223 (260)
T cd08222 158 SC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-GP-----TP 223 (260)
T ss_pred Cc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-CC-----CC
Confidence 22 12234557889999999988889999999999999999999999986321 1222222211 11 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+ +......+.+++.+|+..+|++||++.|+++
T Consensus 224 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 SL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 1233456779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=283.53 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=189.3
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeec-CCcEEEEEEecc
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE-GTNMALIYEYMA 659 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~-~~~~~LV~Ey~~ 659 (892)
+.+.||+|+||.||+++. +++.||||++... .....+.+.+|++++++++||||+++.+++.. ....++|+||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 457899999999999986 7889999987643 22334678899999999999999999998865 56789999998
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+++|.+++... .+++.....++.|+++||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 93 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----- 161 (328)
T cd07856 93 GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----- 161 (328)
T ss_pred ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC-----
Confidence 46888887643 378888899999999999999998 9999999999999999999999999998754211
Q ss_pred cccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCC---------ccHHHHHHhHhhcCCCcc
Q 002688 740 STTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGH---------THVAQWVSSMLDKGDIRS 809 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~---------~~l~~~~~~~~~~~~~~~ 809 (892)
.....++..|+|||.+.+ ..++.++||||||++++||++|++||........ ....+|............
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 123456788999998766 5689999999999999999999999964432100 000111111111110000
Q ss_pred ccCCCCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 810 TVDPRLKGDFDI-----NSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 810 ~~D~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
...-........ .....+.+++.+|++.+|++||++.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000011111 123567899999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=287.77 Aligned_cols=258 Identities=24% Similarity=0.323 Sum_probs=188.0
Q ss_pred hhhceecccccEEEEEEEE--C--CcEEEEEEccCC--CchhhHHHHHHHHHHHhc-cccceeeEeeEeecC----CcEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--D--NDEVAVKMLSPS--SSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG----TNMA 652 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~----~~~~ 652 (892)
.+.+.||+|+||.||+++. . +..||+|++... .....+.+.+|+++++++ +|+||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 4567899999999999998 3 668999998643 222346788999999999 599999999875432 4577
Q ss_pred EEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+++||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.+.
T Consensus 83 ~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 8888886 58988886543 489999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCc--cccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHH------------H
Q 002688 733 VEGGT--HVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQ------------W 797 (892)
Q Consensus 733 ~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~------------~ 797 (892)
..... .......|+..|+|||.+.+ ..++.++||||||++++||++|++||...... .... +
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCCCHHH
Confidence 32211 11223468899999998765 46899999999999999999999998753310 0000 0
Q ss_pred HHhHhhcCC--CccccC--CCC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 798 VSSMLDKGD--IRSTVD--PRL-KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 798 ~~~~~~~~~--~~~~~D--~~l-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......... ....++ +.. ...........+.+++.+|++.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 000000 000 00000112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=283.51 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=188.0
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCch--hhHHHHHHHHHHHhccccceeeEeeEeecC--------CcE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ--GYKQFQAEVKLLLRVHHRNLTTLVGYCDEG--------TNM 651 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--------~~~ 651 (892)
.+.+.||+|+||.||+|+. +++.+|||++...... ....+.+|+++++.++|+||+++++++... ...
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 4457899999999999988 6789999998654222 234678899999999999999999887443 346
Q ss_pred EEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccc
Q 002688 652 ALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731 (892)
Q Consensus 652 ~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~ 731 (892)
++|+||+.. +|...+.... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||+++..
T Consensus 91 ~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 91 YMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 999999975 6766665432 3499999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCc---------cccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhH
Q 002688 732 PVEGGT---------HVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSM 801 (892)
Q Consensus 732 ~~~~~~---------~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~ 801 (892)
...... .......++..|+|||.+.+. .++.++||||||++++||++|++||....... ...... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~~~-~~ 242 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHLIF-KL 242 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HH
Confidence 332211 111234567889999988654 58899999999999999999999997433211 011100 00
Q ss_pred hhc---------CCCcccc--------CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 802 LDK---------GDIRSTV--------DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 802 ~~~---------~~~~~~~--------D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
... ..+.... .+.+...+ ......+.+++.+|++.+|++||++.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 0000000 01110000 012245789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=272.70 Aligned_cols=235 Identities=29% Similarity=0.420 Sum_probs=192.3
Q ss_pred ecccccEEEEEEEE--CCcEEEEEEccCCCc---hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 589 LGKGGFGTVYHGKL--DNDEVAVKMLSPSSS---QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 589 IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
||+|+||.||+++. +++.+|+|.+..... .....+..|++++++++|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999988 578999999876432 2445788999999999999999999999999999999999999999
Q ss_pred hhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccc
Q 002688 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743 (892)
Q Consensus 664 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 743 (892)
.+++.... .+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99997653 489999999999999999999998 99999999999999999999999999988753321 123345
Q ss_pred cCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHH
Q 002688 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823 (892)
Q Consensus 744 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~ 823 (892)
.++..|+|||...+...+.++|+||||++++||++|+.||..... .+....... +.. .+. ...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~------~~~----~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-DPL------RFP----EFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CCC------CCC----CCC
Confidence 678899999999888899999999999999999999999964332 222222221 110 111 111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHH
Q 002688 824 VWKAVEIAMACVSSNANRRPFMNQ 847 (892)
Q Consensus 824 ~~~l~~l~~~Cl~~~P~~RPsm~e 847 (892)
...+.+++.+|+..+|++||++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 345679999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=282.78 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=188.0
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCC------cEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT------NMAL 653 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~------~~~L 653 (892)
.+.+.||+|+||.||+|.. ++..||||++.... ....+.+.+|++++++++|+||+++++++.... ..++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence 3457899999999999987 68899999986432 223456889999999999999999999886543 4689
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
||||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 98 v~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 98 VMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 99998 67898887642 489999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCC---------ccHHHHHHhHhh
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGH---------THVAQWVSSMLD 803 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~---------~~l~~~~~~~~~ 803 (892)
. .....++..|+|||.+.+ ..++.++|+||||+++++|++|++||........ .....|......
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 1 123457889999999876 4588999999999999999999999974321000 000001100000
Q ss_pred cCCCccccC--CCCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 804 KGDIRSTVD--PRLKG----DFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 804 ~~~~~~~~D--~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
........ +.... .........+.+++.+|++.+|++||++.++++
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 246 -EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred -hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 00000 000112335779999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=284.44 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=188.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecC------------
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG------------ 648 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~------------ 648 (892)
+.+.+.||.|+||.||+|.. +++.||+|.+........+.+.+|++++++++|+||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 34557899999999999987 6789999998776666667889999999999999999999766543
Q ss_pred --CcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEc-CCCcEEEeee
Q 002688 649 --TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN-EKFQAKLADF 725 (892)
Q Consensus 649 --~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~-~~~~vkl~Df 725 (892)
...++|+||++ ++|.+++... .+++.....++.|++.||+|||+. +++||||||+||+++ +++.+|++||
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 5888887543 388999999999999999999998 999999999999997 4567999999
Q ss_pred cCcccccCCCCc-cccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhH--
Q 002688 726 GLSRVFPVEGGT-HVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSM-- 801 (892)
Q Consensus 726 Gla~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~-- 801 (892)
|+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~ 237 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILESVPV 237 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence 998765321111 11123357889999998754 568889999999999999999999997443210 000000000
Q ss_pred ---------hhc--CCCc-cccCCCCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 802 ---------LDK--GDIR-STVDPRLK-GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 802 ---------~~~--~~~~-~~~D~~l~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
... .... ....+... ..........+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0000 00000000 0000012345779999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=264.75 Aligned_cols=263 Identities=22% Similarity=0.374 Sum_probs=202.2
Q ss_pred CHHHHHHHhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEeecCCc
Q 002688 574 TYSEVLRMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTN 650 (892)
Q Consensus 574 ~~~el~~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~ 650 (892)
++.|+-+.|. +.||+|+++.|--.+. ++.++|||++.+.......+..+|++++.+. .|+||++|+.+++++..
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 3556666654 5899999999987655 8999999999988777888999999999888 59999999999999999
Q ss_pred EEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC---cEEEeeecC
Q 002688 651 MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF---QAKLADFGL 727 (892)
Q Consensus 651 ~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~---~vkl~DfGl 727 (892)
.|||||-|.+|.|..+|++.. .+++.+..++..+||.||.|||.+ +|.||||||+|||-.... -+||+||.|
T Consensus 151 FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999999998754 489999999999999999999999 999999999999997544 389999998
Q ss_pred cccccCCC-----CccccccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCC-----Cc
Q 002688 728 SRVFPVEG-----GTHVSTTIAGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENG-----HT 792 (892)
Q Consensus 728 a~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~-----~~ 792 (892)
..-+.... .+......+|+..|||||+.. ...|+.++|.||||||+|-|++|.+||.+.=..+ +.
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 76543221 112234567899999999973 2468999999999999999999999997653211 11
Q ss_pred ---cHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 793 ---HVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 793 ---~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
...+-...-+++|... .=|... ........+++...+..++.+|-++.+++.
T Consensus 306 ~Cr~CQ~~LFesIQEGkYe-FPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKYE-FPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCCc-CChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111111222333221 000000 112334557888888899999999999887
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=282.79 Aligned_cols=261 Identities=21% Similarity=0.318 Sum_probs=190.6
Q ss_pred HHHHHHhhhh--hceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecC-
Q 002688 576 SEVLRMTNNF--ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG- 648 (892)
Q Consensus 576 ~el~~~t~~f--~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~- 648 (892)
.++...+.+| .+.||+|+||.||+|.. +++.||+|++.... ....+.+.+|++++++++|+||+++.+++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 3444444444 46899999999999986 67899999987542 22345688899999999999999999987543
Q ss_pred -----CcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEe
Q 002688 649 -----TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLA 723 (892)
Q Consensus 649 -----~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~ 723 (892)
...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence 3467888876 77998887643 389999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhH-
Q 002688 724 DFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSM- 801 (892)
Q Consensus 724 DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~- 801 (892)
|||+++.... ......++..|+|||.+.+ ..++.++|||||||+++||++|++||...... ..+.......
T Consensus 163 dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~ 235 (345)
T cd07877 163 DFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVG 235 (345)
T ss_pred cccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence 9999876421 1223467889999999866 56889999999999999999999998643211 0111100000
Q ss_pred ---------hhcCC-------CccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 802 ---------LDKGD-------IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 802 ---------~~~~~-------~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
+.... +...-..... .........+.+++.+|++.+|++||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0000000000 0000123457799999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=260.63 Aligned_cols=245 Identities=24% Similarity=0.396 Sum_probs=191.0
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC-CchhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS-SSQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
..||.|..|.|++++. .|..+|||.+... +....++++..+.++.+-+ +|.||+.+|||..+....+.||.|.. -
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 4699999999999988 5689999998765 4555677888888776665 89999999999999999999999853 3
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 742 (892)
++.+|. ....++++.-.-++...+.+||.||.+++ +|||||+||+|||+|+.|++|+||||++..+... ...+.
T Consensus 177 ~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kAhtr 250 (391)
T KOG0983|consen 177 AEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KAHTR 250 (391)
T ss_pred HHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc---ccccc
Confidence 344443 33445888888889999999999999874 8999999999999999999999999999887432 23345
Q ss_pred ccCCCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 743 IAGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 743 ~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
.+|-+.|||||.+.- .+|+.++||||||+.++||.||+-||....- +. +-...++.++. |.|.+..
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----dF-e~ltkvln~eP------P~L~~~~ 319 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----DF-EVLTKVLNEEP------PLLPGHM 319 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----cH-HHHHHHHhcCC------CCCCccc
Confidence 578899999999964 4699999999999999999999999975331 11 11222222111 3333221
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.....+.+++..|+..|+.+||...++++.
T Consensus 320 --gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 --GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 134567799999999999999999998873
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=283.48 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=189.3
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCc------EEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTN------MAL 653 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~------~~L 653 (892)
.+.+.||+|++|.||+|+. +++.||||++... .....+.+.+|+.++++++|+|++++.+++...+. .++
T Consensus 18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence 3457899999999999988 5788999998653 22334667889999999999999999987765544 899
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
|+||+ +++|.+++... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 98 v~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 98 VTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 99998 56999988753 489999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhc-CCCc---
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK-GDIR--- 808 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~--- 808 (892)
. .....++..|+|||.+.+ ..++.++||||||++++||++|+.||..... .+.+...... +...
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~------~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH------IDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred c-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCCHHH
Confidence 1 233457888999999865 3678999999999999999999999964321 1111111110 0000
Q ss_pred ----------cccC---CCCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 809 ----------STVD---PRLKGDF---DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 809 ----------~~~D---~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..+. ..-...+ .......+.+++.+|++.+|++|||+.||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000 0000000 0012456889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-31 Score=314.64 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=193.8
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
..||.|.||.||-|.. +|.-.|+|.++.. .....+...+|+.++..++|||+|+++|+-.+.+..++.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 4799999999999987 6777899988754 33455678899999999999999999999999999999999999999
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc--ccc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT--HVS 740 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~--~~~ 740 (892)
|.+.+...+. .++.....+..|++.|++|||++ +|+||||||.||+|+.+|.+|++|||.|..+...... ...
T Consensus 1321 La~ll~~gri--~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1321 LASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred HHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 9999986543 56666777889999999999999 9999999999999999999999999999887543211 122
Q ss_pred ccccCCCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHh-HhhcCCCccccCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSS-MLDKGDIRSTVDPRLK 816 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~---~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~D~~l~ 816 (892)
....||+.|||||++.+.+ -..+.||||+|||++||+||++||...+. +|+-- .+..|.. |.+.
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~-----Pq~P 1463 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHK-----PQIP 1463 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCC-----CCCc
Confidence 3567999999999997543 45689999999999999999999985442 23211 1112221 1222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
......-.+++.+|++.||++|.++.|+++.
T Consensus 1464 ----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1464 ----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1122334589999999999999888866553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-31 Score=268.17 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=199.5
Q ss_pred ccCHHHHHHHhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCc-hhhHHHHHHHHHHHhc-cccceeeEeeEeec
Q 002688 572 QFTYSEVLRMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRV-HHRNLTTLVGYCDE 647 (892)
Q Consensus 572 ~~~~~el~~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~ 647 (892)
.|+-.+|... ..||.|+||+|+|-.+ .|+..|||+++.... ..+++++.|.+...+- +.||||+++|.+..
T Consensus 60 ~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 60 TFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred ccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 4554444433 3699999999999887 788999999987654 5678899998865544 79999999999999
Q ss_pred CCcEEEEEEeccCCchhhhc---cccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEee
Q 002688 648 GTNMALIYEYMANGNLEEHL---SDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLAD 724 (892)
Q Consensus 648 ~~~~~LV~Ey~~~gsL~~~L---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~D 724 (892)
++.+++.||.|+- ||+.+- ....+..+++.-.-+|...+..||.||.+. ..|||||+||+||||+..|.+||||
T Consensus 135 EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 135 EGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred CCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeec
Confidence 9999999999964 555433 333344588888888888999999999986 4899999999999999999999999
Q ss_pred ecCcccccCCCCccccccccCCCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHh
Q 002688 725 FGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSML 802 (892)
Q Consensus 725 fGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~ 802 (892)
||++..+. .+...+.-+|-..|||||.+.. ..|+.++||||||+.|+|+.||+-|+..... +.+-+.+++
T Consensus 212 FGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv 283 (361)
T KOG1006|consen 212 FGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV 283 (361)
T ss_pred ccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH
Confidence 99987663 2334456678899999999964 3599999999999999999999999874432 223333333
Q ss_pred hcCCCccccCCCCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 803 DKGDIRSTVDPRLKGD-FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 803 ~~~~~~~~~D~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.. +. |.+... -..+....+..++-.|+..+-.+||...++.+.
T Consensus 284 ~g-dp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IG-DP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cC-CC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22 11 112211 123456778899999999999999999998764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=265.39 Aligned_cols=221 Identities=21% Similarity=0.196 Sum_probs=176.1
Q ss_pred cccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchhhhccc
Q 002688 592 GGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSD 669 (892)
Q Consensus 592 G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~ 669 (892)
|.+|.||+++. +++.+|+|++.... .+..|...+....|||++++++++......++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999988 78899999987643 234455555666799999999999999999999999999999999875
Q ss_pred cCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccccCCCCc
Q 002688 670 SSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGY 749 (892)
Q Consensus 670 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y 749 (892)
.. .+++.....++.|++.||+|||+. +++||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y 148 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY 148 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence 43 389999999999999999999998 9999999999999999999999999987654321 1233456789
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHH
Q 002688 750 LDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVE 829 (892)
Q Consensus 750 ~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~ 829 (892)
+|||...+..++.++||||+|++++||++|+.|+....... .......+.. .....+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~~~~~----~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTLNIPE----WVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccccCCcc----cCCHHHHH
Confidence 99999988889999999999999999999998765321100 0000001111 12345678
Q ss_pred HHHHccccCCCCCCCHHHH
Q 002688 830 IAMACVSSNANRRPFMNQV 848 (892)
Q Consensus 830 l~~~Cl~~~P~~RPsm~eV 848 (892)
++.+|++.+|++||++.+.
T Consensus 208 li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 208 LLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHccCCHHHhcCCCcc
Confidence 9999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=297.88 Aligned_cols=141 Identities=31% Similarity=0.473 Sum_probs=126.4
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.||+|+||.||+|.. +++.||||+++... ......+..|+.++..++|+||+++++++....+.++||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 3457899999999999998 58899999987542 233467889999999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~ 729 (892)
.+++|.+++.... .+++...+.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999987543 388899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=257.00 Aligned_cols=237 Identities=28% Similarity=0.467 Sum_probs=192.9
Q ss_pred ccEEEEEEEE--CCcEEEEEEccCCCchh-hHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchhhhccc
Q 002688 593 GFGTVYHGKL--DNDEVAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSD 669 (892)
Q Consensus 593 ~fG~Vy~~~~--~~~~vAVK~l~~~~~~~-~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~ 669 (892)
+||.||+|+. +++.+|+|++....... .+.+.+|++.+++++|+|++++.+++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5899999998 46899999998765544 67899999999999999999999999999999999999999999999876
Q ss_pred cCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccccCCCCc
Q 002688 670 SSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGY 749 (892)
Q Consensus 670 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y 749 (892)
... +++..+..++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 543 88999999999999999999998 99999999999999999999999999998764322 22345678899
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHH
Q 002688 750 LDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVE 829 (892)
Q Consensus 750 ~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~ 829 (892)
++||.+.+..++.++||||||++++||++|+.||.... +....... ...+...... . .......+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~~-~~~~~~~~~~-~------~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFKK-IGKPKPPFPP-P------EWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHH-HhccCCCCcc-c------cccCCHHHHH
Confidence 99999998889999999999999999999999986431 11112211 1111111000 0 0002346789
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 002688 830 IAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 830 l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=261.88 Aligned_cols=236 Identities=25% Similarity=0.358 Sum_probs=189.6
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCch---hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ---GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
+|.++||+|.||.|-..+- .++-+|+|++++...- ...--..|-++|+.-+||.+..+.-.+...+.+++||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 4568999999999987765 7889999999876332 2233467889999999999999999999999999999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
.+|.|.-+|... +.++......+-.+|..||.|||++ +|+.||||-+|.|||.+|++||+||||++.-. ....
T Consensus 251 nGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~ 323 (516)
T KOG0690|consen 251 NGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGD 323 (516)
T ss_pred cCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc--cccc
Confidence 999999998764 3488888888999999999999998 99999999999999999999999999998532 2234
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
.....+||+.|+|||++....|....|.|.+||+||||++|+.||...+.+ .+-+. +--+++ +..
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeL----Il~ed~------kFP-- 388 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFEL----ILMEDL------KFP-- 388 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHH----HHhhhc------cCC--
Confidence 556789999999999999999999999999999999999999999743321 11111 111111 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRP 843 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RP 843 (892)
.....+...|....+..+|++|.
T Consensus 389 --r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 389 --RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --ccCCHHHHHHHHHHhhcChHhhc
Confidence 11122345677788999999996
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=258.47 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=194.3
Q ss_pred hhhceecccccEEEEEEEE----C--CcEEEEEEccCCCch--hhHHHHHHHHHHHhccccceeeEeeEeec-CCcEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL----D--NDEVAVKMLSPSSSQ--GYKQFQAEVKLLLRVHHRNLTTLVGYCDE-GTNMALI 654 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~----~--~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~-~~~~~LV 654 (892)
+....||+|.+|.||+|+. + ...+|||+++..... -.....+|+.+++.++|+|++.+..++.+ +...+++
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 3456799999999999965 2 236899999765322 23456899999999999999999998876 7789999
Q ss_pred EEeccCCchhhhccccC---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC----CcEEEeeecC
Q 002688 655 YEYMANGNLEEHLSDSS---KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK----FQAKLADFGL 727 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~----~~vkl~DfGl 727 (892)
+||.+. +|.+.++.++ .+.++-.....|+.||+.|+.|||+. =|+||||||.|||+..+ |.+||+|+|+
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999988 8888886443 35688899999999999999999998 79999999999999877 8999999999
Q ss_pred cccccCCCCcc-ccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCcc----HHH--HHH
Q 002688 728 SRVFPVEGGTH-VSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTH----VAQ--WVS 799 (892)
Q Consensus 728 a~~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~----l~~--~~~ 799 (892)
++.+...-... ....++-|.-|+|||.+.+. .|+.+.|||+.|||+.||++-++.|.+..++.... ..+ .+.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 99885332222 23456678899999999875 58999999999999999999999887765432211 111 111
Q ss_pred hHhhcCCCcccc----CCCCC--------CCCCH---H--------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 800 SMLDKGDIRSTV----DPRLK--------GDFDI---N--------SVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 800 ~~~~~~~~~~~~----D~~l~--------~~~~~---~--------~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
.++.......+- -|+.. ..++. . .....++|..+++..||..|.|.+++++.
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111110000000 01110 00000 0 01126789999999999999999988763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=281.99 Aligned_cols=236 Identities=24% Similarity=0.351 Sum_probs=189.8
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEecc
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
+.+...+|.|+|+.|-+... +++..+||++..... +-.+|+.++... +|+||+++.+.+.++.+.++|||.+.
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 44566799999999988877 778899999977622 335667665555 79999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEE-cCCCcEEEeeecCcccccCCCCcc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI-NEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl-~~~~~vkl~DfGla~~~~~~~~~~ 738 (892)
+|-+.+.+..... .. .++..|+.+++.++.|||++ +++||||||+|||+ ++.++++|+|||.++.....
T Consensus 400 g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 9988777765432 22 67778999999999999998 99999999999999 58899999999999876433
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
....+-|..|.|||++....|++++|+||||++||||++|+.||.....+ .-+...+..+...
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s---------- 532 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS---------- 532 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc----------
Confidence 23446688999999999999999999999999999999999999754432 1122333333322
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
........+|+.+|++.+|.+||+|.++...
T Consensus 533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 --ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2223456699999999999999999999763
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=254.35 Aligned_cols=244 Identities=22% Similarity=0.336 Sum_probs=190.6
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEeecC----CcEEEEEEecc
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG----TNMALIYEYMA 659 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~----~~~~LV~Ey~~ 659 (892)
++||-|-.|.|-.... +++.+|+|++... ....+|++.--.. .|+|||++++++... ..+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 6899999999987765 7889999998754 3346677754333 699999999988543 45789999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEc---CCCcEEEeeecCcccccCCCC
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN---EKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~---~~~~vkl~DfGla~~~~~~~~ 736 (892)
||.|.+.+++++.+.+++.+...|..||+.|+.|||+. +|.||||||+|+|.. .|..+||+|||.|+.-..
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--- 216 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--- 216 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC---
Confidence 99999999999888899999999999999999999998 999999999999996 456799999999986422
Q ss_pred ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
.......+-|+.|.|||++-.++|+...|+||+||+||-|++|.+||...... .+.-=.+..+..|... .=+|+.
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy~-FP~pEW- 291 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQYE-FPEPEW- 291 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCcc-CCChhH-
Confidence 23345667899999999999999999999999999999999999999744321 1111111222222211 001111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
........++++.++..+|.+|-|+.|+..
T Consensus 292 ----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 292 ----SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ----hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 123445679999999999999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=279.33 Aligned_cols=247 Identities=25% Similarity=0.433 Sum_probs=200.0
Q ss_pred hhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEee-----cCCcEEEEE
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCD-----EGTNMALIY 655 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~-----~~~~~~LV~ 655 (892)
.|.++||+|.+|.||+++. +++.+|||++...... .++.+.|.++++.. +|||++.++|++. .++.++|||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 4568999999999998876 8889999998766433 46778899999888 6999999999985 346799999
Q ss_pred EeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~ 735 (892)
|||.+||.-|+++...+..+.|..+..|+++++.||.+||.. .++|||||-.|||++.++.+|++|||++..+..
T Consensus 101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds-- 175 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS-- 175 (953)
T ss_pred eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec--
Confidence 999999999999887777899999999999999999999998 999999999999999999999999999887632
Q ss_pred CccccccccCCCCccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccc
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISN-----RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRST 810 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 810 (892)
.........||+.|||||++... .|+.++|+||||++..||-.|.+|+.+... ..-.....+
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mraLF~IpR------- 242 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIPR------- 242 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hhhhccCCC-------
Confidence 22334466799999999999643 477899999999999999999999875432 111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 811 ~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.|...-.-+..=..++.+++..|+..+-++||++.++++
T Consensus 243 -NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 243 -NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 122111122334556789999999999999999998875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=270.74 Aligned_cols=242 Identities=25% Similarity=0.394 Sum_probs=191.4
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
+++||+|-||+||-|++ +|+.||||++.+.. .+...++.+|+.+|++++||.||.+-..|+..+..+.|||-+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47999999999999988 89999999987642 33446789999999999999999999999999999999999965
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC---CcEEEeeecCcccccCCCCcc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK---FQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~---~~vkl~DfGla~~~~~~~~~~ 738 (892)
+..+.+-...+..|+......++.||+.||.|||.+ +|+|+||||+||||... .++||||||.|+.+.. ..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KS 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch---hh
Confidence 655555444445588888899999999999999998 99999999999999643 5799999999998743 33
Q ss_pred ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 739 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
....+.||+.|+|||++..+.|...-|+||.||++|--++|..||.... ++.+-++... .+-|.-.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQIQNAa-------FMyPp~P-- 787 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQIQNAA-------FMYPPNP-- 787 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHhhccc-------cccCCCc--
Confidence 4567899999999999999999999999999999999999999997432 3333222211 1111100
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVV 849 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl 849 (892)
=.+.....++++...++..=++|-+..+.+
T Consensus 788 -W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 -WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 012233456777788888777787776654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-29 Score=290.83 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=196.7
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
+.+.++||+|+||.|..+++ .++.+|.|++.+- .......|..|-.+|..-+.+-|+.+.-.|.+..++|+||||
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY 156 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY 156 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence 34568999999999999988 6788999998762 233445688999999999999999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
|+||+|-.+|.+.. .++......++..|.-||.-||+. |+|||||||+|||||..|++||+|||.+..+.. ++.
T Consensus 157 ~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~-dG~ 230 (1317)
T KOG0612|consen 157 MPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-DGT 230 (1317)
T ss_pred ccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC-CCc
Confidence 99999999998876 488888899999999999999998 999999999999999999999999999887743 344
Q ss_pred cccccccCCCCccCccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhh-cCCCcccc
Q 002688 738 HVSTTIAGTPGYLDPEYYI----S-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD-KGDIRSTV 811 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~----~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~ 811 (892)
-.+...+|||-|++||++. + +.|...+|.||+||++|||+.|..||.... +++=..++.. +..+.-.
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk~~l~FP- 303 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHKESLSFP- 303 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchhhhcCCC-
Confidence 4556678999999999995 2 579999999999999999999999997422 2222222221 1111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPF---MNQVVM 850 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---m~eVl~ 850 (892)
...+......+|+++.+. +|+.|-. +.++-.
T Consensus 304 -------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 304 -------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred -------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 112234455677777766 5788877 777765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=233.52 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=188.3
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
++||+|.+|+||||+. .++.||+|+++-.. ..-.....+|+-+++.++|+|||++++....+...-+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 5799999999999987 56789999986543 22235678999999999999999999999999999999999976 7
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccc
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 742 (892)
|..+.....+. ++......+..|+++||.+.|++ ++.|||+||.|.||+.+|+.|++|||+++.+...- .....
T Consensus 87 lkkyfdslng~-~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv--rcysa 160 (292)
T KOG0662|consen 87 LKKYFDSLNGD-LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYSA 160 (292)
T ss_pred HHHHHHhcCCc-CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce--Eeeec
Confidence 87777655443 88889999999999999999999 99999999999999999999999999999874321 11233
Q ss_pred ccCCCCccCccccccCC-CCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCC---ccccCCCCCC
Q 002688 743 IAGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDI---RSTVDPRLKG 817 (892)
Q Consensus 743 ~~gt~~Y~aPE~~~~~~-~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~D~~l~~ 817 (892)
..-|.-|.+|+++.+.+ |+...|+||-||++.|+.. |++.|.+.+-++.-.-.-|+.....+... .+.-|-....
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 45688999999998865 7889999999999999987 56556544322111111122222222221 1121211111
Q ss_pred CCCHHH-----HHH----HHHHHHHccccCCCCCCCHHHHHH
Q 002688 818 DFDINS-----VWK----AVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 818 ~~~~~~-----~~~----l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.++..- ..+ =.++.++.+.-+|.+|.++++.++
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111 111 136777777789999999887765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=284.99 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=165.1
Q ss_pred hhhceecccccEEEEEEEE--C----CcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeE------eecCCcE
Q 002688 584 NFERVLGKGGFGTVYHGKL--D----NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY------CDEGTNM 651 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~--~----~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~------~~~~~~~ 651 (892)
.+.+.||+|+||.||+|++ + +..||||++...... +....| .+.+..+.++..++.. +..+...
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 4457999999999999998 4 678999997643221 111111 1222223333222211 2456679
Q ss_pred EEEEEeccCCchhhhccccCcc------------------cCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEE
Q 002688 652 ALIYEYMANGNLEEHLSDSSKE------------------ILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNIL 713 (892)
Q Consensus 652 ~LV~Ey~~~gsL~~~L~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NIL 713 (892)
++|+||+.+++|.+++...... ......+..++.|++.||+|||+. +|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence 9999999999999988654210 011234567999999999999998 9999999999999
Q ss_pred EcC-CCcEEEeeecCcccccCCCCccccccccCCCCccCccccccC----------------------CCCchhhHHHHH
Q 002688 714 INE-KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN----------------------RLTEKSDVYSFG 770 (892)
Q Consensus 714 l~~-~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~ksDV~SlG 770 (892)
+++ ++.+||+|||+++.+... .........+++.|||||.+... .++.++||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 986 689999999999865322 22233456789999999976422 234567999999
Q ss_pred HHHHHHHhCCCCCCccc-------cCCCccHHHHHHhHhhcCCCccccCCCCCCCCC--HHHHHHHHHHHHHccccCCCC
Q 002688 771 VVLLEIITGHPVISKSA-------ENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD--INSVWKAVEIAMACVSSNANR 841 (892)
Q Consensus 771 vvl~ELltG~~p~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~--~~~~~~l~~l~~~Cl~~~P~~ 841 (892)
|+||||+++..+.+... ...+.++..|....... ..+.+...++ ........+|+.+|++.||++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 99999999776543211 01111223332211110 0000000000 001123458999999999999
Q ss_pred CCCHHHHHHH
Q 002688 842 RPFMNQVVME 851 (892)
Q Consensus 842 RPsm~eVl~~ 851 (892)
|||++|+++.
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999884
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-29 Score=261.79 Aligned_cols=239 Identities=25% Similarity=0.412 Sum_probs=189.0
Q ss_pred HhhhhhceecccccEEEEEEEEC--CcEEEEEEccCCCc---hhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEE
Q 002688 581 MTNNFERVLGKGGFGTVYHGKLD--NDEVAVKMLSPSSS---QGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV 654 (892)
.-.+|..+||+|+||.|-.|... .+-+|||++++... ...+--+.|-++|.-. +-|.++++..++..-+.+++|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 33478899999999999999874 45699999987522 2223334555666555 467888998889999999999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
|||+.+|+|--++++.++ +.+.....+|.+||-||-+||++ +||.||||-+|||||.+|.+||+|||+++.-...
T Consensus 429 MEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 999999999999987665 77888899999999999999999 9999999999999999999999999998753222
Q ss_pred CCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 735 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
.......+||+.|+|||++....|...+|.|||||+||||+.|++||++.+++ +..+.+. + ..
T Consensus 504 --~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------elF~aI~-e--------hn 566 (683)
T KOG0696|consen 504 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQAIM-E--------HN 566 (683)
T ss_pred --CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH-H--------cc
Confidence 23445789999999999999999999999999999999999999999876542 1222211 1 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRP 843 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 843 (892)
. .++.....+.+.+....+...|..|.
T Consensus 567 v--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 V--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred C--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 12333345566778888888888885
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=260.54 Aligned_cols=261 Identities=24% Similarity=0.379 Sum_probs=196.8
Q ss_pred HHHHHHhhhhhceecccccEEEEEEEE--CCcEEEEEEccCC--Cchhh-----HHHHHHHHHHHhccccceeeEeeEee
Q 002688 576 SEVLRMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGY-----KQFQAEVKLLLRVHHRNLTTLVGYCD 646 (892)
Q Consensus 576 ~el~~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~-----~~f~~Ei~~l~~l~H~NIv~l~g~~~ 646 (892)
.-++..++-+...||+|||+.||||.. ..+.||||+-... ..... +-..+|..+-+.++||.||++++++.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 334455555667899999999999977 6778999985432 21111 23567899999999999999999996
Q ss_pred cC-CcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC---CCcEEE
Q 002688 647 EG-TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE---KFQAKL 722 (892)
Q Consensus 647 ~~-~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~---~~~vkl 722 (892)
-+ ...+-|+|||++.+|+-+|+.++ .+++.+...|++||+.||.||.+. +++|||-||||.||||-+ -|.+||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 44 56889999999999999998765 489999999999999999999985 789999999999999954 578999
Q ss_pred eeecCcccccCCCCcc-----ccccccCCCCccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCcc
Q 002688 723 ADFGLSRVFPVEGGTH-----VSTTIAGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTH 793 (892)
Q Consensus 723 ~DfGla~~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~ 793 (892)
+||||++.+..+...+ ......||.-|++||.+.-+ +.+.|+||||.|||+|+++.|+.||..... .+
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQ- 691 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQ- 691 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HH-
Confidence 9999999986544332 33467799999999998633 578899999999999999999999974321 11
Q ss_pred HHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 794 VAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 794 l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.++.+..+...-.-.... ..........++++|++..-++|-...++..
T Consensus 692 ------dILqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 ------DILQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ------HHHhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 122222221111111111 1112234568999999999999988777654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=272.29 Aligned_cols=253 Identities=18% Similarity=0.252 Sum_probs=175.2
Q ss_pred hhhceecccccEEEEEEEE------------------CCcEEEEEEccCCCchhhHH--------------HHHHHHHHH
Q 002688 584 NFERVLGKGGFGTVYHGKL------------------DNDEVAVKMLSPSSSQGYKQ--------------FQAEVKLLL 631 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~------------------~~~~vAVK~l~~~~~~~~~~--------------f~~Ei~~l~ 631 (892)
.+.++||+|+||.||+|.+ +++.||||++........++ +..|+.++.
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~ 227 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA 227 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence 3457999999999999964 34579999987654333333 344677777
Q ss_pred hccccce-----eeEeeEeec--------CCcEEEEEEeccCCchhhhccccC----------------------cccCC
Q 002688 632 RVHHRNL-----TTLVGYCDE--------GTNMALIYEYMANGNLEEHLSDSS----------------------KEILN 676 (892)
Q Consensus 632 ~l~H~NI-----v~l~g~~~~--------~~~~~LV~Ey~~~gsL~~~L~~~~----------------------~~~l~ 676 (892)
+++|.++ ++++++|.. .+..+|||||+++|+|.++|+... ...++
T Consensus 228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 8876654 677787753 356899999999999999886421 12356
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccc
Q 002688 677 WEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756 (892)
Q Consensus 677 ~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 756 (892)
|..+..++.|++.+|+|||+. +|+||||||+|||++.++.+||+|||+++.+..... .......+++.|+|||.+.
T Consensus 308 ~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhc
Confidence 788999999999999999998 999999999999999999999999999976532211 1111223478999999985
Q ss_pred cCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCcccc------CCCccHHHHHHhHhhcCCC
Q 002688 757 SNRL----------------------TEKSDVYSFGVVLLEIITGHP-VISKSAE------NGHTHVAQWVSSMLDKGDI 807 (892)
Q Consensus 757 ~~~~----------------------s~ksDV~SlGvvl~ELltG~~-p~~~~~~------~~~~~l~~~~~~~~~~~~~ 807 (892)
.... ..+.||||+||+++||++|.. |+..... ....++..|... .....
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~~~~~ 461 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--KGQKY 461 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--cccCC
Confidence 4321 234799999999999999974 6542211 111222233211 11111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 002688 808 RSTVDPRLKGDFDINSVWKAVEIAMACVSSNA---NRRPFMNQVVM 850 (892)
Q Consensus 808 ~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPsm~eVl~ 850 (892)
+-... ........+++.+|+..+| .+|+|++|+++
T Consensus 462 ----~~~~~----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 462 ----DFSLL----DRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ----Ccccc----cccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11100 1122345688889998765 78999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=250.68 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=191.4
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCC-chh-hHHHHHHHHHHHhccccceeeEeeEeecC--------CcEEEE
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQG-YKQFQAEVKLLLRVHHRNLTTLVGYCDEG--------TNMALI 654 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~-~~~-~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~--------~~~~LV 654 (892)
.+||+|.||.||+|+. .++.||+|++-... ..+ -....+|+.+|..++|+|++.++..|... ...++|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 4799999999999987 66778998764322 122 24568999999999999999999988543 348999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~ 734 (892)
|++|+. +|.-+|.... ..++..++.++..++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+++.+...
T Consensus 103 f~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred HHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 999987 8888887653 3489999999999999999999998 9999999999999999999999999999887533
Q ss_pred CCc--cccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHH-HHHhHhhcCC----
Q 002688 735 GGT--HVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQ-WVSSMLDKGD---- 806 (892)
Q Consensus 735 ~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~-~~~~~~~~~~---- 806 (892)
... ...+..+-|..|.+||.+.+. .|+++.|||.-||+|.||+||.+.+.+..+...-++.. ...+...+-|
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d 257 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD 257 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence 221 223455678999999999875 68999999999999999999999888665432211111 1111111111
Q ss_pred ---Ccccc--CCCCCCCCC--HHH------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 807 ---IRSTV--DPRLKGDFD--INS------VWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 807 ---~~~~~--D~~l~~~~~--~~~------~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+.+.+ .|--.+.+. .+. ....++++..++..||.+|+...+++.
T Consensus 258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11111 111111110 011 125678999999999999999988764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=231.81 Aligned_cols=193 Identities=27% Similarity=0.367 Sum_probs=161.3
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC-CchhhHHHHHHHHHH-HhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS-SSQGYKQFQAEVKLL-LRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l-~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
+.||+|++|.|-+-++ +|+..|||++... ..+..++.+.|+.+. +...+|.+|.++|........++.||.|+- |
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 4699999999876666 8999999999765 455667888888865 445799999999999999999999999965 7
Q ss_pred hhhhcccc--CcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 663 LEEHLSDS--SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 663 L~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+.+-.+- .+..+++...-+|+..+..||.|||++ ..+||||+||+||||+.+|++|+||||++..+.+ +-..
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---SiAk 205 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD---SIAK 205 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh---hhHH
Confidence 76654331 244588888999999999999999987 4899999999999999999999999999987642 2223
Q ss_pred ccccCCCCccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCc
Q 002688 741 TTIAGTPGYLDPEYYIS----NRLTEKSDVYSFGVVLLEIITGHPVISK 785 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~----~~~s~ksDV~SlGvvl~ELltG~~p~~~ 785 (892)
+...|...|||||.+.. ..|+-|+||||||+.+.||.+++.||+.
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 34568889999999853 3689999999999999999999999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-28 Score=275.56 Aligned_cols=242 Identities=28% Similarity=0.396 Sum_probs=187.2
Q ss_pred hceecccccEE-EEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 586 ERVLGKGGFGT-VYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 586 ~~~IG~G~fG~-Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
.+++|.|+.|+ ||+|..++++||||++-.. ...-..+|+..|+.- +|||||++++.-.+..+.|+..|.|.. +|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 46899999875 6999999999999998643 223457899999887 599999999999999999999999965 99
Q ss_pred hhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC---C--CcEEEeeecCcccccCCCC
Q 002688 664 EEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE---K--FQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 664 ~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~---~--~~vkl~DfGla~~~~~~~~ 736 (892)
.+++.... .....-...+.+..|++.||++||+. +|+||||||.||||+. + ..++|+|||+++.+.....
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 99998741 11112144567889999999999997 9999999999999975 2 5799999999998865443
Q ss_pred cc-ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCccccCCCccHHHHHHhHhhcCCCccccCCC
Q 002688 737 TH-VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 737 ~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~ 814 (892)
+. ......||-||+|||++....-+..+||||+||++|+.++| .+||...-+.+. +++....-...+.+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~L~~- 737 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVHLEP- 737 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceeeecc-
Confidence 32 23467799999999999998888899999999999999997 899975433211 11111110001111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 815 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..++ ...+|+.+|+..+|..||++.+|+.
T Consensus 738 -----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 738 -----LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1112 5679999999999999999999975
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-28 Score=262.87 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=194.9
Q ss_pred ceecccccEEEEEEEECCcE--EEEEEccCC---CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 587 RVLGKGGFGTVYHGKLDNDE--VAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~--vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
..||-||||.|=.++.+++. +|+|.+++. .....+-...|-++|...+.+.||+++..+.+....|+.||-|-+|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 36999999999998886655 788877654 3334455778999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
.|...|++.+. ++......++.-+++|++|||.+ +||.|||||+|++|+.+|-+||.|||.|+.+.... ..-
T Consensus 506 ElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KTw 577 (732)
T KOG0614|consen 506 ELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTW 577 (732)
T ss_pred hhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC---cee
Confidence 99999987653 88888889999999999999999 99999999999999999999999999999875433 344
Q ss_pred cccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCH
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~ 821 (892)
..+||+.|.|||++.++..+..+|.||||++++||++|.+||...++- ..+ ...++. +|. -.++.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-----ktY-n~ILkG------id~---i~~Pr 642 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-----KTY-NLILKG------IDK---IEFPR 642 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-----HHH-HHHHhh------hhh---hhccc
Confidence 789999999999999999999999999999999999999999865531 111 111111 110 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002688 822 NSVWKAVEIAMACVSSNANRRPF-----MNQVVM 850 (892)
Q Consensus 822 ~~~~~l~~l~~~Cl~~~P~~RPs-----m~eVl~ 850 (892)
.......+++++....+|.+|.. +.++.+
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 23344668888999999999986 555544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-28 Score=255.31 Aligned_cols=268 Identities=18% Similarity=0.290 Sum_probs=201.1
Q ss_pred cCHHHHHHHhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccc--c----ceeeEeeE
Q 002688 573 FTYSEVLRMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH--R----NLTTLVGY 644 (892)
Q Consensus 573 ~~~~el~~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~----NIv~l~g~ 644 (892)
+...|.+...+.+...+|+|.||.|-+... .+..||||+++....- .+..+-|++++.++.+ | -+|.+.+|
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 444555566667778999999999988766 5678999998754322 2445779999999942 2 37888899
Q ss_pred eecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC--------
Q 002688 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-------- 716 (892)
Q Consensus 645 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-------- 716 (892)
++-.++.++|+|.| |-|+.++|..++-.+++...+..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEec
Confidence 99999999999988 44999999998877899999999999999999999998 9999999999999932
Q ss_pred ------------CCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002688 717 ------------KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVIS 784 (892)
Q Consensus 717 ------------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~ 784 (892)
+..+||+|||.|..-.. .+ ..++.|..|.|||++.+-.++.++||||+||||.|+.+|...|.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e---~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHE---HH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceecc---Cc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 34589999999976321 12 45678999999999999999999999999999999999998886
Q ss_pred ccccCCCccHHHH--------------HHhHhhcCCC-----------ccccCCCCC----CCCCHHHHHHHHHHHHHcc
Q 002688 785 KSAENGHTHVAQW--------------VSSMLDKGDI-----------RSTVDPRLK----GDFDINSVWKAVEIAMACV 835 (892)
Q Consensus 785 ~~~~~~~~~l~~~--------------~~~~~~~~~~-----------~~~~D~~l~----~~~~~~~~~~l~~l~~~Cl 835 (892)
.-+..+.-.+.+- ..+....+.+ ....++-.. -.....+...+++|+++|+
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 5442110001110 1111111111 111111100 0112346777999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 002688 836 SSNANRRPFMNQVVM 850 (892)
Q Consensus 836 ~~~P~~RPsm~eVl~ 850 (892)
..||.+|+|..|+++
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=241.13 Aligned_cols=241 Identities=22% Similarity=0.374 Sum_probs=195.1
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEecc
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.++||+|+++.|-.+++ +.+.+|+|++++.- .+.....+.|-.+.... +||.+|.+..++.....+++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 46899999999999988 66789999987642 22233345555555444 79999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|+|--+++..++ +++.....+..+|.-||.|||+. +||.||||-+|+|+|..|.+|++|+|+.+.--. ....
T Consensus 335 ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~--~gd~ 407 (593)
T KOG0695|consen 335 GGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG--PGDT 407 (593)
T ss_pred Ccceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC--CCcc
Confidence 9999888876544 89999999999999999999999 999999999999999999999999999875322 2334
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcc-ccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKS-AENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
....+||+.|+|||++.+..|....|.|++||+|+||+.|+.||+.. .+..+.+-.++..+++-+.+++- |
T Consensus 408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---p----- 479 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---P----- 479 (593)
T ss_pred cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---c-----
Confidence 56789999999999999999999999999999999999999999844 33445566677777776655441 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRP 843 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RP 843 (892)
.....+...+.+.-+..||.+|.
T Consensus 480 --rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 --RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --ceeehhhHHHHHHhhcCCcHHhc
Confidence 11223445778888999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=256.35 Aligned_cols=199 Identities=27% Similarity=0.431 Sum_probs=167.4
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCchhh---HHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGY---KQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~---~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
+.||-|+||+|..++. +...+|.|.+.+...-.. .-...|-.+|...+.+-||+|+-.|.+++.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 5799999999999876 445689999877643322 33577889999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC--------
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV-------- 733 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~-------- 733 (892)
++-.+|-..+ .+.+.....++.++++|+++.|.. |+|||||||+|||||.+|.+||+||||+.-+.-
T Consensus 715 DmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 715 DMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred cHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 9999887654 377888888999999999999998 999999999999999999999999999765420
Q ss_pred CCCcc--------------------------------ccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 002688 734 EGGTH--------------------------------VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781 (892)
Q Consensus 734 ~~~~~--------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~ 781 (892)
.+..+ ..-..+||..|+|||++....++..+|.||.||||+||+.|++
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 00000 0013469999999999999999999999999999999999999
Q ss_pred CCCccccCC
Q 002688 782 VISKSAENG 790 (892)
Q Consensus 782 p~~~~~~~~ 790 (892)
||......+
T Consensus 870 pf~~~tp~~ 878 (1034)
T KOG0608|consen 870 PFLADTPGE 878 (1034)
T ss_pred CccCCCCCc
Confidence 998776544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-26 Score=230.76 Aligned_cols=209 Identities=34% Similarity=0.630 Sum_probs=183.0
Q ss_pred ecccccEEEEEEEEC--CcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchhh
Q 002688 589 LGKGGFGTVYHGKLD--NDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEE 665 (892)
Q Consensus 589 IG~G~fG~Vy~~~~~--~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 665 (892)
||+|.+|.||+++.. ++.+++|++...... ..+.+.+|++.++.+.|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999995 899999999876443 34678999999999999999999999999999999999999999999
Q ss_pred hccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC-CCcEEEeeecCcccccCCCCcccccccc
Q 002688 666 HLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-KFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 666 ~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 987653 3489999999999999999999998 9999999999999999 89999999999986643221 123345
Q ss_pred CCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHH
Q 002688 745 GTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823 (892)
Q Consensus 745 gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~ 823 (892)
+...|++||..... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 77899999999877 888999999999999999
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 824 VWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 824 ~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 346699999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-28 Score=242.90 Aligned_cols=260 Identities=21% Similarity=0.342 Sum_probs=190.9
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecC-----CcEEEEEEe
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG-----TNMALIYEY 657 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~-----~~~~LV~Ey 657 (892)
+.||-|+||.||..+. +|+.||.|++... +....+++.+|+.+|..++|.|++..++..... ++++.+.|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 5899999999999988 8999999998654 334568899999999999999999988776433 356778888
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 737 (892)
|.. +|...+-. .+.++-....-+..||++||+|||+. +|.||||||.|.|++.+..+||+|||+++.-..++..
T Consensus 139 mQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 139 MQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 854 77777654 44588888889999999999999998 9999999999999999999999999999976544433
Q ss_pred cccccccCCCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccH-HHH-------HHhHhhcCCCc
Q 002688 738 HVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHV-AQW-------VSSMLDKGDIR 808 (892)
Q Consensus 738 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l-~~~-------~~~~~~~~~~~ 808 (892)
+ ++...-|..|.|||.+++. .|+...||||.||++.||+.++..|......+.-++ .+. ..+..-+|.-.
T Consensus 213 h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 213 N-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred h-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 3 3445568899999999985 599999999999999999998877764332111000 000 00001111111
Q ss_pred ccc-----CCCCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002688 809 STV-----DPRLKGDF----DINSVWKAVEIAMACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 809 ~~~-----D~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
.++ -|.+...+ ..+.-...+.+.+.++..+|+.|.+..+.+..+.
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111 11111111 1122334567788899999999999999887654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=227.04 Aligned_cols=196 Identities=34% Similarity=0.522 Sum_probs=171.1
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEccCCCch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
+.+.||+|++|.||+++. +++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 457899999999999998 3689999999876555 6678999999999999999999999999989999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++...... +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 83 ~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 83 DLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred CHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 999998765432 78999999999999999999998 999999999999999999999999999887643321 1223
Q ss_pred cccCCCCccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCc
Q 002688 742 TIAGTPGYLDPEYY-ISNRLTEKSDVYSFGVVLLEIITGHPVISK 785 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~-~~~~~s~ksDV~SlGvvl~ELltG~~p~~~ 785 (892)
...++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34577889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-26 Score=235.08 Aligned_cols=248 Identities=24% Similarity=0.311 Sum_probs=189.6
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCC--CchhhHHHHHHHHHHHhccccceeeEeeEeecC------CcEEEEEE
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG------TNMALIYE 656 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~------~~~~LV~E 656 (892)
+.+|.|.- .|-.+.. .+++||+|++... .....++..+|...+..+.|+|+++++.++.-. .+.++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 35777777 5555544 7889999987543 334457788999999999999999999988543 45899999
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
+|.. +|...+.. .++-.....|..|+++|++|||+. +|+||||||+||++..+..+||.|||+|+.-. .
T Consensus 102 ~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~---~ 170 (369)
T KOG0665|consen 102 LMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED---T 170 (369)
T ss_pred hhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC---c
Confidence 9965 88887762 277788899999999999999999 99999999999999999999999999998642 2
Q ss_pred ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCc--------
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR-------- 808 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------- 808 (892)
....+....+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+ ..++.+|-+..-.-|...
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-----~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-----KDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-----chHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 2456677889999999999988899999999999999999999988873 344556644332211110
Q ss_pred -------------------ccc-CCCCCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 809 -------------------STV-DPRLKGD--FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 809 -------------------~~~-D~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
+.+ |...... .+.-....+.+++.+|+..+|++|-+.+++++.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 0000000 011123445689999999999999999999873
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=221.28 Aligned_cols=252 Identities=19% Similarity=0.328 Sum_probs=188.6
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEee-EeecCCcEEEEEEe
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVG-YCDEGTNMALIYEY 657 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g-~~~~~~~~~LV~Ey 657 (892)
.+++.+.+|+|.||.+-.+.+ .++.+++|-+.... ...++|.+|...--.+ .|.||+.-++ .+...+.+.+++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 456778999999999999988 56789999887653 3457899998866666 5899997665 45666788999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEc--CCCcEEEeeecCcccccCCC
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN--EKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~--~~~~vkl~DfGla~~~~~~~ 735 (892)
++.|+|.+-+...+ +.+....+++.|+++|+.|||++ +++|||||.+||||- +..++||||||+.+....
T Consensus 104 aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-- 175 (378)
T KOG1345|consen 104 APRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-- 175 (378)
T ss_pred CccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence 99999999887644 78888999999999999999999 999999999999993 345899999999875421
Q ss_pred CccccccccCCCCccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccc
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISN-----RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRST 810 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 810 (892)
.......+..|.+||..... ...+.+|+|.||++++.++||++||..... .+..+.+|.+-. .+.
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~--~rk---- 245 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWL--KRK---- 245 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHh--ccc----
Confidence 11223345679999987543 356789999999999999999999984433 334455554321 111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 811 ~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
.+++...++ ....+++.+.++-+..+|++|-...++.++...
T Consensus 246 -~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 246 -NPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred -CccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 122332222 223456677888899999999777777665544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=217.43 Aligned_cols=251 Identities=21% Similarity=0.352 Sum_probs=191.1
Q ss_pred hhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhcc-ccceeeEeeEeecC--CcEEEEEEe
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEG--TNMALIYEY 657 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~--~~~~LV~Ey 657 (892)
+++.+.+|+|.+++||.|.. +++.++||++++. ..+.+.+|+.+|..+. ||||+.+++...+. ....||+||
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 34557899999999999985 8889999999865 3467899999999997 99999999988654 457899999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC-CCcEEEeeecCcccccCCCC
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-KFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-~~~vkl~DfGla~~~~~~~~ 736 (892)
+.+.+...+-.. ++...+..++.+++.||.|+|+. ||+|||+||.|++||. .-.++|+|+|||..+.+...
T Consensus 117 v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 117 VNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 999887666532 67778889999999999999999 9999999999999995 45799999999998865543
Q ss_pred ccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHH--------hHhhcCCC
Q 002688 737 THVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVS--------SMLDKGDI 807 (892)
Q Consensus 737 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~~ 807 (892)
.. ....+..|.-||.+.. ..|+..-|+|||||++.+|+..+.||-...... ..++..+. ..+.+..+
T Consensus 189 Yn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 189 YN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHHHHHcc
Confidence 32 2345667888999875 468889999999999999999999987544321 11222221 11111121
Q ss_pred ccccCCCCCC---CCC-------------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 808 RSTVDPRLKG---DFD-------------INSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 808 ~~~~D~~l~~---~~~-------------~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
. +||++.. ... .-...++++++.+.+..|-.+|||++|+..
T Consensus 265 ~--Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 D--LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred C--CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1 4444321 110 012356789999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-25 Score=244.51 Aligned_cols=190 Identities=23% Similarity=0.364 Sum_probs=163.4
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCCc--------hhhHHHHHHHHHHHhcc---ccceeeEeeEeecCCcEE
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--------QGYKQFQAEVKLLLRVH---HRNLTTLVGYCDEGTNMA 652 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~---H~NIv~l~g~~~~~~~~~ 652 (892)
-+.+|.|+||.|+.+.+ +..+|+||++.+... ...-..-.|+++|..++ |+||++++.+|+++++++
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 36899999999999988 567899999876421 11123567999999997 999999999999999999
Q ss_pred EEEEec-cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccc
Q 002688 653 LIYEYM-ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731 (892)
Q Consensus 653 LV~Ey~-~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~ 731 (892)
|++|-. ++.+|.+++..+.+ +++.+...|+.|++.|+++||+. +|+|||||-+|+.++.+|-+||+|||.+...
T Consensus 646 l~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred EEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhh
Confidence 999965 45599999987654 99999999999999999999999 9999999999999999999999999998876
Q ss_pred cCCCCccccccccCCCCccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCC
Q 002688 732 PVEGGTHVSTTIAGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLEIITGHPVIS 784 (892)
Q Consensus 732 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SlGvvl~ELltG~~p~~ 784 (892)
... .....+||.+|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 721 ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 KSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 432 23457899999999999998875 56899999999999999988874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=241.13 Aligned_cols=268 Identities=23% Similarity=0.290 Sum_probs=208.0
Q ss_pred CccCHHHHHHHhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhcc------ccceeeEe
Q 002688 571 RQFTYSEVLRMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH------HRNLTTLV 642 (892)
Q Consensus 571 ~~~~~~el~~~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~------H~NIv~l~ 642 (892)
..+.+.|++...|.+....|+|-|++|.+|.. .+..||||++..... ..+.=++|+++|.+|. .-++++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 34667888888888888999999999999988 678999999976532 2355578999999995 35789999
Q ss_pred eEeecCCcEEEEEEeccCCchhhhccccC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC-CcE
Q 002688 643 GYCDEGTNMALIYEYMANGNLEEHLSDSS-KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK-FQA 720 (892)
Q Consensus 643 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~-~~v 720 (892)
..|.+.+++|||+|-+.. +|.+.|.+.+ ...|....+..++.|+.-||..|... +|+|.||||+|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 999999999999998865 8999998765 44588899999999999999999987 99999999999999975 568
Q ss_pred EEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHH--
Q 002688 721 KLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWV-- 798 (892)
Q Consensus 721 kl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~-- 798 (892)
||||||.|...... .-+...-+..|.|||++.+-.|+...|+||.||.||||.||+..|.+.... ++..+.
T Consensus 577 KLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN---~MLrl~me 649 (752)
T KOG0670|consen 577 KLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN---QMLRLFME 649 (752)
T ss_pred eeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH---HHHHHHHH
Confidence 99999998765322 122334466899999999999999999999999999999999999876542 222222
Q ss_pred ------HhHhhcCCCc-cccCCCC--------------------------------CC--CCC---HHHHHHHHHHHHHc
Q 002688 799 ------SSMLDKGDIR-STVDPRL--------------------------------KG--DFD---INSVWKAVEIAMAC 834 (892)
Q Consensus 799 ------~~~~~~~~~~-~~~D~~l--------------------------------~~--~~~---~~~~~~l~~l~~~C 834 (892)
..++..+.+. +.+|..+ .+ .++ ......+.+|...|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 2233333221 1122111 11 011 23455677999999
Q ss_pred cccCCCCCCCHHHHHH
Q 002688 835 VSSNANRRPFMNQVVM 850 (892)
Q Consensus 835 l~~~P~~RPsm~eVl~ 850 (892)
+..||+.|-+..|+++
T Consensus 730 l~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 730 LILDPEKRITVNQALK 745 (752)
T ss_pred hccChhhcCCHHHHhc
Confidence 9999999999999876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=228.98 Aligned_cols=130 Identities=27% Similarity=0.420 Sum_probs=110.5
Q ss_pred HhhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhcc-----c---cceeeEeeEeec---
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-----H---RNLTTLVGYCDE--- 647 (892)
Q Consensus 581 ~t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----H---~NIv~l~g~~~~--- 647 (892)
.+|-+.++||=|-|++||.+.. ..+-||+|+.+....- .+..+.||.+|++++ | ..||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5566678999999999999977 6678999998754222 245688999999883 2 469999999964
Q ss_pred -CCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEE
Q 002688 648 -GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI 714 (892)
Q Consensus 648 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl 714 (892)
+.++++|+|++ |-+|..+|....-+.++...+.+|++|++.||.|||.+| +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56899999998 458999998877677999999999999999999999998 99999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-24 Score=239.58 Aligned_cols=245 Identities=22% Similarity=0.377 Sum_probs=196.7
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCch
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL 663 (892)
...+|.|.+|.|||++. .++..|||+++-......+-..+|+-+++.-+|+||+.++|.+......++.||||.+|+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 46899999999999988 7888999999877666677788999999999999999999999999999999999999999
Q ss_pred hhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccc
Q 002688 664 EEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743 (892)
Q Consensus 664 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 743 (892)
++.-+... +++..+....+++.++||+|||+. +=+|||||-.|||+++.+.+|++|||.+..+.. .-......
T Consensus 100 Qdiy~~Tg--plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~Krksf 172 (829)
T KOG0576|consen 100 QDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKRKSF 172 (829)
T ss_pred cceeeecc--cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh--hhhhhhcc
Confidence 99876544 488899999999999999999998 889999999999999999999999998876521 11233467
Q ss_pred cCCCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCC-CCCCC
Q 002688 744 AGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR-LKGDF 819 (892)
Q Consensus 744 ~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~-l~~~~ 819 (892)
.||+.|||||+.. .+.|..++|||++|+...|+---++|...... .+ +..+.. ...++|. +..+
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr-~l~LmT----kS~~qpp~lkDk- 240 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MR-ALFLMT----KSGFQPPTLKDK- 240 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HH-HHHHhh----ccCCCCCcccCC-
Confidence 7999999999984 45799999999999999999888888653221 01 111111 1223322 2211
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
..-...+-++++.|+..+|++||+.+.+++
T Consensus 241 -~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 -TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 122334669999999999999999988765
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=206.10 Aligned_cols=168 Identities=24% Similarity=0.253 Sum_probs=126.6
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccc
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 740 (892)
|+|.++++... ..++|..+..++.|++.||+|||+. + ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence 68999997543 3599999999999999999999987 4 999999999999999 9998765321
Q ss_pred ccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCC
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~ 820 (892)
...|++.|||||++.+..++.++|||||||++|||++|+.||..... ............... ++.-. ...
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~---~~~~~-~~~ 132 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPAD---DPRDR-SNL 132 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhccC---Ccccc-ccH
Confidence 12588999999999999999999999999999999999999864322 111122211111100 01000 001
Q ss_pred HHHH--HHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 821 INSV--WKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 821 ~~~~--~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
.... ..+.+++.+|+..+|++||++.|+++.+....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 1111 25889999999999999999999999988754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-24 Score=262.57 Aligned_cols=196 Identities=16% Similarity=0.196 Sum_probs=139.5
Q ss_pred hccc-cceeeEeeEe-------ecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCcc
Q 002688 632 RVHH-RNLTTLVGYC-------DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703 (892)
Q Consensus 632 ~l~H-~NIv~l~g~~-------~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 703 (892)
.++| +||++++++| .+....++++|++ +++|.++|.... ..+++.+++.++.||++||+|||++ +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4556 6888888887 2234567788887 559999997543 4499999999999999999999998 999
Q ss_pred ccCCCCccEEEcC-------------------CCcEEEeeecCcccccCCCC--------------ccccccccCCCCcc
Q 002688 704 HRDVKSTNILINE-------------------KFQAKLADFGLSRVFPVEGG--------------THVSTTIAGTPGYL 750 (892)
Q Consensus 704 HrDLkp~NILl~~-------------------~~~vkl~DfGla~~~~~~~~--------------~~~~~~~~gt~~Y~ 750 (892)
||||||+||||+. ++.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999965 44556666666653211000 00011235788899
Q ss_pred CccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHH
Q 002688 751 DPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEI 830 (892)
Q Consensus 751 aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l 830 (892)
|||++.+..++.++|||||||+||||++|.+|+.... ..+..+... .+.+... .......++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~---------~~~~~~~-----~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR---------VLPPQIL-----LNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh---------hcChhhh-----hcCHHHHHH
Confidence 9999999999999999999999999999988765211 011111111 1111111 112345678
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 002688 831 AMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 831 ~~~Cl~~~P~~RPsm~eVl~ 850 (892)
+.+|++.+|.+||+|.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 88999999999999999976
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-23 Score=207.22 Aligned_cols=250 Identities=20% Similarity=0.371 Sum_probs=195.1
Q ss_pred hhhceecccccEEEEEEEECCcEEEEEEccCCC--chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCC
Q 002688 584 NFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~g 661 (892)
++..+|.....|+.|+|++.|..+++|++.... ....++|..|.-.|+.+.||||++++|.|....+..++..||+.|
T Consensus 193 nl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 344578888899999999999999999987553 233468999999999999999999999999999999999999999
Q ss_pred chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccc
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 741 (892)
+|...|++...-..+-.+..+++.++|+|++|||+. .+-|..--|.+..+++|++.+++|+= +-+ ..+....
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~------kfsfqe~ 344 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADT------KFSFQEV 344 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccc------eeeeecc
Confidence 999999998877788899999999999999999985 43444557999999999999988762 111 1122223
Q ss_pred cccCCCCccCccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCC
Q 002688 742 TIAGTPGYLDPEYYISNRL---TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 742 ~~~gt~~Y~aPE~~~~~~~---s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~ 818 (892)
...-.+.||+||.++.... -+.+|+|||.+++|||.|...||.....-+..- + +.-+.++-.+-|
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------k-ialeglrv~ipp----- 412 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------K-IALEGLRVHIPP----- 412 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------h-hhhccccccCCC-----
Confidence 3445688999999987653 357899999999999999999998654322110 1 111122222222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 819 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~ 856 (892)
.....+.+++.-|+.+||.+||.+..|+-.|++++
T Consensus 413 ---gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 ---GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 23345678999999999999999999999999863
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=216.90 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=190.3
Q ss_pred hceecccccEEEEEEEE-----CCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEecc
Q 002688 586 ERVLGKGGFGTVYHGKL-----DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~-----~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.++||.|.|++||++++ ....||+|.+...+.. .+...|+++|..+ .|.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 46899999999999977 3467999998776443 5688999999999 59999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC-CCcEEEeeecCcccccCCC---
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-KFQAKLADFGLSRVFPVEG--- 735 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-~~~vkl~DfGla~~~~~~~--- 735 (892)
.....++... ++..+...+++.+..||+++|.. |||||||||+|+|.+. .+.-.|.|||||.......
T Consensus 119 H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 119 HDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred ccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 9888888765 67888999999999999999999 9999999999999985 4678999999998321000
Q ss_pred ---------------------------------------CccccccccCCCCccCcccccc-CCCCchhhHHHHHHHHHH
Q 002688 736 ---------------------------------------GTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLE 775 (892)
Q Consensus 736 ---------------------------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~E 775 (892)
.........||+||.|||++.. ..-+.+.||||.|||++-
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 0001124579999999999975 456889999999999999
Q ss_pred HHhCCCCCCccccCCCccHHHHHHhH---------hhcCC--Ccc---------------ccC-CCCCC--C--CC----
Q 002688 776 IITGHPVISKSAENGHTHVAQWVSSM---------LDKGD--IRS---------------TVD-PRLKG--D--FD---- 820 (892)
Q Consensus 776 LltG~~p~~~~~~~~~~~l~~~~~~~---------~~~~~--~~~---------------~~D-~~l~~--~--~~---- 820 (892)
+++++.||-....+- ..+.+.+... ...|. +.+ .++ ..+.. . ..
T Consensus 271 lls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 999999997665322 2222221100 00111 110 010 00000 0 00
Q ss_pred -HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 821 -INSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 821 -~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
......++++..+|++.+|.+|-+++++++
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011225789999999999999999999987
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.2e-21 Score=210.78 Aligned_cols=161 Identities=19% Similarity=0.155 Sum_probs=125.1
Q ss_pred hhhhceecccccEEEEEEEE---CCcEEEEEEccCC-----CchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEE
Q 002688 583 NNFERVLGKGGFGTVYHGKL---DNDEVAVKMLSPS-----SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~---~~~~vAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV 654 (892)
+.+.+.||+|+||+||+|.. +++.||||++... .....+.|.+|+++|++++|+|+++.+.. .+..++|
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence 45568999999999999987 4667899987533 12235668999999999999999864332 2457999
Q ss_pred EEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCC-CCccEEEcCCCcEEEeeecCcccccC
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDV-KSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL-kp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
|||+++++|... ... . ...++.+++++|+|||+. +|+|||| ||+|||++.++.+||+|||+++.+..
T Consensus 97 mE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 97 RGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 999999999632 111 1 146788999999999998 9999999 99999999999999999999998754
Q ss_pred CCCccc------cccccCCCCccCccccccC
Q 002688 734 EGGTHV------STTIAGTPGYLDPEYYISN 758 (892)
Q Consensus 734 ~~~~~~------~~~~~gt~~Y~aPE~~~~~ 758 (892)
...... .+...+++.|+|||++...
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 332111 1356688899999998644
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-19 Score=200.08 Aligned_cols=262 Identities=20% Similarity=0.250 Sum_probs=192.5
Q ss_pred hhhhhceecccccEEEEEEEECC---cEEEEEEccCCCchhhHHHHHHHHHHHhccc----cceeeEeeEe-ecCCcEEE
Q 002688 582 TNNFERVLGKGGFGTVYHGKLDN---DEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH----RNLTTLVGYC-DEGTNMAL 653 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~~~---~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H----~NIv~l~g~~-~~~~~~~L 653 (892)
.+.+.+.||+|+||.||++.... ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 34566899999999999998733 3688888765433322367888898888873 5778888877 46778899
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC-----CcEEEeeecCc
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK-----FQAKLADFGLS 728 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~-----~~vkl~DfGla 728 (892)
||+.+ +.+|.++......+.++-.+.+.|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99976 66999987655556699999999999999999999998 99999999999999864 46999999999
Q ss_pred c--cccCCCCc---cc---cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHh
Q 002688 729 R--VFPVEGGT---HV---STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSS 800 (892)
Q Consensus 729 ~--~~~~~~~~---~~---~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~ 800 (892)
+ .+...... .. .....||..|++++...+...+.+.|+||++.++.|++.|..||........ ..+ +..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~-~~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSK-FEK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHH-HHH
Confidence 9 43222211 11 2345699999999999999999999999999999999999999865432111 111 111
Q ss_pred HhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 002688 801 MLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAME 859 (892)
Q Consensus 801 ~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e 859 (892)
..... .... ........+.++...+-..+..++|....+...|+++...+
T Consensus 252 ~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 DPRKL----LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred Hhhhh----cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111 1111 11112233445555666689999999999999988875544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5e-19 Score=192.64 Aligned_cols=259 Identities=27% Similarity=0.451 Sum_probs=196.4
Q ss_pred hhceecccccEEEEEEEECCcEEEEEEccCCCch---hhHHHHHHHHHHHhcccc-ceeeEeeEeecCCcEEEEEEeccC
Q 002688 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQ---GYKQFQAEVKLLLRVHHR-NLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~-NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.||.|+||.||++... ..+++|.+...... ....+.+|+..+..+.|+ +++++...+......+++++++.+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred eEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 4568999999999999887 88899998765332 367899999999999988 799999999777778999999999
Q ss_pred CchhhhccccCc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC-cEEEeeecCcccccCCCCcc
Q 002688 661 GNLEEHLSDSSK-EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF-QAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 661 gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~-~vkl~DfGla~~~~~~~~~~ 738 (892)
+++.+++..... ..+.......+..|++.+++|+|+. +++|||+||+||+++... .++++|||.++.+.......
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 999976665432 2488899999999999999999998 899999999999999988 79999999998654333221
Q ss_pred ----ccccccCCCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCcccc
Q 002688 739 ----VSTTIAGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811 (892)
Q Consensus 739 ----~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 811 (892)
......|+..|+|||.+.+ .......|+||+|++++++++|+.|+...... .........+...... ..
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SL 235 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-cc
Confidence 3456789999999999987 57889999999999999999999996543321 0011111111111111 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 812 D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
...............+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0011100001223456789999999999999999988775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-20 Score=219.16 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=186.5
Q ss_pred hhceecccccEEEEEEEE--CCcEEEEEEcc----CCC-ch-hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEE
Q 002688 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLS----PSS-SQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~----~~~-~~-~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~E 656 (892)
..+++|.|++|.|+.... .....+.|... ... .. ....+..|+.+-..++|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 346899999997776654 33334444332 111 11 11225667778888999999888877777666666699
Q ss_pred eccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCC
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~ 736 (892)
|+++ +|..++.... .+...++-.++.|+..|++|||+. +|.|||+|++|++++.++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 9999987753 378888999999999999999999 999999999999999999999999999988754444
Q ss_pred c--cccccccCCCCccCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCC
Q 002688 737 T--HVSTTIAGTPGYLDPEYYISNRLTEK-SDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 737 ~--~~~~~~~gt~~Y~aPE~~~~~~~s~k-sDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~ 813 (892)
. +.....+|+..|+|||.+.+..|++. .||||.|+++..|++|+.||......+... ......++......+
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEGP 550 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccCh
Confidence 3 66778899999999999999999875 799999999999999999997655433221 000111111100000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.............++.++++.+|.+|-+|++|++
T Consensus 551 ---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 ---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0011223344568899999999999999999986
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.9e-19 Score=197.85 Aligned_cols=218 Identities=25% Similarity=0.377 Sum_probs=166.6
Q ss_pred HHhccccceeeEeeEeecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCc-cccCCC
Q 002688 630 LLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI-VHRDVK 708 (892)
Q Consensus 630 l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-iHrDLk 708 (892)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.... ..++|.....+.++++.||+|||.. +| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 456899999999999999999999999999999999998743 4499999999999999999999986 44 999999
Q ss_pred CccEEEcCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCC-------CCchhhHHHHHHHHHHHHhCCC
Q 002688 709 STNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR-------LTEKSDVYSFGVVLLEIITGHP 781 (892)
Q Consensus 709 p~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------~s~ksDV~SlGvvl~ELltG~~ 781 (892)
++|+++|..+.+||+|||+....................-|.|||.+.... .+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988764211111111222445799999987631 4678999999999999999999
Q ss_pred CCCccccCCC-ccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 002688 782 VISKSAENGH-THVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 782 p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~ 858 (892)
||+....... ..+..++.+ .-...+-|.+.... +....++.++..||..+|++||++++|-..++.+...
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9986543222 223333322 11122223332111 2333688999999999999999999999999876543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.8e-19 Score=181.52 Aligned_cols=173 Identities=15% Similarity=0.191 Sum_probs=133.0
Q ss_pred HHHHHhhhhhceecccccEEEEEEEECCcEEEEEEccCCCchhhH---H------HHHHHHHHHhccccceeeEeeEeec
Q 002688 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYK---Q------FQAEVKLLLRVHHRNLTTLVGYCDE 647 (892)
Q Consensus 577 el~~~t~~f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~---~------f~~Ei~~l~~l~H~NIv~l~g~~~~ 647 (892)
+++.-.+...+++|.|+||.||....++..+|||.+........+ . +.+|++.+.++.|++|..+..++..
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 345555666789999999999997777889999999765332222 2 6899999999999999998887543
Q ss_pred C--------CcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCc
Q 002688 648 G--------TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQ 719 (892)
Q Consensus 648 ~--------~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~ 719 (892)
. ...++||||++|.+|.++.. ++. ....+++.+|..+|+. +++|||+||+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 2 35889999999999988732 222 2456899999999999 999999999999999988
Q ss_pred EEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHH
Q 002688 720 AKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEII 777 (892)
Q Consensus 720 vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELl 777 (892)
++|+|||........... ..+.....+..++|+||||+.+....
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987654211100 11334455778999999999887654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.7e-17 Score=194.53 Aligned_cols=150 Identities=14% Similarity=0.117 Sum_probs=101.2
Q ss_pred EeccCCCCC---CCcccCCC--ceEeecCccccccC-----Cccccchh-hccc--cccccccccccCCC-Ccceeeeee
Q 002688 31 SLDCGLPKD---SSYTETST--KLRYTSDANYIETG-----LPKSILLQ-YRRM--KQQQVWSLRSFPDG-IRNCYRFNL 96 (892)
Q Consensus 31 ~idCG~~~~---~~~~~~~~--~~~~~~D~~~~~~g-----~~~~i~~~-~~~~--~~~~~~tlR~Fp~~-~~nCY~l~~ 96 (892)
-||||+... ..|.||.- .+.|.+|..|.... .+..|... ..+. +...|+|.|.+-++ ..-.|.+++
T Consensus 195 R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~v 274 (623)
T PLN03150 195 RLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTMDV 274 (623)
T ss_pred EEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEeec
Confidence 599997532 33555554 79999998876321 11222210 1111 22358999998864 356899999
Q ss_pred cCCceeEEeEEeeecCCCC-CCCCCceeEEeCCceee-eeeecC----CccceEEEEEEEeccCceeEEEEecCCCCcce
Q 002688 97 TRNTKYLIRATFMYGNYDE-QNNLPEFDVHLGPNLWG-TIKIEN----VSVDYSVEIIHVLSSDYLSVCIVNTNKGTPFI 170 (892)
Q Consensus 97 ~~~~~ylvR~~f~ygnyd~-~~~~p~Fd~~~~~~~w~-~v~~~~----~~~~~~~e~i~~~~~~~~~vcl~~~~~~~pfi 170 (892)
.++++|+||++|.--.... ....-+||++++|..+. .+++.. ....++.+..+.+.++.+.|.|+++....|||
T Consensus 275 ~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~s~pil 354 (623)
T PLN03150 275 DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTHAII 354 (623)
T ss_pred CCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeCCCCccee
Confidence 9999999999996554322 22445799999998753 333321 23345667777777788999999876556999
Q ss_pred eeeeeeecCC
Q 002688 171 SALELRPLDN 180 (892)
Q Consensus 171 s~lE~~~l~~ 180 (892)
||||+..+-.
T Consensus 355 NaiEI~~~~~ 364 (623)
T PLN03150 355 NAIEVFEIIT 364 (623)
T ss_pred eeeeeeeccc
Confidence 9999998775
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=175.10 Aligned_cols=137 Identities=16% Similarity=0.180 Sum_probs=106.0
Q ss_pred ceecccccEEEEEEEE-CCcEEEEEEccCCCch--h-------hHH-----------------HHHHHHHHHhcccccee
Q 002688 587 RVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQ--G-------YKQ-----------------FQAEVKLLLRVHHRNLT 639 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~--~-------~~~-----------------f~~Ei~~l~~l~H~NIv 639 (892)
..||+|+||.||+|.. +|+.||||+++..... . ..+ ...|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 5799999999999988 7899999998754211 0 112 23499999999887764
Q ss_pred eEeeEeecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHH-HhCCCCCccccCCCCccEEEcCCC
Q 002688 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKF 718 (892)
Q Consensus 640 ~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDLkp~NILl~~~~ 718 (892)
....+.. ...++||||++++++...+... ..++......++.|++.+|+++ |+. +|+||||||+|||++ ++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence 3332222 2238999999998776543222 2488999999999999999999 677 999999999999998 47
Q ss_pred cEEEeeecCcccc
Q 002688 719 QAKLADFGLSRVF 731 (892)
Q Consensus 719 ~vkl~DfGla~~~ 731 (892)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-19 Score=211.53 Aligned_cols=244 Identities=21% Similarity=0.255 Sum_probs=179.1
Q ss_pred hhhceecccccEEEEEEEECCcEEEEEEccCCC-chhhHHHHHHHHH--HHhccccceeeEeeEeecCCcEEEEEEeccC
Q 002688 584 NFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSS-SQGYKQFQAEVKL--LLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~--l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
.+.+.||.+.|=+|.+|+.+...|+||++-+.. .-..+.|.++++- ...++|||.+++..+-......+||-+|+.+
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred eeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 456789999999999999988889999986654 2334444444433 4556899999998877777777888888866
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc--CC---C
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP--VE---G 735 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~--~~---~ 735 (892)
+|.|.|.-+ ..+...+..-|+.|++.||.-+|.. +|+|+|||.+||||+.-.-+.|+||..-+... .+ +
T Consensus 106 -nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 106 -NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred -hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 899988754 3477888899999999999999998 99999999999999999999999998665431 11 1
Q ss_pred CccccccccCCCCccCccccccC-----------CCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHh--H
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISN-----------RLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSS--M 801 (892)
Q Consensus 736 ~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~--~ 801 (892)
......+...-.+|+|||.+... ..+++-||||+||++.||++ |+++|.-+. +..+-.. .
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr~~~~~ 253 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYRSGNAD 253 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHhccCcc
Confidence 22222233444589999998541 16788999999999999988 688886321 1111000 0
Q ss_pred hhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002688 802 LDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 802 ~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~ 851 (892)
..+.-+.++-|+ .+.+++..|++.+|+.|-++++.++.
T Consensus 254 ~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 000011222233 24589999999999999999999997
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.9e-17 Score=172.83 Aligned_cols=263 Identities=17% Similarity=0.275 Sum_probs=192.5
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEec
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.++||+|.||.++.|+. +++.||||.-...+.. .++..|....+.|. .+.|...+-+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 345668999999999999976 9999999986554332 46777888888774 678877776667777889999988
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC-----CcEEEeeecCcccccC
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK-----FQAKLADFGLSRVFPV 733 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~-----~~vkl~DfGla~~~~~ 733 (892)
+-||.|+..-..+ .++..+..-+|.|+..-++|+|++ .+|.|||||+|+||... ..+.|+|||+|+.+.+
T Consensus 107 -GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 5599998876654 399999999999999999999999 99999999999999643 3589999999998843
Q ss_pred CCC-----ccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCc
Q 002688 734 EGG-----THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR 808 (892)
Q Consensus 734 ~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 808 (892)
... ........||.+||+-....+.+-+.+.|+=|||-++.+.+-|..||.+...... .+-.+++-...+.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn---K~kYeKIGe~Kr~- 257 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN---KEKYEKIGETKRS- 257 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch---HHHHHHhcccccc-
Confidence 321 1223466799999999999999999999999999999999999999987653221 1111111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhh
Q 002688 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEA 860 (892)
Q Consensus 809 ~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~e~ 860 (892)
..++ .|...+ .++....+..++ ..+-.+-|...-+...+.+++....
T Consensus 258 T~i~-~Lc~g~-P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 258 TPIE-VLCEGF-PEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred CCHH-HHHhcC-HHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcC
Confidence 1111 112222 234444444444 3456677888877777777765443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=167.66 Aligned_cols=188 Identities=17% Similarity=0.136 Sum_probs=143.0
Q ss_pred hceecccccEEEEEEEECCcEEEEEEccCCCch----hhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEeccC
Q 002688 586 ERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQ----GYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~----~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~~ 660 (892)
...|++|+||+||.+..++.+++.+.+...... ....+.+|+++|++++ |+++.+++++ ...+++|||+.+
T Consensus 7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred ceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 358999999999988778889988888765331 1225789999999995 5788888886 346999999999
Q ss_pred CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCC-CCccEEEcCCCcEEEeeecCcccccCCCCc--
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDV-KSTNILINEKFQAKLADFGLSRVFPVEGGT-- 737 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL-kp~NILl~~~~~vkl~DfGla~~~~~~~~~-- 737 (892)
.+|.+.+.. ....++.|++++|+++|+. +|+|||| ||.|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 83 AAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred ccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 988754321 1135778999999999999 9999999 799999999999999999999865432210
Q ss_pred -cc--------cccccCCCCccCccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCccccC
Q 002688 738 -HV--------STTIAGTPGYLDPEYYISN-RLT-EKSDVYSFGVVLLEIITGHPVISKSAEN 789 (892)
Q Consensus 738 -~~--------~~~~~gt~~Y~aPE~~~~~-~~s-~ksDV~SlGvvl~ELltG~~p~~~~~~~ 789 (892)
.. .-....++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.....++
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 00 1123367788888865422 233 5679999999999999999887755543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.5e-18 Score=169.73 Aligned_cols=200 Identities=23% Similarity=0.342 Sum_probs=163.5
Q ss_pred hhhhhceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccc-cceeeEeeEeecCCcEEEEEEec
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH-RNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 582 t~~f~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
.+.+.+.||.|+||.+|.|.. +|.+||||.-+..... .++..|..+...++| ..|..+..+..+..+-.+|||.+
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 345668999999999999987 8999999997654332 467788888888875 45666667777888889999988
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC---CcEEEeeecCcccccCCC
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK---FQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~---~~vkl~DfGla~~~~~~~ 735 (892)
+-+|.+++.-..+ .++..+.+-.+-|++.-++|+|.+ ++|||||||+|+|..-+ ..+.++|||||+.+.+..
T Consensus 94 -GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 94 -GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred -CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 5699998865543 388899999999999999999999 99999999999999643 468999999999874322
Q ss_pred -Cc----cccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Q 002688 736 -GT----HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAE 788 (892)
Q Consensus 736 -~~----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~ 788 (892)
.. .......||.+|.+-....+..-+.+.|+=|+|.+|..+--|..||.+-..
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 11 123456799999999888888889999999999999999999999986553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=168.82 Aligned_cols=138 Identities=21% Similarity=0.250 Sum_probs=108.9
Q ss_pred hceecccccEEEEEEEE-CCcEEEEEEccCCCchh--------------------------hHHHHHHHHHHHhccccce
Q 002688 586 ERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQG--------------------------YKQFQAEVKLLLRVHHRNL 638 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~--------------------------~~~f~~Ei~~l~~l~H~NI 638 (892)
.+.||+|++|.||+|+. +|+.||||++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999988 69999999987642110 1123578999999999987
Q ss_pred eeEeeEeecCCcEEEEEEeccCCchhhh-ccccCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCccccCCCCccEEEcC
Q 002688 639 TTLVGYCDEGTNMALIYEYMANGNLEEH-LSDSSKEILNWEERLRIAVEAALGLEYLHQ-GCKPPIVHRDVKSTNILINE 716 (892)
Q Consensus 639 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~-L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLkp~NILl~~ 716 (892)
.....+... ..++||||++++++... +.. ..++......++.+++.++.++|+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 544433332 24899999998865443 332 237788899999999999999999 7 999999999999999
Q ss_pred CCcEEEeeecCccccc
Q 002688 717 KFQAKLADFGLSRVFP 732 (892)
Q Consensus 717 ~~~vkl~DfGla~~~~ 732 (892)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=194.44 Aligned_cols=251 Identities=18% Similarity=0.239 Sum_probs=179.8
Q ss_pred HHHHhhhhhceecccccEEEEEEEE-CCcEEEEEEccCCCchhhHHHHHHHHHHHhcc---ccceeeEeeEeecCCcEEE
Q 002688 578 VLRMTNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH---HRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 578 l~~~t~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~NIv~l~g~~~~~~~~~L 653 (892)
+....+.+.+.||+|++|+||+|.. +++.||+|+-++.+... |.--.+++.+|+ -+.|..+...+.-.+..+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3334445678899999999999988 78899999988776542 222223344444 1223333333444566789
Q ss_pred EEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEc-------CCCcEEEeeec
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN-------EKFQAKLADFG 726 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~-------~~~~vkl~DfG 726 (892)
|+||.+.|+|.+++.. .+.++|...+.++.|+++.+++||.. +|||+||||+|+||. +...++|+|||
T Consensus 772 v~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999984 44599999999999999999999998 999999999999994 23469999999
Q ss_pred CcccccCCCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCC
Q 002688 727 LSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD 806 (892)
Q Consensus 727 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 806 (892)
.+..+..-.........++|-.+-.+|+..+..++...|.|.+.-+++-|+.|+. ++ ...|.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y----------------~q--~~~g~ 908 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY----------------ME--VKNGS 908 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH----------------HH--hcCCc
Confidence 9987754333344556788999999999999999999999999999999999972 11 11111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 002688 807 IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 807 ~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~~~~ 858 (892)
...++..+..... .++|. ++...+|..+-..=|...++...|++.+..
T Consensus 909 -~~~~~~~~~Ry~~-~~~W~--~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 909 -SWMVKTNFPRYWK-RDMWN--KFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred -ceeccccchhhhh-HHHHH--HHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 1122332222222 23332 444455555545557888888888887653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=168.81 Aligned_cols=227 Identities=21% Similarity=0.271 Sum_probs=146.5
Q ss_pred hceecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccc-----------cceeeEeeE-----
Q 002688 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHH-----------RNLTTLVGY----- 644 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H-----------~NIv~l~g~----- 644 (892)
.+.||.|+++.||.++. +++++|||.+.... ....+++.+|.-....+.+ +-++++--.
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 46899999999999999 57999999975443 2345667777655555322 222222111
Q ss_pred ---eecCC--------cEEEEEEeccCCchhhhccc---cC--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCC
Q 002688 645 ---CDEGT--------NMALIYEYMANGNLEEHLSD---SS--KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVK 708 (892)
Q Consensus 645 ---~~~~~--------~~~LV~Ey~~~gsL~~~L~~---~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk 708 (892)
..... ..+++|+-+ .++|.+++.. .. ...+....++.+..|+.+.+++||.. +++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 11111 246777777 4588887642 11 22355667788889999999999999 99999999
Q ss_pred CccEEEcCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccC--------CCCchhhHHHHHHHHHHHHhCC
Q 002688 709 STNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN--------RLTEKSDVYSFGVVLLEIITGH 780 (892)
Q Consensus 709 p~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~s~ksDV~SlGvvl~ELltG~ 780 (892)
|+|++++++|.++|+||+...... .. ... ...+..|.+||..... .++.+.|.|++|+++|.|.+|+
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g---~~-~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAG---TR-YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETT---EE-EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecC---ce-eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999998766432 11 111 3345789999987442 4788999999999999999999
Q ss_pred CCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 002688 781 PVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRR 842 (892)
Q Consensus 781 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 842 (892)
.||........... .+ ..+. +....+..|+..+++.+|++|
T Consensus 248 lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99986543221110 11 1223 556677899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-16 Score=162.55 Aligned_cols=133 Identities=18% Similarity=0.234 Sum_probs=104.9
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhc-----cccceeeEeeEeecCC---c-EEEEEEe
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-----HHRNLTTLVGYCDEGT---N-MALIYEY 657 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-----~H~NIv~l~g~~~~~~---~-~~LV~Ey 657 (892)
+.||+|+||.||....+.. .+||++........+++.+|+.+++.+ .||||++++|++..+. . ..+|+||
T Consensus 8 ~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~ 86 (210)
T PRK10345 8 SPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADF 86 (210)
T ss_pred ceecCCCceEEEECCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecC
Confidence 5899999999996332444 479988765445567899999999999 5799999999998763 3 3378999
Q ss_pred --ccCCchhhhccccCcccCCHHHHHHHHHHHHHHH-HHHHhCCCCCccccCCCCccEEEcC----CCcEEEeeecCc
Q 002688 658 --MANGNLEEHLSDSSKEILNWEERLRIAVEAALGL-EYLHQGCKPPIVHRDVKSTNILINE----KFQAKLADFGLS 728 (892)
Q Consensus 658 --~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiHrDLkp~NILl~~----~~~vkl~DfGla 728 (892)
+.+|+|.+++.+.. ++.. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+|++.+
T Consensus 87 ~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 87 DGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 55899999996532 5544 35677888777 999999 9999999999999974 347999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.2e-16 Score=160.84 Aligned_cols=134 Identities=19% Similarity=0.378 Sum_probs=114.7
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCCch--------hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQ--------GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~--------~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
+.||+|++|.||+|..++..++||+....... ...++.+|++++..++|+++.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 47899999999999999999999986643211 1245788999999999999887777777777889999999
Q ss_pred cCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
++++|.+++.... + .+..++.+++.+|.++|+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999886432 2 8889999999999999998 999999999999999 78999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=157.82 Aligned_cols=130 Identities=25% Similarity=0.398 Sum_probs=108.1
Q ss_pred eecccccEEEEEEEECCcEEEEEEccCCCc---h-----hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 588 VLGKGGFGTVYHGKLDNDEVAVKMLSPSSS---Q-----GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~---~-----~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.||+|+||.||+|.+++..+++|....... . ..+++.+|++++..++|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 489999999999999999999998654321 1 12567789999999999876655555556667789999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
+++|.+.+..... .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988754321 7899999999999998 999999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.9e-17 Score=182.64 Aligned_cols=224 Identities=26% Similarity=0.297 Sum_probs=171.5
Q ss_pred eecccccEEEEEEE-----ECCcEEEEEEccCCCchh--hHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEecc
Q 002688 588 VLGKGGFGTVYHGK-----LDNDEVAVKMLSPSSSQG--YKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~-----~~~~~vAVK~l~~~~~~~--~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
++|+|.||.|+..+ ..+.-+|.|.+++..... ......|..++...+ |+.+|++--.+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999998542 255668888876653221 123456778888887 9999999999999999999999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 739 (892)
+|.|...+.+... ++......+...++-+++++|+. +++|||+|++||+++.+|.+|+.|||+++..-...
T Consensus 81 gg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 9999988876543 66667777888899999999998 99999999999999999999999999998753221
Q ss_pred cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCC
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~ 819 (892)
..+||..|||||+.. .....+|.||||++++||+||..||.. +-...+.... + ..
T Consensus 152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~~---------~--~~ 206 (612)
T KOG0603|consen 152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKAE---------L--EM 206 (612)
T ss_pred --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhhc---------c--CC
Confidence 128999999999987 567889999999999999999999974 1111111110 0 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFM 845 (892)
Q Consensus 820 ~~~~~~~l~~l~~~Cl~~~P~~RPsm 845 (892)
+.+....+.+++..++..+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 22233344577778888888888755
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.1e-15 Score=158.39 Aligned_cols=139 Identities=18% Similarity=0.226 Sum_probs=107.5
Q ss_pred hhhhceecccccEEEEEEE-E--CCcEEEEEEccCCCch------------------------hhHHHHHHHHHHHhccc
Q 002688 583 NNFERVLGKGGFGTVYHGK-L--DNDEVAVKMLSPSSSQ------------------------GYKQFQAEVKLLLRVHH 635 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~-~--~~~~vAVK~l~~~~~~------------------------~~~~f~~Ei~~l~~l~H 635 (892)
+.+.+.||+|+||.||+|. . +++.||||.+...... ....+..|++.+.++.|
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3456799999999999998 3 7899999998754210 11235689999999976
Q ss_pred cc--eeeEeeEeecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCC-ccccCCCCccE
Q 002688 636 RN--LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP-IVHRDVKSTNI 712 (892)
Q Consensus 636 ~N--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiHrDLkp~NI 712 (892)
.. +.+.+++ ...++||||+++++|........ .+.......++.|++.++++||+. + ++||||||+||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 43 3334432 23479999999988877653322 255566788999999999999998 8 99999999999
Q ss_pred EEcCCCcEEEeeecCcccc
Q 002688 713 LINEKFQAKLADFGLSRVF 731 (892)
Q Consensus 713 Ll~~~~~vkl~DfGla~~~ 731 (892)
+++ ++.++|+|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999988754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.3e-15 Score=177.24 Aligned_cols=131 Identities=22% Similarity=0.373 Sum_probs=110.5
Q ss_pred hceecccccEEEEEEEECCcEEEEEEccCCC--c------hhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEe
Q 002688 586 ERVLGKGGFGTVYHGKLDNDEVAVKMLSPSS--S------QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~--~------~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.+.||+|+||.||+|.+.+..+++|+..... . ...+++.+|++++..++|++++....++......++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 5789999999999999977776666532221 1 1235688999999999999998888888777778999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
+++++|.+++. .+..++.+++++|.+||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 418 ~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999998875 3567899999999999998 99999999999999 677999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.8e-15 Score=150.92 Aligned_cols=134 Identities=18% Similarity=0.191 Sum_probs=106.1
Q ss_pred hhhhceecccccEEEEEEEE-CCcEEEEEEccCCCch----------------------hhHHHHHHHHHHHhccccc--
Q 002688 583 NNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQ----------------------GYKQFQAEVKLLLRVHHRN-- 637 (892)
Q Consensus 583 ~~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~----------------------~~~~f~~Ei~~l~~l~H~N-- 637 (892)
+.+.+.||+|+||.||++.. +++.||||++...... ....+..|+..+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 45568899999999999988 7899999987543210 1123577889999998874
Q ss_pred eeeEeeEeecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC
Q 002688 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK 717 (892)
Q Consensus 638 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~ 717 (892)
+...++. ...++||||+++++|...... .....++.+++.++.++|+. +++||||||+||+++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 4444432 345899999999998776431 23457888999999999998 99999999999999999
Q ss_pred CcEEEeeecCcccc
Q 002688 718 FQAKLADFGLSRVF 731 (892)
Q Consensus 718 ~~vkl~DfGla~~~ 731 (892)
+.++|+|||++...
T Consensus 162 ~~~~liDfg~~~~~ 175 (198)
T cd05144 162 EKIYIIDWPQMVST 175 (198)
T ss_pred CcEEEEECCccccC
Confidence 99999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.8e-15 Score=156.92 Aligned_cols=198 Identities=21% Similarity=0.238 Sum_probs=137.8
Q ss_pred cccceeeEeeEeec---------------------------CCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHH
Q 002688 634 HHRNLTTLVGYCDE---------------------------GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVE 686 (892)
Q Consensus 634 ~H~NIv~l~g~~~~---------------------------~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ 686 (892)
+|||||++.++|.+ +..+++||.-.+. +|.+++..+. .+...+.-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 69999998876633 2346788876654 8888887654 566777788999
Q ss_pred HHHHHHHHHhCCCCCccccCCCCccEEEc--CC--CcEEEeeecCcccccCCC----CccccccccCCCCccCccccccC
Q 002688 687 AALGLEYLHQGCKPPIVHRDVKSTNILIN--EK--FQAKLADFGLSRVFPVEG----GTHVSTTIAGTPGYLDPEYYISN 758 (892)
Q Consensus 687 ia~gL~yLH~~~~~~iiHrDLkp~NILl~--~~--~~vkl~DfGla~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~ 758 (892)
+++|+.|||++ +|.|||+|++|||+. +| -.+.|+|||++-.-...+ ...-.....|...-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 999999999999993 33 357899999875422211 11111234577789999998532
Q ss_pred C------CCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHH
Q 002688 759 R------LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAM 832 (892)
Q Consensus 759 ~------~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~ 832 (892)
. --.|+|.|+.|-+.||++....||....+ ..-+...+. +.++ |.+. ..+...+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Yq-----e~qL-----Palp----~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTYQ-----ESQL-----PALP----SRVPPVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhhh-----hhhC-----CCCc----ccCChHHHHHHH
Confidence 1 23689999999999999999999975322 111111111 1111 2222 233445678999
Q ss_pred HccccCCCCCCCHHHHHHHHH
Q 002688 833 ACVSSNANRRPFMNQVVMELN 853 (892)
Q Consensus 833 ~Cl~~~P~~RPsm~eVl~~L~ 853 (892)
..++.+|.+|++..-....|+
T Consensus 492 ~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHhcCCccccCCccHHHhHHH
Confidence 999999999999877666555
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.9e-16 Score=171.05 Aligned_cols=172 Identities=24% Similarity=0.359 Sum_probs=129.5
Q ss_pred CcEEEEEEeccCCchhhhccccC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecC
Q 002688 649 TNMALIYEYMANGNLEEHLSDSS-KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGL 727 (892)
Q Consensus 649 ~~~~LV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGl 727 (892)
.+.++.|++|...+|.+||.... ....+|...+.++.|++.|++| + +.+|||+||.||+...+.++||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 35789999999999999997443 5568899999999999999999 4 899999999999999999999999999
Q ss_pred cccccCCC----CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHh
Q 002688 728 SRVFPVEG----GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSML 802 (892)
Q Consensus 728 a~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~ 802 (892)
........ .....+...||..||+||++.+..|+.|+||||||++|+|++. -..+++.. -...-+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhh
Confidence 88764333 1223456789999999999999999999999999999999998 22222110 011112
Q ss_pred hcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002688 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFM 845 (892)
Q Consensus 803 ~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm 845 (892)
+.+.+ +|....+++ .-..+.++++...|.+||+.
T Consensus 473 r~g~i----p~~~~~d~p-----~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 473 RDGII----PPEFLQDYP-----EEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hcCCC----ChHHhhcCc-----HHHHHHHHhcCCCcccCchH
Confidence 22222 222221221 12378889999999999943
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.3e-14 Score=136.16 Aligned_cols=133 Identities=20% Similarity=0.214 Sum_probs=115.5
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhccc--cceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH--RNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
+.||+|.++.||+++.++..++||....... ...+.+|+..+..++| ..+.+++++....+..++++||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 5799999999999999889999999876543 4678999999999987 48889998888878899999999987776
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
.+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 82 ~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 54 4567788899999999999986545799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.1e-13 Score=143.39 Aligned_cols=134 Identities=19% Similarity=0.212 Sum_probs=106.4
Q ss_pred ceec-ccccEEEEEEEECCcEEEEEEccCCC-------------chhhHHHHHHHHHHHhccccce--eeEeeEeecCC-
Q 002688 587 RVLG-KGGFGTVYHGKLDNDEVAVKMLSPSS-------------SQGYKQFQAEVKLLLRVHHRNL--TTLVGYCDEGT- 649 (892)
Q Consensus 587 ~~IG-~G~fG~Vy~~~~~~~~vAVK~l~~~~-------------~~~~~~f~~Ei~~l~~l~H~NI--v~l~g~~~~~~- 649 (892)
.+|| .||.|+||++...+..++||.+.... ......+.+|++++.+++|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4788 89999999999999999999885421 1223567889999999999885 66776654322
Q ss_pred ---cEEEEEEeccC-CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeee
Q 002688 650 ---NMALIYEYMAN-GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADF 725 (892)
Q Consensus 650 ---~~~LV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~Df 725 (892)
..++|+|++++ .+|.+++... .++.. .+.+++.+|.+||+. +|+||||||.|||++.++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 6898887643 24433 356899999999999 9999999999999999899999999
Q ss_pred cCccc
Q 002688 726 GLSRV 730 (892)
Q Consensus 726 Gla~~ 730 (892)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-13 Score=138.83 Aligned_cols=134 Identities=20% Similarity=0.266 Sum_probs=96.3
Q ss_pred hceecccccEEEEEEEE-CCcEEEEEEccCCCch--hhHH----------------------HHHHHHHHHhccccc--e
Q 002688 586 ERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQ--GYKQ----------------------FQAEVKLLLRVHHRN--L 638 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~--~~~~----------------------f~~Ei~~l~~l~H~N--I 638 (892)
.+.||+|+||.||+|.. +++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999988 5899999998754221 1111 134556666665443 3
Q ss_pred eeEeeEeecCCcEEEEEEeccCCchhh-hccccCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCCccccCCCCccEEEcC
Q 002688 639 TTLVGYCDEGTNMALIYEYMANGNLEE-HLSDSSKEILNWEERLRIAVEAALGLEYLHQ-GCKPPIVHRDVKSTNILINE 716 (892)
Q Consensus 639 v~l~g~~~~~~~~~LV~Ey~~~gsL~~-~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLkp~NILl~~ 716 (892)
.+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++|. . +++|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 333332 24589999999965432 122111 11 5677899999999999998 6 999999999999999
Q ss_pred CCcEEEeeecCcccc
Q 002688 717 KFQAKLADFGLSRVF 731 (892)
Q Consensus 717 ~~~vkl~DfGla~~~ 731 (892)
++.++++|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3e-14 Score=168.51 Aligned_cols=203 Identities=23% Similarity=0.356 Sum_probs=137.2
Q ss_pred ceecccccEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
+.|..|++|.||..++ ..+.+|.|+ .+... +.+- ++.....|.+| |+-.
T Consensus 89 klisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee---------------------chhh
Confidence 6789999999999977 366777743 22211 0100 22222233222 5555
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCC---------
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG--------- 735 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~--------- 735 (892)
..++..+..+. +++.+++|||+. +|+|||+||+|.+|+.-|.+|+.|||+.+.--...
T Consensus 140 tllk~~g~lPv----------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 140 TLLKNIGPLPV----------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhcccCCCCcc----------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 55655443222 227789999998 99999999999999999999999999987531110
Q ss_pred ----CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcC-CCccc
Q 002688 736 ----GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG-DIRST 810 (892)
Q Consensus 736 ----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~ 810 (892)
.......++||+.|+|||++....|...+|.|++|+|+||.+.|+.||.+...+ +.+.+++... ...|-
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe------elfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVISDDIEWPEE 280 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH------HHHhhhhhhhcccccc
Confidence 111224678999999999999999999999999999999999999999865321 2222222221 11111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 002688 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMN 846 (892)
Q Consensus 811 ~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~ 846 (892)
|+.+ ..++.+++.+.++.+|.+|--..
T Consensus 281 -dea~--------p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 281 -DEAL--------PPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred -CcCC--------CHHHHHHHHHHHHhChHhhcccc
Confidence 3222 23456888899999999996443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-14 Score=171.06 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=185.3
Q ss_pred hhhceecccccEEEEEEEE---CCcEEEEEEccCCC--chhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEe
Q 002688 584 NFERVLGKGGFGTVYHGKL---DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~---~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey 657 (892)
.+.+.||+|.|+.|-.... ....+|+|.+.... ....+....|..+=..+. |+|++.+++...+.+..++..+|
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 3445699999999977655 33456777765543 222233344666666665 99999999999999999999999
Q ss_pred ccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHH-hCCCCCccccCCCCccEEEcCCC-cEEEeeecCcccccC-C
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKPPIVHRDVKSTNILINEKF-QAKLADFGLSRVFPV-E 734 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDLkp~NILl~~~~-~vkl~DfGla~~~~~-~ 734 (892)
..+|++.+.+........+......++.|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..+.. .
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 99999999883222223666677788999999999999 66 999999999999999999 999999999998866 4
Q ss_pred CCccccccccC-CCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccC
Q 002688 735 GGTHVSTTIAG-TPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 735 ~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D 812 (892)
+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... .....|...... ...
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~---~~~--- 252 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKGR---FTQ--- 252 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccccc---ccc---
Confidence 44445556678 9999999999885 44677899999999999999999988665432 223333322110 000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 813 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
... ..-.....++..+++..+|..|.+.+++..
T Consensus 253 -~~~----~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 253 -LPW----NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -Ccc----ccCChhhhhcccccccCCchhccccccccc
Confidence 000 011223457778888899999999888754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.6e-12 Score=144.62 Aligned_cols=139 Identities=20% Similarity=0.228 Sum_probs=99.0
Q ss_pred ceecccccEEEEEEEE-CCcEEEEEEccCCCchhh----------------------------------------HHHHH
Q 002688 587 RVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGY----------------------------------------KQFQA 625 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~----------------------------------------~~f~~ 625 (892)
+.||.|++|.||+|++ +|+.||||+.++...... -+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999 899999999876421110 02445
Q ss_pred HHHHHHhcc----ccceeeEeeEe-ecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 002688 626 EVKLLLRVH----HRNLTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLHQGCK 699 (892)
Q Consensus 626 Ei~~l~~l~----H~NIv~l~g~~-~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~ 699 (892)
|.+.+.++. |.+-+.+-..+ ......+|||||+++++|.+....... .. .+.+++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC--
Confidence 565555552 22223322222 334557999999999999887653211 12 23456666665 46788887
Q ss_pred CCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 700 ~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+++|+|+||.||+++++++++++|||++..+.
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987663
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.8e-12 Score=134.44 Aligned_cols=201 Identities=22% Similarity=0.373 Sum_probs=140.4
Q ss_pred HHHHhccccceeeEeeEeecC-----CcEEEEEEeccCCchhhhccccC--cccCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 002688 628 KLLLRVHHRNLTTLVGYCDEG-----TNMALIYEYMANGNLEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGCKP 700 (892)
Q Consensus 628 ~~l~~l~H~NIv~l~g~~~~~-----~~~~LV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 700 (892)
.-|..+.|.|||++..|+.+. ....++.|||+.|++..+|++.. ...+......+++-||..||.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 455667899999999998654 34789999999999999998654 3457778888999999999999998 689
Q ss_pred CccccCCCCccEEEcCCCcEEEeeecCcccccC---CCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHH
Q 002688 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPV---EGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEII 777 (892)
Q Consensus 701 ~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~---~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELl 777 (892)
+|+|+++.-+-|++..++-+|+.--- -..... ...........+-++|.+||+-.....+-.+|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999988875211 000000 00011112334678999999987778888999999999999998
Q ss_pred hCCCCCCccccCCCccHHH-HHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002688 778 TGHPVISKSAENGHTHVAQ-WVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 778 tG~~p~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~ 850 (892)
.+...-.... .....+ -....+ ..+...+. ..++..|++..|..||+|++++.
T Consensus 277 ilEiq~tnse---S~~~~ee~ia~~i------~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSE---SKVEVEENIANVI------IGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCc---ceeehhhhhhhhe------eeccCccc-----------cCcCcccccCCCCCCcchhhhhc
Confidence 8864311110 000000 000000 00111111 25677999999999999999865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.6e-11 Score=154.69 Aligned_cols=102 Identities=31% Similarity=0.658 Sum_probs=66.6
Q ss_pred CCCChhHHHHHHHHHHhcC----CCCCCC-CCCCCCCCCCCCeeeecCCCCCCCCEEEEEcCCCCccccchhhhhhccCC
Q 002688 359 SQTDEQDVDAIMNIKSFYG----LKKNWQ-GDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTML 433 (892)
Q Consensus 359 ~~~~~~d~~al~~~k~~~~----~~~~w~-~~~C~~~~~~w~gv~C~~~~~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L 433 (892)
.-..++|..||+++|+.+. ...+|+ ++.|| .|.||+|+. ..+|+.|+|++|+++|.+|..|..|++|
T Consensus 24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~----~~~v~~L~L~~~~i~~~~~~~~~~l~~L 95 (968)
T PLN00113 24 SMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC----LWQGITCNN----SSRVVSIDLSGKNISGKISSAIFRLPYI 95 (968)
T ss_pred cCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC----cCcceecCC----CCcEEEEEecCCCccccCChHHhCCCCC
Confidence 3457789999999999873 356895 45565 799999963 3467777777777666666666666666
Q ss_pred CcccCCCCccCCCCCcCCC-CCCCCCEEEcCCCcCC
Q 002688 434 TSLDLSNNNLTGPVPKFLS-QLSSLKFLNLARNKLT 468 (892)
Q Consensus 434 ~~L~L~~N~l~g~iP~~~~-~l~~L~~L~l~~N~l~ 468 (892)
+.|+|++|+++|.+|..+. .+++|++|+|++|+++
T Consensus 96 ~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~ 131 (968)
T PLN00113 96 QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFT 131 (968)
T ss_pred CEEECCCCccCCcCChHHhccCCCCCEEECcCCccc
Confidence 6666666666666665433 4444444444444333
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.3e-11 Score=117.66 Aligned_cols=131 Identities=17% Similarity=0.131 Sum_probs=98.5
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchhhh
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEH 666 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 666 (892)
+.++.|.++.||+++..+..+++|....... ....+..|+..+..+.+.++++-+-.+. ....++||||+++.++.+.
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGSELLTE 81 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCCccccc
Confidence 4688999999999999999999999765432 2345688999999987766654333332 2345799999999887653
Q ss_pred ccccCcccCCHHHHHHHHHHHHHHHHHHHhCC--CCCccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 667 LSDSSKEILNWEERLRIAVEAALGLEYLHQGC--KPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 667 L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
- . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 82 ~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 0 11345678999999999872 22369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.5e-09 Score=126.71 Aligned_cols=136 Identities=17% Similarity=0.198 Sum_probs=87.4
Q ss_pred ceecccccEEEEEEEE-C-CcEEEEEEccCCCchh----------------------------------hH------HHH
Q 002688 587 RVLGKGGFGTVYHGKL-D-NDEVAVKMLSPSSSQG----------------------------------YK------QFQ 624 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~-~-~~~vAVK~l~~~~~~~----------------------------------~~------~f~ 624 (892)
+.||+|++|.||+|++ + |+.||||+.++..... .+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 4799999999999998 5 8999999997642110 01 234
Q ss_pred HHHHHHHhcc----ccceeeEeeEee-cCCcEEEEEEeccCCchhhh--ccccCcccCCHHHHHHHHHHHHH-HHHHHHh
Q 002688 625 AEVKLLLRVH----HRNLTTLVGYCD-EGTNMALIYEYMANGNLEEH--LSDSSKEILNWEERLRIAVEAAL-GLEYLHQ 696 (892)
Q Consensus 625 ~Ei~~l~~l~----H~NIv~l~g~~~-~~~~~~LV~Ey~~~gsL~~~--L~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~ 696 (892)
+|+..+.+++ +.+.+.+-..+. -....+|||||++|+.+.+. +...+ .+.. .++...+. -+..++.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~---~la~~~v~~~~~Qif~ 278 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMK---LLAERGVEVFFTQVFR 278 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHH---HHHHHHHHHHHHHHHh
Confidence 4444444442 333333222222 24567899999999999774 22221 2211 12221111 1223344
Q ss_pred CCCCCccccCCCCccEEEcCCC----cEEEeeecCcccc
Q 002688 697 GCKPPIVHRDVKSTNILINEKF----QAKLADFGLSRVF 731 (892)
Q Consensus 697 ~~~~~iiHrDLkp~NILl~~~~----~vkl~DfGla~~~ 731 (892)
. +++|+|+||.||+++.++ ++++.|||++..+
T Consensus 279 ~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 279 D---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred C---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 4 999999999999999888 9999999998765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-10 Score=132.71 Aligned_cols=255 Identities=20% Similarity=0.199 Sum_probs=176.4
Q ss_pred HHHHhhhhhceecc--cccEEEEEEEE----CCcEEEEEEccCC--CchhhHHHHHHHHHHHhc-cccceeeEeeEeecC
Q 002688 578 VLRMTNNFERVLGK--GGFGTVYHGKL----DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG 648 (892)
Q Consensus 578 l~~~t~~f~~~IG~--G~fG~Vy~~~~----~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~~~~ 648 (892)
..+.+..+.+.+|. |.+|.||++.. +...+|+|+-+.. .....+.=.+|+....++ .|+|.++....+..+
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34444556678999 99999999876 5677999984432 223333445677776777 499999988888888
Q ss_pred CcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHH----HHHHHHhCCCCCccccCCCCccEEEcCC-CcEEEe
Q 002688 649 TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL----GLEYLHQGCKPPIVHRDVKSTNILINEK-FQAKLA 723 (892)
Q Consensus 649 ~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiHrDLkp~NILl~~~-~~vkl~ 723 (892)
+..++-.|++. .+|.++.+.... .++....+.+..+..+ ||.++|.. +++|-|+||.||+...+ ...++.
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 89999999886 577777654332 2555666677777777 99999998 99999999999999999 889999
Q ss_pred eecCcccccCCCCccc---cccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHh
Q 002688 724 DFGLSRVFPVEGGTHV---STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSS 800 (892)
Q Consensus 724 DfGla~~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~ 800 (892)
|||+...+........ .....|...|++||.. .+.++...|+|++|.+++|-.++..+...... ..|.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~-- 336 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWS-- 336 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCcc--
Confidence 9999988754432221 1223577889999976 45778899999999999999998655432211 0121
Q ss_pred HhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 002688 801 MLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 801 ~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~~ 855 (892)
.++...+ ..++.......+......+++.+|..|++.+.+. .|.-+
T Consensus 337 -----~~r~~~i---p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~-~l~~i 382 (524)
T KOG0601|consen 337 -----QLRQGYI---PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT-ALNVI 382 (524)
T ss_pred -----ccccccC---chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh-ccccc
Confidence 1111111 1111111122333478899999999999876654 34433
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=6e-09 Score=119.80 Aligned_cols=164 Identities=22% Similarity=0.277 Sum_probs=124.2
Q ss_pred CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHH
Q 002688 603 DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR 682 (892)
Q Consensus 603 ~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~ 682 (892)
++.+|.|+..+...........+-+..|+.++||||++++......+..|+|+|-+.. |..++.+ +.......
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~-----l~~~~v~~ 108 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE-----LGKEEVCL 108 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH-----hHHHHHHH
Confidence 7888988888766554345567788999999999999999999999999999998753 5555554 33455666
Q ss_pred HHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCccccccccCCCCccCccccccCCCCc
Q 002688 683 IAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE 762 (892)
Q Consensus 683 i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ 762 (892)
.+.||+.||.|||..| +++|++|.-+.|+++..|+.||++|-++......+. ......---.|..|+.+.... -
T Consensus 109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--c
Confidence 7789999999999775 899999999999999999999999988765421111 111111122456666543322 3
Q ss_pred hhhHHHHHHHHHHHHhC
Q 002688 763 KSDVYSFGVVLLEIITG 779 (892)
Q Consensus 763 ksDV~SlGvvl~ELltG 779 (892)
..|.|-||++++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 46999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=1e-08 Score=107.07 Aligned_cols=141 Identities=20% Similarity=0.268 Sum_probs=109.5
Q ss_pred ceecccccEEEEEEEECC-cEEEEEEccCCCc-hhhHHHHHHHHHHHhccccc--eeeEeeEeecCC---cEEEEEEecc
Q 002688 587 RVLGKGGFGTVYHGKLDN-DEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRN--LTTLVGYCDEGT---NMALIYEYMA 659 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~-~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~N--Iv~l~g~~~~~~---~~~LV~Ey~~ 659 (892)
+.|+.|..+.||++...+ ..+++|....... ....++..|++++..+++.+ +.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998854 8999999765432 23467899999999997644 566777776542 5689999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC----------------------------------------- 698 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 698 (892)
+.++.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876542 23677788888888999998888521
Q ss_pred ------------CCCccccCCCCccEEEcC--CCcEEEeeecCccc
Q 002688 699 ------------KPPIVHRDVKSTNILINE--KFQAKLADFGLSRV 730 (892)
Q Consensus 699 ------------~~~iiHrDLkp~NILl~~--~~~vkl~DfGla~~ 730 (892)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.7e-08 Score=102.90 Aligned_cols=134 Identities=19% Similarity=0.215 Sum_probs=95.8
Q ss_pred ceecccccEEEEEEEEC--------CcEEEEEEccCCC----------------------chhhHHH----HHHHHHHHh
Q 002688 587 RVLGKGGFGTVYHGKLD--------NDEVAVKMLSPSS----------------------SQGYKQF----QAEVKLLLR 632 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~--------~~~vAVK~l~~~~----------------------~~~~~~f----~~Ei~~l~~ 632 (892)
..||.|-=+.||.|... +..+|||+.+... ....+.+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999763 3689999864321 0011223 379999998
Q ss_pred ccc--cceeeEeeEeecCCcEEEEEEeccCCchhh-hccccCcccCCHHHHHHHHHHHHHHHHHH-HhCCCCCccccCCC
Q 002688 633 VHH--RNLTTLVGYCDEGTNMALIYEYMANGNLEE-HLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVK 708 (892)
Q Consensus 633 l~H--~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~-~L~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDLk 708 (892)
+.. -++...+++ ...++||||+.++.+.. .+... .++......+..+++.+|..| |+. +++|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 864 344555543 45689999998754422 22221 244455667788999999998 777 99999999
Q ss_pred CccEEEcCCCcEEEeeecCcccc
Q 002688 709 STNILINEKFQAKLADFGLSRVF 731 (892)
Q Consensus 709 p~NILl~~~~~vkl~DfGla~~~ 731 (892)
+.|||+++ +.++|+|||.+...
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeC
Confidence 99999974 68999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.9e-08 Score=98.82 Aligned_cols=141 Identities=18% Similarity=0.247 Sum_probs=105.6
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCC--------chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEec
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSS--------SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~ 658 (892)
..+.||+-+.|+++.+.|+...||.-.... .-..++-.+|+..+.+++--.|.-..-++.+...-.++|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 578899999999999999998888643321 113456788999999887655554444555566668999999
Q ss_pred cC-CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC---cEEEeeecCccc
Q 002688 659 AN-GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF---QAKLADFGLSRV 730 (892)
Q Consensus 659 ~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~---~vkl~DfGla~~ 730 (892)
++ .++.+++................+..+-+.+.-||.. +|||+||..+||+|..++ .+.++|||++..
T Consensus 93 ~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 93 DGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 77 3777777654433233333467888889999999999 999999999999997554 358999999764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.4e-08 Score=98.59 Aligned_cols=130 Identities=21% Similarity=0.332 Sum_probs=102.3
Q ss_pred eecccccEEEEEEEECCcEEEEEEccCCC---ch-----hhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEecc
Q 002688 588 VLGKGGFGTVYHGKLDNDEVAVKMLSPSS---SQ-----GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~---~~-----~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
.+++|+=+.+|.+.+-+.++++|.-.++. +. ...+-.+|+.++.+++--.|.-..-+..+.....++|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 57899999999998877777777643331 11 12345779999999876666555556677778899999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~ 730 (892)
+..|.+.+... +..++..+-.-+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 83 G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888754 356677777888899998 999999999999998875 99999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.1e-09 Score=119.48 Aligned_cols=239 Identities=21% Similarity=0.255 Sum_probs=167.8
Q ss_pred hceecccccEEEEEEEE---CCcEEEEEEccCCCchhhHH--HHHHHHHHHhc-cccceeeEeeEeecCCcEEEEEEecc
Q 002688 586 ERVLGKGGFGTVYHGKL---DNDEVAVKMLSPSSSQGYKQ--FQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~---~~~~vAVK~l~~~~~~~~~~--f~~Ei~~l~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~ 659 (892)
...||.|.|+.|++... ++..+++|.+.........+ -..|+.+...+ .|.++++....+......++--||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 35799999999998755 56789999887654333222 24566555555 48888887777777777789999999
Q ss_pred CCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC-CcEEEeeecCcccccCCCCcc
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK-FQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~-~~vkl~DfGla~~~~~~~~~~ 738 (892)
++++...+ .....++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..+...
T Consensus 350 ~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---- 420 (524)
T KOG0601|consen 350 GGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---- 420 (524)
T ss_pred Ccchhhhh--HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee----
Confidence 99877665 2234478888999999999999999987 99999999999999886 88999999998653211
Q ss_pred ccccccCCCCcc--CccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCC
Q 002688 739 VSTTIAGTPGYL--DPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 739 ~~~~~~gt~~Y~--aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~ 816 (892)
.......-+++ +++......+-.+.|+||||.-+.|.+++.+--... .+|. .+..+ .-+.+.
T Consensus 421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~--~i~~~-----~~p~~~ 484 (524)
T KOG0601|consen 421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSL--TIRSG-----DTPNLP 484 (524)
T ss_pred -cccccccccccccchhhccccccccccccccccccccccccCcccCccc--------ccce--eeecc-----cccCCC
Confidence 11112233444 455555667889999999999999999987432211 1111 11111 112222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 817 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVl~~L~~ 854 (892)
+ .. ..+..+++.+...++..||...+.....+.
T Consensus 485 ~----~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 485 G----LK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred c----hH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1 11 455678888999999999999887765553
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.4e-07 Score=101.53 Aligned_cols=139 Identities=17% Similarity=0.134 Sum_probs=101.7
Q ss_pred eecccccEEEEEEEECCcEEEEEEccCCCch-hhH----------HHHHHHHHHHhccccce--eeEeeEeec-----CC
Q 002688 588 VLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQ-GYK----------QFQAEVKLLLRVHHRNL--TTLVGYCDE-----GT 649 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~-~~~----------~f~~Ei~~l~~l~H~NI--v~l~g~~~~-----~~ 649 (892)
.+-.-....|.+..++|+.+.||........ ..+ .+.+|...+.++...+| ...+++... ..
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 3333344457788889999999987543311 112 37889999988865444 344555533 23
Q ss_pred cEEEEEEeccCC-chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcC-------CCcEE
Q 002688 650 NMALIYEYMANG-NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-------KFQAK 721 (892)
Q Consensus 650 ~~~LV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-------~~~vk 721 (892)
..+||+|++++. +|.+++........+...+..++.+++..+.-||.. +|+|+|++++|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEE
Confidence 478999999986 788887532222355667788999999999999999 9999999999999975 57899
Q ss_pred EeeecCcc
Q 002688 722 LADFGLSR 729 (892)
Q Consensus 722 l~DfGla~ 729 (892)
++||+.+.
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999775
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.5e-07 Score=102.36 Aligned_cols=166 Identities=17% Similarity=0.233 Sum_probs=126.9
Q ss_pred cEEEEEEEE--CCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEee----cCCcEEEEEEeccC-Cchhhh
Q 002688 594 FGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD----EGTNMALIYEYMAN-GNLEEH 666 (892)
Q Consensus 594 fG~Vy~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~----~~~~~~LV~Ey~~~-gsL~~~ 666 (892)
-.+.||+.. ||..|++|+++....+....-..-++.++++.|.|+|++...+. .+..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899876 89999999996554443333456688999999999999998875 33468999999886 467664
Q ss_pred ccccC-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccC
Q 002688 667 LSDSS-------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 667 L~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~ 733 (892)
--... +...++...+.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 42211 23367789999999999999999998 999999999999999999999998887766543
Q ss_pred CCCccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~ 781 (892)
+.. |-+. --.+-|.=.||.+++-|.||..
T Consensus 446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 320 1111 1236788999999999999963
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.5e-07 Score=94.82 Aligned_cols=137 Identities=19% Similarity=0.258 Sum_probs=76.2
Q ss_pred eEeccCCCCCCCcccCCCceEeecCccccccCCc-----------cccchhhc-cccccccccccccCCCCcceeeeeec
Q 002688 30 ISLDCGLPKDSSYTETSTKLRYTSDANYIETGLP-----------KSILLQYR-RMKQQQVWSLRSFPDGIRNCYRFNLT 97 (892)
Q Consensus 30 ~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~-----------~~i~~~~~-~~~~~~~~tlR~Fp~~~~nCY~l~~~ 97 (892)
+.||||+ ..| ++..|+.|.+|..|...+.. ........ ..-.+.|+|-|+=|. ...|.+|+.
T Consensus 3 ~~IN~Gg---~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--~f~Y~ip~~ 76 (174)
T PF11721_consen 3 LRINAGG---PAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--SFSYDIPVV 76 (174)
T ss_dssp EEEEETS---SSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--SEEEEEE--
T ss_pred EEEECCC---Ccc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--ceEEEEecC
Confidence 5799996 334 46789999999988643330 01111111 222355789999544 577999999
Q ss_pred CCceeEEeEEe---eecCCCCCCCCC---ceeEEeCCce-eeeeeecCCc---c-ceEEEE-EEEeccCceeEEEEe---
Q 002688 98 RNTKYLIRATF---MYGNYDEQNNLP---EFDVHLGPNL-WGTIKIENVS---V-DYSVEI-IHVLSSDYLSVCIVN--- 162 (892)
Q Consensus 98 ~~~~ylvR~~f---~ygnyd~~~~~p---~Fd~~~~~~~-w~~v~~~~~~---~-~~~~e~-i~~~~~~~~~vcl~~--- 162 (892)
+.|.|-||++| +++. ++....| +||+.++|+. ...+++.... . ....+. -+.+.++.+.++|..
T Consensus 77 ~~G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~ 155 (174)
T PF11721_consen 77 PNGTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGK 155 (174)
T ss_dssp S-EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--
T ss_pred CCcEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCC
Confidence 99999999999 3333 2222333 7999999966 6667654322 1 223333 234478899999986
Q ss_pred --------cCCCCcceeee
Q 002688 163 --------TNKGTPFISAL 173 (892)
Q Consensus 163 --------~~~~~pfis~l 173 (892)
...+.|.||||
T Consensus 156 ~~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 156 GTLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp SEEEEEEESSSSSSSEEEE
T ss_pred CcEEeeccccCCCcEEeeC
Confidence 44566888886
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.5e-08 Score=81.19 Aligned_cols=61 Identities=44% Similarity=0.627 Sum_probs=55.0
Q ss_pred CCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcC
Q 002688 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKL 467 (892)
Q Consensus 407 ~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l 467 (892)
++|+.|+|++|+|+..-+..|..+++|++|+|++|+|+..-|..|..|++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999985557899999999999999999966667899999999999999986
|
... |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=6.9e-09 Score=99.87 Aligned_cols=146 Identities=21% Similarity=0.319 Sum_probs=111.8
Q ss_pred ceEEEEEecCCCCCCcccceeeEEEeecccCC--CCChhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCeeeecCCCCC
Q 002688 328 QYNFSLIKTGNSTHPPIINAIEIYEVKEFSQS--QTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDD 405 (892)
Q Consensus 328 ~~~~~l~~~~~s~lpp~ina~e~~~~~~~~~~--~~~~~d~~al~~~k~~~~~~~~w~~~~C~~~~~~w~gv~C~~~~~~ 405 (892)
-+.++|.-+..+.+||-|.-+-.++++++.+. +..|.....|..+|-.---.+..+-- |+.| +.
T Consensus 35 ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~l---prgf-----------gs 100 (264)
T KOG0617|consen 35 ITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNIL---PRGF-----------GS 100 (264)
T ss_pred hhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcC---cccc-----------CC
Confidence 35678888999999999999888888887654 77788888888887643111111111 2211 55
Q ss_pred CCCEEEEEcCCCCccc-cchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCCce
Q 002688 406 SPRITSLNLSASELTG-GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL 484 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g-~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~l 484 (892)
.+.+..|||+.|+|+. .+|..|.-|+.|+.|+|+.|.|. .+|+.+++|++|+.|.|.+|.|- ++|.+++.+.+|+.+
T Consensus 101 ~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrel 178 (264)
T KOG0617|consen 101 FPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLREL 178 (264)
T ss_pred CchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHH
Confidence 6789999999999965 58888989999999999999998 88999999999999999999888 899999988877654
Q ss_pred eeeccCC
Q 002688 485 ELRFDGN 491 (892)
Q Consensus 485 ~l~~~~n 491 (892)
...||
T Consensus 179 --hiqgn 183 (264)
T KOG0617|consen 179 --HIQGN 183 (264)
T ss_pred --hcccc
Confidence 34455
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.2e-08 Score=98.22 Aligned_cols=84 Identities=31% Similarity=0.438 Sum_probs=78.9
Q ss_pred CCCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCCce
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL 484 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~l 484 (892)
...+++.|-||+|.|+- +|+.|+.|.+|+.|+|++|++. .+|.++++|++|+.|+++-|+|. .+|..++.++.|..+
T Consensus 31 ~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 45678999999999997 9999999999999999999999 89999999999999999999999 899999999999999
Q ss_pred eeeccCC
Q 002688 485 ELRFDGN 491 (892)
Q Consensus 485 ~l~~~~n 491 (892)
++.+++-
T Consensus 108 dltynnl 114 (264)
T KOG0617|consen 108 DLTYNNL 114 (264)
T ss_pred hcccccc
Confidence 9998763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2e-08 Score=120.02 Aligned_cols=240 Identities=20% Similarity=0.299 Sum_probs=154.8
Q ss_pred eecccccEEEEEEEE--CCcEEEEEEccCCC---chhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCc
Q 002688 588 VLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gs 662 (892)
.+-+|.++.++.++- .+...++|...... ....+....+-.++...+||-++....-+.......|+++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 567788888886654 33333343332211 1111222333334444456666655544445567899999999999
Q ss_pred hhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCC----C---
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE----G--- 735 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~----~--- 735 (892)
|...|+.... .+.......+..+..+++|||.. .+.|||++|.|+++..++..+++|||........ +
T Consensus 891 ~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg 965 (1205)
T KOG0606|consen 891 LPSKLHNSGC--LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG 965 (1205)
T ss_pred chhhhhcCCC--cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence 9999987652 34344445566778899999987 6999999999999999999999999844332100 0
Q ss_pred ----------------------CccccccccCCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccCCCcc
Q 002688 736 ----------------------GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTH 793 (892)
Q Consensus 736 ----------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~~~~~~~~~~ 793 (892)
.........+|+.|.+||...+......+|.|+.|++++|.++|.+||.......
T Consensus 966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~--- 1042 (1205)
T KOG0606|consen 966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ--- 1042 (1205)
T ss_pred ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh---
Confidence 0011224568999999999999999999999999999999999999998654311
Q ss_pred HHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 002688 794 VAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMN 846 (892)
Q Consensus 794 l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~ 846 (892)
-++.+. .+.+ ... ....+......+++...+..+|.+|-.|.
T Consensus 1043 ---~f~ni~-~~~~------~~p-~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 ---IFENIL-NRDI------PWP-EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ---hhhccc-cCCC------CCC-CCccccChhhhhhhhhhhccCchhccCcc
Confidence 111111 1111 000 01122233345666777778888887665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=6.8e-07 Score=90.91 Aligned_cols=124 Identities=26% Similarity=0.309 Sum_probs=79.3
Q ss_pred EEEEEEE-CCcEEEEEEccCCC---------------------ch-----hhHHHHHHHHHHHhccccc--eeeEeeEee
Q 002688 596 TVYHGKL-DNDEVAVKMLSPSS---------------------SQ-----GYKQFQAEVKLLLRVHHRN--LTTLVGYCD 646 (892)
Q Consensus 596 ~Vy~~~~-~~~~vAVK~l~~~~---------------------~~-----~~~~f~~Ei~~l~~l~H~N--Iv~l~g~~~ 646 (892)
.||.|.. ++..+|||..+... .. ......+|++.|.++..-+ +.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899987 78899999865421 00 1234578999999997664 44555442
Q ss_pred cCCcEEEEEEecc--CCchhhhccccCcccCCHHHHHHHHHHHHHHHHH-HHhCCCCCccccCCCCccEEEcCCCcEEEe
Q 002688 647 EGTNMALIYEYMA--NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEY-LHQGCKPPIVHRDVKSTNILINEKFQAKLA 723 (892)
Q Consensus 647 ~~~~~~LV~Ey~~--~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~iiHrDLkp~NILl~~~~~vkl~ 723 (892)
...+||||++ +..+..+.... ++......++.+++..+.. +|.. +|+|+||.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3479999998 54444433221 1123445677777775555 5676 99999999999999988 99999
Q ss_pred eecCcccc
Q 002688 724 DFGLSRVF 731 (892)
Q Consensus 724 DfGla~~~ 731 (892)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.9e-07 Score=100.98 Aligned_cols=84 Identities=31% Similarity=0.421 Sum_probs=71.0
Q ss_pred CCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccC----------------------CCCCcC-CCCCCCCCEEEc
Q 002688 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT----------------------GPVPKF-LSQLSSLKFLNL 462 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~----------------------g~iP~~-~~~l~~L~~L~l 462 (892)
.++++.|+|++|-|.. +|.+++.+..|+.||||+|+|. |.+|++ +.+|.+|..|||
T Consensus 434 l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL 512 (565)
T KOG0472|consen 434 LQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDL 512 (565)
T ss_pred hhcceeeecccchhhh-cchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceecc
Confidence 4688889999888876 9999999999999999988765 345555 889999999999
Q ss_pred CCCcCCCCCchhhhhhccCCceeeeccCCCC
Q 002688 463 ARNKLTGPLPVELLEKQENNTLELRFDGNPD 493 (892)
Q Consensus 463 ~~N~l~g~iP~~l~~~~~l~~l~l~~~~n~~ 493 (892)
.+|.+. .||+.++++.+++.+ .+.|||.
T Consensus 513 ~nNdlq-~IPp~LgnmtnL~hL--eL~gNpf 540 (565)
T KOG0472|consen 513 QNNDLQ-QIPPILGNMTNLRHL--ELDGNPF 540 (565)
T ss_pred CCCchh-hCChhhccccceeEE--EecCCcc
Confidence 999999 999999999988865 4568886
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=3e-06 Score=86.89 Aligned_cols=138 Identities=17% Similarity=0.186 Sum_probs=106.1
Q ss_pred ecccccEEEEEEEECCcEEEEEEccCC---C---chhhHHHHHHHHHHHhccccc--eeeEeeEee-c----CCcEEEEE
Q 002688 589 LGKGGFGTVYHGKLDNDEVAVKMLSPS---S---SQGYKQFQAEVKLLLRVHHRN--LTTLVGYCD-E----GTNMALIY 655 (892)
Q Consensus 589 IG~G~fG~Vy~~~~~~~~vAVK~l~~~---~---~~~~~~f~~Ei~~l~~l~H~N--Iv~l~g~~~-~----~~~~~LV~ 655 (892)
-|+||-+-|++-.++|..+-+|+-... + +.+...|.+|+..|.++...+ +.+.+ ++. . ...-.||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 367899999999888888999986522 1 335678999999999996443 33444 332 1 12367999
Q ss_pred EeccC-CchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCc--EEEeeecCccc
Q 002688 656 EYMAN-GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQ--AKLADFGLSRV 730 (892)
Q Consensus 656 Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~--vkl~DfGla~~ 730 (892)
|-+.+ -+|.+++........+...+..++.+++..++-||+. ++.|+|+.+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 4888888665444467788899999999999999999 9999999999999986666 99999986653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.5e-05 Score=87.42 Aligned_cols=258 Identities=17% Similarity=0.202 Sum_probs=154.7
Q ss_pred hceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhc-cccceeeEeeEe------e-cCCcEEEEEEe
Q 002688 586 ERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYC------D-EGTNMALIYEY 657 (892)
Q Consensus 586 ~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~NIv~l~g~~------~-~~~~~~LV~Ey 657 (892)
.+.||+|+-+.+|-.---+. .+-|+++........+ .++.|... .||-+-.-+.+= . .+....++|..
T Consensus 16 gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchhhc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 35799999999995422122 3346666554433222 22333333 455433212111 1 12225677777
Q ss_pred ccCC-chhhhccccC----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCccccc
Q 002688 658 MANG-NLEEHLSDSS----KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 658 ~~~g-sL~~~L~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~ 732 (892)
+.+. -+..++.... -...+|...++.++.+|.+.+-||.. |..-+|+.++|+|+.+++.+.+.|=..-...
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~- 167 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN- 167 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec-
Confidence 6654 2233332111 22478999999999999999999998 9999999999999999999999985432221
Q ss_pred CCCCccccccccCCCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCccccCC--CccHH-HHHHhHhh
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLEIITG-HPVISKSAENG--HTHVA-QWVSSMLD 803 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~ELltG-~~p~~~~~~~~--~~~l~-~~~~~~~~ 803 (892)
.........+|...|.+||.-. +-.-+...|.|.|||++++++.| ++||.+-.... ..-+. +..
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia----- 240 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA----- 240 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh-----
Confidence 2223334567889999999754 23456789999999999999987 99998653211 00000 111
Q ss_pred cCCCccccCCCC-----CCCCCHH-HHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHHHhh
Q 002688 804 KGDIRSTVDPRL-----KGDFDIN-SVWKAVEIAMACVSSN--ANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 804 ~~~~~~~~D~~l-----~~~~~~~-~~~~l~~l~~~Cl~~~--P~~RPsm~eVl~~L~~~~~~ 858 (892)
.+.+...-|... ....+.+ -...+.-+..+|+... +.-||+.+--+..|..+.+.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 111111111000 0011111 1123456777888763 67899999988888776543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.8e-05 Score=89.54 Aligned_cols=141 Identities=21% Similarity=0.272 Sum_probs=91.6
Q ss_pred hhh-ceecccccEEEEEEEE-CCcEEEEEEccCCCchh------------------------------hH----------
Q 002688 584 NFE-RVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQG------------------------------YK---------- 621 (892)
Q Consensus 584 ~f~-~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~------------------------------~~---------- 621 (892)
+|+ +.|+.++-|.||+|++ +|+.||||+.++.-... .+
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 444 5799999999999999 69999999976642110 01
Q ss_pred HHHHHHHHHHhcc-----ccceeeEeeEeecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHH-HHHHH
Q 002688 622 QFQAEVKLLLRVH-----HRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALG-LEYLH 695 (892)
Q Consensus 622 ~f~~Ei~~l~~l~-----H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~g-L~yLH 695 (892)
++.+|..-+.+++ .+++.---=|++-.....|+|||++|..+.+...-.. ...+-.. ++..++++ +..+-
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~ 282 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLL 282 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHH
Confidence 1334444444442 2333222223333566799999999998888743222 2245333 33333322 22332
Q ss_pred hCCCCCccccCCCCccEEEcCCCcEEEeeecCcccc
Q 002688 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731 (892)
Q Consensus 696 ~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~ 731 (892)
.. +++|.|.+|.||+++.++++.+.|||+...+
T Consensus 283 ~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 283 RD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred hc---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence 33 8999999999999999999999999998765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.3e-06 Score=86.85 Aligned_cols=106 Identities=23% Similarity=0.262 Sum_probs=83.5
Q ss_pred hHHHHHHHHHHHhccccc--eeeEeeEeecC----CcEEEEEEeccCC-chhhhccccCcccCCHHHHHHHHHHHHHHHH
Q 002688 620 YKQFQAEVKLLLRVHHRN--LTTLVGYCDEG----TNMALIYEYMANG-NLEEHLSDSSKEILNWEERLRIAVEAALGLE 692 (892)
Q Consensus 620 ~~~f~~Ei~~l~~l~H~N--Iv~l~g~~~~~----~~~~LV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~ 692 (892)
.....+|...+..+.... ..+.+++.... ...+||+|++++. +|.+++..... .+...+..++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 346788888888886443 34556665542 2358999999884 79998876332 556677889999999999
Q ss_pred HHHhCCCCCccccCCCCccEEEcCCC---cEEEeeecCccc
Q 002688 693 YLHQGCKPPIVHRDVKSTNILINEKF---QAKLADFGLSRV 730 (892)
Q Consensus 693 yLH~~~~~~iiHrDLkp~NILl~~~~---~vkl~DfGla~~ 730 (892)
-||+. +|+|+|+++.|||++.+. .+.++||+.++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.1e-06 Score=88.45 Aligned_cols=132 Identities=19% Similarity=0.312 Sum_probs=68.9
Q ss_pred eeehhcCCCCCCcccccCCCCCccccCCC---CCCCcccccc--c--cccCCCCCCCCCCHHHHhhcccccCCCcceEEe
Q 002688 193 SIRLDVGSTSNATFRYIDDAYDRVWWPYD---LDEWEPFSTS--E--AVDADGSKNFKPPPRAMKSAVRPVNASNSLDFS 265 (892)
Q Consensus 193 ~~r~~~g~~~~~~~ryp~D~~dR~W~p~~---~~~~~~~~t~--~--~i~~~~~~~~~~P~~v~~tA~t~~~~~~~l~~~ 265 (892)
+.|+|+|++. | +|..++.|.+.. ...|.-..+. . .......-....++.++||+.... ..+.+.
T Consensus 2 ~~~IN~Gg~~-----~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~ 72 (174)
T PF11721_consen 2 VLRINAGGPA-----Y-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYD 72 (174)
T ss_dssp EEEEEETSSS-----E-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEE
T ss_pred EEEEECCCCc-----c-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEE
Confidence 5799999853 4 899999999742 3334111110 0 001111222456779999999833 245555
Q ss_pred eCCCCCCcceEEeeehhhcccccc------ccceEEEEEECCccccCCccccCce------eeEEEeeeeccCCceEEEE
Q 002688 266 INASDPTSQLYVYMHFAEIEELKA------NESRLFNITRNGNLWYGPLKLNYLS------STTVFSQSAMSGGQYNFSL 333 (892)
Q Consensus 266 ~~~~~~~~~~~v~lhFae~~~~~~------~~~R~F~i~ing~~~~~~~~p~~~~------~~~v~~~~~~~~~~~~~~l 333 (892)
.+. .++-.|-|.|||||+.. .. .++|+|||+|||+...+.|++-.-. +...+..-....|.+.|.+
T Consensus 73 ip~-~~~G~Y~V~L~FaE~~~-~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f 150 (174)
T PF11721_consen 73 IPV-VPNGTYTVRLHFAELYF-GASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQF 150 (174)
T ss_dssp EE---S-EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTE
T ss_pred Eec-CCCcEEEEEEEeccccc-cccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEE
Confidence 442 45667999999999964 44 6799999999999887777653211 1112212233567777766
Q ss_pred Ee
Q 002688 334 IK 335 (892)
Q Consensus 334 ~~ 335 (892)
..
T Consensus 151 ~~ 152 (174)
T PF11721_consen 151 VW 152 (174)
T ss_dssp EE
T ss_pred Ee
Confidence 63
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.7e-07 Score=101.24 Aligned_cols=142 Identities=23% Similarity=0.306 Sum_probs=103.4
Q ss_pred EEEEecCCCCCCcccceeeEEEeecccCC--CCChhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCeeeecCCCCCCCC
Q 002688 331 FSLIKTGNSTHPPIINAIEIYEVKEFSQS--QTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPR 408 (892)
Q Consensus 331 ~~l~~~~~s~lpp~ina~e~~~~~~~~~~--~~~~~d~~al~~~k~~~~~~~~w~~~~C~~~~~~w~gv~C~~~~~~~~~ 408 (892)
+.+.-+....+||-+.++.-++-++.... ++.|+|...|..+-..|-..+.-..-|-.| .|+ .
T Consensus 165 l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~~lPef~--------gcs-------~ 229 (565)
T KOG0472|consen 165 LDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIRFLPEFP--------GCS-------L 229 (565)
T ss_pred hhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccccCCCCC--------ccH-------H
Confidence 44455566667777666666665554322 778888888877776663322222222111 132 5
Q ss_pred EEEEEcCCCCccccchhhhh-hccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCCceeee
Q 002688 409 ITSLNLSASELTGGFAHYLT-NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELR 487 (892)
Q Consensus 409 l~~l~L~~n~l~g~ip~~~~-~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~l~l~ 487 (892)
+..|+++.|+|.- +|.+.+ +|.+|.+|||..|+|. ++|+++..|.+|.+||||+|.++ .+|.+++++ .|+ .+.
T Consensus 230 L~Elh~g~N~i~~-lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~--~L~ 303 (565)
T KOG0472|consen 230 LKELHVGENQIEM-LPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLK--FLA 303 (565)
T ss_pred HHHHHhcccHHHh-hHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eee--ehh
Confidence 7788899999885 887776 9999999999999999 89999999999999999999999 699999888 444 466
Q ss_pred ccCCCC
Q 002688 488 FDGNPD 493 (892)
Q Consensus 488 ~~~n~~ 493 (892)
+.|||.
T Consensus 304 leGNPl 309 (565)
T KOG0472|consen 304 LEGNPL 309 (565)
T ss_pred hcCCch
Confidence 788885
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.6e-05 Score=83.48 Aligned_cols=133 Identities=20% Similarity=0.202 Sum_probs=93.8
Q ss_pred hhhceecccccEEEEEEEE-CCcEEEEEEccCCCc----------------------hhhHHHHHHHHHHHhcccc--ce
Q 002688 584 NFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSS----------------------QGYKQFQAEVKLLLRVHHR--NL 638 (892)
Q Consensus 584 ~f~~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~----------------------~~~~~f~~Ei~~l~~l~H~--NI 638 (892)
.+.++||-|-=+.||.|.. ++.++|||.-+.... -.....++|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3457899999999999998 699999997432110 0123457899999998755 56
Q ss_pred eeEeeEeecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCC
Q 002688 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF 718 (892)
Q Consensus 639 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~ 718 (892)
.+.+++ +...+|||++++--|...- ++-...-.++..|++-+.-+-.. ||+|+|+.+-||+++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 666554 3458999999986655432 11222334444555555554455 999999999999999999
Q ss_pred cEEEeeecCccc
Q 002688 719 QAKLADFGLSRV 730 (892)
Q Consensus 719 ~vkl~DfGla~~ 730 (892)
.+.++||-.+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976653
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5e-07 Score=102.05 Aligned_cols=143 Identities=24% Similarity=0.306 Sum_probs=91.4
Q ss_pred EEEEEecCCCCCCcccceeeEEEeeccc--CCCCChhHHHHHHHHHHhc---CCCCCCCCCCCCCCCCCCCeeeecCCCC
Q 002688 330 NFSLIKTGNSTHPPIINAIEIYEVKEFS--QSQTDEQDVDAIMNIKSFY---GLKKNWQGDPCAPQDYLWEGLNCSYPDD 404 (892)
Q Consensus 330 ~~~l~~~~~s~lpp~ina~e~~~~~~~~--~~~~~~~d~~al~~~k~~~---~~~~~w~~~~C~~~~~~w~gv~C~~~~~ 404 (892)
=+.|..|....+|..+.++..++-+.+. +-.+.-.+...|-.|++.. +.+++ +|-|- + ..
T Consensus 36 WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKn-sGiP~------------d--iF 100 (1255)
T KOG0444|consen 36 WLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKN-SGIPT------------D--IF 100 (1255)
T ss_pred EEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhcccccc-CCCCc------------h--hc
Confidence 3566677777777777666665544432 1233333333344444332 22221 12221 1 13
Q ss_pred CCCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcC-CCCCCCCCEEEcCCCcCCCCCchhhhhhccCCc
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF-LSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~-~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~ 483 (892)
....|+.||||+|+|.. .|..+..-+++-.|+||+|++. +||.. +-+|+.|-+||||+|+|. .+|+.+-.+..|+.
T Consensus 101 ~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~Lqt 177 (1255)
T KOG0444|consen 101 RLKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQT 177 (1255)
T ss_pred ccccceeeecchhhhhh-cchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhh
Confidence 45678888888888886 8888888888888888888888 78855 467888888888888888 78888777776665
Q ss_pred eeeeccCCC
Q 002688 484 LELRFDGNP 492 (892)
Q Consensus 484 l~l~~~~n~ 492 (892)
|. +++||
T Consensus 178 L~--Ls~NP 184 (1255)
T KOG0444|consen 178 LK--LSNNP 184 (1255)
T ss_pred hh--cCCCh
Confidence 43 34554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.7e-05 Score=80.24 Aligned_cols=138 Identities=15% Similarity=0.256 Sum_probs=85.5
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhccccce--eeEeeEeecCCcEEEEEEeccCCc-h
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNL--TTLVGYCDEGTNMALIYEYMANGN-L 663 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NI--v~l~g~~~~~~~~~LV~Ey~~~gs-L 663 (892)
+.||+|..+.||+. .+..+++|....... .....+|.++++.+..-.+ .+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 47899999999984 355778888765432 2456889999999875444 566777777777889999999863 2
Q ss_pred hhhc---------------------cccCcccCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCccccCCCC
Q 002688 664 EEHL---------------------SDSSKEILNWEERLR-IAV----------EAAL-GLEYLHQG-CKPPIVHRDVKS 709 (892)
Q Consensus 664 ~~~L---------------------~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~~-~~~~iiHrDLkp 709 (892)
...+ |...........+.. +.. .+.. ...+|... ..+.++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 2111 111000111111100 000 0111 12222221 133578999999
Q ss_pred ccEEEcCCCcEEEeeecCcc
Q 002688 710 TNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 710 ~NILl~~~~~vkl~DfGla~ 729 (892)
.||++++++ +.|+||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=8.5e-07 Score=102.87 Aligned_cols=151 Identities=21% Similarity=0.325 Sum_probs=99.7
Q ss_pred HHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcc-------ccccccCCCCccCcccccc
Q 002688 685 VEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH-------VSTTIAGTPGYLDPEYYIS 757 (892)
Q Consensus 685 ~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~-------~~~~~~gt~~Y~aPE~~~~ 757 (892)
.+++.||.|+|.. .+++|++|.|++|.++.++..||+.|+.+.......... ..........|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3456999999987 589999999999999999999999999876543211110 0111223467999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCccccCCCccHHHHHHhHhhcCCCccccCCCCCCCCCHHHHHHHHHHHHHccc
Q 002688 758 NRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVS 836 (892)
Q Consensus 758 ~~~s~ksDV~SlGvvl~ELlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~D~~l~~~~~~~~~~~l~~l~~~Cl~ 836 (892)
...+.++|+||+|+++|-+.. |+.-+...... .......... +.... .+...-..++.+=+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~---~~~~~~~~~~---------~~~~~-~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL---LSYSFSRNLL---------NAGAF-GYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc---chhhhhhccc---------ccccc-cccccCcHHHHHHHHHHhc
Confidence 889999999999999999994 44444322111 0111111111 10000 1112233456677788899
Q ss_pred cCCCCCCCHHHHHH
Q 002688 837 SNANRRPFMNQVVM 850 (892)
Q Consensus 837 ~~P~~RPsm~eVl~ 850 (892)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998777654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.3e-07 Score=101.90 Aligned_cols=78 Identities=27% Similarity=0.329 Sum_probs=54.9
Q ss_pred CCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCC-CCCchhhhhhccCCce
Q 002688 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT-GPLPVELLEKQENNTL 484 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~-g~iP~~l~~~~~l~~l 484 (892)
...|+.||||+|.|+. +....+...+|++|+||.|+|+ .+|+.+.+|++|+.|.+.+|+|+ --||+.++.+.+|..+
T Consensus 244 l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf 321 (1255)
T KOG0444|consen 244 LRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVF 321 (1255)
T ss_pred hhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHH
Confidence 4566777777777765 6666666777777777777777 67777777777777777777665 2377777777766544
Q ss_pred e
Q 002688 485 E 485 (892)
Q Consensus 485 ~ 485 (892)
.
T Consensus 322 ~ 322 (1255)
T KOG0444|consen 322 H 322 (1255)
T ss_pred H
Confidence 3
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.2e-06 Score=64.38 Aligned_cols=37 Identities=46% Similarity=0.636 Sum_probs=26.6
Q ss_pred cCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCC
Q 002688 431 TMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468 (892)
Q Consensus 431 ~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~ 468 (892)
++|++|+|++|+|+ .||+.|++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 46777777777777 67777777777777777777777
|
... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.2e-05 Score=97.83 Aligned_cols=66 Identities=32% Similarity=0.408 Sum_probs=31.9
Q ss_pred CEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCC
Q 002688 408 RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENN 482 (892)
Q Consensus 408 ~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~ 482 (892)
.|+.|+|++|+|++ +|... ++|+.|+|++|+|+ .||.. ..+|+.|+|++|+|+ .||.+++.+..+.
T Consensus 383 ~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~ 448 (788)
T PRK15387 383 GLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSET 448 (788)
T ss_pred ccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCC
Confidence 35555555555554 44322 34555555555555 34432 123445555555555 4555555544444
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00015 Score=74.82 Aligned_cols=129 Identities=14% Similarity=0.169 Sum_probs=84.7
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCCchhhHHH---------HHHHHHHHhcc---ccceeeEeeEee-----cCC
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQF---------QAEVKLLLRVH---HRNLTTLVGYCD-----EGT 649 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f---------~~Ei~~l~~l~---H~NIv~l~g~~~-----~~~ 649 (892)
+++.......|.+-..+++.+++|.........++.| .+++..+.+++ -.....++.+.. -..
T Consensus 37 kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~ 116 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTS 116 (229)
T ss_pred EeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecccee
Confidence 4555555566666677999999999876543333322 23344444442 222223222222 223
Q ss_pred cEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcc
Q 002688 650 NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~ 729 (892)
..+++|||++|..|.+... ++. .++..+++++.-||+. |+.|+|..|+|++++++ .+++.||+..+
T Consensus 117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 4679999999988776542 221 2445677889999999 99999999999999965 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.7e-06 Score=100.91 Aligned_cols=76 Identities=32% Similarity=0.458 Sum_probs=52.8
Q ss_pred CCCEEEEEcCCCCccccch-hhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCCce
Q 002688 406 SPRITSLNLSASELTGGFA-HYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL 484 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip-~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~l 484 (892)
..+|+.|+|++|+|.. +| ..+.+|..|+.|+||+|+|+ .||.++.++..|++|...+|+|. .+| ++..+++++.+
T Consensus 382 ~~hLKVLhLsyNrL~~-fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~l 457 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLNS-FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVL 457 (1081)
T ss_pred ccceeeeeeccccccc-CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEE
Confidence 4578889999998876 55 46788888888888888888 67766666666666666666665 555 55555554444
Q ss_pred e
Q 002688 485 E 485 (892)
Q Consensus 485 ~ 485 (892)
+
T Consensus 458 D 458 (1081)
T KOG0618|consen 458 D 458 (1081)
T ss_pred e
Confidence 3
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00012 Score=76.68 Aligned_cols=142 Identities=18% Similarity=0.219 Sum_probs=86.0
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhccccc--eeeEeeEee---cCCcEEEEEEeccCC
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRN--LTTLVGYCD---EGTNMALIYEYMANG 661 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~N--Iv~l~g~~~---~~~~~~LV~Ey~~~g 661 (892)
+.++.|..+.||+...+++.+++|..... .......+|..+++.+.... +.+++.++. .....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 46889999999999997789999997654 45567888999998886443 345665442 233578999999998
Q ss_pred chhh----------------hc---ccc--CcccCCHHH---------HHHH------------HHHHHH-HHHHHHh--
Q 002688 662 NLEE----------------HL---SDS--SKEILNWEE---------RLRI------------AVEAAL-GLEYLHQ-- 696 (892)
Q Consensus 662 sL~~----------------~L---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~-- 696 (892)
.+.. .+ +.. ......+.. .... ...+.. .++.+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7777 11 111 000111111 0000 111222 3333432
Q ss_pred --CCCCCccccCCCCccEEEc-CCCcEEEeeecCccc
Q 002688 697 --GCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRV 730 (892)
Q Consensus 697 --~~~~~iiHrDLkp~NILl~-~~~~vkl~DfGla~~ 730 (892)
.....++|+|+.+.|||++ +++.+.|.||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1345799999999999999 667778999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.2e-05 Score=91.08 Aligned_cols=144 Identities=21% Similarity=0.177 Sum_probs=95.3
Q ss_pred CceEEEEEecCCCCCCcc----cceeeEEEeecccC----CCCChhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCeee
Q 002688 327 GQYNFSLIKTGNSTHPPI----INAIEIYEVKEFSQ----SQTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLN 398 (892)
Q Consensus 327 ~~~~~~l~~~~~s~lpp~----ina~e~~~~~~~~~----~~~~~~d~~al~~~k~~~~~~~~w~~~~C~~~~~~w~gv~ 398 (892)
..+++.|.++..|+||+- ++.||.+.+....- .-|+. ....|+.+|-.-+...-.+ +|+-
T Consensus 198 sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFq-gL~Sl~nlklqrN~I~kL~-----------DG~F 265 (873)
T KOG4194|consen 198 SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQ-GLPSLQNLKLQRNDISKLD-----------DGAF 265 (873)
T ss_pred hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhc-CchhhhhhhhhhcCccccc-----------Ccce
Confidence 457889999999999886 44455444322110 01111 1223333332211111110 1110
Q ss_pred ecCCCCCCCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhh
Q 002688 399 CSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEK 478 (892)
Q Consensus 399 C~~~~~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~ 478 (892)
-....+..|+|+.|+++..--.++-+|++|+.||||+|.+...-++.+.-.++|+.|||++|+|+--=|.++..+
T Consensus 266 -----y~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L 340 (873)
T KOG4194|consen 266 -----YGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVL 340 (873)
T ss_pred -----eeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHH
Confidence 123478899999999988666789999999999999999998778999999999999999999995555677777
Q ss_pred ccCCceeee
Q 002688 479 QENNTLELR 487 (892)
Q Consensus 479 ~~l~~l~l~ 487 (892)
.+|+.|.++
T Consensus 341 ~~Le~LnLs 349 (873)
T KOG4194|consen 341 SQLEELNLS 349 (873)
T ss_pred HHhhhhccc
Confidence 777665543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.80 E-value=7.9e-05 Score=76.06 Aligned_cols=102 Identities=28% Similarity=0.303 Sum_probs=82.1
Q ss_pred HHHHHHHHhccc-cceeeEeeEeecCCcEEEEEEeccCCchhhh---ccccCcccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 002688 624 QAEVKLLLRVHH-RNLTTLVGYCDEGTNMALIYEYMANGNLEEH---LSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699 (892)
Q Consensus 624 ~~Ei~~l~~l~H-~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~---L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 699 (892)
..|.-+++.+++ +++.+++|+|.+ ++|.||...+++... +... ..-+|..|.+||.++++.+++|+....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357888888876 689999999964 789999988766432 1111 126899999999999999999998644
Q ss_pred CCccccCCCCccEEEcCCCcEEEeeecCcccc
Q 002688 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731 (892)
Q Consensus 700 ~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~ 731 (892)
..+.-.|++++|+-+++++++|+.|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 46778999999999999999999999876554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.77 E-value=1.3e-05 Score=80.42 Aligned_cols=82 Identities=32% Similarity=0.447 Sum_probs=35.1
Q ss_pred CCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCC-CCCCCCCEEEcCCCcCCCCCc--hhhhhhccCC
Q 002688 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFL-SQLSSLKFLNLARNKLTGPLP--VELLEKQENN 482 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~-~~l~~L~~L~l~~N~l~g~iP--~~l~~~~~l~ 482 (892)
..+++.|+|++|+|+. |+ .+..|+.|+.|+|++|+++ .|++.+ ..+++|+.|+|++|++.. +- ..+..+++|.
T Consensus 41 l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~ 116 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLR 116 (175)
T ss_dssp -TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--
T ss_pred hcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcc
Confidence 3578999999999986 54 5778899999999999999 576545 368999999999999873 32 2344555554
Q ss_pred ceeeeccCCCC
Q 002688 483 TLELRFDGNPD 493 (892)
Q Consensus 483 ~l~l~~~~n~~ 493 (892)
.+++.|||.
T Consensus 117 --~L~L~~NPv 125 (175)
T PF14580_consen 117 --VLSLEGNPV 125 (175)
T ss_dssp --EEE-TT-GG
T ss_pred --eeeccCCcc
Confidence 456678874
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=97.77 E-value=9.7e-06 Score=66.56 Aligned_cols=56 Identities=39% Similarity=0.495 Sum_probs=47.2
Q ss_pred cCCCcccCCCCccCCCCC-cCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCCceeee
Q 002688 431 TMLTSLDLSNNNLTGPVP-KFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELR 487 (892)
Q Consensus 431 ~~L~~L~L~~N~l~g~iP-~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~l~l~ 487 (892)
++|+.|+|++|+|+ .|| ..|..+++|+.|+|++|+++..-|..+..+++|+.++++
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~ 57 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLS 57 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEET
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCc
Confidence 57899999999999 555 688999999999999999995555678889888865544
|
... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00027 Score=75.26 Aligned_cols=138 Identities=15% Similarity=0.122 Sum_probs=84.6
Q ss_pred eccccc-EEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhcc-ccceeeEeeEeecCCcEEEEEEeccCCchhhh
Q 002688 589 LGKGGF-GTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEYMANGNLEEH 666 (892)
Q Consensus 589 IG~G~f-G~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 666 (892)
|-.|.. ..||+...++..+.||+..... ..+..+|++++..+. +--+.+++++....+..++|||+++|.++...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 334444 7899998777788888876543 345678999888884 33344667776666678899999998777643
Q ss_pred c-------------------cccCc--ccCC--HHHHHHHHH--------------------HHHHHHHHHHhC----CC
Q 002688 667 L-------------------SDSSK--EILN--WEERLRIAV--------------------EAALGLEYLHQG----CK 699 (892)
Q Consensus 667 L-------------------~~~~~--~~l~--~~~~~~i~~--------------------~ia~gL~yLH~~----~~ 699 (892)
. +.... ..+. ...+..... .+...++.|-.. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11100 0011 001110000 011112222111 23
Q ss_pred CCccccCCCCccEEEcCCCcEEEeeecCcc
Q 002688 700 PPIVHRDVKSTNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 700 ~~iiHrDLkp~NILl~~~~~vkl~DfGla~ 729 (892)
+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 468999999999999998778999999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00029 Score=82.01 Aligned_cols=140 Identities=26% Similarity=0.270 Sum_probs=88.5
Q ss_pred ceecccccEEEEEEEE-CCcEEEEEEccCCCchh-------------------------------hH------HHHHHHH
Q 002688 587 RVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQG-------------------------------YK------QFQAEVK 628 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~-------------------------------~~------~f~~Ei~ 628 (892)
+.||.-..|.||+|++ +|+.||||+-++.-.+. .+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999 88899999976642110 01 2445554
Q ss_pred HHHhc----ccccee---eEeeE-eecCCcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 002688 629 LLLRV----HHRNLT---TLVGY-CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700 (892)
Q Consensus 629 ~l~~l----~H~NIv---~l~g~-~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 700 (892)
-..+. .|-+.. .+=.. +.-.....|+||||+|..+.+.-.-. +..++-.....-+.++. +++-...
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~-----~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAY-----LEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHH-----HHHHHhc
Confidence 33333 455511 11122 23345789999999999777653211 12255444433333322 2211223
Q ss_pred CccccCCCCccEEEcC----CCcEEEeeecCccccc
Q 002688 701 PIVHRDVKSTNILINE----KFQAKLADFGLSRVFP 732 (892)
Q Consensus 701 ~iiHrDLkp~NILl~~----~~~vkl~DfGla~~~~ 732 (892)
|++|+|=.|.||+++. ++++.+.|||+.....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 8999999999999984 6789999999987653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.68 E-value=2.1e-05 Score=78.91 Aligned_cols=78 Identities=29% Similarity=0.425 Sum_probs=25.9
Q ss_pred CCCCEEEEEcCCCCccccchhhhh-hccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhh-hhccCC
Q 002688 405 DSPRITSLNLSASELTGGFAHYLT-NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELL-EKQENN 482 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~-~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~-~~~~l~ 482 (892)
++.+++.|+|++|.|+- | +.++ .|++|+.|||++|.|+ .|+. +..|+.|+.|+|++|+++ .++..+. .+++|.
T Consensus 17 n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~~-l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLEG-LPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---TT-----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred ccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-cccC-ccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence 34478999999999986 4 4576 6899999999999999 6764 889999999999999999 6766553 578777
Q ss_pred ceeee
Q 002688 483 TLELR 487 (892)
Q Consensus 483 ~l~l~ 487 (892)
.|.++
T Consensus 92 ~L~L~ 96 (175)
T PF14580_consen 92 ELYLS 96 (175)
T ss_dssp EEE-T
T ss_pred EEECc
Confidence 66543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00048 Score=71.86 Aligned_cols=134 Identities=22% Similarity=0.257 Sum_probs=88.5
Q ss_pred eecccccEEEEEEEE-CCcEEEEEEccCCCchhh------------------------HHHHHHHHHHHhcc--ccceee
Q 002688 588 VLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGY------------------------KQFQAEVKLLLRVH--HRNLTT 640 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~-~~~~vAVK~l~~~~~~~~------------------------~~f~~Ei~~l~~l~--H~NIv~ 640 (892)
.|+.|.-+.||+|.. ++..+|||+++....... ....+|+.-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 567777889999987 789999999865421110 01245666666653 223333
Q ss_pred EeeEeecCCcEEEEEEeccCC-chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCc
Q 002688 641 LVGYCDEGTNMALIYEYMANG-NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQ 719 (892)
Q Consensus 641 l~g~~~~~~~~~LV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~ 719 (892)
.+++. +-.|||||+... .-.-.|.... +...+...+..++++.+.-|-..+ +++|+||..-|||+. ++.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~---~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDVP---LELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccCC---cCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCe
Confidence 34333 237999998654 2222333222 222256667778888888887632 999999999999999 889
Q ss_pred EEEeeecCcccc
Q 002688 720 AKLADFGLSRVF 731 (892)
Q Consensus 720 vkl~DfGla~~~ 731 (892)
+.|+|+|.|...
T Consensus 205 p~iID~~QaV~~ 216 (268)
T COG1718 205 PYIIDVSQAVTI 216 (268)
T ss_pred EEEEECcccccc
Confidence 999999988654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00038 Score=68.80 Aligned_cols=128 Identities=23% Similarity=0.284 Sum_probs=87.3
Q ss_pred hhceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhccccceeeEeeEeecCCcEEEEEEeccCCchh
Q 002688 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664 (892)
Q Consensus 585 f~~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 664 (892)
..+.|++|.+|.||.+.+.+.++|+|+-...++ ...+..|+++|..+.-.++.+=+-.+.. -.+.|||+.|-.|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchh
Confidence 346799999999999999999999999776544 4678999999999987776654333322 23459999987776
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCC--ccEEEcCCCcEEEeeecCccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKS--TNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp--~NILl~~~~~vkl~DfGla~~ 730 (892)
++-... +-.+. ..+++.---|-.. +|-|..|.- .||++.+ ..+.|+||.-|..
T Consensus 101 ~~~~~~-----~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG-----DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc-----cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 654321 11222 2233332223222 888888864 4555554 4999999998874
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.65 E-value=2.5e-05 Score=59.49 Aligned_cols=41 Identities=32% Similarity=0.516 Sum_probs=34.8
Q ss_pred CCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCc
Q 002688 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPK 449 (892)
Q Consensus 407 ~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~ 449 (892)
++|+.|+|++|+|+. ||+.|++|++|+.|+|++|+|+ .+|.
T Consensus 1 ~~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~-~i~~ 41 (44)
T PF12799_consen 1 KNLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPIS-DISP 41 (44)
T ss_dssp TT-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCS-BEGG
T ss_pred CcceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCC-CCcC
Confidence 368899999999995 9999999999999999999999 5553
|
... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=1.4e-05 Score=91.78 Aligned_cols=180 Identities=22% Similarity=0.210 Sum_probs=131.0
Q ss_pred eecccccEEEEEEEEC-CcEEEEEEccCCCchhhHHHHHHHHHHHhccccc-eeeEeeEeecCCcEEEEEEeccCC-chh
Q 002688 588 VLGKGGFGTVYHGKLD-NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRN-LTTLVGYCDEGTNMALIYEYMANG-NLE 664 (892)
Q Consensus 588 ~IG~G~fG~Vy~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~N-Iv~l~g~~~~~~~~~LV~Ey~~~g-sL~ 664 (892)
-.++|+.+.+||.+-. .+....+.+... ....-++++|.+++||| .++.++-+..+....++++++..+ +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 4688999999998763 233334444332 34456889999999999 777777777778889999999887 322
Q ss_pred hhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCCCcEEEeeecCcccccCCCCcccccccc
Q 002688 665 EHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744 (892)
Q Consensus 665 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 744 (892)
...... ...+...+...+.+.-+++++++|+. .=+||| ||+..+ ...|..||+....+.... ......
T Consensus 324 ~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~ 391 (829)
T KOG0576|consen 324 LEMTVS-EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI 391 (829)
T ss_pred ccCChh-hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence 222111 11244455566777788999999986 458998 777766 688999999887664322 344567
Q ss_pred CCCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002688 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVIS 784 (892)
Q Consensus 745 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ELltG~~p~~ 784 (892)
+++.++|||....+.+..+.|+|++|+-..+|--|-+|-.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 8999999999999999999999999987777777766543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=2.3e-05 Score=85.22 Aligned_cols=92 Identities=26% Similarity=0.261 Sum_probs=78.9
Q ss_pred CCCCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCCc
Q 002688 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483 (892)
Q Consensus 404 ~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~ 483 (892)
...++|+.|+|++|.|++.-+..|..+..|+.|.|..|+|.-.--..|..|..|+.|+|.+|+++-.-|..+..+..|.
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~- 349 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS- 349 (498)
T ss_pred hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee-
Confidence 6789999999999999998889999999999999999999843345688999999999999999977787777666665
Q ss_pred eeeeccCCCCCCCC
Q 002688 484 LELRFDGNPDLCRS 497 (892)
Q Consensus 484 l~l~~~~n~~~c~~ 497 (892)
.+.+-+||+.|.+
T Consensus 350 -~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 350 -TLNLLSNPFNCNC 362 (498)
T ss_pred -eeehccCcccCcc
Confidence 3556789999883
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=6.8e-05 Score=91.33 Aligned_cols=58 Identities=33% Similarity=0.355 Sum_probs=35.2
Q ss_pred EEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhh
Q 002688 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVEL 475 (892)
Q Consensus 409 l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l 475 (892)
++.|+|++|+|++ ||.. .++|+.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .||...
T Consensus 364 L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~ 421 (788)
T PRK15387 364 LYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP 421 (788)
T ss_pred cceehhhcccccc-Cccc---ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch
Confidence 3444444444443 3432 245777777777777 46653 356788888888888 477643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=2.3e-05 Score=85.23 Aligned_cols=86 Identities=27% Similarity=0.337 Sum_probs=70.8
Q ss_pred eeecC------CCCCCCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcC-CCcCCC
Q 002688 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA-RNKLTG 469 (892)
Q Consensus 397 v~C~~------~~~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~-~N~l~g 469 (892)
|.|+. |.+.++..+.|+|..|+|+-.-|..|+.|.+|+.||||+|+|+-.=|+.|..|++|..|-|- +|+++
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~- 129 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT- 129 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-
Confidence 88885 55677899999999999998666799999999999999999998789999999998776554 59999
Q ss_pred CCchh-hhhhccCCc
Q 002688 470 PLPVE-LLEKQENNT 483 (892)
Q Consensus 470 ~iP~~-l~~~~~l~~ 483 (892)
.+|.. +..+..++.
T Consensus 130 ~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQR 144 (498)
T ss_pred hhhhhHhhhHHHHHH
Confidence 78864 445554443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=2e-05 Score=73.89 Aligned_cols=77 Identities=27% Similarity=0.367 Sum_probs=65.5
Q ss_pred CCCCEEEEEcCCCCccccchhhhhhc-cCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCCc
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNL-TMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l-~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~ 483 (892)
...+|+.++|++|.|.. +|+.|... +.++.|+|++|.|+ .+|.++..++.|+.|++++|.|. ..|..+..+.++..
T Consensus 51 ~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~ 127 (177)
T KOG4579|consen 51 KGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDM 127 (177)
T ss_pred CCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHH
Confidence 34688999999999987 77777665 58999999999999 89999999999999999999999 78888887776544
Q ss_pred e
Q 002688 484 L 484 (892)
Q Consensus 484 l 484 (892)
|
T Consensus 128 L 128 (177)
T KOG4579|consen 128 L 128 (177)
T ss_pred h
Confidence 3
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0019 Score=70.95 Aligned_cols=75 Identities=12% Similarity=0.039 Sum_probs=56.2
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhccc---cceeeEeeEeec---CCcEEEEEEeccC
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH---RNLTTLVGYCDE---GTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---~NIv~l~g~~~~---~~~~~LV~Ey~~~ 660 (892)
+.||.|..+.||+....+..+++|..+... ....+..|.+.|+.+.. -.+.+++++|.. .+..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 479999999999988755667778754311 22578899999988853 356778887754 3568999999998
Q ss_pred Cch
Q 002688 661 GNL 663 (892)
Q Consensus 661 gsL 663 (892)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0018 Score=66.55 Aligned_cols=130 Identities=22% Similarity=0.402 Sum_probs=91.5
Q ss_pred ceecccccEEEEEEEECCcEEEEEEccCCC----------------chhhHHHHHHHHHHHhcc------ccceeeEeeE
Q 002688 587 RVLGKGGFGTVYHGKLDNDEVAVKMLSPSS----------------SQGYKQFQAEVKLLLRVH------HRNLTTLVGY 644 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~~~vAVK~l~~~~----------------~~~~~~f~~Ei~~l~~l~------H~NIv~l~g~ 644 (892)
..||+|+.-.||..-. +....||+..... ....++..+|+.....+. +..|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 4799999999996543 3456688876654 223466777777666665 7889999999
Q ss_pred eecCCcEEEEEEeccC--C----chhhhccccCcccCCHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCccEEEcCC-
Q 002688 645 CDEGTNMALIYEYMAN--G----NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK- 717 (892)
Q Consensus 645 ~~~~~~~~LV~Ey~~~--g----sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~- 717 (892)
...+....+|+|.+.+ | +|.+++.+.. ++. .. ...+-+-.+||-+. +|+.+|++|+||++...
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~---~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-EL---RQALDEFKRYLLDH---HIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HH---HHHHHHHHHHHHHc---CCeecCCCcccEEEEecC
Confidence 9999999999998654 2 5677775432 444 32 33334445677776 89999999999999643
Q ss_pred --C-cEEEee-ecC
Q 002688 718 --F-QAKLAD-FGL 727 (892)
Q Consensus 718 --~-~vkl~D-fGl 727 (892)
. .+.|+| ||-
T Consensus 156 ~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 156 SGEFRLVLIDGLGE 169 (199)
T ss_pred CCceEEEEEeCCCC
Confidence 2 577777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0017 Score=81.40 Aligned_cols=144 Identities=17% Similarity=0.272 Sum_probs=90.5
Q ss_pred ceecccccEEEEEEEECC----cEEEEEEccCCC-chhhHHHHHHHHHHHhcc-ccce--eeEeeEeecC---CcEEEEE
Q 002688 587 RVLGKGGFGTVYHGKLDN----DEVAVKMLSPSS-SQGYKQFQAEVKLLLRVH-HRNL--TTLVGYCDEG---TNMALIY 655 (892)
Q Consensus 587 ~~IG~G~fG~Vy~~~~~~----~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~NI--v~l~g~~~~~---~~~~LV~ 655 (892)
+.++.|.+..+|+....+ ..+++|+..... ......+.+|+++++.+. |.++ .+++++|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 468889999999987743 467788765432 123357889999999995 6665 6777887654 4678999
Q ss_pred EeccCCchhhh-----------------------ccccCc---------ccCCHHH--HHHH---------------HHH
Q 002688 656 EYMANGNLEEH-----------------------LSDSSK---------EILNWEE--RLRI---------------AVE 686 (892)
Q Consensus 656 Ey~~~gsL~~~-----------------------L~~~~~---------~~l~~~~--~~~i---------------~~~ 686 (892)
||+++..+.+. ||.... ....+.. ...+ .-.
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 99987653321 111100 0111111 1000 012
Q ss_pred HHHHHHHHHhCCC--------CCccccCCCCccEEEcC-CCc-EEEeeecCccc
Q 002688 687 AALGLEYLHQGCK--------PPIVHRDVKSTNILINE-KFQ-AKLADFGLSRV 730 (892)
Q Consensus 687 ia~gL~yLH~~~~--------~~iiHrDLkp~NILl~~-~~~-vkl~DfGla~~ 730 (892)
+...+++|..+.. +.++|+|+++.|++++. +.. .-|.||.++..
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 3344667754322 35999999999999985 333 57999998764
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00017 Score=54.71 Aligned_cols=34 Identities=32% Similarity=0.854 Sum_probs=24.3
Q ss_pred ChhHHHHHHHHHHhcC-----CCCCCCC----CCCCCCCCCCCeeeec
Q 002688 362 DEQDVDAIMNIKSFYG-----LKKNWQG----DPCAPQDYLWEGLNCS 400 (892)
Q Consensus 362 ~~~d~~al~~~k~~~~-----~~~~w~~----~~C~~~~~~w~gv~C~ 400 (892)
+++|++||++||+.+. .+.+|+. +|| +|.||+|+
T Consensus 1 ~~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-----~W~GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-----SWSGVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-----CSTTEEE-
T ss_pred CcHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-----eeccEEeC
Confidence 3679999999999874 3679963 566 79999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00019 Score=81.51 Aligned_cols=85 Identities=25% Similarity=0.308 Sum_probs=73.6
Q ss_pred CCCCCEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCCc
Q 002688 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483 (892)
Q Consensus 404 ~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~ 483 (892)
.-++..+.|||++|.|+-.-+..|-+|++|+.++|.+|.|+ .||.......+|+.|+|.+|.++..-.+++..++.++.
T Consensus 75 ~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrs 153 (873)
T KOG4194|consen 75 FLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRS 153 (873)
T ss_pred cCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhh
Confidence 34566789999999999988899999999999999999999 89997777778999999999999555678888888888
Q ss_pred eeeecc
Q 002688 484 LELRFD 489 (892)
Q Consensus 484 l~l~~~ 489 (892)
++++-|
T Consensus 154 lDLSrN 159 (873)
T KOG4194|consen 154 LDLSRN 159 (873)
T ss_pred hhhhhc
Confidence 777644
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=5.9e-05 Score=89.90 Aligned_cols=80 Identities=34% Similarity=0.568 Sum_probs=58.4
Q ss_pred CEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhhhhhccCCceeee
Q 002688 408 RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELR 487 (892)
Q Consensus 408 ~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l~~~~~l~~l~l~ 487 (892)
+|+.|||++|+++- .|..+..+.+|+.|+++.|-+. .+|.+.+++.+|++|+|.+|++. .+|.++.++.+|+.++++
T Consensus 46 ~L~~l~lsnn~~~~-fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQISS-FPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeecccccccc-CCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 47778888777764 7777777777777777777777 67777777777777777777777 677777777777766666
Q ss_pred ccC
Q 002688 488 FDG 490 (892)
Q Consensus 488 ~~~ 490 (892)
|+.
T Consensus 123 ~N~ 125 (1081)
T KOG0618|consen 123 FNH 125 (1081)
T ss_pred hhc
Confidence 553
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0017 Score=69.71 Aligned_cols=137 Identities=15% Similarity=0.087 Sum_probs=81.1
Q ss_pred ecccccEEEEEEEECCcEEEEEEccCCCchhhHHHHHHHHHHHhcccccee-eEeeEeecCCcEEEEEEeccCCchhhh-
Q 002688 589 LGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLT-TLVGYCDEGTNMALIYEYMANGNLEEH- 666 (892)
Q Consensus 589 IG~G~fG~Vy~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~NIv-~l~g~~~~~~~~~LV~Ey~~~gsL~~~- 666 (892)
+..|-...+|+...++..+++|..........-+..+|.++++.+....++ ++++.+. -.+|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~ 79 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQ 79 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccccc
Confidence 456778899998888888999886543222112457889999888654443 3343332 2689999998765421
Q ss_pred ----------------ccccC--cccCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCccccCCCCccEE
Q 002688 667 ----------------LSDSS--KEILNWEER-LRIAVE---------AALGLEYLHQG-----CKPPIVHRDVKSTNIL 713 (892)
Q Consensus 667 ----------------L~~~~--~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~iiHrDLkp~NIL 713 (892)
||... ...++...+ ..+..+ +...++.+... ..+.++|+|+.|.||+
T Consensus 80 ~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil 159 (256)
T TIGR02721 80 FVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLV 159 (256)
T ss_pred ccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEE
Confidence 12111 111222211 111111 11112222211 1336899999999999
Q ss_pred EcCCCcEEEeeecCccc
Q 002688 714 INEKFQAKLADFGLSRV 730 (892)
Q Consensus 714 l~~~~~vkl~DfGla~~ 730 (892)
+++++ ++|+||..+..
T Consensus 160 ~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 160 VTPQG-LKLIDWEYASD 175 (256)
T ss_pred EeCCC-CEEEeccccCc
Confidence 99876 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0022 Score=65.53 Aligned_cols=125 Identities=26% Similarity=0.349 Sum_probs=88.6
Q ss_pred Hhhhhhceeccccc-EEEEEEEECCcEEEEEEccC---CCc------------------hhhHHHHHHHHHHHhcc---c
Q 002688 581 MTNNFERVLGKGGF-GTVYHGKLDNDEVAVKMLSP---SSS------------------QGYKQFQAEVKLLLRVH---H 635 (892)
Q Consensus 581 ~t~~f~~~IG~G~f-G~Vy~~~~~~~~vAVK~l~~---~~~------------------~~~~~f~~Ei~~l~~l~---H 635 (892)
...+|-+.||.|.. |.|||++.+|+.+|+|.+.. ... .-...|..|.+...+++ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 34456688999999 99999999999999999322 110 01134788998888775 4
Q ss_pred cce--eeEeeEeecC------------------CcEEEEEEeccCCchhhhccccCcccCCHHHHHHHHHHHHHHHHHHH
Q 002688 636 RNL--TTLVGYCDEG------------------TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695 (892)
Q Consensus 636 ~NI--v~l~g~~~~~------------------~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH 695 (892)
.++ |+..||..-. ..+.+|.||++... .+. .+-+.++.+-|..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHHH
Confidence 455 8888887211 12467888776532 122 233556777788899
Q ss_pred hCCCCCccccCCCCccEEEcCCCcEEEeeecCc
Q 002688 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLS 728 (892)
Q Consensus 696 ~~~~~~iiHrDLkp~NILl~~~~~vkl~DfGla 728 (892)
.. +|+-+|+++.|.. .-||+|||.+
T Consensus 182 k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HC---CeeeccCcccccc-----CCEEEecccC
Confidence 88 9999999999986 4589999854
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00034 Score=85.69 Aligned_cols=61 Identities=30% Similarity=0.475 Sum_probs=33.7
Q ss_pred CEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhh
Q 002688 408 RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVEL 475 (892)
Q Consensus 408 ~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l 475 (892)
.|+.|+|++|+|+. +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+
T Consensus 263 ~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l 323 (754)
T PRK15370 263 ALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETL 323 (754)
T ss_pred CCCEEECcCCccCc-cccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCccc
Confidence 45666666666653 555443 35666666666666 3554433 35666666666666 355433
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0015 Score=73.35 Aligned_cols=148 Identities=16% Similarity=0.205 Sum_probs=90.4
Q ss_pred eEeccCCCC-CCCcccCCCceEeecC---ccccccCCccccc--hhhc--cccccccccccccCCCCcceeeee---ecC
Q 002688 30 ISLDCGLPK-DSSYTETSTKLRYTSD---ANYIETGLPKSIL--LQYR--RMKQQQVWSLRSFPDGIRNCYRFN---LTR 98 (892)
Q Consensus 30 ~~idCG~~~-~~~~~~~~~~~~~~~D---~~~~~~g~~~~i~--~~~~--~~~~~~~~tlR~Fp~~~~nCY~l~---~~~ 98 (892)
.-++||++. ...|.+|.-.|.|.+. .+..+-..+..|. .... ..+...|+|+|.=.....+ ++|. +.+
T Consensus 181 ~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s~~-~nltw~~~~~ 259 (347)
T PF12819_consen 181 YRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQTARTPSNSSDP-LNLTWSFVDP 259 (347)
T ss_pred EeecCCCcccccCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHhhhcccccccc-eEEEeccCCC
Confidence 459999754 3778889999999963 2232222222332 1111 1233447899888766422 4432 567
Q ss_pred CceeEEeEEeeecCCCCCC-CCCceeEEeCCceeee-eeecCCc---cceEEEEE-EEeccCceeEEEEecCCC--Ccce
Q 002688 99 NTKYLIRATFMYGNYDEQN-NLPEFDVHLGPNLWGT-IKIENVS---VDYSVEII-HVLSSDYLSVCIVNTNKG--TPFI 170 (892)
Q Consensus 99 ~~~ylvR~~f~ygnyd~~~-~~p~Fd~~~~~~~w~~-v~~~~~~---~~~~~e~i-~~~~~~~~~vcl~~~~~~--~pfi 170 (892)
+-.|+||++|-==..-..+ ..-.||++++|..|.. +...... ..++...+ -+..+..+.|.|..+..+ .|+|
T Consensus 260 ~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~lppiL 339 (347)
T PF12819_consen 260 GFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTLPPIL 339 (347)
T ss_pred CccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCCcCcee
Confidence 8899999999533222112 2458999999999873 3321111 11233333 344456899999987655 4999
Q ss_pred eeeeeeec
Q 002688 171 SALELRPL 178 (892)
Q Consensus 171 s~lE~~~l 178 (892)
+|+|+..+
T Consensus 340 NalEIy~v 347 (347)
T PF12819_consen 340 NALEIYKV 347 (347)
T ss_pred EeeeeEeC
Confidence 99999753
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00046 Score=84.47 Aligned_cols=61 Identities=33% Similarity=0.517 Sum_probs=30.3
Q ss_pred CEEEEEcCCCCccccchhhhhhccCCCcccCCCCccCCCCCcCCCCCCCCCEEEcCCCcCCCCCchhh
Q 002688 408 RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVEL 475 (892)
Q Consensus 408 ~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~l~~N~l~g~iP~~l 475 (892)
.|+.|+|++|+|++ ||..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+
T Consensus 326 sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l 386 (754)
T PRK15370 326 GLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENL 386 (754)
T ss_pred cceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhH
Confidence 45555555555554 444432 45555555555555 3454332 34555555555555 344443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 892 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-56 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-55 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-53 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-44 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-44 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-40 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-31 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-27 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-25 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-24 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-24 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-20 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-17 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-17 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-16 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-16 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-15 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-15 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-15 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-15 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-15 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-15 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-15 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 485 bits (1251), Expect = e-166
Identities = 125/317 (39%), Positives = 181/317 (57%), Gaps = 8/317 (2%)
Query: 548 RLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNF--ERVLGKGGFGTVYHGKL-DN 604
+ S + S + S + ++ TNNF + ++G G FG VY G L D
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 605 DEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLE 664
+VA+K +P SSQG ++F+ E++ L H +L +L+G+CDE M LIY+YM NGNL+
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 665 EHL--SDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKL 722
HL SD ++WE+RL I + AA GL YLH I+HRDVKS NIL++E F K+
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 723 ADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPV 782
DFG+S+ TH+ST + GT GY+DPEY+I RLTEKSDVYSFGVVL E++
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 783 ISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRR 842
I +S ++A+W + G + VDP L S+ K + A+ C++ ++ R
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300
Query: 843 PFMNQVVMELNDCLAME 859
P M V+ +L L ++
Sbjct: 301 PSMGDVLWKLEYALRLQ 317
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 395 bits (1017), Expect = e-131
Identities = 110/312 (35%), Positives = 171/312 (54%), Gaps = 21/312 (6%)
Query: 560 NRSYESLDLSSRQFTYSEVLRMTNNFER--------VLGKGGFGTVYHGKLDNDEVAVKM 611
N+S E D F++ E+ +TNNF+ +G+GGFG VY G ++N VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK 61
Query: 612 LS----PSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL 667
L+ ++ + +QF E+K++ + H NL L+G+ +G ++ L+Y YM NG+L + L
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 668 SD-SSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFG 726
S L+W R +IA AA G+ +LH+ +HRD+KS NIL++E F AK++DFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178
Query: 727 LSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKS 786
L+R T +++ I GT Y+ PE + +T KSD+YSFGVVLLEIITG P + +
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 787 AENGHTHVAQWVSSML-DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFM 845
E + + ++ I +D ++ D D SV +A C+ N+RP +
Sbjct: 238 REPQ--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 846 NQVVMELNDCLA 857
+V L + A
Sbjct: 295 KKVQQLLQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 390 bits (1005), Expect = e-129
Identities = 121/310 (39%), Positives = 187/310 (60%), Gaps = 12/310 (3%)
Query: 569 SSRQFTYSEVLRMTNNF--ERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYK-QFQ 624
++F+ E+ ++NF + +LG+GGFG VY G+L D VAVK L +QG + QFQ
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 625 AEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL--SDSSKEILNWEERLR 682
EV+++ HRNL L G+C T L+Y YMANG++ L S+ L+W +R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 683 IAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742
IA+ +A GL YLH C P I+HRDVK+ NIL++E+F+A + DFGL+++ THV+T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTA 194
Query: 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVI--SKSAENGHTHVAQWVSS 800
+ GT G++ PEY + + +EK+DV+ +GV+LLE+ITG ++ A + + WV
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 801 MLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMEL-NDCLA-- 857
+L + + + VD L+G++ V + +++A+ C S+ RP M++VV L D LA
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER 314
Query: 858 MEAAQKKESI 867
E QK+E
Sbjct: 315 WEEWQKEEMF 324
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 1e-88
Identities = 75/322 (23%), Positives = 124/322 (38%), Gaps = 28/322 (8%)
Query: 562 SYESLDLSSRQFTYSEVLRMTNNFE--RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQG 619
+ S + + + V +G FG V+ +L N+ VAVK+ Q
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS 62
Query: 620 YKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMA----LIYEYMANGNLEEHLSDSSKEIL 675
+ Q + EV L + H N+ +G GT++ LI + G+L + L ++
Sbjct: 63 W-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVV 118
Query: 676 NWEERLRIAVEAALGLEYLHQ-------GCKPPIVHRDVKSTNILINEKFQAKLADFGLS 728
+W E IA A GL YLH+ G KP I HRD+KS N+L+ A +ADFGL+
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 729 RVFPVEGGTHVSTTIAGTPGYLDPEY-----YISNRLTEKSDVYSFGVVLLEIITGHPVI 783
F + GT Y+ PE + D+Y+ G+VL E+ +
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 784 SKSAENGHTHVAQWVSSMLDKGDIRSTV-----DPRLKGDFDINSVWKAV-EIAMACVSS 837
+ + + D++ V P L+ + ++ + E C
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 838 NANRRPFMNQVVMELNDCLAME 859
+A R V + +
Sbjct: 299 DAEARLSAGCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 5e-72
Identities = 85/277 (30%), Positives = 143/277 (51%), Gaps = 29/277 (10%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLV 642
+ +G G FGTV+ + +VAVK+L ++ +F EV ++ R+ H N+ +
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 643 GYCDEGTNMALIYEYMANGNLEEHL-SDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
G + N++++ EY++ G+L L ++E L+ RL +A + A G+ YLH PP
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
IVHR++KS N+L+++K+ K+ DFGLSR+ + S + AGTP ++ PE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSN 217
Query: 762 EKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSMLDKG---DIRSTVDPRLKG 817
EKSDVYSFGV+L E+ T P G+ + AQ V+++ K +I ++P++
Sbjct: 218 EKSDVYSFGVILWELATLQQP-------WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA- 269
Query: 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854
I C ++ +RP ++ L
Sbjct: 270 -----------AIIEGCWTNEPWKRPSFATIMDLLRP 295
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-67
Identities = 72/330 (21%), Positives = 124/330 (37%), Gaps = 39/330 (11%)
Query: 572 QFTYSEVLRMTNNFE--RVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKL 629
+ SE +N + ++G+G +G VY G LD VAVK+ S ++ Q + + +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 630 LLRVHHRNLTTLVGYCDEG-----TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIA 684
+ + H N+ + + L+ EY NG+L ++LS +W R+A
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCRLA 117
Query: 685 VEAALGLEYLHQ------GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF------P 732
GL YLH KP I HRD+ S N+L+ ++DFGLS
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 733 VEGGTHVSTTIAGTPGYLDPEY-------YISNRLTEKSDVYSFGVVLLEIITGHPVISK 785
+ + + GT Y+ PE ++ D+Y+ G++ EI +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 786 SAENGHTHVA--QWVSSMLDKGDIRSTVD-----PRLKGDFDINSVWKAV--EIAMACVS 836
+A V + D++ V P+ + NS+ E C
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 837 SNANRRPFMNQVVMELNDCLAMEAAQKKES 866
+A R + + + + K S
Sbjct: 298 QDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 5e-67
Identities = 54/282 (19%), Positives = 115/282 (40%), Gaps = 38/282 (13%)
Query: 584 NFERVLGKGGFGTVYHGKLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTL 641
NF L + G ++ G+ +++ VK+L S++ + F E L H N+ +
Sbjct: 13 NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 642 VGYCDE--GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
+G C + LI +M G+L L + + +++ + ++ A++ A G+ +LH +
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE---YYI 756
P I + S +++I+E A+++ + F S P ++ PE
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKP 184
Query: 757 SNRLTEKSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQWVSSMLDKG---DIRSTVD 812
+ +D++SF V+L E++T P + + +G I +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVP-------FADLSNMEIGMKVALEGLRPTIPPGIS 237
Query: 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854
P + ++ C++ + +RP + +V L
Sbjct: 238 PHVS------------KLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 7e-66
Identities = 78/286 (27%), Positives = 122/286 (42%), Gaps = 42/286 (14%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPS----SSQGYKQFQAEVKLLLRVHHRNLTT 640
E ++G GGFG VY DEVAVK SQ + + E KL + H N+
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
L G C + N+ L+ E+ G L LS + + + AV+ A G+ YLH
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 701 PIVHRDVKSTNILINEKFQ--------AKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
PI+HRD+KS+NILI +K + K+ DFGL+R + + AG ++ P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAP 183
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQWVSSMLDKG---DIR 808
E ++ ++ SDV+S+GV+L E++TG P + I
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP-------FRGIDGLAVAYGVAMNKLALPIP 236
Query: 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854
ST ++ C + + + RP ++ +L
Sbjct: 237 STCPEPFA------------KLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 8e-66
Identities = 84/290 (28%), Positives = 141/290 (48%), Gaps = 46/290 (15%)
Query: 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQG-------YKQFQAEVKLLLRVHH 635
+E+ +GKGGFG V+ G+L D VA+K L S+G +++FQ EV ++ ++H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
N+ L G ++ E++ G+L L D + + W +LR+ ++ ALG+EY+
Sbjct: 83 PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ 139
Query: 696 QGCKPPIVHRDVKSTNILINEK-----FQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYL 750
PPIVHRD++S NI + AK+ADFGLS+ H + + G ++
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLLGNFQWM 193
Query: 751 DPE--YYISNRLTEKSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQWVSSMLDKG-- 805
PE TEK+D YSF ++L I+TG P + ++++ + ++G
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKIKFINMIREEGLR 248
Query: 806 -DIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854
I PRL+ + C S + +RP + +V EL++
Sbjct: 249 PTIPEDCPPRLR------------NVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 8e-66
Identities = 79/282 (28%), Positives = 136/282 (48%), Gaps = 36/282 (12%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLV 642
+ +G G FGTVY GK + +VAVKML+ + + Q + F+ EV +L + H N+ +
Sbjct: 28 VGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
GY +A++ ++ +L HL S + ++ + IA + A G++YLH I
Sbjct: 87 GYSTAP-QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE---YYISNR 759
+HRD+KS NI ++E K+ DFGL+ G+H ++G+ ++ PE SN
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 760 LTEKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSS------MLDKGDIRSTVD 812
+ +SDVY+FG+VL E++TG P + + Q + D +RS
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854
R+K + C+ + RP +++ E+ +
Sbjct: 256 KRMK------------RLMAECLKKKRDERPSFPRILAEIEE 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-65
Identities = 66/287 (22%), Positives = 118/287 (41%), Gaps = 33/287 (11%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
E V+G+G FG V K +VA+K + S + K F E++ L RV+H N+ L G
Sbjct: 12 VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 645 CDEGTNMALIYEYMANGNLEEHL-SDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
C + L+ EY G+L L + ++ + G+ YLH ++
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 704 HRDVKSTNILINEKFQ-AKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE 762
HRD+K N+L+ K+ DFG + T G+ ++ PE + + +E
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 763 KSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQWVSSMLDKG---DIRSTVDPRLKGD 818
K DV+S+G++L E+IT P + A + + G + + ++
Sbjct: 183 KCDVFSWGIILWEVITRRKPF------DEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE-- 234
Query: 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKE 865
+ C S + ++RP M ++V + + +
Sbjct: 235 ----------SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-62
Identities = 61/285 (21%), Positives = 114/285 (40%), Gaps = 37/285 (12%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLV 642
++GKG FG VYHG+ + EVA++++ + K F+ EV + H N+ +
Sbjct: 37 IGELIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
G C ++A+I L + D +K +L+ + +IA E G+ YLH I
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS---TTIAGTPGYLDPEYYISNR 759
+H+D+KS N+ + + + DFGL + V G +L PE
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 760 L---------TEKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSMLDKGDIRS 809
++ SDV++ G + E+ P ++ AE + + + + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE----AIIWQMGTGMKPNLSQI 266
Query: 810 TVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854
+ + +I + C + RP +++ L
Sbjct: 267 GMGKEIS------------DILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-61
Identities = 72/301 (23%), Positives = 125/301 (41%), Gaps = 28/301 (9%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
+ +GKG +G V+ GK ++VAVK+ + + + E+ + + H N+ +
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASW-FRETEIYQTVLMRHENILGFIAA 99
Query: 645 CDEG----TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH----- 695
+G T + LI +Y NG+L ++L ++ L+ + L++A + GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH--VSTTIAGTPGYLDPE 753
KP I HRD+KS NIL+ + +AD GL+ F + T GT Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 754 ------YYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDI 807
+ +D+YSFG++L E+ V E V S D+
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRC-VSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 808 RSTVD-----PRLKGDFDINSVWKAV-EIAMACVSSNANRRPFMNQVVMELNDCLAMEAA 861
R V P + + + + ++ C + N R +V L +
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335
Query: 862 Q 862
+
Sbjct: 336 K 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 8e-60
Identities = 70/295 (23%), Positives = 118/295 (40%), Gaps = 32/295 (10%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKL--LLRVHHRNLTTLV 642
+GKG +G V+ G + VAVK+ S S+ K + E +L + + H N+ +
Sbjct: 12 LLECVGKGRYGEVWRGSWQGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 643 GYC----DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH--- 695
T + LI Y G+L ++L L+ LRI + A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 696 --QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV--STTIAGTPGYLD 751
KP I HRD+KS NIL+ + Q +AD GL+ + + GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 752 PE------YYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG 805
PE ++ D+++FG+VL E+ + E+ V +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS-NGIVEDYKPPFYDVVPNDPSFE 244
Query: 806 DIRSTVD-----PRLKGDFDINSVWKAV-EIAMACVSSNANRRPFMNQVVMELND 854
D+R V P + + + ++ ++ C N + R ++ L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-58
Identities = 68/287 (23%), Positives = 108/287 (37%), Gaps = 38/287 (13%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
VLGKG FG + + + +K L + + F EVK++ + H N+ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
G + + I EY+ G L + + W +R+ A + A G+ YLH I
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT------------HVSTTIAGTPGYL 750
+HRD+ S N L+ E +ADFGL+R+ E T+ G P ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 751 DPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG---DI 807
PE EK DV+SFG+VL EII +A+ + +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGR-----VNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 808 RSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854
P I + C + +RP ++ L
Sbjct: 245 PPNCPPSFF------------PITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-58
Identities = 67/306 (21%), Positives = 124/306 (40%), Gaps = 38/306 (12%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAE--VKLLLRVHHRNLTTLV 642
+ +GKG FG V+ GK +EVAVK+ S S+ + + E + + + H N+ +
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 643 GYC----DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ-- 696
T + L+ +Y +G+L ++L+ + + E +++A+ A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 697 ---GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH--VSTTIAGTPGYLD 751
KP I HRD+KS NIL+ + +AD GL+ T GT Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 752 PE------YYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAE---------NGHTHVAQ 796
PE +++D+Y+ G+V EI + + V +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 797 WVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856
+ ++ +R + R + + + +I C +N R ++ L+
Sbjct: 280 MRKVVCEQK-LRPNIPNRWQSCEALRVM---AKIMRECWYANGAARLTALRIKKTLSQLS 335
Query: 857 AMEAAQ 862
E +
Sbjct: 336 QQEGIK 341
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 65/268 (24%), Positives = 108/268 (40%), Gaps = 31/268 (11%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVK--MLSPSSSQGYKQFQAEVKLLLRVHHRNLTT 640
F+ +G+G F TVY G EVA + ++F+ E ++L + H N+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 641 LVGY----CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
+ L+ E M +G L+ +L + + + GL++LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLH- 146
Query: 697 GCKPPIVHRDVKSTNILINEKF-QAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
PPI+HRD+K NI I K+ D GL+ + + + GTP ++ PE Y
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMY 202
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815
+ E DVY+FG+ +LE+ T S+ + + V+S + P +
Sbjct: 203 -EEKYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPASFDKVAIPEV 259
Query: 816 KGDFDINSVWKAVEIAMACVSSNANRRP 843
K EI C+ N + R
Sbjct: 260 K------------EIIEGCIRQNKDERY 275
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-41
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSP-SSSQGYKQFQAEVKLLLRVHHRNLTTL 641
+G+G FG V+ G+L DN VAVK +F E ++L + H N+ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
+G C + + ++ E + G+ L + L + L++ +AA G+EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG------TPGYLDPEYY 755
+HRD+ + N L+ EK K++DFG+SR G + ++ T PE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTA----PEAL 287
Query: 756 ISNRLTEKSDVYSFGVVLLEIIT 778
R + +SDV+SFG++L E +
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 27/203 (13%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
+ +GKG FG V G ++VAVK + ++ + F AE ++ ++ H NL L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 645 C-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPI 702
+E + ++ EYMA G+L ++L + +L + L+ +++ +EYL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---- 138
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG-------TPGYLDPEYY 755
VHRD+ + N+L++E AK++DFGL++ S+T T PE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTA----PEAL 186
Query: 756 ISNRLTEKSDVYSFGVVLLEIIT 778
+ + KSDV+SFG++L EI +
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYS 209
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-41
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 27/203 (13%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
+ +GKG FG V G ++VAVK + ++ + F AE ++ ++ H NL L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 645 C-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPI 702
+E + ++ EYMA G+L ++L + +L + L+ +++ +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---- 310
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG-------TPGYLDPEYY 755
VHRD+ + N+L++E AK++DFGL++ S+T T PE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTA----PEAL 358
Query: 756 ISNRLTEKSDVYSFGVVLLEIIT 778
+ + KSDV+SFG++L EI +
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-40
Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 11/198 (5%)
Query: 585 FERVLGKGGFGTVYHGKLDNDE--VAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
+ LG G +G VY G VAVK L + + ++F E ++ + H NL L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKPP 701
G C +I E+M GNL ++L + +++ ++ L +A + + +EYL +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 339
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRL 760
+HR++ + N L+ E K+ADFGLSR+ + G T+ + A P + PE N+
Sbjct: 340 -IHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 761 TEKSDVYSFGVVLLEIIT 778
+ KSDV++FGV+L EI T
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-40
Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 11/198 (5%)
Query: 585 FERVLGKGGFGTVYHGKLDNDE--VAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
+ LG G +G VY G VAVK L + + ++F E ++ + H NL L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPP 701
G C +I E+M GNL ++L + +++ ++ L +A + + +EYL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRL 760
+HRD+ + N L+ E K+ADFGLSR+ + G T+ + A P + PE N+
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 761 TEKSDVYSFGVVLLEIIT 778
+ KSDV++FGV+L EI T
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 583 NNFE--RVLGKGGFGTVYHG--KLDNDEVAVKM--LSPSSSQGYKQFQAEVKLLLRVHHR 636
++E +G G +G K D + K + + +EV LL + H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 637 NLTTLVGYCD-----EGTNMALIYEYMANGNLEEHLSDSSKEILNWEER--LRIAVEAAL 689
N+ V Y D T + ++ EY G+L ++ +KE +E LR+ + L
Sbjct: 66 NI---VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 690 GLEYLHQGCKPP--IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP 747
L+ H+ ++HRD+K N+ ++ K KL DFGL+R+ T + T GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTP 180
Query: 748 GYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
Y+ PE EKSD++S G +L E+ P
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 585 FERVLGKGGFGTVYHGKLD------NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNL 638
F + LGKG FG+V + D + VAVK L S+ + + F+ E+++L + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 639 TTLVGYC--DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH- 695
G C N+ LI EY+ G+L ++L + ++ + L+ + G+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT 132
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
+ +HRD+ + NIL+ + + K+ DFGL++V P + +P + PE
Sbjct: 133 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
++ + SDV+SFGVVL E+ T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 585 FERVLGKGGFGTVYHGKLD------NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNL 638
F + LGKG FG+V + D + VAVK L S+ + + F+ E+++L + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 639 TTLVGYC--DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH- 695
G C N+ LI EY+ G+L ++L KE ++ + L+ + G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
+ +HRD+ + NIL+ + + K+ DFGL++V P + + +P + PE
Sbjct: 164 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
++ + SDV+SFGVVL E+ T
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 62/205 (30%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 585 FERVLGKGGFGTVYHGKLDND------EVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRN 637
R LG+G FG V + D + +VAVK L P S + + E+++L ++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 638 LTTLVGYC--DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
+ G C D G + LI E++ +G+L+E+L + + +N +++L+ AV+ G++YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLG 143
Query: 696 -QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPE 753
+ VHRD+ + N+L+ + Q K+ DFGL++ + + +P + PE
Sbjct: 144 SRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 754 YYISNRLTEKSDVYSFGVVLLEIIT 778
+ ++ SDV+SFGV L E++T
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-39
Identities = 55/226 (24%), Positives = 103/226 (45%), Gaps = 15/226 (6%)
Query: 562 SYESLDLSSRQFTYSEVLRMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKM--LSPS 615
+DL + + M + + +G+G FG D + +K +S
Sbjct: 7 HSSGVDLGTENLYFQS---M-EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM 62
Query: 616 SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEIL 675
SS+ ++ + EV +L + H N+ +E ++ ++ +Y G+L + ++ +
Sbjct: 63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122
Query: 676 NWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735
++ L V+ L L+++H I+HRD+KS NI + + +L DFG++RV
Sbjct: 123 QEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NS 177
Query: 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
++ GTP YL PE + KSD+++ G VL E+ T
Sbjct: 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-39
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 585 FERVLGKGGFGTVYHGKLDND------EVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRN 637
R LG+G FG V D VAVK L + ++ ++ E+ +L ++H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 638 LTTLVGYC--DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
+ G C ++ L+ EY+ G+L ++L S + + L A + G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 151
Query: 696 -QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPE 753
Q +HRD+ + N+L++ K+ DFGL++ P + +P + PE
Sbjct: 152 AQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 754 YYISNRLTEKSDVYSFGVVLLEIIT 778
+ SDV+SFGV L E++T
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 585 FERVLGKGGFGTVYHGKLDND------EVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNL 638
+ LGKG FG+V + D VAVK L S + FQ E+++L +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 639 TTLVGYC--DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH- 695
G ++ L+ EY+ +G L + L L+ L + + G+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGS 145
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEY 754
+ C VHRD+ + NIL+ + K+ADFGL+++ P++ +V +P + PE
Sbjct: 146 RRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
N + +SDV+SFGVVL E+ T
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 585 FERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
F + +G G FG V+ G + D+VA+K + + + F E ++++++ H L L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPI 702
C E + L+ E+M +G L ++L + + + E L + ++ G+ YL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACV---- 125
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLDPEYYIS 757
+HRD+ + N L+ E K++DFG++R V + S+T + PE +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWAS----PEVFSF 179
Query: 758 NRLTEKSDVYSFGVVLLEIIT 778
+R + KSDV+SFGV++ E+ +
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFS 200
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 12/202 (5%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVK---MLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
+ +G+G F VY LD VA+K + ++ E+ LL +++H N+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEER--LRIAVEAALGLEYLHQGCK 699
E + ++ E G+L + K+ ER + V+ LE++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
++HRD+K N+ I KL D GL R F T + ++ GTP Y+ PE N
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 760 LTEKSDVYSFGVVLLEIITGHP 781
KSD++S G +L E+
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQS 234
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-38
Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 585 FERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
E LG+G FG V+ G VA+K L P + + F E +++ ++ H L L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKPPI 702
E ++ EYM+ G+L + L + + L + + +A + A G+ Y+
Sbjct: 247 VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---- 301
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLT 761
VHRD+++ NIL+ E K+ADFGL+R+ +E + + A P + PE + R T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 762 EKSDVYSFGVVLLEIIT 778
KSDV+SFG++L E+ T
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 585 FERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
+ LG G FG V GK +VAVKM+ S +F E + ++++ H L G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPI 702
C + + ++ EY++NG L +L K L + L + + G+ +L
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQF---- 125
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLDPEYYIS 757
+HRD+ + N L++ K++DFG++R V +VS+ + + PE +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVKWSA----PEVFHY 179
Query: 758 NRLTEKSDVYSFGVVLLEIIT 778
+ + KSDV++FG+++ E+ +
Sbjct: 180 FKYSSKSDVWAFGILMWEVFS 200
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-38
Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 585 FERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
E LG+G FG V+ G VA+K L P + + F E +++ ++ H L L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKPPI 702
E ++ EYM+ G+L + L + + L + + +A + A G+ Y+
Sbjct: 330 VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---- 384
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISNRLT 761
VHRD+++ NIL+ E K+ADFGL+R+ +E + + A P + PE + R T
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 762 EKSDVYSFGVVLLEIIT 778
KSDV+SFG++L E+ T
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 22/229 (9%)
Query: 562 SYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKL-----DNDEVAVKMLSP-S 615
+YE + R FT E+ + E+++G G G V +G+L + VA+K L
Sbjct: 31 TYEEPGRAGRSFTR-EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 616 SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEIL 675
+ + + F +E ++ + H N+ L G G ++ EYM NG+L+ L +
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-F 148
Query: 676 NWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734
+ + + G+ YL G VHRD+ + N+L++ K++DFGLSRV +
Sbjct: 149 TIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 735 GGTHVSTT-----IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+TT I T PE + SDV+SFGVV+ E++
Sbjct: 205 PDAAYTTTGGKIPIRWTA----PEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-37
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 585 FERVLGKGGFGTVYHGKLDND-EVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
E+ LG G FG V+ + +VAVK + P S + F AE ++ + H L L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPI 702
+ +I E+MA G+L + L + + + + A G+ ++ +
Sbjct: 251 VVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---- 305
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLDPEYYIS 757
+HRD+++ NIL++ K+ADFGL+RV +E + + I T PE
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINF 359
Query: 758 NRLTEKSDVYSFGVVLLEIIT 778
T KSDV+SFG++L+EI+T
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 585 FERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
F + LG G FG V +GK +VA+KM+ S +F E K+++ + H L L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPI 702
C + + +I EYMANG L +L + ++ L + + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQF---- 141
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLDPEYYIS 757
+HRD+ + N L+N++ K++DFGLSR V + S+ + +P PE +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSP----PEVLMY 195
Query: 758 NRLTEKSDVYSFGVVLLEIIT 778
++ + KSD+++FGV++ EI +
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYS 216
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKMLSPSSSQGYKQFQAEVKL 629
+ R + LG+G FG V+ + N VAVK L +S + FQ E +L
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 630 LLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL-------------SDSSKEILN 676
L + H+++ G C EG + +++EYM +G+L L D + L
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 677 WEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735
+ L +A + A G+ YL VHRD+ + N L+ + K+ DFG+SR
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--- 209
Query: 736 GTHVSTTIAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
G L PE + + T +SDV+SFGVVL EI T
Sbjct: 210 --STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 68/229 (29%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKMLSPSSSQGYKQFQAEVKL 629
+ R +R LG+G FG V+ + N VAVK L + K FQ E +L
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 630 LLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSS--------------KEIL 675
L + H ++ G C +G + +++EYM +G+L + L K L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 676 NWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734
+ L IA + A G+ YL Q VHRD+ + N L+ K+ DFG+SR
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDV--- 183
Query: 735 GGTHVSTTIAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
G L PE + + T +SDV+SFGV+L EI T
Sbjct: 184 --YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 3e-37
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 585 FERVLGKGGFGTVYHGKLDND------EVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRN 637
+VLG G FGTVY G + VA+K L ++S + E ++ V + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQ 696
+ L+G C T LI + M G L +++ + K+ + + L V+ A G+ YL +
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT----IAGTPGYLDP 752
VHRD+ + N+L+ K+ DFGL+++ E + + I
Sbjct: 137 RL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA----L 188
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIIT 778
E + T +SDV+S+GV + E++T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 586 ERVLGKGGFGTVYHGKLDND----EVAVKMLSP--SSSQGYKQFQAEVKLLLRVHHRNLT 639
++ LG G FGTV G VAVK+L + + AE ++ ++ + +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGC 698
++G C+ + M L+ E G L ++L + + + + + + ++G++YL
Sbjct: 82 RMIGICEAESWM-LVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNF 138
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLDPE 753
VHRD+ + N+L+ + AK++DFGLS+ + + + T + PE
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PE 190
Query: 754 YYISNRLTEKSDVYSFGVVLLEIIT 778
+ + KSDV+SFGV++ E +
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 47/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 586 ERVLGKGGFGTVYHGKLDND----EVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTT 640
+ LG G FG+V G +VA+K+L + + + E +++ ++ + +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCK 699
L+G C M L+ E G L + L +E + + + ++G++YL +
Sbjct: 75 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF- 131
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLDPEY 754
VHRD+ + N+L+ + AK++DFGLS+ + + + + + PE
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PEC 184
Query: 755 YISNRLTEKSDVYSFGVVLLEIIT 778
+ + +SDV+S+GV + E ++
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALS 208
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 53/215 (24%), Positives = 80/215 (37%), Gaps = 21/215 (9%)
Query: 585 FERVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
F + LG+GGF V G D A+K + Q ++ Q E + +H N+ LV
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 643 GYCDEGTNMA----LIYEYMANGNLEEHLSDSSKEILNWEER--LRIAVEAALGLEYLHQ 696
YC L+ + G L + + E L + + GLE +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA-------GTPGY 749
HRD+K TNIL+ ++ Q L D G + T Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 750 LDPE---YYISNRLTEKSDVYSFGVVLLEIITGHP 781
PE + E++DV+S G VL ++ G
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 585 FERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
LG G FG V+ G + +VAVK L S F AE L+ ++ H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPI 702
+ +I EYM NG+L + L S L + L +A + A G+ ++ +
Sbjct: 76 VVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---- 130
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLDPEYYIS 757
+HRD+++ NIL+++ K+ADFGL+R+ +E + + I T PE
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTA----PEAINY 184
Query: 758 NRLTEKSDVYSFGVVLLEIIT 778
T KSDV+SFG++L EI+T
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 24/206 (11%)
Query: 585 FERVLGKGGFGTVYHGKLDNDE-----VAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNL 638
R+LG+G FG VY G N + VAVK + K+ F +E ++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQG 697
L+G +E +I E G L +L + L + +++ + YL
Sbjct: 76 VKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESIN 133
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLDP 752
C VHRD+ NIL+ KL DFGLSR +E + + I P
Sbjct: 134 C----VHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWMS----P 183
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIIT 778
E R T SDV+ F V + EI++
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 49/222 (22%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 580 RMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH 635
R +F+ ++G GGFG V+ ++D +K + ++ ++ + EVK L ++ H
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDH 63
Query: 636 RN----------------LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEE 679
N ++ + + + E+ G LE+ + E L+
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 680 RLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739
L + + G++Y+H +++RD+K +NI + + Q K+ DFGL
Sbjct: 124 ALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGK 177
Query: 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
T GT Y+ PE S ++ D+Y+ G++L E++
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-37
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 585 FERVLGKGGFGTVYHGKL-----DNDEVAVKMLSP-SSSQGYKQFQAEVKLLLRVHHRNL 638
++V+G G FG V G+L VA+K L + + + F E ++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQG 697
L G + + ++ EYM NG+L+ L + + + + A G++YL G
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLDP 752
VHRD+ + NILIN K++DFGL RV + +T I T P
Sbjct: 168 Y----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----P 219
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIIT 778
E + T SDV+S+G+VL E+++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 24/206 (11%)
Query: 585 FERVLGKGGFGTVYHGKLDNDE-----VAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNL 638
R +G+G FG V+ G + E VA+K +S ++ F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQG 697
L+G E +I E G L L L+ + A + + L YL +
Sbjct: 79 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR 136
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLDP 752
VHRD+ + N+L++ KL DFGLSR +E T+ + I P
Sbjct: 137 F----VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA----P 186
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIIT 778
E R T SDV+ FGV + EI+
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-----VAVKMLSP--SSSQGYKQFQAEVKL 629
+ R ++LG+G FG+V G L ++ VAVK + SS + ++F +E
Sbjct: 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 630 LLRVHHRNLTTLVGYCDEGTNMA-----LIYEYMANGNLEEHL----SDSSKEILNWEER 680
+ H N+ L+G C E ++ +I +M G+L +L ++ + + +
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 681 LRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740
L+ V+ ALG+EYL +HRD+ + N ++ + +ADFGLS+ + G
Sbjct: 150 LKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKK--IYSG---D 201
Query: 741 TTIAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
G + E T KSDV++FGV + EI T
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 25/214 (11%)
Query: 580 RMTNNFERVLGKGGFGTVYHGKLDNDE-----VAVKMLSPSSSQG-YKQFQAEVKLLLRV 633
R+ + +RV+GKG FG VYHG+ + A+K LS + + F E L+ +
Sbjct: 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 634 HHRNLTTLVGYC--DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGL 691
+H N+ L+G EG ++ YM +G+L + + + ++ + ++ A G+
Sbjct: 80 NHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGM 137
Query: 692 EYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV------FPVEGGTHVSTTIA 744
EYL Q VHRD+ + N +++E F K+ADFGL+R + V+ H +
Sbjct: 138 EYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
T E + R T KSDV+SFGV+L E++T
Sbjct: 194 WTA----LESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 23/233 (9%)
Query: 559 CNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKLDND------EVAVKML 612
+ + +FT E+ ++V+G G FG VY G L VA+K L
Sbjct: 23 QGAMGSDPNQAVLKFTT-EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL 81
Query: 613 SP-SSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSS 671
+ + F E ++ + H N+ L G + M +I EYM NG L++ L +
Sbjct: 82 KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD 141
Query: 672 KEILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730
E + + + + A G++YL + VHRD+ + NIL+N K++DFGLSRV
Sbjct: 142 GE-FSVLQLVGMLRGIAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRV 196
Query: 731 FPVEGGTHVSTT-----IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ +T+ I T PE + T SDV+SFG+V+ E++T
Sbjct: 197 LEDDPEATYTTSGGKIPIRWTA----PEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 58/207 (28%), Positives = 80/207 (38%), Gaps = 22/207 (10%)
Query: 585 FERVLGKGGFGTVYHGKL-----DNDEVAVKMLSP---SSSQGYKQFQAEVKLLLRVHHR 636
LG G FG V G+ VAVK L P S + F EV + + HR
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
NL L G ++ E G+L + L R AV+ A G+ YL
Sbjct: 82 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES 139
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-----IAGTPGYLD 751
+HRD+ + N+L+ + K+ DFGL R P +V A
Sbjct: 140 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA---- 192
Query: 752 PEYYISNRLTEKSDVYSFGVVLLEIIT 778
PE + + SD + FGV L E+ T
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 584 NFERVLGKGGFGTVYHGKLDNDE-----VAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRN 637
+F V+G+G FG VYHG L +++ AVK L+ + G F E ++ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 638 LTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH- 695
+ +L+G C + ++ YM +G+L + + + ++ + ++ A G++YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLAS 146
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV------FPVEGGTHVSTTIAGTPGY 749
+ VHRD+ + N +++EKF K+ADFGL+R + V T +
Sbjct: 147 KKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA-- 200
Query: 750 LDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
E + + T KSDV+SFGV+L E++T
Sbjct: 201 --LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 29/223 (13%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKMLSPSSSQG-YKQFQAEVK 628
EV R R LG+G FG VY G VA+K ++ ++S +F E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL--------SDSSKEILNWEER 680
++ + ++ L+G +G +I E M G+L+ +L ++ + +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 681 LRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740
+++A E A G+ YL+ VHRD+ + N ++ E F K+ DFG++R +
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYET---D 192
Query: 741 TTIAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
G G L PE T SDV+SFGVVL EI T
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 64/233 (27%)
Query: 585 FERVLGKGGFGTVYHGKLDNDE----VAVKMLSPSSSQGYKQ-FQAEVKLLLRV-HHRNL 638
F+ V+G+G FG V ++ D A+K + +S+ + F E+++L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHL--------------SDSSKEILNWEERLRIA 684
L+G C+ + L EY +GNL + L ++S+ L+ ++ L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 685 VEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743
+ A G++YL + +HRD+ + NIL+ E + AK+ADFGLSR
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190
Query: 744 AGTPGYLDPEYYIS------------------NRLTEKSDVYSFGVVLLEIIT 778
E Y+ + T SDV+S+GV+L EI++
Sbjct: 191 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 24/221 (10%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-----VAVKMLSP--SSSQGYKQFQAEVKL 629
+ R+LGKG FG+V +L ++ VAVKML +S ++F E
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 630 LLRVHHRNLTTLVGYCDEGTNMA------LIYEYMANGNLEEHL----SDSSKEILNWEE 679
+ H ++ LVG +I +M +G+L L + L +
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 680 RLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738
+R V+ A G+EYL + +HRD+ + N ++ E +ADFGLSR G +
Sbjct: 139 LVRFMVDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKI-YSGDYY 193
Query: 739 VSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ P +L E N T SDV++FGV + EI+T
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 47/237 (19%)
Query: 579 LRMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH 634
LR ++FE VLG+G FG V LD+ A+K + + + +EV LL ++
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN 60
Query: 635 HRNLTTLVGYCDEGTNMAL----------IY---EYMANGNLEEHLSDSSKEILNWEERL 681
H+ + E N ++ EY NG L + + +E
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYW 119
Query: 682 RIAVEAALGLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--------- 731
R+ + L Y+H QG I+HRD+K NI I+E K+ DFGL++
Sbjct: 120 RLFRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 732 ---PVEGGTHVSTTIAGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLEIITG 779
+ G + T+ GT Y+ E +Y EK D+YS G++ E+I
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP 227
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 61/232 (26%), Positives = 90/232 (38%), Gaps = 21/232 (9%)
Query: 560 NRSYESLDLSSRQFTYSEVL-RMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVK--ML 612
R S L S + S +F+ LG G +G V+ K D AVK M
Sbjct: 33 FRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS 92
Query: 613 SPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSS 671
+ + AEV +V H L +EG + L E +L++H
Sbjct: 93 PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWG 151
Query: 672 KEILNWEERLR-IAVEAALGLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729
+ E ++ + L L +LH QG +VH DVK NI + + + KL DFGL
Sbjct: 152 ASLP--EAQVWGYLRDTLLALAHLHSQG----LVHLDVKPANIFLGPRGRCKLGDFGLLV 205
Query: 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
G G P Y+ PE + +DV+S G+ +LE+
Sbjct: 206 ELGTAGAGE---VQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 37/230 (16%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKMLSPSSSQGYKQ-FQAEVK 628
E+ F LG+ FG VY G L VA+K L + ++ F+ E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSS--------------KEI 674
L R+ H N+ L+G + +++I+ Y ++G+L E L S K
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 675 LNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733
L + + + + A G+EYL VH+D+ + N+L+ +K K++D GL R V
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFRE--V 178
Query: 734 EGGTHVSTTIAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
L PE + + + SD++S+GVVL E+ +
Sbjct: 179 YAA---DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 584 NFERVLGKGGFGTVYHGKLDNDE-----VAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRN 637
+F V+G+G FG VYHG L +++ AVK L+ + G QF E ++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 638 LTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-H 695
+ +L+G C + ++ YM +G+L + + + ++ + ++ A G+++L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLAS 210
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV------FPVEGGTHVSTTIAGTPGY 749
+ VHRD+ + N +++EKF K+ADFGL+R V T +
Sbjct: 211 KKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA-- 264
Query: 750 LDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
E + + T KSDV+SFGV+L E++T
Sbjct: 265 --LESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-35
Identities = 47/200 (23%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 586 ERVLGKGGFGTVYHGKLDND----EVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTT 640
+ LG G FG+V G +VA+K+L + + + E +++ ++ + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQGCK 699
L+G C M L+ E G L + L +E + + + ++G++YL +
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF- 457
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYISN 758
VHR++ + N+L+ + AK++DFGLS+ + + + + P + PE
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 759 RLTEKSDVYSFGVVLLEIIT 778
+ + +SDV+S+GV + E ++
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 585 FERVLGKGGFGTVYHGKLDND------EVAVKML-SPSSSQGYKQFQAEVKLLLRVHHRN 637
+VLG G FGTV+ G + V +K++ S Q ++ + + + H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-Q 696
+ L+G C + L+ +Y+ G+L +H+ L + L V+ A G+ YL
Sbjct: 77 IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEH 134
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYY 755
G VHR++ + N+L+ Q ++ADFG++ + P + + A TP ++ E
Sbjct: 135 GM----VHRNLAARNVLLKSPSQVQVADFGVADLLP-PDDKQLLYSEAKTPIKWMALESI 189
Query: 756 ISNRLTEKSDVYSFGVVLLEIIT 778
+ T +SDV+S+GV + E++T
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMT 212
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 31/228 (13%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKMLSPSSSQG-YKQFQAEVK 628
E R + LG+G FG V + VAVKML ++ ++ +E+K
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 629 LLLRV-HHRNLTTLVGYC-DEGTNMALIYEYMANGNLEEHL--------------SDSSK 672
+L+ + HH N+ L+G C G + +I E+ GNL +L D K
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 673 EILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731
+ L E + + + A G+E+L + C +HRD+ + NIL++EK K+ DFGL+R
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 732 PVEGGTHVSTTIAGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ +V A P ++ PE T +SDV+SFGV+L EI +
Sbjct: 199 -YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 585 FERVLGKGGFGTVYHGKLDND------EVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRN 637
+VLG G FGTVY G + VA+K L ++S + E ++ V + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL-HQ 696
+ L+G C T LI + M G L +++ + K+ + + L V+ A G+ YL +
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT----IAGTPGYLDP 752
VHRD+ + N+L+ K+ DFGL+++ E + + I
Sbjct: 137 RL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA----L 188
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIIT 778
E + T +SDV+S+GV + E++T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 33/228 (14%)
Query: 580 RMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLS-PSSSQGYKQFQAEVKLLLRVH 634
R +FE + LG+GGFG V+ K+D+ A+K + P+ ++ EVK L ++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 635 HRNLTTLVGYCDEGTNM---------ALIY---EYMANGNLEEHLSD-SSKEILNWEERL 681
H + E +Y + NL++ ++ + E L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 682 RIAVEAALGLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV---------- 730
I ++ A +E+LH +G ++HRD+K +NI K+ DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 731 FPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT 778
T GT Y+ PE N + K D++S G++L E++
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 7e-35
Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 26/206 (12%)
Query: 586 ERVLGKGGFGTVYHGK---LDNDEVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTTL 641
+ + GG G +Y ++ V +K L S + AE + L V H ++ +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 642 --VGYCDEGTNMALIY---EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH- 695
+ + Y EY+ +L+ + L E + +E L YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
G +V+ D+K NI++ E+ Q KL D G GTPG+ PE
Sbjct: 201 IG----LVYNDLKPENIMLTEE-QLKLIDLGAVSRI-----NSFGYLY-GTPGFQAPEI- 248
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
+ T +D+Y+ G L + P
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLP 274
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 583 NNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYK---QFQAEVKLLLRVHH 635
+FE R LGKG FG VY K +A+K+L + + Q + EV++ + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
N+ L GY + T + LI EY G + L SK + + E A L Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 126
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
++HRD+K N+L+ + K+ADFG S V + T + GT YL PE
Sbjct: 127 SKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPE-M 178
Query: 756 ISNRL-TEKSDVYSFGVVLLEIITGHP 781
I R+ EK D++S GV+ E + G P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 585 FERVLGKGGFGTVYHGKLDNDE-----VAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNL 638
R +G+G FG V+ G + E VA+K +S ++ F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QG 697
L+G E +I E G L L L+ + A + + L YL +
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR 511
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP-GYLDPEYYI 756
VHRD+ + N+L++ KL DFGLSR +E T+ + P ++ PE
Sbjct: 512 F----VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESIN 565
Query: 757 SNRLTEKSDVYSFGVVLLEIIT 778
R T SDV+ FGV + EI+
Sbjct: 566 FRRFTSASDVWMFGVCMWEILM 587
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 51/241 (21%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKMLSPSSSQGYKQ-FQAEVK 628
E R + LG+G FG V + + VAVKML ++S + +E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL--------------------- 667
+L +V+H ++ L G C + + LI EY G+L L
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 668 -SDSSKEILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADF 725
+ L + + A + + G++YL VHRD+ + NIL+ E + K++DF
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDF 194
Query: 726 GLSRVFPVEGGTHVSTT---IAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEII 777
GLSR V + + G + E + T +SDV+SFGV+L EI+
Sbjct: 195 GLSR--------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 778 T 778
T
Sbjct: 247 T 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 65/236 (27%), Positives = 108/236 (45%), Gaps = 46/236 (19%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE---------VAVKMLSPSSSQGYKQ-FQAE 626
E R + LG+G FG V + + VAVKML +++ +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 627 VKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL--------------SDSS 671
++++ + H+N+ L+G C + + +I EY + GNL E+L +
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 672 KEILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730
+E + +++ + + A G+EYL Q C +HRD+ + N+L+ E K+ADFGL+R
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 731 FPVEGGTHVSTT---IAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
++ T G L PE T +SDV+SFGV++ EI T
Sbjct: 207 --------INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 47/225 (20%), Positives = 84/225 (37%), Gaps = 54/225 (24%)
Query: 585 FERVLGKGGFGTVYHGKLDND---------EVAVKMLSPSSSQGYKQFQAEVKLLLRVHH 635
F LG+G F ++ G EV +K+L + + F ++ ++ H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL- 694
++L G C G L+ E++ G+L+ +L + +N +L +A + A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLE 130
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQ--------AKLADFGLSRVFPVEGGTHVSTTIAGT 746
+H +V + NIL+ + KL+D G+S
Sbjct: 131 ENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--------------- 171
Query: 747 PGYLDPEYY-----------ISN--RLTEKSDVYSFGVVLLEIIT 778
L + I N L +D +SFG L EI +
Sbjct: 172 ---LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 67/270 (24%), Positives = 110/270 (40%), Gaps = 33/270 (12%)
Query: 533 RKKQLPDPQILIWLVRLSSGR--KVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLG 590
+ ++ +LS R + + N +Y +S EV R R LG
Sbjct: 21 YFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLG 80
Query: 591 KGGFGTVYHGKLDNDE-------VAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTTLV 642
G FG VY G++ VAVK L S+ + F E ++ + +H+N+ +
Sbjct: 81 HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI 140
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEI-----LNWEERLRIAVEAALGLEYL-HQ 696
G + ++ E MA G+L+ L ++ L + L +A + A G +YL
Sbjct: 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200
Query: 697 GCKPPIVHRDVKSTNILIN---EKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYL--- 750
+HRD+ + N L+ AK+ DFG++R G L
Sbjct: 201 HF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----GYYRKGGCAMLPVK 251
Query: 751 --DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
PE ++ T K+D +SFGV+L EI +
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKMLSPSSSQGYKQ-FQAEVK 628
EV R R LG G FG VY G++ VAVK L S+ + F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEI-----LNWEERLRI 683
++ + +H+N+ +G + ++ E MA G+L+ L ++ L + L +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 684 AVEAALGLEYL-HQGCKPPIVHRDVKSTNILIN---EKFQAKLADFGLSRVFPVEGGTHV 739
A + A G +YL +HRD+ + N L+ AK+ DFG++R
Sbjct: 146 ARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----- 196
Query: 740 STTIAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
S G L PE ++ T K+D +SFGV+L EI +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 76/259 (29%), Positives = 108/259 (41%), Gaps = 52/259 (20%)
Query: 560 NRSYESLDLSSRQFTYS-EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKM 611
N Y+ + L S E R + R +G+G FG V+ + VAVKM
Sbjct: 25 NPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM 84
Query: 612 LSPSSSQGYKQ-FQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDS 670
L +S + FQ E L+ + N+ L+G C G M L++EYMA G+L E L
Sbjct: 85 LKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM 144
Query: 671 SKEILNWEER----------------------LRIAVEAALGLEYLH-QGCKPPIVHRDV 707
S + L IA + A G+ YL + VHRD+
Sbjct: 145 SPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDL 200
Query: 708 KSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT---IAGTPGYL-----DPEYYISNR 759
+ N L+ E K+ADFGLSR + + A + PE NR
Sbjct: 201 ATRNCLVGENMVVKIADFGLSRN--------IYSADYYKADGNDAIPIRWMPPESIFYNR 252
Query: 760 LTEKSDVYSFGVVLLEIIT 778
T +SDV+++GVVL EI +
Sbjct: 253 YTTESDVWAYGVVLWEIFS 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 50/212 (23%), Positives = 85/212 (40%), Gaps = 25/212 (11%)
Query: 587 RVLGKGGFGTVYHGK-LDNDEVAVKM--LSPSSSQGYKQFQAEVKLL--LRVHHRNLTTL 641
+ +G GG V+ A+K L + +Q ++ E+ L L+ H + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKP 700
Y + ++ E N +L L K+ ++ ER + +H G
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHG--- 147
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE------- 753
IVH D+K N LI + KL DFG++ + + V + GT Y+ PE
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 754 ----YYISNRLTEKSDVYSFGVVLLEIITGHP 781
++++ KSDV+S G +L + G
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 583 NNFE--RVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYK---QFQAEVKLLLRVHH 635
+F+ +LGKG F VY + EVA+KM+ + + Q EVK+ ++ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
++ L Y ++ + L+ E NG + +L + K E R + G+ YLH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLH 129
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
I+HRD+ +N+L+ K+ADFGL+ + H T+ GTP Y+ PE
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTPNYISPE-I 183
Query: 756 ISNRL-TEKSDVYSFGVVLLEIITGHP 781
+ +SDV+S G + ++ G P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 50/212 (23%), Positives = 85/212 (40%), Gaps = 25/212 (11%)
Query: 587 RVLGKGGFGTVYHGK-LDNDEVAVKM--LSPSSSQGYKQFQAEVKLL--LRVHHRNLTTL 641
+ +G GG V+ A+K L + +Q ++ E+ L L+ H + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKP 700
Y + ++ E N +L L K+ ++ ER + +H G
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE------- 753
IVH D+K N LI + KL DFG++ + + V + GT Y+ PE
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 754 ----YYISNRLTEKSDVYSFGVVLLEIITGHP 781
++++ KSDV+S G +L + G
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-34
Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 46/267 (17%)
Query: 546 LVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKLDND 605
LVR+++ A+ + + E R + LG+G FG V +
Sbjct: 46 LVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGI 105
Query: 606 E---------VAVKMLSPSSSQGYKQ-FQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALI 654
+ VAVKML +++ +E++++ + H+N+ L+G C + + +I
Sbjct: 106 DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165
Query: 655 YEYMANGNLEEHL--------------SDSSKEILNWEERLRIAVEAALGLEYL-HQGCK 699
EY + GNL E+L + +E + +++ + + A G+EYL Q C
Sbjct: 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC- 224
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT---IAGTPGYL-----D 751
+HRD+ + N+L+ E K+ADFGL+R ++ T G L
Sbjct: 225 ---IHRDLAARNVLVTENNVMKIADFGLARD--------INNIDYYKKTTNGRLPVKWMA 273
Query: 752 PEYYISNRLTEKSDVYSFGVVLLEIIT 778
PE T +SDV+SFGV++ EI T
Sbjct: 274 PEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 50/236 (21%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGK---LDNDE----VAVKMLSPSSSQGYKQ-FQAEVK 628
E R F + LG G FG V L ++ VAVKML ++ K+ +E+K
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 629 LLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL------------SDSSKEIL 675
++ + H N+ L+G C G + +I EY G+L L +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 676 NWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734
+ + L + + A G+ +L + C +HRDV + N+L+ AK+ DFGL+R
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLAR----- 212
Query: 735 GGTHVSTTIAGTPGYLD------------PEYYISNRLTEKSDVYSFGVVLLEIIT 778
I Y+ PE T +SDV+S+G++L EI +
Sbjct: 213 -------DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 40/233 (17%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGK---LDNDE----VAVKMLSPSSSQGYKQ-FQAEVK 628
E R +F + LG G FG V L + VAVKML PS+ ++ +E+K
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 629 LLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL----------------SDSS 671
+L + +H N+ L+G C G +I EY G+L L +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 672 KEILNWEERLRIAVEAALGLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730
+ L+ E+ L + + A G+ +L + C +HRD+ + NIL+ K+ DFGL+R
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 194
Query: 731 FPVEGGTHVSTTIAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
+ + L PE + T +SDV+S+G+ L E+ +
Sbjct: 195 IKNDS-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 51/227 (22%), Positives = 87/227 (38%), Gaps = 35/227 (15%)
Query: 583 NNFE--RVLGKGGFGTVYHGKLDNDEVAVKMLS-----------------PSSSQGYKQF 623
N++ R L +G F + + DN A+K S Y F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 624 QAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL-- 681
+ E++++ + + T G + +IYEYM N ++ + N+ +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 682 ----RIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737
I Y+H + I HRDVK +NIL+++ + KL+DFG S
Sbjct: 151 QVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV----D 204
Query: 738 HVSTTIAGTPGYLDPEYYISNRLT---EKSDVYSFGVVLLEIITGHP 781
GT ++ PE + SN + K D++S G+ L +
Sbjct: 205 KKIKGSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 586 ERVLGKGGFGTVYHGK---LDNDEVAVKMLSPSSSQG---YKQFQAEVKLLLRVHHRNLT 639
LG GG TVY + L+ VA+K + + K+F+ EV ++ H+N+
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI- 73
Query: 640 TLVGYCDEGTNMALIY---EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
V D Y EY+ L E++ L+ + + + G+++ H
Sbjct: 74 --VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHD 129
Query: 697 -GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
IVHRD+K NILI+ K+ DFG+++ T + + GT Y PE
Sbjct: 130 MR----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQA 184
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
E +D+YS G+VL E++ G P
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
VLGKG +G VY G + +A+K + S+ + E+ L + H+N+ +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL-GLEYLH-QGCKPPI 702
E + + E + G+L L + + E+ + + L GL+YLH I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ----I 143
Query: 703 VHRDVKSTNILINEKF-QAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL- 760
VHRD+K N+LIN K++DFG S+ + G + T GT Y+ PE
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 761 -TEKSDVYSFGVVLLEIITGHP 781
+ +D++S G ++E+ TG P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKP 223
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 586 ERVLGKGGFGTVY---HGKLDNDEVAVKMLSP--SSSQGYKQ-FQAEVKLLLRVHHRNLT 639
R++G+GG G VY + VA+K++S SS ++ Q E + R+ ++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERI-VALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV- 96
Query: 640 TLVGYCDEGTNMALIY---EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
V D G +Y + +L L L + I + L+ H
Sbjct: 97 --VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHA 152
Query: 697 -GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
G HRDVK NIL++ A L DFG++ E T + T+ GT Y+ PE +
Sbjct: 153 AG----ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERF 207
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
+ T ++D+Y+ VL E +TG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSP 233
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-33
Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 40/233 (17%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE---------VAVKMLSPSSSQG-YKQFQAE 626
E+ R + LG+G FG V + + VAVKML +++ +E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 627 VKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL--------------SDSS 671
++++ + H+N+ L+G C + + +I EY + GNL E+L S +
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 672 KEILNWEERLRIAVEAALGLEYL-HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730
+E L+ ++ + A + A G+EYL + C +HRD+ + N+L+ E K+ADFGL+R
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 731 FPVEGGTHVSTTIAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
T G L PE T +SDV+SFGV+L EI T
Sbjct: 241 IHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 26/221 (11%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLV 642
RVL +GGF VY + E A+K L + + + EV + ++ H N+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 643 GYC-------DEGTNMALIYEYMANGNLEEHL-SDSSKEILNWEERLRIAVEAALGLEYL 694
D G L+ + G L E L S+ L+ + L+I + ++++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST----------TIA 744
H+ KPPI+HRD+K N+L++ + KL DFG + S T
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 745 GTPGYLDPE---YYISNRLTEKSDVYSFGVVLLEIITG-HP 781
TP Y PE Y + + EK D+++ G +L + HP
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-33
Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 49/240 (20%)
Query: 577 EVLRMTNNFERVLGKGGFGTVYHGKLDNDE-------VAVKMLSPSSSQG-YKQFQAEVK 628
E R F +VLG G FG V + VAVKML + + +E+K
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 629 LLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL-------------------- 667
++ ++ H N+ L+G C + LI+EY G+L +L
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 668 -SDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFG 726
+ +L +E+ L A + A G+E+L VHRD+ + N+L+ K+ DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFG 217
Query: 727 LSRVFPVEGGTHVSTT---IAGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLEIIT 778
L+R + + + L PE T KSDV+S+G++L EI +
Sbjct: 218 LAR--------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 586 ERVLGKGGFGTVYHGK---LDNDEVAVKMLSPSSSQG---YKQFQAEVKLLLRVHHRNLT 639
+LG GG V+ + D VAVK+L ++ Y +F+ E + ++H +
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRD-VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 640 TL--VGYCDEGTNMALIY---EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
+ G E L Y EY+ L + + + + + + +A L +
Sbjct: 76 AVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFS 132
Query: 695 HQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST-TIAGTPGYLDP 752
HQ G I+HRDVK NI+I+ K+ DFG++R G + T + GT YL P
Sbjct: 133 HQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIITGHP 781
E + + +SDVYS G VL E++TG P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 26/217 (11%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRNLTT 640
+LG+G V+ G K D A+K+ + S E ++L +++H+N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 641 LVGYCDEGT--NMALIYEYMANGNLEEHLSD-SSKEILNWEERLRIAVEAALGLEYLH-Q 696
L +E T + LI E+ G+L L + S+ L E L + + G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 697 GCKPPIVHRDVKSTNILI----NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
G IVHR++K NI+ + + KL DFG +R ++ GT YL P
Sbjct: 132 G----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHP 184
Query: 753 EYYISNRL--------TEKSDVYSFGVVLLEIITGHP 781
+ Y L D++S GV TG
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 25/212 (11%)
Query: 587 RVLGKGGFGTVYHGK-LDNDEVAVKM--LSPSSSQGYKQFQAEVKLL--LRVHHRNLTTL 641
+ +G GG V+ A+K L + +Q ++ E+ L L+ H + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKP 700
Y + ++ E N +L L K+ ++ ER + +H G
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE------- 753
IVH D+K N LI + KL DFG++ + + V + G Y+ PE
Sbjct: 176 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 754 ----YYISNRLTEKSDVYSFGVVLLEIITGHP 781
++++ KSDV+S G +L + G
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 583 NNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYK---QFQAEVKLLLRVHH 635
++F+ R LGKG FG VY K + +A+K+L S + Q + E+++ + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
N+ + Y + + L+ E+ G L + L + + + E A L Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCH 131
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
+ ++HRD+K N+L+ K + K+ADFG S V T+ GT YL PE
Sbjct: 132 ERK---VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRR---TMCGTLDYLPPE-M 183
Query: 756 ISNRL-TEKSDVYSFGVVLLEIITGHP 781
I + EK D++ GV+ E + G P
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-32
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 584 NFERVLGKGGFGTVYH-GKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTL 641
+ VLG G GT+ + G DN +VAVK + P + EV+LL H N+
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRY 83
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKP 700
+ + E A L+E++ L E + + + GL +LH
Sbjct: 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG-LEPITLLQQTTSGLAHLHSLN--- 138
Query: 701 PIVHRDVKSTNILINEK-----FQAKLADFGLSRVF-PVEGGTHVSTTIAGTPGYLDPEY 754
IVHRD+K NILI+ +A ++DFGL + + + GT G++ PE
Sbjct: 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 755 YISN---RLTEKSDVYSFGVVLLEIITG--HP 781
+ T D++S G V +I+ HP
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 587 RVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYK---QFQAEVKLLLRVHHRNLTTL 641
R LGKGGF + + A K++ S + E+ + + H+++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
G+ ++ + ++ E +L E L E + LG +YLH+
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNR--- 161
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL- 760
++HRD+K N+ +NE + K+ DFGL+ +G + GTP Y+ PE +S +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPE-VLSKKGH 218
Query: 761 TEKSDVYSFGVVLLEIITGHP 781
+ + DV+S G ++ ++ G P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKP 239
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 587 RVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYK---QFQAEVKLLLRVHHRNLTTL 641
R LGKGGF + + A K++ S + E+ + + H+++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
G+ ++ + ++ E +L E L E + LG +YLH+
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNR--- 135
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL- 760
++HRD+K N+ +NE + K+ DFGL+ +G + GTP Y+ PE +S +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPE-VLSKKGH 192
Query: 761 TEKSDVYSFGVVLLEIITGHP 781
+ + DV+S G ++ ++ G P
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKP 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLS-PSSSQGYKQFQAEVKLLLRVHHRNLTT 640
+LG+G V+ G K D A+K+ + S + E ++L +++H+N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 641 LVGYCDEGT--NMALIYEYMANGNLEEHLSD-SSKEILNWEERLRIAVEAALGLEYLH-Q 696
L +E T + LI E+ G+L L + S+ L E L + + G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 697 GCKPPIVHRDVKSTNILI----NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
G IVHR++K NI+ + + KL DFG +R ++ GT YL P
Sbjct: 132 G----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHP 184
Query: 753 EYYISNRL--------TEKSDVYSFGVVLLEIITGHP 781
+ Y L D++S GV TG
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 24/236 (10%), Positives = 53/236 (22%), Gaps = 49/236 (20%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLT 639
L G V+ ++ A+K+ + S ++ R+ +
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 640 TLVGYC--------------------------DEGTNMALIYEYMANGNLEEHLS----- 668
N L+ + +LE S
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV 184
Query: 669 DSSKEILNWEERLRIAVEAALGLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGL 727
+ + + L +G +VH N+ I + L D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL--TEKSDVYSFGVVLLEIITGHP 781
+ Y E+ ++ T + + G+ + +
Sbjct: 241 LWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-31
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTTL 641
+ LG GGFG V + ++VA+K S ++ + E++++ +++H N+ +
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 642 VGYCDEGTNMA------LIYEYMANGNLEEHLSDSSKE-ILNWEERLRIAVEAALGLEYL 694
D +A L EY G+L ++L+ L + + + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQA---KLADFGLSRVFPVEGGTHVSTTIAGTPGYLD 751
H+ I+HRD+K NI++ Q K+ D G ++ + T GT YL
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQYLA 191
Query: 752 PEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
PE + T D +SFG + E ITG
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 32/218 (14%), Positives = 69/218 (31%), Gaps = 24/218 (11%)
Query: 585 FERVLGKGGFGTVYHGK-------LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRN 637
+LG+G F VY + + +K+ P++ + ++ L
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHL---SDSSKEILNWEERLRIAVEAALGLEYL 694
L+ E + G L + ++ ++++ + A+ +E +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQA-----------KLADFGLSRVFPVEGGTHVSTTI 743
H I+H D+K N ++ F L D G S + + T
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
T G+ E + + D + + ++ G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 27/237 (11%), Positives = 62/237 (26%), Gaps = 47/237 (19%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLS----------------------------PSS 616
VLG+ + + V +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 617 SQGYKQFQAEVKLLLRVHHRNLTTLVG-YCDEGTNMALIYEYMANGNLEEHLSD-----S 670
++ + +F L+ + + + D NL+ S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 671 SKEILNWEERLRIAVEAALGLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729
+ + L RL++ ++ L LH G +VH ++ +I+++++ L F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 730 VFPVEGGTHVSTTIAGTPGYLDPE-----YYISNRLTEKSDVYSFGVVLLEIITGHP 781
+ P + +T D ++ G+ + I
Sbjct: 260 RDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-30
Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 561 RSYESLDLSSRQFTYSEVLRMTNN---------FERV--LGKGGFGTVYHG--KLDNDEV 607
+ E L+L +Q E FE++ LG G G V+ K +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 608 AVK-MLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEH 666
A K + Q E+++L + + G +++ E+M G+L+
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-- 119
Query: 667 LSDSSKEILNWEERL--RIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLAD 724
K+ E++ ++++ GL YL + K I+HRDVK +NIL+N + + KL D
Sbjct: 120 --QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCD 175
Query: 725 FGLSRVFPVEGGTHVST---TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
FG+S G + + + GT Y+ PE + +SD++S G+ L+E+ G
Sbjct: 176 FGVS-------GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-30
Identities = 32/243 (13%), Positives = 72/243 (29%), Gaps = 58/243 (23%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLS----------------------------PSS 616
VLG+ + + V +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 617 SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM-ANGNLEEHLSD-----S 670
++ + +F L+ + + + + ++ + Y NL+ S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 671 SKEILNWEERLRIAVEAALGLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729
+ + L RL++ ++ L LH G +VH ++ +I+++++ L F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHL- 253
Query: 730 VFPVEGGTHVSTTIAGTPGYLDPEY-----------YISNRLTEKSDVYSFGVVLLEIIT 778
V G + + G+ PE +T D ++ G+V+ I
Sbjct: 254 ---VRDGA--RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 779 GHP 781
Sbjct: 309 ADL 311
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 588 VLGKGGFGTVYHG--KLDNDEVAVK-MLSPSSSQGYKQFQAEVKLLLR-VHHRNLTTLVG 643
LG+G +G V +AVK + + +SQ K+ ++ + +R V T G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL------RIAVEAALGLEYLHQG 697
++ + E M L K++++ + + +IAV LE+LH
Sbjct: 74 ALFREGDVWICMELMDTS-----LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
++HRDVK +N+LIN Q K+ DFG+S AG Y+ PE I+
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPE-RIN 182
Query: 758 NRLTE-----KSDVYSFGVVLLEIITGHP 781
L + KSD++S G+ ++E+
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-30
Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 40/230 (17%)
Query: 584 NFERVLGKGGFGTVYH-GKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTL 641
E++LG G GTV G VAVK + E+KLL H N+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRY 74
Query: 642 VGYCDEGTNMALIYEYMANGNLEE-----HLSDSSKEILNWEERLRIAVEAALGLEYLH- 695
+ + E N NL++ ++SD + ++ + + + A G+ +LH
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 696 QGCKPPIVHRDVKSTNILINEK-------------FQAKLADFGLSRVFPVEGGTHVST- 741
I+HRD+K NIL++ + ++DFGL + + +
Sbjct: 134 LK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 742 -TIAGTPGYLDPE-------YYISNRLTEKSDVYSFGVVLLEIITG--HP 781
+GT G+ PE RLT D++S G V I++ HP
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 45/233 (19%), Positives = 84/233 (36%), Gaps = 42/233 (18%)
Query: 580 RMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVK--MLSPSSSQGYKQFQAEVKLLLRV 633
R T F +G G FG+V+ +LD A+K + S + EV +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 634 -HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEER--LRIAVEAALG 690
H ++ E +M + EY G+L + +S++ + + ++E + ++ G
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 691 LEYLH-QGCKPPIVHRDVKSTNILINE-------------------KFQAKLADFGLSRV 730
L Y+H +VH D+K +NI I+ K K+ D G
Sbjct: 128 LRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 731 FPVEGGTHVSTTIAGTPGYLDPEYYISNRL--TEKSDVYSFGVVLLEIITGHP 781
G +L E + K+D+++ + ++ P
Sbjct: 184 IS------SPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEP 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 19/206 (9%)
Query: 588 VLGKGGFGTVYHG--KLDNDEVAVKMLSP-SSSQGYKQFQAEVKLLLR-VHHRNLTTLVG 643
+G+G +G+V K +AVK + + KQ ++ +++R + G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNW--EERL-RIAVEAALGLEYLHQGCKP 700
+ + E M+ + ++ + + EE L +I + L +L + K
Sbjct: 89 ALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
I+HRD+K +NIL++ KL DFG+S + T AG Y+ PE I
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPE-RIDPSA 201
Query: 761 TE-----KSDVYSFGVVLLEIITGHP 781
+ +SDV+S G+ L E+ TG
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRF 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRNLTT 640
F+R LG G FG V+ + E +K ++ SQ +Q +AE+++L + H N+
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEER-----LRIAVEAALGLEYLH 695
+ ++ NM ++ E G L E + + E ++ + A L Y H
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFH 141
Query: 696 -QGCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLD 751
Q +VH+D+K NIL + K+ DFGL+ +F ST AGT Y+
Sbjct: 142 SQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTNAAGTALYMA 194
Query: 752 PEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
PE +T K D++S GVV+ ++TG
Sbjct: 195 PE-VFKRDVTFKCDIWSAGVVMYFLLTGCL 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 55/249 (22%), Positives = 93/249 (37%), Gaps = 56/249 (22%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKM-----LSPSSSQGYKQFQAEVKLLLRVHHRN 637
+ +G+G +G V A+K+ + + + ++ + EV+L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV------------ 685
+ L ++ + L+ E G+L + L+ + +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 686 -------------------EAA-------LGLEYLH-QGCKPPIVHRDVKSTNILINEKF 718
+ L YLH QG I HRD+K N L +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNK 205
Query: 719 QA--KLADFGLSRVFPV--EGGTHVSTTIAGTPGYLDPE--YYISNRLTEKSDVYSFGVV 772
KL DFGLS+ F G + TT AGTP ++ PE + K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 773 LLEIITGHP 781
L ++ G
Sbjct: 266 LHLLLMGAV 274
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLS---PSSSQGYKQFQAEVKLLLRVHHRNL 638
+RVLGKG FG V K+ E AVK++S + EV+LL ++ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QG 697
L + ++ L+ E G L + + S++ + + RI + G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 698 CKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
IVHRD+K N+L+ ++ ++ DFGLS F + GT Y+ PE
Sbjct: 147 ----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPE- 198
Query: 755 YISNRLTEKSDVYSFGVVLLEIITGHP 781
+ EK DV+S GV+L +++G P
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCP 225
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 32/204 (15%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
F VLG G F V+ +L A+K + S + + E+ +L ++ H N+ TL
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 642 VGYCDEGTNMALIYEYMANGNL------EEHLS--DSSKEILNWEERLRIAVEAALGLEY 693
+ T+ L+ + ++ G L + D+S I + + A ++Y
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI-------QQVLSA---VKY 121
Query: 694 LH-QGCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGY 749
LH G IVHRD+K N+L E + + DFGLS++ + +T GTPGY
Sbjct: 122 LHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGY 173
Query: 750 LDPEYYISNRLTEKSDVYSFGVVL 773
+ PE ++ D +S GV+
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 584 NFERVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQ---AEVKLLLRVHHRNL 638
F ++LG+G F TV + E A+K+L + E ++ R+ H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLH-Q 696
L + + Y NG L +++ K E R E LEYLH +
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
G I+HRD+K NIL+NE ++ DFG ++V E + + GT Y+ PE
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 757 SNRLTEKSDVYSFGVVLLEIITGHP 781
+ SD+++ G ++ +++ G P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLP 230
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 48/201 (23%), Positives = 81/201 (40%), Gaps = 20/201 (9%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD 646
+G+G FG V+ K + AVK + + E+ + + L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR 120
Query: 647 EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL--RIAVEAALGLEYLHQGCKPPIVH 704
EG + + E + G+L + + E +A GLEYLH I+H
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCL----PEDRALYYLGQALEGLEYLHTRR---ILH 173
Query: 705 RDVKSTNILINEK-FQAKLADFGLSRVFPVEGGTHVST---TIAGTPGYLDPEYYISNRL 760
DVK+ N+L++ +A L DFG + +G I GT ++ PE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 761 TEKSDVYSFGVVLLEIITGHP 781
K D++S ++L ++ G
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCH 254
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-28
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTT 640
+ LG G +G V K+ + E A+K++ + S+ + EV +L + H N+
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCK 699
L + ++ N L+ E G L + + + N + I + G+ YLH
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLHKHN-- 156
Query: 700 PPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
IVHRD+K N+L+ + K+ DFGLS VF GT Y+ PE +
Sbjct: 157 --IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPE-VL 210
Query: 757 SNRLTEKSDVYSFGVVLLEIITGHP 781
+ EK DV+S GV+L ++ G+P
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYP 235
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 588 VLGKGGFGTVYHG--KLDNDEVAVK-MLSPSSSQGYKQFQAEVKLLLR-VHHRNLTTLVG 643
+G G G V+ + +AVK M + + K+ ++ ++L+ + G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERL-RIAVEAALGLEYLHQGCKPPI 702
T++ + E M E+ I E L ++ V L YL + +
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQGPIP--ERILGKMTVAIVKALYYLKEKHG--V 146
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE 762
+HRDVK +NIL++E+ Q KL DFG+S AG Y+ PE T+
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 763 -----KSDVYSFGVVLLEIITGHP 781
++DV+S G+ L+E+ TG
Sbjct: 204 PDYDIRADVWSLGISLVELATGQF 227
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 46/205 (22%), Positives = 80/205 (39%), Gaps = 25/205 (12%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKM-----LSPSSSQGYKQFQAEVKLLLRVHHRN 637
V+GKG F V + + AVK+ + S + + E + + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEER-----LRIAVEAALGLE 692
+ L+ + +++E+M +L + + + E +R +EA L
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LR 144
Query: 693 YLH-QGCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG 748
Y H I+HRDVK +L+ KL FG++ G V+ GTP
Sbjct: 145 YCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPH 198
Query: 749 YLDPEYYISNRLTEKSDVYSFGVVL 773
++ PE + DV+ GV+L
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 47/210 (22%), Positives = 79/210 (37%), Gaps = 22/210 (10%)
Query: 588 VLGKG--GFGTVYHG--KLDNDEVAVKM--LSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
V+GKG TV K + V V+ L S++ Q E+ + +H N+
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV---EAALGLEYLHQGC 698
+ ++ +MA G+ ++ + + + E IA L+Y+H
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--NELA-IAYILQGVLKALDYIHHMG 148
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG-----THVSTTIAGTPGYLDPE 753
VHR VK+++ILI+ + L+ + G +L PE
Sbjct: 149 Y---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 754 YYISNRL--TEKSDVYSFGVVLLEIITGHP 781
N KSD+YS G+ E+ GH
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 53/221 (23%), Positives = 81/221 (36%), Gaps = 54/221 (24%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQ---------FQAEVKLLLRV 633
+ +LG+G V K E AVK++ + + EV +L +V
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 634 -HHRNLTTLVGYCDEGTNMALIYEYMANGNL------EEHLSDSSKEILNWEERLRIAVE 686
H N+ L + T L+++ M G L + LS E+ E
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS----------EK-----E 125
Query: 687 AAL-------GLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738
+ LH IVHRD+K NIL+++ KL DFG S
Sbjct: 126 TRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGE 178
Query: 739 VSTTIAGTPGYLDPE------YYISNRLTEKSDVYSFGVVL 773
+ GTP YL PE ++ D++S GV++
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 38/215 (17%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
E +G+G +G V K A K + + +F+ E++++ + H N+ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 642 VGYCDEGTNMALIYEYMANGNL------EEHLSDSSKEILNWEER-----LRIAVEAALG 690
++ T++ L+ E G L + E ++ + A
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFR----------ESDAARIMKDVLSA--- 118
Query: 691 LEYLH-QGCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGT 746
+ Y H + HRD+K N L + KL DFGL+ F + T GT
Sbjct: 119 VAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGT 171
Query: 747 PGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
P Y+ P+ + + D +S GV++ ++ G+P
Sbjct: 172 PYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYP 205
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 588 VLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTTLVGY 644
+GKG FG V+ G VA+K++ ++ + Q E+ +L + +T G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 645 CDEGTNMALIYEYMANGNL----------EEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
+ T + +I EY+ G+ E ++ +EIL GL+YL
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL-------------KGLDYL 135
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
H K +HRD+K+ N+L++E + KLADFG++ + T GTP ++ PE
Sbjct: 136 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV 190
Query: 755 YISNRLTEKSDVYSFGVVLLEIITGHP 781
+ K+D++S G+ +E+ G P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEP 217
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 47/207 (22%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
LG G FG VY K A K++ S + + + E+++L H + L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVH 704
+ ++ E+ G ++ + L + + + L +LH +H
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI---IH 140
Query: 705 RDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST-----TIAGTPGYLDPEYYISNR 759
RD+K+ N+L+ + +LADFG+S ++ T + GTP ++ PE +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVS-------AKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 760 LTE-----KSDVYSFGVVLLEIITGHP 781
+ + K+D++S G+ L+E+ P
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 18/220 (8%)
Query: 572 QFTYSEVLRMT-NNFE--RVLGKGGFGTVYHGKL-DNDEV-AVKMLSPS---SSQGYKQF 623
Q+ + E +T N F RVLGKGGFG V ++ ++ A K L +G
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 624 QAEVKLLLRVHHRNLTTLVGYCDE-GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR 682
E ++L +V+ R + +L Y E + L+ M G+L+ H+ + E R
Sbjct: 232 LNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAV 289
Query: 683 I-AVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741
A E GLE LH+ IV+RD+K NIL+++ +++D GL+ P
Sbjct: 290 FYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--- 343
Query: 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
GT GY+ PE + R T D ++ G +L E+I G
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 588 VLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNLTTLVGY 644
V+G G V ++VA+K ++ Q E++ + + HH N+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR---IAV---EAALGLEYLHQGC 698
+ L+ + ++ G++ + + + + L IA E GLEYLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS---TTIAGTPGYLDPE-- 753
+ +HRDVK+ NIL+ E ++ADFG+S G + T GTP ++ PE
Sbjct: 142 Q---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 754 ----YYISNRLTEKSDVYSFGVVLLEIITGHP 781
Y K+D++SFG+ +E+ TG
Sbjct: 199 EQVRGY-----DFKADIWSFGITAIELATGAA 225
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLS-------------PSSSQGYKQFQAEVKL 629
R LG G +G V K + E A+K++ + + +++ E+ L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 630 LLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL 689
L + H N+ L ++ L+ E+ G L E + ++ + + I +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANIMKQILS 157
Query: 690 GLEYLH-QGCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAG 745
G+ YLH IVHRD+K NIL+ N K+ DFGLS F + G
Sbjct: 158 GICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDRLG 210
Query: 746 TPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
T Y+ PE + + EK DV+S GV++ ++ G+P
Sbjct: 211 TAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 46/200 (23%), Positives = 81/200 (40%), Gaps = 23/200 (11%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
+ LG G FG V+ K K ++ + E+ ++ ++HH L L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEER-----LRIAVEAALGLEYLH- 695
++ M LI E+++ G L + ++ E E +R A E GL+++H
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACE---GLKHMHE 167
Query: 696 QGCKPPIVHRDVKSTNILINEKFQA--KLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
IVH D+K NI+ K + K+ DFGL+ + T + PE
Sbjct: 168 HS----IVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPE 220
Query: 754 YYISNRLTEKSDVYSFGVVL 773
+ +D+++ GV+
Sbjct: 221 IVDREPVGFYTDMWAIGVLG 240
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 17/221 (7%)
Query: 572 QFTYSEVLRMT-NNFE--RVLGKGGFGTVYHGKL-DNDEV-AVKMLSPS---SSQGYKQF 623
Q+ + E M + F RVLG+GGFG V+ ++ ++ A K L+ +GY+
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 624 QAEVKLLLRVHHRNLTTLVGYCDE-GTNMALIYEYMANGNLEEHLSDSSKEILNW-EERL 681
E K+L +VH R + +L Y E T++ L+ M G++ H+ + ++ + E R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 682 RI-AVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740
+ GLE+LHQ I++RD+K N+L+++ +++D GL+ +
Sbjct: 292 IFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--T 346
Query: 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
AGTPG++ PE + D ++ GV L E+I
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLT 639
N +LGKG FG V ++ E AVK+++ + ++ EV+LL ++ H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGC 698
L ++ ++ ++ E G L + + ++ + + RI + G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 699 KPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
IVHRD+K NIL+ + K+ DFGLS F GT Y+ PE
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-V 194
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
+ EK DV+S GV+L +++G P
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 54/255 (21%), Positives = 98/255 (38%), Gaps = 53/255 (20%)
Query: 550 SSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHG--KLDNDEV 607
+ K N + + ++ + + V+G+G V + E
Sbjct: 63 DAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEF 122
Query: 608 AVKMLSPSSSQG--------YKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEYM 658
AVK++ ++ + + + E +L +V H ++ TL+ + + M L+++ M
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182
Query: 659 ANGNL------EEHLSDSSKEILNWEERLRIAVEAAL-------GLEYLH-QGCKPPIVH 704
G L + LS E+ E + +LH IVH
Sbjct: 183 RKGELFDYLTEKVALS----------EK-----ETRSIMRSLLEAVSFLHANN----IVH 223
Query: 705 RDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE------YYISN 758
RD+K NIL+++ Q +L+DFG S + GTPGYL PE
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAPEILKCSMDETHP 280
Query: 759 RLTEKSDVYSFGVVL 773
++ D+++ GV+L
Sbjct: 281 GYGKEVDLWACGVIL 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-27
Identities = 59/254 (23%), Positives = 104/254 (40%), Gaps = 54/254 (21%)
Query: 559 CNRSYESLDLSSR-QFTYSEVLRMTNNFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPS 615
N+ + DL+ Q Y + LR + LG G G V + +VA++++S
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKR 171
Query: 616 --------SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNL---- 663
+ + E+++L +++H + + + D + ++ E M G L
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV 230
Query: 664 --EEHLSDSSKEILNWEERLRIAVEAAL-------GLEYLH-QGCKPPIVHRDVKSTNIL 713
+ L E L ++YLH G I+HRD+K N+L
Sbjct: 231 VGNKRLK----------EA-----TCKLYFYQMLLAVQYLHENG----IIHRDLKPENVL 271
Query: 714 INEK---FQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE---YYISNRLTEKSDVY 767
++ + K+ DFG S++ G T + T+ GTP YL PE + D +
Sbjct: 272 LSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 328
Query: 768 SFGVVLLEIITGHP 781
S GV+L ++G+P
Sbjct: 329 SLGVILFICLSGYP 342
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 33/206 (16%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKML--SPSSSQGYKQFQAEVKLLLRVHHRNLT 639
+ + LGKG F V K E A K++ S++ +++ + E ++ ++ H N+
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 640 TLVGYCDEGTNMALIYEYMANGNL------EEHLS--DSSKEILNWEERLRIAVEAALGL 691
L E + L+++ + G L E S D+S I + +E+ +
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-------QQILES---I 118
Query: 692 EYLH-QGCKPPIVHRDVKSTNILINEKFQA---KLADFGLSRVFPVEGGTHVSTTIAGTP 747
Y H G IVHR++K N+L+ K + KLADFGL+ + AGTP
Sbjct: 119 AYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTP 171
Query: 748 GYLDPEYYISNRLTEKSDVYSFGVVL 773
GYL PE + ++ D+++ GV+L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 40/217 (18%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLT 639
N +LGKG FG V ++ E AVK+++ + ++ EV+LL ++ H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 640 TLVGYCDEGTNMALIYEYMANGNL------EEHLSDSSKEILNWEER-----LRIAVEAA 688
L ++ ++ ++ E G L + S E ++
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS----------EHDAARIIKQVFSG- 133
Query: 689 LGLEYLH-QGCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIA 744
+ Y+H IVHRD+K NIL+ + K+ DFGLS F
Sbjct: 134 --ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRI 184
Query: 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
GT Y+ PE + EK DV+S GV+L +++G P
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 65/241 (26%), Positives = 107/241 (44%), Gaps = 35/241 (14%)
Query: 560 NRSYESLDLSSRQFTYSEVLRMTNNFERV--LGKGGFGTVYHG--KLDNDEVAVKMLSPS 615
RS + +DLS+ + FE V +G G +G VY G A+K++
Sbjct: 8 ARSLDEIDLSALR-------DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DV 59
Query: 616 SSQGYKQFQAEVKLLLRV-HHRNLTTLVG------YCDEGTNMALIYEYMANGNLEEHLS 668
+ ++ + E+ +L + HHRN+ T G + L+ E+ G++ + +
Sbjct: 60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 669 DSSKEILNWEERLRIAV---EAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADF 725
++ L E IA E GL +LHQ +HRD+K N+L+ E + KL DF
Sbjct: 120 NTKGNTLKEEW---IAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDF 173
Query: 726 GLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE-----KSDVYSFGVVLLEIITGH 780
G+S G T GTP ++ PE + + KSD++S G+ +E+ G
Sbjct: 174 GVSAQLDRTVGRR--NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
Query: 781 P 781
P
Sbjct: 232 P 232
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 583 NNFE--RVLGKGGFGTVYHG-KLDNDEV-AVKMLSPSSSQGYKQFQ---AEVKLLLRVHH 635
++FE R +GKG FG V K D ++ A+K ++ + + E++++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 636 RNLTTLVGYC--DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLE 692
L L Y DE +M ++ + + G+L HL + + EE +++ E + L+
Sbjct: 75 PFLVNLW-YSFQDE-EDMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALD 129
Query: 693 YLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLD 751
YL Q I+HRD+K NIL++E + DF ++ + P E TT+AGT Y+
Sbjct: 130 YLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMA 182
Query: 752 PEYYISNRLTEKS---DVYSFGVVLLEIITGHP 781
PE + S + S D +S GV E++ G
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 44/214 (20%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVK------MLSPSSSQGYKQFQAEVKLLLRVHH 635
LG G F V K E A K + S ++ + EV +L + H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNL------EEHLSDSSKEILNWEER-----LRIA 684
N+ TL + T++ LI E ++ G L +E L+ E L+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT----------EDEATQFLKQI 117
Query: 685 VEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQA----KLADFGLSRVFPVEGGTHV 739
++ G+ YLH I H D+K NI++ +K KL DFG++ E G
Sbjct: 118 LD---GVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEF 168
Query: 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVL 773
I GTP ++ PE L ++D++S GV+
Sbjct: 169 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD 646
+G+G GTVY EVA++ ++ + E+ ++ + N+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 647 EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRD 706
G + ++ EY+A G+L + ++ + ++ + + E LE+LH +HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQV---IHRD 141
Query: 707 VKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDV 766
+KS NIL+ KL DFG + +T+ GTP ++ PE K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 767 YSFGVVLLEIITGHP 781
+S G++ +E+I G P
Sbjct: 200 WSLGIMAIEMIEGEP 214
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 13/195 (6%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
+ LG G FG V+ + + A K + + + E++ + + H L L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH-QGCKP 700
++ M +IYE+M+ G L E ++D ++ +E + + GL ++H
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN--- 275
Query: 701 PIVHRDVKSTNILINEKFQA--KLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
VH D+K NI+ K KL DFGL+ + V GT + PE
Sbjct: 276 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSV-KVTTGTAEFAAPEVAEGK 331
Query: 759 RLTEKSDVYSFGVVL 773
+ +D++S GV+
Sbjct: 332 PVGYYTDMWSVGVLS 346
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 44/214 (20%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLS------PSSSQGYKQFQAEVKLLLRVHH 635
+ LG G F V K E A K + ++ + EV +L +V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNL------EEHLSDSSKEILNWEER-----LRIA 684
N+ TL + T++ LI E ++ G L +E LS E ++
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS----------EEEATSFIKQI 124
Query: 685 VEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEK----FQAKLADFGLSRVFPVEGGTHV 739
++ G+ YLH I H D+K NI++ +K KL DFGL+
Sbjct: 125 LD---GVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVE 174
Query: 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVL 773
I GTP ++ PE L ++D++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 39/208 (18%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKML--SPSSSQGYKQFQAEVKLLLRVHHRNLTT 640
+ LGKG F V K E A K++ S++ +++ + E ++ ++ H N+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 641 LVGYCDEGTNMALIYEYMANGNL------EEHLSDSSKEILNWEER-----LRIAVEAAL 689
L E + L+++ + G L E S E ++ +E+
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS----------EADASHCIQQILES-- 140
Query: 690 GLEYLH-QGCKPPIVHRDVKSTNILINEKFQA---KLADFGLSRVFPVEGGTHVSTTIAG 745
+ Y H G IVHR++K N+L+ K + KLADFGL+ + AG
Sbjct: 141 -IAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAG 192
Query: 746 TPGYLDPEYYISNRLTEKSDVYSFGVVL 773
TPGYL PE + ++ D+++ GV+L
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 586 ERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
LG+G +G+VY K VA+K + ++ E+ ++ + ++ G
Sbjct: 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
+ T++ ++ EY G++ + + + L +E I GLEYLH K +
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---I 147
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIA------GTPGYLDPEYYIS 757
HRD+K+ NIL+N + AKLADFG++ ++ T+A GTP ++ PE
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVA--------GQLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 758 NRLTEKSDVYSFGVVLLEIITGHP 781
+D++S G+ +E+ G P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKP 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 585 FERVLGKGGFGTVYHGK--LDNDEVAVKMLS----PSSSQGYKQFQAEVKLLLRVHHRNL 638
+LG+G +G V AVK+L G + E++LL R+ H+N+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 639 TTL--VGYCDEGTNMALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYLH 695
L V Y +E M ++ EY G E + DS ++ + + GLEYLH
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
IVH+D+K N+L+ K++ G++ T G+P + PE
Sbjct: 127 SQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 756 ISNRLTE--KSDVYSFGVVLLEIITGH 780
K D++S GV L I TG
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 32/205 (15%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKML--SPSSSQGYKQFQAEVKLLLRVHHRNLTT 640
LGKG F V L E A ++ S++ +++ + E ++ + H N+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 641 LVGYCDEGTNMALIYEYMANGNL------EEHLS--DSSKEILNWEERLRIAVEAALGLE 692
L E + LI++ + G L E+ S D+S I + +EA +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-------QQILEA---VL 124
Query: 693 YLH-QGCKPPIVHRDVKSTNILINEKFQA---KLADFGLSRVFPVEGGTHVSTTIAGTPG 748
+ H G +VHR++K N+L+ K + KLADFGL+ EG AGTPG
Sbjct: 125 HCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAGTPG 178
Query: 749 YLDPEYYISNRLTEKSDVYSFGVVL 773
YL PE + + D+++ GV+L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 35/221 (15%)
Query: 573 FTYSEVLRMTNNFE--------RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQ 622
F + V +LG G FG V+ ++A K++ + ++
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 623 FQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR 682
+ E+ ++ ++ H NL L + ++ L+ EY+ G L + + D L E
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID-ESYNLT--EL-- 187
Query: 683 IAVEAAL-------GLEYLHQ-GCKPPIVHRDVKSTNILINEKFQA--KLADFGLSRVFP 732
+ L G+ ++HQ I+H D+K NIL + K+ DFGL+R +
Sbjct: 188 ---DTILFMKQICEGIRHMHQMY----ILHLDLKPENILCVNRDAKQIKIIDFGLARRY- 239
Query: 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVL 773
GTP +L PE + ++ +D++S GV+
Sbjct: 240 --KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 42/209 (20%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLR-VHHRNLTT 640
+ +G G + K N E AVK++ S E+++LLR H N+ T
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIIT 80
Query: 641 LVGYCDEGTNMALIYEYMANGNL------EEHLSDSSKEILNWEER-----LRIAVEAAL 689
L D+G + ++ E M G L ++ S ER L +
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS----------EREASAVLFTITKT-- 128
Query: 690 GLEYLH-QGCKPPIVHRDVKSTNILINEKFQA----KLADFGLSRVFPVEGGTHVSTTIA 744
+EYLH QG +VHRD+K +NIL ++ ++ DFG ++ E G + T
Sbjct: 129 -VEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPC 181
Query: 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVL 773
T ++ PE D++S GV+L
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 53/220 (24%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPS--------SSQGYKQFQAEVKLLLRV 633
+ LG G G V + +VA+K++S + + E+++L ++
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 634 HHRNLTTLVGYCDEGTNMALIYEYMANGNL------EEHLSDSSKEILNWEERLRIAVEA 687
+H + + + D + ++ E M G L + L E
Sbjct: 73 NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLK----------EA-----TC 116
Query: 688 AL-------GLEYLH-QGCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGG 736
L ++YLH G I+HRD+K N+L+ E K+ DFG S++ G
Sbjct: 117 KLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 169
Query: 737 THVSTTIAGTPGYLDPE---YYISNRLTEKSDVYSFGVVL 773
T + T+ GTP YL PE + D +S GV+L
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 44/214 (20%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVK------MLSPSSSQGYKQFQAEVKLLLRVHH 635
+ LG G F V K + A K S + + EV +L + H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNL------EEHLSDSSKEILNWEER-----LRIA 684
N+ TL + T++ LI E +A G L +E L+ E L+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT----------EEEATEFLKQI 123
Query: 685 VEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQA----KLADFGLSRVFPVEGGTHV 739
+ + YLH I H D+K NI++ ++ K+ DFGL+ +
Sbjct: 124 LNG---VYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNE 173
Query: 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVL 773
I GTP ++ PE L ++D++S GV+
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 44/214 (20%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQ------FQAEVKLLLRVHH 635
+ LG G F V K E A K + S+ ++ + EV +L +V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNL------EEHLSDSSKEILNWEER-----LRIA 684
N+ TL + T++ LI E ++ G L +E LS E ++
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS----------EEEATSFIKQI 124
Query: 685 VEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEK----FQAKLADFGLSRVFPVEGGTHV 739
++ G+ YLH I H D+K NI++ +K KL DFGL+
Sbjct: 125 LD---GVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVE 174
Query: 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVL 773
I GTP ++ PE L ++D++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 589 LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCD 646
+G+G G V K +VAVKM+ Q + EV ++ H N+ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 647 EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRD 706
G + ++ E++ G L + +S LN E+ + L YLH ++HRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRD 166
Query: 707 VKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDV 766
+KS +IL+ + KL+DFG + ++ GTP ++ PE + + D+
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQ--ISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224
Query: 767 YSFGVVLLEIITGHP 781
+S G++++E++ G P
Sbjct: 225 WSLGIMVIEMVDGEP 239
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 54/228 (23%), Positives = 86/228 (37%), Gaps = 33/228 (14%)
Query: 565 SLDLSSRQFTYSEVLRMTNNFE---RVLGKGGFGTVYHG--KLDNDEVAVKML--SPSSS 617
+DL + + + N + + LG+G F V K E A K L
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 618 QGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILN 676
+ E+ +L + L + + + LI EY A G + E+++
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129
Query: 677 WEERLRIAVEAAL-------GLEYLH-QGCKPPIVHRDVKSTNILI---NEKFQAKLADF 725
E + G+ YLH IVH D+K NIL+ K+ DF
Sbjct: 130 --EN-----DVIRLIKQILEGVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 726 GLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVL 773
G+SR G I GTP YL PE + +T +D+++ G++
Sbjct: 179 GMSRKI---GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-25
Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 25/244 (10%)
Query: 551 SGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFE--RVLGKGGFGTVYHG-KLDNDEV 607
G + + + L M N+F R++G+GGFG VY K D ++
Sbjct: 158 RGDVFQKFIESDKFTRFCQWKNVELNIHLTM-NDFSVHRIIGRGGFGEVYGCRKADTGKM 216
Query: 608 -AVKMLSPS---SSQGYKQFQAEVKLLLRVH---HRNLTTLVGYCDE-GTNMALIYEYMA 659
A+K L QG E +L V + + Y ++ I + M
Sbjct: 217 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMN 275
Query: 660 NGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF 718
G+L HLS + + E +R A E LGLE++H +V+RD+K NIL++E
Sbjct: 276 GGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHG 329
Query: 719 QAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLEII 777
+++D GL+ F + H GT GY+ PE + S D +S G +L +++
Sbjct: 330 HVRISDLGLACDFS-KKKPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 778 TGHP 781
GH
Sbjct: 386 RGHS 389
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 57/252 (22%), Positives = 108/252 (42%), Gaps = 38/252 (15%)
Query: 585 FERVLGKGGFGTVYHGK--LDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTT 640
+ +GKG F V + L EVA+K++ + + ++ EV+++ ++H N+
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
L + + LI EY + G + ++L + + +E + ++Y HQ
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKR-- 134
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
IVHRD+K+ N+L++ K+ADFG S F G + G P Y PE +
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAF-CGAPPYAAPE-LFQGKK 189
Query: 761 TE--KSDVYSFGVVLLEIITGH--------PVISKSAENGHTHVAQWVSS--------ML 802
+ + DV+S GV+L +++G + + G + ++S+ L
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 249
Query: 803 DKGDIRSTVDPR 814
++P
Sbjct: 250 -------VLNPI 254
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLS---PSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
R +G G FG VY +++ VA+K +S S++ ++ EV+ L ++ H N
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV---EAALGLEYLHQGC 698
G L+ EY + L + K+ L E IA A GL YLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVE---IAAVTHGALQGLAYLHSHN 174
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
+HRDVK+ NIL++E KL DFG + + + GTP ++ PE ++
Sbjct: 175 M---IHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPEVILAM 225
Query: 759 RLTE---KSDVYSFGVVLLEIITGHP 781
+ K DV+S G+ +E+ P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKP 251
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 39/209 (18%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
LG+G FG V+ K + + E+ +L HRN+ L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 642 VGYCDEGTNMALIYEYMANGNL-------EEHLSDSSKEILNWEERLRIAVEAAL----- 689
+ + +I+E+++ ++ L+ ER E
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELN----------ER-----EIVSYVHQV 111
Query: 690 --GLEYLH-QGCKPPIVHRDVKSTNILINEKFQA--KLADFGLSRVFPVEGGTHVSTTIA 744
L++LH I H D++ NI+ + + K+ +FG +R + G + +
Sbjct: 112 CEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNF-RLLF 164
Query: 745 GTPGYLDPEYYISNRLTEKSDVYSFGVVL 773
P Y PE + + ++ +D++S G ++
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 583 NNFE--RVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQ---FQAEVKLLLRVHH 635
+FE +V+G+G FG V KL + D+V A+K+L+ + F+ E +L+
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYL 694
+ +TTL + N+ L+ +Y G+L LS + EE R E + ++ +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP--EEMARFYLAEMVIAIDSV 191
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
HQ VHRD+K NIL++ +LADFG +E GT S+ GTP Y+ PE
Sbjct: 192 HQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEI 247
Query: 755 YISNRLTEKS-----DVYSFGVVLLEIITGHP 781
+ + D +S GV + E++ G
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 26/236 (11%)
Query: 564 ESLDLSSRQFTYSEVLRMT-NNFE--RVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQ 618
+ L + + +R+ ++FE +V+G+G F V K+ +V A+K+++
Sbjct: 41 DFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML 100
Query: 619 GYKQ---FQAEVKLLLRVHHRNLTTLVGYC--DEGTNMALIYEYMANGNLEEHLSDSSKE 673
+ F+ E +L+ R +T L + DE + L+ EY G+L LS +
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLH-FAFQDE-NYLYLVMEYYVGGDLLTLLSKFGER 158
Query: 674 ILNWEERLRI-AVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732
I E R E + ++ +H+ VHRD+K NIL++ +LADFG
Sbjct: 159 IP--AEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213
Query: 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVY-------SFGVVLLEIITGHP 781
+G S GTP YL PE + + Y + GV E+ G
Sbjct: 214 ADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 585 FERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRNLTTL 641
+ LG+G +G V + + VAVK++ + + + E+ + ++H N+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
G+ EG L EY + G L + + + + R + G+ YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG--- 125
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL- 760
I HRD+K N+L++E+ K++DFGL+ VF + + GT Y+ PE + R
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREF 184
Query: 761 -TEKSDVYSFGVVLLEIITGH 780
E DV+S G+VL ++ G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 583 NNFE--RVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQ---AEVKLLLRVHH 635
+ F+ + LG G FG V K + A+K+L KQ + E ++L V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYL 694
L L + +N+ ++ EY+A G + HL + + E R A + L EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FS-EPHARFYAAQIVLTFEYL 157
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
H +++RD+K N+LI+++ ++ DFG ++ V+G T T+ GTP L PE
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW---TLCGTPEALAPEI 209
Query: 755 YISNRLTEKSDVYSFGVVLLEIITGHP 781
+S + D ++ GV++ E+ G+P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 53/200 (26%), Positives = 83/200 (41%), Gaps = 28/200 (14%)
Query: 586 ERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLV 642
++ LG+G F K N AVK++S Q E+ L H N+ L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLH 72
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEER-----LRIAVEAALGLEYLH-Q 696
+ + L+ E + G L E + ++ E +R V A + ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKK----HFSETEASYIMRKLVSA---VSHMHDV 125
Query: 697 GCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
G +VHRD+K N+L N+ + K+ DFG +R+ P + T T Y PE
Sbjct: 126 G----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPE 179
Query: 754 YYISNRLTEKSDVYSFGVVL 773
N E D++S GV+L
Sbjct: 180 LLNQNGYDESCDLWSLGVIL 199
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 53/208 (25%), Positives = 79/208 (37%), Gaps = 22/208 (10%)
Query: 586 ERVLGKGGFGTVYHG--KLDNDEVAVKML--------SPSSSQGYKQFQAEVKLLLRVHH 635
LG G FG V+ K N EV VK + + E+ +L RV H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGN-LEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
N+ ++ + L+ E +G L + L+ I + + YL
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYL 146
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
I+HRD+K NI+I E F KL DFG + E G T GT Y PE
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTF-CGTIEYCAPE- 199
Query: 755 YISNRLTE--KSDVYSFGVVLLEIITGH 780
+ + +++S GV L ++
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 586 ERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLV 642
E VLG+G V + + E AVK++ + EV++L + HRN+ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEER-----LRIAVEAALGLEYLH-Q 696
+ +E L++E M G++ H+ ++ E ++ A L++LH +
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASA---LDFLHNK 130
Query: 697 GCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEG-----GTHVSTTIAGTPG 748
G I HRD+K NIL N+ K+ DF L + G T T G+
Sbjct: 131 G----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 749 YLDPE-----YYISNRLTEKSDVYSFGVVL 773
Y+ PE ++ ++ D++S GV+L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 585 FERVLGKGGFGTVYHGK--LDNDEVAVKML------SPSSSQGYKQFQAEVKLLLRVHHR 636
+LG GGFG+VY G DN VA+K + + EV LL +V
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 637 --NLTTLVGYCDEGTNMALIYEYMAN-GNLEEHLSDSSKEILNWEERLRIAVEAALGLEY 693
+ L+ + + + LI E +L + +++ L E + + +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRH 164
Query: 694 LHQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
H ++HRD+K NILI+ + + KL DFG + T + GT Y P
Sbjct: 165 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDF-DGTRVYSPP 217
Query: 753 EYYISNRLTE--KSDVYSFGVVLLEIITGH 780
E +I + V+S G++L +++ G
Sbjct: 218 E-WIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 585 FERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRNLTTL 641
+ LG+G +G V + + VAVK++ + + + E+ + ++H N+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
G+ EG L EY + G L + + + + R + G+ YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG--- 125
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL- 760
I HRD+K N+L++E+ K++DFGL+ VF + + GT Y+ PE + R
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREF 184
Query: 761 -TEKSDVYSFGVVLLEIITGH 780
E DV+S G+VL ++ G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 39/206 (18%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
E LG+G VY K A+K+L + + K + E+ +LLR+ H N+ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLK 114
Query: 643 GYCDEGTNMALIYEYMANGNL-----------EEHLSDSSKEILNWEERLRIAVEAALGL 691
+ T ++L+ E + G L E +D+ K+IL +
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE-------------AV 161
Query: 692 EYLH-QGCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP 747
YLH G IVHRD+K N+L K+ADFGLS++ + T+ GTP
Sbjct: 162 AYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTP 214
Query: 748 GYLDPEYYISNRLTEKSDVYSFGVVL 773
GY PE + D++S G++
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKML------SPSSSQGYKQFQAEVKLLLRVH--- 634
+LGKGGFGTV+ G D +VA+K++ S EV LL +V
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 635 -HRNLTTLVGYCDEGTNMALIYEYMANGN-LEEHLSDSSKEILNWEERLRIAVEAALGLE 692
H + L+ + + L+ E L +++++ L + ++
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQ 153
Query: 693 YLHQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLD 751
+ H +VHRD+K NILI+ + AKL DFG + + GT Y
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDF-DGTRVYSP 206
Query: 752 PEYYISNRLTE--KSDVYSFGVVLLEIITGH 780
PE +IS + V+S G++L +++ G
Sbjct: 207 PE-WISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 67/252 (26%), Positives = 115/252 (45%), Gaps = 39/252 (15%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTT 640
LG G FG V G+ L +VAVK+L+ S + + E++ L H ++
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
L T+ ++ EY++ G L +++ + + E R+ + ++Y H+
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHM-- 131
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
+VHRD+K N+L++ AK+ADFGLS + G + T+ G+P Y PE IS RL
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTS-CGSPNYAAPE-VISGRL 186
Query: 761 TE--KSDVYSFGVVLLEIITGH--------PVISKSAENGHTHVAQWVSS--------ML 802
+ D++S GV+L ++ G P + K G ++ ++++ ML
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHML 246
Query: 803 DKGDIRSTVDPR 814
VDP
Sbjct: 247 Q-------VDPL 251
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 583 NNFE--RVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQF---QAEVKLLLRVHH 635
N FE ++LGKG FG V K A+K+L + E ++L H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 636 RNLTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEY 693
LT L Y + + EY G L HLS +E + E+R R E L+Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDY 263
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
LH + +V+RD+K N+++++ K+ DFGL + +G T T GTP YL PE
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPE 319
Query: 754 YYISNRLTEKSDVYSFGVVLLEIITGHP 781
N D + GVV+ E++ G
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/237 (24%), Positives = 94/237 (39%), Gaps = 61/237 (25%)
Query: 587 RVLGKGGFGTVYHGK--LDNDEVAVKMLS---------------PSSSQGYKQFQA---- 625
+GKG +G V DN A+K+LS P ++
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 626 -------EVKLLLRVHHRNLTTLVGYCDEGTNMAL--IYEYMANGNLEEHLSDSSKEILN 676
E+ +L ++ H N+ LV D+ L ++E + G ++
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG-----------PVME 127
Query: 677 WEERLRIAVEAA--------LGLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGL 727
++ + A G+EYLH Q I+HRD+K +N+L+ E K+ADFG+
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 728 SRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE----KSDVYSFGVVLLEIITGH 780
S F +G + + GTP ++ PE +S DV++ GV L + G
Sbjct: 184 SNEF--KGSDALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 583 NNFE--RVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQFQ---AEVKLLLRVHH 635
+F+ R LG G FG V+ + N A+K+L KQ + E +L V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYL 694
+ + G + + +I +Y+ G L L S + + A E L LEYL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYL 122
Query: 695 H-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
H + I++RD+K NIL+++ K+ DFG ++ V T+ T+ GTP Y+ PE
Sbjct: 123 HSKD----IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY---TLCGTPDYIAPE 173
Query: 754 YYISNRLTEKSDVYSFGVVLLEIITGHP 781
+ + D +SFG+++ E++ G+
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 21/231 (9%)
Query: 562 SYESLDLSSRQFTYSEVLRMTN-NFERVLGKGGFGTVY----HGKLDNDEV-AVKMLSPS 615
S + + ++ E + +VLG+G FG V+ D ++ A+K+L +
Sbjct: 4 SIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA 63
Query: 616 SSQGYKQFQ--AEVKLLLRVHHRNLTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSK 672
+ + + + E +L+ V+H + L Y + LI +++ G+L LS K
Sbjct: 64 TLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS---K 119
Query: 673 EILNWEERLRI-AVEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730
E++ EE ++ E AL L++LH G I++RD+K NIL++E+ KL DFGLS+
Sbjct: 120 EVMFTEEDVKFYLAELALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKE 175
Query: 731 FPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
+ + GT Y+ PE T+ +D +SFGV++ E++TG
Sbjct: 176 SIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 42/219 (19%), Positives = 74/219 (33%), Gaps = 31/219 (14%)
Query: 613 SPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSD-SS 671
SS +++ + +N + + + + NL++ ++ S
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 672 KEILNWEERLRIAVEAALGLEYLH-QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730
E L I ++ A +E+LH +G ++HRD+K +NI K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 731 ----------FPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEII--- 777
T GT Y+ PE N + K D++S G++L E++
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273
Query: 778 -TGH-----------PVISKSAENGHTHVAQWVSSMLDK 804
T + V ML
Sbjct: 274 STQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSP 312
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 580 RMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLS-PSSSQGYKQFQAEVKLLLRVH 634
R +FE + +G+GGFG V+ K+D+ A+K + P+ ++ EVK L ++
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 635 HRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEE 679
H + E E +E +
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDA 107
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 583 NNFE--RVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQF---QAEVKLLLRVHH 635
N+F+ ++LGKG FG V + A+K+L + E ++L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 636 RNLTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEY 693
LT L Y + + EY G L HLS +E + EER R E LEY
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEY 120
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
LH +V+RD+K N+++++ K+ DFGL + +G T T GTP YL PE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPE 175
Query: 754 YYISNRLTEKSDVYSFGVVLLEIITGHP 781
N D + GVV+ E++ G
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 30/268 (11%), Positives = 69/268 (25%), Gaps = 61/268 (22%)
Query: 586 ERVLGKGGFGTVYHG---KLDNDEVAVKMLSPSSS---QGYKQFQAEVKLLLRVHHRNLT 639
G + LD VA+ + P ++ + L R+ +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQ-VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ-GC 698
++ ++ E++ G+L+E S + +R A + H+ G
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
+ + + ++ LA P +
Sbjct: 150 ---VALSIDHPSRVRVSIDGDVVLAY----------------------PATMPDA----- 179
Query: 759 RLTEKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSMLDKGDIR--STVDPRL 815
+ D+ G L ++ P+ +G + + G + +D +
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-----GQPIEPADIDRDI 232
Query: 816 KGDFDINSVWKAVEIAMACVSSNANRRP 843
+A V + R
Sbjct: 233 PFQIS--------AVAARSVQGDGGIRS 252
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 40/252 (15%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTT 640
LG+G FG V +VA+K +S S + + + E+ L + H ++
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
L T++ ++ EY A G L +++ + + + +E R + +EY H+
Sbjct: 74 LYDVITTPTDIVMVIEY-AGGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHK-- 128
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
IVHRD+K N+L+++ K+ADFGLS + G + T+ G+P Y PE I+ +L
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTS-CGSPNYAAPE-VINGKL 183
Query: 761 TE--KSDVYSFGVVLLEIITGH--------PVISKSAENGHTHVAQWVSS--------ML 802
+ DV+S G+VL ++ G P + K + + ++S M+
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243
Query: 803 DKGDIRSTVDPR 814
DP
Sbjct: 244 V-------ADPM 248
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-22
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 583 NNFE--RVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQ---FQAEVKLLLRVHH 635
++E +V+G+G FG V K A+K+LS F E ++ +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYL 694
+ L + + ++ EYM G+L +S + E+ R E L L+ +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---NYDVP-EKWARFYTAEVVLALDAI 184
Query: 695 HQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
H +HRDVK N+L+++ KLADFG EG T GTP Y+ PE
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPE- 239
Query: 755 YISNRLTEKS-----DVYSFGVVLLEIITGHP 781
+ ++ + D +S GV L E++ G
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 5e-22
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 583 NNFE--RVLGKGGFGTVY-----HGKLDNDEVAVKMLSPSS-SQGYKQF---QAEVKLLL 631
FE RVLGKGG+G V+ G A+K+L + + K +AE +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 632 RVHHRNLTTLVGYC--DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAA 688
V H + L+ Y G + LI EY++ G L L +E + E+ E +
Sbjct: 77 EVKHPFIVDLI-YAFQTGG-KLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEIS 131
Query: 689 LGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP 747
+ L +LHQ G I++RD+K NI++N + KL DFGL + +G + T GT
Sbjct: 132 MALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCGTI 185
Query: 748 GYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
Y+ PE + + D +S G ++ +++TG P
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 34/204 (16%)
Query: 586 ERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLV 642
++VLG G G V + + A+K+L S + + EV + ++ ++
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88
Query: 643 GYCDEGTNMA----LIYEYMANGNLEEHLSDSSKEILNWEER-----LRIAVEAALGLEY 693
+ + +I E M G L + + + + ER +R A +++
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTA---IQF 143
Query: 694 LH-QGCKPPIVHRDVKSTNILI---NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGY 749
LH I HRDVK N+L + KL DFG ++ + T TP Y
Sbjct: 144 LHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTPYY 195
Query: 750 LDPEYYISNRLTEKSDVYSFGVVL 773
+ PE + + D++S GV++
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 33/205 (16%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTL 641
+VLG G G V K ++ A+KML + + EV+L R ++ +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 642 VG-YCDEGTNMALIY---EYMANGNLEEHLSDSSKEILNWEER-----LRIAVEAALGLE 692
V Y + + E + G L + D + ER ++ EA ++
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT--EREASEIMKSIGEA---IQ 175
Query: 693 YLH-QGCKPPIVHRDVKSTNILINEKFQA---KLADFGLSRVFPVEGGTHVSTTIAGTPG 748
YLH I HRDVK N+L K KL DFG ++ + TT TP
Sbjct: 176 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---SHNSLTTPCYTPY 228
Query: 749 YLDPEYYISNRLTEKSDVYSFGVVL 773
Y+ PE + + D++S GV++
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 70/252 (27%), Positives = 120/252 (47%), Gaps = 39/252 (15%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTT 640
LG G FG V GK L +VAVK+L+ S + + E++ L H ++
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
L +++ ++ EY++ G L +++ + + L+ +E R+ + G++Y H+
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
+VHRD+K N+L++ AK+ADFGLS + G + T+ G+P Y PE IS RL
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTS-CGSPNYAAPE-VISGRL 191
Query: 761 TE--KSDVYSFGVVLLEIITGH--------PVISKSAENGHTHVAQWVSS--------ML 802
+ D++S GV+L ++ G P + K +G + Q+++ ML
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHML 251
Query: 803 DKGDIRSTVDPR 814
VDP
Sbjct: 252 Q-------VDPM 256
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 583 NNFE--RVLGKGGFGTVY-----HGKLDNDEV-AVKMLSPSS-SQGYKQF---QAEVKLL 630
NFE +VLG G +G V+ G D ++ A+K+L ++ Q K + E ++L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 631 LRV-HHRNLTTLVGYC--DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVE 686
+ L TL Y E + LI +Y+ G L HLS + E ++I E
Sbjct: 113 EHIRQSPFLVTLH-YAFQTET-KLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGE 167
Query: 687 AALGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG 745
L LE+LH+ G I++RD+K NIL++ L DFGLS+ F V T + G
Sbjct: 168 IVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCG 222
Query: 746 TPGYLDPEYYISNRL--TEKSDVYSFGVVLLEIITGHP 781
T Y+ P+ + D +S GV++ E++TG
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-20
Identities = 65/207 (31%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 584 NFERVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQF---QAEVK-LLLRVHHRN 637
+F +V+GKG FG V + + AVK+L + K+ +E LL V H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 638 LTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLH 695
L L + + + +Y+ G L HL +E E R R A E A L YLH
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLH 156
Query: 696 Q-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEY 754
IV+RD+K NIL++ + L DFGL + T ++T GTP YL PE
Sbjct: 157 SLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEV 210
Query: 755 YISNRLTEKSDVYSFGVVLLEIITGHP 781
D + G VL E++ G P
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 584 NFERVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQF---QAEVKLLLRV-HHRN 637
F RVLGKG FG V ++ + ++ AVK+L E ++L +H
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85
Query: 638 LTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLH 695
LT L C + + E++ G+L H+ K E R R A E L +LH
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLH 141
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
I++RD+K N+L++ + KLADFG+ + G T + T GTP Y+ PE
Sbjct: 142 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEIL 196
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
D ++ GV+L E++ GH
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 583 NNFE--RVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQF---QAEVKLLLRV-H 634
+F+ RV+G+G + V +L D + A+K++ + Q E + + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 635 HRNLTTLVGYCDE-GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLE 692
H L L C + + + + EY+ G+L H+ ++ EE R + E +L L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALN 124
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
YLH+ I++RD+K N+L++ + KL D+G+ + G T ++T GTP Y+ P
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAP 179
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIITGHP 781
E D ++ GV++ E++ G
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 584 NFERVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQF---QAEVKLLLRV-HHRN 637
NF VLGKG FG V + DE+ AVK+L E ++L
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 638 LTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLH 695
LT L C + + EY+ G+L H+ + E A E A+GL +L
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
I++RD+K N++++ + K+ADFG+ + +G T + T GTP Y+ PE
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEII 193
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
+ D ++FGV+L E++ G
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 16/171 (9%)
Query: 581 MTNNFERV--LGKGGFGTVYHG--KLDNDEVAVK-MLSPSSSQGYKQFQA--EVKLLLRV 633
M +E++ +G+G +G V+ + VA+K L K A E+++L ++
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQL 59
Query: 634 HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEY 693
H NL L+ + L++EY + + L D + + I + + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG--TH-VST 741
H+ +HRDVK NILI + KL DFG +R+ V+T
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 584 NFERVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQF---QAEVKLLLRV-HHRN 637
++LGKG FG V+ + ++ A+K L E ++L H
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 638 LTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLH 695
LT + N+ + EY+ G+L H+ R A E LGL++LH
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLH 135
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
IV+RD+K NIL+++ K+ADFG+ + + + T GTP Y+ PE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEIL 190
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
+ + D +SFGV+L E++ G
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 16/201 (7%)
Query: 586 ERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
+ +G G FG KL + VAVK + + + Q E+ + H N+
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
T++A+I EY + G L E + ++ + + +E + G+ Y H I
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQ---IC 138
Query: 704 HRDVKSTNILINEKFQA--KLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLT 761
HRD+K N L++ K+ DFG S+ + + GTP Y+ PE + +
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE-VLLRQEY 194
Query: 762 E--KSDVYSFGVVLLEIITGH 780
+ +DV+S GV L ++ G
Sbjct: 195 DGKIADVWSCGVTLYVMLVGA 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-19
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 584 NFERVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQF---QAEVKLLLRV-HHRN 637
NF VLGKG FG V + DE+ AVK+L E ++L
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 638 LTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLEYLH 695
LT L C + + EY+ G+L H+ + E A E A+GL +L
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
I++RD+K N++++ + K+ADFG+ + +G T + T GTP Y+ PE
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEII 514
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
+ D ++FGV+L E++ G
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 583 NNFE--RVLGKGGFGTVYHGKL-DNDEV-AVKMLSPSSSQGYKQF---QAEVKLLLRV-H 634
+F+ RV+G+G + V +L D + A++++ + Q E + + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 635 HRNLTTLVGYCDE-GTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRI-AVEAALGLE 692
H L L C + + + + EY+ G+L H+ ++ EE R + E +L L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALN 167
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
YLH+ I++RD+K N+L++ + KL D+G+ + G T ++T GTP Y+ P
Sbjct: 168 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAP 222
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIITGHP 781
E D ++ GV++ E++ G
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 55/173 (31%), Positives = 85/173 (49%), Gaps = 16/173 (9%)
Query: 577 EVLRMTNNFERV--LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQ---FQA--EV 627
+V +E++ LG+G F TVY K N VA+K + K A E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 628 KLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEA 687
KLL + H N+ L+ +N++L++++M +LE + + +L +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVII-KDNSLVLTPSHIKAYMLMT 121
Query: 688 ALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTH 738
GLEYLHQ I+HRD+K N+L++E KLADFGL++ F P TH
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-19
Identities = 58/266 (21%), Positives = 96/266 (36%), Gaps = 73/266 (27%)
Query: 585 FERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQG-YKQFQAEVKLLLRV-HH 635
+ LG+G FG V VAVKML ++ ++ +E+K+L+ + HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 636 RNLTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
N+ L+G C G + +I E+ GNL +L E + ++ + + + +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 695 HQGCK-------------------------------PPIVHRDVKSTNILINEKFQ---- 719
K P +++D + LI FQ
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 720 --------------------------AKLADFGLSRVFPVEGGTHVSTTIAGTPG-YLDP 752
K+ DFGL+R + +V A P ++ P
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVRKGDARLPLKWMAP 264
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIIT 778
E T +SDV+SFGV+L EI +
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 29/216 (13%)
Query: 580 RMTNNFERV--LGKGGFGTVYHGKLDNDE-VAVKMLS--------PSSSQGYKQFQAEVK 628
+ ++++ +G+G +G VY K VA+K + PS++ E+
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI------REIS 71
Query: 629 LLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAA 688
LL +HH N+ +L+ + L++E+M +L++ L D +K L + +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLL 129
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTHVSTTIAGT 746
G+ + HQ I+HRD+K N+LIN KLADFGL+R F PV TH T+
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL--- 183
Query: 747 PGYLDPEYYI-SNRLTEKSDVYSFGVVLLEIITGHP 781
Y P+ + S + + D++S G + E+ITG P
Sbjct: 184 -WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 583 NNFERV--LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQA--EVKLLLRVHHR 636
+ F+++ LG G + TVY G K VA+K + S +G A E+ L+ + H
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP-STAIREISLMKELKHE 63
Query: 637 NLTTLVGYCDEGTNMALIYEYMAN---GNLEEHLSDSSKEILNWEERLRIAVEAALGLEY 693
N+ L + L++E+M N ++ ++ L + GL +
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTHVSTTIAGTPGYLD 751
H+ I+HRD+K N+LIN++ Q KL DFGL+R F PV + T+ Y
Sbjct: 124 CHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL----WYRA 176
Query: 752 PE------YYISNRLTEKSDVYSFGVVLLEIITGHP 781
P+ Y + D++S G +L E+ITG P
Sbjct: 177 PDVLMGSRTY-----STSIDIWSCGCILAEMITGKP 207
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 16/169 (9%)
Query: 583 NNFERV--LGKGGFGTVYHG--KLDNDEVAVK-MLSPSSSQGYKQFQA--EVKLLLRVHH 635
+E + +G+G +G V K VA+K L + K A E+KLL ++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRH 83
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
NL L+ C + L++E++ + + + L + L+++ + + G+ + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTH-VST 741
I+HRD+K NIL+++ KL DFG +R P E V+T
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 583 NNFERV--LGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQA--EVKLLLRVHHR 636
+ ++ LG+G + TVY G KL ++ VA+K + +G A EV LL + H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP-CTAIREVSLLKDLKHA 60
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
N+ TL ++ L++EY+ + +L+++L D I+N + GL Y H+
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTHVSTTIAGTPGYLDPEY 754
++HRD+K N+LINE+ + KLADFGL+R P + + T+ Y P+
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL----WYRPPDI 171
Query: 755 YI-SNRLTEKSDVYSFGVVLLEIITGHP 781
+ S + + D++ G + E+ TG P
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 583 NNFERV--LGKGGFGTVYHGKLDNDE-VAVKMLS--------PSSSQGYKQFQAEVKLLL 631
+ + +G+G +G VY + + E A+K + PS++ E+ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI------REISILK 55
Query: 632 RVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGL 691
+ H N+ L + L++E++ + +L++ L D + L ++ G+
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGI 113
Query: 692 EYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTHVSTTIAGTPGY 749
Y H ++HRD+K N+LIN + + K+ADFGL+R F PV TH T+ Y
Sbjct: 114 AYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL----WY 166
Query: 750 LDPE------YYISNRLTEKSDVYSFGVVLLEIITGHP 781
P+ Y + D++S G + E++ G P
Sbjct: 167 RAPDVLMGSKKY-----STTIDIWSVGCIFAEMVNGTP 199
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 580 RMTNNFERV--LGKGGFGTVYHG--KLDNDEVAVKMLS-PSSSQGYKQFQA----EVKLL 630
T+ +E V +G G +GTVY VA+K + P+ G EV LL
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 631 LRVH---HRNLTTLV-----GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR 682
R+ H N+ L+ D + L++E++ +L +L + L E
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 683 IAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG-THVST 741
+ + GL++LH C IVHRD+K NIL+ KLADFGL+R++ + T V
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV 181
Query: 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
T+ Y PE + + D++S G + E+ P
Sbjct: 182 TL----WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 46/170 (27%), Positives = 83/170 (48%), Gaps = 25/170 (14%)
Query: 583 NNFERV--LGKGGFGTVYHG--KLDNDEVAVKMLS--------PSSSQGYKQFQAEVKLL 630
+E++ +G+G +GTV+ + ++ VA+K + PSS+ E+ LL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLL 55
Query: 631 LRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALG 690
+ H+N+ L + L++E+ + +L+++ DS L+ E + G
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYF-DSCNGDLDPEIVKSFLFQLLKG 113
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PVEGGTH 738
L + H ++HRD+K N+LIN + KLA+FGL+R F PV +
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 580 RMTNNFERV--LGKGGFGTVY---HGKLDNDEVAVKMLS--------PSSSQGYKQFQAE 626
R +E V +G+G +G V+ K VA+K + P S+ E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI------RE 61
Query: 627 VKLLLRVH---HRNLTTL-----VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWE 678
V +L + H N+ L V D T + L++E++ + +L +L + + E
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 679 ERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG-T 737
+ + GL++LH +VHRD+K NIL+ Q KLADFGL+R++ + T
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
V T+ Y PE + + D++S G + E+ P
Sbjct: 178 SVVVTL----WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 35/124 (28%), Positives = 57/124 (45%), Gaps = 14/124 (11%)
Query: 361 TDEQDVDAIMNIKSF----YGLKKNWQG--DPCAPQDYLWEGLNCSYPDDDSPRITSLNL 414
+ QD A++ IK L +W D C + W G+ C D + R+ +L+L
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLS-SWLPTTDCC---NRTWLGVLCD-TDTQTYRVNNLDL 57
Query: 415 SASELTGGFA--HYLTNLTMLTSLDLSN-NNLTGPVPKFLSQLSSLKFLNLARNKLTGPL 471
S L + L NL L L + NNL GP+P +++L+ L +L + ++G +
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 472 PVEL 475
P L
Sbjct: 118 PDFL 121
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 23/87 (26%), Positives = 36/87 (41%), Gaps = 4/87 (4%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
++L+ + L + L LDL NN + G +P+ L+QL L LN++ N L
Sbjct: 223 TQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 469 GPLPVELLEKQENNTLELRFDGNPDLC 495
G +P + N LC
Sbjct: 282 GEIPQGG---NLQRFDVSAYANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 17/69 (24%), Positives = 37/69 (53%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ L ++ + ++G +L+ + L +LD S N L+G +P +S L +L + N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 467 LTGPLPVEL 475
++G +P
Sbjct: 161 ISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 17/67 (25%), Positives = 33/67 (49%), Gaps = 1/67 (1%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSL-KFLNLARNKLT 468
+L+ S + L+G +++L L + N ++G +P S L + ++RN+LT
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 469 GPLPVEL 475
G +P
Sbjct: 188 GKIPPTF 194
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 20/64 (31%), Positives = 29/64 (45%), Gaps = 1/64 (1%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
TS+ +S + LTG NL L +DLS N L G + + ++LA+N L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 469 GPLP 472
L
Sbjct: 235 FDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 9e-12
Identities = 20/70 (28%), Positives = 35/70 (50%), Gaps = 2/70 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTML-TSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
P + + + ++G + + L TS+ +S N LTG +P + L +L F++L+RN
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 466 KLTGPLPVEL 475
L G V
Sbjct: 208 MLEGDASVLF 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-17
Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 3/87 (3%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
+ LNL ++++G + +L L LDLS+N L G +P+ +S L+ L ++L+ N L+
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 469 GPLPVELLEKQENNTLELRFDGNPDLC 495
GP+P Q +F NP LC
Sbjct: 718 GPIPE---MGQFETFPPAKFLNNPGLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-15
Identities = 27/69 (39%), Positives = 35/69 (50%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L L + TG L+N + L SL LS N L+G +P L LS L+ L L N
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453
Query: 467 LTGPLPVEL 475
L G +P EL
Sbjct: 454 LEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-15
Identities = 27/71 (38%), Positives = 41/71 (57%)
Query: 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
+ +L L ++LTG L+N T L + LSNN LTG +PK++ +L +L L L+
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523
Query: 465 NKLTGPLPVEL 475
N +G +P EL
Sbjct: 524 NSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-15
Identities = 38/127 (29%), Positives = 65/127 (51%), Gaps = 23/127 (18%)
Query: 356 FSQSQTDEQDVDAIMNIKSFYGLK-----KNWQG--DPCAPQDYLWEGLNCSYPDDDSPR 408
S SQ+ +++ +++ K L +W +PC ++G+ C +
Sbjct: 4 ASPSQSLYREIHQLISFKD--VLPDKNLLPDWSSNKNPCT-----FDGVTC-----RDDK 51
Query: 409 ITSLNLSASELTGGF---AHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
+TS++LS+ L GF + L +LT L SL LSN+++ G V F +SL L+L+RN
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTSLDLSRN 110
Query: 466 KLTGPLP 472
L+GP+
Sbjct: 111 SLSGPVT 117
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-15
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 1/81 (1%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLT-NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFL 460
P + L+L+ ++ TG +L+ LT LDLS N+ G VP F S L+ L
Sbjct: 264 PPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL 323
Query: 461 NLARNKLTGPLPVELLEKQEN 481
L+ N +G LP++ L K
Sbjct: 324 ALSSNNFSGELPMDTLLKMRG 344
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-15
Identities = 21/72 (29%), Positives = 39/72 (54%), Gaps = 1/72 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L++S++ + G L + + L LD+S N L+G + +S + LK LN++ N+
Sbjct: 200 VNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258
Query: 467 LTGPLPVELLEK 478
GP+P L+
Sbjct: 259 FVGPIPPLPLKS 270
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-15
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 2/87 (2%)
Query: 407 PRITSLNLSASELTGGF-AHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLS-SLKFLNLAR 464
+ SL LS++ +G L + L LDLS N +G +P+ L+ LS SL L+L+
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 465 NKLTGPLPVELLEKQENNTLELRFDGN 491
N +GP+ L + +N EL N
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNN 404
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-14
Identities = 19/69 (27%), Positives = 33/69 (47%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
N+++ G + N + LD+S N L+G +PK + + L LNL N
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 467 LTGPLPVEL 475
++G +P E+
Sbjct: 668 ISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-14
Identities = 25/69 (36%), Positives = 37/69 (53%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ SL+LS + L+G L +L+ L L L N L G +P+ L + +L+ L L N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 467 LTGPLPVEL 475
LTG +P L
Sbjct: 478 LTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-14
Identities = 22/69 (31%), Positives = 38/69 (55%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ L L + L G L + L +L L N+LTG +P LS ++L +++L+ N+
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 467 LTGPLPVEL 475
LTG +P +
Sbjct: 502 LTGEIPKWI 510
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-14
Identities = 19/69 (27%), Positives = 38/69 (55%), Gaps = 3/69 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L +S ++++G ++ L LD+S+NN + +P FL S+L+ L+++ NK
Sbjct: 178 GELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNK 234
Query: 467 LTGPLPVEL 475
L+G +
Sbjct: 235 LSGDFSRAI 243
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-13
Identities = 25/82 (30%), Positives = 37/82 (45%), Gaps = 1/82 (1%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTG 469
++LS + LTG ++ L L L LSNN+ +G +P L SL +L+L N G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 470 PLPVELLEKQENNTLELRFDGN 491
+P + KQ G
Sbjct: 553 TIPAAMF-KQSGKIAANFIAGK 573
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-13
Identities = 25/72 (34%), Positives = 36/72 (50%), Gaps = 2/72 (2%)
Query: 406 SPRITSLNLSASELTGGFAHYLTN--LTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
S + +L+LS++ +G L L L L NN TG +P LS S L L+L+
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 464 RNKLTGPLPVEL 475
N L+G +P L
Sbjct: 427 FNYLSGTIPSSL 438
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-12
Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 4/90 (4%)
Query: 406 SPRITSLNLSASELTGGF--AHYLTNLTMLTSLDLSNNNLTGPVPK-FLSQLSSLKFLNL 462
S +TSL+LS + L+G L + + L L++S+N L P +L+SL+ L+L
Sbjct: 99 SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 463 ARNKLTGPLPVELLEKQENNTLE-LRFDGN 491
+ N ++G V + L+ L GN
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGN 188
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-11
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 4/74 (5%)
Query: 407 PRITSLNLSASELTG-GFAHYLTNLTMLTSLDLSNNNLTGPVP---KFLSQLSSLKFLNL 462
+ LN+S++ L G L L LDLS N+++G LK L +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185
Query: 463 ARNKLTGPLPVELL 476
+ NK++G + V
Sbjct: 186 SGNKISGDVDVSRC 199
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-11
Identities = 14/76 (18%), Positives = 30/76 (39%)
Query: 400 SYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKF 459
+D + + E G + L L+ ++++ G S+ F
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
Query: 460 LNLARNKLTGPLPVEL 475
L+++ N L+G +P E+
Sbjct: 637 LDMSYNMLSGYIPKEI 652
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 4e-09
Identities = 17/85 (20%), Positives = 29/85 (34%), Gaps = 4/85 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L LS + +G L + L LDL+ N G +P + + S +A N
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANF 569
Query: 467 LTGPLPVELLEKQENNTLELRFDGN 491
+ G V + +
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLL 594
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 8e-17
Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 38/248 (15%)
Query: 569 SSRQFTYSEVLRMTNNFE--------RVLGKGGFGTVY--HGKLDNDEVAVKMLS-PSSS 617
QF EV + F + +G G G V + + + VA+K LS P +
Sbjct: 44 VDNQFYSVEVGD--STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 101
Query: 618 QGY-KQFQAEVKLLLRVHHRNLTTLV------GYCDEGTNMALIYEYMANGNLEEHLSDS 670
Q + K+ E+ L+ V+H+N+ +L+ +E ++ L+ E M + +L
Sbjct: 102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQV 156
Query: 671 SKEILNWEERLRIAVEAAL-GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729
+ L ER+ + L G+++LH I+HRD+K +NI++ K+ DFGL+R
Sbjct: 157 IQMEL-DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAEN 789
+ T T Y PE + E D++S G ++ E++ +
Sbjct: 213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP----- 264
Query: 790 GHTHVAQW 797
G ++ QW
Sbjct: 265 GRDYIDQW 272
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 38/246 (15%)
Query: 571 RQFTYSEVLRMTNNFE--------RVLGKGGFGTVY--HGKLDNDEVAVKMLS-PSSSQG 619
F E+ + F + +G G G V + + VA+K LS P +Q
Sbjct: 9 NNFYSVEIGD--STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66
Query: 620 Y-KQFQAEVKLLLRVHHRNLTTLV------GYCDEGTNMALIYEYMANGNLEEHLSDSSK 672
+ K+ E+ L+ V+H+N+ L+ +E ++ ++ E M + +L +
Sbjct: 67 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQ 121
Query: 673 EILNWEERLRIAVEAAL-GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731
L+ ER+ + L G+++LH I+HRD+K +NI++ K+ DFGL+R
Sbjct: 122 MELD-HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 732 PVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGH 791
+ T T Y PE + E D++S G ++ E+I G + G
Sbjct: 178 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP-----GT 229
Query: 792 THVAQW 797
H+ QW
Sbjct: 230 DHIDQW 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 52/234 (22%)
Query: 580 RMTNNFERV--LGKGGFGTVYHG--KLDNDEVAVKMLS--------PSSSQGYKQFQAEV 627
+ +E++ +G+G FG V+ + +VA+K + P ++ E+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL------REI 67
Query: 628 KLLLRVHHRNLTTLVG--------YCDEGTNMALIYEYMANGNLEEH----LSDSSKEIL 675
K+L + H N+ L+ Y ++ L++++ EH L +
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKF 121
Query: 676 NWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF--PV 733
E R+ GL Y+H+ I+HRD+K+ N+LI KLADFGL+R F
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 734 EGGTHVSTTIAGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLEIITGHP 781
+ T T Y PE Y D++ G ++ E+ T P
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDY-----GPPIDLWGAGCIMAEMWTRSP 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 60/226 (26%)
Query: 586 ERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQA------EVKLLLRVHHRNL 638
+V+G G FG V+ KL ++DEVA+K K Q E++++ V H N+
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIK----------KVLQDKRFKNRELQIMRIVKHPNV 94
Query: 639 TTL------VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV------E 686
L G + + L+ EY+ E + +S+ ++ + + + +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 687 AALGLEYLH-QGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVF-PVEGGTH-VST- 741
L Y+H G I HRD+K N+L++ KL DFG +++ E + +
Sbjct: 150 LLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205
Query: 742 ------TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
I G Y T D++S G V+ E++ G P
Sbjct: 206 YYRAPELIFGATNY-----------TTNIDIWSTGCVMAELMQGQP 240
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 48/228 (21%)
Query: 580 RMTNNFERV--LGKGGFGTVYHG--KLDNDEVAVKMLS--------PSSSQGYKQFQAEV 627
+ + R+ LG+G +G VY + N+ VA+K + P ++ EV
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI------REV 84
Query: 628 KLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEER------L 681
LL + HRN+ L + LI+EY N +L++++ D + ++ + +
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLI 142
Query: 682 RIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQA-----KLADFGLSRVF--PVE 734
G+ + H +HRD+K N+L++ + K+ DFGL+R F P+
Sbjct: 143 N-------GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192
Query: 735 GGTHVSTTIAGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLEIITGHP 781
TH T+ Y PE + S + D++S + E++ P
Sbjct: 193 QFTHEIITL----WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 61/244 (25%), Positives = 110/244 (45%), Gaps = 49/244 (20%)
Query: 556 DANCNRSYESLDLSSRQFTYSEVLRMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKM 611
D N +R E D S + ++++ R LG+G + V+ +N++V VK+
Sbjct: 13 DVNTHRPREYWDYESHVVEWGN----QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI 68
Query: 612 LSPSSSQGYKQFQAEVKLL--LRVHHRNLTTL--VGYCDEGTNMALIYEYMANGNLEEH- 666
L P + K+ E+K+L LR N+ TL + AL++E++ N + ++
Sbjct: 69 LKPVKKKKIKR---EIKILENLR-GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 124
Query: 667 --LSDSS-----KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN-EKF 718
L+D EIL L+Y H I+HRDVK N++I+ E
Sbjct: 125 QTLTDYDIRFYMYEILK-------------ALDYCHSMG---IMHRDVKPHNVMIDHEHR 168
Query: 719 QAKLADFGLSRVF-PVEGGTH-VSTTIAGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLE 775
+ +L D+GL+ + P + V++ + PE + ++ + S D++S G +L
Sbjct: 169 KLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLAS 223
Query: 776 IITG 779
+I
Sbjct: 224 MIFR 227
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 56/255 (21%), Positives = 106/255 (41%), Gaps = 62/255 (24%)
Query: 566 LDLSSRQFTYSEVLRMTNNFERV---LGKGGFGTVYHGK----LDNDEVAVKMLS----P 614
+D + SE R+ + FE +G+G +G VY K D+ + A+K +
Sbjct: 3 MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 62
Query: 615 SSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMA--LIYEYMANGNLEEH----LS 668
S+ E+ LL + H N+ +L + L+++Y EH +
Sbjct: 63 MSACR------EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA------EHDLWHII 110
Query: 669 DSSKEILNWEERLRIAVEAAL----------GLEYLHQGCKPPIVHRDVKSTNILI---- 714
+ ++ +++ + G+ YLH ++HRD+K NIL+
Sbjct: 111 KFHRASKANKKPVQL--PRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEG 165
Query: 715 NEKFQAKLADFGLSRVF--PVEGGTHVSTTIAGTPGYLDPE------YYISNRLTEKSDV 766
E+ + K+AD G +R+F P++ + + T Y PE +Y T+ D+
Sbjct: 166 PERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHY-----TKAIDI 219
Query: 767 YSFGVVLLEIITGHP 781
++ G + E++T P
Sbjct: 220 WAIGCIFAELLTSEP 234
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 41/250 (16%)
Query: 568 LSSRQFTYSEVLRMTNNFE--------RVLGKGGFGTVY--HGKLDNDEVAVKMLS-PSS 616
+ + F +V + +E +G G +G+V K ++VA+K LS P
Sbjct: 5 IRKKGFYKQDVNK--TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62
Query: 617 SQGY-KQFQAEVKLLLRVHHRNLTTLV------GYCDEGTNMALIYEYMANGNLEEHLSD 669
S+ + K+ E+ LL + H N+ L+ + L+ +M + L
Sbjct: 63 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQK 117
Query: 670 SSKEILNWEERLRIAVEAAL-GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLS 728
+ EE+++ V L GL+Y+H +VHRD+K N+ +NE + K+ DFGL+
Sbjct: 118 IMGLKFS-EEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 729 RVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLEIITGHPVISKSA 787
R E +V T Y PE +S + D++S G ++ E++TG +
Sbjct: 174 RHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK--- 225
Query: 788 ENGHTHVAQW 797
G ++ Q
Sbjct: 226 --GKDYLDQL 233
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 50/230 (21%), Positives = 86/230 (37%), Gaps = 33/230 (14%)
Query: 587 RVLGKGGFGTVYHGK-LDNDEVAVKMLSPSSSQGYKQ--FQA---------EVKLLLRVH 634
R + G +G V G + VA+K + + S G E++LL H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 635 HRNLTTLV-----GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL 689
H N+ L + L+ E M +L + + +++ + ++ + L
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA-QVIHDQRIVIS-PQHIQYFMYHIL 144
Query: 690 -GLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG 748
GL LH+ +VHRD+ NIL+ + + DF L+R + T
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRW 198
Query: 749 YLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQW 797
Y PE + T+ D++S G V+ E+ + G T Q
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR-----GSTFYNQL 243
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 54/234 (23%), Positives = 82/234 (35%), Gaps = 69/234 (29%)
Query: 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQ---------AEVKLLLRVH 634
ER+ G+G FGTV GK VA+K K Q ++ L +H
Sbjct: 28 ERMAGQGTFGTVQLGKEKSTGMSVAIK----------KVIQDPRFRNRELQIMQDLAVLH 77
Query: 635 HRNLTTL--VGYCDEGTNM-----ALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEA 687
H N+ L Y + ++ EY+ + L R ++A
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTL----HRCCRNYYRRQVAPPP 128
Query: 688 AL----------GLEYLHQGCKPPIVHRDVKSTNILINEK-FQAKLADFGLSRVF-PVEG 735
L + LH + HRD+K N+L+NE KL DFG ++ P E
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 736 GTH-VSTT-------IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
+ + I G Y T D++S G + E++ G P
Sbjct: 188 NVAYICSRYYRAPELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGEP 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 59/226 (26%)
Query: 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQA------EVKLLLRVHHRN 637
+V+G G FG VY KL + VA+K K Q E++++ ++ H N
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCN 108
Query: 638 LTTL------VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAV------ 685
+ L G + + L+ +Y+ E + ++ ++ L +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 686 EAALGLEYLHQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVF-PVEGGTH-VST- 741
+ L Y+H I HRD+K N+L++ + KL DFG ++ E + +
Sbjct: 164 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 742 ------TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
I G Y T DV+S G VL E++ G P
Sbjct: 221 YYRAPELIFGATDY-----------TSSIDVWSAGCVLAELLLGQP 255
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGY-KQFQAEVKLLLRVHHRNLTTLV- 642
+G+G +G V + L+ VA+K +SP Q Y ++ E+K+LLR H N+ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 643 ----GYCDEGTNMALIYEYMANGNLE-----EHLSDSSKEILNWEERLRIAVEAALGLEY 693
++ ++ ++ + M +L +HLS+ ++ LR GL+Y
Sbjct: 93 IIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQ-ILR-------GLKY 143
Query: 694 LHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR-VFPVEGGTHVSTTIAGTPGYLDP 752
+H ++HRD+K +N+L+N K+ DFGL+R P T T T Y P
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 753 EYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQW 797
E ++ T+ D++S G +L E+++ P+ G ++ Q
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQL 241
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 49/239 (20%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL--- 641
+ LG GG G V+ + VA+K + + Q K E+K++ R+ H N+ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 642 -----------VGYCDEGTNMALIYEYM---------ANGNLEEHLSDSSKEILNWEERL 681
VG E ++ ++ EYM LEEH ++L
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR----- 131
Query: 682 RIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVF-PVEGGTHV 739
GL+Y+H ++HRD+K N+ IN E K+ DFGL+R+ P
Sbjct: 132 --------GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 740 STTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQW 797
+ T Y P +S N T+ D+++ G + E++TG + + G + Q
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA-----GAHELEQM 234
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 65/253 (25%), Positives = 110/253 (43%), Gaps = 48/253 (18%)
Query: 569 SSRQFTYSEVLRMTNNFE--------RVLGKGGFGTVY--HGKLDNDEVAVKMLS-PSSS 617
+ F EV + +E + +G G +G V +VA+K L P S
Sbjct: 7 ARSGFYRQEVTK--TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS 64
Query: 618 QGY-KQFQAEVKLLLRVHHRNLTTLV------GYCDEGTNMALIYEYMANGNLE-----E 665
+ + K+ E++LL + H N+ L+ D+ T+ L+ +M +L E
Sbjct: 65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE 123
Query: 666 HLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADF 725
L + + L ++ L+ GL Y+H I+HRD+K N+ +NE + K+ DF
Sbjct: 124 KLGEDRIQFLVYQ-MLK-------GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 172
Query: 726 GLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLEIITGHPVIS 784
GL+R E +V T Y PE ++ T+ D++S G ++ E+ITG +
Sbjct: 173 GLARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
Query: 785 KSAENGHTHVAQW 797
G H+ Q
Sbjct: 228 -----GSDHLDQL 235
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 55/241 (22%)
Query: 587 RVLGKGGFGTV---YHGKLDNDEVAVKMLSPSSSQGY-KQFQAEVKLLLRVHHRNLTTL- 641
+LG+G +G V H K + VA+K + P + + E+K+L H N+ T+
Sbjct: 17 SLLGEGAYGVVCSATH-KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF 75
Query: 642 -VGYCDEGTNMALIY---EYMANGNLEEHLSD----SSKEILNWEER--------LRIAV 685
+ D N +Y E M +D S ++L+ ++ LR
Sbjct: 76 NIQRPDSFENFNEVYIIQELMQ--------TDLHRVISTQMLS-DDHIQYFIYQTLR--- 123
Query: 686 EAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG 745
++ LH ++HRD+K +N+LIN K+ DFGL+R+ + T
Sbjct: 124 ----AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 746 TP--GYLDPEYY-------ISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQ 796
+ ++ +Y S + + DV+S G +L E+ P+ G + Q
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP-----GRDYRHQ 231
Query: 797 W 797
Sbjct: 232 L 232
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 587 RVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV--------HHR 636
R LG G F TV+ K ++N VA+K++ + + E+KLL RV
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 637 NLTTLVGYCD-------EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAAL 689
++ D G ++ +++E + NL + + +I+ + L
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILINE------KFQAKLADFGLSRVFPVEGGTHVSTTI 743
GL+Y+H+ C I+H D+K N+L+ Q K+AD G + H + +I
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYTNSI 196
Query: 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
T Y PE + +D++S ++ E+ITG
Sbjct: 197 Q-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 42/159 (26%), Positives = 62/159 (38%), Gaps = 30/159 (18%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTL 641
+VLG G G V K ++ A+KML + + EV+L R ++ +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 642 VG-YCDEGTNMALIY---EYMANGNLEEHLSDSSKEILNWEER-----LRIAVEAALGLE 692
V Y + + E + G L + D + ER ++ EA ++
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT--EREASEIMKSIGEA---IQ 131
Query: 693 YLH-QGCKPPIVHRDVKSTNILINEKFQA---KLADFGL 727
YLH I HRDVK N+L K KL DFG
Sbjct: 132 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 41/205 (20%), Positives = 74/205 (36%), Gaps = 55/205 (26%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQA---------EVKLLLRVHH 635
++G+G +G VY + K VA+K ++ + F+ E+ +L R+
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREITILNRLKS 84
Query: 636 RNLTTLV-----GYCDEGTNMALIYEYMANGNLEEHLSD-----SSKEILNWEER----- 680
+ L + + ++ E SD + L EE
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIAD--------SDLKKLFKTPIFLT-EEHIKTIL 135
Query: 681 ---LRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737
L G ++H+ I+HRD+K N L+N+ K+ DFGL+R E T
Sbjct: 136 YNLLL-------GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 738 HVSTTIAGTPGYLDPEYYISNRLTE 762
++ + + +LT
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKMLS-PSSSQGY-KQFQAEVKLLLRVHHRNLTTLV 642
+G G +G+V VAVK LS P S + K+ E++LL + H N+ L+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 643 ------GYCDEGTNMALIYEYMANGNLE-----EHLSDSSKEILNWEERLRIAVEAALGL 691
+E ++ L+ M +L + L+D + L ++ LR GL
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQ-ILR-------GL 145
Query: 692 EYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLD 751
+Y+H I+HRD+K +N+ +NE + K+ DFGL+R E +V+T Y
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRA 197
Query: 752 PEYYISNRL-TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQW 797
PE ++ + D++S G ++ E++TG + G H+ Q
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP-----GTDHIDQL 239
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 28/107 (26%), Positives = 40/107 (37%), Gaps = 4/107 (3%)
Query: 392 YLWEGLNCSYPDD---DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVP 448
LW+ N P + LNL ++ +L L +DL NNL
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 449 KFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNPDLC 495
+ SLK LNL +N +T + ++ N EL NP C
Sbjct: 578 SVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 24/87 (27%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L+L ++ + + L +LDLS+N L+ QL +L+ L L+ NK
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 467 LTGPLPVELLEKQENNTLE-LRFDGNP 492
+ L E L+ N++L+ L N
Sbjct: 157 IQA-LKSEELDIFANSSLKKLELSSNQ 182
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-10
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 6/82 (7%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF 450
+CS+ PDD IT LNL+ ++L A T + LTSLD+ N ++ P+
Sbjct: 9 ADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68
Query: 451 LSQLSSLKFLNLARNKLTGPLP 472
+L LK LNL N+L+
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSD 90
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 18/78 (23%), Positives = 32/78 (41%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L+LS + L L L L NN+ L L ++++LNL R+
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSF 307
Query: 467 LTGPLPVELLEKQENNTL 484
+ + L K ++ +
Sbjct: 308 TKQSISLASLPKIDDFSF 325
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 17/66 (25%), Positives = 28/66 (42%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + LNL +EL+ T LT L L +N++ + +L L+L+ N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 467 LTGPLP 472
L+
Sbjct: 133 LSSTKL 138
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 18/88 (20%), Positives = 34/88 (38%), Gaps = 3/88 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLT--NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
+ L LS +++ + L + L L+LS+N + P + L L L
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 465 NKLTGPLPVELLEKQENNTL-ELRFDGN 491
+L L +L + N ++ L +
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNS 232
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-09
Identities = 15/66 (22%), Positives = 30/66 (45%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++TSL++ + ++ L ML L+L +N L+ K + ++L L+L N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 467 LTGPLP 472
+
Sbjct: 109 IQKIKN 114
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-09
Identities = 21/64 (32%), Positives = 25/64 (39%), Gaps = 2/64 (3%)
Query: 407 PRITSLNLSASELTG--GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
P + L L L L LT LDLSNNN+ L L L+ L+L
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513
Query: 465 NKLT 468
N L
Sbjct: 514 NNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-09
Identities = 13/64 (20%), Positives = 22/64 (34%), Gaps = 1/64 (1%)
Query: 407 PRITSLNLSASELTGGFAHY-LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
+ L+L +E+ L + + LS N + + SL+ L L R
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 466 KLTG 469
L
Sbjct: 465 ALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 17/88 (19%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLS---QLSSLKFLNLA 463
+ L LS++++ + L L L+N L + + L +S++ L+L+
Sbjct: 171 SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLS 230
Query: 464 RNKLTGPLPVELLEKQENNTLELRFDGN 491
++L+ L + N L N
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 16/77 (20%), Positives = 28/77 (36%), Gaps = 3/77 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTG--PVPKFLSQLSSLKFLNLAR 464
I + LS ++ + + L L L L P L +L L+L+
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 465 NKLTGPLPVELLEKQEN 481
N + + ++LE E
Sbjct: 490 NNIAN-INDDMLEGLEK 505
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 22/71 (30%), Positives = 30/71 (42%), Gaps = 2/71 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNL--TMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
I +L+LS S+L+ L T LT LDLS NNL + L L++ L
Sbjct: 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEY 281
Query: 465 NKLTGPLPVEL 475
N + L
Sbjct: 282 NNIQHLFSHSL 292
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 23/71 (32%), Positives = 28/71 (39%), Gaps = 8/71 (11%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT--------GPVPKFLSQLSSLK 458
+T L+LS + + L L L LDL +NNL G FL LS L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 459 FLNLARNKLTG 469
LNL N
Sbjct: 540 ILNLESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 18/85 (21%), Positives = 35/85 (41%), Gaps = 2/85 (2%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
T ++S + L L L L++ +N++ G + L +LK+L+L+ + +
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 469 -GPLPVELLEKQENNTLE-LRFDGN 491
L E ++ L L N
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKN 391
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-08
Identities = 16/69 (23%), Positives = 25/69 (36%), Gaps = 1/69 (1%)
Query: 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPK-FLSQLSSLKFLNLA 463
D + ++L + L A N L SL+L N +T K F +L L++
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMR 617
Query: 464 RNKLTGPLP 472
N
Sbjct: 618 FNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 16/88 (18%), Positives = 33/88 (37%), Gaps = 5/88 (5%)
Query: 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVP-KFLSQLSSLKFLNLAR 464
+ LNL+ ++++ + + L L LDL N + + + L ++ + L+
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 465 NKLTGPLPVELLEKQENNTLE-LRFDGN 491
NK L +L+ L
Sbjct: 440 NKYLQ-LTRNSFA--LVPSLQRLMLRRV 464
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 5/89 (5%)
Query: 407 PRITSLNLS--ASELTGGFAHYLTNLTM--LTSLDLSNNNLTGPVPKFLSQLSSLKFLNL 462
+ L+LS + L +L L L+L+ N ++ S L L+ L+L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412
Query: 463 ARNKLTGPLPVELLEKQENNTLELRFDGN 491
N++ L + EN E+ N
Sbjct: 413 GLNEIGQELTGQEWRGLENIF-EIYLSYN 440
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-07
Identities = 19/70 (27%), Positives = 32/70 (45%), Gaps = 4/70 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNN--NLTGPVPKFLSQL--SSLKFLNL 462
+ LN+ +++ G ++ T L L L LSN+ +L + L S L LNL
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 463 ARNKLTGPLP 472
+NK++
Sbjct: 389 TKNKISKIES 398
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 15/75 (20%), Positives = 27/75 (36%), Gaps = 9/75 (12%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNN---------NLTGPVPKFLSQLSSL 457
P++ L + + F+H L L + L+L + +L L L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 458 KFLNLARNKLTGPLP 472
+ LN+ N + G
Sbjct: 332 EHLNMEDNDIPGIKS 346
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 17/74 (22%), Positives = 28/74 (37%), Gaps = 5/74 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLT---NLTMLTSLDLSNNNLTGPVPKFLSQL--SSLKFLN 461
R+ L L+ +L L T + +L LSN+ L+ L ++L L+
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 462 LARNKLTGPLPVEL 475
L+ N L
Sbjct: 255 LSYNNLNVVGNDSF 268
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 25/145 (17%), Positives = 48/145 (33%), Gaps = 16/145 (11%)
Query: 352 EVKEFSQSQTDEQDVDAIMN-----IKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDS 406
+ + TD+ V ++ IK + LK+ W G N S +
Sbjct: 4 QFTVKDNALTDDAIVPIKLSRTAEYIKDYLALKEIWDAL---------NGKNWSQQGFGT 54
Query: 407 PRITSLNLSASELTGGFAHYLT--NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
+ N + G ++ + +T L L +G VP + QL+ L+ L L
Sbjct: 55 QPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGS 114
Query: 465 NKLTGPLPVELLEKQENNTLELRFD 489
+ + + N + +
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQ 139
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 19/118 (16%), Positives = 39/118 (33%), Gaps = 8/118 (6%)
Query: 381 NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSN 440
NW + G++ + + R+T L+L +G + LT L L L +
Sbjct: 59 NWNFNKELDMWGAQPGVSL----NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGS 114
Query: 441 NNLTGP----VPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNPDL 494
+ PK +S S + R + ++ ++ + +P
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-10
Identities = 13/61 (21%), Positives = 25/61 (40%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
+ N ++ NL LT +++ N +P FL L ++ +N+A N+
Sbjct: 227 WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286
Query: 469 G 469
Sbjct: 287 S 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 22/84 (26%), Positives = 31/84 (36%), Gaps = 4/84 (4%)
Query: 409 ITSLNLSASELTGGFA-HYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKL 467
I + + + L L + L L+ N L G +P F L LNLA N++
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQI 365
Query: 468 TGPLPVELLEKQENNTLELRFDGN 491
T +P E L F N
Sbjct: 366 TE-IPANFCGFTEQVE-NLSFAHN 387
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 12/85 (14%), Positives = 29/85 (34%), Gaps = 1/85 (1%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
P +D + +++ T + +NN+T V K + +L+ L+
Sbjct: 154 PREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFY 212
Query: 462 LARNKLTGPLPVELLEKQENNTLEL 486
+ + E E + + +
Sbjct: 213 MGNSPFVAENICEAWENENSEYAQQ 237
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 6/77 (7%)
Query: 407 PRITSLNLSASELTG-----GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
P + ++LS + + + L + D N P+ ++ SL L
Sbjct: 513 PYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 462 LARNKLTGPLPVELLEK 478
+ N + + ++
Sbjct: 573 IGSNDIRK-VNEKITPN 588
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 17/78 (21%), Positives = 34/78 (43%), Gaps = 8/78 (10%)
Query: 407 PRITSLNLSASELTGGFAHYLT-------NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKF 459
+++++ S +E+ ++S++LSNN ++ + S S L
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461
Query: 460 LNLARNKLTGPLPVELLE 477
+NL N LT +P L+
Sbjct: 462 INLMGNMLTE-IPKNSLK 478
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 19/86 (22%), Positives = 33/86 (38%), Gaps = 2/86 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ L ++L G + L SL+L+ N +T F ++ L+ A NK
Sbjct: 330 KKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK 388
Query: 467 LTGPLPVELLEKQENNTLELRFDGNP 492
L +P K + + F N
Sbjct: 389 LKY-IPNIFDAKSVSVMSAIDFSYNE 413
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 17/75 (22%), Positives = 28/75 (37%), Gaps = 9/75 (12%)
Query: 407 PRITSLNLSASELTGGFAHY--------LTNLTMLTSLDLSNNNL-TGPVPKFLSQLSSL 457
P + +N++ + G + + + NNL T PV L ++ L
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332
Query: 458 KFLNLARNKLTGPLP 472
L N+L G LP
Sbjct: 333 GMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-09
Identities = 18/89 (20%), Positives = 35/89 (39%), Gaps = 8/89 (8%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTG-------PVPKFLSQLSSLKFLNL 462
+S+NLS ++++ + + L+S++L N LT + L ++L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 463 ARNKLTGPLPVELLEKQENNTLELRFDGN 491
NKLT L + + + N
Sbjct: 496 RFNKLTK-LSDDFRATTLPYLVGIDLSYN 523
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 12/84 (14%), Positives = 27/84 (32%), Gaps = 3/84 (3%)
Query: 412 LNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPL 471
+ + + +T LT L + +N++ K ++ L++ N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITP---NISVLDIKDNPNISID 603
Query: 472 PVELLEKQENNTLELRFDGNPDLC 495
+ E L +D D+
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQDIR 627
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 8/76 (10%)
Query: 407 PRITSLNLSASELTGGFA-HYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFL----- 460
+TS++L ++LT T L L +DLS N+ + P S+LK
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 461 -NLARNKLTGPLPVEL 475
+ N+ P +
Sbjct: 547 RDAQGNRTLREWPEGI 562
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 9/76 (11%), Positives = 35/76 (46%), Gaps = 8/76 (10%)
Query: 405 DSPRITSLNLSASELTG-GFAHYLTNLTMLTSLDLSNNNLTG-------PVPKFLSQLSS 456
+ ++ +L+ + ++L ++++++++D S N + P+ + +
Sbjct: 375 FTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
Query: 457 LKFLNLARNKLTGPLP 472
+ +NL+ N+++
Sbjct: 435 VSSINLSNNQISKFPK 450
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 9/77 (11%), Positives = 23/77 (29%), Gaps = 9/77 (11%)
Query: 408 RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT--------GPVPKFLSQLSSLKF 459
+T + + +L L + ++++ N ++
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 460 LNLARNKL-TGPLPVEL 475
+ + N L T P+ L
Sbjct: 310 IYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 11/89 (12%), Positives = 23/89 (25%), Gaps = 20/89 (22%)
Query: 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGP------------------- 446
+ + T + ++ +T + + LT L + N+
Sbjct: 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240
Query: 447 VPKFLSQLSSLKFLNLARNKLTGPLPVEL 475
L L + + LP L
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 9/62 (14%), Positives = 22/62 (35%), Gaps = 3/62 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P +T L + ++++ N++ LD+ +N ++ L +K
Sbjct: 566 PSLTQLQIGSNDIRKVNEKITPNIS---VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
Query: 467 LT 468
Sbjct: 623 TQ 624
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 19/86 (22%), Positives = 36/86 (41%), Gaps = 1/86 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L+LS +L +L+ L L++S+NN L+SL+ L+ + N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 467 LTGPLPVELLEKQENNTLELRFDGNP 492
+ + L+ ++ L N
Sbjct: 530 IMTSKK-QELQHFPSSLAFLNLTQND 554
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 9e-12
Identities = 18/81 (22%), Positives = 27/81 (33%), Gaps = 6/81 (7%)
Query: 398 NCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFL 451
C PD+ +L+LS + L ++ + L LDLS +
Sbjct: 13 QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 452 SQLSSLKFLNLARNKLTGPLP 472
LS L L L N +
Sbjct: 73 QSLSHLSTLILTGNPIQSLAL 93
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 20/89 (22%), Positives = 40/89 (44%), Gaps = 3/89 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTG-PVPKFLSQLSSLKFLNLARN 465
+ L + L + +L L L++++N + +P++ S L++L+ L+L+ N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 466 KLTGPLPVEL--LEKQENNTLELRFDGNP 492
K+ +L L + L L NP
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 9e-11
Identities = 19/67 (28%), Positives = 27/67 (40%), Gaps = 1/67 (1%)
Query: 407 PRITSLNLSASELTGGFAHY-LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
+ L ++ + F T L LT LDLS L P + LSSL+ LN++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 466 KLTGPLP 472
Sbjct: 505 NFFSLDT 511
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 15/70 (21%), Positives = 30/70 (42%), Gaps = 1/70 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPV-PKFLSQLSSLKFLNLARN 465
+ L++S + F L+ L L ++ N+ P ++L +L FL+L++
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 466 KLTGPLPVEL 475
+L P
Sbjct: 481 QLEQLSPTAF 490
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 2/85 (2%)
Query: 406 SPRITSLNLSASELTGGFAHY-LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
++ L+ S L +L L LD+S+ + + LSSL+ L +A
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 465 NKLTGPLPVELLEKQEN-NTLELRF 488
N ++ + N L+L
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQ 479
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 14/63 (22%), Positives = 26/63 (41%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+++L L+ + + + L+ L L NL + L +LK LN+A N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 467 LTG 469
+
Sbjct: 136 IQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 17/69 (24%), Positives = 28/69 (40%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + L+LS E+ +L+ L++L L+ N + S LSSL+ L
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 467 LTGPLPVEL 475
L +
Sbjct: 112 LASLENFPI 120
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-10
Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 1/90 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQL-SSLKFLNLARN 465
+ LN+S + L L LD S N++ + L SSL FLNL +N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 466 KLTGPLPVELLEKQENNTLELRFDGNPDLC 495
+ + + +L + C
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMEC 583
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 3/82 (3%)
Query: 397 LNCSYPDDDSPRITSLNLSASELT--GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQL 454
++ + D P + L+LS + L+ G + T L LDLS N + FL L
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG-L 395
Query: 455 SSLKFLNLARNKLTGPLPVELL 476
L+ L+ + L +
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVF 417
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 18/71 (25%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 407 PRITSLNLSASELTGG-FAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKF----LN 461
+ LN++ + + Y +NLT L LDLS+N + L L + L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 462 LARNKLTGPLP 472
L+ N + P
Sbjct: 184 LSLNPMNFIQP 194
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 18/70 (25%), Positives = 32/70 (45%), Gaps = 4/70 (5%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT--GPVPKFLSQLSSLKF 459
P + L ++++ F+ +L L LDLS N L+ G + +SLK+
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 460 LNLARNKLTG 469
L+L+ N +
Sbjct: 378 LDLSFNGVIT 387
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 12/97 (12%), Positives = 26/97 (26%), Gaps = 6/97 (6%)
Query: 398 NCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSL 457
+ R+ L+ ++ F LT ++S L + + S
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFN----CLTNVSSFSLVSVTIERVKD--FSYNFGW 306
Query: 458 KFLNLARNKLTGPLPVELLEKQENNTLELRFDGNPDL 494
+ L L K ++L + +
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 10/43 (23%), Positives = 16/43 (37%)
Query: 433 LTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVEL 475
+LDLS N L L+ L+L+R ++
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 16/82 (19%), Positives = 32/82 (39%), Gaps = 5/82 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLT----SLDLSNNNLTGPVPKFLSQLSSLKFLNL 462
+ L+LS++++ + L L + SLDLS N + P ++ L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTL 207
Query: 463 ARNKLTGPLPVELLEKQENNTL 484
N + + ++ +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEV 229
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 11/71 (15%), Positives = 21/71 (29%), Gaps = 2/71 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++S +L + + + L+L N L L L F +
Sbjct: 282 TNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
Query: 467 LTGPLPVELLE 477
+ + LE
Sbjct: 340 AFSEVDLPSLE 350
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 9e-04
Identities = 16/69 (23%), Positives = 27/69 (39%), Gaps = 2/69 (2%)
Query: 411 SLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPK-FLSQLSSLKFLNLARNKLTG 469
SL+LS + + + L L L NN + V K + L+ L+ L +
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 470 PLPVELLEK 478
+E +K
Sbjct: 240 EGNLEKFDK 248
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 42/200 (21%), Positives = 76/200 (38%), Gaps = 40/200 (20%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLS-PSSSQGY-KQFQAEVKLLLRVHHRNLTTL- 641
++G G +G V KL+ VA+K + K+ E+ +L R++H ++ +
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 642 -VGYCDEGTNMALIY---EYM---------ANGNL-EEHLSDSSKEILNWEERLRIAVEA 687
+ + +Y E L E H+ K +L L
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI----KTLLY--NLLV----- 167
Query: 688 ALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP 747
G++Y+H I+HRD+K N L+N+ K+ DFGL+R + I+
Sbjct: 168 --GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 748 GYLDPEYYISNR-----LTE 762
++ + + LT
Sbjct: 223 DDMNLVTFPHTKNLKRQLTG 242
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 46/236 (19%), Positives = 75/236 (31%), Gaps = 47/236 (19%)
Query: 586 ERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL-- 641
+ LG G FG V A+K + + E+ ++ + H N+ L
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVD 67
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEY----LHQG 697
Y + L + + + + +EY LH+
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 698 CKPP------------------------------IVHRDVKSTNILIN-EKFQAKLADFG 726
K I HRD+K N+L+N + KL DFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 727 LSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLEIITGHP 781
++ + V+ I + Y PE + T D++S G V E+I G P
Sbjct: 188 SAKKL-IPSEPSVA-YIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 576 SEVLRMTNNF--ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLL 631
VL + NF + +G G FG + GK N+ VA+K+ S Q E +
Sbjct: 2 MGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYK 59
Query: 632 RVHH-RNLTTLVGYCDEGTNMALIYEYMANG-NLEEHLSDSSKEILNWEERLRIAVEAAL 689
++ + + + G A++ E + G +LE L D + + L IA++
Sbjct: 60 QLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLE-DLFDLCDRTFSLKTVLMIAIQLIS 116
Query: 690 GLEYLHQGCKPPIVHRDVKSTNILI-----NEKFQAKLADFGLSRVF 731
+EY+H +++RDVK N LI + + DF L++ +
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 2e-11
Identities = 30/201 (14%), Positives = 55/201 (27%), Gaps = 54/201 (26%)
Query: 582 TNNFERV--LGKGGFGTVYHGKLDNDEVAVKML---SPSSSQGYKQ-----FQAEVKLL- 630
T +R +G+G FG V+ D+ VA+K++ P G Q E+ +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 631 ----LRVHHRNLTTLVGYCDE----------------------------------GTNMA 652
L N T + +
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNI 712
++ E+ G L ++ + I + L HRD+ N+
Sbjct: 139 IVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193
Query: 713 LINEKFQAKLADFGLSRVFPV 733
L+ + KL + +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTI 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 35/179 (19%), Positives = 67/179 (37%), Gaps = 32/179 (17%)
Query: 586 ERVLGKGGFGTVYHG----------KLDNDEVAVKMLSPSSSQGY----------KQFQA 625
+ + G +Y + ++K L + + K Q
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 626 EV-KLLLRVHHRNLTTLVGY-CDEGTNMALIYEYMANG-NLEEHLSDSSKEILNWEERLR 682
K L + T +G+ + L+ + G +L+ L S K +L+ L+
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQ 163
Query: 683 IAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAK--LADFGLSRVFPVEGGTHV 739
+A LE+LH+ VH +V + NI ++ + Q++ LA +G + + G HV
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY-CPSGKHV 218
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 74/243 (30%)
Query: 587 RVLGKGGFGTV---YHGKLDNDEVAVKMLSPSSSQGYKQFQA---------EVKLLLRVH 634
+ LGKG +G V + + VAVK + FQ E+ +L +
Sbjct: 15 KKLGKGAYGIVWKSID-RRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELS 66
Query: 635 -HRNLTTL--VGYCDEGTNMALIYEYMA-------NGNLEEHLSDSSKE-----ILNWEE 679
H N+ L V D ++ L+++YM N+ L K+ ++
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI---LEPVHKQYVVYQLIK--- 120
Query: 680 RLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739
++YLH G ++HRD+K +NIL+N + K+ADFGLSR F
Sbjct: 121 ----------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 740 STTIAGTPGYLDPEY-------YI-------------SNRLTEKSDVYSFGVVLLEIITG 779
+ ++ + + Y+ S + T+ D++S G +L EI+ G
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
Query: 780 HPV 782
P+
Sbjct: 228 KPI 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 16/162 (9%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH-RNLTTLV 642
R +G G FG +Y G +EVA+K+ + + Q E K+ + + T+
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIR 71
Query: 643 GYCDEGTNMALIYEYMANG-NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
EG ++ E + G +LE+ + S++ + + L +A + +EY+H
Sbjct: 72 WCGAEGDYNVMVMELL--GPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHSKN--- 125
Query: 702 IVHRDVKSTNILI---NEKFQAKLADFGLSRVF-PVEGGTHV 739
+HRDVK N L+ + + DFGL++ + H+
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 32/156 (20%), Positives = 67/156 (42%), Gaps = 17/156 (10%)
Query: 585 FERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH-RNLTTL 641
R +G+G FG ++ G L+N +VA+K Q + E + + + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 642 VGYCDEGTNMALIYEYMANG-NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
+ EG + L+ + + G +LE+ L ++ + + A + ++ +H+
Sbjct: 72 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 701 PIVHRDVKSTNILINEKFQAK-----LADFGLSRVF 731
+V+RD+K N LI + DFG+ + +
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 19/86 (22%), Positives = 32/86 (37%), Gaps = 2/86 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L+LS +L L L L++S+NNL +QL SL L+ + N+
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 467 LTGPLPVELLEKQENNTLELRFDGNP 492
+ + + N
Sbjct: 533 IETSKGILQ--HFPKSLAFFNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 19/79 (24%), Positives = 29/79 (36%), Gaps = 6/79 (7%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF 450
C PDD +++LS + L ++ +N + L LDLS + K
Sbjct: 16 YQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75
Query: 451 LSQLSSLKFLNLARNKLTG 469
L L L L N +
Sbjct: 76 WHGLHHLSNLILTGNPIQS 94
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 15/63 (23%), Positives = 27/63 (42%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+++L L+ + + + LT L +L L + QL +LK LN+A N
Sbjct: 80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 467 LTG 469
+
Sbjct: 140 IHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 17/62 (27%), Positives = 26/62 (41%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
R+ LN+S + L + + L L++LD S N + SL F NL N
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 467 LT 468
+
Sbjct: 557 VA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 15/71 (21%), Positives = 22/71 (30%), Gaps = 1/71 (1%)
Query: 407 PRITSLNLSASELTG-GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
+ L+ S L +L L LD+S N L+SL L +A N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 466 KLTGPLPVELL 476
+
Sbjct: 459 SFKDNTLSNVF 469
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 16/64 (25%), Positives = 24/64 (37%), Gaps = 1/64 (1%)
Query: 407 PRITSLNLSASELTGGFAHY-LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
+ +L ++ + N T LT LDLS L L L+ LN++ N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 466 KLTG 469
L
Sbjct: 508 NLLF 511
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 17/63 (26%), Positives = 26/63 (41%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L+LS E+ L L++L L+ N + P S L+SL+ L K
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 467 LTG 469
L
Sbjct: 116 LAS 118
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 18/87 (20%), Positives = 28/87 (32%), Gaps = 4/87 (4%)
Query: 407 PRITSLNLSASELT--GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
P ++ L+LS + L+ G ++ L LDLS N L L+ L+
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQH 408
Query: 465 NKLTGPLPVELLEKQENNTLELRFDGN 491
+ L L L
Sbjct: 409 STLKRVTEFSAF-LSLEKLLYLDISYT 434
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 20/71 (28%), Positives = 32/71 (45%), Gaps = 4/71 (5%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT--GPVPKFLSQLSSLKF 459
P D P + SL L+ ++ + + L L+ LDLS N L+ G +SL+
Sbjct: 323 PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 460 LNLARNKLTGP 470
L+L+ N
Sbjct: 381 LDLSFNGAIIM 391
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 18/86 (20%), Positives = 35/86 (40%), Gaps = 6/86 (6%)
Query: 407 PRITSLNLSASELTG-GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKF----LN 461
+ LN++ + + Y +NLT L +DLS N + L L L+
Sbjct: 128 ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD 187
Query: 462 LARNKLTGPLPVELLEKQENNTLELR 487
++ N + + + + + + L LR
Sbjct: 188 MSLNPIDF-IQDQAFQGIKLHELTLR 212
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 5/86 (5%)
Query: 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
+ SL++ +L +L L SL L+ N + L SL +L+L+RN
Sbjct: 306 HFKWQSLSIIRCQLKQFPT---LDLPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRN 360
Query: 466 KLTGPLPVELLEKQENNTLELRFDGN 491
L+ + N+ L N
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFN 386
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 12/72 (16%), Positives = 23/72 (31%), Gaps = 5/72 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+++++L+ + + + SL + L L LK L L NK
Sbjct: 285 ANVSAMSLAGVSIK--YLEDVPKHFKWQSLSIIRCQLKQFPT---LDLPFLKSLTLTMNK 339
Query: 467 LTGPLPVELLEK 478
+ L
Sbjct: 340 GSISFKKVALPS 351
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 7/62 (11%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 408 RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKL 467
I L+ + L ++++ L+ ++ + + + L++ R +L
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQL 319
Query: 468 TG 469
Sbjct: 320 KQ 321
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 4e-10
Identities = 20/106 (18%), Positives = 37/106 (34%), Gaps = 8/106 (7%)
Query: 393 LWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT-------G 445
++CS D +++ LS +E+ + ++++ LSNN +T
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 446 PVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGN 491
P L ++L NKLT L + + N
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 28/159 (17%), Positives = 50/159 (31%), Gaps = 9/159 (5%)
Query: 335 KTGNSTHPPIINAIEIYEVKEFSQSQTDEQDVDAIMN-----IKSFYGLKKNWQGDPCAP 389
++G ++ T + +V + IK + LK W+ A
Sbjct: 226 QSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWE----AL 281
Query: 390 QDYLWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPK 449
W + + + + N L N +T L L+ G VP
Sbjct: 282 DGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341
Query: 450 FLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRF 488
+ QL+ LK L+ + T + E+ + E R
Sbjct: 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 16/64 (25%), Positives = 26/64 (40%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTG 469
N ++ +NL LT ++L N +P FL L L+ LN+A N+
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 470 PLPV 473
+
Sbjct: 530 AAQL 533
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 15/116 (12%), Positives = 35/116 (30%), Gaps = 28/116 (24%)
Query: 407 PRITSLNLSASELTG-----GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
P ++++++S + + + L + D N + P ++ SL L
Sbjct: 753 PYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 462 LARNKLTGPLPVELLEK----------------------QENNTLELRFDGNPDLC 495
+ N + + +L + E L +D D+
Sbjct: 813 IGSNDIRK-VDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIR 867
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 7e-08
Identities = 13/74 (17%), Positives = 23/74 (31%), Gaps = 10/74 (13%)
Query: 407 PRITSLNLSASELTGGFAHY---------LTNLTMLTSLDLSNNNLTG-PVPKFLSQLSS 456
P + SLN++ + + + NNL P L ++
Sbjct: 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVK 574
Query: 457 LKFLNLARNKLTGP 470
L L+ NK+
Sbjct: 575 LGLLDCVHNKVRHL 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 23/157 (14%), Positives = 52/157 (33%), Gaps = 19/157 (12%)
Query: 355 EFSQSQTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDY-------------LWEGLNCSY 401
+ ++ +D A+ I K NW+ + +W
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
D++ R+T L+L+ G + LT L L ++ T F + +
Sbjct: 319 LDNNG-RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 462 LARNKLTGPLPVELLEKQEN----NTLELRFDGNPDL 494
++++ L+ + + L+ + NP++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM 414
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 11/76 (14%), Positives = 30/76 (39%), Gaps = 6/76 (7%)
Query: 407 PRITSLNLSASELTG-----GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
+ S++ S +++ + +++ LS N + + + S + +
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703
Query: 462 LARNKLTGPLPVELLE 477
L+ N +T +P L+
Sbjct: 704 LSNNLMTS-IPENSLK 718
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 11/78 (14%), Positives = 22/78 (28%), Gaps = 10/78 (12%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGP---------VPKFLSQLSSL 457
+T + L +L +L L SL+++ N + +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 458 KFLNLARNKLTGPLPVEL 475
+ + N L P
Sbjct: 551 QIFYMGYNNLEE-FPASA 567
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 16/76 (21%), Positives = 31/76 (40%), Gaps = 8/76 (10%)
Query: 407 PRITSLNLSASELTGGFAH-YLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR- 464
+T+++L ++LT T L L+++D+S N + P S LK +
Sbjct: 728 YLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ 786
Query: 465 -----NKLTGPLPVEL 475
N++ P +
Sbjct: 787 RDAEGNRILRQWPTGI 802
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 14/66 (21%), Positives = 21/66 (31%), Gaps = 1/66 (1%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLEL 486
LT L L N + F + ++ L + NKL +P K +
Sbjct: 591 FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSV 649
Query: 487 RFDGNP 492
F N
Sbjct: 650 DFSYNK 655
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 12/84 (14%), Positives = 28/84 (33%), Gaps = 11/84 (13%)
Query: 406 SPRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTG-----PVPKFLSQLSSL 457
+ ++ L S + F ++ ++ S+D S N + + +
Sbjct: 618 TDQVEGLGFSHNKLKYIPNIFN--AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675
Query: 458 KFLNLARNKLTGPLPVELLEKQEN 481
+ L+ N++ P EL
Sbjct: 676 STVTLSYNEIQK-FPTELFATGSP 698
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 9/69 (13%), Positives = 15/69 (21%), Gaps = 5/69 (7%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ + + S T + S L L + L
Sbjct: 448 TKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502
Query: 467 LTGPLPVEL 475
LP L
Sbjct: 503 NMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 12/88 (13%), Positives = 31/88 (35%), Gaps = 6/88 (6%)
Query: 404 DDSPRITSLNLSASELTG----GFAHYLTNLTM-LTSLDLSNNNLTGPVPKFLSQLSSLK 458
D R+ +L + + +++ T + N +T + K + +L+ L+
Sbjct: 393 DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQ 451
Query: 459 FLNLARNKLTGPLPVELLEKQENNTLEL 486
+ A + T E ++ +
Sbjct: 452 IIYFANSPFTYDNIAVDWEDANSDYAKQ 479
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 57/295 (19%), Positives = 103/295 (34%), Gaps = 83/295 (28%)
Query: 589 LGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-----HHRNLTTL 641
LG G F TV+ VA+K++ S+ + E++LL V + N +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 642 VGYCD-------EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
V D GT++ +++E + + +L + + S+ + L +I + GL+YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 695 HQGCKPPIVHRDVKSTNILIN--------------------------------------- 715
H C+ I+H D+K NIL++
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 716 ----------EKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSD 765
EK + K+AD G + T T Y E I + +D
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACW-----VHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 766 VYSFGVVLLEIITGHPVISKSAENGHT----HVAQWVS-------SMLDKGDIRS 809
++S + E+ TG + + +T H+A + ++ G
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-10
Identities = 13/63 (20%), Positives = 24/63 (38%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
R+ +L L+A+ L L+ L L ++ L +L+ L L N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 467 LTG 469
++
Sbjct: 141 ISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-10
Identities = 18/87 (20%), Positives = 31/87 (35%), Gaps = 2/87 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L + ++ L N L SL L +N+++ LK L+ N
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 467 LTGPLPVELLEKQEN-NTLELRFDGNP 492
+ L E + + L L +GN
Sbjct: 165 IHY-LSKEDMSSLQQATNLSLNLNGND 190
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 21/85 (24%), Positives = 33/85 (38%), Gaps = 4/85 (4%)
Query: 407 PRITSLNLSASELTGGFAHY---LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
P + LNL + G L L L L LS +L+ + L + ++L+
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 464 RNKLTGPLPVELLEKQENNTLELRF 488
N+LT +E L + L L
Sbjct: 509 HNRLTS-SSIEALSHLKGIYLNLAS 532
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 18/86 (20%), Positives = 23/86 (26%), Gaps = 7/86 (8%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF 450
NC P L S + L + L LT LDL+ +
Sbjct: 17 YNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76
Query: 451 LSQLSSLKFLNLARNKLTGPLPVELL 476
L L L N L + L
Sbjct: 77 FQSQHRLDTLVLTANPLIF-MAETAL 101
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 28/86 (32%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
R+ L LS +L+ H T+L M+ +DLS+N LT + LS L + +LNLA N
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534
Query: 467 LTGPLPVELLEKQENNTLELRFDGNP 492
++ LP L + + NP
Sbjct: 535 ISIILPSLL--PILSQQRTINLRQNP 558
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 1/64 (1%)
Query: 407 PRITSLNLSASELTGGFAHY-LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
P++ L+L+ + L A NL +L L+LS++ L + L +L+ LNL N
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459
Query: 466 KLTG 469
Sbjct: 460 HFPK 463
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 17/66 (25%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTG---PVPKFLSQLSSLKFLNLA 463
+ LNLS S L L L L+L N+ L L L+ L L+
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 464 RNKLTG 469
L+
Sbjct: 485 FCDLSS 490
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-08
Identities = 18/87 (20%), Positives = 31/87 (35%), Gaps = 3/87 (3%)
Query: 407 PRITSLNLSASELT--GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
+ L+LS ++ L NL+ L SL+LS N + + L+ L+LA
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 465 NKLTGPLPVELLEKQENNTLELRFDGN 491
+L + L +
Sbjct: 410 TRLKVKDAQSPFQNLHLLK-VLNLSHS 435
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 19/71 (26%), Positives = 27/71 (38%), Gaps = 1/71 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L+L+A+ L+ L L+ L L LS N S SL L++ N
Sbjct: 278 SGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336
Query: 467 LTGPLPVELLE 477
L LE
Sbjct: 337 KRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 13/63 (20%), Positives = 25/63 (39%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L+L+ ++ + L +L L+ N L LS +LK L +
Sbjct: 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 467 LTG 469
++
Sbjct: 117 ISS 119
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 1/64 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPV-PKFLSQLSSLKFLNLARN 465
+ L LSA++ +N LT L + N + L L +L+ L+L+ +
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 466 KLTG 469
+
Sbjct: 361 DIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 17/63 (26%), Positives = 34/63 (53%), Gaps = 1/63 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ ++LS + LT L++L + L+L++N+++ +P L LS + +NL +N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 467 LTG 469
L
Sbjct: 559 LDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 8/57 (14%), Positives = 22/57 (38%), Gaps = 1/57 (1%)
Query: 412 LNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
++ +++ L ++ + S++L + S L+ L+L L+
Sbjct: 236 EDMDDEDISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 8e-05
Identities = 13/86 (15%), Positives = 25/86 (29%), Gaps = 3/86 (3%)
Query: 408 RITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLS--QLSSLKFLNLARN 465
SLNL+ +++ G + + SL+ + K L + SL
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 466 KLTGPLPVELLEKQENNTLELRFDGN 491
P E + + +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKH 264
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 12/88 (13%), Positives = 32/88 (36%), Gaps = 3/88 (3%)
Query: 406 SPRITSLNLSASELTGGFAHYLTNLTMLT--SLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
+ ++ L+ + + +++L T SL+L+ N++ G + + + LN
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210
Query: 464 RNKLTGPLPVELLEKQENNTLELRFDGN 491
+ + L + F+
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 20/74 (27%), Positives = 31/74 (41%)
Query: 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
+ R ++ S L A + + LDLS N L+ L+ + L+ LNL+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 465 NKLTGPLPVELLEK 478
N L L +E L
Sbjct: 68 NVLYETLDLESLST 81
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 11/60 (18%), Positives = 25/60 (41%), Gaps = 1/60 (1%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTG-PVPKFLSQLSSLKFLNLARNKLT 468
++ L+ +++T + + LDL N + + + +L+ LNL N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 18/71 (25%), Positives = 34/71 (47%), Gaps = 8/71 (11%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ LNLS++ L L +L+ L +LDL+NN + L S++ L+ A N
Sbjct: 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNN 110
Query: 467 LTGPLPVELLE 477
++ + +
Sbjct: 111 ISR-VSCSRGQ 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 21/109 (19%), Positives = 35/109 (32%), Gaps = 27/109 (24%)
Query: 407 PRITSLNLSASELT----GGFAHYLTNLTM-------------------LTSLDLSNNNL 443
R+ L+L +E+ A L L +LDLS+N L
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKL 203
Query: 444 TGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNP 492
+ + + +++L NKL + L + N GN
Sbjct: 204 AF-MGPEFQSAAGVTWISLRNNKLVL-IEKAL--RFSQNLEHFDLRGNG 248
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 18/82 (21%), Positives = 35/82 (42%), Gaps = 3/82 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ +L+LS+++L + +T + L NN L + K L +L+ +L N
Sbjct: 191 AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNG 248
Query: 467 L-TGPLPVELLEKQENNTLELR 487
G L + Q T+ +
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P I +L+ + + ++ ++ L+NN +T S +++L+L N+
Sbjct: 99 PSIETLHAANNNISRVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 467 LTGPLPVELLEKQENNTLELRFDGN 491
+ + L + L N
Sbjct: 156 IDT-VNFAELAASSDTLEHLNLQYN 179
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 15/62 (24%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ +L+L+ + + L + +L +NNN++ V S+ K + LA NK
Sbjct: 80 STLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR-VS--CSRGQGKKNIYLANNK 131
Query: 467 LT 468
+T
Sbjct: 132 IT 133
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 34/180 (18%), Positives = 66/180 (36%), Gaps = 34/180 (18%)
Query: 586 ERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQ------GYKQFQAEVKLLLR 632
+G+GGFG +Y + + VK+ + Y++ ++
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 633 VHHRNLTTL----VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEER-------L 681
+ R L L Y +M + ++I + L
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI----MDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 682 RIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAK--LADFGLSRVFPVEGGTHV 739
++++ LEY+H+ VH D+K++N+L+N K + L D+GL+ + G H
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY-CPEGVHK 211
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 36/174 (20%), Positives = 64/174 (36%), Gaps = 25/174 (14%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
+ +G GGFG +Y ++ A ++ Q +E+K RV ++
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 644 YCDEGTNMAL--IYEYMANGNLE--------EHLSDSSKEILNWEER------LRIAVEA 687
+ + + Y E L ++I L++ +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRM 160
Query: 688 ALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAK--LADFGLSRVFPVEGGTHV 739
LEY+H+ VH D+K+ N+L+ K + LAD+GLS + G H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY-CPNGNHK 210
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 20/72 (27%), Positives = 30/72 (41%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
R ++ S L A + + LDLS N L+ L+ + L+ LNL+ N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 467 LTGPLPVELLEK 478
L L +E L
Sbjct: 70 LYETLDLESLST 81
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 11/60 (18%), Positives = 25/60 (41%), Gaps = 1/60 (1%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTG-PVPKFLSQLSSLKFLNLARNKLT 468
++ L+ +++T + + LDL N + + + +L+ LNL N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 21/109 (19%), Positives = 35/109 (32%), Gaps = 27/109 (24%)
Query: 407 PRITSLNLSASELT----GGFAHYLTNLTML-------------------TSLDLSNNNL 443
R+ L+L +E+ A L L +LDLS+N L
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKL 203
Query: 444 TGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNP 492
+ + + +++L NKL + L + N GN
Sbjct: 204 AF-MGPEFQSAAGVTWISLRNNKLVL-IEKAL--RFSQNLEHFDLRGNG 248
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 18/82 (21%), Positives = 35/82 (42%), Gaps = 3/82 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ +L+LS+++L + +T + L NN L + K L +L+ +L N
Sbjct: 191 AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNG 248
Query: 467 LT-GPLPVELLEKQENNTLELR 487
G L + Q T+ +
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 18/71 (25%), Positives = 34/71 (47%), Gaps = 8/71 (11%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ LNLS++ L L +L+ L +LDL+NN + L S++ L+ A N
Sbjct: 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN 110
Query: 467 LTGPLPVELLE 477
++ + +
Sbjct: 111 ISR-VSCSRGQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 7/40 (17%), Positives = 18/40 (45%)
Query: 429 NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
N +++++L + ++K L+L+ N L+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS 47
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 11/62 (17%), Positives = 27/62 (43%), Gaps = 3/62 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P I +L+ + + ++ ++ L+NN +T S +++L+L N+
Sbjct: 99 PSIETLHAANNNISRVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 467 LT 468
+
Sbjct: 156 ID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 15/62 (24%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ +L+L+ + + L + +L +NNN++ V S+ K + LA NK
Sbjct: 80 STLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VS--CSRGQGKKNIYLANNK 131
Query: 467 LT 468
+T
Sbjct: 132 IT 133
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 20/92 (21%), Positives = 40/92 (43%), Gaps = 3/92 (3%)
Query: 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT-GPVPKFLSQLSSLKFLNL 462
+ L + L + +L L L++++N + +P++ S L++L+ L+L
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 463 ARNKLTGPLPVEL--LEKQENNTLELRFDGNP 492
+ NK+ +L L + L L NP
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 20/100 (20%), Positives = 32/100 (32%), Gaps = 8/100 (8%)
Query: 398 NCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFL 451
C PD+ +L+LS + L ++ + L LDLS +
Sbjct: 13 QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 452 SQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGN 491
LS L L L N + L + + +L
Sbjct: 73 QSLSHLSTLILTGNPIQS-LALGAFSGLSSLQ-KLVAVET 110
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 16/76 (21%), Positives = 29/76 (38%), Gaps = 1/76 (1%)
Query: 407 PRITSLNLSASELTGGFAHY-LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
++ L+ S L +L L LD+S+ + + LSSL+ L +A N
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 466 KLTGPLPVELLEKQEN 481
++ + N
Sbjct: 456 SFQENFLPDIFTELRN 471
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 3/87 (3%)
Query: 407 PRITSLNLSASELTGGF-AHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
+ L ++ + F T L LT LDLS L P + LSSL+ LN+A N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 466 KLTGPLPVELLEKQENNTLELRFDGNP 492
+L +P + ++ + ++ NP
Sbjct: 505 QLKS-VPDGIFDRLTSLQ-KIWLHTNP 529
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 14/62 (22%), Positives = 26/62 (41%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+++L L+ + + + L+ L L NL + L +LK LN+A N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 467 LT 468
+
Sbjct: 136 IQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 18/74 (24%), Positives = 31/74 (41%), Gaps = 3/74 (4%)
Query: 397 LNCSYPDDDSPRITSLNLSASELT--GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQL 454
++ + D P + L+LS + L+ G + T L LDLS N + + L
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 395
Query: 455 SSLKFLNLARNKLT 468
L+ L+ + L
Sbjct: 396 EQLEHLDFQHSNLK 409
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 19/83 (22%), Positives = 32/83 (38%), Gaps = 2/83 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + L+LS E+ +L+ L++L L+ N + S LSSL+ L
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 467 LTGPLPVELLEKQEN-NTLELRF 488
L L + + L +
Sbjct: 112 LAS-LENFPIGHLKTLKELNVAH 133
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 15/61 (24%), Positives = 28/61 (45%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L+LS +L +L+ L L++++N L +L+SL+ + L N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529
Query: 467 L 467
Sbjct: 530 W 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 15/63 (23%), Positives = 24/63 (38%), Gaps = 2/63 (3%)
Query: 429 NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRF 488
L L L ++N + L SL+FL+L+RN L+ + + L
Sbjct: 323 KLKSLKRLTFTSNKGGN-AFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 489 DGN 491
N
Sbjct: 381 SFN 383
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 587 RVLGKGGFGTVY--HGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHR------NL 638
+V+GKG FG V + + VA+KM+ + + ++Q E+++L + + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
++ ++ + +E ++ NL E + + + + + A L+ LH
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--- 217
Query: 699 KPPIVHRDVKSTNILINE--KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
K I+H D+K NIL+ + + K+ DFG S V T I + Y PE +
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQ-SRFYRAPEVIL 272
Query: 757 SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGH 791
R D++S G +L E++TG+P++ E
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 5e-09
Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 6/86 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ LN+ +++++ L NL+ L SL L+NN L + + L++L L L++N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 467 LTGPLPVELLEKQENNTLELRFDGNP 492
+T P+ L K + F
Sbjct: 323 ITDIRPLASLSKMD----SADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 3e-08
Identities = 17/72 (23%), Positives = 31/72 (43%), Gaps = 3/72 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L L+ ++ L NLT + SL+L N+ LS ++ L +L + +K
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESK 166
Query: 467 LTGPLPVELLEK 478
+ P+ L
Sbjct: 167 VKDVTPIANLTD 178
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 3e-07
Identities = 18/77 (23%), Positives = 33/77 (42%), Gaps = 4/77 (5%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
PD D L + +T L +T L ++ + + + L++L++LN
Sbjct: 17 PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLN 72
Query: 462 LARNKLTGPLPVELLEK 478
L N++T P+ L K
Sbjct: 73 LNGNQITDISPLSNLVK 89
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 6e-07
Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 4/72 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ LNL+ +++T L+NL LT+L + N +T L L++L+ L L +
Sbjct: 66 TNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDN 121
Query: 467 LTGPLPVELLEK 478
++ P+ L K
Sbjct: 122 ISDISPLANLTK 133
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 6e-07
Identities = 18/72 (25%), Positives = 36/72 (50%), Gaps = 4/72 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
R+ SL + +++T L NL+ LT L++ N ++ + L+ LK LN+ N+
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQ 276
Query: 467 LTGPLPVELLEK 478
++ + L +
Sbjct: 277 ISDISVLNNLSQ 288
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 8e-07
Identities = 18/62 (29%), Positives = 31/62 (50%), Gaps = 2/62 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ SL L+ ++L + LT LT+L LS N++T P L+ LS + + A
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
Query: 467 LT 468
+
Sbjct: 345 IK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 18/72 (25%), Positives = 33/72 (45%), Gaps = 4/72 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ +++T + N+T L SL + NN +T L+ LS L +L + N+
Sbjct: 199 TSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQ 254
Query: 467 LTGPLPVELLEK 478
++ V+ L K
Sbjct: 255 ISDINAVKDLTK 266
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 2e-06
Identities = 19/72 (26%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L ++ S++ + NLT L SL L+ N + P L+ L+SL + N+
Sbjct: 155 TGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210
Query: 467 LTGPLPVELLEK 478
+T PV + +
Sbjct: 211 ITDITPVANMTR 222
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 5e-06
Identities = 13/69 (18%), Positives = 24/69 (34%), Gaps = 4/69 (5%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTG 469
+L + + F +L L ++T V +L S+ L +A K+
Sbjct: 3 ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58
Query: 470 PLPVELLEK 478
+E L
Sbjct: 59 IQGIEYLTN 67
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 9e-06
Identities = 18/66 (27%), Positives = 32/66 (48%), Gaps = 4/66 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++T+L + +++T L NLT L L L+ +N++ L+ L+ + LNL N
Sbjct: 88 VKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANH 143
Query: 467 LTGPLP 472
L
Sbjct: 144 NLSDLS 149
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 47/206 (22%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 586 ERVLGKGGFGTVYHGK--LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-HRNLTTLV 642
R +G G FG +Y G N+EVA+K+ + + + Q E K+ + + +
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVR 69
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
+ EG L+ + + +L E L + L+ + L +A + +E++H
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---F 124
Query: 703 VHRDVKSTNILINEKFQAK---LADFGLSRVF-PVEGGTHV----STTIAGTPGYLDPEY 754
+HRD+K N L+ +A + DFGL++ + H+ + + GT Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNT 184
Query: 755 YISNRLTEKSDVYSFGVVLLEIITGH 780
++ + + D+ S G VL+ + G
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 56/258 (21%), Positives = 110/258 (42%), Gaps = 19/258 (7%)
Query: 544 IWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVY--HGK 601
++ +SS +K N Y+ + E + ++GKG FG V + +
Sbjct: 18 LYFQSMSSHKKERKVYNDGYDDDN-YDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDR 76
Query: 602 LDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHR------NLTTLVGYCDEGTNMALIY 655
++ + VA+K++ + Q Q EV+LL ++ + L + ++ L++
Sbjct: 77 VEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135
Query: 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI- 714
E ++ NL + L +++ ++ + A + L +L + I+H D+K NIL+
Sbjct: 136 EMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193
Query: 715 -NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVL 773
++ K+ DFG S G + Y PE + D++S G +L
Sbjct: 194 NPKRSAIKIVDFG-SSCQ--LGQRI--YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCIL 248
Query: 774 LEIITGHPVISKSAENGH 791
+E+ TG P+ S + E
Sbjct: 249 VEMHTGEPLFSGANEVDQ 266
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 18/88 (20%), Positives = 33/88 (37%), Gaps = 9/88 (10%)
Query: 387 CAPQDYLWEGLNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSN 440
C+ QD + C P+ L+L + + + L L+L+
Sbjct: 9 CSAQDRA---VLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNE 65
Query: 441 NNLTGPVPKFLSQLSSLKFLNLARNKLT 468
N ++ P + L +L+ L L N+L
Sbjct: 66 NIVSAVEPGAFNNLFNLRTLGLRSNRLK 93
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 24/89 (26%), Positives = 35/89 (39%), Gaps = 2/89 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ LNLS + ++ L L L + L L P L+ L+ LN++ N+
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 467 LTGPLPVELLEKQENNTLELRFDGNPDLC 495
LT L + N L D NP C
Sbjct: 308 LTT-LEESVFHSVGNLE-TLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 23/87 (26%), Positives = 40/87 (45%), Gaps = 4/87 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L++S +++ + +L L SL++ +N+L + S L+SL+ L L +
Sbjct: 104 SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN 163
Query: 467 LTGPLPVELLEKQENNTL-ELRFDGNP 492
LT +P E L L LR
Sbjct: 164 LTS-IPTEALSHLHG--LIVLRLRHLN 187
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 16/62 (25%), Positives = 29/62 (46%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + L L+ + ++ NL L +L L +N L + LS+L L+++ NK
Sbjct: 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENK 115
Query: 467 LT 468
+
Sbjct: 116 IV 117
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 17/62 (27%), Positives = 27/62 (43%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ +L L ++ L T L+ LT LD+S N + + L +LK L + N
Sbjct: 80 FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND 139
Query: 467 LT 468
L
Sbjct: 140 LV 141
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 15/87 (17%), Positives = 27/87 (31%), Gaps = 4/87 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L L + + L L L++S+ + +L L++
Sbjct: 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235
Query: 467 LTGPLPVELLEKQEN-NTLELRFDGNP 492
LT +P + L L NP
Sbjct: 236 LTA-VPYLAVRHLVYLRFLNL--SYNP 259
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 16/62 (25%), Positives = 23/62 (37%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ SL + ++L + L L L L NLT + LS L L L L
Sbjct: 128 YNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187
Query: 467 LT 468
+
Sbjct: 188 IN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 17/85 (20%), Positives = 26/85 (30%), Gaps = 2/85 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L L LT L++L L L L + N+ +L LK L ++
Sbjct: 152 NSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211
Query: 467 LTGPLPVELLEKQENNTLELRFDGN 491
+ L N L
Sbjct: 212 YLDTMTPNCLYGL--NLTSLSITHC 234
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 8/66 (12%)
Query: 407 PRITSLNLSASELT----GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNL 462
+TSL+++ LT H L L L+LS N ++ L +L L+ + L
Sbjct: 224 LNLTSLSITHCNLTAVPYLAVRH----LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQL 279
Query: 463 ARNKLT 468
+L
Sbjct: 280 VGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 17/62 (27%), Positives = 27/62 (43%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
R+ L +S LTSL +++ NLT + L L+FLNL+ N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 467 LT 468
++
Sbjct: 260 IS 261
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 13/58 (22%), Positives = 27/58 (46%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKL 467
L + ++T L+ LT LT LD+S++ + ++ L + ++L+ N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 12/66 (18%), Positives = 29/66 (43%), Gaps = 2/66 (3%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTG 469
L ++ T + ++ L+ L L + ++T LS L+SL L+++ +
Sbjct: 69 KDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 470 PLPVEL 475
+ ++
Sbjct: 127 SILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 18/72 (25%), Positives = 28/72 (38%), Gaps = 1/72 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L++S S + L + S+DLS N L L LK LN+ +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDG 170
Query: 467 LTGPLPVELLEK 478
+ +E K
Sbjct: 171 VHDYRGIEDFPK 182
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 15/70 (21%), Positives = 30/70 (42%), Gaps = 10/70 (14%)
Query: 409 ITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
+T + L+ ++LTG + + L ++N + T +S LS+L+ L +
Sbjct: 46 LTYITLANINVTDLTG-----IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGK 98
Query: 466 KLTGPLPVEL 475
+T L
Sbjct: 99 DVTSDKIPNL 108
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 12/63 (19%), Positives = 23/63 (36%), Gaps = 3/63 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P++ S++LS + L L L SL++ + + + L L
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
Query: 467 LTG 469
+ G
Sbjct: 193 IGG 195
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 11/101 (10%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF 450
+ CS P D P L+L +++T NL L +L L NN ++ P
Sbjct: 36 VQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95
Query: 451 LSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGN 491
+ L L+ L L++N+L LP ++ + ELR N
Sbjct: 96 FAPLVKLERLYLSKNQLKE-LPEKMPK----TLQELRVHEN 131
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 7/87 (8%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPV--PKFLSQLSSLKFLNLAR 464
+ L + +E+T L + ++L N L + L ++ +A
Sbjct: 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180
Query: 465 NKLTGPLPVELLEKQENNTLELRFDGN 491
+T +P L + EL DGN
Sbjct: 181 TNITT-IPQGLPP----SLTELHLDGN 202
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 20/62 (32%), Positives = 31/62 (50%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P +T L+L +++T A L L L L LS N+++ L+ L+ L+L NK
Sbjct: 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251
Query: 467 LT 468
L
Sbjct: 252 LV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 14/62 (22%), Positives = 28/62 (45%), Gaps = 3/62 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ +L L ++++ L L L LS N L +P+ + +L+ L + N+
Sbjct: 76 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENE 132
Query: 467 LT 468
+T
Sbjct: 133 IT 134
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 14/64 (21%), Positives = 29/64 (45%), Gaps = 5/64 (7%)
Query: 407 PRITSLNLSASELTGGF--AHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
++ + L + L + L+ + +++ N+T +P+ L SL L+L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDG 201
Query: 465 NKLT 468
NK+T
Sbjct: 202 NKIT 205
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 13/68 (19%), Positives = 30/68 (44%), Gaps = 7/68 (10%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTG------PVPKFLSQLSSLKFL 460
P + L+L+ ++L L + + + L NNN++ P + ++ +S +
Sbjct: 240 PHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 461 NLARNKLT 468
+L N +
Sbjct: 299 SLFSNPVQ 306
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 27/101 (26%), Positives = 44/101 (43%), Gaps = 11/101 (10%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF 450
+ CS P + SP T L+L ++++ L L +L L NN ++ K
Sbjct: 38 VQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA 97
Query: 451 LSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGN 491
S L L+ L +++N L +P L + +ELR N
Sbjct: 98 FSPLRKLQKLYISKNHLVE-IPPNLPS----SLVELRIHDN 133
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 6/86 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT-GPVPKFLSQLSSLKFLNLARN 465
+ L + + + + L + +++ N L L +L ++
Sbjct: 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182
Query: 466 KLTGPLPVELLEKQENNTLELRFDGN 491
KLTG +P +L E EL D N
Sbjct: 183 KLTG-IPKDLPE----TLNELHLDHN 203
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 18/67 (26%), Positives = 30/67 (44%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
P D + L+L +++ L + L L L +N + LS L +L+ L+
Sbjct: 188 PKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247
Query: 462 LARNKLT 468
L NKL+
Sbjct: 248 LDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 15/62 (24%), Positives = 28/62 (45%), Gaps = 3/62 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ +L L ++++ + L L L +S N+L +P L SSL L + N+
Sbjct: 78 QHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNR 134
Query: 467 LT 468
+
Sbjct: 135 IR 136
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 22/88 (25%), Positives = 30/88 (34%), Gaps = 5/88 (5%)
Query: 395 EGLNCSYPDDDSPRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTG-PVPKF 450
GL + P + L L +G + L LDLS+N+L
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 451 LSQLSSLKFLNLARNKLTGPLPVELLEK 478
S L LNL+ L +P L K
Sbjct: 249 CDWPSQLNSLNLSFTGLKQ-VPKGLPAK 275
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 20/76 (26%), Positives = 29/76 (38%), Gaps = 9/76 (11%)
Query: 395 EGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQL 454
+C +P ++ SLNLS + L L+ LDLS N L P +L
Sbjct: 245 GAPSCDWP----SQLNSLNLSFTGLKQVPKGLPAKLS---VLDLSYNRLDR-NPSPD-EL 295
Query: 455 SSLKFLNLARNKLTGP 470
+ L+L N
Sbjct: 296 PQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 15/82 (18%), Positives = 26/82 (31%), Gaps = 7/82 (8%)
Query: 407 PRITSLNLSASELTGGFAHYLT----NLTMLTSLDLSNNNLT---GPVPKFLSQLSSLKF 459
P +++L+LS + G L L L N + G + L+
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232
Query: 460 LNLARNKLTGPLPVELLEKQEN 481
L+L+ N L +
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQ 254
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 15/93 (16%), Positives = 25/93 (26%), Gaps = 6/93 (6%)
Query: 405 DSPRITSLNLSASELTGGFAHYLT----NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFL 460
P + LNL A L L ++ + + + +L L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 461 NLARNKLTG--PLPVELLEKQENNTLELRFDGN 491
+L+ N G L L + L
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNA 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 20/89 (22%), Positives = 37/89 (41%), Gaps = 1/89 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L+LS +L +L+ L L++S+NN L+SL+ L+ + N
Sbjct: 175 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234
Query: 467 LTGPLPVELLEKQENNTLELRFDGNPDLC 495
+ + L+ ++ L N C
Sbjct: 235 IMT-SKKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 22/80 (27%), Positives = 35/80 (43%), Gaps = 8/80 (10%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT--GPVP 448
+ C+ P T L L +++L LT LT L LS+N L+ G
Sbjct: 12 IRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 449 KFLSQLSSLKFLNLARNKLT 468
+ +SLK+L+L+ N +
Sbjct: 72 QSDFGTTSLKYLDLSFNGVI 91
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 18/93 (19%), Positives = 32/93 (34%), Gaps = 12/93 (12%)
Query: 407 PRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTG-PVPKFLSQLSSLKFLNL 462
+ L+LS ++ F L L LD ++NL L +L +L++
Sbjct: 78 TSLKYLDLSFNGVITMSSNF----LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 133
Query: 463 ARNKLTGPLPVELLEKQENNTLE-LRFDGNPDL 494
+ + + LE L+ GN
Sbjct: 134 SHTHTRV-AFNGIFNGLSS--LEVLKMAGNSFQ 163
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 19/63 (30%), Positives = 26/63 (41%), Gaps = 1/63 (1%)
Query: 407 PRITSLNLSA-SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
+ L ++ S T L LT LDLS L P + LSSL+ LN++ N
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209
Query: 466 KLT 468
Sbjct: 210 NFF 212
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 10/89 (11%)
Query: 404 DDSPRITSLNLSASELT-----GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLK 458
++ L+ S L F +L L LD+S+ + + LSSL+
Sbjct: 98 LGLEQLEHLDFQHSNLKQMSEFSVF----LSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 153
Query: 459 FLNLARNKLTGPLPVELLEKQEN-NTLEL 486
L +A N ++ + N L+L
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDL 182
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 20/99 (20%), Positives = 35/99 (35%), Gaps = 8/99 (8%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF 450
+ P + + SL+LS +++T L L L L ++ +
Sbjct: 10 CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 451 LSQLSSLKFLNLARNKLTGPLPVELLEKQEN-NTLELRF 488
L SL+ L+L+ N L+ L + L L
Sbjct: 70 FYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMG 107
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 17/88 (19%), Positives = 34/88 (38%), Gaps = 1/88 (1%)
Query: 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
++ I L++ L + + L + + + N+ + F L SL+FL+L+
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 465 NKLTGPLPVELLEKQENNTLE-LRFDGN 491
N + K +L+ L N
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQN 371
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 20/67 (29%), Positives = 29/67 (43%), Gaps = 3/67 (4%)
Query: 404 DDSPRITSLNLSASELT--GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
P + +L LS + L L L LTSLD+S N P+P ++FLN
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416
Query: 462 LARNKLT 468
L+ +
Sbjct: 417 LSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 14/65 (21%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT---GPVPKFLSQLSSLKFLNLA 463
++ + + S++ + +L L LDLS N + SL+ L L+
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 464 RNKLT 468
+N L
Sbjct: 370 QNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 19/95 (20%), Positives = 33/95 (34%), Gaps = 4/95 (4%)
Query: 407 PRITSLNLSASELTG-GFAHYLTNLTMLTSLDLSNNNLTGPVPK-FLSQLSSLKFLNLAR 464
+ LNL + G NLT L +L + N + + + L+SL L +
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 465 NKLTGPLPVELLEKQEN-NTLELRFDGNPDLCRSA 498
L + L+ + + L L + L
Sbjct: 158 LSLRN-YQSQSLKSIRDIHHLTLHLSESAFLLEIF 191
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 20/62 (32%), Positives = 29/62 (46%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L L +S + +L L LDLS+N+L+ + LSSLK+LNL N
Sbjct: 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP 109
Query: 467 LT 468
Sbjct: 110 YQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 18/101 (17%), Positives = 35/101 (34%), Gaps = 11/101 (10%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L + A L + L ++ + L L + + F LSS+++L L
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 467 LTG-----------PLPVELLEKQENNTLELRFDGNPDLCR 496
L P++ L + + + F+ L R
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 21/102 (20%), Positives = 38/102 (37%), Gaps = 14/102 (13%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF 450
LN S + L++S + L L L L +S N L +P
Sbjct: 415 LNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLF----LPRLQELYISRNKLKT-LPDA 469
Query: 451 LSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNP 492
S L + ++RN+L +P + ++ + ++ NP
Sbjct: 470 -SLFPVLLVMKISRNQLKS-VPDGIFDRLTSLQ-KIWLHTNP 508
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 27/198 (13%), Positives = 57/198 (28%), Gaps = 22/198 (11%)
Query: 407 PRITSLNLSAS-ELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
+ +L + + LT L L++ +L + L + + L L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 466 KLTGPLPV--------ELLEKQENNTLELRFDGNPDLCRSASCKKEKKKFVVPVVASVAS 517
+ L + LE ++ N +F P S+ KK + V S
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 518 VFVVLAALIGLWSLKRKKQLPDPQILIWLVRLSSGRKVDANCNRSYESLDLSSRQFTYSE 577
+ +L ++ L + + D N + S +L +
Sbjct: 243 LLKLLRYILELSEV-------------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
Query: 578 VLRMTNNFERVLGKGGFG 595
L + + +
Sbjct: 290 RLHIPQFYLFYDLSTVYS 307
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
PR+ L +S ++L + +L + +S N L +L+SL+ + L N
Sbjct: 451 PRLQELYISRNKLK--TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508
Query: 467 L 467
Sbjct: 509 W 509
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 23/90 (25%), Positives = 36/90 (40%), Gaps = 5/90 (5%)
Query: 407 PRITSLNLSASELTGGF--AHYLTNLTMLTSLDLSNNNLTG-PVPKFLSQLSSLKFLNLA 463
+ L L L+ Y NL LT LDLS N + + +L+SLK ++ +
Sbjct: 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 464 RNKLTGPLPVELLEKQENNTLE-LRFDGNP 492
N++ + LE + TL N
Sbjct: 157 SNQIFL-VCEHELEPLQGKTLSFFSLAANS 185
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 16/62 (25%), Positives = 27/62 (43%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ LNLS + L ++ L + +DL N++ + L L+ L+L N
Sbjct: 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373
Query: 467 LT 468
LT
Sbjct: 374 LT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 20/67 (29%), Positives = 31/67 (46%), Gaps = 5/67 (7%)
Query: 407 PRITSLNLSASELTGGFAHYL-----TNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
P + L L + L + L L+ L L L++N L P S L++L+ L+
Sbjct: 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLS 510
Query: 462 LARNKLT 468
L N+LT
Sbjct: 511 LNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 13/78 (16%), Positives = 26/78 (33%), Gaps = 6/78 (7%)
Query: 397 LNCSYPD-----DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPV-PKF 450
+ + L LS + + A L L L+L + + +
Sbjct: 9 AFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68
Query: 451 LSQLSSLKFLNLARNKLT 468
L +L+ L+L +K+
Sbjct: 69 FRNLPNLRILDLGSSKIY 86
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 15/60 (25%), Positives = 26/60 (43%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
+ L+LS + + L L L+L+ N + + L +L+ LNL+ N L
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 13/62 (20%), Positives = 25/62 (40%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ LNL+ +++ L L L+LS N L L + +++L +N
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 467 LT 468
+
Sbjct: 350 IA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 17/80 (21%), Positives = 29/80 (36%), Gaps = 2/80 (2%)
Query: 398 NCSYPDDDSPRITSLNLSASELTG-GFAHYLTNLTMLTSLDLSNNNLTG-PVPKFLSQLS 455
+ ++LS + L ++L + L L L+ N + + S+
Sbjct: 392 KLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451
Query: 456 SLKFLNLARNKLTGPLPVEL 475
SL+ L L N L EL
Sbjct: 452 SLEQLFLGENMLQLAWETEL 471
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 14/63 (22%), Positives = 21/63 (33%), Gaps = 1/63 (1%)
Query: 407 PRITSLNLSASELTGGFAHY-LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
++ L L + NL L LDL ++ + P L L L L
Sbjct: 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
Query: 466 KLT 468
L+
Sbjct: 108 GLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 18/80 (22%), Positives = 25/80 (31%), Gaps = 6/80 (7%)
Query: 395 EGLNCSYPDDDSPRITSLNLSASELTGGFAHYL-TNLTMLTSLDLSNNNLTGPV-----P 448
E L+ Y P + L L+ + + + L L L N L
Sbjct: 414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW 473
Query: 449 KFLSQLSSLKFLNLARNKLT 468
LS L+ L L N L
Sbjct: 474 DVFEGLSHLQVLYLNHNYLN 493
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 13/61 (21%), Positives = 17/61 (27%), Gaps = 1/61 (1%)
Query: 429 NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQEN-NTLELR 487
L L LS N + L L+ L L + E N L+L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 488 F 488
Sbjct: 82 S 82
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 8/86 (9%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T+L L+ ++L ++NL LT L L NN++ P +S L+ L+ L NK
Sbjct: 287 TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342
Query: 467 LTGPLPVELLEKQENNTLELRFDGNP 492
++ + L L N
Sbjct: 343 VSDVSSLANLTNIN----WLSAGHNQ 364
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 19/72 (26%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ + ++ +++ L NLT LT L L NN +T P L L++L L L+ N
Sbjct: 90 TKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNT 145
Query: 467 LTGPLPVELLEK 478
++ + L
Sbjct: 146 ISDISALSGLTS 157
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 16/86 (18%), Positives = 38/86 (44%), Gaps = 8/86 (9%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L L + ++ +++LT L L NN ++ L+ L+++ +L+ N+
Sbjct: 309 KNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQ 364
Query: 467 LTGPLPVELLEKQENNTLELRFDGNP 492
++ P+ L + +L +
Sbjct: 365 ISDLTPLANLTRIT----QLGLNDQA 386
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 18/77 (23%), Positives = 31/77 (40%), Gaps = 4/77 (5%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
D ++T+L + + L LT ++ SNN LT P L L+ L +
Sbjct: 41 SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 96
Query: 462 LARNKLTGPLPVELLEK 478
+ N++ P+ L
Sbjct: 97 MNNNQIADITPLANLTN 113
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 4/72 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ SL + ++++ L LT L L L+ N L L+ L++L L+LA N+
Sbjct: 199 TNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQ 254
Query: 467 LTGPLPVELLEK 478
++ P+ L K
Sbjct: 255 ISNLAPLSGLTK 266
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 22/70 (31%), Positives = 37/70 (52%), Gaps = 4/70 (5%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
+T +N S ++LT L NLT L + ++NN + P L+ L++L L L N++T
Sbjct: 70 LTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 125
Query: 469 GPLPVELLEK 478
P++ L
Sbjct: 126 DIDPLKNLTN 135
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++T L L A++++ L LT LT+L+L+ N L P +S L +L +L L N
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320
Query: 467 LTGPLPVELLEK 478
++ PV L K
Sbjct: 321 ISDISPVSSLTK 332
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 21/72 (29%), Positives = 37/72 (51%), Gaps = 4/72 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L+L+ ++++ L+ LT LT L L N ++ P L+ L++L L L N+
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298
Query: 467 LTGPLPVELLEK 478
L P+ L+
Sbjct: 299 LEDISPISNLKN 310
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 16/52 (30%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEK 478
L NLT L LD+S+N ++ L++L++L+ L N+++ P+ +L
Sbjct: 173 LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITPLGILTN 222
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 23/70 (32%), Positives = 37/70 (52%), Gaps = 5/70 (7%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
+T L L +++T L NLT L L+LS+N ++ LS L+SL+ L+ N++T
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-GNQVT 168
Query: 469 GPLPVELLEK 478
P+ L
Sbjct: 169 DLKPLANLTT 178
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 12/52 (23%), Positives = 16/52 (30%), Gaps = 2/52 (3%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEK 478
T L L N+T V + L + L R + VE L
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNN 69
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 8e-05
Identities = 18/72 (25%), Positives = 35/72 (48%), Gaps = 5/72 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L LS++ ++ L+ LT L L N +T P L+ L++L+ L+++ NK
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNK 188
Query: 467 LTGPLPVELLEK 478
++ + L
Sbjct: 189 VSDISVLAKLTN 200
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 1/62 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + ++LS +EL H + L L +SNN L + + + +LK L+L+ N
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNH 306
Query: 467 LT 468
L
Sbjct: 307 LL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 21/86 (24%), Positives = 32/86 (37%), Gaps = 7/86 (8%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
R+ L +S + L Y + L LDLS+N+L V + Q L+ L L N
Sbjct: 272 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS 329
Query: 467 LTGPLPVELLEKQENNTLELRFDGNP 492
+ L + + L N
Sbjct: 330 IV-TLKLSTH----HTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 14/62 (22%), Positives = 24/62 (38%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
I L + + + H N+ +LT L L N+L+ L L+++ N
Sbjct: 93 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 152
Query: 467 LT 468
L
Sbjct: 153 LE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 17/86 (19%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ LNL+ ++ + + L + N + P + L L L RN
Sbjct: 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128
Query: 467 LTGPLPVELLEKQENNTLE-LRFDGN 491
L+ LP + L L N
Sbjct: 129 LSS-LPRGIFHNTPK--LTTLSMSNN 151
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 10/79 (12%), Positives = 24/79 (30%), Gaps = 4/79 (5%)
Query: 411 SLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGP 470
+++ ++ GF L + N+ + L ++ LNL ++
Sbjct: 27 HIDMQTQDVYFGFED--ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE- 83
Query: 471 LPVELLEKQEN-NTLELRF 488
+ L + F
Sbjct: 84 IDTYAFAYAHTIQKLYMGF 102
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 17/67 (25%), Positives = 29/67 (43%), Gaps = 2/67 (2%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
+ +T L L + LT +L N L +DLS N L + ++ L+ L
Sbjct: 221 RGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 278
Query: 462 LARNKLT 468
++ N+L
Sbjct: 279 ISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 12/86 (13%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ S + A L + + L+L++ + + +++ L + N
Sbjct: 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 104
Query: 467 LTGPLPVELLEKQENNTLE-LRFDGN 491
+ LP + + L L + N
Sbjct: 105 IRY-LPPHVFQNVPL--LTVLVLERN 127
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 21/62 (33%), Positives = 31/62 (50%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P +T L L ++L+ N LT+L +SNNNL +SL+ L L+ N+
Sbjct: 117 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 176
Query: 467 LT 468
LT
Sbjct: 177 LT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 21/62 (33%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P++T+L++S + L T L +L LS+N LT V LS + SL N++ N
Sbjct: 141 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNL 197
Query: 467 LT 468
L+
Sbjct: 198 LS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 16/62 (25%), Positives = 24/62 (38%), Gaps = 8/62 (12%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + N+S + L+ L + LD S+N++ V L L L N
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNN 237
Query: 467 LT 468
LT
Sbjct: 238 LT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 20/90 (22%), Positives = 31/90 (34%), Gaps = 8/90 (8%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + L+LS + L L +L L +N++ + LS +LK L L+ N
Sbjct: 295 PTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHND 350
Query: 467 LTGPLPVELLEKQENNTLELRFDGNPDLCR 496
L N D C+
Sbjct: 351 WDCNSLRALF----RNVARPAVDDADQHCK 376
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 1/62 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + ++LS +EL H + L L +SNN L + + + +LK L+L+ N
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNH 312
Query: 467 LT 468
L
Sbjct: 313 LL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 16/69 (23%), Positives = 27/69 (39%), Gaps = 6/69 (8%)
Query: 402 PDDDSPRITSLNLSASELT--GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKF 459
+ +T L L + LT N L +DLS N L + ++ L+
Sbjct: 227 RGPVNVELTILKLQHNNLTDTAWLL----NYPGLVEVDLSYNELEKIMYHPFVKMQRLER 282
Query: 460 LNLARNKLT 468
L ++ N+L
Sbjct: 283 LYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 12/86 (13%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ S + A L + + L+L++ + + +++ L + N
Sbjct: 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110
Query: 467 LTGPLPVELLEKQENNTLE-LRFDGN 491
+ LP + + L L + N
Sbjct: 111 IRY-LPPHVFQNVPL--LTVLVLERN 133
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 14/75 (18%), Positives = 26/75 (34%), Gaps = 1/75 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++ LNL+ ++ + + L + N + P + L L L RN
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134
Query: 467 LTGPLPVELLEKQEN 481
L+ LP +
Sbjct: 135 LSS-LPRGIFHNTPK 148
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 10/79 (12%), Positives = 24/79 (30%), Gaps = 4/79 (5%)
Query: 411 SLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGP 470
+++ ++ GF L + N+ + L ++ LNL ++
Sbjct: 33 HIDMQTQDVYFGFED--ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE- 89
Query: 471 LPVELLEKQEN-NTLELRF 488
+ L + F
Sbjct: 90 IDTYAFAYAHTIQKLYMGF 108
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 21/65 (32%), Positives = 32/65 (49%)
Query: 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
+ P +T L L ++L+ N LT+L +SNNNL +SL+ L L+
Sbjct: 120 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 179
Query: 464 RNKLT 468
N+LT
Sbjct: 180 SNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 16/62 (25%), Positives = 24/62 (38%), Gaps = 8/62 (12%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + N+S + L+ L + LD S+N++ V L L L N
Sbjct: 192 PSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNN 243
Query: 467 LT 468
LT
Sbjct: 244 LT 245
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 5e-07
Identities = 26/119 (21%), Positives = 49/119 (41%), Gaps = 8/119 (6%)
Query: 350 IYEVKEFSQSQTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRI 409
I ++ +++ + +K+ ++ + D + L Y D
Sbjct: 389 ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV----- 443
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
L+L+ +LT +L L ++T LDLS+N L +P L+ L L+ L + N L
Sbjct: 444 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 8e-06
Identities = 23/87 (26%), Positives = 34/87 (39%), Gaps = 6/87 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L+LS + L L L L L S+N L ++ L L+ L L N+
Sbjct: 463 LLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNR 519
Query: 467 LTGPLPVELLEKQEN-NTLELRFDGNP 492
L ++ L L L+ GN
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQ--GNS 544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.4 bits (104), Expect = 1e-04
Identities = 18/66 (27%), Positives = 22/66 (33%), Gaps = 9/66 (13%)
Query: 407 PRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTG-PVPKFLSQLSSLKFLNL 462
+ L S + G + NL L L L NN L + L L LNL
Sbjct: 486 RCLEVLQASDNALENVDG-----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL 540
Query: 463 ARNKLT 468
N L
Sbjct: 541 QGNSLC 546
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 23/89 (25%), Positives = 34/89 (38%), Gaps = 2/89 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L +S + L+ L L + N+ ++ L+SL LNLA N
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277
Query: 467 LTGPLPVELLEKQENNTLELRFDGNPDLC 495
L+ LP +L EL NP C
Sbjct: 278 LSS-LPHDLFTPLRYLV-ELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 18/67 (26%), Positives = 25/67 (37%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
P LNL + + A +L L L L N++ + L+SL L
Sbjct: 70 PQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLE 129
Query: 462 LARNKLT 468
L N LT
Sbjct: 130 LFDNWLT 136
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 17/62 (27%), Positives = 27/62 (43%), Gaps = 2/62 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ LNL + LT L L L++S N+ P LSSLK L + ++
Sbjct: 196 FNLKYLNLGMCNIK--DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 467 LT 468
++
Sbjct: 254 VS 255
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 9e-07
Identities = 19/70 (27%), Positives = 29/70 (41%), Gaps = 3/70 (4%)
Query: 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465
P +L L + L F L+ L + + L +P + Q + L+ L LARN
Sbjct: 80 QPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARN 137
Query: 466 KLTGPLPVEL 475
L LP +
Sbjct: 138 PLRA-LPASI 146
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 9/88 (10%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA-RNKLT 468
SL + S L+ + +L L LDL P + LK L L + L
Sbjct: 209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 469 GPLPVEL--LEKQENNTLELRFDGNPDL 494
LP+++ L + E +L G +L
Sbjct: 268 T-LPLDIHRLTQLE----KLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 12/49 (24%), Positives = 21/49 (42%), Gaps = 2/49 (4%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVEL 475
L L SL L + +P ++ L +LK L + + L+ L +
Sbjct: 179 HQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAI 225
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 12/51 (23%), Positives = 21/51 (41%), Gaps = 4/51 (7%)
Query: 427 LTNLTM--LTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVEL 475
L + T +L+L + L P +LS L+ + + L LP +
Sbjct: 75 LEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTM 123
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 10/50 (20%), Positives = 18/50 (36%), Gaps = 1/50 (2%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELL 476
+ LT L LDL +P ++QL + + + + L
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ-LDQHRP 321
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 13/79 (16%), Positives = 27/79 (34%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTG 469
L+L + L L L + + +P + +L+ L+ L+L
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 470 PLPVELLEKQENNTLELRF 488
LP + + N + +
Sbjct: 292 RLPSLIAQLPANCIILVPP 310
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 19/67 (28%), Positives = 30/67 (44%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
PD S LNL +++ + +L L L LS N++ + L++L L
Sbjct: 59 PDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLE 118
Query: 462 LARNKLT 468
L N+LT
Sbjct: 119 LFDNRLT 125
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 18/62 (29%), Positives = 28/62 (45%), Gaps = 2/62 (3%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ LNL+ L LT L L LDLS N+L+ P L L+ L + +++
Sbjct: 185 SNLRYLNLAMCNLR--EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 467 LT 468
+
Sbjct: 243 IQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 17/62 (27%), Positives = 24/62 (38%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L LS + + L L +L+L +N LT LS LK L L N
Sbjct: 88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNP 147
Query: 467 LT 468
+
Sbjct: 148 IE 149
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 25/91 (27%), Positives = 40/91 (43%), Gaps = 2/91 (2%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
P + + SL+LS + +T L L +L L++N + S L SL+ L+
Sbjct: 47 PSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106
Query: 462 LARNKLTGPLPVELLEKQENNTLELRFDGNP 492
L+ N L+ L + + T L GNP
Sbjct: 107 LSYNYLSN-LSSSWFKPLSSLT-FLNLLGNP 135
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 22/97 (22%), Positives = 43/97 (44%), Gaps = 11/97 (11%)
Query: 404 DDSPRITSLNLSA--------SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLS 455
D + + L L SEL+ G + L ++ +++ +L V K L+Q+S
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
Query: 456 SLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNP 492
L L +RN+L +P + ++ + ++ NP
Sbjct: 278 GLLELEFSRNQLKS-VPDGIFDRLTSLQ-KIWLHTNP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 16/77 (20%), Positives = 30/77 (38%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTG 469
L + AS+L L ++ ++ L L + F+ SS++ L L L
Sbjct: 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236
Query: 470 PLPVELLEKQENNTLEL 486
EL + N+ ++
Sbjct: 237 FHFSELSTGETNSLIKK 253
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 20/66 (30%), Positives = 30/66 (45%), Gaps = 8/66 (12%)
Query: 407 PRITSLNLSASELT----GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNL 462
+ +L L+++ + F+ +L L LDLS N L+ + LSSL FLNL
Sbjct: 76 VNLQALVLTSNGINTIEEDSFS----SLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131
Query: 463 ARNKLT 468
N
Sbjct: 132 LGNPYK 137
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 10/42 (23%), Positives = 18/42 (42%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
LT L L++ ++L PK L + ++ L L +
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 76/608 (12%), Positives = 173/608 (28%), Gaps = 200/608 (32%)
Query: 342 PPIINAIEIYEVKEFSQSQTDEQDVDAIMN----------------------IKSFYG-- 377
++ + +V++ +S ++++D I+ ++ F
Sbjct: 27 DAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV 86
Query: 378 LKKN-------WQGDPCAP----------QDYLWEGLNCSYPDDDSPR---ITSLNLSAS 417
L+ N + + P +D L+ N + + R L +
Sbjct: 87 LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND-NQVFAKYNVSRLQPYLKLRQALL 145
Query: 418 ELT----------GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKF-LNLARNK 466
EL G T + + K ++ F LNL
Sbjct: 146 ELRPAKNVLIDGVLGSGK-----TWVALDVCLSY-------KVQCKMDFKIFWLNLKNCN 193
Query: 467 LTGPLPVELLEKQENNTLELRFDGNPDLC-----------RSASCKKEKKKFVVPVVASV 515
P +LE + L + D P+ R S + E ++ +
Sbjct: 194 ----SPETVLEMLQK--LLYQID--PNWTSRSDHSSNIKLRIHSIQAELRRLL--KSKPY 243
Query: 516 ASVFVVLAALIGLWSLKRKKQLPDP--QILIWLVRLSSGRKVDANCNRSYESLDLSSRQF 573
+ +VL + + K + +IL+ R + ++ SLD S
Sbjct: 244 ENCLLVLL---NVQNAKAWNAF-NLSCKILL-TTRFKQVTDFLSAATTTHISLDHHSMTL 298
Query: 574 TYSEVLRMTNNFERVLGK-----------------GGFGTVYHG---------KLDND-- 605
T EV + + L ++ D
Sbjct: 299 TPDEVKSL---LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355
Query: 606 ----EVAVKMLSPSSSQG-YKQ---FQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657
E ++ +L P+ + + + F + + L+ + + M ++ +
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL----LSLIWFDVIKSDVMVVVNKL 411
Query: 658 MANGNLEEHLSDSSKEI--LNWEERLRIAVEAAL----------GLEYLHQGCKPP---- 701
+E+ +S+ I + E ++++ E AL + PP
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
Query: 702 -----IVH---------RDVKSTNILINEKF-QAKLADFGLSRVFPVEGGTHVSTTIAGT 746
I H R + ++ +F + K+ + G+ ++T
Sbjct: 472 YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNAS---GSILNT----- 523
Query: 747 PGYLDPEYYISNRLTEKSDVYS--------FGVVLLEIITGHPVISKSAENGHTHVAQWV 798
++Y + + Y F L I + + SK +T + +
Sbjct: 524 --LQQLKFY-KPYICDNDPKYERLVNAILDF----LPKIEENLICSK-----YTDLLR-- 569
Query: 799 SSMLDKGD 806
+++ + +
Sbjct: 570 IALMAEDE 577
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 16/71 (22%), Positives = 32/71 (45%)
Query: 398 NCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSL 457
N ++ ++ + + +LS S++ ++ T L L L+ N + L+ L
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHL 325
Query: 458 KFLNLARNKLT 468
LNL++N L
Sbjct: 326 LKLNLSQNFLG 336
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 22/92 (23%), Positives = 33/92 (35%), Gaps = 3/92 (3%)
Query: 407 PRITSLNLSASELTGGF--AHYLTNLTMLTSLDLSNNNLTGPVPK-FLSQLSSLKFLNLA 463
+ L L+ L G ++ LT L L L +NN+ P F + L+L
Sbjct: 103 ANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT 162
Query: 464 RNKLTGPLPVELLEKQENNTLELRFDGNPDLC 495
NK+ +LL Q + LR
Sbjct: 163 FNKVKSICEEDLLNFQGKHFTLLRLSSITLQD 194
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 17/67 (25%), Positives = 24/67 (35%), Gaps = 2/67 (2%)
Query: 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPV--PKFLSQLSSLKFLN 461
+ L L ++ L L L L+ NL G V F L+SL+ L
Sbjct: 76 RGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLV 135
Query: 462 LARNKLT 468
L N +
Sbjct: 136 LRDNNIK 142
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 14/74 (18%), Positives = 23/74 (31%), Gaps = 4/74 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPK--FLSQLSSLKFLNLAR 464
+ ++LS + + + L L L + + F LSSL L L
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF-RGLSSLIILKLDY 88
Query: 465 NKLTGPLPVELLEK 478
N+ L
Sbjct: 89 NQFLQ-LETGAFNG 101
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 2/86 (2%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTG 469
LNLS + L + NL L LDLS N++ + L +LK L L N+L
Sbjct: 326 LKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS 385
Query: 470 PLPVELLEKQENNTLELRFDGNPDLC 495
+P + ++ + ++ NP C
Sbjct: 386 -VPDGIFDRLTSLQ-KIWLHTNPWDC 409
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 26/101 (25%), Positives = 39/101 (38%), Gaps = 15/101 (14%)
Query: 404 DDSPRITSLNLSASELT----GGFAHYLTNLTMLTSLDLSNNNLTGPVP----KFLSQLS 455
D + L L + + F ++ L L LS N ++ P K ++L
Sbjct: 109 SDLQALEVLLLYNNHIVVVDRNAF----EDMAQLQKLYLSQNQISR-FPVELIKDGNKLP 163
Query: 456 SLKFLNLARNKLTGPLPVELLEKQENNTLE-LRFDGNPDLC 495
L L+L+ NKL LP+ L+K L NP C
Sbjct: 164 KLMLLDLSSNKLKK-LPLTDLQKLPAWVKNGLYLHNNPLEC 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 28/105 (26%), Positives = 41/105 (39%), Gaps = 13/105 (12%)
Query: 397 LNCSY------PDDDSPRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPV 447
L+CS P L+LS S L + T LT L SL LS+N+L
Sbjct: 23 LSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWT--PTRLTNLHSLLLSHNHLNFIS 80
Query: 448 PKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNP 492
+ + +L++L+L+ N L L L + L N
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALE-VLLLYNNH 123
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
I LNLS++ LTG L + LDL NN + +PK ++ L +L+ LN+A N+L
Sbjct: 430 ILVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK 486
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 16/59 (27%), Positives = 23/59 (38%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
LS S+ + + T L+ + N T V + S L L+ L L RN L
Sbjct: 332 NIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 22/85 (25%), Positives = 30/85 (35%), Gaps = 12/85 (14%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF 450
LN PD IT+L + + LT L +L++S N LT +P
Sbjct: 45 LNVGESGLTTLPDCLPAHITTLVIPDNNLT----SLPALPPELRTLEVSGNQLTS-LPVL 99
Query: 451 LSQLSSLKFLNLARNKLTGPLPVEL 475
L L + L LP L
Sbjct: 100 PPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 21/78 (26%), Positives = 33/78 (42%), Gaps = 8/78 (10%)
Query: 410 TSLNLSASELTGGFAHYL-TNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
L +S + LT L + L SL + N LT +P+ L LSS +NL N L+
Sbjct: 244 KELMVSGNRLT-----SLPMLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS 297
Query: 469 GPLPVELLEKQENNTLEL 486
++ L + +
Sbjct: 298 -ERTLQALREITSAPGYS 314
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 26/83 (31%), Positives = 37/83 (44%), Gaps = 11/83 (13%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTG 469
L +S + LT + L L +S N LT +P S L L++ RN+LT
Sbjct: 224 KELIVSGNRLTSLPVL----PSELKELMVSGNRLTS-LP---MLPSGLLSLSVYRNQLTR 275
Query: 470 PLPVELLEKQENNTLELRFDGNP 492
LP L+ T+ L +GNP
Sbjct: 276 -LPESLIHLSSETTVNL--EGNP 295
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 20/62 (32%), Positives = 34/62 (54%), Gaps = 3/62 (4%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ SLN+S++ LT L + LDL +N + +PK + +L +L+ LN+A N+
Sbjct: 399 KSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQ 455
Query: 467 LT 468
L
Sbjct: 456 LK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 19/78 (24%), Positives = 37/78 (47%), Gaps = 6/78 (7%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF 450
++ S P D S + T LN+S + ++ + + +L+ L L +S+N +
Sbjct: 5 VDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 451 LSQLSSLKFLNLARNKLT 468
L++L+L+ NKL
Sbjct: 65 FKFNQELEYLDLSHNKLV 82
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 16/80 (20%), Positives = 33/80 (41%), Gaps = 2/80 (2%)
Query: 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT--GPVPKFLSQLSSLKFLN 461
L+ S + LT +LT L +L L N L + + +Q+ SL+ L+
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 462 LARNKLTGPLPVELLEKQEN 481
+++N ++ ++
Sbjct: 381 ISQNSVSYDEKKGDCSWTKS 400
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 16/60 (26%), Positives = 25/60 (41%)
Query: 409 ITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
+ N + S + ++ LD SNN LT V + L+ L+ L L N+L
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 18/65 (27%), Positives = 29/65 (44%), Gaps = 3/65 (4%)
Query: 407 PRITSLNLSASELT--GGFAHYLTNLTMLTSLDLSNNNLT-GPVPKFLSQLSSLKFLNLA 463
+ +L L ++L A T + L LD+S N+++ S SL LN++
Sbjct: 348 TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 464 RNKLT 468
N LT
Sbjct: 408 SNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 17/96 (17%), Positives = 32/96 (33%), Gaps = 1/96 (1%)
Query: 400 SYPDDDSPRITSLNLSASELTG-GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLK 458
+ + L+LS + N++ L L LS +L ++ L+ K
Sbjct: 83 KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142
Query: 459 FLNLARNKLTGPLPVELLEKQENNTLELRFDGNPDL 494
L + E L+ +L + F N +
Sbjct: 143 VLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 24/87 (27%), Positives = 34/87 (39%), Gaps = 7/87 (8%)
Query: 398 NCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFL 451
+C P + IT + L + + + L +DLSNN ++ P
Sbjct: 17 DCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAF 76
Query: 452 SQLSSLKFLNLARNKLTGPLPVELLEK 478
L SL L L NK+T LP L E
Sbjct: 77 QGLRSLNSLVLYGNKITE-LPKSLFEG 102
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 8/66 (12%)
Query: 407 PRITSLNLSASELT----GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNL 462
++ ++LS ++++ F L L SL L N +T L SL+ L L
Sbjct: 56 KKLRRIDLSNNQISELAPDAFQG----LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111
Query: 463 ARNKLT 468
NK+
Sbjct: 112 NANKIN 117
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 24/89 (26%), Positives = 32/89 (35%), Gaps = 2/89 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+T L L + ++ L L L L N + P L L L L N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 467 LTGPLPVELLEKQENNTLELRFDGNPDLC 495
L+ LP E L LR + NP +C
Sbjct: 213 LSA-LPTEALAPLRALQ-YLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 17/87 (19%), Positives = 29/87 (33%), Gaps = 1/87 (1%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
P + L + ++ A LT L L +N L + L+ L+ L+
Sbjct: 27 PVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86
Query: 462 LARNKLTGPLPVELLEKQEN-NTLELR 487
L+ N + +TL L
Sbjct: 87 LSDNAQLRSVDPATFHGLGRLHTLHLD 113
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 21/63 (33%), Positives = 27/63 (42%), Gaps = 1/63 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNN-LTGPVPKFLSQLSSLKFLNLARN 465
+T L L ++ L A T L +L LDLS+N L P L L L+L R
Sbjct: 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115
Query: 466 KLT 468
L
Sbjct: 116 GLQ 118
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 16/66 (24%), Positives = 25/66 (37%), Gaps = 8/66 (12%)
Query: 407 PRITSLNLSASELT----GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNL 462
+ L L + L F +L LT L L N ++ + L SL L L
Sbjct: 129 AALQYLYLQDNALQALPDDTFR----DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 463 ARNKLT 468
+N++
Sbjct: 185 HQNRVA 190
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 12/42 (28%), Positives = 17/42 (40%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
L L +L L L P L++L++L L N L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 7e-06
Identities = 17/84 (20%), Positives = 32/84 (38%), Gaps = 7/84 (8%)
Query: 407 PRITSLNLSASELTGGFAHYL---TNLTMLTSLDLSNNNLTG----PVPKFLSQLSSLKF 459
P + L + +E L L ++D+S LT + + ++ LKF
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 460 LNLARNKLTGPLPVELLEKQENNT 483
+N+ N L+ + EL +
Sbjct: 312 INMKYNYLSDEMKKELQKSLPMKI 335
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 12/94 (12%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+TSL+ S +T + LT LT L ++NN+T + LSQ ++L +L NK
Sbjct: 42 ATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNK 96
Query: 467 LTGPLPVELLEK------QENNTLELRFDGNPDL 494
LT L V L K N +L NP L
Sbjct: 97 LTN-LDVTPLTKLTYLNCDTNKLTKLDVSQNPLL 129
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 18/62 (29%), Positives = 33/62 (53%), Gaps = 6/62 (9%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++T+L+ S +++T ++ +L L+ NN+T L+Q L FL+ + NK
Sbjct: 170 TQLTTLDCSFNKIT---ELDVSQNKLLNRLNCDTNNITKLD---LNQNIQLTFLDCSSNK 223
Query: 467 LT 468
LT
Sbjct: 224 LT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 25/104 (24%), Positives = 44/104 (42%), Gaps = 17/104 (16%)
Query: 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKF 450
LNC + + ++T L+ S+++LT +T LT LT D S N LT +
Sbjct: 196 LNCDTNNITKLDLNQNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVNPLT-ELD-- 249
Query: 451 LSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNPDL 494
+S LS L L+ + L + + + + +G +
Sbjct: 250 VSTLSKLTTLHCIQTDLLE-IDLTHN----TQLIYFQAEGCRKI 288
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 20/99 (20%), Positives = 30/99 (30%), Gaps = 12/99 (12%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
PDD+ + L LTSLD N+++T + +L+ L L
Sbjct: 16 PDDNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLI 70
Query: 462 LARNKLTGPLPVELLEK------QENNTLELRFDGNPDL 494
N +T L + N L L
Sbjct: 71 CTSNNITT-LDLSQNTNLTYLACDSNKLTNLDVTPLTKL 108
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 28/113 (24%), Positives = 41/113 (36%), Gaps = 20/113 (17%)
Query: 395 EGLNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVP 448
L C+ + +T L +++LT +T LT LT L+ N LT
Sbjct: 67 TKLICTSNNITTLDLSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLT---K 120
Query: 449 KFLSQLSSLKFLNLARNKLTGPLPVELLEK-------QENNTLELRFDGNPDL 494
+SQ L +LN ARN LT + V + +L L
Sbjct: 121 LDVSQNPLLTYLNCARNTLT-EIDVSHNTQLTELDCHLNKKITKLDVTPQTQL 172
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 14/42 (33%), Positives = 19/42 (45%), Gaps = 3/42 (7%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468
+T+ T L LD +T LSQ L +L L +LT
Sbjct: 293 VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT 331
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 11/99 (11%)
Query: 404 DDSPRITSLNLSASELTGG-----FAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQL---- 454
++ P + +NL+ A L T + + PV L+++
Sbjct: 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVN 92
Query: 455 SSLKFLNLARNKLTGPLPVELLEK-QENNTL-ELRFDGN 491
++LK LN+ N ++G + L+E Q N +L ELR D
Sbjct: 93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQ 131
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 16/66 (24%), Positives = 23/66 (34%), Gaps = 1/66 (1%)
Query: 427 LTNLTMLTSLDLSNNNLTG-PVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLE 485
L L +L L + N L P + L + N +PV + N TL
Sbjct: 101 LKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160
Query: 486 LRFDGN 491
L+ N
Sbjct: 161 LKLYNN 166
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 22/90 (24%), Positives = 36/90 (40%), Gaps = 11/90 (12%)
Query: 407 PRITSLNLSAS-ELTGGFAHYLTNLTMLTSLDLSNNN-LTGPVPKFLSQLSSLKFLNLAR 464
P I+ + +S L +H NL+ +T +++ N LT P L +L LKFL +
Sbjct: 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114
Query: 465 NKLT---------GPLPVELLEKQENNTLE 485
L +LE +N +
Sbjct: 115 TGLKMFPDLTKVYSTDIFFILEITDNPYMT 144
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 11/99 (11%)
Query: 404 DDSPRITSLNLSASELTGG-----FAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQL---- 454
+D + +N++ + N + L+N ++ + L +L
Sbjct: 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETS 97
Query: 455 SSLKFLNLARNKLTGPLPVELLEK-QENNTL-ELRFDGN 491
SL+ LN+ N LT L LL ++ E + D
Sbjct: 98 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ 136
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 19/96 (19%), Positives = 38/96 (39%), Gaps = 11/96 (11%)
Query: 404 DDSPRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTG-PVPKFLSQLSSLKF 459
+ L + L +L L L++++N + +P++ S L++L+
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLK---ELNVAHNLIQSFKLPEYFSNLTNLEH 153
Query: 460 LNLARNKLTGPLPVEL---LEKQENNTLELRFDGNP 492
L+L+ NK+ + L + L L NP
Sbjct: 154 LDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNP 188
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 18/77 (23%), Positives = 27/77 (35%), Gaps = 6/77 (7%)
Query: 398 NCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFL 451
C PD+ +L+LS + L ++ + L LDLS +
Sbjct: 13 QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 452 SQLSSLKFLNLARNKLT 468
LS L L L N +
Sbjct: 73 QSLSHLSTLILTGNPIQ 89
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 8/66 (12%)
Query: 407 PRITSLNLSASELT----GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNL 462
P + L+LS E+ G + L+ L++L L+ N + S LSSL+ L
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQS----LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107
Query: 463 ARNKLT 468
L
Sbjct: 108 VETNLA 113
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 19/82 (23%), Positives = 29/82 (35%), Gaps = 15/82 (18%)
Query: 398 NCSY------PDDDSPRITSLNLSASELT-----GGFAHYLTNLTMLTSLDLSNNNLTGP 446
+CS P+ L L+ +E T G F L L ++ SNN +T
Sbjct: 17 DCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFK----KLPQLRKINFSNNKITDI 72
Query: 447 VPKFLSQLSSLKFLNLARNKLT 468
S + + L N+L
Sbjct: 73 EEGAFEGASGVNEILLTSNRLE 94
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 18/66 (27%), Positives = 31/66 (46%), Gaps = 8/66 (12%)
Query: 407 PRITSLNLSASELT----GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNL 462
P++ +N S +++T G F + + + L++N L K L SLK L L
Sbjct: 57 PQLRKINFSNNKITDIEEGAFEG----ASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112
Query: 463 ARNKLT 468
N++T
Sbjct: 113 RSNRIT 118
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 25/92 (27%), Positives = 40/92 (43%), Gaps = 9/92 (9%)
Query: 404 DDSPRITSLNLSASELT--GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
D+ + L+ LT L L L L+LS+N ++G + + +L LN
Sbjct: 39 DEFEELEFLSTINVGLTSIAN----LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94
Query: 462 LARNKLTGPLPVELLEKQENNTLE-LRFDGNP 492
L+ NK+ +E L+K EN L+ L
Sbjct: 95 LSGNKIKDLSTIEPLKKLEN--LKSLDLFNCE 124
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 18/63 (28%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGP-VPKFLSQLSSLKFLNLARN 465
++ L LS + ++GG LT L+LS N + + L +L +LK L+L
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
Query: 466 KLT 468
++T
Sbjct: 124 EVT 126
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 21/65 (32%), Positives = 34/65 (52%), Gaps = 10/65 (15%)
Query: 407 PRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
++ SL+L S++ G L +L L SL L NN +T LS+L+ L L+L
Sbjct: 112 KKLKSLSLEHNGISDING-----LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE 164
Query: 464 RNKLT 468
N+++
Sbjct: 165 DNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
DD NL +T A L + + +N+++ + + L ++ L
Sbjct: 19 SDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLF 74
Query: 462 LARNKLT 468
L NKLT
Sbjct: 75 LNGNKLT 81
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 20/89 (22%), Positives = 37/89 (41%), Gaps = 11/89 (12%)
Query: 407 PRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
++ +L+L S++ L LT L +L LS N+++ + L+ L +L L L
Sbjct: 156 TKLDTLSLEDNQISDIVP-----LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELF 208
Query: 464 RNKLTGPLPVELLEKQENNTLELRFDGNP 492
+ NT++ DG+
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKN-TDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 19/70 (27%), Positives = 29/70 (41%), Gaps = 10/70 (14%)
Query: 402 PDDDSPRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLK 458
P + + L L +L+ L +L L SL L +N ++ L L L+
Sbjct: 85 PLANLKNLGWLFLDENKVKDLSS-----LKDLKKLKSLSLEHNGIS--DINGLVHLPQLE 137
Query: 459 FLNLARNKLT 468
L L NK+T
Sbjct: 138 SLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 4/62 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
I + + S++ + L +T L L+ N LT K L+ L +L +L L NK
Sbjct: 46 NSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNKLT--DIKPLANLKNLGWLFLDENK 101
Query: 467 LT 468
+
Sbjct: 102 VK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 14/89 (15%)
Query: 407 PRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
P++ SL L +++T L+ LT L +L L +N ++ VP L+ L+ L+ L L+
Sbjct: 134 PQLESLYLGNNKITDITV-----LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186
Query: 464 RNKLTGPLPVELLEKQENNTLELRFDGNP 492
+N ++ + L N L
Sbjct: 187 KNHISDLRALAGL----KNLDVLELFSQE 211
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 31/82 (37%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P +T L++S + LT L L L L L N L P L+ L+ L+LA N
Sbjct: 100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159
Query: 467 LTGPLPVELLEKQEN-NTLELR 487
LT LP LL EN +TL L+
Sbjct: 160 LTE-LPAGLLNGLENLDTLLLQ 180
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 21/68 (30%), Positives = 29/68 (42%), Gaps = 7/68 (10%)
Query: 404 DDSPRITSLNLSASELT---GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFL 460
P + +L+LS ++L L LT LD+S N LT L L L+ L
Sbjct: 74 GTLPVLGTLDLSHNQLQSLPLLGQ----TLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129
Query: 461 NLARNKLT 468
L N+L
Sbjct: 130 YLKGNELK 137
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 4/77 (5%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
PD + S +T +L +T+L +T + + L++L L
Sbjct: 14 PDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLE 69
Query: 462 LARNKLTGPLPVELLEK 478
L N++T P++ L K
Sbjct: 70 LKDNQITDLAPLKNLTK 86
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 16/62 (25%), Positives = 35/62 (56%), Gaps = 4/62 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
I +L+L+++++T L L+ L L L N +T P L+ L++L++L++ +
Sbjct: 107 QSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQ 162
Query: 467 LT 468
++
Sbjct: 163 VS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/89 (22%), Positives = 32/89 (35%), Gaps = 14/89 (15%)
Query: 407 PRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
+ L L + ++ L LT L L + N ++ P L+ LS L L
Sbjct: 129 SNLQVLYLDLNQITNISP-----LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKAD 181
Query: 464 RNKLTGPLPVELLEKQENNTLELRFDGNP 492
NK++ P+ L E+ N
Sbjct: 182 DNKISDISPLASLPNLI----EVHLKNNQ 206
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 15/78 (19%), Positives = 31/78 (39%), Gaps = 4/78 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
++T+L ++++ L +L L + L NN ++ P L+ S+L + L
Sbjct: 173 SKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQT 228
Query: 467 LTGPLPVELLEKQENNTL 484
+T N +
Sbjct: 229 ITNQPVFYNNNLVVPNVV 246
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 15/72 (20%), Positives = 35/72 (48%), Gaps = 4/72 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L++ ++++ L NL+ LT+L +N ++ P L+ L +L ++L N+
Sbjct: 151 TNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206
Query: 467 LTGPLPVELLEK 478
++ P+
Sbjct: 207 ISDVSPLANTSN 218
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 21/72 (29%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L L +++T L NLT +T L+LS N L ++ L S+K L+L +
Sbjct: 63 NNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQ 118
Query: 467 LTGPLPVELLEK 478
+T P+ L
Sbjct: 119 ITDVTPLAGLSN 130
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 21/94 (22%), Positives = 36/94 (38%), Gaps = 8/94 (8%)
Query: 406 SPRITSLNLSASELT-GGFAHYLTNLTMLTSLDLSNNNLT----GPVPKFLSQLSSLKFL 460
S I SL++ EL+ +A L L + L + LT + L +L L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 461 NLARNKLTGPLPVELLE--KQENNTLE-LRFDGN 491
NL N+L +L+ + + ++ L
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 95
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 20/72 (27%), Positives = 28/72 (38%), Gaps = 9/72 (12%)
Query: 406 SPRITSLNLSASELT----GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQL-----SS 456
S +I L+L LT G + L L L L LS+N L + L +
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 457 LKFLNLARNKLT 468
L+ L L L+
Sbjct: 144 LEKLQLEYCSLS 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 25/100 (25%), Positives = 36/100 (36%), Gaps = 16/100 (16%)
Query: 378 LKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGFAHY----LTNLTML 433
L N GD A L E L + ++ SL + + T + L L
Sbjct: 291 LAGNELGDEGAR--LLCETL-----LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 434 TSLDLSNNNLTGPVPKFLSQL-----SSLKFLNLARNKLT 468
L +SNN L + L Q S L+ L LA ++
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 16/79 (20%), Positives = 25/79 (31%), Gaps = 9/79 (11%)
Query: 399 CSYPDDDSPRITSLNLSASELT----GGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQL 454
C S R+ +L + +T G L L L L+ N L + L +
Sbjct: 248 CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET 307
Query: 455 -----SSLKFLNLARNKLT 468
L+ L + T
Sbjct: 308 LLEPGCQLESLWVKSCSFT 326
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 21/63 (33%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVP-KFLSQLSSLKFLNLARN 465
P++ L LS + + GG L LT L+LS N L + L +L LK L+L
Sbjct: 71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
Query: 466 KLT 468
++T
Sbjct: 131 EVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 8e-05
Identities = 23/87 (26%), Positives = 35/87 (40%), Gaps = 5/87 (5%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L+L L L L L L+LS N + G + +L +L LNL+ NK
Sbjct: 49 VNLEFLSLINVGLIS--VSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106
Query: 467 LTGPLPVELLEKQENNTLE-LRFDGNP 492
L +E L ++ L+ L
Sbjct: 107 LKDISTLEPL--KKLECLKSLDLFNCE 131
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 20/69 (28%), Positives = 27/69 (39%), Gaps = 3/69 (4%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLEL 486
L L L +L + + L P L LNL+ N L L + + Q + EL
Sbjct: 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTV--QGLSLQEL 108
Query: 487 RFDGNPDLC 495
GNP C
Sbjct: 109 VLSGNPLHC 117
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 5e-05
Identities = 21/65 (32%), Positives = 34/65 (52%), Gaps = 10/65 (15%)
Query: 407 PRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
++ SL+L S++ G L +L L SL L NN +T LS+L+ L L+L
Sbjct: 109 KKLKSLSLEHNGISDING-----LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLE 161
Query: 464 RNKLT 468
N+++
Sbjct: 162 DNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 7e-05
Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 4/67 (5%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
PDD NL +T A L + + +N+++ + + L ++ L
Sbjct: 16 PDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLF 71
Query: 462 LARNKLT 468
L NKLT
Sbjct: 72 LNGNKLT 78
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 17/65 (26%), Positives = 27/65 (41%), Gaps = 10/65 (15%)
Query: 407 PRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
I + + + G + L +T L L+ N LT P L+ L +L +L L
Sbjct: 43 NSIDQIIANNSDIKSVQG-----IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95
Query: 464 RNKLT 468
NK+
Sbjct: 96 ENKIK 100
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 13/67 (19%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 402 PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
PD NL +T L+ + + + N+N+ + ++LK L+
Sbjct: 14 PDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELH 69
Query: 462 LARNKLT 468
L+ N+++
Sbjct: 70 LSHNQIS 76
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 11/89 (12%)
Query: 407 PRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLA 463
+ L++ + L L+ L LDL N +T L++L + +++L
Sbjct: 128 KNLEILSIRNNKLKSIVM-----LGFLSKLEVLDLHGNEIT--NTGGLTRLKKVNWIDLT 180
Query: 464 RNKLTGPLPVELLEKQENNTLELRFDGNP 492
K E NT++ DG
Sbjct: 181 GQKCVNEPVKYQPELYITNTVKD-PDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 22/91 (24%), Positives = 34/91 (37%), Gaps = 14/91 (15%)
Query: 405 DSPRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLN 461
S ++ L L + L +L L L + NN L V L LS L+ L+
Sbjct: 104 PSACLSRLFLDNNELRDTDS-----LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLD 156
Query: 462 LARNKLTGPLPVELLEKQENNTLELRFDGNP 492
L N++T + L+K + G
Sbjct: 157 LHGNEITNTGGLTRLKKVN----WIDLTGQK 183
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 21/180 (11%), Positives = 58/180 (32%), Gaps = 30/180 (16%)
Query: 189 SLELSIRLDVGSTSNATFRYIDDAYDRVWWPYDLDEWEPFSTSEAVDADGSKNFKPPPRA 248
+ ++ ++ G S+ D + + L+ ++ + ++
Sbjct: 3 ADKVIWAVNAGGESHV------DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVL 56
Query: 249 MKSAVRPVNASNSLDFSINASDPTSQLYVYMHFAEIEELKANESRLFNITRNGNL----- 303
++ R S D I + + + FAE+ ++ + ++F++ NG+
Sbjct: 57 YQTE-RYNEDSFGYDIPI---KEEGEYVLVLKFAEVYFAQSQQ-KVFDVRVNGHTVVKDL 111
Query: 304 ----WYGPLKLNYLSST--------TVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIY 351
G + +V + + G+ + +K P + A+ I
Sbjct: 112 DIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDN--PKVCALFIM 169
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 24/108 (22%), Positives = 36/108 (33%), Gaps = 8/108 (7%)
Query: 369 IMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYL- 427
+ + +Y W+ + E D + L L+ L+ L
Sbjct: 33 VKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-----SLP 87
Query: 428 TNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVEL 475
L SL S N+LT +P+ L SL N L+ LP L
Sbjct: 88 ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-LPPLL 133
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 6/62 (9%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + L +S ++L L N + L +D+ NN+L K SL+F+ N+
Sbjct: 131 PLLEYLGVSNNQLE--KLPELQNSSFLKIIDVDNNSLK----KLPDLPPSLEFIAAGNNQ 184
Query: 467 LT 468
L
Sbjct: 185 LE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 13/59 (22%), Positives = 22/59 (37%), Gaps = 1/59 (1%)
Query: 429 NLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELR 487
+ T L ++NLT +P + S A ++ P E++E LR
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 18/85 (21%), Positives = 30/85 (35%), Gaps = 10/85 (11%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
P + + ++L L NL LT++ NN+L K SL+ + N
Sbjct: 173 PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK----KLPDLPLSLESIVAGNNI 226
Query: 467 LTGPLPVELLEKQENNTLELRFDGN 491
L ++ L + D N
Sbjct: 227 LEELPELQNLPFLT----TIYADNN 247
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 15/88 (17%)
Query: 394 WEGLNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPV 447
+ L + PD+ P+IT L ++ + L L LD +N L+
Sbjct: 61 FSELQLNRLNLSSLPDNLPPQITVLEITQNALI----SLPELPASLEYLDACDNRLS--- 113
Query: 448 PKFLSQLSSLKFLNLARNKLTGPLPVEL 475
+SLK L++ N+LT LP
Sbjct: 114 -TLPELPASLKHLDVDNNQLTM-LPELP 139
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 11/84 (13%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTG 469
+N ++LT T L L + NN LT +P SL+ L+++ N L
Sbjct: 143 EYINADNNQLT----MLPELPTSLEVLSVRNNQLTF-LP---ELPESLEALDVSTNLLES 194
Query: 470 PLPVEL--LEKQENNTLELRFDGN 491
LP E + R N
Sbjct: 195 -LPAVPVRNHHSEETEIFFRCREN 217
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 13/81 (16%), Positives = 25/81 (30%), Gaps = 5/81 (6%)
Query: 410 TSLNLSASELTG---GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+L++S + L + N +T +P+ + L + L N
Sbjct: 183 EALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNP 241
Query: 467 LTGPLPVELLEKQENNTLELR 487
L+ E L +Q
Sbjct: 242 LS-SRIRESLSQQTAQPDYHG 261
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 16/67 (23%), Positives = 23/67 (34%), Gaps = 3/67 (4%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLE- 485
L L +L ++NN + L L L L N L ++ L +L
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS--LKSLTY 117
Query: 486 LRFDGNP 492
L NP
Sbjct: 118 LCILRNP 124
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 39/222 (17%), Positives = 78/222 (35%), Gaps = 36/222 (16%)
Query: 587 RVLGKGGFGTV---YHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHR------N 637
LG+G FG V +VA+K++ + + + + E+ +L ++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIR-NVGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ + + +M + +E + N E L +++ + +A + L +LH+
Sbjct: 84 CVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE- 141
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV------STTIAGTPGYLD 751
+ + H D+K NIL L + S T + S T
Sbjct: 142 NQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT-- 197
Query: 752 PEYYISNRL------------TEKSDVYSFGVVLLEIITGHP 781
++ R + DV+S G +L E G
Sbjct: 198 --TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 19/87 (21%), Positives = 36/87 (41%), Gaps = 6/87 (6%)
Query: 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ L+L + + + L L +S N + + +L +L+ L ++ NK
Sbjct: 70 ENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNK 126
Query: 467 LTGPLPVELLEKQENNTLE-LRFDGNP 492
+T ++ L + LE L GNP
Sbjct: 127 ITNWGEIDKL--AALDKLEDLLLAGNP 151
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 21/98 (21%), Positives = 35/98 (35%), Gaps = 8/98 (8%)
Query: 394 WEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQ 453
+E + L+ + L+ L L LS NN+ LS
Sbjct: 14 FEERKSVVATE--AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE--KISSLSG 68
Query: 454 LSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGN 491
+ +L+ L+L RN + +E L+ + EL N
Sbjct: 69 MENLRILSLGRNLIKK---IENLDAVADTLEELWISYN 103
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 26/84 (30%), Positives = 39/84 (46%), Gaps = 7/84 (8%)
Query: 429 NLTMLTSLDLSNNNLTG--PVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL-E 485
N+ L SL+LSNN L + + + +LK LNL+ N+L L+K + L E
Sbjct: 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS---ERELDKIKGLKLEE 224
Query: 486 LRFDGNPDLCRSASCKKEKKKFVV 509
L DGN LC + + +
Sbjct: 225 LWLDGNS-LCDTFRDQSTYISAIR 247
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 37/228 (16%), Positives = 79/228 (34%), Gaps = 48/228 (21%)
Query: 587 RVLGKGGFGTV---YHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
LG+G FG V K VAVK++ + + + ++E+++L ++ +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVK-NVDRYCEAARSEIQVLEHLNTTD------ 72
Query: 644 YCDEGTNMALIYEY------------MANGNLEEHLSDSSKEILNWEERLRIAVEAALGL 691
+ + E+ + + + + ++ + ++A + +
Sbjct: 73 -PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 692 EYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV------STTIAG 745
+LH K + H D+K NIL + + + + R + S T
Sbjct: 132 NFLHS-NK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 746 TPGYLDPEYYISNR--------L----TEKSDVYSFGVVLLEIITGHP 781
+S R L ++ DV+S G +L+E G
Sbjct: 189 EHHS----TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 18/60 (30%), Positives = 30/60 (50%), Gaps = 2/60 (3%)
Query: 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTG-PVPKFLSQLSSLKFLNLARNKLT 468
L+L +++L+ + LT L L L++N L P F +L +L+ L + NKL
Sbjct: 40 KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF-KELKNLETLWVTDNKLQ 98
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 892 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-71 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 3e-71
Identities = 77/273 (28%), Positives = 132/273 (48%), Gaps = 22/273 (8%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLV 642
+ +G G FGTVY GK + +VAVKML+ + + Q + F+ EV +L + H N+ +
Sbjct: 12 VGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
GY +A++ ++ +L HL + + + IA + A G++YLH I
Sbjct: 71 GYSTAP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY---ISNR 759
+HRD+KS NI ++E K+ DFGL+ V G+H ++G+ ++ PE N
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 760 LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819
+ +SDVY+FG+VL E++TG S + + + M+ +G + P L
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG----YLSPDLS-KV 234
Query: 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852
N + C+ + RP Q++ +
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 5e-68
Identities = 66/297 (22%), Positives = 123/297 (41%), Gaps = 26/297 (8%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
+ +GKG FG V+ GK +EVAVK+ S + +AE+ + + H N+ +
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 645 CDEG----TNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC-- 698
++ T + L+ +Y +G+L ++L+ + + E +++A+ A GL +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 699 ---KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT--HVSTTIAGTPGYLDPE 753
KP I HRD+KS NIL+ + +AD GL+ T GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 754 YYISN------RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHV----AQWVSSMLD 803
+ +++D+Y+ G+V EI + + + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 804 KGDIRSTVDPRLKGDFDINSVWKAV-EIAMACVSSNANRRPFMNQVVMELNDCLAME 859
K + P + + + + +I C +N R ++ L+ E
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-61
Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 22/271 (8%)
Query: 585 FERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
LG G FG V+ G + +VAVK L S F AE L+ ++ H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
+ + +I EYM NG+L + L S L + L +A + A G+ ++ + +
Sbjct: 76 VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEK 763
HRD+++ NIL+++ K+ADFGL+R+ + + PE T K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 764 SDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823
SDV+SFG++L EI+T + + ++ ++ + N
Sbjct: 191 SDVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 824 VWKAVEIAMACVSSNANRRPFMNQVVMELND 854
+ ++ C RP + + L D
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-61
Identities = 65/274 (23%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 584 NFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
F + +G G FG V+ G + D+VA+K + + + F E ++++++ H L L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
G C E + L++E+M +G L ++ + + + E L + ++ G+ YL + +
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYL---EEACV 122
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE 762
+HRD+ + N L+ E K++DFG++R + ST + PE + +R +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 763 KSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDIN 822
KSDV+SFGV++ E+ + + ++ N + V + +S+ PRL
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFR------LYKPRLAST---- 229
Query: 823 SVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856
+I C RP ++++ +L +
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 4e-61
Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 26/276 (9%)
Query: 585 FERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
+ +GKG FG V G ++VAVK + ++ + F AE ++ ++ H NL L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 68
Query: 645 C-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
+E + ++ EYMA G+L ++L + +L + L+ +++ +EYL V
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 125
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEK 763
HRD+ + N+L++E AK++DFGL++ T + PE + + K
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTK 180
Query: 764 SDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823
SDV+SFG++L EI + V V V K D P +
Sbjct: 181 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEKGY-KMDAPDGCPPAVY------- 230
Query: 824 VWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAME 859
E+ C +A RP Q+ +L E
Sbjct: 231 -----EVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-60
Identities = 64/292 (21%), Positives = 119/292 (40%), Gaps = 19/292 (6%)
Query: 582 TNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGY-KQFQAEVKLLLRVHHR 636
++FE LG G G V+ K +A K++ Q E+++L +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
+ G +++ E+M G+L++ L + + + + ++++ GL YL +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE 122
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
K I+HRDVK +NIL+N + + KL DFG+S ++ + GT Y+ PE
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 757 SNRLTEKSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815
+ +SD++S G+ L+E+ G +P+ A+ V + R R
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME-----LNDCLAMEAAQ 862
+ ++S + N + V +N CL A+
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (517), Expect = 8e-60
Identities = 73/294 (24%), Positives = 124/294 (42%), Gaps = 22/294 (7%)
Query: 565 SLDLSSRQFTYSEVLRMTNNFERVLGKGGFGTVYHGKLDND--EVAVKMLSPSSSQGYKQ 622
++D SS + E+ R + LG G +G VY G VAVK L + + ++
Sbjct: 1 AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EE 59
Query: 623 FQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLR 682
F E ++ + H NL L+G C +I E+M GNL ++L + +++ ++ L
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 683 IAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742
+A + + +EYL + +HRD+ + N L+ E K+ADFGLSR+
Sbjct: 120 MATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAG 175
Query: 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSML 802
+ PE N+ + KSDV++FGV+L EI T +
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM---------------SPYPGI 220
Query: 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856
D + ++ + + K E+ AC N + RP ++
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-59
Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 22/272 (8%)
Query: 584 NFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
F + LG G FG V +GK +VA+KM+ S +F E K+++ + H L L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
G C + + +I EYMANG L +L + ++ L + + +EYL
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 703 VHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTE 762
+HRD+ + N L+N++ K++DFGLSR + S + PE + ++ +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 763 KSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDIN 822
KSD+++FGV++ EI + + + + L+
Sbjct: 181 KSDIWAFGVLMWEIYSL---------------GKMPYERFTNSETAEHIAQGLRLYRPHL 225
Query: 823 SVWKAVEIAMACVSSNANRRPFMNQVVMELND 854
+ K I +C A+ RP ++ + D
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (515), Expect = 2e-59
Identities = 68/304 (22%), Positives = 126/304 (41%), Gaps = 39/304 (12%)
Query: 573 FTYSEVLRMTNNF-----------ERVLGKGGFGTVYHGKLDND-----EVAVKMLSPS- 615
FT+ + F E+V+G G FG V G L VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 616 SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEIL 675
+ + + F +E ++ + H N+ L G + T + +I E+M NG+L+ L + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 676 NWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735
+ + + A G++YL VHRD+ + NIL+N K++DFGLSR +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 736 GTHVSTT---IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHT 792
T+ + PE + T SDV+S+G+V+ E+++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS-------------- 228
Query: 793 HVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMEL 852
+ + D+ + ++ + ++ ++ + C + N RP Q+V L
Sbjct: 229 -YGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 853 NDCL 856
+ +
Sbjct: 288 DKMI 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 5e-59
Identities = 65/274 (23%), Positives = 113/274 (41%), Gaps = 31/274 (11%)
Query: 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTT 640
F+ +G+G F TVY G EVA L + ++F+ E ++L + H N+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 641 LVGYC----DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
+ L+ E M +G L+ +L +++ + + GL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 697 GCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
PPI+HRD+K NI I K+ D GL+ + + + GTP ++ PE
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEM- 184
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815
+ E DVY+FG+ +LE+ T S+ + + V+S + P +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVV 849
K EI C+ N + R + ++
Sbjct: 243 K------------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-59
Identities = 68/281 (24%), Positives = 115/281 (40%), Gaps = 22/281 (7%)
Query: 585 FERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVG 643
E LG+G FG V+ G VA+K L P + + F E +++ ++ H L L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 644 YCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIV 703
E + ++ EYM+ G+L + L + + L + + +A + A G+ Y+ + V
Sbjct: 80 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 135
Query: 704 HRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEK 763
HRD+++ NIL+ E K+ADFGL+R+ + + PE + R T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 764 SDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINS 823
SDV+SFG++L E+ T V N ++ V+ +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVN---------------REVLDQVERGYRMPCPPEC 239
Query: 824 VWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKK 864
++ C RP + L D Q +
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (508), Expect = 2e-58
Identities = 86/302 (28%), Positives = 122/302 (40%), Gaps = 50/302 (16%)
Query: 583 NNFE--RVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQGY-KQFQAEVKLLLR 632
NN E R +G+G FG V+ + VAVKML +S FQ E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 633 VHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEI------------------ 674
+ N+ L+G C G M L++EYMA G+L E L S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 675 ----LNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730
L+ E+L IA + A G+ YL + VHRD+ + N L+ E K+ADFGLSR
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 731 FPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENG 790
A ++ PE NR T +SDV+++GVVL EI + G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG----LQPYYG 245
Query: 791 HTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850
H + V + G+I + + N + + C S RP +
Sbjct: 246 MAH--EEVIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 851 EL 852
L
Sbjct: 295 IL 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 7e-58
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 30/278 (10%)
Query: 584 NFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRN 637
++E +G G +G K D + K L S + +EV LL + H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 638 LTTLVGYCDEGTN--MALIYEYMANGNLEEHLSDSSKE--ILNWEERLRIAVEAALGLEY 693
+ + TN + ++ EY G+L ++ +KE L+ E LR+ + L L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 694 LHQ--GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLD 751
H+ ++HRD+K N+ ++ K KL DFGL+R+ T + GTP Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMS 182
Query: 752 PEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811
PE EKSD++S G +L E+ P + + G IR
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELA-------GKIREGK 230
Query: 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVV 849
R+ + + EI ++ RP + +++
Sbjct: 231 FRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 8e-58
Identities = 67/281 (23%), Positives = 115/281 (40%), Gaps = 27/281 (9%)
Query: 584 NFERVLGKGGFGTVYHGKLDND------EVAVKMLSPSSSQGYK-QFQAEVKLLLRVHHR 636
++V+G G FG VY G L VA+K L ++ + F E ++ + H
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
N+ L G + M +I EYM NG + + + + + A G++YL
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG-GTHVSTTIAGTPGYLDPEYY 755
VHRD+ + NIL+N K++DFGLSRV + T+ ++ + PE
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815
+ T SDV+SFG+V+ E++T L ++ ++
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVMKAINDGF 230
Query: 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856
+ ++ ++ M C RRP +V L+ +
Sbjct: 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-57
Identities = 55/279 (19%), Positives = 109/279 (39%), Gaps = 30/279 (10%)
Query: 586 ERVLGKGGFGTVYHGKL----DNDEVAVKMLSPSSSQG-YKQFQAEVKLLLRVHHRNLTT 640
+ LG G FG+V G +VA+K+L + + ++ E +++ ++ + +
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
L+G C + + L+ E G L + L +E + + + ++G++YL +
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEE---K 128
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT-HVSTTIAGTPGYLDPEYYISNR 759
VHRD+ + N+L+ + AK++DFGLS+ + + + PE +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 760 LTEKSDVYSFGVVLLEIITG--HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817
+ +SDV+S+GV + E ++ P + Q + + P L
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRMECPPECPPELY- 242
Query: 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856
+ C RP V + C
Sbjct: 243 -----------ALMSDCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 7e-57
Identities = 74/324 (22%), Positives = 126/324 (38%), Gaps = 52/324 (16%)
Query: 564 ESLDLSSRQFTYS---EVLRMTNNFERVLGKGGFGTVYHGKLDND-------EVAVKMLS 613
E + R++ Y E R F +VLG G FG V + +VAVKML
Sbjct: 17 EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 76
Query: 614 PSSSQGY-KQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL---- 667
+ + +E+K++ ++ H N+ L+G C + LI+EY G+L +L
Sbjct: 77 EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 136
Query: 668 -----------------SDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKST 710
+ +L +E+ L A + A G+E+L VHRD+ +
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193
Query: 711 NILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFG 770
N+L+ K+ DFGL+R + V ++ PE T KSDV+S+G
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253
Query: 771 VVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVE 829
++L EI + G + + + K D + +
Sbjct: 254 ILLWEIFSLGVN---------------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYI 298
Query: 830 IAMACVSSNANRRPFMNQVVMELN 853
I +C + ++ +RP + L
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-56
Identities = 69/287 (24%), Positives = 125/287 (43%), Gaps = 28/287 (9%)
Query: 580 RMTNNFERVLGKGGFGTVYHGKLDNDE-----VAVKMLSPSSSQG-YKQFQAEVKLLLRV 633
+ +F V+G+G FG VYHG L +++ AVK L+ + G QF E ++
Sbjct: 26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 634 HHRNLTTLVGYC-DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLE 692
H N+ +L+G C + ++ YM +G+L + + + ++ + ++ A G+
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGM- 143
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG--THVSTTIAGTPGYL 750
VHRD+ + N +++EKF K+ADFGL+R + H T ++
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 751 DPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRST 810
E + + T KSDV+SFGV+L E++T + + +L R
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTR-----GAPPYPDVNTFDITVYLLQG---RRL 253
Query: 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857
+ P E+ + C A RP +++V ++ +
Sbjct: 254 LQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 2e-56
Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 42/298 (14%)
Query: 585 FERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQGYKQ-FQAEVKLLLRV-HH 635
F + LG G FG V VAVKML PS+ ++ +E+K+L + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHL----------------SDSSKEILNWEE 679
N+ L+G C G +I EY G+L L + + L+ E+
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 680 RLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739
L + + A G+ +L +HRD+ + NIL+ K+ DFGL+R + V
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVS 799
++ PE + T +SDV+S+G+ L E+ +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS--------------SPYP 249
Query: 800 SMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857
M + + ++ + +I C ++ +RP Q+V + ++
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-56
Identities = 70/270 (25%), Positives = 112/270 (41%), Gaps = 31/270 (11%)
Query: 585 FERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLT 639
R LGKG FG VY + +A+K+L + + Q + EV++ + H N+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
L GY + T + LI EY G + L SK + + E A L Y H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS--- 124
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
++HRD+K N+L+ + K+ADFG S P + TT+ GT YL PE
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRM 180
Query: 760 LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819
EK D++S GV+ E + G P +T+ + + V +
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFE-----ANTYQETYKRISRVEFTFPDFVTEGAR--- 232
Query: 820 DINSVWKAVEIAMACVSSNANRRPFMNQVV 849
++ + N ++RP + +V+
Sbjct: 233 ---------DLISRLLKHNPSQRPMLREVL 253
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 2e-55
Identities = 61/272 (22%), Positives = 113/272 (41%), Gaps = 25/272 (9%)
Query: 583 NNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGY-KQFQAEVKLLLRVHHRN 637
+++ + LG+G +G V ++ + VAVK++ + + + E+ + ++H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ G+ EG L EY + G L + + + + R + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG- 121
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
I HRD+K N+L++E+ K++DFGL+ VF + + GT Y+ PE
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 758 NRL-TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816
E DV+S G+VL ++ G + + Q S +K L
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPW-----DQPSDSCQEYSDWKEKK-------TYLN 227
Query: 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQV 848
I+S + + + N + R + +
Sbjct: 228 PWKKIDS--APLALLHKILVENPSARITIPDI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 7e-55
Identities = 75/307 (24%), Positives = 137/307 (44%), Gaps = 45/307 (14%)
Query: 584 NFERVLGKGGFGTVYHGKLDND----EVAVKMLSPSSS-QGYKQFQAEVKLLLRV-HHRN 637
F+ V+G+G FG V ++ D + A+K + +S ++ F E+++L ++ HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHL--------------SDSSKEILNWEERLRI 683
+ L+G C+ + L EY +GNL + L ++S+ L+ ++ L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 684 AVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTI 743
A + A G++YL + +HRD+ + NIL+ E + AK+ADFGLSR V T
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMG 186
Query: 744 AGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD 803
++ E + T SDV+S+GV+L EI++ +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---------------MT 231
Query: 804 KGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQK 863
++ + + + +N + ++ C RP Q+++ LN L ++
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML----EER 287
Query: 864 KESITTT 870
K + TT
Sbjct: 288 KTYVNTT 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-54
Identities = 65/286 (22%), Positives = 107/286 (37%), Gaps = 32/286 (11%)
Query: 575 YSEVLRMTN-----NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEV 627
Y V R N LG G FG VY K + A K++ S + + + E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 628 KLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEA 687
+L H N+ L+ N+ ++ E+ A G ++ + + + L + + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQT 119
Query: 688 ALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTP 747
L YLH I+HRD+K+ NIL KLADFG+S + GTP
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTP 174
Query: 748 GYLDPEYYISNRL-----TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSML 802
++ PE + K+DV+S G+ L+E+ P N + + S
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP--PHHELNPMRVLLKIAKSEP 232
Query: 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQV 848
S K + C+ N + R +Q+
Sbjct: 233 PTLAQPSRWSSNFK------------DFLKKCLEKNVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-54
Identities = 62/278 (22%), Positives = 122/278 (43%), Gaps = 32/278 (11%)
Query: 586 ERVLGKGGFGTVYHGKLDND----EVAVKMLSPSSSQGY--KQFQAEVKLLLRVHHRNLT 639
++ LG G FGTV G VAVK+L ++ + AE ++ ++ + +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
++G C+ + M L+ E G L ++L + + + + + + ++G++YL +
Sbjct: 72 RMIGICEAESWM-LVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEE--- 125
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-IAGTPGYLDPEYYISN 758
VHRD+ + N+L+ + AK++DFGLS+ + + + T + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 759 RLTEKSDVYSFGVVLLEIITG--HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816
+ + KSDV+SFGV++ E + P V++ML+KG+ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGE---------R 228
Query: 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854
+ ++ C + + RP V + L +
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 31/286 (10%)
Query: 585 FERVLGKGGFGTVYHGKLDNDE-----VAVKMLSPSSSQGYKQ-FQAEVKLLLRVHHRNL 638
R +G+G FG V+ G + E VA+K +S ++ F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
L+G E + +I E G L L L+ + A + + L YL
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE--- 125
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
VHRD+ + N+L++ KL DFGLSR + + ++ ++ PE
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 184
Query: 759 RLTEKSDVYSFGVVLLEIITG--HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816
R T SDV+ FGV + EI+ P + + ++ + P L
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMPPNCPPTLY 239
Query: 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQ 862
+ C + + +RRP ++ +L+ L E AQ
Sbjct: 240 ------------SLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-53
Identities = 69/310 (22%), Positives = 130/310 (41%), Gaps = 34/310 (10%)
Query: 584 NFERVLGKGGFGTVYHGKLDND------EVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHR 636
+VLG G FGTVY G + VA+K L ++S + K+ E ++ V +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
++ L+G C T LI + M G L ++ K+ + + L V+ A G+ YL
Sbjct: 72 HVCRLLGICLTSTVQ-LITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
+VHRD+ + N+L+ K+ DFGL+++ E + + ++ E +
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 757 SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816
T +SDV+S+GV + E++T + +I S ++ +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTF---------------GSKPYDGIPASEISSILEKGER 231
Query: 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC-------LAMEAAQKKESITT 869
I + C +A+ RP ++++E + L ++ ++ +
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSP 291
Query: 870 TDSNNSFEMI 879
TDSN ++
Sbjct: 292 TDSNFYRALM 301
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 1e-52
Identities = 67/272 (24%), Positives = 109/272 (40%), Gaps = 36/272 (13%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQG---YKQFQAEVKLLLRVHHRNLTTL 641
R +G G FG VY +++ VA+K +S S Q ++ EV+ L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
G L+ EY + K+ L E + A GL YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 702 IVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS---N 758
++HRDVK+ NIL++E KL DFG + + + + GTP ++ PE ++
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAMDEG 189
Query: 759 RLTEKSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817
+ K DV+S G+ +E+ P+ + +A + H+AQ S L G
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE-------- 241
Query: 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVV 849
+C+ RP ++
Sbjct: 242 --------YFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-52
Identities = 54/264 (20%), Positives = 107/264 (40%), Gaps = 24/264 (9%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGY 644
+G+G GTVY EVA++ ++ + E+ ++ + N+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVH 704
G + ++ EY+A G+L + ++++ + + + E LE+LH ++H
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 705 RDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKS 764
RD+KS NIL+ KL DFG E +T+ GTP ++ PE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197
Query: 765 DVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSV 824
D++S G++ +E+I G P EN + ++ + + +
Sbjct: 198 DIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFR-------- 247
Query: 825 WKAVEIAMACVSSNANRRPFMNQV 848
+ C+ + +R ++
Sbjct: 248 ----DFLNRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 65/282 (23%), Positives = 99/282 (35%), Gaps = 32/282 (11%)
Query: 585 FERVLGKGGFGTVYHGKLDND-----EVAVKMLSP---SSSQGYKQFQAEVKLLLRVHHR 636
LG G FG V G+ D VAVK L P S + F EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
NL L G M ++ E G+L + L R AV+ A G+ YL
Sbjct: 72 NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES 129
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT-IAGTPGYLDPEYY 755
+HRD+ + N+L+ + K+ DFGL R P +V + PE
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 756 ISNRLTEKSDVYSFGVVLLEIITG--HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813
+ + SD + FGV L E+ T P I + + + ++
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERLPRPEDCPQ 242
Query: 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855
+ + + C + RP + L +
Sbjct: 243 DIY------------NVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-51
Identities = 54/269 (20%), Positives = 100/269 (37%), Gaps = 27/269 (10%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLT 639
F ++LG+G F TV + E A+K+L E ++ R+ H
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
L + + Y NG L +++ + E LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH---G 126
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
I+HRD+K NIL+NE ++ DFG ++V E + + GT Y+ PE
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 760 LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819
+ SD+++ G ++ +++ G P + + + D P+ +
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFPKAR--- 238
Query: 820 DINSVWKAVEIAMACVSSNANRRPFMNQV 848
++ + +A +R ++
Sbjct: 239 ---------DLVEKLLVLDATKRLGCEEM 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 71/305 (23%), Positives = 124/305 (40%), Gaps = 36/305 (11%)
Query: 585 FERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQGYK-QFQAEVKLLLRVHHR 636
R LG+G FG VY G VA+K ++ ++S + +F E ++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHL--------SDSSKEILNWEERLRIAVEAA 688
++ L+G +G +I E M G+L+ +L ++ + + +++A E A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPG 748
G+ YL+ VHRD+ + N ++ E F K+ DFG++R
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 749 YLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR 808
++ PE T SDV+SFGVVL EI T + N + V + +G +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVMEGGLL 254
Query: 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQKKESIT 868
D N E+ C N RP +++ + + ME ++ S
Sbjct: 255 DKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFREVSFY 303
Query: 869 TTDSN 873
++ N
Sbjct: 304 YSEEN 308
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-50
Identities = 74/299 (24%), Positives = 131/299 (43%), Gaps = 43/299 (14%)
Query: 585 FERVLGKGGFGTVYHGKL---------DNDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRV- 633
+ LG+G FG V + +VAVKML +++ +E++++ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 634 HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHL--------------SDSSKEILNWEE 679
H+N+ L+G C + + +I EY + GNL E+L S + +E L+ ++
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 680 RLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739
+ A + A G+EYL +HRD+ + N+L+ E K+ADFGL+R
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVS 799
+T ++ PE T +SDV+SFGV+L EI T + +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EELF 247
Query: 800 SMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858
+L +G + D N + + C + ++RP Q+V +L+ +A+
Sbjct: 248 KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 72/296 (24%), Positives = 121/296 (40%), Gaps = 41/296 (13%)
Query: 585 FERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSSQG-YKQFQAEVKLLLR-VHH 635
+ LG+G FG V VAVKML ++ ++ +E+K+L+ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 636 RNLTTLVGYC-DEGTNMALIYEYMANGNLEEHL--------------SDSSKEILNWEER 680
N+ L+G C G + +I E+ GNL +L D K+ L E
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 681 LRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740
+ + + A G+E+L +HRD+ + NIL++EK K+ DFGL+R +
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSS 800
++ PE T +SDV+SFGV+L EI + + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKIDEEFCR 248
Query: 801 MLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856
L +G D + + + + C ++RP +++V L + L
Sbjct: 249 RLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (445), Expect = 4e-49
Identities = 52/272 (19%), Positives = 106/272 (38%), Gaps = 26/272 (9%)
Query: 583 NNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNL 638
++++ LG G FG V+ + + A K + + + E++ + + H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
L ++ M +IYE+M+ G L E ++D + ++ +E + + GL ++H+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN 144
Query: 699 KPPIVHRDVKSTNILINEKF--QAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
VH D+K NI+ K + KL DFGL+ GT + PE
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAE 198
Query: 757 SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816
+ +D++S GV+ +++G G + ++ + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFG-----GENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQV 848
D + + ++ N R ++Q
Sbjct: 254 ED--------GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 7e-47
Identities = 53/268 (19%), Positives = 105/268 (39%), Gaps = 21/268 (7%)
Query: 584 NFERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGY-KQFQAEVKLLLRVHHRNLTT 640
+F VLG G F V K VA+K ++ + +G + E+ +L ++ H N+
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 641 LVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKP 700
L + G ++ LI + ++ G L + + + K + R+ + ++YLH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 701 PIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
+ ++E + ++DFGLS+ +E V +T GTPGY+ PE
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPY 186
Query: 761 TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820
++ D +S GV+ ++ G+P + + + + S +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDSPYWDDISDS-- 239
Query: 821 INSVWKAVEIAMACVSSNANRRPFMNQV 848
A + + + +R Q
Sbjct: 240 ------AKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (428), Expect = 8e-47
Identities = 46/268 (17%), Positives = 98/268 (36%), Gaps = 24/268 (8%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
LG G FG V+ K K ++ + E+ ++ ++HH L L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
++ M LI E+++ G L + ++ + ++ E + +A GL+++H+ I
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHE---HSI 148
Query: 703 VHRDVKSTNILI--NEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
VH D+K NI+ + K+ DFGL+ + T + PE +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPV 205
Query: 761 TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820
+D+++ GV+ +++G G + + + + +
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPF-----AGEDDLETLQNVKRCDWEFDEDAFSSVSPE-- 258
Query: 821 INSVWKAVEIAMACVSSNANRRPFMNQV 848
A + + +R ++
Sbjct: 259 ------AKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 2e-46
Identities = 65/276 (23%), Positives = 116/276 (42%), Gaps = 30/276 (10%)
Query: 580 RMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQG---YKQFQAEVKLLLR 632
+++ +E +LG GG V+ + +VAVK+L ++ Y +F+ E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 633 VHHRNLTTLVGYC----DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAA 688
++H + + G ++ EY+ L + + + + + + +A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 121
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST-TIAGTP 747
L + HQ I+HRDVK NI+I+ K+ DFG++R G + T + GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 748 GYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDI 807
YL PE + + +SDVYS G VL E++TG P + G + V+ + +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-----GDSPVSVAYQHVREDPIP 233
Query: 808 RSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRP 843
S L D D + + ++ N R
Sbjct: 234 PSARHEGLSADLD--------AVVLKALAKNPENRY 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-45
Identities = 45/268 (16%), Positives = 99/268 (36%), Gaps = 25/268 (9%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
LG+G FG V+ K + + + E+ +L HRN+ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLH 67
Query: 643 GYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPI 702
+ + +I+E+++ ++ E ++ S+ E LN E + + L++LH I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 703 VHRDVKSTNILINEK--FQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL 760
H D++ NI+ + K+ +FG +R + P Y PE + + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 761 TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820
+ +D++S G ++ +++G T+ + M + + +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFL-----AETNQQIIENIMNAEYTFDEEAFKEISIE-- 233
Query: 821 INSVWKAVEIAMACVSSNANRRPFMNQV 848
A++ + R ++
Sbjct: 234 ------AMDFVDRLLVKERKSRMTASEA 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-44
Identities = 63/273 (23%), Positives = 107/273 (39%), Gaps = 30/273 (10%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRV-HHRNL 638
++LGKG FG V+ K N A+K L + E ++L H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 639 TTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
T + N+ + EY+ G+L H+ K + A E LGL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL---H 120
Query: 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISN 758
IV+RD+K NIL+++ K+ADFG+ + + T GTP Y+ PE +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQ 178
Query: 759 RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818
+ D +SFGV+L E++ G +G + S +D ++ K
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPF-----HGQDEEELFHSIRMDNPFYPRWLEKEAK-- 231
Query: 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851
++ + +R + + +
Sbjct: 232 ----------DLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (396), Expect = 2e-43
Identities = 60/282 (21%), Positives = 103/282 (36%), Gaps = 39/282 (13%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGY---------KQFQAEVKLLLRV 633
+ +LG+G V K E AVK++ + + + EV +L +V
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 634 H-HRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLE 692
H N+ L + T L+++ M G L ++L++ K L+ +E +I +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVIC 124
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
LH K IVHRD+K NIL+++ KL DFG S + GTP YL P
Sbjct: 125 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAP 178
Query: 753 EYYISNRL------TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD 806
E + ++ D++S GV++ ++ G P + M
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIMSGNYQ 233
Query: 807 IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQV 848
S ++ + +R +
Sbjct: 234 FGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (393), Expect = 7e-43
Identities = 43/285 (15%), Positives = 96/285 (33%), Gaps = 29/285 (10%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTL 641
R +G+G FG ++ G L+N +VA+K S Q + E + + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNV 66
Query: 642 VGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPP 701
+ EG + L+ + + G E L D + + A + ++ +H+
Sbjct: 67 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 702 IVHRDVKSTNILINEKF-----QAKLADFGLSRVFPVEGGT-----HVSTTIAGTPGYLD 751
+V+RD+K N LI + DFG+ + + ++GT Y+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 752 PEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811
++ + + D+ + G V + + G + + + +R
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856
+ + + + P + + + L
Sbjct: 242 A-------GFPEEFY--KYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 1e-42
Identities = 52/290 (17%), Positives = 102/290 (35%), Gaps = 27/290 (9%)
Query: 579 LRMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH 634
LR+ N + R +G G FG +Y G +EVA+K+ + Q E K+ +
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60
Query: 635 HRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
+ +C + ++ + +LE+ + S++ + + L +A + +EY+
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYI 119
Query: 695 HQGCKPPIVHRDVKSTNILINEK---FQAKLADFGLSRVFPVEGGT-----HVSTTIAGT 746
H +HRDVK N L+ + DFGL++ + + + GT
Sbjct: 120 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 747 PGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD 806
Y ++ + + D+ S G VL+ G A ++
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW-------QGLKAATKRQKYERIS 229
Query: 807 IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856
+ P S + C S + +P + + +
Sbjct: 230 EKKMSTPIEVLCKGYPS--EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (394), Expect = 1e-42
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 583 NNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQ---FQAEVKLLLRVHH 635
+F+ R LG G FG V+ + + A+K+L KQ E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
+ + G + + +I +Y+ G L L S + A E L LEYLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLH 121
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
I++RD+K NIL+++ K+ DFG ++ P V+ T+ GTP Y+ PE
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVV 173
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHP 781
+ + D +SFG+++ E++ G+
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-42
Identities = 57/293 (19%), Positives = 106/293 (36%), Gaps = 30/293 (10%)
Query: 580 RMTNNFE--RVLGKGGFGTVY---HGKLDNDEVAVKMLSPSSSQGYKQFQ-----AEVKL 629
R +E +G+G +G V+ K VA+K + + + A ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 630 LLRVHHRNLTTLVGYCDEGTNMALIYEYM----ANGNLEEHLSDSSKEILNWEERLRIAV 685
L H N+ L C + + +L +L + + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 686 EAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAG 745
+ GL++LH +VHRD+K NIL+ Q KLADFGL+R++ T++
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVV 177
Query: 746 TPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAEN----------GHTHVA 795
T Y PE + + D++S G + E+ P+ S++ G
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 796 QWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQV 848
W + + + F + ++ + C++ N +R
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 7e-42
Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 26/281 (9%)
Query: 587 RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQG-----YKQFQAEVKLLLRVHHRNLT 639
LG+G F TVY K N VA+K + + E+KLL + H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 640 TLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCK 699
L+ +N++L++++M + +L + GLEYLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 700 PPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNR 759
I+HRD+K N+L++E KLADFGL++ F + T T Y PE R
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGAR 176
Query: 760 L-TEKSDVYSFGVVLLEIITGHPVISKSAE----------NGHTHVAQWVSSMLDKGDIR 808
+ D+++ G +L E++ P + ++ G QW +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 809 STVDPRLKGDFDINSVWK-AVEIAMACVSSNANRRPFMNQV 848
P + ++ +++ N R Q
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-41
Identities = 60/294 (20%), Positives = 124/294 (42%), Gaps = 25/294 (8%)
Query: 577 EVLRMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGY-KQFQAEVKLLL 631
+V + + +G+G +G V ++ VA+K +SP Q Y ++ E+K+LL
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 632 RVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKE-ILNWEERLRIAVEAALG 690
R H N+ + T + Y+ + L K L+ + + G
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH-VSTTIAGTPGY 749
L+Y+H ++HRD+K +N+L+N K+ DFGL+RV + T T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 750 LDPEYYISNRL-TEKSDVYSFGVVLLEIITGHP---------VISKSAENGHTHVAQWVS 799
PE ++++ T+ D++S G +L E+++ P ++ + + ++
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 800 SMLDKGDIRSTVDPRLKGDFDINSVWK-----AVEIAMACVSSNANRRPFMNQV 848
+++ + K N ++ A+++ ++ N ++R + Q
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (387), Expect = 2e-41
Identities = 61/272 (22%), Positives = 106/272 (38%), Gaps = 34/272 (12%)
Query: 583 NNFE--RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS---SSQGYKQFQAEV---KLLLR 632
N+F R++G+GGFG VY + A+K L QG E L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 633 VHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLE 692
+ + ++ I + M G+L HLS + + + A E LGLE
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLE 121
Query: 693 YLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
++H +V+RD+K NIL++E +++D GL+ F GT GY+ P
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAP 174
Query: 753 EYYISNR-LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTV 811
E +D +S G +L +++ GH + + + +M ++ +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSF 232
Query: 812 DPRLKGDFDINSVWKAVEIAMACVSSNANRRP 843
P L+ + + + NRR
Sbjct: 233 SPELR------------SLLEGLLQRDVNRRL 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 584 NFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRN 637
NF+ +G+G +G VY KL + VA+K + + E+ LL ++H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ L+ + L++E++ + +L++ + S+ + + GL +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
++HRD+K N+LIN + KLADFGL+R F V T+ T T Y PE +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLG 176
Query: 758 NR-LTEKSDVYSFGVVLLEIITGHP 781
+ + D++S G + E++T
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-40
Identities = 54/273 (19%), Positives = 99/273 (36%), Gaps = 30/273 (10%)
Query: 586 ERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLV 642
+VLG G G V K ++ A+KML + + EV+L R ++ +V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 643 GYCD----EGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC 698
+ + ++ E + G L + D + E I ++YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 699 KPPIVHRDVKSTNILINEKFQ---AKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
I HRDVK N+L K KL DFG ++ T TP Y+ PE
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815
+ + D++S GV++ ++ G+P N ++ + + + G
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQV 848
+ + + + + +R + +
Sbjct: 243 EVSEE------VKMLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-40
Identities = 56/276 (20%), Positives = 98/276 (35%), Gaps = 43/276 (15%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGY------KQFQAEVKLL--LRVH 634
+LG GGFG+VY G DN VA+K + + + EV LL +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 635 HRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYL 694
+ L+ + + + LI E + + L E + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHC 126
Query: 695 HQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
++HRD+K NILI+ + + KL DFG + V T GT Y PE
Sbjct: 127 ---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 179
Query: 754 YYISNRL-TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812
+ +R + V+S G++L +++ G E + + R V
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIRGQVFFRQRVS 228
Query: 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQV 848
+ + C++ + RP ++
Sbjct: 229 SECQ------------HLIRWCLALRPSDRPTFEEI 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (365), Expect = 3e-39
Identities = 52/284 (18%), Positives = 108/284 (38%), Gaps = 25/284 (8%)
Query: 583 NNFE--RVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRN 637
+ +G+G +G VY + + A+K + E+ +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 638 LTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQG 697
+ L + L++E++ + D + L ++ G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHD- 118
Query: 698 CKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYIS 757
++HRD+K N+LIN + + K+ADFGL+R F + + T T Y P+ +
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMG 174
Query: 758 N-RLTEKSDVYSFGVVLLEIITGHPV------------ISKSAENGHTHVAQWVSSMLDK 804
+ + + D++S G + E++ G P+ I + ++ V+ +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 805 GDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQV 848
+ +P F +++ + + N+R Q
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 59/276 (21%), Positives = 101/276 (36%), Gaps = 33/276 (11%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQG------YKQFQAEVKLLLRVHHR 636
LG G F V K + A K + ++ + + EV +L + H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
N+ TL + T++ LI E +A G L + + KE L EE + G+ YLH
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLH- 130
Query: 697 GCKPPIVHRDVKSTNILINE----KFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDP 752
I H D+K NI++ + K + K+ DFGL+ + I GTP ++ P
Sbjct: 131 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAP 185
Query: 753 EYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812
E L ++D++S GV+ +++G G T + +
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPF-----LGDTKQETLANVSAVNYEFEDEYF 240
Query: 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQV 848
A + + + +R +
Sbjct: 241 SNTSAL--------AKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 64/241 (26%), Positives = 98/241 (40%), Gaps = 19/241 (7%)
Query: 583 NNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHH 635
N+F+ ++LGKG FG V K A+K+L + E ++L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
LT L + + EY G L HLS + + E E LEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH 122
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYY 755
+V+RD+K N+++++ K+ DFGL + +G T T GTP YL PE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVL 177
Query: 756 ISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815
N D + GVV+ E++ G H + ++++ T+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 816 K 816
K
Sbjct: 233 K 233
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-38
Identities = 53/266 (19%), Positives = 93/266 (34%), Gaps = 19/266 (7%)
Query: 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL 641
+V+G G FG VY KL + VA+K + + E++++ ++ H N+ L
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRL 78
Query: 642 VGYCDEG------TNMALIYEYMANGNLEEHLSDS-SKEILNWEERLRIAVEAALGLEYL 694
+ + L+ +Y+ S +K+ L + L Y+
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 695 HQGCKPPIVHRDVKSTNILINEK-FQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPE 753
H I HRD+K N+L++ KL DFG ++ G + I
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPEL 193
Query: 754 YYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813
+ + T DV+S G VL E++ G P+ + V + IR
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 814 RLKGDFDINSVWKAVEIAMACVSSNA 839
+ F ++ A
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEA 279
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-38
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 22/216 (10%)
Query: 583 NNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQG--YKQFQAEVKLLLRVHHR 636
+ +E +G+G FG V+ + +VA+K + + + E+K+L + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 637 NLTTLVGYCDEGT--------NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAA 688
N+ L+ C ++ L++++ + + K E R+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQML- 126
Query: 689 LGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS--TTIAGT 746
L L+ + I+HRD+K+ N+LI KLADFGL+R F + + + T T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 747 PGYLDPEYYISNRL-TEKSDVYSFGVVLLEIITGHP 781
Y PE + R D++ G ++ E+ T P
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 1e-37
Identities = 59/257 (22%), Positives = 107/257 (41%), Gaps = 22/257 (8%)
Query: 567 DLSSRQFTYSEVLRMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPS---SSQG 619
D + T S+ + F+ + LG G FG V K + A+K+L +
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ 84
Query: 620 YKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEE 679
+ E ++L V+ L L + +N+ ++ EY+A G + HL + +
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPH 142
Query: 680 RLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739
A + L EYLH +++RD+K N+LI+++ ++ DFG ++
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GR 194
Query: 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVS 799
+ T+ GTP L PE +S + D ++ GV++ E+ G+P + +
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-----FADQPIQIYEK 249
Query: 800 SMLDKGDIRSTVDPRLK 816
+ K S LK
Sbjct: 250 IVSGKVRFPSHFSSDLK 266
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 583 NNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHR 636
+E +G+G +GTV+ + ++ VA+K + E+ LL + H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 637 NLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ 696
N+ L + L++E+ + DS L+ E + GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 697 GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYI 756
++HRD+K N+LIN + KLA+FGL+R F + + + T Y P+
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLF 174
Query: 757 SNR-LTEKSDVYSFGVVLLEIITGHP 781
+ + D++S G + E+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 4e-34
Identities = 58/261 (22%), Positives = 112/261 (42%), Gaps = 33/261 (12%)
Query: 549 LSSGRKV--DANCNRSYESLDLSSRQFTYSEVLRMTNNFE--RVLGKGGFGTVYHG--KL 602
+ S +V D N +R E D S + ++++ R LG+G + V+
Sbjct: 3 VPSRARVYTDVNTHRPREYWDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINIT 58
Query: 603 DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTN--MALIYEYMA 659
+N++V VK+L P K+ + E+K+L + N+ TL + + AL++E++
Sbjct: 59 NNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115
Query: 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF- 718
N + ++ + L + E L+Y H I+HRDVK N++I+ +
Sbjct: 116 NTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 167
Query: 719 QAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLEII 777
+ +L D+GL+ + + + PE + ++ D++S G +L +I
Sbjct: 168 KLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224
Query: 778 TGHPVISKSAENGHTHVAQWV 798
+GH + Q V
Sbjct: 225 FRKEPFF----HGHDNYDQLV 241
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-33
Identities = 63/271 (23%), Positives = 102/271 (37%), Gaps = 26/271 (9%)
Query: 573 FTYSEVLRMTNNFE------RVLGKGGFGTVYHG--KLDNDEVAVKMLSPS--SSQGYKQ 622
F EV + + +G G +G V +VA+K L S K+
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 623 FQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDS--SKEILNWEER 680
E++LL + H N+ L+ + ++ E L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 681 LRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740
+ + GL Y+H HRD+K N+ +NE + K+ DFGL+R E
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----M 175
Query: 741 TTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVS 799
T T Y PE ++ R T+ D++S G ++ E+ITG + G H+ Q
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-----KGSDHLDQLKE 230
Query: 800 SMLDKGDIRSTVDPRLKGDFDINSVWKAVEI 830
M G + RL+ D N + E+
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 261
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-32
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 583 NNFE--RVLGKGGFGTVY-----HGKLDNDEVAVKMLSPSS----SQGYKQFQAEVKLLL 631
NFE +VLG G +G V+ G A+K+L ++ ++ + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 632 RV-HHRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALG 690
+ L TL T + LI +Y+ G L HLS + E E L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLA 141
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYL 750
LE+LH K I++RD+K NIL++ L DFGLS+ F +
Sbjct: 142 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 751 DPEYYISNR-LTEKSDVYSFGVVLLEIITGHP 781
+ + D +S GV++ E++TG
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 51/231 (22%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 563 YESLDLSSRQFTYSEVLRMTNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPS--S 616
+ S+++ FT + ++ + +G G G V + + VA+K LS +
Sbjct: 3 FYSVEVGDSTFT------VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 56
Query: 617 SQGYKQFQAEVKLLLRVHHRNLTTLVGYC------DEGTNMALIYEYMANGNLEEHLSDS 670
K+ E+ L+ V+H+N+ +L+ +E ++ L+ E M + +
Sbjct: 57 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 116
Query: 671 SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730
E + + G+++LH I+HRD+K +NI++ K+ DFGL+R
Sbjct: 117 D-----HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168
Query: 731 FPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHP 781
G + + T T Y PE + E D++S G ++ E++
Sbjct: 169 A---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-29
Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 23/212 (10%)
Query: 582 TNNFE--RVLGKGGFGTVYHG--KLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHH 635
++ +G G +G+V VAVK LS S K+ E++LL + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 636 RNLTTLVGYCDEGT-----NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALG 690
N+ L+ N + ++ +L + L + + + G
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRG 133
Query: 691 LEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYL 750
L+Y+H HRD+K +N+ +NE + K+ DFGL+R T T Y
Sbjct: 134 LKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYR 185
Query: 751 DPEYYISNR-LTEKSDVYSFGVVLLEIITGHP 781
PE ++ + D++S G ++ E++TG
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 4e-27
Identities = 47/237 (19%), Positives = 93/237 (39%), Gaps = 22/237 (9%)
Query: 585 FERVLGKGGFGTVYHG--KLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLV 642
R LG G F TV+ ++N VA+K++ + + E+KLL RV+ + T
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKED 75
Query: 643 GYC---------------DEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEA 687
G ++ +++E + L + I +I+ +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI-PLIYVKQISKQL 134
Query: 688 ALGLEYLHQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVFPVEGGTHVSTTIAGT 746
LGL+Y+H + I+H D+K N+L+ L ++ + T T
Sbjct: 135 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 747 PGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD 803
Y PE + +D++S ++ E+ITG + + +T ++ +++
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.3 bits (218), Expect = 2e-20
Identities = 28/154 (18%), Positives = 48/154 (31%), Gaps = 20/154 (12%)
Query: 587 RVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSS----------QGYKQFQAEVKLLLRVHH 635
+++G+G V++ E VK + G F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 636 RNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLH 695
R L L G + +Y + N L E + + E + + +
Sbjct: 66 RALQKLQGL-----AVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 696 QGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729
IVH D+ N+L++E + DF S
Sbjct: 121 H---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 25/94 (26%), Positives = 34/94 (36%), Gaps = 3/94 (3%)
Query: 381 NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSN 440
+ S + L+L + + G LT L L SL++S
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 441 NNLTGPVPKFLSQLSSLKFLNLARNK-LTG-PLP 472
NNL G +P+ L A NK L G PLP
Sbjct: 278 NNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 21/71 (29%), Positives = 30/71 (42%), Gaps = 3/71 (4%)
Query: 425 HYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL 484
+ L LDL NN + G +P+ L+QL L LN++ N L G +P
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ---GGNLQRFD 294
Query: 485 ELRFDGNPDLC 495
+ N LC
Sbjct: 295 VSAYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 12/112 (10%)
Query: 362 DEQDVDAIMNIKSFYG---LKKNWQ--GDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSA 416
+ QD A++ IK G +W D C + W G+ C D + R+ +L+LS
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCC---NRTWLGVLCD-TDTQTYRVNNLDLSG 59
Query: 417 SELTGGFA--HYLTNLTMLTSLDLSNN-NLTGPVPKFLSQLSSLKFLNLARN 465
L + L NL L L + NL GP+P +++L+ L +L +
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.5 bits (140), Expect = 2e-09
Identities = 17/109 (15%), Positives = 42/109 (38%), Gaps = 4/109 (3%)
Query: 370 MNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTN 429
+ + + L P + +T L L + ++ +++
Sbjct: 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSS 327
Query: 430 LTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEK 478
LT L L +NN ++ L+ L+++ +L+ N+++ P+ L +
Sbjct: 328 LTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTR 374
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.5 bits (122), Expect = 3e-07
Identities = 25/181 (13%), Positives = 57/181 (31%), Gaps = 14/181 (7%)
Query: 292 SRLFNITRNGNLWYGPLKLNYLSSTTVFSQSAMSGGQYNFSLIKTGNSTHPPIINAIEIY 351
S + + NL L N L + + L S P+ ++
Sbjct: 210 SDITPLGILTNLDELSLNGNQLKDIGTLASLTN---LTDLDLANNQISNLAPLSGLTKLT 266
Query: 352 EVKEFSQSQTDEQDVDAIMNIKSFYGLKKNWQGDPCAPQDYLWEGLNCSY-------PDD 404
E+K + ++ + + + + + + L + P
Sbjct: 267 ELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS 326
Query: 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLAR 464
++ L + ++++ L NLT + L +N ++ P L+ L+ + L L
Sbjct: 327 SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382
Query: 465 N 465
Sbjct: 383 Q 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.8 bits (115), Expect = 2e-06
Identities = 16/78 (20%), Positives = 31/78 (39%), Gaps = 4/78 (5%)
Query: 401 YPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFL 460
+ D L + +T T+L +T+L + + L++L +
Sbjct: 16 FTDTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQI 71
Query: 461 NLARNKLTGPLPVELLEK 478
N + N+LT P++ L K
Sbjct: 72 NFSNNQLTDITPLKNLTK 89
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 10/63 (15%)
Query: 402 PDDDSPRITSLNLSA---SELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLK 458
D ++T+L + G + L LT ++ SNN LT P L L+ L
Sbjct: 39 SQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLV 91
Query: 459 FLN 461
+
Sbjct: 92 DIL 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.3 bits (136), Expect = 5e-09
Identities = 20/87 (22%), Positives = 36/87 (41%), Gaps = 5/87 (5%)
Query: 406 SPRITSLNLSASELT-GGFAHYLTNLTMLTSLDLSNNNLTG----PVPKFLSQLSSLKFL 460
S I SL++ EL+ +A L L + L + LT + L +L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 461 NLARNKLTGPLPVELLEKQENNTLELR 487
NL N+L +L+ + + +++
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 17/85 (20%), Positives = 29/85 (34%), Gaps = 9/85 (10%)
Query: 407 PRITSLNLSASELTG----GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQ-----LSSL 457
+ L L+ +++ A L L LDLSNN L L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 458 KFLNLARNKLTGPLPVELLEKQENN 482
+ L L + + L +++
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 13/68 (19%), Positives = 27/68 (39%), Gaps = 4/68 (5%)
Query: 425 HYLTNLTMLTSLDLSNNNLTG----PVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQE 480
++L L L++ +++ + L SL+ L+L+ N L ++L+E
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 481 NNTLELRF 488
L
Sbjct: 423 QPGCLLEQ 430
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 12/65 (18%), Positives = 21/65 (32%), Gaps = 9/65 (13%)
Query: 407 PRITSLNLSASELTG----GFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQL-----SSL 457
+ + L LT + L L L+L +N L + Q +
Sbjct: 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 86
Query: 458 KFLNL 462
+ L+L
Sbjct: 87 QKLSL 91
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.9 bits (128), Expect = 3e-08
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 6/82 (7%)
Query: 394 WEGLNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPV 447
+ CS P D P L+L +++T NL L +L L NN ++
Sbjct: 12 LRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 448 PKFLSQLSSLKFLNLARNKLTG 469
P + L L+ L L++N+L
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKE 93
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 13/45 (28%), Positives = 17/45 (37%)
Query: 431 TMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVEL 475
LDL NN +T L +L L L NK++ P
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 19/104 (18%), Positives = 33/104 (31%), Gaps = 10/104 (9%)
Query: 381 NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSN 440
P D P + LN+S ++L L L S
Sbjct: 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI----ELPALPPRLERLIASF 313
Query: 441 NNLTGPVPKFLSQLSSLKFLNLARNKLTG--PLPVELLEKQENN 482
N+L + +LK L++ N L +P + + + N+
Sbjct: 314 NHLA----EVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 18/112 (16%), Positives = 31/112 (27%), Gaps = 10/112 (8%)
Query: 381 NWQGDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSN 440
N+ D L + + + L L++SN
Sbjct: 234 NYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSN 293
Query: 441 NNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNP 492
N L + + L+ L + N L +P N +L + NP
Sbjct: 294 NKLI----ELPALPPRLERLIASFNHLAE-VPELP-----QNLKQLHVEYNP 335
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 17/76 (22%), Positives = 29/76 (38%), Gaps = 4/76 (5%)
Query: 401 YPDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFL 460
+ DD NL +T A L + + +N+++ + L ++ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 461 NLARNKLTGPLPVELL 476
L NKLT P+ L
Sbjct: 74 FLNGNKLTDIKPLANL 89
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 13/36 (36%), Positives = 20/36 (55%), Gaps = 2/36 (5%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNL 462
L LT L +L LS N+++ + L+ L +L L L
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLEL 207
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 9e-05
Identities = 7/42 (16%), Positives = 12/42 (28%)
Query: 425 HYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
+ LD+S + L L L+ + K
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 11/36 (30%), Positives = 18/36 (50%), Gaps = 2/36 (5%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNL 462
L +L L + L NN ++ P L+ S+L + L
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 14/54 (25%), Positives = 27/54 (50%), Gaps = 2/54 (3%)
Query: 425 HYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEK 478
L NL+ LT+L +N ++ P L+ L +L ++L N+++ P+
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSN 218
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 4e-04
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 10/92 (10%)
Query: 393 LWEGL---NCSYPDDDSPRITS-----LNLSASELTGGFAHYLTNLTMLTSLDLSNNNLT 444
LW+ L + D + R+ S S + A + + + +DLSN+ +
Sbjct: 1 LWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIE 59
Query: 445 G-PVPKFLSQLSSLKFLNLARNKLTGPLPVEL 475
+ LSQ S L+ L+L +L+ P+ L
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTL 91
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 6e-04
Identities = 13/39 (33%), Positives = 14/39 (35%), Gaps = 1/39 (2%)
Query: 432 MLTSLDLSNNNLTG-PVPKFLSQLSSLKFLNLARNKLTG 469
L L L NN L + L L LNL N L
Sbjct: 66 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 14/72 (19%), Positives = 23/72 (31%), Gaps = 12/72 (16%)
Query: 429 NLTMLTSLDLSNNNLTGPVPKFL-----SQLSSLKFLNLARNKLT--GPLPVELLEKQEN 481
L +L L N + + L ++ L FL L N+ + + E+
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEI-----R 325
Query: 482 NTLELRFDGNPD 493
R G D
Sbjct: 326 EVFSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 7/61 (11%), Positives = 18/61 (29%), Gaps = 4/61 (6%)
Query: 411 SLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGP----VPKFLSQLSSLKFLNLARNK 466
L+ +E L + + LS N + + + ++ L+ +
Sbjct: 11 KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70
Query: 467 L 467
Sbjct: 71 T 71
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 9/58 (15%), Positives = 20/58 (34%), Gaps = 1/58 (1%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL 484
TN LDL + + + L ++ + N++ LL + + +
Sbjct: 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 70
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 12/34 (35%), Positives = 14/34 (41%)
Query: 433 LTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNK 466
T L LS N L L + L LNL R +
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 13/34 (38%), Positives = 22/34 (64%), Gaps = 2/34 (5%)
Query: 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFL 460
L NLT L LD+S+N ++ L++L++L+ L
Sbjct: 168 LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 892 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.85 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.34 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.18 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.06 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.01 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.94 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.82 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.81 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.74 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.7 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.68 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.67 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.65 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.44 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.42 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.28 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.21 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.19 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.18 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.16 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.1 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.98 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.94 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.86 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 97.79 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.67 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.51 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.44 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.27 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.18 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.13 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.08 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.78 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.13 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.06 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 94.2 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.59 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 89.11 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 84.55 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=364.97 Aligned_cols=267 Identities=25% Similarity=0.421 Sum_probs=213.3
Q ss_pred CCCHHHHHHHHHHH-----------HCEECCCCCEEEEEEEE--CCC---EEEEEECCCCC-CHHHHHHHHHHHHHHHCC
Q ss_conf 55778999986431-----------02003006499999998--892---79999916899-245687999999988416
Q 002688 572 QFTYSEVLRMTNNF-----------ERVLGKGGFGTVYHGKL--DND---EVAVKMLSPSS-SQGYKQFQAEVKLLLRVH 634 (892)
Q Consensus 572 ~~~~~el~~~t~~~-----------~~~IG~G~fG~Vy~a~~--~~~---~vaVK~l~~~~-~~~~~~f~~E~~~l~~l~ 634 (892)
.++++++.+++.+| .+.||+|+||.||+|.. +++ .||||.+.... ....++|.+|+.++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC
T ss_conf 88879899999604622080042785698027882999999957997889999999784459899999999999998579
Q ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEE
Q ss_conf 42101376476439818999995458860211013675547999999999999999999970899995356789763798
Q 002688 635 HRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILI 714 (892)
Q Consensus 635 H~nIv~l~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl 714 (892)
||||+++++++..++..++|||||++|+|.+++....+ .++|..+..++.|++.||+|||++ +++||||||+|||+
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEE
T ss_conf 98886189999628877999972279853002104567-999999999999999988988527---98357615044898
Q ss_pred CCCCCEEEEEECCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf 6899389953068632237999632---114568987448100023899940349999999999992-999998653589
Q 002688 715 NEKFQAKLADFGLSRVFPVEGGTHV---STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENG 790 (892)
Q Consensus 715 ~~~~~vkI~DfGla~~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~Ellt-G~~pf~~~~~~~ 790 (892)
+.++.+||+|||+++.+........ .....|++.|+|||.+.++.++.++|||||||++|||+| |++||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-- 239 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-- 239 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred CCCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--
T ss_conf 899919988844315756777765365025666883003878883699786121445357899998679999999999--
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 75299999967302987643489788999978899999999973324979999988999999997766
Q 002688 791 HTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 791 ~~~l~~~v~~~~~~~~~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~~ 858 (892)
.+........... ..+.++...+.+|+.+||+.+|++||||.||++.|+++++.
T Consensus 240 ----~~~~~~i~~~~~~----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 240 ----QDVINAIEQDYRL----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----HHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHHHHHCCCCC----------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf ----9999999737889----------99742269999999997587976892999999999998418
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.62 Aligned_cols=258 Identities=30% Similarity=0.517 Sum_probs=206.9
Q ss_pred HHHHCEECCCCCEEEEEEEECCCEEEEEECCCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECCC
Q ss_conf 431020030064999999988927999991689--924568799999998841642101376476439818999995458
Q 002688 583 NNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~~~~~vaVK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~~ 660 (892)
+.+.+.||+|+||.||+|++.+ .||||++... .....+.|.+|+.++.+++||||+++++++.+ ...++||||+++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEECCCC
T ss_conf 8998898307885899999999-89999997346998999999999999984799878645679715-589999965899
Q ss_pred CCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCC
Q ss_conf 86021101367554799999999999999999997089999535678976379868993899530686322379996321
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 88 g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 88 SSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCCCCC
T ss_conf 888999852357-899999999999999998887509---9951614789979818997887500221333556776312
Q ss_pred CCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 14568987448100023---899940349999999999992999998653589752999999673029876434897889
Q 002688 741 TTIAGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 741 ~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~ 817 (892)
....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... . ..+...+..+... |.+.
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-----~-~~~~~~~~~~~~~----p~~~- 232 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----R-DQIIFMVGRGYLS----PDLS- 232 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----H-HHHHHHHHHTSCC----CCGG-
T ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-----H-HHHHHHHHCCCCC----CCCH-
T ss_conf 566557431799999505689999531516359999999978899899896-----9-9999999658889----8600-
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 9997889999999997332497999998899999999776
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 818 ~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
.....+...+.+|+.+|++.+|++|||++++++.|+.+..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 0365554999999999758897689299999999999997
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=364.53 Aligned_cols=258 Identities=28% Similarity=0.403 Sum_probs=211.4
Q ss_pred HHHHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEE
Q ss_conf 98643102003006499999998--8927999991689924568799999998841642101376476439818999995
Q 002688 580 RMTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 580 ~~t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey 657 (892)
...+.+.+.||+|+||.||+|.+ ++..||||+++.... ..++|.+|+.+++.++||||+++++++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf 7993986598208880899999999996999999777610-399999999999867999882677527457854787631
Q ss_pred CCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 45886021101367554799999999999999999997089999535678976379868993899530686322379996
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++.......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TY 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SS
T ss_pred CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCCC-CC
T ss_conf 4676067775303554157999999999999978889878---9305760457689989992898324454653788-72
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 32114568987448100023899940349999999999992999998653589752999999673029876434897889
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~ 817 (892)
.......|+..|+|||++.++.++.++|||||||++|||++|+.|+.... ...+.. ..+..+. .+
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~~~~-~~i~~~~-----~~---- 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVY-ELLEKDY-----RM---- 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHH-HHHHTTC-----CC----
T ss_pred EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHH-HHHHCCC-----CC----
T ss_conf 21035566546669278727999810430217899999986799887742-----599999-9985588-----88----
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 9997889999999997332497999998899999999776
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 818 ~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
..+......+.+|+.+|++.+|++||||+++++.|+.+.+
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 8874330999999999757797689399999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.57 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=207.2
Q ss_pred HHHHCEECCCCCEEEEEEEE-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECCCC
Q ss_conf 43102003006499999998-89279999916899245687999999988416421013764764398189999954588
Q 002688 583 NNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANG 661 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~-~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~~g 661 (892)
+.+.+.||+|+||.||+|++ ++..||||++..... ..++|.+|+++++.++||||++++++|..++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred CEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECCCC
T ss_conf 588889820888299999988999999999878867-6899999999999668997565352431599337999836999
Q ss_pred CHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCCC
Q ss_conf 60211013675547999999999999999999970899995356789763798689938995306863223799963211
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++.... ..+++..+..++.|+|.||+|||+. +++||||||+|||++.++.+||+|||+++...... .....
T Consensus 86 ~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~ 160 (263)
T d1sm2a_ 86 CLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSST 160 (263)
T ss_dssp BHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC-CEEEC
T ss_conf 1899752013-4788999999999999987765316---43104431532666688776865532100236887-33504
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 45689874481000238999403499999999999929-99998653589752999999673029876434897889999
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG-HPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 742 ~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG-~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~~~~ 820 (892)
...|+..|+|||++.+..++.++|||||||++|||+|+ ++|+.... ..+.......... ...|
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~~~~---~~~p------- 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFR---LYKP------- 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHHTCC---CCCC-------
T ss_pred CEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCC------HHHHHHHHHHCCC---CCCC-------
T ss_conf 30017666785786079998403321059999999878988877899------9999999980688---8995-------
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 7889999999997332497999998899999999776
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 821 ~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
..+...+.+++.+|++.+|++||||+++++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 4367999999999765797689199999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.08 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=206.5
Q ss_pred HHHHHHCEECCCCCEEEEEEEE-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECC
Q ss_conf 8643102003006499999998-892799999168992456879999999884164210137647643981899999545
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 581 ~t~~~~~~IG~G~fG~Vy~a~~-~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~ 659 (892)
..+.+.+.||+|+||.||+|.+ ++..||||++..... ..++|.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEECC
T ss_conf 99388679810798289999999999999999864768-88999999999986799988578731045-97699999578
Q ss_pred CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCC
Q ss_conf 88602110136755479999999999999999999708999953567897637986899389953068632237999632
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++.......+++..++.|+.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.+... ....
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTA 166 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEEC
T ss_pred CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCC-CCCC
T ss_conf 98288887514789887889999999999999999748---9546756422515620244042341014773588-6442
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 11456898744810002389994034999999999999299999865358975299999967302987643489788999
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDF 819 (892)
Q Consensus 740 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~~~ 819 (892)
.....|+..|+|||++.++.++.++|||||||++|||+||..|+.... ...+.... +..+. .+..
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~-i~~~~-----~~~~---- 231 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQN-LERGY-----RMVR---- 231 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHH-HHTTC-----CCCC----
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH-HHHCC-----CCCC----
T ss_conf 035677444458289837999824564525799999996898888888-----99999999-97068-----8889----
Q ss_pred CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 97889999999997332497999998899999999776
Q 002688 820 DINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 820 ~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
+......+.+|+.+|++.+|++||||++|++.|++..+
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 65571999999999758897689399999998611321
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.54 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=209.4
Q ss_pred HHHHHHHHCEECCCCCEEEEEEEEC--C-----CEEEEEECCCCC-CHHHHHHHHHHHHHHHC-CCCCEEEEEEEEECCC
Q ss_conf 9986431020030064999999988--9-----279999916899-24568799999998841-6421013764764398
Q 002688 579 LRMTNNFERVLGKGGFGTVYHGKLD--N-----DEVAVKMLSPSS-SQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGT 649 (892)
Q Consensus 579 ~~~t~~~~~~IG~G~fG~Vy~a~~~--~-----~~vaVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~ 649 (892)
.+..+.+.+.||+|+||.||+|+.. + ..||+|.+.... ......+.+|+.++.++ +|||||++++++...+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 78993970198307881999999857885542049999996633587899999999999997158996868778886299
Q ss_pred CEEEEEEECCCCCHHHHCCCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 18999995458860211013675---------------------547999999999999999999970899995356789
Q 002688 650 NMALIYEYMANGNLEEHLSDSSK---------------------EILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVK 708 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk 708 (892)
..++||||+++|+|.++|+.... ..+++..++.++.|++.||+|||++ +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCC
T ss_conf 589999727999599999862577751022100001222001257789999999999999999999739---90505270
Q ss_pred CCCEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 7637986899389953068632237999632114568987448100023899940349999999999992-999998653
Q 002688 709 STNILINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSA 787 (892)
Q Consensus 709 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~Ellt-G~~pf~~~~ 787 (892)
|+|||++.++.+||+|||+|+...............|++.|+|||++.++.++.++|||||||++|||+| |++||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887279999633030003999999838999999989
Q ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 5897529999996730298764348978899997889999999997332497999998899999999
Q 002688 788 ENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELND 854 (892)
Q Consensus 788 ~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~ 854 (892)
.. ..+.. .+..+. .+ +.+......+.+|+.+|++.+|++|||++||+++|..
T Consensus 272 ~~--~~~~~----~~~~~~-----~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VD--ANFYK----LIQNGF-----KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CS--HHHHH----HHHTTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--HHHHH----HHHCCC-----CC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 89--99999----985699-----89----9887678999999999758896689399999999748
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.70 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=203.5
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECC
Q ss_conf 43102003006499999998--892799999168992-456879999999884164210137647643981899999545
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~ 659 (892)
+++.+.||+|+||.||+|+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECCC
T ss_conf 08998972174809999999999979999998456641279999999999985799888469654046743679886458
Q ss_pred CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCC
Q ss_conf 88602110136755479999999999999999999708999953567897637986899389953068632237999632
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~ 739 (892)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+........
T Consensus 87 gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 87 GGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp TEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCCCC
T ss_conf 980899975379--999999999999999999999975---983575468997887899879832314224046886531
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 114568987448100023899-9403499999999999929999986535897529999996730298764348978899
Q 002688 740 STTIAGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 740 ~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~~ 818 (892)
.....||+.|+|||++.+..+ +.++||||+||++|||++|++||....... ..+.. ........ .
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~----~~~~~~~~---------~ 227 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSD----WKEKKTYL---------N 227 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHH----HHTTCTTS---------T
T ss_pred CCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHH-HHHHH----HHCCCCCC---------C
T ss_conf 1132557474287286189999971016173799999982997888898599-99999----86388878---------8
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 99788999999999733249799999889999
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 819 ~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~ 850 (892)
........+.+|+.+|++.+|++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 64469999999999976799668909999961
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.10 Aligned_cols=247 Identities=22% Similarity=0.366 Sum_probs=204.5
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECCC
Q ss_conf 43102003006499999998--8927999991689924568799999998841642101376476439818999995458
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~~ 660 (892)
|.+.+.||+|+||.||+|.. ++..||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred CEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECCC
T ss_conf 38878981285829999999899989999998430172799999999999867999880585779889998999970379
Q ss_pred CCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCC
Q ss_conf 86021101367554799999999999999999997089999535678976379868993899530686322379996321
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.... ...
T Consensus 102 g~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~ 173 (293)
T d1yhwa1 102 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 173 (293)
T ss_dssp CBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCB
T ss_pred CCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC--CCC
T ss_conf 8089886415---999999999999999999999987---97226776888688789968642515641321366--644
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 14568987448100023899940349999999999992999998653589752999999673029876434897889999
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~~~~ 820 (892)
....||+.|+|||++.+..++.++||||+||++|||++|++||..... .+........+... + ..+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~~------~--~~~ 239 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTPE------L--QNP 239 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSCC------C--SSG
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHCCCCC------C--CCC
T ss_conf 444447773682664479988012031372999998048899899799------99999998579998------8--885
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 7889999999997332497999998899999
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 821 ~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
......+.+++.+|++.+|++|||+.|+++.
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5379999999999866996689099999649
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.13 Aligned_cols=257 Identities=27% Similarity=0.400 Sum_probs=206.3
Q ss_pred HHHHCEECCCCCEEEEEEEEC--C----CEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 431020030064999999988--9----2799999168992-45687999999988416421013764764398189999
Q 002688 583 NNFERVLGKGGFGTVYHGKLD--N----DEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~~--~----~~vaVK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~ 655 (892)
+...+.||+|+||.||+|.+. + ..||||++..... ...++|.+|+.+++.++||||+++++++.+....++|+
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEE
T ss_conf 68615981177909999999689987879999999884459689999999999998568987832367783388038999
Q ss_pred EECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 95458860211013675547999999999999999999970899995356789763798689938995306863223799
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~ 735 (892)
||+.+|++.+.+.... ..++|..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.+....
T Consensus 89 e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 89 EYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp ECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EECCCCCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCCC
T ss_conf 7213574022210234-5420899999999999854121212---34257656442788899849984551030035787
Q ss_pred C-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 9-632114568987448100023899940349999999999992999998653589752999999673029876434897
Q 002688 736 G-THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 736 ~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~ 814 (892)
. ........|+..|+|||++.++.++.++|||||||++|||+++..|+.... ...+.... +..+.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----~~~~~~~~-i~~~~-------- 230 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHEVMKA-INDGF-------- 230 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHH-HHTTC--------
T ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC-----CHHHHHHH-HHCCC--------
T ss_conf 65267426777734348888704999973556344898999996798865568-----99999999-86357--------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 88999978899999999973324979999988999999997766
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 815 l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~~ 858 (892)
....+..+...+.+|+.+||+.+|++||+|.+|++.|+.+++.
T Consensus 231 -~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 -RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -8998504579999999997767976893999999999998669
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.04 Aligned_cols=252 Identities=22% Similarity=0.404 Sum_probs=203.8
Q ss_pred HHC-EECCCCCEEEEEEEE----CCCEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEEC
Q ss_conf 102-003006499999998----89279999916899-245687999999988416421013764764398189999954
Q 002688 585 FER-VLGKGGFGTVYHGKL----DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 585 ~~~-~IG~G~fG~Vy~a~~----~~~~vaVK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~ 658 (892)
+.+ .||+|+||.||+|.+ ++..||||+++... ....++|.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEEEEC
T ss_conf 878487306080999999960897689999998820397899999999999986799888068656036-8079999807
Q ss_pred CCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC-
Q ss_conf 5886021101367554799999999999999999997089999535678976379868993899530686322379996-
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT- 737 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~- 737 (892)
++|+|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.+......
T Consensus 91 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 91 GGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp TTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCCCCC
T ss_conf 8996899752125-6999999999999999987899868---81057676466045468854203313421155434321
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 32114568987448100023899940349999999999992-99999865358975299999967302987643489788
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 738 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~Ellt-G~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~ 816 (892)
.......|++.|+|||++.++.++.++|||||||++|||+| |+.||..... ..+. ..+..+... .
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~----~~i~~~~~~-----~-- 232 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVM----AFIEQGKRM-----E-- 232 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHH----HHHHTTCCC-----C--
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH---HHHH----HHHHCCCCC-----C--
T ss_conf 1356211374335868872799995412322017899999389999999799---9999----999818999-----9--
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 99997889999999997332497999998899999999776
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 817 ~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
.+......+.+|+.+||+.+|++||+|.+|++.|+.+..
T Consensus 233 --~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 --CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp --CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf --997678999999999757797689099999999999999
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=340.97 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=206.1
Q ss_pred HHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECC
Q ss_conf 643102003006499999998--892799999168992456879999999884164210137647643981899999545
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~ 659 (892)
.|.+.+.||+|+||.||+|+. ++..||||++........+.+.+|+.+++.++||||+++++++.+++..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf 75898898407681999999889998999999845243169999999999986799799929999998999999998579
Q ss_pred CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC--CCCCEEEEEECCCCCCCCCCCC
Q ss_conf 88602110136755479999999999999999999708999953567897637986--8993899530686322379996
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN--EKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~--~~~~vkI~DfGla~~~~~~~~~ 737 (892)
+|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||++ .++.+||+|||+++.+...
T Consensus 107 gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--- 179 (350)
T d1koaa2 107 GGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 179 (350)
T ss_dssp SCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---
T ss_pred CCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC---
T ss_conf 9889999976237-899999999999999999999756---976000154673641688986999545210442565---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 32114568987448100023899940349999999999992999998653589752999999673029876434897889
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~ 817 (892)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.......... . .++
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-~--~~~---- 246 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDW-N--MDD---- 246 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-C--SCC----
T ss_pred CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHCCC-C--CCC----
T ss_conf 432000686242188997589987267655465999999859899899799------999999984788-9--894----
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9997889999999997332497999998899999
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 818 ~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
.........+.+|+.+|++.+|++|||++|++++
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2235899999999999756896679089998629
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.82 Aligned_cols=249 Identities=24% Similarity=0.432 Sum_probs=202.1
Q ss_pred CEECCCCCEEEEEEEE----CCCEEEEEECCCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECCC
Q ss_conf 2003006499999998----8927999991689--924568799999998841642101376476439818999995458
Q 002688 587 RVLGKGGFGTVYHGKL----DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 587 ~~IG~G~fG~Vy~a~~----~~~~vaVK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~~ 660 (892)
+.||+|+||.||+|.+ .++.||||+++.. .....++|.+|+.++++++||||++++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC-CC
Q ss_conf 86021101367554799999999999999999997089999535678976379868993899530686322379996-32
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT-HV 739 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~-~~ 739 (892)
|+|.+++..... +++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 92 g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf 968999752257--89999999999999997668747---9556777611310235675123413453313432344322
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 114568987448100023899940349999999999992-9999986535897529999996730298764348978899
Q 002688 740 STTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGD 818 (892)
Q Consensus 740 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~Ellt-G~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~~ 818 (892)
.....|++.|+|||.+.+..++.++|||||||++|||++ |++||..... .+ +...+..+... .
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------~~-~~~~i~~~~~~---------~ 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SE-VTAMLEKGERM---------G 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HH-HHHHHHTTCCC---------C
T ss_pred CCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH------HH-HHHHHHCCCCC---------C
T ss_conf 44567784203916653799984344303403132896589999999899------99-99999828999---------9
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 997889999999997332497999998899999999776
Q 002688 819 FDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 819 ~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
.+..+...+.+|+.+|++.+|++|||+++|++.|+....
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHH
T ss_conf 986567999999999758897689098999998528875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=339.01 Aligned_cols=250 Identities=18% Similarity=0.293 Sum_probs=205.7
Q ss_pred HHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECC
Q ss_conf 643102003006499999998--892799999168992456879999999884164210137647643981899999545
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~ 659 (892)
.|++.+.||+|+||.||+|.. ++..||||++........+.+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf 35998999317782999999989997999999887264679999999999986799798919999998999999998289
Q ss_pred CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC--CCCCEEEEEECCCCCCCCCCCC
Q ss_conf 88602110136755479999999999999999999708999953567897637986--8993899530686322379996
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN--EKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~--~~~~vkI~DfGla~~~~~~~~~ 737 (892)
+|+|.+.+.... ..+++.....++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 110 gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--- 182 (352)
T d1koba_ 110 GGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--- 182 (352)
T ss_dssp CCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---
T ss_pred CCHHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC---
T ss_conf 980888898638-9989999999999999999999977---926513144553113467884899525630343788---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 32114568987448100023899940349999999999992999998653589752999999673029876434897889
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~ 817 (892)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||..... .+....... .... ...
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~-~~~~------~~~ 249 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKR-CDWE------FDE 249 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHH-CCCC------CCS
T ss_pred CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHH-CCCC------CCC
T ss_conf 720100476453489997479989763338989999999968899899799------999999984-7889------893
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9997889999999997332497999998899999
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 818 ~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
.........+.+|+.+|++.+|++|||+.|+++.
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 0024799999999999756996689189999609
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.29 Aligned_cols=242 Identities=29% Similarity=0.425 Sum_probs=201.2
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEE
Q ss_conf 43102003006499999998--89279999916899---24568799999998841642101376476439818999995
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey 657 (892)
+.+.+.||+|+||.||+|+. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEE
T ss_conf 69988985177858999999899949999998168856768999999999999856888888599999989998999850
Q ss_pred CCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 45886021101367554799999999999999999997089999535678976379868993899530686322379996
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++..... +++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 88 APLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred CCCCCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCCC---
T ss_conf 479858988750489--99999999999999999999988---9465220234414668998711555633544888---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 32114568987448100023899940349999999999992999998653589752999999673029876434897889
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~ 817 (892)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...... .... .+
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~-~~~~------~~-- 223 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRIS-RVEF------TF-- 223 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHH-TTCC------CC--
T ss_pred -CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC------HHHHHHHHH-CCCC------CC--
T ss_conf -5235578876349999758998931440467599999832999988899------999999997-1899------99--
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999788999999999733249799999889999
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 818 ~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~ 850 (892)
+......+.+++.+|++.+|++|||++|+++
T Consensus 224 --p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 --PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --8668999999999976479768909999971
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.70 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=207.1
Q ss_pred HHHHHCEECCCCCEEEEEEEE-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECCC
Q ss_conf 643102003006499999998-8927999991689924568799999998841642101376476439818999995458
Q 002688 582 TNNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~-~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~~ 660 (892)
.+++.+.||+|+||.||+|++ ++..||||++..... ..+.|.+|+.++++++|+||+++++++.+ +..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEECCC
T ss_conf 9798469930798099999999999999999880448-88999999999986666788689999823-975999994479
Q ss_pred CCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCC
Q ss_conf 86021101367554799999999999999999997089999535678976379868993899530686322379996321
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~ 740 (892)
|+|..++.......++|..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.+.... ....
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~ 171 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTAR 171 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC-CEEE
T ss_conf 9435420000355305999999999999999987541---14335312307999899929984425554256887-3352
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 14568987448100023899940349999999999992999998653589752999999673029876434897889999
Q 002688 741 TTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 741 ~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~~~~ 820 (892)
....|+..|+|||++..+.++.++||||||+++|||++|+.|+.... ...+....+.. +.. + ...
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~~i~~-~~~-----~----~~~ 236 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVER-GYR-----M----PCP 236 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHT-TCC-----C----CCC
T ss_pred CCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHH-CCC-----C----CCC
T ss_conf 45455665458089837998917741323589999986899999888-----89999999982-689-----9----998
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 7889999999997332497999998899999999776
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 821 ~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
......+.+++.+|++.+|++||+|++|+++|++...
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 3237999999999756697589199999998766623
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.73 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=206.9
Q ss_pred HHHCEECCCCCEEEEEEEE-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECCCCC
Q ss_conf 3102003006499999998-892799999168992456879999999884164210137647643981899999545886
Q 002688 584 NFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMANGN 662 (892)
Q Consensus 584 ~~~~~IG~G~fG~Vy~a~~-~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~~gs 662 (892)
.+.+.||+|+||.||+|++ ++..||||.++.... ..++|.+|+.++++++||||++++|++.++...++||||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCCCCC
T ss_conf 99689820788399999988998999999874757-78999999999996689860158899850781699997048993
Q ss_pred HHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 02110136755479999999999999999999708999953567897637986899389953068632237999632114
Q 002688 663 LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVSTT 742 (892)
Q Consensus 663 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~ 742 (892)
|.+++..... .+++..+.+++.|+++||+|||+. +++||||||+|||++.++.+||+|||+++.+.... ......
T Consensus 86 l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 160 (258)
T d1k2pa_ 86 LLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVG 160 (258)
T ss_dssp HHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCCC
T ss_pred HHHHHHCCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC-CEEECC
T ss_conf 8886410246-776899999999999999987546---84346654135887699847988614420235787-225246
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCH
Q ss_conf 568987448100023899940349999999999992-9999986535897529999996730298764348978899997
Q 002688 743 IAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFDI 821 (892)
Q Consensus 743 ~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~Ellt-G~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~~~~~ 821 (892)
..|+..|+|||.+.+..++.++||||||+++|||+| |+.||..... .+.. ..+..+.. ...| .
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------~~~~-~~i~~~~~--~~~p-------~ 224 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETA-EHIAQGLR--LYRP-------H 224 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHH-HHHHTTCC--CCCC-------T
T ss_pred CCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH------HHHH-HHHHHCCC--CCCC-------C
T ss_conf 57887757807863799885210336432467397559999889999------9999-99980797--8996-------5
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 8899999999973324979999988999999997
Q 002688 822 NSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 822 ~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~ 855 (892)
.....+.+++.+||+.+|++|||++++++.|.++
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 4659999999997668976893999999874188
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.79 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=203.4
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECCC
Q ss_conf 43102003006499999998--8927999991689924568799999998841642101376476439818999995458
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~~ 660 (892)
|++.+.||+|+||.||+|.. ++..||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCC
T ss_conf 59847993077819999999999939999998728999999999999999867999988498898009958999962799
Q ss_pred CCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCC
Q ss_conf 86021101367554799999999999999999997089999535678976379868993899530686322379996321
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVS 740 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~ 740 (892)
|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 94 g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~ 167 (288)
T d2jfla1 94 GAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 167 (288)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHH
T ss_pred CCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC--CCCC
T ss_conf 81889998628-9999999999999999999999988---9887140700314878999899716123035778--6410
Q ss_pred CCCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 1456898744810002-----38999403499999999999929999986535897529999996730298764348978
Q 002688 741 TTIAGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRL 815 (892)
Q Consensus 741 ~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l 815 (892)
....|++.|+|||++. ...++.++||||+||++|||++|+.||...... .. ........ .. .+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~---~~~i~~~~-~~-----~~ 235 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RV---LLKIAKSE-PP-----TL 235 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GH---HHHHHHSC-CC-----CC
T ss_pred CCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHCCC-CC-----CC
T ss_conf 010256264799998320257888880665787899999982088999998999---99---99997079-98-----77
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 899997889999999997332497999998899999
Q 002688 816 KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 816 ~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
..+......+.+|+.+|++.+|++|||++|+++.
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --7656699999999999766996689199999629
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.37 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=206.6
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCC----EEEEEECCCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 43102003006499999998--892----7999991689-9245687999999988416421013764764398189999
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DND----EVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~----~vaVK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~ 655 (892)
+++.+.||+|+||.||+|.+ +++ .||+|++... .....++|.+|+.++++++||||++++++|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEEEE
T ss_conf 9783198208992999999958998898999999965134979999999999999867998881589999619-836999
Q ss_pred EECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 95458860211013675547999999999999999999970899995356789763798689938995306863223799
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~ 735 (892)
|++.+|+|.+.+.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 90 e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp ECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EECCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEECCCCC
T ss_conf 8426874010111334-5799999999999999999999876---95047621203116799875860255222335444
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 9632114568987448100023899940349999999999992-999998653589752999999673029876434897
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 736 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~Ellt-G~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~ 814 (892)
.........|+..|+|||++.++.++.++|||||||++|||+| |++||...... .+...+ ..+...
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i----~~~~~~------ 232 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSIL----EKGERL------ 232 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHH----HHTCCC------
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HCCCCC------
T ss_conf 5322365105864467088746999835654407999999997799999999989---999999----759989------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 8899997889999999997332497999998899999999776
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 815 l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
..+..+...+.+|+.+|++.+|++|||+.++++.|+.+..
T Consensus 233 ---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---9985568999999998478993469199999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.94 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=202.8
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECC
Q ss_conf 43102003006499999998--89279999916899-2456879999999884164210137647643981899999545
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~ 659 (892)
+.+.+.||+|+||.||+|.. ++..||+|+++... ....+++.+|+.+++.++||||+++++++.+..+.++||||++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf 88978971277809999999899969999998754097899999999999986799999949999998999999997679
Q ss_pred CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 8860211013675547999999999999999999970-899995356789763798689938995306863223799963
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~ 738 (892)
+|+|.+++..... +++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---- 158 (322)
T d1s9ja_ 88 GGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 158 (322)
T ss_dssp TEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred CCCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC----
T ss_conf 9868998742499--999999999999999999999859---9971445779946878998999548776256788----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHH-----------CCC-
Q ss_conf 21145689874481000238999403499999999999929999986535897529999996730-----------298-
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD-----------KGD- 806 (892)
Q Consensus 739 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~-----------~~~- 806 (892)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......... ..+...... ...
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE--LMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHH--HHC---------------------
T ss_pred CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 621113771411946875899894888998999999999888998998878999--999887517754577421233322
Q ss_pred -CCCCC-------------------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHH
Q ss_conf -76434-------------------8978899997889999999997332497999998899999--999
Q 002688 807 -IRSTV-------------------DPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME--LND 854 (892)
Q Consensus 807 -~~~~i-------------------Dp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~--L~~ 854 (892)
..... .+.+. .......+.+++.+|++.+|++|||++|++++ +++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 111122235413477887665026876676---4448999999999986899467908999960986476
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.16 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=205.2
Q ss_pred HHHHCEECCCCCEEEEEEEE-C-C---CEEEEEECCCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCCEEEEE
Q ss_conf 43102003006499999998-8-9---27999991689-92456879999999884164210137647643-98189999
Q 002688 583 NNFERVLGKGGFGTVYHGKL-D-N---DEVAVKMLSPS-SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE-GTNMALIY 655 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~-~-~---~~vaVK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~LV~ 655 (892)
.+|.++||+|+||+||+|.+ + + ..||||++... .....++|.+|++++++++||||++++|++.. +...++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 52666981368809999999779987999999998843697899999999999986789998678678980699438999
Q ss_pred EECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 95458860211013675547999999999999999999970899995356789763798689938995306863223799
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~ 735 (892)
|||++|+|.+++..... .+++..++.++.|++.||.|+|+. +++||||||+|||+++++.+||+|||+++......
T Consensus 109 E~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp ECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEECCCHHHHHCCCCC-CCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 87406741442101345-404899999999988765200336---76257766875767799988991065232255665
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 96--3211456898744810002389994034999999999999299999865358975299999967302987643489
Q 002688 736 GT--HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 736 ~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp 813 (892)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... . ++........+. ..|
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~---~~~~~i~~g~~~---~~p 256 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--F---DITVYLLQGRRL---LQP 256 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCCC---CCC
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH--H---HHHHHHHCCCCC---CCC
T ss_conf 55310025655564556768874379997457466199999999789999888999--9---999999808988---996
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 78899997889999999997332497999998899999999776
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
..+...+.+|+.+||+.+|++||+|.||++.|+.+++
T Consensus 257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -------4475999999999768897689399999999999997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.14 Aligned_cols=245 Identities=27% Similarity=0.458 Sum_probs=194.5
Q ss_pred HHHCEECCCCCEEEEEEEE--CCCEEEEEECCCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC----CCCEEEEE
Q ss_conf 3102003006499999998--8927999991689--92456879999999884164210137647643----98189999
Q 002688 584 NFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPS--SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE----GTNMALIY 655 (892)
Q Consensus 584 ~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~LV~ 655 (892)
+|.+.||+|+||.||+|.. ++..||+|.+... .....+.+.+|+++++.++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC-CCCCEEEEEECCCCCCCCC
Q ss_conf 954588602110136755479999999999999999999708999953567897637986-8993899530686322379
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN-EKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~-~~~~vkI~DfGla~~~~~~ 734 (892)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +++|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred ECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC-
T ss_conf 5789894899975135--546999999999999999999978-997996876743511667999889800576542368-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99632114568987448100023899940349999999999992999998653589752999999673029876434897
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 735 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~ 814 (892)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ...+.... +..+.....++
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~~~~~~~-i~~~~~~~~~~-- 235 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRR-VTSGVKPASFD-- 235 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHH-HTTTCCCGGGG--
T ss_pred ---CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH-HHCCCCCCCCC--
T ss_conf ---76677553813008988478-99986711007999999987889998765-----59999999-97389986567--
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 889999788999999999733249799999889999
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 815 l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~ 850 (892)
......+.+|+.+|++.+|++|||++|+++
T Consensus 236 ------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 ------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ------557899999999976379758929999967
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=341.04 Aligned_cols=255 Identities=32% Similarity=0.452 Sum_probs=209.2
Q ss_pred HHHHCEECCCCCEEEEEEEEC-------CCEEEEEECCCCCCH-HHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEE
Q ss_conf 431020030064999999988-------927999991689924-568799999998841642101376476439818999
Q 002688 583 NNFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSSSQ-GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~~-------~~~vaVK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV 654 (892)
+++.+.||+|+||.||+|+.. +..||||++...... ..++|.+|+++++.++|+|++++++++......+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCCEEEE
T ss_conf 38867982078839999998887657788299999988210857999999999999966899765524666059803899
Q ss_pred EEECCCCCHHHHCCCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCE
Q ss_conf 99545886021101367----------------------55479999999999999999999708999953567897637
Q 002688 655 YEYMANGNLEEHLSDSS----------------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNI 712 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NI 712 (892)
+||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEECCCCE
T ss_conf 98158992999998527554210000111001210346788989999999999999985541357---868548840116
Q ss_pred EECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCCCCC
Q ss_conf 98689938995306863223799963211456898744810002389994034999999999999299-99986535897
Q 002688 713 LINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGH-PVISKSAENGH 791 (892)
Q Consensus 713 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~-~pf~~~~~~~~ 791 (892)
|++.++.+||+|||+++.+.............|+..|+|||.+.+..++.++|||||||++|||++|. +||.....
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~--- 248 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--- 248 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---
T ss_pred EECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCH---
T ss_conf 89899928983314421136776411157777676767989972688980563025236299998068999999899---
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 52999999673029876434897889999788999999999733249799999889999999977
Q 002688 792 THVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCL 856 (892)
Q Consensus 792 ~~l~~~v~~~~~~~~~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~ 856 (892)
.+.... +..+.... . +...+..+.+|+.+||+.+|++||||.||+++|+++.
T Consensus 249 ---~e~~~~-v~~~~~~~-----~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 ---EEVIYY-VRDGNILA-----C----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ---HHHHHH-HHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---HHHHHH-HHCCCCCC-----C----CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf ---999999-97399788-----8----7325299999999974889657939999999999842
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=337.90 Aligned_cols=250 Identities=23% Similarity=0.390 Sum_probs=203.1
Q ss_pred HHHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEE
Q ss_conf 8643102003006499999998--892799999168992-4568799999998841642101376476439818999995
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 581 ~t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey 657 (892)
..|++.+.||+|+||.||+|.. ++..||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 66699889940658399999999999899999981577312899999999999867998999198999989988898852
Q ss_pred CCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC---CCCCEEEEEECCCCCCCCC
Q ss_conf 4588602110136755479999999999999999999708999953567897637986---8993899530686322379
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN---EKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~---~~~~vkI~DfGla~~~~~~ 734 (892)
+++|+|.+++.... .+++.....++.|++.||+|||+. +++||||||+|||+. +++.+||+|||+++.....
T Consensus 89 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 89 VSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC
T ss_conf 68984888653036--788789999999999998752413---0556870463001104688824998315435872589
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99632114568987448100023899940349999999999992999998653589752999999673029876434897
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPR 814 (892)
Q Consensus 735 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~ 814 (892)
.......||+.|+|||++.+..++.++||||+||++|||++|++||..... .+....... ....
T Consensus 164 ---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~-~~~~------ 227 (307)
T d1a06a_ 164 ---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQILK-AEYE------ 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHT-TCCC------
T ss_pred ---CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHC-CCCC------
T ss_conf ---704400328422591887379998078734515999999859799999899------999999861-6877------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 8899997889999999997332497999998899999
Q 002688 815 LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 815 l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
............+.+|+.+|++.+|++|||++|+++.
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 7876666789999999999760897579189998629
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.73 Aligned_cols=271 Identities=24% Similarity=0.370 Sum_probs=206.2
Q ss_pred HHHHHCEECCCCCEEEEEEEECCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----CEEEEEEE
Q ss_conf 64310200300649999999889279999916899245687999999988416421013764764398----18999995
Q 002688 582 TNNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT----NMALIYEY 657 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~LV~Ey 657 (892)
++-+.+.||+|+||.||+|++++..||||++...... ...++.|+..+..++||||++++++|...+ .+++||||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEEC
T ss_conf 8999889820788199999999989999998720046-799999999996279986832688998379860489999964
Q ss_pred CCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 45886021101367554799999999999999999997089-----9995356789763798689938995306863223
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGC-----KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~ 732 (892)
|++|+|.++++.. .++|..++.++.++|.||+|+|+.. .++|+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 83 HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCC
T ss_conf 6698989998658---9998999999999999999988766520468986615317313578688776887638662346
Q ss_pred CCCCCC--CCCCCCCCCCCCCCCCCCCCC------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC---------CCCHH
Q ss_conf 799963--211456898744810002389------9940349999999999992999998653589---------75299
Q 002688 733 VEGGTH--VSTTIAGTPGYLDPEYYISNR------LTEKSDVYSFGVVLLEIITGHPVISKSAENG---------HTHVA 795 (892)
Q Consensus 733 ~~~~~~--~~~~~~gt~~y~APE~~~~~~------~s~ksDVwSlGvil~ElltG~~pf~~~~~~~---------~~~l~ 795 (892)
...... ......|++.|+|||++.+.. ++.++|||||||++|||+||.+|+....... ....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~- 238 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV- 238 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-
T ss_pred CCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCHH-
T ss_conf 7776200135525035476782210565454677767501220159999999628998876631124101225564309-
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 999967302987643489788999-978899999999973324979999988999999997766631
Q 002688 796 QWVSSMLDKGDIRSTVDPRLKGDF-DINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAA 861 (892)
Q Consensus 796 ~~v~~~~~~~~~~~~iDp~l~~~~-~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~~~~~ 861 (892)
+........+. .+|.+.... ..+....+.+|+.+||+.+|++|||+.||++.|+++.+.+..
T Consensus 239 ~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 239 EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHCCC----CCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCC
T ss_conf 99999875024----6888776557768999999999997606985895999999999988886599
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.94 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=204.5
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEE
Q ss_conf 43102003006499999998--89279999916899---24568799999998841642101376476439818999995
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey 657 (892)
+.+.+.||+|+||.||+|+. ++..||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEC
T ss_conf 78988985087909999999899979999998657755777899999999999876888861799999989988999970
Q ss_pred CCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 45886021101367554799999999999999999997089999535678976379868993899530686322379996
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+......
T Consensus 90 ~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 90 AKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCCCHHHHHHCCCC--CCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCC
T ss_conf 489877776531599--99999999999999999762165---0884767741236688853886032102422567764
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 32114568987448100023899940349999999999992999998653589752999999673029876434897889
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~ 817 (892)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+...... .... .+.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~-~~~~------~~p- 230 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKII-KLEY------DFP- 230 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-TTCC------CCC-
T ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-CCCC------CCC-
T ss_conf 333555677552584400268989666230456999998038899899599------99999997-1899------998-
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9997889999999997332497999998899999
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 818 ~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
......+.+|+.+|++.+|++|||++|++..
T Consensus 231 ---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 231 ---EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf ---5479999999999855797689197897377
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.33 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=207.3
Q ss_pred HHHHHHHCEECCCCCEEEEEEEE-------CCCEEEEEECCCCCC-HHHHHHHHHHHHHHHC-CCCCEEEEEEEEECC-C
Q ss_conf 98643102003006499999998-------892799999168992-4568799999998841-642101376476439-8
Q 002688 580 RMTNNFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG-T 649 (892)
Q Consensus 580 ~~t~~~~~~IG~G~fG~Vy~a~~-------~~~~vaVK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 649 (892)
+..+.+.+.||+|+||.||+|.. +++.||||++..... ...+.+..|...+.++ +|+||+.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCC
T ss_conf 79979844984167839999998677755578399999986001717899999999998861499849974115404797
Q ss_pred CEEEEEEECCCCCHHHHCCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC
Q ss_conf 1899999545886021101367--------------55479999999999999999999708999953567897637986
Q 002688 650 NMALIYEYMANGNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN 715 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~ 715 (892)
..++|||||++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEC
T ss_conf 57999984589929999985366666532220233214689999999999999999988737---971786773106577
Q ss_pred CCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCH
Q ss_conf 8993899530686322379996321145689874481000238999403499999999999929-999986535897529
Q 002688 716 EKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG-HPVISKSAENGHTHV 794 (892)
Q Consensus 716 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG-~~pf~~~~~~~~~~l 794 (892)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++| .+||......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~----- 243 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----- 243 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-----
T ss_pred CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH-----
T ss_conf 998289845752001135665222475166721020368646889966322136789999986889999899989-----
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 99999673029876434897889999788999999999733249799999889999999977666
Q 002688 795 AQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAME 859 (892)
Q Consensus 795 ~~~v~~~~~~~~~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~~~ 859 (892)
+.....+..+... .. +......+.+++.+|++.+|++|||++|++++|+++++..
T Consensus 244 -~~~~~~~~~~~~~-----~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 244 -EEFCRRLKEGTRM-----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp -HHHHHHHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHCCCCC-----CC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf -9999999638988-----88----8657899999999976779667919999999997998677
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.48 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=201.6
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CCCEEEEEE
Q ss_conf 43102003006499999998--89279999916899--2456879999999884164210137647643--981899999
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE--GTNMALIYE 656 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~LV~E 656 (892)
+++.+.||+|+||.||+|+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+ ....++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 79967983088919999999999979999998746579799999999999999778999824899999178998999995
Q ss_pred ECCCCCHHHHCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 545886021101367--554799999999999999999997089--9995356789763798689938995306863223
Q 002688 657 YMANGNLEEHLSDSS--KEILNWEERLRIAVEAALGLEYLHQGC--KPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 657 y~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~ 732 (892)
|+++|+|.+++.... ...+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEECC
T ss_conf 68999389999851545789999999999999999999999716778878858676542574788857980010003224
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 79996321145689874481000238999403499999999999929999986535897529999996730298764348
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iD 812 (892)
.. ........||+.|+|||++.+..++.++|||||||++|||++|++||..... .+... .+..+....
T Consensus 166 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~-~i~~~~~~~--- 233 (269)
T d2java1 166 HD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAG-KIREGKFRR--- 233 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHH-HHHHTCCCC---
T ss_pred CC--CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH------HHHHH-HHHCCCCCC---
T ss_conf 57--7755667788232799998399999389887527899998018899899899------99999-997189988---
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 97889999788999999999733249799999889999
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 813 p~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~ 850 (892)
+. ......+.+|+.+|++.+|++|||+.|+++
T Consensus 234 --~~----~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 --IP----YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf --97----435999999999976799557918999972
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.38 Aligned_cols=261 Identities=26% Similarity=0.351 Sum_probs=210.4
Q ss_pred HHHHHHHCEECCCCCEEEEEEEEC-----CCEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
Q ss_conf 986431020030064999999988-----92799999168992-456879999999884164210137647643981899
Q 002688 580 RMTNNFERVLGKGGFGTVYHGKLD-----NDEVAVKMLSPSSS-QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 580 ~~t~~~~~~IG~G~fG~Vy~a~~~-----~~~vaVK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~L 653 (892)
+..+++.+.||+|+||.||+|++. +..||||.+..... ...+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 99954588602110136755479999999999999999999708999953567897637986899389953068632237
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~ 733 (892)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.+..
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 998406980776542247-8999999999999998775230226---744141026553206789678765034213367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 999632114568987448100023899940349999999999992-9999986535897529999996730298764348
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~Ellt-G~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iD 812 (892)
. .........|++.|+|||++.+..++.++|||||||++|||++ |++||...... .+...+ ..+...
T Consensus 161 ~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i----~~~~~~---- 228 (273)
T d1mp8a_ 161 S-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI----ENGERL---- 228 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH----HTTCCC----
T ss_pred C-CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HCCCCC----
T ss_conf 7-6233054005831032667516998874524442478999982699998889999---999999----818999----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHC
Q ss_conf 97889999788999999999733249799999889999999977666310
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAMEAAQ 862 (892)
Q Consensus 813 p~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~~~~~~ 862 (892)
. .+......+.+|+.+|++.+|++|||+.+|++.|+.+++.+.+|
T Consensus 229 -~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~q 273 (273)
T d1mp8a_ 229 -P----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273 (273)
T ss_dssp -C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred -C----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHCC
T ss_conf -8----98777999999999976879768929999999999997786179
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.90 Aligned_cols=250 Identities=28% Similarity=0.425 Sum_probs=207.2
Q ss_pred HHHHCEECCCCCEEEEEEEECCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCCEEEEEEECCCC
Q ss_conf 43102003006499999998892799999168992456879999999884164210137647643-98189999954588
Q 002688 583 NNFERVLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE-GTNMALIYEYMANG 661 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~LV~Ey~~~g 661 (892)
+.+.+.||+|+||.||+|.+.+..||||+++... ..+++.+|+.++++++||||++++++|.+ .+..++||||+++|
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEEEEEEECCCCEEEEEEEECCEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCCCC
T ss_conf 4885798207980899999999099999988577--79999999999986789898549878872389289999636999
Q ss_pred CHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCCC
Q ss_conf 60211013675547999999999999999999970899995356789763798689938995306863223799963211
Q 002688 662 NLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHVST 741 (892)
Q Consensus 662 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~ 741 (892)
+|.+++.......++|..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||+++..... ..
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~ 158 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QD 158 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCC-----CC
T ss_conf 899998745788889999999999998523211337---6553666567601468997763245600344787-----76
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 4568987448100023899940349999999999992-999998653589752999999673029876434897889999
Q 002688 742 TIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKGDFD 820 (892)
Q Consensus 742 ~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~Ellt-G~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~~~~ 820 (892)
...++..|+|||++.++.++.++||||||+++|||+| |++|+..... ..+..++ ..+. .+.. +
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i----~~~~-----~~~~----~ 222 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGY-----KMDA----P 222 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH----TTTC-----CCCC----C
T ss_pred CCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HCCC-----CCCC----C
T ss_conf 556664677817872798885887775799999999789999999999---9999999----8089-----9999----7
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 78899999999973324979999988999999997766
Q 002688 821 INSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 821 ~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~~ 858 (892)
......+.+|+.+|++.+|++||||.+++++|+++.+-
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 65799999999997566976893999999999999867
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.11 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=211.8
Q ss_pred HHHHHHHHHCEECCCCCEEEEEEEE-------CCCEEEEEECCCCCC-HHHHHHHHHHHHHHHC-CCCCEEEEEEEEECC
Q ss_conf 9998643102003006499999998-------892799999168992-4568799999998841-642101376476439
Q 002688 578 VLRMTNNFERVLGKGGFGTVYHGKL-------DNDEVAVKMLSPSSS-QGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEG 648 (892)
Q Consensus 578 l~~~t~~~~~~IG~G~fG~Vy~a~~-------~~~~vaVK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~ 648 (892)
+.+..+.+.+.||+|+||.||+|++ ++..||||+++.... .....+.+|+.++..+ +||||++++++|...
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
T ss_conf 77899698549820688299999980664477886999999874248779999999999987626999887899898319
Q ss_pred CCEEEEEEECCCCCHHHHCCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCE
Q ss_conf 81899999545886021101367----------------55479999999999999999999708999953567897637
Q 002688 649 TNMALIYEYMANGNLEEHLSDSS----------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNI 712 (892)
Q Consensus 649 ~~~~LV~Ey~~~gsL~~~L~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NI 712 (892)
...++||||+++|+|.++++... ...+++..+..++.|++.||+|||++ +++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCC
T ss_conf 97899997379987999998535665444445332223345889999999999999999988757---926662410210
Q ss_pred EECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCCCCC
Q ss_conf 9868993899530686322379996321145689874481000238999403499999999999929-999986535897
Q 002688 713 LINEKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITG-HPVISKSAENGH 791 (892)
Q Consensus 713 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG-~~pf~~~~~~~~ 791 (892)
|++.++.+|++|||+++...............|++.|+|||++.++.++.++||||||+++|||+|+ ++|+......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred CCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH--
T ss_conf 000257521023401023367886158620135968767788617999974001025899999985899887789989--
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 5299999967302987643489788999978899999999973324979999988999999997766
Q 002688 792 THVAQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 792 ~~l~~~v~~~~~~~~~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~~ 858 (892)
..+.. .+..+.. + ..+......+.+|+.+|++.+|++||||.+++++|+++++.
T Consensus 255 ~~~~~----~i~~~~~-----~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 SKFYK----MIKEGFR-----M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHH----HHHHTCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH----HHHCCCC-----C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 99999----9866898-----8----98543659999999997577965792999999999876534
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=339.44 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=198.1
Q ss_pred HHHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCC---HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 8643102003006499999998--892799999168992---45687999999988416421013764764398189999
Q 002688 581 MTNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS---QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIY 655 (892)
Q Consensus 581 ~t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~ 655 (892)
..+...+.||+|+||.||+|+. ++..||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 95458860211013675547999999999999999999970899995356789763798689938995306863223799
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~ 735 (892)
|||++|+|..++.... .+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC--
T ss_conf 8069994578997379--999999999999999999999868---976667884217987999789844365334677--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 9632114568987448100023---8999403499999999999929999986535897529999996730298764348
Q 002688 736 GTHVSTTIAGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 736 ~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iD 812 (892)
.....||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... .+......... ..
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~-~~---- 232 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-SP---- 232 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CC----
T ss_pred ----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHCC-CC----
T ss_conf ----8731347663688998346788867214545589999999878899999799------99999998289-99----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 97889999788999999999733249799999889999
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 813 p~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~ 850 (892)
.+. +......+.+|+.+|++.+|++|||++|+++
T Consensus 233 -~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 -ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -888---7888999999999977379657918999971
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.06 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=201.2
Q ss_pred HHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCC------HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
Q ss_conf 643102003006499999998--892799999168992------456879999999884164210137647643981899
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS------QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~L 653 (892)
.|++.+.||+|+||.||+|.. ++..||||++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 77982798117895999999999998999999875663213406899999999999986799899938899997998999
Q ss_pred EEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCC----CEEEEEECCCC
Q ss_conf 99954588602110136755479999999999999999999708999953567897637986899----38995306863
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF----QAKLADFGLSR 729 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~----~vkI~DfGla~ 729 (892)
|||||++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++ .+|++|||++.
T Consensus 91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEECCCCCCCCCHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCHHHHH
T ss_conf 998677864310010356--421557899999999998766625---422113330127982589866646964334421
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 22379996321145689874481000238999403499999999999929999986535897529999996730298764
Q 002688 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRS 809 (892)
Q Consensus 730 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~ 809 (892)
..... .......|++.|+|||++.+..++.++||||+||++|||++|+.||..... .+...... .....
T Consensus 166 ~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~-~~~~~- 234 (293)
T d1jksa_ 166 KIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVS-AVNYE- 234 (293)
T ss_dssp ECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-TTCCC-
T ss_pred HCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH------HHHHHHHH-HCCCC-
T ss_conf 05777---631224777743099998189999766522140999999708899889999------99999998-16888-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 34897889999788999999999733249799999889999
Q 002688 810 TVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 810 ~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~ 850 (892)
............+.+|+.+|++.+|++|||++|+++
T Consensus 235 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----870104788999999999986389668919999961
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.30 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=212.2
Q ss_pred HHHHHHCEECCCCCEEEEEEEEC---------CCEEEEEECCCCCC-HHHHHHHHHHHHHHHC-CCCCEEEEEEEEECCC
Q ss_conf 86431020030064999999988---------92799999168992-4568799999998841-6421013764764398
Q 002688 581 MTNNFERVLGKGGFGTVYHGKLD---------NDEVAVKMLSPSSS-QGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGT 649 (892)
Q Consensus 581 ~t~~~~~~IG~G~fG~Vy~a~~~---------~~~vaVK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~ 649 (892)
..+.+.+.||+|+||.||+|+.. +..||||+++.... ....++.+|...+.++ +||||++++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286889999999999998139996973465220188
Q ss_pred CEEEEEEECCCCCHHHHCCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC
Q ss_conf 1899999545886021101367--------------55479999999999999999999708999953567897637986
Q 002688 650 NMALIYEYMANGNLEEHLSDSS--------------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN 715 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~ 715 (892)
..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEEEC
T ss_conf 68999973699909999986067764322233457434679999999999999999876637---978630221022454
Q ss_pred CCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCH
Q ss_conf 899389953068632237999632114568987448100023899940349999999999992-9999986535897529
Q 002688 716 EKFQAKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHV 794 (892)
Q Consensus 716 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~Ellt-G~~pf~~~~~~~~~~l 794 (892)
.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |++||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH------
T ss_conf 78976762211101135555543146678884663266751798882555477588888740179898999999------
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 99999673029876434897889999788999999999733249799999889999999977666
Q 002688 795 AQWVSSMLDKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAME 859 (892)
Q Consensus 795 ~~~v~~~~~~~~~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~~~ 859 (892)
.+ +...+..+.. +.. +......+.+|+.+|++.+|++|||+.||++.|+++++..
T Consensus 244 ~~-~~~~i~~~~~-----~~~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 244 EE-LFKLLKEGHR-----MDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp HH-HHHHHHTTCC-----CCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HH-HHHHHHCCCC-----CCC----CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 99-9999972888-----898----7435299999999976679767939999999998886047
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.33 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=204.7
Q ss_pred HHHCEECCCCCEEEEEEEE--CCC--EEEEEECCCC-CCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEECCCCEEEEEEE
Q ss_conf 3102003006499999998--892--7999991689-924568799999998841-642101376476439818999995
Q 002688 584 NFERVLGKGGFGTVYHGKL--DND--EVAVKMLSPS-SSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 584 ~~~~~IG~G~fG~Vy~a~~--~~~--~vaVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~LV~Ey 657 (892)
++.+.||+|+||.||+|++ ++. .||||++... .....+.|.+|++++.++ +||||+++++++..++..++|+||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEE
T ss_conf 88779820788289999998999699999999782338579999999999998622899883678888418736999980
Q ss_pred CCCCCHHHHCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEE
Q ss_conf 4588602110136--------------75547999999999999999999970899995356789763798689938995
Q 002688 658 MANGNLEEHLSDS--------------SKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLA 723 (892)
Q Consensus 658 ~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~ 723 (892)
+++|+|.++|+.. ....+++..+..++.|++.||.|+|+. +++||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCCEEEC
T ss_conf 289869999864035555512310123457899999999999999998766308---95455505204898688763874
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 306863223799963211456898744810002389994034999999999999299-9998653589752999999673
Q 002688 724 DFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSML 802 (892)
Q Consensus 724 DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~-~pf~~~~~~~~~~l~~~v~~~~ 802 (892)
|||+++..... .......|+..|+|||.+.++.++.++||||||+++|||++|. +||.... ..+......
T Consensus 170 DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~~i~ 240 (309)
T d1fvra_ 170 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLP 240 (309)
T ss_dssp CTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHGG
T ss_pred CCCCCCCCCCC---CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC------HHHHHHHHH
T ss_conf 34432244422---345530137755553875269999622153138899999836899999999------999999998
Q ss_pred HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 02987643489788999978899999999973324979999988999999997766
Q 002688 803 DKGDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAM 858 (892)
Q Consensus 803 ~~~~~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~~ 858 (892)
. +. .+. .+......+.+|+.+|++.+|++||||++|++.|+++++.
T Consensus 241 ~-~~-----~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 241 Q-GY-----RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp G-TC-----CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred H-CC-----CCC----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 2-68-----888----8766789999999997678966894999999999999861
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.68 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=201.3
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEE
Q ss_conf 43102003006499999998--89279999916899---24568799999998841642101376476439818999995
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey 657 (892)
+++.+.||+|+||.||+++. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCEEC
T ss_conf 28988983176849999999899989999998156544979999999999999867999887787640356421110003
Q ss_pred CCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 45886021101367554799999999999999999997089999535678976379868993899530686322379996
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~ 737 (892)
+++|+|.+++..... +++.....++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..... .
T Consensus 87 ~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~ 159 (337)
T d1o6la_ 87 ANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--G 159 (337)
T ss_dssp CTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--T
T ss_pred CCCCCHHHHHHCCCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC--C
T ss_conf 579860555532567--75999999999996521134315---9622464777847658998888205652003567--8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 32114568987448100023899940349999999999992999998653589752999999673029876434897889
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~ 817 (892)
......+||+.|+|||++.+..++.++||||+||++|||++|++||..... .+...... .+... ..
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~-~~~~~------~p- 225 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELIL-MEEIR------FP- 225 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCCC------CC-
T ss_pred CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-CCCCC------CC-
T ss_conf 620551008899666650489888333102230678899878999999699------99999985-28998------98-
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 999788999999999733249799999-----889999
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPF-----MNQVVM 850 (892)
Q Consensus 818 ~~~~~~~~~l~~Li~~Cl~~~P~~RPs-----m~evl~ 850 (892)
......+.+|+.+|++.+|++|++ ++++++
T Consensus 226 ---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 ---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf ---66899999999866638934422565234999972
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.53 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=208.9
Q ss_pred HHHHHCEECCCCCEEEEEEEEC-------CCEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
Q ss_conf 6431020030064999999988-------9279999916899-2456879999999884164210137647643981899
Q 002688 582 TNNFERVLGKGGFGTVYHGKLD-------NDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMAL 653 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~~-------~~~vaVK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~L 653 (892)
.+.+.+.||+|+||.||+|.+. +..||||+++... ......|.+|+.++++++|+||+++++++...+..++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 91883598207881899999878644778968999998701286899999999999997699988412547842881067
Q ss_pred EEEECCCCCHHHHCCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEE
Q ss_conf 999545886021101367--------554799999999999999999997089999535678976379868993899530
Q 002688 654 IYEYMANGNLEEHLSDSS--------KEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADF 725 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~Df 725 (892)
|+||+++|+|.+++.... ...+++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEEEEEC
T ss_conf 7760489988999875033211344468879999999999999999987647---9654328677540359964999424
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 6863223799963211456898744810002389994034999999999999299-999865358975299999967302
Q 002688 726 GLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGH-PVISKSAENGHTHVAQWVSSMLDK 804 (892)
Q Consensus 726 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~-~pf~~~~~~~~~~l~~~v~~~~~~ 804 (892)
|+++.+.............|++.|+|||.+.++.++.++||||||+++|||+||. +||... ...+........
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVMEG 251 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHHTT
T ss_pred CCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC------CHHHHHHHHHHC
T ss_conf 54202357763031340231632378888736998833344437899999996899999998------999999999808
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 98764348978899997889999999997332497999998899999999776
Q 002688 805 GDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 805 ~~~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
.. .. .+......+.+++.+|++.+|++||||++|+++|++.++
T Consensus 252 ~~-~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GL-LD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CC-CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CC-CC---------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 88-88---------863353999999999757796589399999999787617
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=329.12 Aligned_cols=242 Identities=24% Similarity=0.371 Sum_probs=200.4
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEE
Q ss_conf 43102003006499999998--89279999916899---24568799999998841642101376476439818999995
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey 657 (892)
+++.+.||+|+||.||+|+. ++..||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEEEE
T ss_conf 08888972076808999999899979999998457754889999999999999863696753303568528800567650
Q ss_pred CCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 45886021101367554799999999999999999997089999535678976379868993899530686322379996
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~ 737 (892)
+++|+|..++..... +++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 86 IEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred CCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECCC---
T ss_conf 378632234322221--11007999999998765541247---6770556810503868998898317521671245---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 32114568987448100023899940349999999999992999998653589752999999673029876434897889
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~ 817 (892)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||.... ..+........ ... .
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~-~~~------~-- 220 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNA-ELR------F-- 220 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHC-CCC------C--
T ss_pred --CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCC------HHHHHHHHHCC-CCC------C--
T ss_conf --643457634359999838999804304653336899975989999969------99999999708-988------9--
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 99978899999999973324979999-----98899999
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRP-----FMNQVVME 851 (892)
Q Consensus 818 ~~~~~~~~~l~~Li~~Cl~~~P~~RP-----sm~evl~~ 851 (892)
+......+.+++.+|++.+|.+|+ ++++++++
T Consensus 221 --p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 221 --PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf --9778999999999995449976664310219999819
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=323.54 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=206.6
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----CEEE
Q ss_conf 43102003006499999998--89279999916899---245687999999988416421013764764398----1899
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT----NMAL 653 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~L 653 (892)
|.+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEEEE
T ss_conf 69868996089929999999999989999998556646989999999999999856999887311435432688766999
Q ss_pred EEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 99954588602110136755479999999999999999999708999953567897637986899389953068632237
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~ 733 (892)
||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +++||||||+|||++.++..+++|||.+.....
T Consensus 89 vmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEECCCCCEEHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCC
T ss_conf 997788987101120358--999999999999999999999857---952763467556657543201003444322123
Q ss_pred CC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 99-96321145689874481000238999403499999999999929999986535897529999996730298764348
Q 002688 734 EG-GTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 734 ~~-~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iD 812 (892)
.. .........|++.|+|||++.+..++.++||||+||++|||+||++||.... ..+.....+........
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~~~-- 235 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIPPS-- 235 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCCGG--
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCC------HHHHHHHHHHCCCCCCC--
T ss_conf 5443333464257624369999839999966320265289999976979989969------99999999846999971--
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 9788999978899999999973324979999-9889999999977
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRP-FMNQVVMELNDCL 856 (892)
Q Consensus 813 p~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RP-sm~evl~~L~~~~ 856 (892)
.........+.+++.+|++.+|++|| +++++.+.|.++.
T Consensus 236 -----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 -----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----HHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf -----0034789999999999866797677739999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.33 Aligned_cols=245 Identities=21% Similarity=0.298 Sum_probs=194.6
Q ss_pred CEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEC----CCCEEEEEEECC
Q ss_conf 2003006499999998--8927999991689924568799999998841-64210137647643----981899999545
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRV-HHRNLTTLVGYCDE----GTNMALIYEYMA 659 (892)
Q Consensus 587 ~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~~LV~Ey~~ 659 (892)
+.||+|+||.||+|+. +++.||||++... ..+.+|+.++.++ +||||+++++++.+ ....++|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEEEECCC
T ss_conf 7965454869999998899989999998974-----77999999999866999978298999503468978999997789
Q ss_pred CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC---CCCEEEEEECCCCCCCCCCC
Q ss_conf 886021101367554799999999999999999997089999535678976379868---99389953068632237999
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE---KFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~---~~~vkI~DfGla~~~~~~~~ 736 (892)
+|+|.+++.......+++..+..++.|++.||+|||+. +++||||||+|||++. .+.+||+|||+++......
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~- 168 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 168 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-
T ss_pred CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC-
T ss_conf 98499999862787757999999999999999999976---98644410022011355556631135455123336888-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 63211456898744810002389994034999999999999299999865358975299999967302987643489788
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 737 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~ 816 (892)
......|++.|+|||++.+..++.++||||+||++|||++|++||........ .......+..+. ....
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~------~~~~ 237 (335)
T d2ozaa1 169 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQ------YEFP 237 (335)
T ss_dssp --CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS------SSCC
T ss_pred --CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH---HHHHHHHHHCCC------CCCC
T ss_conf --64322677563792777489888888887645167788658899889887788---999999985388------8889
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 99997889999999997332497999998899999
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 817 ~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
..........+.+|+.+|++.+|++|||+.|++++
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 85434699999999999756996579099999709
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=326.78 Aligned_cols=245 Identities=23% Similarity=0.322 Sum_probs=192.8
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCC---HHHHHHHH---HHHHHHHCCCCCEEEEEEEEECCCCEEEE
Q ss_conf 43102003006499999998--892799999168992---45687999---99998841642101376476439818999
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS---QGYKQFQA---EVKLLLRVHHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~---~~~~~f~~---E~~~l~~l~H~nIv~l~~~~~~~~~~~LV 654 (892)
+.+.+.||+|+||.||+|+. ++..||+|++..... .....+.+ ++.+++.++||||+++++++...+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
T ss_conf 85101884288909999999999979999998458754266799999999999998508998588999999989988999
Q ss_pred EEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 99545886021101367554799999999999999999997089999535678976379868993899530686322379
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~ 734 (892)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.+...
T Consensus 86 mE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp ECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEECCCC
T ss_conf 99148983899987325--532789999999999999999977---9622044422167858896798220102333788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99632114568987448100023-89994034999999999999299999865358975299999967302987643489
Q 002688 735 GGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDP 813 (892)
Q Consensus 735 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp 813 (892)
......||+.|+|||++.. ..++.++||||+||++|||++|+.||....... ....... ..... +
T Consensus 161 ----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~-~~~~~------~ 226 (364)
T d1omwa3 161 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRM-TLTMA------V 226 (364)
T ss_dssp ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHHHH-SSSCC------C
T ss_pred ----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHH-CCCCC------C
T ss_conf ----64331134554216876038999844104677899999985999888899899---9999986-04688------8
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 7889999788999999999733249799999-----889999
Q 002688 814 RLKGDFDINSVWKAVEIAMACVSSNANRRPF-----MNQVVM 850 (892)
Q Consensus 814 ~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPs-----m~evl~ 850 (892)
.. +......+.+|+.+|++.+|++||+ ++++++
T Consensus 227 ~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC----CCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf 78----877899999999998566988808874357999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.66 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=203.6
Q ss_pred HHHHCEECCCCCEEEEEEEEC---C--CEEEEEECCCC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEE
Q ss_conf 431020030064999999988---9--27999991689---924568799999998841642101376476439818999
Q 002688 583 NNFERVLGKGGFGTVYHGKLD---N--DEVAVKMLSPS---SSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~~---~--~~vaVK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV 654 (892)
+++.+.||+|+||.||+|++. + ..||||++... .....++|.+|+.+++.++||||+++++++.++ ..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred EEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHHEE
T ss_conf 19978980388839999999889990799999999835557989999999999999868999987898777401-00114
Q ss_pred EEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 99545886021101367554799999999999999999997089999535678976379868993899530686322379
Q 002688 655 YEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVE 734 (892)
Q Consensus 655 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~ 734 (892)
+||+++|++.+.+..... .+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++.+...
T Consensus 89 ~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred EEEECCCCHHHHHHCCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHHCCCC
T ss_conf 654238612544421268-999999999999999999875217---8752056688815655654332561155530358
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 9963-2114568987448100023899940349999999999992-9999986535897529999996730298764348
Q 002688 735 GGTH-VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIIT-GHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVD 812 (892)
Q Consensus 735 ~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~Ellt-G~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iD 812 (892)
.... ......|+..|+|||++.+..++.++||||||+++|||+| |++||.... ..+....+...+...
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~~~~---- 234 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGERL---- 234 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCCCC----
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC------HHHHHHHHHHCCCCC----
T ss_conf 8752654763257310799998379999421566148999999968999999969------999999998479999----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 9788999978899999999973324979999988999999997
Q 002688 813 PRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDC 855 (892)
Q Consensus 813 p~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~ 855 (892)
. ........+.+|+.+||..+|++|||+.+|.+.|+++
T Consensus 235 -~----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 -P----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf -9----8544539999999997688966792999999999964
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=327.06 Aligned_cols=241 Identities=23% Similarity=0.347 Sum_probs=199.5
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEE
Q ss_conf 43102003006499999998--89279999916899---24568799999998841642101376476439818999995
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEY 657 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey 657 (892)
+++.+.||+|+||.||+|+. ++..||||++.... ....+.+.+|+.+++.++||||+++++++......++|+||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf 08988961176808999999899989999998267745889999999999999974877274034444322222322223
Q ss_pred CCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 45886021101367554799999999999999999997089999535678976379868993899530686322379996
Q 002688 658 MANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGT 737 (892)
Q Consensus 658 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~ 737 (892)
+.+|+|.+++.... .+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 123 ~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp CTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred CCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC---
T ss_conf 34662266675158--989999999999999989999859---9861767999936077897886101033322566---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 32114568987448100023899940349999999999992999998653589752999999673029876434897889
Q 002688 738 HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLKG 817 (892)
Q Consensus 738 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~~ 817 (892)
.....|++.|+|||++.+..++.++|||||||++|||++|++||.... .......... +... ..
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~-~~~~------~p- 258 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVS-GKVR------FP- 258 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-CCCC------CC-
T ss_pred --CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC------HHHHHHHHHC-CCCC------CC-
T ss_conf --643367635678899717998853311450078999975889989959------9999999861-7988------97-
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 99978899999999973324979999-----9889999
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRP-----FMNQVVM 850 (892)
Q Consensus 818 ~~~~~~~~~l~~Li~~Cl~~~P~~RP-----sm~evl~ 850 (892)
......+.+++.+|++.+|.+|+ +++++++
T Consensus 259 ---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 ---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf ---66899999999998340998606553454999971
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.02 Aligned_cols=247 Identities=17% Similarity=0.277 Sum_probs=201.3
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECCC
Q ss_conf 43102003006499999998--8927999991689924568799999998841642101376476439818999995458
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMAN 660 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~~ 660 (892)
|.+.+.||+|+||.||+|.. ++..||+|.+..... ....+.+|+.++..++||||+++++++.+.+..++|||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCC
T ss_conf 5887898317783999999989996999999757866-599999999999857997989098999889988999953899
Q ss_pred CCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC--CCCEEEEEECCCCCCCCCCCCC
Q ss_conf 86021101367554799999999999999999997089999535678976379868--9938995306863223799963
Q 002688 661 GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE--KFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 661 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~--~~~vkI~DfGla~~~~~~~~~~ 738 (892)
|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+|||++. ...+||+|||+++.... ..
T Consensus 86 g~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~---~~ 158 (321)
T d1tkia_ 86 LDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GD 158 (321)
T ss_dssp CBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---TC
T ss_pred CCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC---CC
T ss_conf 80889987538-9999999999999999999999876---99751355444344378851899764411100346---77
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCC-CCCCCCCCCCC
Q ss_conf 21145689874481000238999403499999999999929999986535897529999996730298-76434897889
Q 002688 739 VSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD-IRSTVDPRLKG 817 (892)
Q Consensus 739 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~-~~~~iDp~l~~ 817 (892)
......+++.|+|||...+..++.++||||+||++|||++|+.||..... .+.......... ......+
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~~---- 228 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTFDEEAFK---- 228 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCCCHHHHT----
T ss_pred CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHCCCCCCHHHCC----
T ss_conf 53212233222340210487778401130279999999828999999899------99999998389998802236----
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9997889999999997332497999998899999
Q 002688 818 DFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 818 ~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
.....+.+++.+|++.+|++|||+.|++++
T Consensus 229 ----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 ----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----789999999999866996689099999639
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.65 Aligned_cols=244 Identities=25% Similarity=0.408 Sum_probs=197.3
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC---CHHHHHHHHHHHHHH-HCCCCCEEEEEEEEECCCCEEEEEE
Q ss_conf 43102003006499999998--89279999916899---245687999999988-4164210137647643981899999
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS---SQGYKQFQAEVKLLL-RVHHRNLTTLVGYCDEGTNMALIYE 656 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~---~~~~~~f~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~LV~E 656 (892)
+.+.+.||+|+||+||+|+. +++.||||++.... ....+.+..|..++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEEEE
T ss_conf 18865894087828999999999989999998055533848999999999999984799968789889704983167775
Q ss_pred ECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf 54588602110136755479999999999999999999708999953567897637986899389953068632237999
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~ 736 (892)
|+++|+|.+++..... +++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 84 y~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp CCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred ECCCCCHHHHHHCCCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC--
T ss_conf 0379808998640478--99999999999999999999868---9340347654044448996301555302323566--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 63211456898744810002389994034999999999999299999865358975299999967302987643489788
Q 002688 737 THVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRSTVDPRLK 816 (892)
Q Consensus 737 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~iDp~l~ 816 (892)
........|++.|+|||++.+..++.++||||+||++|||++|+.||.+... .+.. ..+..+. +...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~-~~i~~~~------~~~p 223 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELF-HSIRMDN------PFYP 223 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHCC------CCCC
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHH-HHHHCCC------CCCC
T ss_conf 5334545787776899998279988323201122789898738899999899------9999-9997189------9897
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 999978899999999973324979999988-9999
Q 002688 817 GDFDINSVWKAVEIAMACVSSNANRRPFMN-QVVM 850 (892)
Q Consensus 817 ~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~-evl~ 850 (892)
......+.+|+.+|++.+|++||++. ++++
T Consensus 224 ----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 ----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf ----5679999999999654489878388999980
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.89 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=195.5
Q ss_pred CEECCCCCEEEEEEEE--CCCEEEEEECCCCCCH-----HHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECC
Q ss_conf 2003006499999998--8927999991689924-----56879999999884164210137647643981899999545
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ-----GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 587 ~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~ 659 (892)
+.||+|+||.||+|+. +++.||||++...... ..+.+.+|+.+++.++||||+++++++..+++.++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHHC
T ss_conf 38512728299999999999699999984202124567999999999999986799998689854225874022045534
Q ss_pred CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCC
Q ss_conf 88602110136755479999999999999999999708999953567897637986899389953068632237999632
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~ 739 (892)
++++..+.... ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++...... ..
T Consensus 84 ~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~ 156 (299)
T d1ua2a_ 84 TDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RA 156 (299)
T ss_dssp EEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CC
T ss_pred CHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC--CC
T ss_conf 50776554126--6778999999999999999886316---35503577625885377841146576100057875--54
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCC---CCCCC---CC
Q ss_conf 1145689874481000238-99940349999999999992999998653589752999999673029---87643---48
Q 002688 740 STTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG---DIRST---VD 812 (892)
Q Consensus 740 ~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~---~~~~~---iD 812 (892)
.....|++.|+|||++... .++.++||||+||++|||++|++||....+. +....+....... ..... .+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHH---HHHHHHHHHCCCCCHHHCCCHHCCCH
T ss_conf 330204733363999726778880564363042899998596999999999---99999998518997254521000213
Q ss_pred C-CCC--CCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9-788--99997-----889999999997332497999998899999
Q 002688 813 P-RLK--GDFDI-----NSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 813 p-~l~--~~~~~-----~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
. ... ..... .....+.+|+.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44303478988678565689999999999763894569089999679
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=316.35 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=200.5
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCH---------HHHHHHHHHHHHHHCC-CCCEEEEEEEEECCCC
Q ss_conf 43102003006499999998--8927999991689924---------5687999999988416-4210137647643981
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQ---------GYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTN 650 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~---------~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 650 (892)
+.+.+.||+|+||.||+++. +++.+|||++...... ..+.+.+|+.++++++ ||||+++++++.++++
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCC
T ss_conf 88852884176849999999999989999999624464114788899999999999999985079974799762146760
Q ss_pred EEEEEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 89999954588602110136755479999999999999999999708999953567897637986899389953068632
Q 002688 651 MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 651 ~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~ 730 (892)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCHHEEE
T ss_conf 599997689866899998659--999999999999999999999875---994323462548986899838712403167
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 237999632114568987448100023------89994034999999999999299999865358975299999967302
Q 002688 731 FPVEGGTHVSTTIAGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK 804 (892)
Q Consensus 731 ~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~ 804 (892)
+... .......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..... .. ....+..
T Consensus 160 ~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~-~~~~i~~ 229 (277)
T d1phka_ 160 LDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------ML-MLRMIMS 229 (277)
T ss_dssp CCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHH
T ss_pred CCCC---CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCH------HH-HHHHHHH
T ss_conf 2688---721345246788898886053445678899233185656023103228889889999------99-9999981
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 98764348978899997889999999997332497999998899999
Q 002688 805 GDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 805 ~~~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
+... ............+.+++.+|++.+|++||+++|+++.
T Consensus 230 ~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCC------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8988------8985434689999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=312.71 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=197.6
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCC--HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEEC
Q ss_conf 43102003006499999998--892799999168992--45687999999988416421013764764398189999954
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS--QGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~ 658 (892)
|.+.+.||+|+||.||+|+. +++.||||+++.... ...+++.+|+.+++.++||||+++++++.++.+.++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEEC
T ss_conf 77651772376809999999999979999998022257589999999999998679983887445332243203788623
Q ss_pred CCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 58860211013675547999999999999999999970899995356789763798689938995306863223799963
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~ 738 (892)
.+ ++.+.+.......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 84 ~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~ 157 (298)
T d1gz8a_ 84 HQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VR 157 (298)
T ss_dssp SE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SB
T ss_pred CC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC--CC
T ss_conf 77-445554420256888899999999999999986528---8992135711401134676210357861343688--64
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCC--CCCCC-CCCC
Q ss_conf 211456898744810002389-9940349999999999992999998653589752999999673029--87643-4897
Q 002688 739 VSTTIAGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG--DIRST-VDPR 814 (892)
Q Consensus 739 ~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~--~~~~~-iDp~ 814 (892)
......|++.|+|||...... ++.++||||+||++|||++|+.||...... ..+........... ..... ..+.
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHH--HHHHHHHHHCCCCCHHHCCCCCCCCC
T ss_conf 1001036521541122136657774221033331342796687998988999--99999998328983331444222421
Q ss_pred CCC------CCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 889------999-----7889999999997332497999998899999
Q 002688 815 LKG------DFD-----INSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 815 l~~------~~~-----~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
... ... ......+.+|+.+|++.+|++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 243454322220444166789999999999763995579189999678
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.22 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=190.8
Q ss_pred HHHHCEECCCCCEEEEEEEE--C-CCEEEEEECCCCC--CHHHHHHHHHHHHHHHC---CCCCEEEEEEEEEC-----CC
Q ss_conf 43102003006499999998--8-9279999916899--24568799999998841---64210137647643-----98
Q 002688 583 NNFERVLGKGGFGTVYHGKL--D-NDEVAVKMLSPSS--SQGYKQFQAEVKLLLRV---HHRNLTTLVGYCDE-----GT 649 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~-~~~vaVK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nIv~l~~~~~~-----~~ 649 (892)
|++.+.||+|+||.||+|+. + ++.||||++.... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 79888992155869999999888998999999802324516799999999999987425898802366322146666674
Q ss_pred CEEEEEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 18999995458860211013675547999999999999999999970899995356789763798689938995306863
Q 002688 650 NMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 650 ~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~ 729 (892)
..++++|+++++.+...... ....+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEEEEECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEECCHHHHH
T ss_conf 69999974058714444430-378999899999999999999999758---89835798627898589975421000101
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCC--CC
Q ss_conf 2237999632114568987448100023899940349999999999992999998653589752999999673029--87
Q 002688 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKG--DI 807 (892)
Q Consensus 730 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~--~~ 807 (892)
... .........||+.|+|||++.+..++.++||||+||++|||++|++||....... .+........... ..
T Consensus 165 ~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 165 IYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCGGGS
T ss_pred HHC---CCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHHCCCCHHCC
T ss_conf 100---2345777654851148310017988811100032899999987879989989899--99999984079961105
Q ss_pred -C------CCCCC---CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -6------43489---78899997889999999997332497999998899999
Q 002688 808 -R------STVDP---RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 808 -~------~~iDp---~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
. ..... .............+.+|+.+|++.+|++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 321111033302234564544044589999999999874896679189999669
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=307.30 Aligned_cols=262 Identities=20% Similarity=0.283 Sum_probs=191.2
Q ss_pred HHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC------CCEEE
Q ss_conf 643102003006499999998--8927999991689924568799999998841642101376476439------81899
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG------TNMAL 653 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~L 653 (892)
+|+..++||+|+||+||+|+. +++.||||++..... ...+|+++++.++|+||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCC-CEEEEEECCCCCC
Q ss_conf 9995458860211013-6755479999999999999999999708999953567897637986899-3899530686322
Q 002688 654 IYEYMANGNLEEHLSD-SSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKF-QAKLADFGLSRVF 731 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~-~vkI~DfGla~~~ 731 (892)
||||++++.+...... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 984168860788886310368999999999999999999999866---87645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH-----------
Q ss_conf 37999632114568987448100023-899940349999999999992999998653589752999999-----------
Q 002688 732 PVEGGTHVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVS----------- 799 (892)
Q Consensus 732 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~----------- 799 (892)
.... ......|+..|+|||.+.+ ..++.++||||+||++|||++|++||......+ .+.....
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred CCCC---CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHH--HHHHHHHHHCCCHHHHHH
T ss_conf 4776---53200255555682776404688821000246527785502879989879999--999999974898177654
Q ss_pred HHHHC---CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf 67302---98764348978899997889999999997332497999998899999--9997
Q 002688 800 SMLDK---GDIRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME--LNDC 855 (892)
Q Consensus 800 ~~~~~---~~~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~--L~~~ 855 (892)
..... ......................+.+|+.+|++.||++|||+.|++++ ++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 3062101103554456744443156899999999999765895579299999669845246
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=305.52 Aligned_cols=259 Identities=20% Similarity=0.296 Sum_probs=197.5
Q ss_pred HHHHCEECCCCCEEEEEEEE-CCCEEEEEECCCCCCH--HHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEECC
Q ss_conf 43102003006499999998-8927999991689924--56879999999884164210137647643981899999545
Q 002688 583 NNFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSSQ--GYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~-~~~~vaVK~l~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~~ 659 (892)
|+..+.||+|+||+||+|+. +++.||||++...... ..+++.+|+.+++.++||||+++++++...+..++++|++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred CEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEEEH
T ss_conf 63431872277818999996899999999981232685899999999999986799868766012046773158997400
Q ss_pred CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCC
Q ss_conf 88602110136755479999999999999999999708999953567897637986899389953068632237999632
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTHV 739 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~ 739 (892)
++.+....... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.+....... ..
T Consensus 84 ~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 156 (286)
T d1ob3a_ 84 QDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RK 156 (286)
T ss_dssp EEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC--CC
T ss_conf 45678998604--7751445689999999999986057---48826787750568689978732366430114676--54
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHC--CCCCCC-----C
Q ss_conf 1145689874481000238-9994034999999999999299999865358975299999967302--987643-----4
Q 002688 740 STTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK--GDIRST-----V 811 (892)
Q Consensus 740 ~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~--~~~~~~-----i 811 (892)
.....+++.|+|||.+.+. .++.++||||+||++|||++|+.||....+. ..+.......... ...... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHH--HHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 101024311013788717888884100211175899997797998988989--999999986389971104212333221
Q ss_pred CCCCC-------CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 89788-------9999788999999999733249799999889999
Q 002688 812 DPRLK-------GDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 812 Dp~l~-------~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~ 850 (892)
+.... ..........+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 4333335676466651258999999999986689668909999856
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=305.62 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=194.5
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--------CCC
Q ss_conf 43102003006499999998--89279999916899--2456879999999884164210137647643--------981
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE--------GTN 650 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~--------~~~ 650 (892)
|.+.+.||+|+||+||+|+. +++.||||++.... ....+++.+|+.+++.++|+|++++++.+.. ..+
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCCCE
T ss_conf 88999972274829999999899979999998422246378999999999999835999660676540246544445763
Q ss_pred EEEEEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 89999954588602110136755479999999999999999999708999953567897637986899389953068632
Q 002688 651 MALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 651 ~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~ 730 (892)
.++|+|++.++.+........ .++......++.|++.||.|||+. +|+||||||+|||++.++.+|++|||+++.
T Consensus 92 ~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp EEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEECCEEEE
T ss_conf 899985357874101222034--433089999999999999885229---988567672220366899687631350022
Q ss_pred CCCCCCC--CCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHC---
Q ss_conf 2379996--321145689874481000238-9994034999999999999299999865358975299999967302---
Q 002688 731 FPVEGGT--HVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDK--- 804 (892)
Q Consensus 731 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~--- 804 (892)
+...... .......||+.|+|||++.+. .++.++||||+||++|||++|++||...... ............
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSITP 243 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCT
T ss_pred CCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHH---HHHHHHHHHCCCCCH
T ss_conf 35544432113566024978742899707999891787006786466174487998998999---999999984189982
Q ss_pred CCCCCCCCCCC--------CCCCCHH-------HHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 98764348978--------8999978-------89999999997332497999998899999
Q 002688 805 GDIRSTVDPRL--------KGDFDIN-------SVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 805 ~~~~~~iDp~l--------~~~~~~~-------~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
........... ....... ....+.+|+.+|++.+|++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 55344320344433201334455503340444599899999999873896589099999749
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=312.28 Aligned_cols=238 Identities=24% Similarity=0.387 Sum_probs=191.8
Q ss_pred HHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCC------HHHHHHHHHHHHHHHCC--CCCEEEEEEEEECCCCE
Q ss_conf 643102003006499999998--892799999168992------45687999999988416--42101376476439818
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSS------QGYKQFQAEVKLLLRVH--HRNLTTLVGYCDEGTNM 651 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~------~~~~~f~~E~~~l~~l~--H~nIv~l~~~~~~~~~~ 651 (892)
.|.+.+.||+|+||.||+|+. ++..||||++..... ...+++.+|+.+++.++ ||||+++++++...+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred EEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEE
T ss_conf 37996798408783999999999997999999856884433455679999999999997435898812799998309968
Q ss_pred EEEEEECCC-CCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC-CCCEEEEEECCCC
Q ss_conf 999995458-86021101367554799999999999999999997089999535678976379868-9938995306863
Q 002688 652 ALIYEYMAN-GNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-KFQAKLADFGLSR 729 (892)
Q Consensus 652 ~LV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-~~~vkI~DfGla~ 729 (892)
++|+|++.+ +++.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++. ++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEECCCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCCCCCE
T ss_conf 999983368622899986158--999999999999999999999877---975566761114774478848977546535
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 2237999632114568987448100023899-940349999999999992999998653589752999999673029876
Q 002688 730 VFPVEGGTHVSTTIAGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR 808 (892)
Q Consensus 730 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~ 808 (892)
.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+ ... +..
T Consensus 160 ~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~-~~~- 221 (273)
T d1xwsa_ 160 LLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIR-GQV- 221 (273)
T ss_dssp ECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH-CCC-
T ss_pred ECCC----CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH------------HHH-CCC-
T ss_conf 3244----4556656587747999984899788653325540345367568899887367------------761-544-
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 4348978899997889999999997332497999998899999
Q 002688 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 809 ~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
.+.+ . ....+.+++.+|++.+|++|||++|+++.
T Consensus 222 -~~~~----~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 -FFRQ----R----VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -CCSS----C----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCC----C----CCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -7787----7----99999999999760897589399998539
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=301.61 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=197.2
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEE-EEEEECCCCEEEEEEECC
Q ss_conf 43102003006499999998--892799999168992456879999999884164210137-647643981899999545
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLTTL-VGYCDEGTNMALIYEYMA 659 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l-~~~~~~~~~~~LV~Ey~~ 659 (892)
|.+.+.||+|+||.||+|+. +++.||||++..... .+++..|+++++.++|++++.. ..+.......++||||+.
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEECC
T ss_conf 9996898507880999999988998999999721005--88899999999970389960179999951987789998738
Q ss_pred CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC---CCCCEEEEEECCCCCCCCCCC
Q ss_conf 88602110136755479999999999999999999708999953567897637986---899389953068632237999
Q 002688 660 NGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILIN---EKFQAKLADFGLSRVFPVEGG 736 (892)
Q Consensus 660 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~---~~~~vkI~DfGla~~~~~~~~ 736 (892)
+++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++|||+++.+.....
T Consensus 87 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 87 -PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp -CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred -CCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCC
T ss_conf -71333244306-8876899999999999999999979---944266787660643357776156504675134255445
Q ss_pred C-----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC-HHHHHHHHHHCCCCCCC
Q ss_conf 6-----32114568987448100023899940349999999999992999998653589752-99999967302987643
Q 002688 737 T-----HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTH-VAQWVSSMLDKGDIRST 810 (892)
Q Consensus 737 ~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~-l~~~v~~~~~~~~~~~~ 810 (892)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ...+....... ...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 238 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIE-- 238 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CHH--
T ss_pred CCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC-CHH--
T ss_conf 54100013577678735329999918998983218861778999984987665530577999999852356789-835--
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 48978899997889999999997332497999998899999999776
Q 002688 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLA 857 (892)
Q Consensus 811 iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~ 857 (892)
.+. ...+..+.+++..|++.+|++||++.++.+.|+.+..
T Consensus 239 ---~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 ---VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ---HHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---HHC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---753----4788999999999843995579199999999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=299.20 Aligned_cols=262 Identities=16% Similarity=0.235 Sum_probs=204.7
Q ss_pred HHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEECCCCEEEEEEEC
Q ss_conf 643102003006499999998--892799999168992456879999999884164-21013764764398189999954
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHH-RNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~LV~Ey~ 658 (892)
.|.+.+.||+|+||.||+|+. +++.||||++..... ..++.+|++.+..+.| +|++.+++++..+...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEC
T ss_conf 06997998417882999999988997999999750258--2999999999999648999877999960188117999964
Q ss_pred CCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC-----CCCEEEEEECCCCCCCC
Q ss_conf 5886021101367554799999999999999999997089999535678976379868-----99389953068632237
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINE-----KFQAKLADFGLSRVFPV 733 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~-----~~~vkI~DfGla~~~~~ 733 (892)
+++|.+.+.... ..+++..+..++.|++.||+|||+. +++||||||+|||++. ++.+||+|||+++.+..
T Consensus 84 -~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 84 -GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHHC-CCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCC
T ss_conf -888799997520-3110689999999999999999977---96626677131523475434479568723660577146
Q ss_pred CCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 9996-----32114568987448100023899940349999999999992999998653589752999999673029876
Q 002688 734 EGGT-----HVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR 808 (892)
Q Consensus 734 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~ 808 (892)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+..........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCCHH
T ss_conf 76654111024676277510267989648888869998983199999986987678853021999999997056799958
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 434897889999788999999999733249799999889999999977666
Q 002688 809 STVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVMELNDCLAME 859 (892)
Q Consensus 809 ~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~L~~~~~~~ 859 (892)
+ +.. ..+..+.+++..|+..+|++||+++.+.+.|+++....
T Consensus 239 ~-----l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 239 E-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp H-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-----HCC----CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf 9-----657----99899999999984399300859999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=305.51 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=194.4
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----CEEEEE
Q ss_conf 43102003006499999998--89279999916899-245687999999988416421013764764398----189999
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS-SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT----NMALIY 655 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~LV~ 655 (892)
|++.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|+++|+.++|+|++++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 59978994064809999999999949999998031095899999999999997689898858889950564554149999
Q ss_pred EECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 95458860211013675547999999999999999999970899995356789763798689938995306863223799
Q 002688 656 EYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 656 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~ 735 (892)
+++.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEECCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf 962598656644058---999999999999999999999978---98677787643788799977875457056504777
Q ss_pred CC-CCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCC-----
Q ss_conf 96-32114568987448100023-899940349999999999992999998653589752999999673029876-----
Q 002688 736 GT-HVSTTIAGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIR----- 808 (892)
Q Consensus 736 ~~-~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~----- 808 (892)
.. .......|++.|+|||++.. ..++.++||||+||+++||++|+.||....... ...............
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHTC
T ss_pred CCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHH---HHHHHHHHCCCCCHHHHHHH
T ss_conf 641010110265200038786047888741010046701337766979978888899---99987652069975664234
Q ss_pred --------CCCCCCCCCCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --------4348978899997-----889999999997332497999998899999
Q 002688 809 --------STVDPRLKGDFDI-----NSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 809 --------~~iDp~l~~~~~~-----~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
....+... ..+. .....+.+|+.+|++.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKN-KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCC-CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHCCCCCCCCCC-CCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3322220244677557-787778378999999999999764895679089998619
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=299.96 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=194.9
Q ss_pred HHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC------CE
Q ss_conf 643102003006499999998--89279999916899--245687999999988416421013764764398------18
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGT------NM 651 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~------~~ 651 (892)
.|.+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.+|+.++|||++++++++...+ +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCEE
T ss_conf 18998898017781999999999998999999852225969999999999999866898754799986357655554159
Q ss_pred EEEEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf 99999545886021101367554799999999999999999997089999535678976379868993899530686322
Q 002688 652 ALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVF 731 (892)
Q Consensus 652 ~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~ 731 (892)
++||||+ +.+|...++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++..
T Consensus 99 ~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp EEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEECC-CCCHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCCEECC
T ss_conf 9998405-52189998740---226999999999999999998737---8764566851111210012211343102206
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHH-------
Q ss_conf 379996321145689874481000238-999403499999999999929999986535897529999996730-------
Q 002688 732 PVEGGTHVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLD------- 803 (892)
Q Consensus 732 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~------- 803 (892)
... .....|+..|+|||.+.+. .++.++||||+||++|||++|++||....... .+.........
T Consensus 172 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 172 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred CCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHH--HHHHHHHCCCCCCHHHHH
T ss_conf 876-----3102455333588998178789965010300389999997869988897689--999998503788488886
Q ss_pred CCC----------CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf 298----------764348978899997889999999997332497999998899999--9997
Q 002688 804 KGD----------IRSTVDPRLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME--LNDC 855 (892)
Q Consensus 804 ~~~----------~~~~iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~--L~~~ 855 (892)
... ..+.....+. .........+.+|+.+|++.+|++|||++|+++. ++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHCCHHHHHHHCCCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 53000344331157866655667-7556899999999999772995579299999639623758
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.6e-45 Score=293.04 Aligned_cols=255 Identities=20% Similarity=0.293 Sum_probs=192.3
Q ss_pred HHHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC--CCCEEEEEE
Q ss_conf 643102003006499999998--89279999916899245687999999988416-4210137647643--981899999
Q 002688 582 TNNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDE--GTNMALIYE 656 (892)
Q Consensus 582 t~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~LV~E 656 (892)
.+.+.+.||+|+||+||+|+. +++.||||+++... .+++.+|+++|..++ |+||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEE
T ss_conf 7189789831748199999988999799999988899---9999999999985157998767999998168771268886
Q ss_pred ECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCC-CCEEEEEECCCCCCCCCC
Q ss_conf 5458860211013675547999999999999999999970899995356789763798689-938995306863223799
Q 002688 657 YMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEK-FQAKLADFGLSRVFPVEG 735 (892)
Q Consensus 657 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~-~~vkI~DfGla~~~~~~~ 735 (892)
|+++++|....+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ ..+||+|||+++......
T Consensus 113 ~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 113 HVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred ECCCCCHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCC
T ss_conf 317985899746-----899999999999999999887643---344345644123774899836641565426646887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCC-----------CHHHHHHHHHH
Q ss_conf 96321145689874481000238-9994034999999999999299999865358975-----------29999996730
Q 002688 736 GTHVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHT-----------HVAQWVSSMLD 803 (892)
Q Consensus 736 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~-----------~l~~~v~~~~~ 803 (892)
......++..|+|||.+.+. .++.++||||+||+++||++|+.||......... ....+......
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred ---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf ---44432248642476102688888845232335455587604889998876018999999998788415555542254
Q ss_pred CCC--CCCCCCC--------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 298--7643489--------7889999788999999999733249799999889999
Q 002688 804 KGD--IRSTVDP--------RLKGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVM 850 (892)
Q Consensus 804 ~~~--~~~~iDp--------~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~ 850 (892)
... ....... .............+.+|+.+|++.+|++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 447430000033343311211552112448999999999986699568908999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=299.01 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=199.1
Q ss_pred HHHHCEECCCCCEEEEEEEE-----CCCEEEEEECCCCC----CHHHHHHHHHHHHHHHCCC-CCEEEEEEEEECCCCEE
Q ss_conf 43102003006499999998-----89279999916899----2456879999999884164-21013764764398189
Q 002688 583 NNFERVLGKGGFGTVYHGKL-----DNDEVAVKMLSPSS----SQGYKQFQAEVKLLLRVHH-RNLTTLVGYCDEGTNMA 652 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~-----~~~~vaVK~l~~~~----~~~~~~f~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~ 652 (892)
+++.+.||+|+||.||+|+. +++.||||.+.... ....+.+.+|+.++.+++| +||+++++++......+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEE
T ss_conf 59998983287839999998765887948999998367721016899999999999986467983999620002487300
Q ss_pred EEEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 99995458860211013675547999999999999999999970899995356789763798689938995306863223
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~ 732 (892)
+++||+.+|+|.+++..... +.......++.|++.||+|+|+. +++||||||+|||++.++.+||+|||+++.+.
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEECCCCCHHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCHHHHC
T ss_conf 12312341179999873045--43788888899999999885149---98965477320124699988874132022203
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 79996321145689874481000238--9994034999999999999299999865358975299999967302987643
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGDIRST 810 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~~~~~ 810 (892)
... ........|++.|++||.+.+. .++.++||||+||++|||++|+.||....... .............
T Consensus 181 ~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--~~~~i~~~~~~~~----- 252 (322)
T d1vzoa_ 181 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE----- 252 (322)
T ss_dssp GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCC-----
T ss_pred CCC-CCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHCCCCC-----
T ss_conf 444-43221222333331068760577688713251777799999976899988887777--9999998335689-----
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 4897889999788999999999733249799999-----889999
Q 002688 811 VDPRLKGDFDINSVWKAVEIAMACVSSNANRRPF-----MNQVVM 850 (892)
Q Consensus 811 iDp~l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPs-----m~evl~ 850 (892)
+. .+......+.+++.+|++.+|++||+ ++|+++
T Consensus 253 --~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 --PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --CC----CCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf --98----8654799999999997445898819997450999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=291.97 Aligned_cols=257 Identities=20% Similarity=0.260 Sum_probs=197.9
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEEC
Q ss_conf 43102003006499999998--89279999916899--245687999999988416421013764764398189999954
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEGTNMALIYEYM 658 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~~~~~LV~Ey~ 658 (892)
|++.+.||+|+||+||+|+. +++.||||+++... ....+++.+|+.+++.++|+||+++++++......+++++++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEEC
T ss_conf 78626971286819999999999969999998032178689999999999998567578882135444443115886302
Q ss_pred CCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 58860211013675547999999999999999999970899995356789763798689938995306863223799963
Q 002688 659 ANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPVEGGTH 738 (892)
Q Consensus 659 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~ 738 (892)
.++++..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++...... .
T Consensus 84 ~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~ 156 (292)
T d1unla_ 84 DQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--R 156 (292)
T ss_dssp SEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--S
T ss_pred CCCCCCCCCCCCC--CCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC--C
T ss_conf 3322211212356--540367899999999998774339---98600146761211337826652046011046887--5
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHH---HCC---CCC---
Q ss_conf 211456898744810002389-9940349999999999992999998653589752999999673---029---876---
Q 002688 739 VSTTIAGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSML---DKG---DIR--- 808 (892)
Q Consensus 739 ~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~---~~~---~~~--- 808 (892)
......++..|+|||.+.... ++.++||||+||++|||++|+.||.... +..+...... ... ...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCC-----CHHHHHHHHHHHCCCCCHHHHHHHH
T ss_conf 10010344310146675069888804440265418899851899998899-----9999999998611899735513443
Q ss_pred CCCC----CCC-----CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 4348----978-----899997889999999997332497999998899999
Q 002688 809 STVD----PRL-----KGDFDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 809 ~~iD----p~l-----~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
...+ +.. ...........+.+|+.+|++.+|++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2221133444544310433065689999999999864996689099999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=292.56 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=194.6
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC------CCCEE
Q ss_conf 43102003006499999998--89279999916899--2456879999999884164210137647643------98189
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDE------GTNMA 652 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~------~~~~~ 652 (892)
|++.+.||+|+||+||+|.. ++..||||++.... ....+++.+|+.+++.++||||+++++++.. ..+.+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCEEE
T ss_conf 59988962175859999999999989999998823369799999999999998648987648998970256434576269
Q ss_pred EEEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 99995458860211013675547999999999999999999970899995356789763798689938995306863223
Q 002688 653 LIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFP 732 (892)
Q Consensus 653 LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~ 732 (892)
+||||+.++.+. .+.. .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+|++|||+++...
T Consensus 99 iv~Ey~~~~l~~-~~~~----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 99 LVMELMDANLCQ-VIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEECCSEEHHH-HHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEECCCHHHHH-HHHC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHHHCCC
T ss_conf 998414467787-6503----899999999999999999886522---11245677632113654431320102321146
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH--------------
Q ss_conf 799963211456898744810002389994034999999999999299999865358975299999--------------
Q 002688 733 VEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWV-------------- 798 (892)
Q Consensus 733 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v-------------- 798 (892)
. ........++..|+|||++.+..++.++||||+||+++||++|++||....... ......
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 171 T---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHTTS
T ss_pred C---CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHH--HHHHHHHHCCCCCHHHHHHH
T ss_conf 6---655332214655558133147777877433356625789865989988897788--99999972058987999876
Q ss_pred ----HHHHHCC-CC-----CCCCCCCCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----9673029-87-----64348978899---997889999999997332497999998899999
Q 002688 799 ----SSMLDKG-DI-----RSTVDPRLKGD---FDINSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 799 ----~~~~~~~-~~-----~~~iDp~l~~~---~~~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
....... .. ...+....... ........+.+|+.+|++.+|++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 566777764175435666421264333543210133379999999999876994579089999669
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=291.26 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=192.3
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-----CCEEE
Q ss_conf 43102003006499999998--89279999916899--24568799999998841642101376476439-----81899
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSS--SQGYKQFQAEVKLLLRVHHRNLTTLVGYCDEG-----TNMAL 653 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~L 653 (892)
|+..+.||+|+||+||+|+. +++.||||++.... ....+++.+|+.+++.++|+|++++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEEE
T ss_conf 18888983178839999999999979999998820028689999999999998668987425999996346456686499
Q ss_pred EEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 99954588602110136755479999999999999999999708999953567897637986899389953068632237
Q 002688 654 IYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLADFGLSRVFPV 733 (892)
Q Consensus 654 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~~~~ 733 (892)
+++++.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 100 i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD- 172 (348)
T ss_dssp EEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT-
T ss_pred EEEEECCCCHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCC-
T ss_conf 99962588623200224---530999999999999999999738---87651667763345543220013210001257-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCC------
Q ss_conf 9996321145689874481000238-999403499999999999929999986535897529999996730298------
Q 002688 734 EGGTHVSTTIAGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTHVAQWVSSMLDKGD------ 806 (892)
Q Consensus 734 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~l~~~v~~~~~~~~------ 806 (892)
.......|+..|+|||...+. .++.++||||+||++|||++|++||....... ....+........
T Consensus 173 ----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 173 ----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp ----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHTT
T ss_pred ----CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHCCCCCHHHHHH
T ss_conf ----544443454355583553377567855124320589999976889978898899---9999997307997577320
Q ss_pred -C----CCCCC--CCCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -7----64348--97889999-----7889999999997332497999998899999
Q 002688 807 -I----RSTVD--PRLKGDFD-----INSVWKAVEIAMACVSSNANRRPFMNQVVME 851 (892)
Q Consensus 807 -~----~~~iD--p~l~~~~~-----~~~~~~l~~Li~~Cl~~~P~~RPsm~evl~~ 851 (892)
. ..... +... ... ......+.+|+.+|++.+|++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCC-CCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHCCCCC-CCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 01024454443035578-755566267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-41 Score=268.69 Aligned_cols=288 Identities=22% Similarity=0.292 Sum_probs=200.9
Q ss_pred HHHHCEECCCCCEEEEEEEE--CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCC-----------CCCEEEEEEEEEC--
Q ss_conf 43102003006499999998--89279999916899245687999999988416-----------4210137647643--
Q 002688 583 NNFERVLGKGGFGTVYHGKL--DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-----------HRNLTTLVGYCDE-- 647 (892)
Q Consensus 583 ~~~~~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~nIv~l~~~~~~-- 647 (892)
|.+.+.||+|+||.||+|+. +++.||||++..... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 7998997507781899999999997999999834313-368999999999984014555554227676478998763125
Q ss_pred CCCEEEEEEECCCCC-HHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCC------C
Q ss_conf 981899999545886-0211013675547999999999999999999970-8999953567897637986899------3
Q 002688 648 GTNMALIYEYMANGN-LEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQ-GCKPPIVHRDVKSTNILINEKF------Q 719 (892)
Q Consensus 648 ~~~~~LV~Ey~~~gs-L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLkp~NILl~~~~------~ 719 (892)
....+++++++..+. ............+++..+..++.|++.||+|||+ . +|+||||||+|||++.++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred CCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCCCCCCE
T ss_conf 6520234320003542000001223467868999999999999988876405---8646567705705630576564430
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC----HH
Q ss_conf 89953068632237999632114568987448100023899940349999999999992999998653589752----99
Q 002688 720 AKLADFGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEIITGHPVISKSAENGHTH----VA 795 (892)
Q Consensus 720 vkI~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ElltG~~pf~~~~~~~~~~----l~ 795 (892)
++++|||.+...... .....|+..|+|||++....++.++||||+||+++||++|+.||.......... +.
T Consensus 171 ~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred EEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
T ss_conf 567531442123445-----422366521057132146677764320123789999987889989875543210268999
Q ss_pred HHHHHHH-------HC----------CCCCCCCCCC----------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 9999673-------02----------9876434897----------8899997889999999997332497999998899
Q 002688 796 QWVSSML-------DK----------GDIRSTVDPR----------LKGDFDINSVWKAVEIAMACVSSNANRRPFMNQV 848 (892)
Q Consensus 796 ~~v~~~~-------~~----------~~~~~~iDp~----------l~~~~~~~~~~~l~~Li~~Cl~~~P~~RPsm~ev 848 (892)
..+.... .. ......+... ............+.+|+.+|+..||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 99998379987886245322000132012202432357764442100015674358999999999877994579089999
Q ss_pred HHH--HHHHHH---HHHHCCCCCCCCCCCCCCCCCE
Q ss_conf 999--999776---6631035773246899841000
Q 002688 849 VME--LNDCLA---MEAAQKKESITTTDSNNSFEMI 879 (892)
Q Consensus 849 l~~--L~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 879 (892)
+++ +++... .+.+.+.-...+.+.|..|+|+
T Consensus 326 L~Hp~f~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 361 (362)
T d1q8ya_ 326 VNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEV 361 (362)
T ss_dssp HTCGGGTTCTTCTTCCCTTSCTTCBSTTSTTSSSCC
T ss_pred HCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHC
T ss_conf 669340789874447799866678889998435440
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.2e-22 Score=154.88 Aligned_cols=169 Identities=17% Similarity=0.182 Sum_probs=117.3
Q ss_pred HHHCEECCCCCEEEEEEEE-CCCEEEEEECCCCCC------------------HHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 3102003006499999998-892799999168992------------------456879999999884164210137647
Q 002688 584 NFERVLGKGGFGTVYHGKL-DNDEVAVKMLSPSSS------------------QGYKQFQAEVKLLLRVHHRNLTTLVGY 644 (892)
Q Consensus 584 ~~~~~IG~G~fG~Vy~a~~-~~~~vaVK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~nIv~l~~~ 644 (892)
.+.++||+|+||.||+|.. ++..||||++..... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EECCCCEEEEEEECCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEE
Q ss_conf 64398189999954588602110136755479999999999999999999708999953567897637986899389953
Q 002688 645 CDEGTNMALIYEYMANGNLEEHLSDSSKEILNWEERLRIAVEAALGLEYLHQGCKPPIVHRDVKSTNILINEKFQAKLAD 724 (892)
Q Consensus 645 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLkp~NILl~~~~~vkI~D 724 (892)
.. .+++||+++++.+.+ ++......++.|++.+++|||+. +++||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred CC----CEEEEEEECCCCCCC---------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEEEE
T ss_conf 28----889999504565420---------01578999999999999998268---88983689036114289-899987
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 06863223799963211456898744810002389994034999999999
Q 002688 725 FGLSRVFPVEGGTHVSTTIAGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 774 (892)
Q Consensus 725 fGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ 774 (892)
||+|+............ ..... -.+. ..+.++.++|+||..--++
T Consensus 146 FG~a~~~~~~~~~~~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREILE---RDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHH---HHHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 78843089987099998---77999-9999-7578998446899999874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.85 E-value=8.3e-22 Score=149.59 Aligned_cols=126 Identities=29% Similarity=0.535 Sum_probs=106.4
Q ss_pred CCCHHHHHHHHHHHHHCC---CCCCCC-CCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCC--CCHHHHHHCCCC
Q ss_conf 899557999999998529---999999-99999999998712202799999978999908998643--250343201388
Q 002688 360 QTDEQDVDAIMNIKSFYG---LKKNWQ-GDPCAPQDYLWEGLNCSYPDDDSPRITSLNLSASELTG--GFAHYLTNLTML 433 (892)
Q Consensus 360 ~~~~~d~~~l~~~k~~~~---~~~~w~-g~pc~~~~~~w~Gv~C~~~~~~~~~l~~l~L~~n~l~g--~ip~~~~~l~~L 433 (892)
-|.|+|..||.+||+.+. .+.+|. +..||. ..|+||+|+. .+...||+.|+|++++++| .||++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~--~~w~gv~C~~-~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWLGVLCDT-DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT--TCSTTEEECC-SSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC--CCCCCEEEEC-CCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCC
T ss_conf 9898999999999997799986778899999988--9488969748-999479889989899888888798478467533
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCEEEEC
Q ss_conf 7214888-844777885788999997998489967899702222001477413310
Q 002688 434 TSLDLSN-NNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRF 488 (892)
Q Consensus 434 ~~L~Ls~-N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l~l~~ 488 (892)
++|+|++ |+++|.||.++++|++|++|+|++|++.|..|..+..+..+..++++.
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~ 134 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 52020265433300243114542001102035643443322222011100111122
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.34 E-value=1.6e-13 Score=98.17 Aligned_cols=93 Identities=28% Similarity=0.383 Sum_probs=79.8
Q ss_pred CCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCC
Q ss_conf 99997899990899864325034320138872148888447778857889999979984899678997022220014774
Q 002688 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483 (892)
Q Consensus 404 ~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~ 483 (892)
.....++.++++++++++.+| .++.++.|+.|+|++|+|+|.+|..|+.|++|+.|+|++|+|+|.+|. +.++..+.
T Consensus 218 ~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~- 294 (313)
T d1ogqa_ 218 GSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFD- 294 (313)
T ss_dssp CTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSC-
T ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCC-
T ss_conf 222221112222222222222-222455444444765706660876884799999897958835166898-66679989-
Q ss_pred EEEECCCCCCCCCC--CCC
Q ss_conf 13310599888789--542
Q 002688 484 LELRFDGNPDLCRS--ASC 500 (892)
Q Consensus 484 l~l~~~~n~~~c~~--~~c 500 (892)
.+.+.+|+.+||. ++|
T Consensus 295 -~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 295 -VSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp -GGGTCSSSEEESTTSSCC
T ss_pred -HHHHCCCCCCCCCCCCCC
T ss_conf -788688950019898898
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.32 E-value=2.7e-12 Score=90.57 Aligned_cols=93 Identities=27% Similarity=0.283 Sum_probs=43.2
Q ss_pred CCCEEEECC------CCCCCCCEEEEECCCCCCCCCC-HHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 987122027------9999997899990899864325-034320138872148888447778857889999979984899
Q 002688 393 LWEGLNCSY------PDDDSPRITSLNLSASELTGGF-AHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465 (892)
Q Consensus 393 ~w~Gv~C~~------~~~~~~~l~~l~L~~n~l~g~i-p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 465 (892)
.|..|.|+. |.+.+..++.|+|++|.|++.+ +..|.++++|+.|+|++|++.+..+..+..+++|+.|+|++|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CCCEEEEECCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf 69999970899670298989787889848987755302002578762721301363221212122211222210100355
Q ss_pred CCCCCCCHHHHHHCCCCCEE
Q ss_conf 67899702222001477413
Q 002688 466 KLTGPLPVELLEKQENNTLE 485 (892)
Q Consensus 466 ~l~g~iP~~l~~~~~l~~l~ 485 (892)
++++..|..+..+.+++.|+
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEE
T ss_pred CCCCCCHHHHHCCCCCCCCC
T ss_conf 34434979980797465524
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=1.6e-11 Score=85.83 Aligned_cols=108 Identities=26% Similarity=0.349 Sum_probs=85.2
Q ss_pred CCCCCCCCCCCEEEECCCC--------CCCCCEEEEECCCCC-CCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 9999999998712202799--------999978999908998-6432503432013887214888844777885788999
Q 002688 385 DPCAPQDYLWEGLNCSYPD--------DDSPRITSLNLSASE-LTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLS 455 (892)
Q Consensus 385 ~pc~~~~~~w~Gv~C~~~~--------~~~~~l~~l~L~~n~-l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 455 (892)
+.|++. .+++|+|+... ...++++.|+|++|+ |+..-+..|.+|++|+.|+|++|+|+..-|..|..++
T Consensus 3 ~~C~c~--~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~ 80 (156)
T d2ifga3 3 DACCPH--GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80 (156)
T ss_dssp SSSCCS--SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS
T ss_pred CCCCCC--CCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf 978869--999698528997658600257656574316898664436921225666667216202124774201112455
Q ss_pred CCCEEECCCCCCCCCCCHHHHHHCCCCCEEEECCCCCCCCCC
Q ss_conf 997998489967899702222001477413310599888789
Q 002688 456 SLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNPDLCRS 497 (892)
Q Consensus 456 ~L~~L~L~~N~l~g~iP~~l~~~~~l~~l~l~~~~n~~~c~~ 497 (892)
+|+.|+|++|+|+ .+|........+. .+.+++||+.|.+
T Consensus 81 ~L~~L~Ls~N~l~-~l~~~~~~~~~l~--~L~L~~Np~~C~C 119 (156)
T d2ifga3 81 RLSRLNLSFNALE-SLSWKTVQGLSLQ--ELVLSGNPLHCSC 119 (156)
T ss_dssp CCCEEECCSSCCS-CCCSTTTCSCCCC--EEECCSSCCCCCG
T ss_pred CCCCEECCCCCCC-CCCHHHHCCCCCC--CCCCCCCCCCCCC
T ss_conf 4333322678785-1574563353212--4335798633881
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=1.7e-11 Score=85.71 Aligned_cols=91 Identities=30% Similarity=0.319 Sum_probs=80.5
Q ss_pred CCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCC
Q ss_conf 99997899990899864325034320138872148888447778857889999979984899678997022220014774
Q 002688 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483 (892)
Q Consensus 404 ~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~ 483 (892)
....++..|++++|.++...+..+..++.|+.|++++|+|++..|..|..+++|+.|+|++|+|+ .+|.++..+..++
T Consensus 121 ~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~- 198 (266)
T d1p9ag_ 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP- 198 (266)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCS-
T ss_pred CCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCC-
T ss_conf 22211112212434210221233322111000000015652237200134212423430139785-5686677788899-
Q ss_pred EEEECCCCCCCCCC
Q ss_conf 13310599888789
Q 002688 484 LELRFDGNPDLCRS 497 (892)
Q Consensus 484 l~l~~~~n~~~c~~ 497 (892)
.+.+.|||+.|.+
T Consensus 199 -~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 199 -FAFLHGNPWLCNC 211 (266)
T ss_dssp -EEECCSCCBCCSG
T ss_pred -EEEECCCCCCCCC
T ss_conf -9983699987886
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.06 E-value=1.7e-10 Score=79.42 Aligned_cols=91 Identities=24% Similarity=0.269 Sum_probs=81.0
Q ss_pred CCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCE
Q ss_conf 99978999908998643250343201388721488884477788578899999799848996789970222200147741
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL 484 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l 484 (892)
..+.++.|+|++|+|++..+..|..+++|+.|++++|++++..|..|..+++|+.|++++|.+++..|..+..+..+.
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~-- 228 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ-- 228 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC--
T ss_pred CCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC--
T ss_conf 434050223141765662566654656341314211434662816766532000233333522100000235546568--
Q ss_pred EEECCCCCCCCCC
Q ss_conf 3310599888789
Q 002688 485 ELRFDGNPDLCRS 497 (892)
Q Consensus 485 ~l~~~~n~~~c~~ 497 (892)
.+.+++|++.|.+
T Consensus 229 ~L~l~~N~l~C~C 241 (284)
T d1ozna_ 229 YLRLNDNPWVCDC 241 (284)
T ss_dssp EEECCSSCEECSG
T ss_pred EEEECCCCCCCCC
T ss_conf 8981199887875
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.01 E-value=5e-10 Score=76.52 Aligned_cols=92 Identities=29% Similarity=0.306 Sum_probs=60.8
Q ss_pred EEECC------CCCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 22027------999999789999089986432503432013887214888844777885788999997998489967899
Q 002688 397 LNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGP 470 (892)
Q Consensus 397 v~C~~------~~~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~ 470 (892)
|.|++ |.+.++.++.|+|++|.|++..+..|.++++|+.|+|++|+|+ .+|. ++.+++|+.|+|++|++++
T Consensus 15 v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~~- 91 (266)
T d1p9ag_ 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQS- 91 (266)
T ss_dssp EECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCSS-
T ss_pred EECCCCCCCEECCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCCC-CCCCCCCCCCCCCCCCCCC-
T ss_conf 980699988619675768898988499289859778634565522135665444-4311-1112232111112222211-
Q ss_pred CCHHHHHHCCCCCEEEECCCC
Q ss_conf 702222001477413310599
Q 002688 471 LPVELLEKQENNTLELRFDGN 491 (892)
Q Consensus 471 iP~~l~~~~~l~~l~l~~~~n 491 (892)
+|..+..+..++.++++.+..
T Consensus 92 ~~~~~~~l~~L~~L~l~~~~~ 112 (266)
T d1p9ag_ 92 LPLLGQTLPALTVLDVSFNRL 112 (266)
T ss_dssp CCCCTTTCTTCCEEECCSSCC
T ss_pred CCCCCCCCCCCCCCCCCCCCC
T ss_conf 111212222222222222311
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.94 E-value=1.1e-09 Score=74.38 Aligned_cols=86 Identities=22% Similarity=0.262 Sum_probs=50.4
Q ss_pred CCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHH-------HH
Q ss_conf 99789999089986432503432013887214888844777885788999997998489967899702222-------00
Q 002688 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELL-------EK 478 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~-------~~ 478 (892)
.+.++.|++++|.+++..+..+.++++|+.|+|++|+|+ .||..+..+++|+.|+|++|+++ .++.... ..
T Consensus 194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~ 271 (305)
T d1xkua_ 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKK 271 (305)
T ss_dssp CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCHHCCC
T ss_conf 341330154455332223454334433224302554002-46311033467898989898657-6381002672100215
Q ss_pred CCCCCEEEECCCCCCCC
Q ss_conf 14774133105998887
Q 002688 479 QENNTLELRFDGNPDLC 495 (892)
Q Consensus 479 ~~l~~l~l~~~~n~~~c 495 (892)
..+. .+.+.+|++.+
T Consensus 272 ~~L~--~L~L~~N~~~~ 286 (305)
T d1xkua_ 272 ASYS--GVSLFSNPVQY 286 (305)
T ss_dssp CCCS--EEECCSSSSCG
T ss_pred CCCC--EEECCCCCCCC
T ss_conf 8889--78898995766
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.82 E-value=1.9e-09 Score=72.90 Aligned_cols=92 Identities=24% Similarity=0.342 Sum_probs=79.5
Q ss_pred CCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCC
Q ss_conf 99997899990899864325034320138872148888447778857889999979984899678997022220014774
Q 002688 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483 (892)
Q Consensus 404 ~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~ 483 (892)
...++++.|+|++|++.+..+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..|..+..+.+++
T Consensus 51 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~- 129 (192)
T d1w8aa_ 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT- 129 (192)
T ss_dssp GGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC-
T ss_pred CCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC-
T ss_conf 7876272130136322121212221122221010035534434979980797465524577453535977856875334-
Q ss_pred EEEECCCCCCCCCC
Q ss_conf 13310599888789
Q 002688 484 LELRFDGNPDLCRS 497 (892)
Q Consensus 484 l~l~~~~n~~~c~~ 497 (892)
.+.+.+|++.|..
T Consensus 130 -~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 130 -SLNLASNPFNCNC 142 (192)
T ss_dssp -EEECTTCCBCCSG
T ss_pred -CCCCCCCCCCCCC
T ss_conf -2000364434353
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.81 E-value=6.1e-09 Score=69.82 Aligned_cols=84 Identities=27% Similarity=0.306 Sum_probs=64.5
Q ss_pred CCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--HHHHHHCCC
Q ss_conf 999978999908998643250343201388721488884477788578899999799848996789970--222200147
Q 002688 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLP--VELLEKQEN 481 (892)
Q Consensus 404 ~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP--~~l~~~~~l 481 (892)
.....++.|+|++|.|+. +|+.++.+++|+.|++++|+++ .+|. ++.+++|+.|++++|+++. +| ..+..++.+
T Consensus 17 ~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i~~-~~~~~~l~~~~~L 92 (124)
T d1dcea3 17 EQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRL 92 (124)
T ss_dssp GGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCCS-SSTTGGGGGCTTC
T ss_pred CCCCCCCEEECCCCCCCC-CHHHHHHHHCCCCCCCCCCCCC-CCCC-CCCCCCCCEEECCCCCCCC-CCCCHHHCCCCCC
T ss_conf 058988989797871686-5215655431354532432112-3574-1233555768888986588-8882565379999
Q ss_pred CCEEEECCCCCC
Q ss_conf 741331059988
Q 002688 482 NTLELRFDGNPD 493 (892)
Q Consensus 482 ~~l~l~~~~n~~ 493 (892)
.. +.+.+|+.
T Consensus 93 ~~--L~l~~N~i 102 (124)
T d1dcea3 93 VL--LNLQGNSL 102 (124)
T ss_dssp CE--EECTTSGG
T ss_pred CE--EECCCCCC
T ss_conf 99--98979968
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.74 E-value=8.2e-09 Score=69.01 Aligned_cols=75 Identities=29% Similarity=0.375 Sum_probs=63.2
Q ss_pred EEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCEEEECC
Q ss_conf 99990899864325034320138872148888447778857889999979984899678997022220014774133105
Q 002688 410 TSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFD 489 (892)
Q Consensus 410 ~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l~l~~~ 489 (892)
+.|+|++|+|+. ++ .+.+++.|++|+|++|+++ .+|+.++.+++|+.|++++|+++ .+| .+..+++++.++++.+
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCC
T ss_conf 989868998988-71-0105898898979787168-65215655431354532432112-357-4123355576888898
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.70 E-value=1.5e-08 Score=67.39 Aligned_cols=84 Identities=29% Similarity=0.368 Sum_probs=64.9
Q ss_pred CCCCEEEECC------CCCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 9987122027------9999997899990899864325034320138872148888447778857889999979984899
Q 002688 392 YLWEGLNCSY------PDDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN 465 (892)
Q Consensus 392 ~~w~Gv~C~~------~~~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 465 (892)
+.|.+|.|+. |.+.++.++.|+|++|+|+...+.+|.++++|+.|++++|.+....|..|..+++|+.|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ECCCEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCC
T ss_conf 55999985599988519888999798978499189869657604656523112344344523566527985578315687
Q ss_pred CCCCCCCHHHH
Q ss_conf 67899702222
Q 002688 466 KLTGPLPVELL 476 (892)
Q Consensus 466 ~l~g~iP~~l~ 476 (892)
+++ .+|..+.
T Consensus 90 ~l~-~l~~~~~ 99 (305)
T d1xkua_ 90 QLK-ELPEKMP 99 (305)
T ss_dssp CCS-BCCSSCC
T ss_pred CCC-CCCCCHH
T ss_conf 567-6764001
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.68 E-value=1.7e-08 Score=67.08 Aligned_cols=82 Identities=18% Similarity=0.238 Sum_probs=61.0
Q ss_pred CCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHH-HHHHCCCCC
Q ss_conf 9997899990899864325034320138872148888447778857889999979984899678997022-220014774
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVE-LLEKQENNT 483 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~-l~~~~~l~~ 483 (892)
.+.+++.|+|++|+|+. |+..+..+++|+.|+|++|+++ .++. +..+++|+.|+|++|+++ .+|.. +..++.+..
T Consensus 16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTE 91 (162)
T ss_dssp CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EECC-CCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCE
T ss_pred CCCCCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCC-CCCC-CCCCCCHHHHHCCCCCCC-CCCCCCCCCCCCCCC
T ss_conf 85748489788997886-5762004145998989799787-6477-445761306431021345-777632233453443
Q ss_pred EEEECCCCC
Q ss_conf 133105998
Q 002688 484 LELRFDGNP 492 (892)
Q Consensus 484 l~l~~~~n~ 492 (892)
+++ .+|.
T Consensus 92 L~L--~~N~ 98 (162)
T d1a9na_ 92 LIL--TNNS 98 (162)
T ss_dssp EEC--CSCC
T ss_pred CEE--CCCC
T ss_conf 420--3000
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.67 E-value=1.7e-08 Score=66.97 Aligned_cols=87 Identities=22% Similarity=0.166 Sum_probs=71.4
Q ss_pred CCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCC
Q ss_conf 99997899990899864325034320138872148888447778857889999979984899678997022220014774
Q 002688 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483 (892)
Q Consensus 404 ~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~ 483 (892)
.....+..+++++|+|++..+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|++++..|..+..+.++..
T Consensus 126 ~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~ 205 (284)
T d1ozna_ 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205 (284)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCC
T ss_conf 20001211020014314458057404340502231417656625666546563413142114346628167665320002
Q ss_pred EEEECCC
Q ss_conf 1331059
Q 002688 484 LELRFDG 490 (892)
Q Consensus 484 l~l~~~~ 490 (892)
++++.+.
T Consensus 206 L~l~~N~ 212 (284)
T d1ozna_ 206 LYLFANN 212 (284)
T ss_dssp EECCSSC
T ss_pred CCCCCCC
T ss_conf 3333352
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.65 E-value=1.8e-08 Score=66.85 Aligned_cols=78 Identities=23% Similarity=0.372 Sum_probs=64.8
Q ss_pred CCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCC
Q ss_conf 99997899990899864325034320138872148888447778857889999979984899678997022220014774
Q 002688 404 DDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNT 483 (892)
Q Consensus 404 ~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~ 483 (892)
...+.++.|+|++|++++ ++ .+..+++|+.|+|++|++++ +| .++.+++|+.|+|++|++++..| +..+++++.
T Consensus 304 ~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~ 377 (384)
T d2omza2 304 SNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQ 377 (384)
T ss_dssp GGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSE
T ss_pred CHHCCCCEEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCE
T ss_conf 000246767777887789-84-53668988989898998999-74-67089999989897995899800--003999999
Q ss_pred EEEE
Q ss_conf 1331
Q 002688 484 LELR 487 (892)
Q Consensus 484 l~l~ 487 (892)
|+++
T Consensus 378 L~L~ 381 (384)
T d2omza2 378 LGLN 381 (384)
T ss_dssp EECC
T ss_pred EECC
T ss_conf 6397
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=6.5e-07 Score=57.21 Aligned_cols=133 Identities=16% Similarity=0.146 Sum_probs=88.3
Q ss_pred CCC-CEEEEEEEECCCEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECCCCEEEEEEECCCCCHHHHCC
Q ss_conf 006-49999999889279999916899245687999999988416-4210137647643981899999545886021101
Q 002688 591 KGG-FGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVH-HRNLTTLVGYCDEGTNMALIYEYMANGNLEEHLS 668 (892)
Q Consensus 591 ~G~-fG~Vy~a~~~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~LV~Ey~~~gsL~~~L~ 668 (892)
.|. .+.||+...+++.+.+|+...........+.+|...+..+. +--+.+++.+...++..++||+++++.++.+...
T Consensus 23 ~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 23 EGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp CCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCCCCCEEEEEECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCCCCCCC
T ss_conf 89987718999908986999984887653255699999999987606998728999750896499998604334354334
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------------------------
Q ss_conf 367554799999999999999999997089--------------------------------------------------
Q 002688 669 DSSKEILNWEERLRIAVEAALGLEYLHQGC-------------------------------------------------- 698 (892)
Q Consensus 669 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------------- 698 (892)
.. .. ...++.+++..+..||+..
T Consensus 103 ~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 103 DE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp TC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred CC----CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHH
T ss_conf 40----26---999999899999998556842143576446565557789987765555430332320057999999998
Q ss_pred ------CCCCCCCCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf ------99953567897637986899389953068632
Q 002688 699 ------KPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 699 ------~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~ 730 (892)
.+.++|+|+.+.|||++++...-|+||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 44986781789860047642364996599960231441
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=6.7e-08 Score=63.32 Aligned_cols=83 Identities=22% Similarity=0.178 Sum_probs=61.7
Q ss_pred CCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH--HHHHHCCCCC
Q ss_conf 99789999089986432503432013887214888844777885788999997998489967899702--2220014774
Q 002688 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPV--ELLEKQENNT 483 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~--~l~~~~~l~~ 483 (892)
...++.|+|++|.|+. ++ .|..+++|+.|+|++|+++...+..+..+++|+.|+|++|+++ .++. .+..++++.
T Consensus 40 l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~- 115 (162)
T d1a9na_ 40 LDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLT- 115 (162)
T ss_dssp TTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCC-
T ss_pred CCCCCEEECCCCCCCC-CC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEECCCCCC-CCCCCCCCCCCCCCC-
T ss_conf 1459989897997876-47-7445761306431021345777632233453443420300016-654211001365320-
Q ss_pred EEEECCCCCC
Q ss_conf 1331059988
Q 002688 484 LELRFDGNPD 493 (892)
Q Consensus 484 l~l~~~~n~~ 493 (892)
.+.+.+|+.
T Consensus 116 -~L~l~~N~i 124 (162)
T d1a9na_ 116 -YLCILRNPV 124 (162)
T ss_dssp -EEECCSSGG
T ss_pred -HHHCCCCCC
T ss_conf -664079963
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.42 E-value=2.4e-07 Score=59.88 Aligned_cols=77 Identities=19% Similarity=0.322 Sum_probs=63.5
Q ss_pred CCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCE
Q ss_conf 99978999908998643250343201388721488884477788578899999799848996789970222200147741
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL 484 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l 484 (892)
..++++.|++++|.++.. + .++++++|+.|+|++|++++ +|. ++.+++|+.|+|++|++++ +|. +..++.+..+
T Consensus 149 ~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L 222 (227)
T d1h6ua2 149 GLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VSP-LANTSNLFIV 222 (227)
T ss_dssp GCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEE
T ss_pred CCCCCCCCCCCCCCCCCC-H-HHCCCCCCEECCCCCCCCCC-CHH-HCCCCCCCEEECCCCCCCC-CCC-CCCCCCCCEE
T ss_conf 021110023333333310-0-10564633564458884177-853-4479999989795996899-802-0369998989
Q ss_pred EEE
Q ss_conf 331
Q 002688 485 ELR 487 (892)
Q Consensus 485 ~l~ 487 (892)
+++
T Consensus 223 ~ls 225 (227)
T d1h6ua2 223 TLT 225 (227)
T ss_dssp EEE
T ss_pred EEE
T ss_conf 712
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.37 E-value=5.5e-07 Score=57.66 Aligned_cols=77 Identities=29% Similarity=0.365 Sum_probs=51.1
Q ss_pred CCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCE
Q ss_conf 99978999908998643250343201388721488884477788578899999799848996789970222200147741
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL 484 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l 484 (892)
....+..+.++.|.+++ ++ .+..++.++.|+|++|++++ ++. +..+++|+.|+|++|++++ +| .+..++.++.+
T Consensus 283 ~~~~l~~l~~~~n~l~~-~~-~~~~~~~l~~L~ls~n~l~~-l~~-l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L 356 (384)
T d2omza2 283 GLTALTNLELNENQLED-IS-PISNLKNLTYLTLYFNNISD-ISP-VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWL 356 (384)
T ss_dssp TCTTCSEEECCSSCCSC-CG-GGGGCTTCSEEECCSSCCSC-CGG-GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEE
T ss_pred CCCCCCCCCCCCCCCCC-CC-CCCHHCCCCEEECCCCCCCC-CCC-CCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEE
T ss_conf 56522223323233333-22-10000246767777887789-845-3668988989898998999-74-67089999989
Q ss_pred EEE
Q ss_conf 331
Q 002688 485 ELR 487 (892)
Q Consensus 485 ~l~ 487 (892)
+++
T Consensus 357 ~l~ 359 (384)
T d2omza2 357 SAG 359 (384)
T ss_dssp ECC
T ss_pred ECC
T ss_conf 897
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=7e-07 Score=57.02 Aligned_cols=63 Identities=25% Similarity=0.124 Sum_probs=39.5
Q ss_pred CCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 9997899990899864325034320138872148888447778857889999979984899678
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~ 468 (892)
..++|+.|+|++|+|+...+..|..+++|+.|+|++|+|+ .+|.......+|+.|+|++|.|.
T Consensus 54 ~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 54 GLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 6666672162021247742011124554333322678785-15745633532124335798633
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=5.3e-07 Score=57.76 Aligned_cols=77 Identities=23% Similarity=0.248 Sum_probs=52.3
Q ss_pred CCCEEEEECCCCCCCCCCHHHHHHCCCCCCC-CCCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCH-HHHHHCCCC
Q ss_conf 9978999908998643250343201388721-4888844777885-788999997998489967899702-222001477
Q 002688 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSL-DLSNNNLTGPVPK-FLSQLSSLKFLNLARNKLTGPLPV-ELLEKQENN 482 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L-~Ls~N~l~g~iP~-~l~~l~~L~~L~L~~N~l~g~iP~-~l~~~~~l~ 482 (892)
...++.|++++|+++. ++....+.+++..+ ++++|+++ .||. .|..+++|+.|+|++|+++ .+|. .+.++..++
T Consensus 152 ~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~ 228 (242)
T d1xwdc1 152 SFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLR 228 (242)
T ss_dssp BSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEE
T ss_pred CCCCEEEECCCCCCCC-CCCCCCCCHHHHCCCCCCCCCCC-CCCHHHHCCCCCCCEEECCCCCCC-CCCHHHHCCCCCCC
T ss_conf 3310012200123333-22222220111012123543246-424788668999998989799289-45977973771341
Q ss_pred CEE
Q ss_conf 413
Q 002688 483 TLE 485 (892)
Q Consensus 483 ~l~ 485 (892)
.++
T Consensus 229 ~l~ 231 (242)
T d1xwdc1 229 ARS 231 (242)
T ss_dssp SSS
T ss_pred CCC
T ss_conf 476
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.19 E-value=2.4e-06 Score=53.72 Aligned_cols=77 Identities=30% Similarity=0.454 Sum_probs=58.3
Q ss_pred CCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCE
Q ss_conf 99978999908998643250343201388721488884477788578899999799848996789970222200147741
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL 484 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l 484 (892)
..+.+..++++.|.+++ +..++++++|+.+++++|++++ +++ ++.+++|+.|+|++|+++ .+| .+..+.+++.|
T Consensus 132 ~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L 205 (210)
T d1h6ta2 132 HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVL 205 (210)
T ss_dssp GCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEE
T ss_pred CCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEE
T ss_conf 11112221122233345--4310001332100134643025-645-367898999989799899-872-11699998999
Q ss_pred EEE
Q ss_conf 331
Q 002688 485 ELR 487 (892)
Q Consensus 485 ~l~ 487 (892)
+++
T Consensus 206 ~Ls 208 (210)
T d1h6ta2 206 ELF 208 (210)
T ss_dssp EEE
T ss_pred ECC
T ss_conf 711
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.18 E-value=2.2e-06 Score=54.00 Aligned_cols=40 Identities=35% Similarity=0.474 Sum_probs=13.9
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 320138872148888447778857889999979984899678
Q 002688 427 LTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468 (892)
Q Consensus 427 ~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~ 468 (892)
+..+++|+.|+|++|++++ +|+ ++.+++|+.|++++|+++
T Consensus 64 l~~l~~L~~L~L~~n~i~~-l~~-~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 64 IQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVK 103 (210)
T ss_dssp GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred HHHCCCCCEEECCCCCCCC-CCC-CCCCCCCCCCCCCCCCCC
T ss_conf 7648998987698960258-601-135862120143333321
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.16 E-value=3.1e-06 Score=53.01 Aligned_cols=72 Identities=25% Similarity=0.436 Sum_probs=50.7
Q ss_pred CCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCC
Q ss_conf 999789999089986432503432013887214888844777885788999997998489967899702222001477
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENN 482 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~ 482 (892)
..++++.|++++|++.. ++ .+..+++|+.|++++|++++ +++ ++.+++|+.|+|++|+++. +| .+..+.+++
T Consensus 126 ~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~-l~~-l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~ 197 (199)
T d2omxa2 126 NLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTD-LKP-LANLTTLERLDISSNKVSD-IS-VLAKLTNLE 197 (199)
T ss_dssp TCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCS
T ss_pred HHHHHHHHHHHHHHHCC-CC-CCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCEEECCCCCCCC-CC-CCCCCCCCC
T ss_conf 12236776431111002-34-33321111112234555567-701-1679989999787997998-81-012789989
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.10 E-value=5.1e-06 Score=51.67 Aligned_cols=75 Identities=33% Similarity=0.455 Sum_probs=34.8
Q ss_pred CCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCEE
Q ss_conf 99789999089986432503432013887214888844777885788999997998489967899702222001477413
Q 002688 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLE 485 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l~ 485 (892)
.+.++.|+++++.+.. ++ .+..+++|+.|++++|++. .+| .+..+++|+.|++++|++++ ++ .+..+++++.++
T Consensus 105 l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ 178 (199)
T d2omxa2 105 LTNLTGLTLFNNQITD-ID-PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLD 178 (199)
T ss_dssp CTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEE
T ss_pred CCCCCCCCCCCCCCCC-CC-CCCHHHHHHHHHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCEEE
T ss_conf 2232221112222223-21-0001223677643111100-234-33321111112234555567-70-116799899997
Q ss_pred E
Q ss_conf 3
Q 002688 486 L 486 (892)
Q Consensus 486 l 486 (892)
+
T Consensus 179 l 179 (199)
T d2omxa2 179 I 179 (199)
T ss_dssp C
T ss_pred C
T ss_conf 8
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=0.00016 Score=42.36 Aligned_cols=140 Identities=15% Similarity=0.071 Sum_probs=80.3
Q ss_pred EECCCCC-EEEEEEEEC-CCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCC--EEEEEEEEECCCCEEEEEEECCCCCH
Q ss_conf 0030064-999999988-9279999916899245687999999988416421--01376476439818999995458860
Q 002688 588 VLGKGGF-GTVYHGKLD-NDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRN--LTTLVGYCDEGTNMALIYEYMANGNL 663 (892)
Q Consensus 588 ~IG~G~f-G~Vy~a~~~-~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~LV~Ey~~~gsL 663 (892)
.+..|.. +.||+...+ +..+.+|....... ..+..|...++.+.... +.+++.++.+++..++|++++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 76786547758999938987899995896677---689999999999986599988613222456615999874413554
Q ss_pred HHHC-----------------CCCC--CCC--CCHHHHHHHHH--------------------HHHHHHHHHHHCC----
Q ss_conf 2110-----------------1367--554--79999999999--------------------9999999997089----
Q 002688 664 EEHL-----------------SDSS--KEI--LNWEERLRIAV--------------------EAALGLEYLHQGC---- 698 (892)
Q Consensus 664 ~~~L-----------------~~~~--~~~--l~~~~~~~i~~--------------------~ia~gL~yLH~~~---- 698 (892)
.+.. +... ... -.+.....-.. .....+..+....
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 32212689999999999998736885448875541246889999998754110113401121379999999987187657
Q ss_pred CCCCCCCCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 99953567897637986899389953068632
Q 002688 699 KPPIVHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 699 ~~~iiHrDLkp~NILl~~~~~vkI~DfGla~~ 730 (892)
.+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 95678678887635773796589998533265
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.98 E-value=8.5e-06 Score=50.28 Aligned_cols=65 Identities=28% Similarity=0.299 Sum_probs=51.1
Q ss_pred CCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHH
Q ss_conf 99978999908998643250343201388721488884477788578899999799848996789970222200
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEK 478 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~ 478 (892)
.++.++.|+|++|+|+. +|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+++ .+|.....+
T Consensus 282 ~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L 346 (353)
T d1jl5a_ 282 LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESV 346 (353)
T ss_dssp CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTC
T ss_pred CCCCCCEEECCCCCCCC-CCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCCCCC
T ss_conf 68988989797991683-5665---487998989999687-54532---288898987699189-777652656
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.97 E-value=1.4e-07 Score=61.30 Aligned_cols=80 Identities=16% Similarity=0.199 Sum_probs=57.9
Q ss_pred CCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCE
Q ss_conf 99978999908998643250343201388721488884477788578899999799848996789970222200147741
Q 002688 405 DSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTL 484 (892)
Q Consensus 405 ~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l 484 (892)
....++.|+|++|+|+. ++ .+..|++|+.|+|++|+++ .+|.....+++|+.|++++|+++ .++ .+..+.+++.+
T Consensus 46 ~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L 120 (198)
T d1m9la_ 46 TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVL 120 (198)
T ss_dssp HTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEE
T ss_pred CCCCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCC
T ss_conf 26046151994468998-64-4247825357341353432-10000332212333333332222-222-22222234111
Q ss_pred EEECC
Q ss_conf 33105
Q 002688 485 ELRFD 489 (892)
Q Consensus 485 ~l~~~ 489 (892)
+++.+
T Consensus 121 ~L~~N 125 (198)
T d1m9la_ 121 YMSNN 125 (198)
T ss_dssp EESEE
T ss_pred CCCCC
T ss_conf 23410
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.94 E-value=8.9e-06 Score=50.17 Aligned_cols=75 Identities=27% Similarity=0.320 Sum_probs=53.5
Q ss_pred CCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCEE
Q ss_conf 99789999089986432503432013887214888844777885788999997998489967899702222001477413
Q 002688 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLE 485 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l~ 485 (892)
+......++..+.+.+ ++ ..+++|+.|+|++|+|+ .+|.. +++|+.|+|++|+++ .+|..+. +++.
T Consensus 263 ~~~~~~~~~~~~~~~~-~~---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~~~---~L~~-- 328 (353)
T d1jl5a_ 263 PPNLYYLNASSNEIRS-LC---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELPQ---NLKQ-- 328 (353)
T ss_dssp CTTCCEEECCSSCCSE-EC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCCT---TCCE--
T ss_pred CCHHCCCCCCCCCCCC-CC---CCCCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCCC---CCCE--
T ss_conf 3000123333575323-45---66898898979799168-35665---487998989999687-5453228---8898--
Q ss_pred EECCCCCCC
Q ss_conf 310599888
Q 002688 486 LRFDGNPDL 494 (892)
Q Consensus 486 l~~~~n~~~ 494 (892)
+.+.+|+-.
T Consensus 329 L~L~~N~L~ 337 (353)
T d1jl5a_ 329 LHVEYNPLR 337 (353)
T ss_dssp EECCSSCCS
T ss_pred EECCCCCCC
T ss_conf 987699189
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.88 E-value=1.3e-07 Score=61.49 Aligned_cols=59 Identities=20% Similarity=0.308 Sum_probs=26.4
Q ss_pred CCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 97899990899864325034320138872148888447778857889999979984899678
Q 002688 407 PRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLT 468 (892)
Q Consensus 407 ~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~ 468 (892)
++++.|+|++|.|+. +|..+..+..|+.|++++|+++ .++. +..+++|+.|+|++|+++
T Consensus 70 ~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 70 ENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp TTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECC-CHHH-HHHHHHSSEEEESEEECC
T ss_pred CCCCCHHHCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC-CCCC-CCCCCCCCCCCCCCCHHC
T ss_conf 253573413534321-0000332212333333332222-2222-222223411123410212
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.86 E-value=0.00011 Score=43.48 Aligned_cols=75 Identities=13% Similarity=0.162 Sum_probs=45.9
Q ss_pred CEECCCCCEEEEEEEE--CCCEEEEEECCCC-------CCHHHHHHHHHHHHHHHCC--C-CCEEEEEEEEECCCCEEEE
Q ss_conf 2003006499999998--8927999991689-------9245687999999988416--4-2101376476439818999
Q 002688 587 RVLGKGGFGTVYHGKL--DNDEVAVKMLSPS-------SSQGYKQFQAEVKLLLRVH--H-RNLTTLVGYCDEGTNMALI 654 (892)
Q Consensus 587 ~~IG~G~fG~Vy~a~~--~~~~vaVK~l~~~-------~~~~~~~f~~E~~~l~~l~--H-~nIv~l~~~~~~~~~~~LV 654 (892)
+.||.|....||+... ++..++||.-... ......+...|.+.+..+. - ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf 9807985276899995799848999617713034677788877899999999998650579885528998--59887798
Q ss_pred EEECCCCCH
Q ss_conf 995458860
Q 002688 655 YEYMANGNL 663 (892)
Q Consensus 655 ~Ey~~~gsL 663 (892)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EECCCCCCC
T ss_conf 713577653
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=97.79 E-value=3.5e-05 Score=46.45 Aligned_cols=76 Identities=24% Similarity=0.294 Sum_probs=47.2
Q ss_pred CCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCEE
Q ss_conf 99789999089986432503432013887214888844777885788999997998489967899702222001477413
Q 002688 406 SPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLE 485 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l~ 485 (892)
.+.+..+.++++.+.... .+.++++|+.|++++|.+++ ++. ++.+++|+.|+|++|++++ +|. +..++++..|+
T Consensus 128 ~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~-~~~-l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~ 201 (227)
T d1h6ua2 128 LSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVH 201 (227)
T ss_dssp CTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEE
T ss_pred CCCHHHHHCHHHHHCHHH--HHCCCCCCCCCCCCCCCCCC-CHH-HCCCCCCEECCCCCCCCCC-CHH-HCCCCCCCEEE
T ss_conf 230122200000000000--00102111002333333331-001-0564633564458884177-853-44799999897
Q ss_pred EE
Q ss_conf 31
Q 002688 486 LR 487 (892)
Q Consensus 486 l~ 487 (892)
++
T Consensus 202 Ls 203 (227)
T d1h6ua2 202 LK 203 (227)
T ss_dssp CT
T ss_pred CC
T ss_conf 95
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.67 E-value=4.7e-06 Score=51.88 Aligned_cols=75 Identities=29% Similarity=0.293 Sum_probs=49.5
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCEEEECCCCCCCC
Q ss_conf 6432503432013887214888844777--8857889999979984899678997022220014774133105998887
Q 002688 419 LTGGFAHYLTNLTMLTSLDLSNNNLTGP--VPKFLSQLSSLKFLNLARNKLTGPLPVELLEKQENNTLELRFDGNPDLC 495 (892)
Q Consensus 419 l~g~ip~~~~~l~~L~~L~Ls~N~l~g~--iP~~l~~l~~L~~L~L~~N~l~g~iP~~l~~~~~l~~l~l~~~~n~~~c 495 (892)
+...++..+..++.|+.|+|++|+++.. ++..+..+++|+.|+|++|.++ .++. +..+.......+.+.|||..+
T Consensus 53 ~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~-l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 53 MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERE-LDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGG-HHHHTTCCCSSCCCTTSTTSS
T ss_pred HHHHHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCC-CCHH-HHHHHCCCCCEEECCCCCCCC
T ss_conf 7666078897487878863777666677315889865885610004357213-4234-422203310426648997676
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=8.4e-05 Score=44.14 Aligned_cols=98 Identities=14% Similarity=0.117 Sum_probs=66.6
Q ss_pred CCCCEEEECCC------CCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCEEECC-
Q ss_conf 99871220279------99999789999089986432503432013887214888844777885-78899999799848-
Q 002688 392 YLWEGLNCSYP------DDDSPRITSLNLSASELTGGFAHYLTNLTMLTSLDLSNNNLTGPVPK-FLSQLSSLKFLNLA- 463 (892)
Q Consensus 392 ~~w~Gv~C~~~------~~~~~~l~~l~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~L~- 463 (892)
+.+..|.|+.. ...+..++.|+|++|.|+...+..|.++++|++|+|++|.+...+|. .|..++.++.|.+.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CCCCEEEEECCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf 73999998189988768888998899987699189649668614643232110221124201001122222222211111
Q ss_pred CCCCCCCCCHHHHHHCCCCCEEEECC
Q ss_conf 99678997022220014774133105
Q 002688 464 RNKLTGPLPVELLEKQENNTLELRFD 489 (892)
Q Consensus 464 ~N~l~g~iP~~l~~~~~l~~l~l~~~ 489 (892)
.|++....+..+..+++++.+.+.-+
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~ 113 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNT 113 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 23432222221222222222234211
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.44 E-value=9.4e-06 Score=50.02 Aligned_cols=67 Identities=27% Similarity=0.222 Sum_probs=53.8
Q ss_pred CCCEEEEECCCCCCCCC--CHHHHHHCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCH
Q ss_conf 99789999089986432--503432013887214888844777885-788999997998489967899702
Q 002688 406 SPRITSLNLSASELTGG--FAHYLTNLTMLTSLDLSNNNLTGPVPK-FLSQLSSLKFLNLARNKLTGPLPV 473 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~--ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~L~~N~l~g~iP~ 473 (892)
.+.++.|+|++|+|+.. ++..+..+++|+.|+|++|+++ .+++ .......|+.|+|++|.++.....
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~ 133 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRD 133 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred CCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCC-CCHHHHHHHCCCCCEEECCCCCCCCCCCC
T ss_conf 87878863777666677315889865885610004357213-42344222033104266489976767666
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.27 E-value=3.2e-05 Score=46.76 Aligned_cols=82 Identities=24% Similarity=0.269 Sum_probs=46.7
Q ss_pred CCCEEEEECCCCCCCCC-CHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCC-CCHHHHHHCCCC
Q ss_conf 99789999089986432-5034320138872148888447778857889999979984899-67899-702222001477
Q 002688 406 SPRITSLNLSASELTGG-FAHYLTNLTMLTSLDLSNNNLTGPVPKFLSQLSSLKFLNLARN-KLTGP-LPVELLEKQENN 482 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~-ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N-~l~g~-iP~~l~~~~~l~ 482 (892)
..+++.|+|+++.++.. +...+.++++|++|+|+++.+++..+..++.+++|+.|+|+++ .++.. +..-...+++++
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCC
T ss_conf 78788788989845777999999748776514523467986789998518997571510013412355403657887435
Q ss_pred CEEEE
Q ss_conf 41331
Q 002688 483 TLELR 487 (892)
Q Consensus 483 ~l~l~ 487 (892)
.++++
T Consensus 125 ~L~ls 129 (284)
T d2astb2 125 ELNLS 129 (284)
T ss_dssp EEECC
T ss_pred CCCCC
T ss_conf 65224
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.27 E-value=3.9e-05 Score=46.21 Aligned_cols=63 Identities=32% Similarity=0.397 Sum_probs=38.9
Q ss_pred CCEEEEECCCCCCCCCCHHHHH-----HCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 9789999089986432503432-----013887214888844777----88578899999799848996789
Q 002688 407 PRITSLNLSASELTGGFAHYLT-----NLTMLTSLDLSNNNLTGP----VPKFLSQLSSLKFLNLARNKLTG 469 (892)
Q Consensus 407 ~~l~~l~L~~n~l~g~ip~~~~-----~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~g 469 (892)
+.++.|+|++|.|+..-...+. ..+.|+.|+|++|+++.. ++..+..+++|+.|+|++|.++.
T Consensus 55 ~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 55 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf 998889795985972899999999843788778877888775432210121100003432002444332023
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.20 E-value=0.0047 Score=33.29 Aligned_cols=133 Identities=15% Similarity=0.192 Sum_probs=72.6
Q ss_pred EEEEEEEE-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEE--EEEE-----EEECCCCEEEEEEECCCCCHHHH
Q ss_conf 99999998-8927999991689924568799999998841642101--3764-----76439818999995458860211
Q 002688 595 GTVYHGKL-DNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLT--TLVG-----YCDEGTNMALIYEYMANGNLEEH 666 (892)
Q Consensus 595 G~Vy~a~~-~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv--~l~~-----~~~~~~~~~LV~Ey~~~gsL~~~ 666 (892)
-.||++.. +|..+++|+..... ...+++..|...+..+....+. ..+. ....++..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred CEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf 02699983899979999847877-88999999999999998559987875206898056653479999865277688999
Q ss_pred ----C----------C----CC---CCCCCCHH----------------------HHHHHHHHHHHHHHHHH-HCCCCCC
Q ss_conf ----0----------1----36---75547999----------------------99999999999999997-0899995
Q 002688 667 ----L----------S----DS---SKEILNWE----------------------ERLRIAVEAALGLEYLH-QGCKPPI 702 (892)
Q Consensus 667 ----L----------~----~~---~~~~l~~~----------------------~~~~i~~~ia~gL~yLH-~~~~~~i 702 (892)
+ + .. .+..+++. .....+..+...+.-.- .....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEE
T ss_conf 99999998999999886303578655677897887665689998747699889899999999999999984545687120
Q ss_pred CCCCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 3567897637986899389953068632
Q 002688 703 VHRDVKSTNILINEKFQAKLADFGLSRV 730 (892)
Q Consensus 703 iHrDLkp~NILl~~~~~vkI~DfGla~~ 730 (892)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.18 E-value=0.0039 Score=33.81 Aligned_cols=140 Identities=9% Similarity=0.023 Sum_probs=72.9
Q ss_pred EECCCCCEEEEEEEECCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEE--EEEE------EEECCCCEEEEEEECC
Q ss_conf 0030064999999988927999991689924568799999998841642101--3764------7643981899999545
Q 002688 588 VLGKGGFGTVYHGKLDNDEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLT--TLVG------YCDEGTNMALIYEYMA 659 (892)
Q Consensus 588 ~IG~G~fG~Vy~a~~~~~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv--~l~~------~~~~~~~~~LV~Ey~~ 659 (892)
.|..|---+.|+.+.++..+++|+..... ..++...|...+..+....+. ..+. ..........++.+..
T Consensus 25 ~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCCCCCCEEEEEECCCCEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEEECC
T ss_conf 37888526738999789728999807899--9889999999987543025554556410489762134125502453114
Q ss_pred CCCHHHHC--------------CC----C----CCCCC-----------------CHHHHHHHHHHHHHHHHHHHH-CCC
Q ss_conf 88602110--------------13----6----75547-----------------999999999999999999970-899
Q 002688 660 NGNLEEHL--------------SD----S----SKEIL-----------------NWEERLRIAVEAALGLEYLHQ-GCK 699 (892)
Q Consensus 660 ~gsL~~~L--------------~~----~----~~~~l-----------------~~~~~~~i~~~ia~gL~yLH~-~~~ 699 (892)
+......- +. . ..... ........+......+...+. ...
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 65533320467888889987645444320245310111012002456777765311412799999998764204855454
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 995356789763798689938995306863
Q 002688 700 PPIVHRDVKSTNILINEKFQAKLADFGLSR 729 (892)
Q Consensus 700 ~~iiHrDLkp~NILl~~~~~vkI~DfGla~ 729 (892)
.+++|+|+.++|++++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 503337863656402045412674222123
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.13 E-value=0.00029 Score=40.82 Aligned_cols=81 Identities=31% Similarity=0.321 Sum_probs=55.0
Q ss_pred CCCEEEEECCCC--CCCC-CCHHHHHHCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCHHHHHHCC
Q ss_conf 997899990899--8643-25034320138872148888-44777885788999997998489-9678997022220014
Q 002688 406 SPRITSLNLSAS--ELTG-GFAHYLTNLTMLTSLDLSNN-NLTGPVPKFLSQLSSLKFLNLAR-NKLTGPLPVELLEKQE 480 (892)
Q Consensus 406 ~~~l~~l~L~~n--~l~g-~ip~~~~~l~~L~~L~Ls~N-~l~g~iP~~l~~l~~L~~L~L~~-N~l~g~iP~~l~~~~~ 480 (892)
.+.++.|+|++. .++. .+..-+.++++|+.|+|+++ .+++..+..++.+++|+.|+|++ +.++......+.++++
T Consensus 147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~ 226 (284)
T d2astb2 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226 (284)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCC
T ss_conf 11110122135542444443434232322212355322347783033332135768779899999787378999726999
Q ss_pred CCCEEE
Q ss_conf 774133
Q 002688 481 NNTLEL 486 (892)
Q Consensus 481 l~~l~l 486 (892)
++.+++
T Consensus 227 L~~L~l 232 (284)
T d2astb2 227 LKTLQV 232 (284)
T ss_dssp CCEEEC
T ss_pred CCEEEE
T ss_conf 898964
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.08 E-value=3.2e-05 Score=46.75 Aligned_cols=78 Identities=24% Similarity=0.224 Sum_probs=39.6
Q ss_pred CEEEEECCCCCCCC----CCHHHHHHCCCCCCCCCCCCCCCC----CCCCCCCC-CCCCCEEECCCCCCCCC----CCHH
Q ss_conf 78999908998643----250343201388721488884477----78857889-99997998489967899----7022
Q 002688 408 RITSLNLSASELTG----GFAHYLTNLTMLTSLDLSNNNLTG----PVPKFLSQ-LSSLKFLNLARNKLTGP----LPVE 474 (892)
Q Consensus 408 ~l~~l~L~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g----~iP~~l~~-l~~L~~L~L~~N~l~g~----iP~~ 474 (892)
.++.|+|++|+++- .|+..+..+++|+.|||++|+++. .+...+.. ..+|+.|+|++|+++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCH
T ss_conf 99999828999988999999999853999888979598597289999999984378877887788877543221012110
Q ss_pred HHHHCCCCCEE
Q ss_conf 22001477413
Q 002688 475 LLEKQENNTLE 485 (892)
Q Consensus 475 l~~~~~l~~l~ 485 (892)
+..+..++.++
T Consensus 108 l~~~~~L~~L~ 118 (460)
T d1z7xw1 108 LRTLPTLQELH 118 (460)
T ss_dssp TTSCTTCCEEE
T ss_pred HHCCCCCCCCC
T ss_conf 00034320024
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.78 E-value=0.00018 Score=42.10 Aligned_cols=64 Identities=13% Similarity=0.127 Sum_probs=35.9
Q ss_pred CCEEEEECCCCCCCCC----CHHHHHHCCCCCCCCCCCCCCCCC----------CCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 9789999089986432----503432013887214888844777----------885788999997998489967899
Q 002688 407 PRITSLNLSASELTGG----FAHYLTNLTMLTSLDLSNNNLTGP----------VPKFLSQLSSLKFLNLARNKLTGP 470 (892)
Q Consensus 407 ~~l~~l~L~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----------iP~~l~~l~~L~~L~L~~N~l~g~ 470 (892)
..++.|+|++|.+... +...+..++.|+.|+|+++.+... +-..+...++|+.|+|++|.++..
T Consensus 31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 108 (344)
T d2ca6a1 31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108 (344)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTT
T ss_pred CCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 997889784983778999999999985899888888777543345421067879998875477756330000134554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.56 E-value=0.016 Score=30.03 Aligned_cols=72 Identities=17% Similarity=0.257 Sum_probs=45.2
Q ss_pred CEECCCCCEEEEEEEECC---------CEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEE-EEEEEEECCCCEEEEEE
Q ss_conf 200300649999999889---------27999991689924568799999998841642101-37647643981899999
Q 002688 587 RVLGKGGFGTVYHGKLDN---------DEVAVKMLSPSSSQGYKQFQAEVKLLLRVHHRNLT-TLVGYCDEGTNMALIYE 656 (892)
Q Consensus 587 ~~IG~G~fG~Vy~a~~~~---------~~vaVK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~LV~E 656 (892)
+.|+.|-.-.+|+..... ..+.+++.... . ......+|..+++.+.-.++. ++++++.. ..|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-C-HHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf 99178533434899968877544578981799965996-1-165899999999999757999808998189----56999
Q ss_pred ECCCCCHH
Q ss_conf 54588602
Q 002688 657 YMANGNLE 664 (892)
Q Consensus 657 y~~~gsL~ 664 (892)
|+++..+.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EECCCCCC
T ss_conf 73455488
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.13 E-value=0.00089 Score=37.77 Aligned_cols=16 Identities=25% Similarity=0.272 Sum_probs=5.7
Q ss_pred CCCCCCEEECCCCCCC
Q ss_conf 9999979984899678
Q 002688 453 QLSSLKFLNLARNKLT 468 (892)
Q Consensus 453 ~l~~L~~L~L~~N~l~ 468 (892)
..++|+.|+|++|.++
T Consensus 241 ~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 241 SWPNLRELGLNDCLLS 256 (344)
T ss_dssp GCTTCCEEECTTCCCC
T ss_pred CCCCCHHHHHHCCCCC
T ss_conf 3221111030047567
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.06 E-value=0.0025 Score=34.94 Aligned_cols=62 Identities=18% Similarity=0.318 Sum_probs=26.7
Q ss_pred CCEEEEECCCC-CCCCC----CHHHHHHCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf 97899990899-86432----503432013887214888844777----8857889999979984899678
Q 002688 407 PRITSLNLSAS-ELTGG----FAHYLTNLTMLTSLDLSNNNLTGP----VPKFLSQLSSLKFLNLARNKLT 468 (892)
Q Consensus 407 ~~l~~l~L~~n-~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~ 468 (892)
+.++.|+|+++ .++.. +-..+...+.|+.|+|++|.+... +...+...+.|+.|+|++|.++
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCC
T ss_conf 99819782799998989999999997637764540120156215679887531000234330033010214
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=94.20 E-value=0.0084 Score=31.72 Aligned_cols=63 Identities=16% Similarity=0.227 Sum_probs=49.7
Q ss_pred CCCEEEEECCCCCCCC----CCHHHHHHCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf 9978999908998643----2503432013887214888844777----8857889999979984899678
Q 002688 406 SPRITSLNLSASELTG----GFAHYLTNLTMLTSLDLSNNNLTGP----VPKFLSQLSSLKFLNLARNKLT 468 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~ 468 (892)
...|+.|+|++|.+.. .+...+...+.|+.|+|++|.++.. +-..+..-++|+.|+|++|.+.
T Consensus 43 n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 43 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred CCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCCC
T ss_conf 77645401201562156798875310002343300330102145999999999984893898778877688
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.59 E-value=0.0087 Score=31.64 Aligned_cols=86 Identities=19% Similarity=0.245 Sum_probs=48.8
Q ss_pred CCCEEEEECCC-CCCCCC----CHHHHHHCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCC----
Q ss_conf 99789999089-986432----503432013887214888844777----88578899999799848996789970----
Q 002688 406 SPRITSLNLSA-SELTGG----FAHYLTNLTMLTSLDLSNNNLTGP----VPKFLSQLSSLKFLNLARNKLTGPLP---- 472 (892)
Q Consensus 406 ~~~l~~l~L~~-n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~g~iP---- 472 (892)
.+.++.|+|++ +.++.. +-..+...+.|+.|+|++|.++.. +-..+...++|+.|++++|.++..--
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHHHH
T ss_conf 99986887689999898999999988841982574301589611778999998775212210121025432201478899
Q ss_pred HHHHHHCCCCCEEEECCCC
Q ss_conf 2222001477413310599
Q 002688 473 VELLEKQENNTLELRFDGN 491 (892)
Q Consensus 473 ~~l~~~~~l~~l~l~~~~n 491 (892)
..+.....+..+.+...+|
T Consensus 96 ~~l~~~~~L~~l~L~l~~n 114 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQ 114 (166)
T ss_dssp HGGGGCSSCCEEECCCCSS
T ss_pred HHHHHCCCCCEEEECCCCC
T ss_conf 9998486524773216778
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=89.11 E-value=0.042 Score=27.40 Aligned_cols=83 Identities=17% Similarity=0.216 Sum_probs=49.9
Q ss_pred CCCEEEEECCCCCCCCC----CHHHHHHCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCEEECC--CCCCCCC----C
Q ss_conf 99789999089986432----503432013887214888844777----88578899999799848--9967899----7
Q 002688 406 SPRITSLNLSASELTGG----FAHYLTNLTMLTSLDLSNNNLTGP----VPKFLSQLSSLKFLNLA--RNKLTGP----L 471 (892)
Q Consensus 406 ~~~l~~l~L~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~--~N~l~g~----i 471 (892)
-+.++.|+|++|+++.. +...+...+.|+.|++++|.++.. +-..+...++|+.++|+ +|.+... +
T Consensus 45 n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~L 124 (166)
T d1io0a_ 45 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 124 (166)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHH
T ss_conf 98257430158961177899999877521221012102543220147889999984865247732167786767999999
Q ss_pred CHHHHHHCCCCCEEEEC
Q ss_conf 02222001477413310
Q 002688 472 PVELLEKQENNTLELRF 488 (892)
Q Consensus 472 P~~l~~~~~l~~l~l~~ 488 (892)
-..+...+.+..+++.+
T Consensus 125 a~~L~~n~~L~~L~l~~ 141 (166)
T d1io0a_ 125 ANMLEKNTTLLKFGYHF 141 (166)
T ss_dssp HHHHHHCSSCCEEECCC
T ss_pred HHHHHHCCCCCEEECCC
T ss_conf 99998499847885818
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=84.55 E-value=0.76 Score=19.58 Aligned_cols=81 Identities=15% Similarity=0.139 Sum_probs=40.9
Q ss_pred CCCEEEEEECCCCEEEEEEEEEECCCCCCCCCCCEEEEECCCEEEEEEECCCCCCEEEEEEEEECCCCEEEEEEECCCC-
Q ss_conf 8642464203795047968754227789999980467847823346652378643079999994159346999755899-
Q 002688 88 IRNCYRFNLTRNTKYLIRATFMYGNYDEQNNLPEFDVHLGPNLWGTIKIENVSVDYSVEIIHVLSSDYLSVCIVNTNKG- 166 (892)
Q Consensus 88 ~~nCY~l~~~~~~~ylvR~~f~ygnyd~~~~~p~Fd~~~~~~~w~~v~~~~~~~~~~~e~i~~~~~~~~~vcl~~~~~~- 166 (892)
...-|.++ .++|.|.|+..|- + .-..++.+.|-.=-... .... ......+.+.+..+.+-|.....|
T Consensus 63 ~~~~f~v~-vPnG~Y~Vtv~~G--d------~~~~~~~~eg~~~~~~~-~g~~--~~~~~~V~VtDG~L~l~ft~~~~G~ 130 (146)
T d2o14a1 63 SNNTFNVD-LPNGLYEVKVTLG--N------TARASVAAEGVFQVINM-TGDG--AEDTFQIPVTDGQLNLLVTEGKAGT 130 (146)
T ss_dssp CSCCEEEE-CCSEEEEEEEEES--S------CSEEEEEETTEEEEEEE-ESTT--CEEEEEEEECSSEEEEEEEESSTTS
T ss_pred CCCEEEEE-CCCCEEEEEEEEE--C------CCCCCEEEEEEEECCCC-CCCC--EEEEEEEEEECCEEEEEEECCCCCC
T ss_conf 88669998-8997189999993--6------77762778517800266-8731--7789999987994879984377898
Q ss_pred CCCEEEEEEEECCC
Q ss_conf 85011124432698
Q 002688 167 TPFISALELRPLDN 180 (892)
Q Consensus 167 ~pfis~lE~~~l~~ 180 (892)
.|=||+||+.+..+
T Consensus 131 ~~~in~l~I~~~~d 144 (146)
T d2o14a1 131 AFTLSALKIKKLSD 144 (146)
T ss_dssp CCEEEEEEEEEEES
T ss_pred CCEEEEEEEEECCC
T ss_conf 63887999982266
|